data_2l7r_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l7r _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -102.61 118.39 36.75 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.682 0.793 . . . . 0.0 110.252 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 pp -133.55 165.26 25.31 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.302 0.641 . . . . 0.0 110.35 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -101.05 142.39 32.58 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.057 0.943 . . . . 0.0 109.528 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.1 t -125.46 109.62 22.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 C-N-CA 123.903 0.881 . . . . 0.0 108.674 171.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 35.5 ttt85 -79.48 95.35 5.78 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.084 1.353 . . . . 0.0 110.862 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.17 -174.82 3.33 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.582 1.153 . . . . 0.0 108.032 165.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -42.15 -36.18 1.12 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 123.567 0.747 . . . . 0.0 111.62 167.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -111.05 136.25 50.34 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 164.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -70.88 123.28 21.62 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 173.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -126.1 154.42 43.13 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.498 0.719 . . . . 0.0 109.769 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.3 m -113.91 143.15 45.18 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.812 0.845 . . . . 0.0 108.809 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -136.61 129.36 30.66 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.793 0.837 . . . . 0.0 110.043 -174.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -90.74 114.71 27.13 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 166.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.3 m -115.37 155.48 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.192 0.997 . . . . 0.0 110.463 -169.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.0 m -83.03 -9.9 59.03 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -171.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.5 -50.68 4.07 Favored Glycine 0 C--N 1.358 1.776 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -174.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -79.65 7.06 9.11 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.855 0.862 . . . . 0.0 110.802 167.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -59.57 121.05 10.6 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.765 1.226 . . . . 0.0 109.176 168.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.674 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 51.1 p -78.88 167.41 21.19 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 118.765 0.711 . . . . 0.0 110.385 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.52 HG22 ' HB3' ' A' ' 48' ' ' LEU . 80.3 t -67.52 -32.52 57.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 123.157 0.583 . . . . 0.0 110.069 174.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.65 -36.43 84.25 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.601 0.761 . . . . 0.0 110.635 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -69.3 -40.86 77.43 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.307 0.643 . . . . 0.0 110.963 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.526 HD12 HD13 ' A' ' 54' ' ' LEU . 40.9 mm -57.95 -45.82 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.591 0.757 . . . . 0.0 110.151 175.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.557 ' HE2' ' HA ' ' A' ' 40' ' ' VAL . 92.6 mttt -59.6 -49.59 77.19 Favored 'General case' 0 C--O 1.21 -1.017 0 O-C-N 124.52 1.137 . . . . 0.0 110.603 176.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.01 -42.96 91.36 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.007 0.923 . . . . 0.0 112.025 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -59.41 -53.15 61.45 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.871 0.868 . . . . 0.0 111.019 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.438 HG11 HG22 ' A' ' 67' ' ' VAL . 11.6 p -75.39 -27.57 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.46 -175.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.77 -37.15 79.13 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.726 0.81 . . . . 0.0 110.985 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.4 t -67.13 -40.88 86.87 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 123.39 0.431 . . . . 0.0 110.44 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.1 mt -61.9 -49.71 75.11 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 123.445 0.466 . . . . 0.0 111.916 176.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 28' ' ' VAL . 3.2 mm-40 -86.58 -3.43 59.02 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.115 0.566 . . . . 0.0 111.693 -175.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.56 16.87 70.21 Favored Glycine 0 C--N 1.357 1.711 0 O-C-N 123.315 0.384 . . . . 0.0 113.285 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 36.1 pt -98.65 175.84 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.936 0.894 . . . . 0.0 110.937 -175.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.39 133.29 38.75 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.814 0.846 . . . . 0.0 110.355 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -66.76 -16.77 51.2 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.699 2.266 . . . . 0.0 111.964 171.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -76.71 -19.34 57.8 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.642 0.777 . . . . 0.0 111.579 174.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -97.89 19.7 13.38 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.588 0.755 . . . . 0.0 111.131 -172.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -152.87 166.43 32.34 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.651 -0.656 . . . . 0.0 112.024 -172.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.557 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . 11.2 p -142.29 149.22 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.653 1.181 . . . . 0.0 108.993 172.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.432 ' HB ' HG11 ' A' ' 21' ' ' VAL . 63.1 t -102.65 132.55 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.22 0.608 . . . . 0.0 109.638 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.438 HD11 ' HA ' ' A' ' 47' ' ' PRO . 2.7 mm? -117.75 113.54 21.99 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.648 1.579 . . . . 0.0 108.657 -174.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.541 HD11 ' HB ' ' A' ' 59' ' ' VAL . 2.9 tt -80.15 98.26 7.24 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 57.85 26.48 13.29 Favored 'General case' 0 CA--C 1.556 1.175 0 O-C-N 124.007 0.817 . . . . 0.0 111.842 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.27 -18.79 32.85 Favored Glycine 0 C--N 1.357 1.719 0 CA-C-N 115.927 -0.578 . . . . 0.0 114.207 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.84 117.31 67.81 Favored Pre-proline 0 N--CA 1.483 1.184 0 C-N-CA 123.516 0.726 . . . . 0.0 111.422 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.438 ' HA ' HD11 ' A' ' 42' ' ' LEU . 36.3 Cg_endo -62.11 108.95 0.73 Allowed 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.09 2.527 . . . . 0.0 113.204 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.52 ' HB3' HG22 ' A' ' 21' ' ' VAL . 73.7 mt -82.78 139.97 33.27 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.133 177.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -80.56 131.9 35.58 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.024 0.93 . . . . 0.0 110.334 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.24 -49.87 22.4 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.038 1.335 . . . . 0.0 113.628 -174.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -18.79 49.89 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.955 0.502 . . . . 0.0 112.173 -173.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.73 140.36 45.92 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.107 0.563 . . . . 0.0 110.791 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.674 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 47.6 p -85.43 170.87 12.28 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.734 0.414 . . . . 0.0 110.673 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.526 HD13 HD12 ' A' ' 24' ' ' ILE . 36.8 mt -68.74 -29.93 68.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.117 0.567 . . . . 0.0 111.117 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.02 -42.39 92.52 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.05 172.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -68.89 -31.34 70.19 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.842 0.857 . . . . 0.0 111.271 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 79.0 m -71.96 -28.87 63.73 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.304 0.642 . . . . 0.0 110.635 172.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.76 22.07 54.23 Favored Glycine 0 C--N 1.348 1.21 0 O-C-N 123.495 0.497 . . . . 0.0 112.91 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.541 ' HB ' HD11 ' A' ' 43' ' ' LEU . 7.5 p -96.94 135.7 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.44 0.696 . . . . 0.0 110.235 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -106.77 -168.57 1.43 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.247 1.019 . . . . 0.0 109.925 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.35 175.79 6.6 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.107 0.563 . . . . 0.0 111.26 176.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 58.59 26.02 13.91 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.869 1.268 . . . . 0.0 112.439 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.6 m -111.63 153.94 25.61 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.854 0.862 . . . . 0.0 109.832 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 54.5 m -114.44 108.82 17.39 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.08 0.552 . . . . 0.0 109.889 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.57 149.96 21.03 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 171.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -125.19 139.25 53.91 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 119.087 0.858 . . . . 0.0 110.758 -176.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.438 HG22 HG11 ' A' ' 28' ' ' VAL . 77.1 t -97.14 122.23 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.526 0.731 . . . . 0.0 110.071 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -118.3 149.91 40.36 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.426 0.69 . . . . 0.0 110.543 173.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.39 90.57 1.68 Allowed Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -123.3 10.29 9.25 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.708 0.803 . . . . 0.0 110.422 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 37.7 tpp . . . . . 0 N--CA 1.479 1.01 0 C-N-CA 122.868 0.467 . . . . 0.0 110.698 -169.138 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.498 ' HE3' HD21 ' A' ' 3' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 30.1 tt0 -145.26 123.06 11.9 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.498 HD21 ' HE3' ' A' ' 1' ' ' MET . 4.6 pp -119.9 166.79 12.85 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.312 0.577 . . . . 0.0 110.715 -174.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -102.57 137.62 40.57 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.9 t -107.15 114.39 46.01 Favored 'Isoleucine or valine' 0 C--O 1.248 0.995 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 172.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.5 ttt85 -83.09 90.51 7.06 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.231 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.59 -176.8 3.19 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 114.373 -1.285 . . . . 0.0 107.988 174.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -43.66 -29.22 0.48 Allowed 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 124.352 1.061 . . . . 0.0 112.316 170.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -135.68 140.89 44.82 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.908 1.283 . . . . 0.0 107.921 166.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.9 126.28 30.09 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.24 0.616 . . . . 0.0 110.076 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -119.96 160.38 22.87 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.058 0.943 . . . . 0.0 108.93 172.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.0 m -124.58 131.65 53.47 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -132.16 126.51 33.8 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.598 0.759 . . . . 0.0 109.939 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 11.3 pt-20 -89.15 135.54 33.51 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.097 0.475 . . . . 0.0 109.764 173.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.467 ' O ' ' HB3' ' A' ' 1' ' ' MET . 30.1 m -134.74 150.21 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.8 0.84 . . . . 0.0 109.598 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.1 p -93.58 12.51 25.03 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.164 0.585 . . . . 0.0 111.26 172.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.409 ' O ' ' HB ' ' A' ' 53' ' ' THR . . . 93.62 -35.4 4.16 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-O 119.647 -0.529 . . . . 0.0 112.798 176.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -68.0 -21.13 65.06 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.974 0.91 . . . . 0.0 112.301 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -62.0 134.64 56.9 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 26.4 p -82.6 168.6 17.16 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.36 0.6 . . . . 0.0 110.637 174.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.528 HG21 ' HB3' ' A' ' 48' ' ' LEU . 55.9 t -63.16 -32.78 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.425 170.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' A' ' 50' ' ' ASP . . . -60.74 -42.42 97.31 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.36 0.664 . . . . 0.0 111.064 173.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -67.83 -37.47 81.95 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.348 0.259 . . . . 0.0 111.232 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.402 HD13 HD22 ' A' ' 54' ' ' LEU . 44.0 mm -57.32 -48.1 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 122.837 0.455 . . . . 0.0 110.032 173.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 21' ' ' VAL . 96.6 mttt -61.26 -40.81 95.44 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.783 0.833 . . . . 0.0 111.223 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.87 -43.56 94.64 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.884 0.874 . . . . 0.0 112.069 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -65.54 -42.59 91.77 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.034 0.533 . . . . 0.0 111.044 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.8 t -64.71 -39.88 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.086 0.555 . . . . 0.0 109.76 176.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.98 -35.19 79.36 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.258 1.023 . . . . 0.0 112.316 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.5 m -64.81 -50.13 67.92 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.345 0.658 . . . . 0.0 110.843 175.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.5 mt -71.59 -38.44 70.89 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -174.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -91.35 -14.61 30.43 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.055 0.542 . . . . 0.0 111.662 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.92 27.26 69.17 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 116.405 -0.362 . . . . 0.0 112.565 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.2 pt -108.09 177.97 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.793 0.837 . . . . 0.0 109.795 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.27 138.92 20.62 Favored Pre-proline 0 N--CA 1.478 0.957 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.61 -20.48 70.95 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 123.296 2.664 . . . . 0.0 113.053 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -67.95 -35.36 78.27 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.573 0.749 . . . . 0.0 111.006 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 71' ' ' MET . 10.6 m-20 -73.26 -18.06 61.26 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.073 0.549 . . . . 0.0 112.261 -172.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.53 ' HB2' HG11 ' A' ' 67' ' ' VAL . 12.3 pt20 -112.95 151.22 30.8 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.399 0.679 . . . . 0.0 111.074 -174.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -132.12 132.94 61.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 124.744 1.218 . . . . 0.0 107.986 171.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.6 t -88.78 131.2 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.0 mt -122.93 115.19 21.52 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.952 1.301 . . . . 0.0 108.983 -174.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.509 ' HB2' HD11 ' A' ' 48' ' ' LEU . 42.2 tp -81.94 95.14 7.28 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 176.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 56.97 24.52 9.55 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.058 0.943 . . . . 0.0 112.027 -174.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.6 -8.19 37.1 Favored Glycine 0 C--N 1.354 1.528 0 CA-C-O 119.597 -0.557 . . . . 0.0 113.86 -177.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.72 118.84 74.55 Favored Pre-proline 0 N--CA 1.483 1.211 0 CA-C-N 117.444 0.622 . . . . 0.0 110.849 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.29 102.04 0.31 Allowed 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.746 2.298 . . . . 0.0 112.519 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.528 ' HB3' HG21 ' A' ' 21' ' ' VAL . 67.1 mt -81.0 134.4 35.67 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.463 177.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -82.52 139.0 34.14 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.834 0.854 . . . . 0.0 110.333 -176.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.487 ' HB3' ' HB3' ' A' ' 22' ' ' ALA . 2.0 m-20 -59.96 -30.13 68.88 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.792 0.837 . . . . 0.0 111.835 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -73.35 -25.55 60.65 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.215 1.006 . . . . 0.0 111.206 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.98 131.74 35.87 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.921 -174.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 81.1 p -80.59 167.71 19.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.27 0.628 . . . . 0.0 109.541 172.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.402 HD22 HD13 ' A' ' 24' ' ' ILE . 2.7 mm? -65.51 -30.66 71.45 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.241 0.473 . . . . 0.0 110.42 176.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.27 -36.0 70.33 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.511 173.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -72.11 -38.05 69.4 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.465 0.706 . . . . 0.0 110.638 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 76.6 m -71.32 -18.63 62.39 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.905 0.882 . . . . 0.0 111.088 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.92 29.52 75.21 Favored Glycine 0 C--N 1.352 1.431 0 O-C-N 123.497 0.498 . . . . 0.0 112.663 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.453 HG23 HD12 ' A' ' 65' ' ' LEU . 4.5 p -87.08 133.29 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -81.77 174.24 11.52 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.505 0.722 . . . . 0.0 110.979 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.403 ' HB3' ' HA ' ' A' ' 1' ' ' MET . . . -72.71 160.37 32.33 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.784 175.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 64.84 12.16 7.52 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.743 1.617 . . . . 0.0 112.96 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.4 m -85.11 154.37 22.08 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.3 m -114.32 116.08 28.4 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.146 0.498 . . . . 0.0 110.181 -177.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.453 HD12 HG23 ' A' ' 59' ' ' VAL . 6.9 mp -103.57 122.14 44.36 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.085 1.354 . . . . 0.0 108.142 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -94.71 145.32 24.93 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.025 0.53 . . . . 0.0 111.841 -171.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.53 HG11 ' HB2' ' A' ' 39' ' ' GLN . 73.6 t -94.12 135.97 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 124.211 1.004 . . . . 0.0 109.989 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.63 141.26 51.67 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.113 0.965 . . . . 0.0 109.503 171.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.14 92.06 1.52 Allowed Glycine 0 N--CA 1.472 1.065 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -121.97 -68.5 0.89 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 117.321 0.561 . . . . 0.0 111.959 -172.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.449 ' O ' ' HA ' ' A' ' 38' ' ' ASP . 51.2 tpp . . . . . 0 N--CA 1.482 1.153 0 C-N-CA 123.456 0.703 . . . . 0.0 111.141 -174.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 60.8 tt0 -122.14 114.33 20.73 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.922 0.889 . . . . 0.0 109.389 -175.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.3 pp -120.79 165.13 15.57 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.938 0.495 . . . . 0.0 111.635 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -98.51 152.24 19.76 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.636 0.774 . . . . 0.0 109.254 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.7 t -135.13 109.31 10.99 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 C-N-CA 124.767 1.227 . . . . 0.0 108.179 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -76.33 92.83 3.37 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.866 0.866 . . . . 0.0 110.776 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.31 -176.87 4.26 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.297 1.039 . . . . 0.0 108.398 165.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -47.55 -30.15 3.35 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.17 0.588 . . . . 0.0 112.156 171.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -124.0 144.07 50.04 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.175 0.99 . . . . 0.0 108.661 161.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.86 133.95 47.94 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 122.947 0.499 . . . . 0.0 110.391 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -131.02 148.49 52.76 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.837 0.855 . . . . 0.0 109.406 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.2 m -119.5 133.74 55.54 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -128.45 119.3 24.66 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.977 0.911 . . . . 0.0 109.997 -175.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 42.0 tt0 -95.35 104.43 16.32 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 171.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.0 m -112.8 174.44 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.126 0.97 . . . . 0.0 110.864 -172.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.7 m -83.09 -45.53 13.88 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.678 0.791 . . . . 0.0 110.106 174.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.23 -35.06 3.2 Favored Glycine 0 C--N 1.35 1.321 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -174.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -65.55 -10.13 32.42 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.476 0.71 . . . . 0.0 111.53 173.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -52.64 129.08 28.3 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.854 1.261 . . . . 0.0 110.408 169.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.658 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 45.5 p -84.77 164.73 18.33 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 118.272 0.487 . . . . 0.0 109.94 173.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.447 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 68.4 t -67.22 -30.27 48.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.235 174.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 50' ' ' ASP . . . -62.12 -40.42 95.85 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.572 0.749 . . . . 0.0 110.802 174.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -68.5 -40.17 81.0 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.746 177.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.9 mm -57.97 -42.84 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 123.229 0.612 . . . . 0.0 110.529 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.429 ' HE2' ' HA ' ' A' ' 40' ' ' VAL . 94.9 mttt -59.43 -51.87 68.04 Favored 'General case' 0 C--N 1.359 0.998 0 O-C-N 123.975 0.797 . . . . 0.0 110.015 174.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.61 -42.97 75.63 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.861 0.726 . . . . 0.0 111.924 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.411 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 48.5 m-70 -61.54 -54.62 40.79 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.686 0.794 . . . . 0.0 111.655 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.485 HG13 HG22 ' A' ' 67' ' ' VAL . 12.8 p -72.42 -30.01 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.637 -174.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.404 ' HB1' ' NE2' ' A' ' 39' ' ' GLN . . . -72.45 -34.69 67.95 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.388 0.675 . . . . 0.0 111.526 177.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 t -67.16 -37.65 84.12 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.957 0.503 . . . . 0.0 110.309 176.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 27' ' ' HIS . 88.5 mt -63.4 -45.81 89.29 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 123.705 0.628 . . . . 0.0 111.711 177.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.15 -20.0 45.93 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.082 0.553 . . . . 0.0 111.785 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.27 30.81 66.73 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 112.014 -0.434 . . . . 0.0 112.014 -173.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.3 pt -111.57 179.83 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.189 0.996 . . . . 0.0 110.634 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.74 123.43 88.34 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 124.237 1.015 . . . . 0.0 112.576 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.23 -31.59 35.41 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 122.548 2.165 . . . . 0.0 112.567 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.98 5.95 34.69 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.34 0.656 . . . . 0.0 112.062 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -78.83 -31.45 45.77 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 122.35 1.071 . . . . 0.0 109.205 166.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.404 ' NE2' ' HB1' ' A' ' 29' ' ' ALA . 18.8 mt-30 -89.85 147.39 23.8 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 113.725 -1.579 . . . . 0.0 112.337 -167.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.429 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . 7.7 p -131.05 129.18 63.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 165.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.446 ' HB ' HG13 ' A' ' 21' ' ' VAL . 59.3 t -87.89 131.69 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.6 mt -118.59 148.78 42.33 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.927 1.291 . . . . 0.0 109.519 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.432 ' HB2' HD12 ' A' ' 48' ' ' LEU . 42.3 tp -131.44 102.15 5.82 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 171.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 58.66 33.83 23.37 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.457 1.103 . . . . 0.0 111.398 -175.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.84 -24.01 33.96 Favored Glycine 0 C--N 1.354 1.554 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.297 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.35 119.4 76.84 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 123.325 0.65 . . . . 0.0 110.506 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.28 106.44 1.02 Allowed 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.881 2.387 . . . . 0.0 111.964 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.432 HD12 ' HB2' ' A' ' 43' ' ' LEU . 90.8 mt -69.56 124.12 23.1 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.356 0.663 . . . . 0.0 110.014 173.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -72.46 131.7 42.9 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.366 0.666 . . . . 0.0 110.63 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.476 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 7.8 p-10 -58.79 -36.79 75.01 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.008 0.923 . . . . 0.0 112.832 -173.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -74.75 -25.72 59.29 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.1 0.56 . . . . 0.0 111.05 -176.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.72 139.51 40.49 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.504 0.722 . . . . 0.0 110.609 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.658 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 53.2 p -83.67 170.36 14.34 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.925 0.393 . . . . 0.0 110.751 177.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.7 mp -72.8 -26.48 61.53 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.9 0.88 . . . . 0.0 110.292 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.3 -43.19 71.79 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.037 172.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -64.42 -39.16 93.3 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.237 0.615 . . . . 0.0 110.77 175.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 46.1 t -63.73 -31.35 72.49 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.624 0.77 . . . . 0.0 111.406 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.38 23.96 69.43 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.272 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.429 HG22 HG22 ' A' ' 63' ' ' THR . 14.7 p -79.44 150.24 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.072 0.549 . . . . 0.0 109.551 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -127.42 -171.68 2.48 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.362 0.665 . . . . 0.0 111.262 -169.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.76 154.8 41.31 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.468 0.707 . . . . 0.0 111.404 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 62.9 1.48 0.84 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 126.183 1.793 . . . . 0.0 114.06 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.429 HG22 HG22 ' A' ' 59' ' ' VAL . 32.3 m -72.37 147.76 45.94 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 47.1 m -113.34 103.71 11.58 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 122.072 -0.393 . . . . 0.0 109.951 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.402 HD21 HD13 ' A' ' 43' ' ' LEU . 62.2 mt -78.18 169.92 17.46 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 170.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -136.08 155.16 50.62 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.485 HG22 HG13 ' A' ' 28' ' ' VAL . 48.7 t -120.38 126.55 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.263 1.025 . . . . 0.0 108.956 175.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.01 142.65 51.5 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.671 0.789 . . . . 0.0 109.805 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.24 89.79 1.64 Allowed Glycine 0 C--N 1.342 0.909 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -130.03 5.06 4.91 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.89 0.876 . . . . 0.0 110.72 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.1 ttm . . . . . 0 N--CA 1.474 0.77 0 C-N-CA 123.438 0.695 . . . . 0.0 109.403 -170.881 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.444 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 44.1 ttm . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -91.01 105.03 17.54 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 170.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.5 pp -114.85 163.89 14.89 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.645 0.778 . . . . 0.0 109.985 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -107.41 158.8 16.88 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.513 0.725 . . . . 0.0 109.391 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.9 t -129.66 111.88 23.09 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 C-N-CA 124.037 0.935 . . . . 0.0 109.884 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -70.89 91.33 0.85 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.111 0.964 . . . . 0.0 109.42 173.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.03 -179.37 3.9 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 125.478 1.511 . . . . 0.0 107.808 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -59.21 -33.16 70.65 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 118.581 0.628 . . . . 0.0 109.715 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -111.18 127.5 55.61 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 165.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.99 120.07 14.28 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 -111.33 158.3 19.19 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.571 0.749 . . . . 0.0 109.622 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.7 m -134.0 135.73 43.61 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.297 1.039 . . . . 0.0 108.735 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -133.06 124.79 28.28 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.88 0.872 . . . . 0.0 110.46 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -98.1 105.74 17.93 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 170.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.476 HG11 HD13 ' A' ' 24' ' ' ILE . 28.8 m -120.53 157.77 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.952 1.301 . . . . 0.0 109.412 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.603 ' HB ' ' HG2' ' A' ' 18' ' ' GLN . 20.4 m -75.94 -14.24 60.25 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-O 121.058 0.456 . . . . 0.0 110.907 173.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.439 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 103.26 -31.79 8.32 Favored Glycine 0 C--N 1.351 1.411 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -172.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.603 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 12.6 pt20 -70.74 -4.43 23.74 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.924 0.89 . . . . 0.0 112.304 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -79.23 145.5 33.55 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.754 0.422 . . . . 0.0 109.936 175.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.6 p -82.38 153.46 25.72 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.181 0.515 . . . . 0.0 111.134 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.0 t -62.35 -28.17 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 124.277 1.031 . . . . 0.0 110.522 175.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.62 -50.09 75.23 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 124.331 1.052 . . . . 0.0 110.793 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -67.43 -36.15 80.66 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.312 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.476 HD13 HG11 ' A' ' 15' ' ' VAL . 48.0 mm -57.59 -54.86 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 O-C-N 123.829 0.705 . . . . 0.0 110.301 177.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -73.0 -27.9 62.05 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.105 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.15 -46.48 90.35 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.52 0.728 . . . . 0.0 110.571 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -66.08 -40.18 90.63 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.266 0.627 . . . . 0.0 110.348 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.482 HG13 HG21 ' A' ' 67' ' ' VAL . 72.6 t -56.92 -49.72 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 173.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.33 -34.86 77.47 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.048 0.939 . . . . 0.0 112.609 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.5 t -65.58 -36.74 84.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.488 0.715 . . . . 0.0 110.746 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.1 mt -80.45 -34.84 35.69 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.933 0.893 . . . . 0.0 112.24 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.49 ' HB2' HG12 ' A' ' 34' ' ' ILE . 6.1 mm-40 -75.65 -36.14 60.24 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.891 0.876 . . . . 0.0 110.172 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.93 36.5 15.28 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.479 -171.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.49 HG12 ' HB2' ' A' ' 32' ' ' GLU . 25.0 pt -127.2 -179.56 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 123.897 0.879 . . . . 0.0 111.03 -176.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.18 114.19 37.75 Favored Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 123.937 0.895 . . . . 0.0 112.218 -176.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.85 -33.1 85.38 Favored 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 123.521 2.814 . . . . 0.0 114.009 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -69.39 -37.56 77.58 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.247 0.342 . . . . 0.0 110.691 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -64.84 -44.55 89.44 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 123.812 0.695 . . . . 0.0 111.116 -170.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.553 ' HB2' HG12 ' A' ' 67' ' ' VAL . 11.7 pt20 -75.75 150.96 37.69 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.976 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.2 144.15 37.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 124.975 1.31 . . . . 0.0 108.139 175.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.7 t -90.46 133.35 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 122.915 0.486 . . . . 0.0 109.86 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 66.5 mt -117.28 108.87 16.15 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.896 1.278 . . . . 0.0 108.961 -176.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.2 tp -80.44 96.63 6.79 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 175.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 57.85 28.34 15.9 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.059 0.944 . . . . 0.0 112.036 -176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.46 -25.38 19.84 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-O 119.608 -0.551 . . . . 0.0 113.556 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.3 113.54 32.18 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 123.132 0.573 . . . . 0.0 110.563 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -64.61 115.15 3.05 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.501 2.134 . . . . 0.0 111.526 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 93.2 mt -79.86 158.16 26.81 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.537 0.735 . . . . 0.0 111.358 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -86.29 128.71 34.96 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -62.57 -36.59 83.16 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 121.057 0.456 . . . . 0.0 110.911 -176.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -78.8 -9.41 59.44 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.736 0.815 . . . . 0.0 111.843 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.87 148.16 24.77 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 123.356 0.662 . . . . 0.0 109.974 175.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.4 p -92.34 166.34 12.63 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.467 0.707 . . . . 0.0 110.62 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.439 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 3.5 mm? -65.19 -28.47 69.41 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.638 0.775 . . . . 0.0 110.107 175.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.1 -37.02 44.24 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.231 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -67.76 -41.85 82.7 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.019 0.527 . . . . 0.0 110.05 174.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 80.7 m -63.5 -25.84 68.44 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.144 0.578 . . . . 0.0 110.773 174.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.99 25.88 70.32 Favored Glycine 0 C--N 1.35 1.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.667 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.414 HG12 HD12 ' A' ' 54' ' ' LEU . 7.7 p -81.52 160.81 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 122.891 0.477 . . . . 0.0 109.795 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -110.87 -177.08 3.13 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.395 0.678 . . . . 0.0 110.67 -178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.444 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -76.86 166.25 23.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.294 0.638 . . . . 0.0 111.022 177.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 67.92 6.29 5.05 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.965 1.306 . . . . 0.0 112.909 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.1 m -79.94 150.89 30.36 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.164 0.585 . . . . 0.0 109.746 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.2 m -117.17 112.06 20.32 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.4 mp -96.42 146.9 24.36 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 124.65 1.18 . . . . 0.0 108.112 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -102.01 156.21 17.68 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.065 0.546 . . . . 0.0 110.88 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.553 HG12 ' HB2' ' A' ' 39' ' ' GLN . 6.6 t -118.62 131.29 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.368 1.067 . . . . 0.0 109.311 173.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.32 126.74 20.08 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.121 0.968 . . . . 0.0 109.992 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 39' ' ' GLN . . . -75.97 96.01 1.06 Allowed Glycine 0 C--N 1.344 0.982 0 N-CA-C 111.961 -0.455 . . . . 0.0 111.961 -178.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -120.6 -68.38 0.91 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.778 0.831 . . . . 0.0 111.438 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 21.3 mmt . . . . . 0 N--CA 1.487 1.41 0 C-N-CA 122.712 0.405 . . . . 0.0 111.862 -168.516 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.466 ' HE2' HD22 ' A' ' 3' ' ' LEU . 20.8 ttt . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -85.32 127.54 34.37 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.466 HD22 ' HE2' ' A' ' 1' ' ' MET . 4.4 pp -136.2 167.24 21.65 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -109.64 147.95 32.18 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.112 0.565 . . . . 0.0 109.8 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.6 t -122.26 109.09 23.28 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 C-N-CA 125.128 1.371 . . . . 0.0 108.059 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -79.76 91.69 5.34 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.462 -1.244 . . . . 0.0 109.58 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.8 -177.84 3.49 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 114.262 -1.335 . . . . 0.0 108.345 177.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -52.29 -27.49 15.36 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.29 0.567 . . . . 0.0 110.847 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.415 ' HB2' ' HE2' ' A' ' 11' ' ' HIS . 14.2 mm-40 -117.36 141.07 48.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.006 1.322 . . . . 0.0 108.468 163.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -83.29 109.45 17.27 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.436 ' CD2' HG22 ' A' ' 28' ' ' VAL . 88.9 m-70 -110.61 132.46 54.17 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.694 0.798 . . . . 0.0 109.704 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.4 t -106.07 136.09 46.37 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -125.63 128.03 47.24 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.695 0.798 . . . . 0.0 109.923 -176.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -90.11 104.82 17.35 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 170.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.8 m -111.85 172.35 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.362 1.065 . . . . 0.0 109.428 176.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.1 m -107.49 -9.96 15.83 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.376 0.671 . . . . 0.0 109.801 174.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.525 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 108.41 -35.78 4.76 Favored Glycine 0 C--N 1.353 1.473 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.754 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -4.89 39.47 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -176.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -78.11 147.33 34.69 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.854 0.462 . . . . 0.0 109.815 170.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.633 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 61.7 p -86.42 164.59 16.92 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.349 0.595 . . . . 0.0 111.745 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.409 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 71.3 t -66.32 -27.69 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.04 172.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.69 -41.86 95.74 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.83 0.852 . . . . 0.0 110.664 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -69.62 -38.97 77.45 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.608 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 27.9 mm -54.49 -45.59 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 123.661 0.784 . . . . 0.0 110.387 173.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 21' ' ' VAL . 92.4 mttt -61.35 -49.2 77.9 Favored 'General case' 0 C--N 1.36 1.061 0 O-C-N 124.049 0.843 . . . . 0.0 111.068 176.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.85 -38.54 78.97 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 124.328 1.017 . . . . 0.0 111.365 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -61.27 -58.14 9.49 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.726 0.811 . . . . 0.0 110.961 177.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.436 HG22 ' CD2' ' A' ' 11' ' ' HIS . 6.3 p -66.8 -30.94 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.449 -174.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.26 -43.39 77.92 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.935 0.894 . . . . 0.0 111.444 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.1 t -61.79 -41.5 97.82 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.384 0.673 . . . . 0.0 110.597 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.7 mt -65.0 -49.99 68.07 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.932 0.893 . . . . 0.0 111.863 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -90.44 -2.71 57.95 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.341 0.656 . . . . 0.0 112.185 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.1 17.82 77.47 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-O 120.159 -0.245 . . . . 0.0 113.511 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.1 pt -102.08 -179.1 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.939 0.895 . . . . 0.0 110.248 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.45 ' HB1' ' HG2' ' A' ' 37' ' ' GLU . . . -102.69 133.82 20.23 Favored Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 123.052 0.541 . . . . 0.0 111.756 -175.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.448 ' HA ' ' HG2' ' A' ' 39' ' ' GLN . 68.3 Cg_endo -70.61 -17.84 33.43 Favored 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 122.678 2.252 . . . . 0.0 111.583 175.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.45 ' HG2' ' HB1' ' A' ' 35' ' ' ALA . 10.0 pt-20 -89.4 -2.16 58.31 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.924 1.29 . . . . 0.0 112.012 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -107.62 -20.8 13.12 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.532 0.733 . . . . 0.0 110.164 175.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.489 ' HB2' HG13 ' A' ' 67' ' ' VAL . 11.3 pt20 -106.79 157.85 17.43 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.703 0.763 . . . . 0.0 110.671 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.6 m -132.37 158.98 43.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 C-N-CA 125.166 1.386 . . . . 0.0 108.356 169.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.473 HG11 HD11 ' A' ' 48' ' ' LEU . 66.2 t -111.68 124.6 68.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 176.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.5 mt -108.44 154.14 22.3 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 124.902 1.281 . . . . 0.0 109.346 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.2 tp -130.91 106.67 8.58 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 169.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 59.92 24.42 13.5 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.005 0.922 . . . . 0.0 111.317 -174.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.53 -28.47 14.86 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.155 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.99 120.59 80.36 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.101 0.56 . . . . 0.0 110.767 -174.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.04 106.22 0.64 Allowed 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 123.082 2.521 . . . . 0.0 112.407 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.473 HD11 HG11 ' A' ' 41' ' ' VAL . 80.2 mt -68.13 121.24 15.73 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.967 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -60.19 126.63 28.26 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.968 0.793 . . . . 0.0 110.004 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -58.85 -43.28 90.72 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.447 0.699 . . . . 0.0 111.846 -174.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -77.14 -17.62 58.49 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.639 0.375 . . . . 0.0 111.441 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.77 133.63 40.65 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.633 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 55.2 p -78.2 168.26 20.12 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.696 0.798 . . . . 0.0 110.537 177.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.525 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 2.5 mm? -61.49 -35.54 77.96 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 120.958 0.409 . . . . 0.0 110.165 177.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.37 -33.77 61.22 Favored Glycine 0 C--N 1.355 1.625 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.536 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -72.57 -37.69 68.12 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.215 0.606 . . . . 0.0 110.681 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 78.6 m -68.23 -28.6 67.37 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.35 0.66 . . . . 0.0 110.321 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.35 24.98 69.38 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.755 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.584 HG21 HD21 ' A' ' 65' ' ' LEU . 6.2 p -77.87 138.64 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -91.14 178.95 5.85 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.125 0.57 . . . . 0.0 110.95 -175.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.65 160.32 31.75 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.28 0.632 . . . . 0.0 111.205 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 61.4 10.65 3.25 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.454 1.501 . . . . 0.0 113.423 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.1 m -82.53 147.05 28.87 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.097 0.475 . . . . 0.0 110.156 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.4 m -104.59 106.49 17.01 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.841 0.856 . . . . 0.0 109.838 -175.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.584 HD21 HG21 ' A' ' 59' ' ' VAL . 43.9 mt -92.14 128.05 37.85 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.415 1.086 . . . . 0.0 108.444 176.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -99.0 140.97 32.35 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.758 0.708 . . . . 0.0 111.965 -172.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.489 HG13 ' HB2' ' A' ' 39' ' ' GLN . 69.4 t -95.78 125.47 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.067 0.947 . . . . 0.0 109.42 173.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.01 149.35 48.78 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.093 0.957 . . . . 0.0 109.294 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.19 89.28 1.39 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -106.62 -40.3 5.58 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.387 0.675 . . . . 0.0 109.88 176.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 48.4 tpp . . . . . 0 CA--C 1.547 0.841 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 172.73 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.413 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 22.1 ttt . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 121.312 0.577 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 53.3 tt0 -91.36 140.15 30.05 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.505 HD11 HD11 ' A' ' 65' ' ' LEU . 4.5 pp -146.91 159.85 43.04 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.274 0.63 . . . . 0.0 109.443 176.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -103.45 116.12 31.8 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.696 0.798 . . . . 0.0 109.505 -174.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.1 t -88.72 106.59 16.89 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 170.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.48 ' HB3' ' HA ' ' A' ' 66' ' ' GLU . 19.9 ttt180 -76.86 91.4 3.54 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.527 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -109.55 -176.43 3.01 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 125.347 1.459 . . . . 0.0 108.608 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -46.23 -39.57 10.06 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.538 0.735 . . . . 0.0 112.277 174.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -106.2 156.06 18.84 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 163.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.67 108.63 7.55 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -107.34 141.83 38.09 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.437 0.695 . . . . 0.0 109.505 175.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.7 t -126.8 135.13 50.63 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -128.36 131.55 48.57 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.337 1.055 . . . . 0.0 108.792 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 43.7 tt0 -91.36 113.77 26.12 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 167.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.525 HG23 ' HG ' ' A' ' 54' ' ' LEU . 27.6 m -110.3 144.82 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.953 0.901 . . . . 0.0 110.121 -174.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.6 p -85.95 3.34 42.47 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.073 0.549 . . . . 0.0 111.499 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 89.9 -38.31 3.23 Favored Glycine 0 C--N 1.353 1.495 0 CA-C-O 119.682 -0.51 . . . . 0.0 113.325 175.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -70.25 -19.81 63.1 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.988 0.915 . . . . 0.0 112.459 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -64.9 135.78 56.09 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.331 0.652 . . . . 0.0 109.483 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.673 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 70.1 p -83.59 165.55 18.94 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.326 0.584 . . . . 0.0 111.269 -177.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.6 t -66.42 -29.13 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 123.189 0.596 . . . . 0.0 110.351 174.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.476 ' HB1' ' HB3' ' A' ' 50' ' ' ASP . . . -63.25 -39.9 95.9 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.284 0.634 . . . . 0.0 111.254 173.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -71.66 -35.08 70.23 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.906 0.482 . . . . 0.0 110.955 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 31.4 mm -58.32 -47.12 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.272 0.629 . . . . 0.0 110.384 171.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' A' ' 40' ' ' VAL . 98.6 mttt -61.52 -42.09 98.29 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.212 0.605 . . . . 0.0 111.342 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.81 80.68 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 124.138 0.899 . . . . 0.0 111.586 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.0 m-70 -60.16 -51.08 71.14 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.875 0.47 . . . . 0.0 111.041 175.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.438 HG11 HD13 ' A' ' 34' ' ' ILE . 49.0 t -67.26 -28.49 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.722 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.64 -34.97 62.87 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.875 0.87 . . . . 0.0 111.441 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.7 t -73.43 -40.1 64.49 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.118 0.567 . . . . 0.0 111.053 178.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.5 mt -77.18 -53.08 8.2 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.219 0.607 . . . . 0.0 111.633 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.31 -17.37 46.04 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.558 0.743 . . . . 0.0 111.738 -177.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.33 17.45 78.89 Favored Glycine 0 N--CA 1.471 0.984 0 N-CA-C 112.605 -0.198 . . . . 0.0 112.605 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.438 HD13 HG11 ' A' ' 28' ' ' VAL . 37.0 pt -91.41 166.23 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.596 0.758 . . . . 0.0 111.099 -175.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.99 118.1 67.87 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 123.257 0.623 . . . . 0.0 110.704 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.92 -19.85 51.9 Favored 'Trans proline' 0 C--N 1.387 2.57 0 C-N-CA 122.584 2.189 . . . . 0.0 111.84 176.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -74.41 -29.58 61.57 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.263 1.025 . . . . 0.0 111.836 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -85.93 -41.31 15.04 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.302 0.641 . . . . 0.0 110.697 -175.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.478 ' HB2' HG12 ' A' ' 67' ' ' VAL . 12.9 pt20 -76.58 157.08 32.28 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.998 -172.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.568 HG11 ' HB2' ' A' ' 70' ' ' ARG . 9.8 p -142.39 148.0 20.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 C-N-CA 125.186 1.394 . . . . 0.0 108.297 177.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.1 t -101.56 117.77 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.8 0.84 . . . . 0.0 109.308 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.419 HD21 ' HB3' ' A' ' 68' ' ' ALA . 2.3 mm? -103.89 104.61 14.62 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.47 1.108 . . . . 0.0 109.69 -175.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.3 tp -81.75 97.19 7.83 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 58.31 26.05 13.5 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.952 0.901 . . . . 0.0 112.016 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.5 -19.82 33.29 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.511 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.83 114.99 48.66 Favored Pre-proline 0 N--CA 1.477 0.903 0 C-N-CA 123.456 0.702 . . . . 0.0 111.001 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -67.96 110.88 2.27 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 122.673 2.249 . . . . 0.0 111.018 174.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.5 mt -72.4 170.46 14.2 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.844 177.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -96.05 138.6 33.45 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.476 ' HB3' ' HB1' ' A' ' 22' ' ' ALA . 1.8 m-20 -55.92 -38.67 70.58 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.261 0.624 . . . . 0.0 111.402 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.45 -24.28 46.13 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.748 0.819 . . . . 0.0 111.48 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.97 132.89 42.86 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.061 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.673 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 21.1 p -81.35 173.5 12.4 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.525 ' HG ' HG23 ' A' ' 15' ' ' VAL . 3.3 mm? -64.26 -23.45 67.31 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 118.285 0.493 . . . . 0.0 110.258 174.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.42 -39.26 26.61 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.942 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.449 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 14.5 mm-40 -73.75 -29.75 62.41 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.411 0.684 . . . . 0.0 110.422 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 74.2 m -81.32 -18.17 46.68 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.791 0.837 . . . . 0.0 110.724 172.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.38 33.18 81.29 Favored Glycine 0 C--N 1.353 1.476 0 O-C-N 123.416 0.448 . . . . 0.0 113.461 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.1 t -70.49 135.59 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.336 0.654 . . . . 0.0 110.056 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -93.49 172.15 8.45 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.371 0.668 . . . . 0.0 110.534 176.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.23 165.05 25.44 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.065 0.546 . . . . 0.0 111.277 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 58.31 16.6 4.14 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 125.228 1.411 . . . . 0.0 112.798 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.8 m -90.98 147.84 22.82 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.656 0.782 . . . . 0.0 109.845 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 42.5 m -113.52 105.22 13.09 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.718 0.807 . . . . 0.0 109.26 -175.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.505 HD11 HD11 ' A' ' 3' ' ' LEU . 4.5 mp -103.03 123.44 46.63 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.48 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . 38.0 tt0 -93.56 150.7 20.22 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.9 0.48 . . . . 0.0 111.436 -171.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.478 HG12 ' HB2' ' A' ' 39' ' ' GLN . 73.3 t -104.11 118.59 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.911 0.884 . . . . 0.0 108.932 175.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.419 ' HB3' HD21 ' A' ' 42' ' ' LEU . . . -126.58 165.74 18.59 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.907 0.883 . . . . 0.0 109.669 175.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -98.22 90.12 1.02 Allowed Glycine 0 N--CA 1.471 0.977 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 175.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.568 ' HB2' HG11 ' A' ' 40' ' ' VAL . 73.7 mtp180 -134.74 17.29 3.57 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.407 0.683 . . . . 0.0 110.8 -176.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 44.5 tpp . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.214 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.456 ' HG3' ' HB3' ' A' ' 61' ' ' ALA . 62.1 ttp . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -77.01 118.56 19.7 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.212 1.005 . . . . 0.0 109.62 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.1 pp -137.74 161.23 37.09 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.113 0.565 . . . . 0.0 109.775 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -96.53 152.42 18.64 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.656 0.782 . . . . 0.0 109.836 -175.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.0 t -137.85 101.82 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 124.676 1.191 . . . . 0.0 107.962 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -76.33 94.88 3.67 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.057 0.943 . . . . 0.0 111.843 -175.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.78 -176.51 3.11 Favored 'General case' 0 C--O 1.245 0.867 0 C-N-CA 124.811 1.245 . . . . 0.0 108.099 165.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -45.29 -31.41 1.57 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.514 0.726 . . . . 0.0 112.153 171.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -114.72 137.29 52.1 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 162.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.32 113.47 8.4 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -91.82 155.76 17.99 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.647 0.779 . . . . 0.0 109.482 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.3 m -141.5 115.6 9.31 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 173.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -116.25 134.54 54.8 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.386 0.675 . . . . 0.0 110.601 -173.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -89.17 103.56 16.17 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 166.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.451 HG21 ' HG ' ' A' ' 54' ' ' LEU . 18.7 m -112.15 141.61 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.208 1.003 . . . . 0.0 109.225 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.2 t -91.41 5.55 48.93 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 120.657 0.265 . . . . 0.0 110.806 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.503 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 101.19 -25.97 26.32 Favored Glycine 0 C--N 1.357 1.718 0 CA-C-O 119.727 -0.485 . . . . 0.0 113.513 171.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -80.56 -14.32 58.32 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.881 0.473 . . . . 0.0 111.985 -174.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.404 ' O ' HD22 ' A' ' 54' ' ' LEU . 25.4 mp0 -65.31 130.62 43.98 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 69.0 p -75.13 168.81 19.26 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.189 0.518 . . . . 0.0 110.04 174.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.447 HG13 ' HE3' ' A' ' 25' ' ' LYS . 33.6 t -65.59 -29.21 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.464 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . . . -62.47 -41.82 99.04 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.69 0.796 . . . . 0.0 110.553 171.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -67.52 -36.84 81.83 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.869 0.468 . . . . 0.0 111.079 177.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.494 HD12 HD23 ' A' ' 54' ' ' LEU . 39.6 mm -60.13 -48.11 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.284 0.634 . . . . 0.0 110.177 175.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.447 ' HE3' HG13 ' A' ' 21' ' ' VAL . 92.5 mttt -60.05 -43.07 95.64 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.446 0.698 . . . . 0.0 110.745 176.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.26 -45.55 90.9 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.858 1.263 . . . . 0.0 111.7 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -61.74 -47.37 85.51 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.612 0.765 . . . . 0.0 110.448 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.8 t -63.1 -40.48 89.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 123.763 0.664 . . . . 0.0 110.296 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.31 -33.35 71.42 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.739 1.216 . . . . 0.0 112.258 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.7 t -70.78 -38.05 73.38 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.474 0.71 . . . . 0.0 110.512 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.1 mt -72.71 -51.69 18.24 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.15 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -86.58 -19.27 29.65 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -172.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.68 29.84 58.89 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 112.303 -0.319 . . . . 0.0 112.303 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.7 pt -101.62 176.96 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.474 0.709 . . . . 0.0 110.618 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -96.26 120.41 62.61 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 123.425 0.69 . . . . 0.0 110.422 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.01 -7.06 20.21 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.557 2.171 . . . . 0.0 111.813 172.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -60.7 -38.99 86.86 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 125.373 1.469 . . . . 0.0 110.492 171.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -88.21 -25.52 22.85 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.686 -178.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -75.27 133.0 41.44 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.706 -174.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.15 138.98 52.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 C-N-CA 124.353 1.061 . . . . 0.0 108.241 165.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.2 t -97.88 133.5 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.2 mt -117.76 128.62 55.05 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.604 1.161 . . . . 0.0 109.445 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.501 ' HB2' HD12 ' A' ' 48' ' ' LEU . 54.6 tp -105.99 104.85 14.65 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 169.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 60.33 26.51 16.03 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.845 0.858 . . . . 0.0 111.675 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.22 -15.59 58.91 Favored Glycine 0 C--N 1.352 1.448 0 CA-C-O 119.745 -0.475 . . . . 0.0 113.664 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.8 120.22 77.18 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 117.44 0.62 . . . . 0.0 109.668 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.8 112.2 1.93 Allowed 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.564 2.176 . . . . 0.0 112.06 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.501 HD12 ' HB2' ' A' ' 43' ' ' LEU . 80.4 mt -81.81 131.27 35.25 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.847 0.859 . . . . 0.0 110.158 175.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -72.01 142.96 49.33 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.718 0.636 . . . . 0.0 110.865 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.464 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . 11.1 p-10 -61.45 -26.17 67.71 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.293 1.037 . . . . 0.0 111.976 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -76.02 -25.91 56.14 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.829 0.851 . . . . 0.0 111.583 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.18 133.3 37.8 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.849 0.86 . . . . 0.0 110.965 -175.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 70.3 p -80.64 173.4 12.65 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.951 0.5 . . . . 0.0 110.395 174.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.503 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 2.9 mm? -61.81 -35.14 77.34 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 173.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.16 -43.6 96.9 Favored Glycine 0 C--N 1.355 1.616 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.975 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -69.63 -38.06 77.03 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.231 0.612 . . . . 0.0 111.397 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 83.9 m -73.63 -16.11 61.24 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.426 0.69 . . . . 0.0 111.155 175.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.29 26.48 71.68 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 123.582 0.551 . . . . 0.0 113.493 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.9 p -90.15 117.02 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.443 0.697 . . . . 0.0 109.68 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -87.22 -172.79 4.11 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.19 0.996 . . . . 0.0 111.932 -172.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.456 ' HB3' ' HG3' ' A' ' 1' ' ' MET . . . -71.82 154.0 41.56 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.653 0.781 . . . . 0.0 111.043 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 67.85 4.03 3.78 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.595 1.558 . . . . 0.0 112.679 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.9 m -85.15 151.67 23.94 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 34.4 m -113.9 111.48 21.77 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.247 0.546 . . . . 0.0 110.33 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.1 mt -78.68 160.85 27.29 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 165.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -132.61 142.28 49.06 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 122.115 -0.366 . . . . 0.0 110.886 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.8 t -95.95 132.62 39.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.892 0.877 . . . . 0.0 109.113 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.87 167.15 22.86 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.84 0.856 . . . . 0.0 109.83 177.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -109.97 90.36 0.59 Allowed Glycine 0 C--N 1.341 0.812 0 N-CA-C 112.29 -0.324 . . . . 0.0 112.29 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -103.56 -48.59 3.92 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.534 0.734 . . . . 0.0 109.056 171.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 42.4 tpp . . . . . 0 CA--C 1.549 0.929 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.656 -178.973 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.435 ' HE2' ' HA ' ' A' ' 60' ' ' GLU . 27.3 ttt . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -101.46 124.26 46.85 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.2 pp -137.49 166.57 23.56 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.486 0.715 . . . . 0.0 110.627 -178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -98.58 161.5 13.63 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.288 0.635 . . . . 0.0 110.615 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.489 HG23 ' HB2' ' A' ' 65' ' ' LEU . 44.7 t -133.32 117.08 26.95 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 C-N-CA 124.55 1.14 . . . . 0.0 108.512 173.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -71.13 94.11 1.11 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.741 1.216 . . . . 0.0 109.207 174.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -118.77 -179.45 3.81 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.544 1.138 . . . . 0.0 108.998 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -44.86 -35.32 2.73 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 123.54 0.736 . . . . 0.0 111.234 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -128.98 137.38 51.33 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 166.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.5 mt -66.69 128.83 37.77 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.077 0.551 . . . . 0.0 110.861 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -124.26 160.91 26.91 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.381 0.673 . . . . 0.0 109.926 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.4 m -130.26 125.33 34.54 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.01 0.924 . . . . 0.0 108.966 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -120.73 132.55 55.13 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.268 1.027 . . . . 0.0 110.588 -173.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -92.36 106.31 18.34 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 169.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.3 167.84 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.497 1.119 . . . . 0.0 110.741 -172.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.3 p -100.44 -4.29 29.21 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.98 -52.36 4.72 Favored Glycine 0 C--N 1.358 1.804 0 N-CA-C 112.147 -0.381 . . . . 0.0 112.147 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -66.1 -10.84 44.35 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.0 0.92 . . . . 0.0 110.986 169.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -57.45 127.05 30.06 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.226 1.01 . . . . 0.0 110.754 170.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 82.8 p -85.64 160.23 19.64 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.678 0.391 . . . . 0.0 110.737 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.549 HG11 ' HB ' ' A' ' 41' ' ' VAL . 50.8 t -63.93 -31.68 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 123.963 0.905 . . . . 0.0 111.668 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.421 ' HB1' ' HB2' ' A' ' 50' ' ' ASP . . . -66.53 -42.28 87.48 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.512 0.725 . . . . 0.0 110.674 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -74.88 -29.61 61.06 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.14 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.515 HD12 HD13 ' A' ' 54' ' ' LEU . 30.4 mm -57.58 -50.33 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 168.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -57.01 -45.88 82.74 Favored 'General case' 0 C--N 1.36 1.036 0 O-C-N 123.86 0.725 . . . . 0.0 111.054 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.09 -48.05 76.87 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 124.604 1.19 . . . . 0.0 111.987 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -71.47 -41.33 69.5 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.242 0.217 . . . . 0.0 111.056 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.9 t -59.97 -41.53 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.13 -42.36 93.94 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.225 1.01 . . . . 0.0 111.702 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.5 t -62.13 -40.09 94.76 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 123.862 0.727 . . . . 0.0 111.496 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 33.0 mt -80.16 -39.94 28.31 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 120.928 0.394 . . . . 0.0 111.502 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.92 -6.07 59.13 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.792 0.837 . . . . 0.0 111.95 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.56 20.32 77.07 Favored Glycine 0 CA--C 1.532 1.104 0 O-C-N 123.506 0.504 . . . . 0.0 113.651 176.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.0 pt -107.63 -179.27 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.048 0.939 . . . . 0.0 110.454 -176.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.83 134.49 30.33 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 123.274 0.63 . . . . 0.0 110.265 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -68.12 -24.67 38.3 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.622 2.214 . . . . 0.0 112.311 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -67.68 -29.84 69.22 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.929 0.891 . . . . 0.0 111.464 175.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -81.05 -18.7 45.79 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.995 0.918 . . . . 0.0 111.902 -170.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.428 ' HB2' HG11 ' A' ' 67' ' ' VAL . 12.3 pt20 -107.57 158.18 17.44 Favored 'General case' 0 C--O 1.245 0.818 0 C-N-CA 123.069 0.548 . . . . 0.0 110.86 -176.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.434 HG13 ' HB2' ' A' ' 70' ' ' ARG . 12.6 p -128.94 134.56 64.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.649 172.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.549 ' HB ' HG11 ' A' ' 21' ' ' VAL . 95.2 t -98.7 121.91 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 66' ' ' GLU . 27.4 mt -113.62 157.72 21.76 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.687 1.595 . . . . 0.0 108.426 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 tt -105.06 96.85 6.82 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 106.266 -1.754 . . . . 0.0 106.266 163.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 51.45 40.62 27.13 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.513 1.125 . . . . 0.0 112.41 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.69 -30.78 8.4 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-O 119.405 -0.664 . . . . 0.0 114.106 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.98 116.85 54.64 Favored Pre-proline 0 N--CA 1.484 1.27 0 CA-C-N 117.704 0.752 . . . . 0.0 111.466 -176.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -60.78 108.7 0.57 Allowed 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.008 2.472 . . . . 0.0 113.246 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.09 137.19 33.69 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.949 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -77.41 136.33 38.39 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.808 0.692 . . . . 0.0 109.904 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.421 ' HB2' ' HB1' ' A' ' 22' ' ' ALA . 7.8 p-10 -58.78 -41.66 87.16 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.713 0.805 . . . . 0.0 112.284 -174.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -79.57 -15.58 57.43 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.204 0.601 . . . . 0.0 111.468 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.83 136.62 38.93 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 123.224 0.61 . . . . 0.0 110.276 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 43.7 p -80.09 165.88 22.06 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.205 0.602 . . . . 0.0 110.144 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.515 HD13 HD12 ' A' ' 24' ' ' ILE . 86.5 mt -64.73 -38.1 89.84 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.988 0.515 . . . . 0.0 111.243 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.97 -41.82 99.69 Favored Glycine 0 C--N 1.349 1.285 0 O-C-N 123.854 0.721 . . . . 0.0 112.623 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -74.82 -29.93 61.23 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.818 0.447 . . . . 0.0 111.386 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 89.1 m -75.41 -7.47 54.15 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.55 0.74 . . . . 0.0 111.728 173.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.17 15.88 81.16 Favored Glycine 0 C--N 1.351 1.404 0 C-N-CA 123.05 0.357 . . . . 0.0 113.866 173.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 p -99.34 132.72 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.136 0.574 . . . . 0.0 109.605 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.435 ' HA ' ' HE2' ' A' ' 1' ' ' MET . 44.9 mt-10 -121.54 -168.14 1.64 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.359 1.063 . . . . 0.0 110.495 -175.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.34 150.74 48.59 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.172 0.589 . . . . 0.0 111.057 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 70.22 2.5 4.01 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.678 1.591 . . . . 0.0 113.0 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.6 m -88.05 163.6 16.18 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 174.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.2 m -123.8 116.84 23.64 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.562 0.745 . . . . 0.0 109.664 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.489 ' HB2' HG23 ' A' ' 5' ' ' VAL . 3.2 mm? -75.05 -178.95 4.05 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.422 0.689 . . . . 0.0 109.595 170.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 35.7 tt0 -144.24 108.86 4.88 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.563 0.345 . . . . 0.0 110.703 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.428 HG11 ' HB2' ' A' ' 39' ' ' GLN . 55.5 t -85.94 117.84 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 172.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.42 168.94 10.79 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 123.943 0.897 . . . . 0.0 109.971 175.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.57 87.5 1.1 Allowed Glycine 0 C--N 1.344 1.02 0 N-CA-C 111.881 -0.488 . . . . 0.0 111.881 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.434 ' HB2' HG13 ' A' ' 40' ' ' VAL . 39.0 mtp180 -143.63 141.55 30.65 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.745 1.218 . . . . 0.0 107.75 170.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 C--O 1.242 0.701 0 C-N-CA 123.14 0.576 . . . . 0.0 110.204 -178.045 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.432 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 62.9 mtp . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -88.34 116.16 26.36 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.417 HD13 HD12 ' A' ' 65' ' ' LEU . 3.4 pp -132.21 150.4 52.16 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.432 0.693 . . . . 0.0 109.981 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -89.05 152.17 21.83 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.292 1.037 . . . . 0.0 109.8 -177.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -135.93 109.75 9.85 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 C-N-CA 124.343 1.057 . . . . 0.0 108.484 -177.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.425 ' HA ' HD11 ' A' ' 10' ' ' LEU . 3.7 tmm_? -73.66 94.96 2.26 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.45 1.1 . . . . 0.0 110.022 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -112.85 -177.41 3.13 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.283 1.033 . . . . 0.0 108.811 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -45.69 -25.45 0.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.15 0.98 . . . . 0.0 113.044 171.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -127.24 150.0 49.74 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.176 0.99 . . . . 0.0 108.913 158.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.425 HD11 ' HA ' ' A' ' 6' ' ' ARG . 4.5 mm? -76.2 109.57 9.99 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 122.987 0.515 . . . . 0.0 110.144 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -94.03 162.24 13.97 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.119 0.968 . . . . 0.0 110.168 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.7 t -141.03 142.23 34.24 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 164.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -133.97 131.57 39.14 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.653 0.781 . . . . 0.0 110.178 -175.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -92.47 104.13 16.48 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.753 174.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.8 m -111.18 161.26 9.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 C-N-CA 123.858 0.863 . . . . 0.0 110.259 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.4 m -87.12 -29.68 21.65 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.853 0.861 . . . . 0.0 110.366 176.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.529 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 116.45 -29.36 7.01 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.19 -173.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -85.77 -4.13 59.08 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.506 0.723 . . . . 0.0 112.532 -173.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -76.06 145.68 39.94 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.445 ' HB ' ' O ' ' A' ' 50' ' ' ASP . 59.0 p -82.82 160.89 22.13 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.354 0.597 . . . . 0.0 110.516 175.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.609 HG11 ' HB ' ' A' ' 41' ' ' VAL . 52.8 t -60.42 -30.53 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 123.715 0.806 . . . . 0.0 110.428 175.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 50' ' ' ASP . . . -58.57 -47.07 85.48 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 124.08 0.952 . . . . 0.0 111.051 171.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -64.58 -39.83 94.45 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.611 0.364 . . . . 0.0 110.624 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.526 HD11 HD22 ' A' ' 54' ' ' LEU . 41.8 mm -60.09 -49.27 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 122.979 0.512 . . . . 0.0 111.364 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.487 ' HB3' HG22 ' A' ' 41' ' ' VAL . 62.9 pttt -74.51 -29.58 61.46 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 119.686 -0.197 . . . . 0.0 110.702 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.404 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . . . -64.18 -34.21 77.56 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.306 0.642 . . . . 0.0 110.92 175.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.445 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 32.6 m170 -68.38 -46.25 70.56 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.117 0.567 . . . . 0.0 110.378 174.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.5 t -56.08 -39.96 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.449 0.642 . . . . 0.0 110.14 174.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.85 -45.65 77.52 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.903 1.281 . . . . 0.0 112.369 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.2 p -69.43 -27.63 65.42 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.01 0.524 . . . . 0.0 111.539 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 27' ' ' HIS . 86.1 mt -76.82 -48.47 18.4 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.817 0.447 . . . . 0.0 111.202 178.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -91.9 -5.47 53.17 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -174.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.04 5.98 85.52 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 113.859 0.304 . . . . 0.0 113.859 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.9 pt -81.74 169.06 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.325 0.65 . . . . 0.0 110.303 178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.32 136.5 43.09 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.605 0.762 . . . . 0.0 109.986 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.404 ' HB3' ' HA ' ' A' ' 26' ' ' ALA . 56.3 Cg_endo -68.71 -22.68 37.01 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.394 2.063 . . . . 0.0 111.741 174.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -80.02 -8.98 59.64 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.974 0.91 . . . . 0.0 111.626 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -75.52 -29.04 59.34 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.197 0.599 . . . . 0.0 111.987 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.427 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -144.76 179.9 7.01 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.14 0.495 . . . . 0.0 111.372 -170.552 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.2 p -145.4 149.92 16.22 Favored 'Isoleucine or valine' 0 C--O 1.25 1.101 0 C-N-CA 124.867 1.267 . . . . 0.0 108.138 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.609 ' HB ' HG11 ' A' ' 21' ' ' VAL . 46.5 t -86.65 138.04 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.361 0.601 . . . . 0.0 109.763 176.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -116.21 140.41 49.33 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -179.524 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.3 tp -86.48 95.91 9.87 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 169.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 55.17 28.92 11.75 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.858 0.863 . . . . 0.0 112.661 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.72 -14.01 35.1 Favored Glycine 0 CA--C 1.536 1.398 0 CA-C-O 119.5 -0.611 . . . . 0.0 114.001 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.57 110.83 24.33 Favored Pre-proline 0 N--CA 1.484 1.261 0 CA-C-N 117.845 0.823 . . . . 0.0 110.622 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.405 ' HA ' HD12 ' A' ' 42' ' ' LEU . 50.2 Cg_exo -56.45 107.07 0.24 Allowed 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 123.645 2.897 . . . . 0.0 114.077 -176.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.517 ' HB3' HG22 ' A' ' 21' ' ' VAL . 96.4 mt -80.45 139.74 36.3 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.485 0.714 . . . . 0.0 110.735 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -71.57 130.21 40.66 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.771 0.669 . . . . 0.0 109.667 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 22' ' ' ALA . 71.3 m-20 -62.25 -27.57 69.09 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.079 0.552 . . . . 0.0 112.216 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -80.06 -21.18 43.71 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.663 0.785 . . . . 0.0 111.617 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.26 138.54 39.46 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.516 0.726 . . . . 0.0 110.517 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 58.2 p -88.0 168.28 12.98 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.037 0.535 . . . . 0.0 110.587 177.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.529 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 2.5 mm? -62.28 -33.68 75.1 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 174.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.03 -30.78 56.87 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.891 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -76.18 -36.41 58.69 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 52.9 t -67.63 -35.65 79.32 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.2 0.6 . . . . 0.0 110.303 173.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.52 18.52 61.94 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.256 -177.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.56 135.88 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.037 0.535 . . . . 0.0 110.043 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -97.3 -169.26 1.82 Allowed 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.625 0.77 . . . . 0.0 111.896 -176.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.432 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -79.5 169.96 17.27 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.52 0.728 . . . . 0.0 111.091 173.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 58.34 18.67 5.69 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.301 1.44 . . . . 0.0 112.669 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.5 m -90.09 161.37 15.83 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 56.5 m -121.96 104.58 9.63 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 173.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.417 HD12 HD13 ' A' ' 3' ' ' LEU . 6.8 mp -84.31 -176.07 6.08 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.498 172.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 44.9 tt0 -139.38 157.43 45.89 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.974 0.509 . . . . 0.0 110.575 -172.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.7 t -119.13 131.65 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.401 1.081 . . . . 0.0 108.688 171.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.455 ' HB3' HD22 ' A' ' 42' ' ' LEU . . . -152.01 144.71 24.29 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.398 0.679 . . . . 0.0 109.664 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 39' ' ' GLN . . . -82.07 84.42 1.5 Allowed Glycine 0 C--N 1.345 1.077 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -110.93 7.59 21.77 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.922 0.889 . . . . 0.0 109.146 170.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 48.0 tpp . . . . . 0 CA--C 1.541 0.613 0 C-N-CA 125.036 1.334 . . . . 0.0 107.788 176.313 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.505 ' SD ' ' HA ' ' A' ' 60' ' ' GLU . 63.6 ttp . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 35.1 tt0 -78.44 131.52 36.93 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 pp -141.84 166.19 25.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.938 0.895 . . . . 0.0 110.0 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -102.14 137.23 40.68 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.841 0.856 . . . . 0.0 109.76 -177.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.5 t -117.18 114.91 47.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 172.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.485 ' HB3' ' HA ' ' A' ' 66' ' ' GLU . 40.4 ttt85 -80.55 92.47 5.92 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.443 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.68 -177.29 3.74 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.471 1.108 . . . . 0.0 108.059 168.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -47.18 -32.79 4.68 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 122.945 0.498 . . . . 0.0 111.316 170.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -112.6 137.23 51.16 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 125.057 1.343 . . . . 0.0 108.016 164.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -71.0 118.99 14.48 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -116.93 162.01 18.44 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.946 0.898 . . . . 0.0 109.784 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.3 t -130.02 146.77 51.71 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 172.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -137.61 129.28 28.43 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.423 1.089 . . . . 0.0 108.643 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 34.2 tt0 -87.97 106.28 18.02 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 169.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.7 m -112.43 178.96 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.025 1.33 . . . . 0.0 108.976 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 58.6 p -107.07 -37.4 6.31 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.583 0.753 . . . . 0.0 110.797 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.5 -23.21 4.06 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-N 116.422 -0.354 . . . . 0.0 112.53 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -82.51 -12.63 57.65 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.0 0.52 . . . . 0.0 112.274 -175.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.442 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 22.7 mp0 -65.79 133.08 50.24 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.943 0.897 . . . . 0.0 108.671 177.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.618 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 82.2 p -80.07 166.24 21.72 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 121.59 0.709 . . . . 0.0 110.095 176.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.487 HG12 ' HE3' ' A' ' 25' ' ' LYS . 56.0 t -61.38 -31.11 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.187 173.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.63 -41.67 95.33 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.1 0.96 . . . . 0.0 111.208 173.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -66.24 -38.76 88.67 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.123 0.569 . . . . 0.0 111.098 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.521 HD11 HD13 ' A' ' 54' ' ' LEU . 50.5 mm -63.18 -45.27 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 O-C-N 123.716 0.635 . . . . 0.0 110.331 176.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.559 ' HE2' ' HA ' ' A' ' 40' ' ' VAL . 93.6 mttt -57.5 -45.81 84.49 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 123.645 0.59 . . . . 0.0 110.352 176.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.44 -45.57 91.2 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.334 1.054 . . . . 0.0 112.166 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -68.93 -43.3 75.38 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.86 0.464 . . . . 0.0 111.894 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.8 t -67.76 -32.03 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 122.813 0.445 . . . . 0.0 110.39 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.47 -37.99 80.67 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.191 0.996 . . . . 0.0 111.566 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.6 t -64.46 -44.37 91.31 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.571 0.748 . . . . 0.0 110.535 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.8 mt -72.87 -58.07 3.6 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.06 0.544 . . . . 0.0 111.558 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.31 -14.29 60.11 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.452 1.101 . . . . 0.0 112.405 -176.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.51 16.58 75.81 Favored Glycine 0 N--CA 1.473 1.135 0 CA-C-N 117.484 0.129 . . . . 0.0 113.078 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.7 pt -93.35 171.82 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.36 1.064 . . . . 0.0 110.397 -176.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.03 118.19 71.13 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 122.862 0.465 . . . . 0.0 110.849 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.412 ' HA ' HE21 ' A' ' 39' ' ' GLN . 47.5 Cg_endo -64.39 -24.96 63.92 Favored 'Trans proline' 0 C--N 1.388 2.621 0 C-N-CA 123.009 2.472 . . . . 0.0 111.484 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -68.42 -35.7 78.01 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.547 1.139 . . . . 0.0 111.148 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -85.39 -16.91 38.27 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.331 0.653 . . . . 0.0 111.213 -175.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.412 HE21 ' HA ' ' A' ' 36' ' ' PRO . 51.4 mt-30 -77.71 152.45 33.68 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.573 0.701 . . . . 0.0 112.16 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.559 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . 13.9 p -141.04 148.55 21.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 113.934 -1.485 . . . . 0.0 107.575 162.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.437 ' HB ' HG11 ' A' ' 21' ' ' VAL . 97.8 t -103.96 128.05 57.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 68.7 mt -115.62 116.66 28.51 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.645 1.178 . . . . 0.0 108.779 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.512 ' HB2' HD11 ' A' ' 48' ' ' LEU . 41.2 tp -90.47 98.13 11.59 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 57.04 32.24 21.32 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.029 0.932 . . . . 0.0 111.691 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.4 -32.4 7.2 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.246 -178.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.4 116.65 39.07 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 123.271 0.628 . . . . 0.0 111.499 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -63.44 105.53 0.51 Allowed 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 123.223 2.615 . . . . 0.0 112.262 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.512 HD11 ' HB2' ' A' ' 43' ' ' LEU . 43.0 mt -78.11 129.81 35.64 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.881 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -64.88 134.74 54.67 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.238 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.435 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 8.0 p-10 -61.54 -27.2 68.45 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.356 0.663 . . . . 0.0 111.727 -178.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -80.72 -25.98 37.74 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.62 0.768 . . . . 0.0 111.76 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.09 133.35 46.19 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 123.213 0.605 . . . . 0.0 110.542 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.618 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 31.1 p -79.1 170.64 16.35 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 176.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.599 ' HA ' ' SG ' ' A' ' 57' ' ' CYS . 86.2 mt -69.15 -25.72 64.51 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.548 0.739 . . . . 0.0 110.896 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.84 -36.41 42.15 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.327 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.401 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 87.2 mm-40 -79.22 -34.8 42.51 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.92 0.488 . . . . 0.0 111.703 -177.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.599 ' SG ' ' HA ' ' A' ' 54' ' ' LEU . 31.3 p -77.84 -22.22 50.28 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.927 0.491 . . . . 0.0 110.312 175.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.85 38.79 9.11 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.68 169.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.554 HG23 HD12 ' A' ' 65' ' ' LEU . 8.7 p -101.76 148.86 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 123.043 0.537 . . . . 0.0 109.849 176.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.505 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 10.7 pt-20 -136.32 -165.56 1.74 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.949 0.9 . . . . 0.0 111.085 -174.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.14 149.5 50.19 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 124.017 0.927 . . . . 0.0 112.587 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 68.18 -5.07 0.93 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.119 1.768 . . . . 0.0 113.263 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.7 m -77.26 147.9 36.05 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.124 0.57 . . . . 0.0 109.528 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.3 m -119.01 112.5 19.65 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 123.758 0.823 . . . . 0.0 109.825 -174.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.554 HD12 HG23 ' A' ' 59' ' ' VAL . 2.1 mp -104.18 132.71 50.14 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.462 1.105 . . . . 0.0 108.261 -178.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.485 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . 45.5 tt0 -96.13 140.17 31.23 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.055 0.542 . . . . 0.0 111.37 -172.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 78.8 t -93.8 128.37 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.806 0.842 . . . . 0.0 108.965 174.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.05 -168.04 2.83 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.875 0.87 . . . . 0.0 109.749 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -121.67 108.16 1.29 Allowed Glycine 0 C--N 1.35 1.352 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -122.26 -60.27 1.57 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 CA--C 1.533 0.31 0 CA-C-N 114.636 -1.166 . . . . 0.0 108.43 174.022 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.4 mtp . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -78.92 119.87 22.71 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.945 0.498 . . . . 0.0 109.702 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 pp -142.63 167.49 21.97 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.417 0.687 . . . . 0.0 110.564 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -100.68 148.37 24.94 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.3 t -133.19 107.13 10.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.892 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 172.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -76.7 93.09 3.6 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.252 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.95 -178.5 5.23 Favored 'General case' 0 C--O 1.248 0.977 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 160.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -51.52 -30.33 19.98 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.719 0.408 . . . . 0.0 111.217 172.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -107.33 130.67 54.75 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 161.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -72.61 125.61 27.89 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -125.66 146.05 49.9 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.171 0.589 . . . . 0.0 109.88 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.5 m -108.41 128.41 54.75 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.487 0.715 . . . . 0.0 109.389 175.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -120.73 143.06 48.97 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.193 0.997 . . . . 0.0 109.758 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -105.59 110.22 22.46 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.517 HG22 ' HG ' ' A' ' 54' ' ' LEU . 4.6 m -108.72 151.01 11.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 C-N-CA 124.154 0.982 . . . . 0.0 109.282 -171.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.414 ' H ' ' HB2' ' A' ' 19' ' ' GLU . 8.1 m -81.21 -11.82 59.31 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.746 -175.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.66 -55.59 2.67 Favored Glycine 0 C--N 1.353 1.523 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -174.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -76.27 2.87 12.1 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.081 0.952 . . . . 0.0 110.759 167.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.414 ' HB2' ' H ' ' A' ' 16' ' ' THR . 8.8 tp10 -60.21 118.05 5.91 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.921 1.289 . . . . 0.0 108.734 165.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 74.8 p -76.41 158.43 31.39 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.38 0.536 . . . . 0.0 110.81 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 t -64.53 -31.34 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 124.032 0.933 . . . . 0.0 110.254 175.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.64 -47.73 81.44 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.848 0.718 . . . . 0.0 110.82 173.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -64.15 -42.89 96.6 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 123.86 0.725 . . . . 0.0 111.141 177.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.464 ' O ' HG22 ' A' ' 28' ' ' VAL . 48.1 mm -56.87 -51.33 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 123.757 0.823 . . . . 0.0 110.708 176.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.53 ' NZ ' ' SD ' ' A' ' 71' ' ' MET . 85.3 tttt -62.42 -45.46 93.02 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.126 1.37 . . . . 0.0 110.424 -174.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.515 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . . . -67.99 -35.84 79.01 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.338 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -64.27 -46.53 83.28 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.33 0.652 . . . . 0.0 110.045 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 24' ' ' ILE . 73.2 t -60.02 -46.08 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 O-C-N 123.791 0.682 . . . . 0.0 109.91 177.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.37 -41.02 92.86 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.894 0.878 . . . . 0.0 112.434 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.3 t -65.25 -38.85 91.62 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.445 0.698 . . . . 0.0 110.649 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.5 mt -71.41 -37.34 71.52 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.636 0.374 . . . . 0.0 111.362 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -78.18 -13.8 59.71 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.897 0.879 . . . . 0.0 111.54 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.77 17.83 79.36 Favored Glycine 0 C--N 1.35 1.311 0 C-N-CA 123.147 0.404 . . . . 0.0 113.641 178.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.4 pt -111.27 176.67 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.866 0.866 . . . . 0.0 110.052 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.24 136.32 46.61 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 123.057 0.543 . . . . 0.0 109.855 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.515 ' HB3' ' HA ' ' A' ' 26' ' ' ALA . 18.6 Cg_endo -57.11 -33.9 96.69 Favored 'Trans proline' 0 C--N 1.383 2.38 0 C-N-CA 123.458 2.772 . . . . 0.0 112.683 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -60.0 -24.12 64.21 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.964 0.905 . . . . 0.0 113.061 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -76.51 -12.79 60.09 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.19 0.596 . . . . 0.0 111.965 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.43 ' O ' ' HB3' ' A' ' 71' ' ' MET . 22.3 mt-30 -104.09 173.17 6.42 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.792 0.837 . . . . 0.0 111.992 -171.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.403 HG13 ' HB2' ' A' ' 70' ' ' ARG . 7.1 p -160.87 134.42 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 169.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.6 p -106.23 136.05 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 121.628 0.727 . . . . 0.0 110.428 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -120.56 143.32 48.67 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.163 1.785 . . . . 0.0 108.495 -171.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.1 tp -110.93 99.16 8.11 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 167.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 59.98 26.44 15.73 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.195 0.998 . . . . 0.0 111.611 -176.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.78 -21.77 31.46 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 115.716 -0.675 . . . . 0.0 113.232 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.37 116.27 54.72 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.397 0.679 . . . . 0.0 111.023 -177.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.76 114.39 2.56 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.948 2.432 . . . . 0.0 112.41 -177.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.516 HD13 HD13 ' A' ' 65' ' ' LEU . 96.7 mt -72.98 130.25 39.93 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.937 0.895 . . . . 0.0 110.647 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -66.18 125.71 26.41 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.807 0.692 . . . . 0.0 110.216 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -65.25 -28.05 69.08 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.32 0.648 . . . . 0.0 112.13 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -77.78 -20.36 53.46 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.212 0.605 . . . . 0.0 110.711 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.66 145.67 28.67 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.301 0.64 . . . . 0.0 111.264 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 59.5 p -91.6 177.55 6.18 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.427 0.691 . . . . 0.0 110.16 173.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.517 ' HG ' HG22 ' A' ' 15' ' ' VAL . 3.8 mm? -63.4 -36.62 84.33 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 173.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.43 -31.94 65.34 Favored Glycine 0 C--N 1.354 1.547 0 CA-C-N 115.605 -0.725 . . . . 0.0 113.144 177.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 61.0 tp60 -71.24 -39.38 71.69 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.405 0.682 . . . . 0.0 110.451 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.449 ' HB2' HG13 ' A' ' 59' ' ' VAL . 62.4 m -68.1 -26.28 65.74 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.187 173.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.62 23.06 68.3 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 123.793 0.683 . . . . 0.0 112.269 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.449 HG13 ' HB2' ' A' ' 57' ' ' CYS . 7.3 p -99.95 134.63 38.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.565 0.746 . . . . 0.0 109.355 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -90.56 -175.45 4.44 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.811 0.845 . . . . 0.0 111.718 -173.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.93 169.25 17.27 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.83 171.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 68.54 3.14 3.68 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 125.298 1.439 . . . . 0.0 112.935 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.3 m -81.84 155.5 25.35 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.347 0.659 . . . . 0.0 109.303 176.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.8 m -113.12 106.93 15.25 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.516 HD13 HD13 ' A' ' 48' ' ' LEU . 2.2 mm? -80.67 171.66 14.74 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 169.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -140.87 125.3 17.68 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 118.585 0.63 . . . . 0.0 111.172 -177.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.2 t -96.4 109.84 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 122.898 0.479 . . . . 0.0 110.098 177.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.56 176.7 5.24 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.488 1.115 . . . . 0.0 109.281 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -124.41 89.86 0.4 Allowed Glycine 0 N--CA 1.469 0.889 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.403 ' HB2' HG13 ' A' ' 40' ' ' VAL . 65.6 mtp180 -126.01 -48.47 1.61 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.634 0.774 . . . . 0.0 110.501 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.53 ' SD ' ' NZ ' ' A' ' 25' ' ' LYS . 46.3 ttm . . . . . 0 N--CA 1.473 0.679 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.942 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.489 ' HE1' ' HB3' ' A' ' 54' ' ' LEU . 25.5 ttt . . . . . 0 N--CA 1.478 0.947 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -98.99 117.44 33.51 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.425 0.69 . . . . 0.0 110.387 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.464 HD23 ' HE3' ' A' ' 1' ' ' MET . 3.8 pp -131.11 154.44 48.3 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.711 0.767 . . . . 0.0 111.398 175.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -90.33 144.28 25.98 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.817 1.247 . . . . 0.0 108.561 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.1 t -123.23 113.81 39.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 174.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.423 ' HB3' ' HA ' ' A' ' 66' ' ' GLU . 20.4 tpt180 -85.5 93.18 8.71 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.537 -172.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -111.6 -178.93 3.57 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 124.35 1.06 . . . . 0.0 108.333 169.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -45.38 -35.22 3.48 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.557 0.743 . . . . 0.0 111.324 167.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -111.63 127.36 55.73 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.153 0.981 . . . . 0.0 108.493 167.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -75.85 115.69 15.8 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -116.86 131.73 56.88 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.64 0.776 . . . . 0.0 109.662 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.5 m -105.74 118.63 37.09 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -102.71 140.78 36.53 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.118 0.967 . . . . 0.0 111.119 -175.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -94.6 104.76 16.7 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 165.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.0 m -113.72 163.61 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.142 0.977 . . . . 0.0 110.423 -177.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.8 m -99.9 -3.54 32.21 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.46 0.704 . . . . 0.0 111.513 -174.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.16 -45.26 3.38 Favored Glycine 0 C--N 1.352 1.464 0 O-C-N 122.027 -0.421 . . . . 0.0 112.247 -177.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -65.14 -14.04 59.6 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.372 0.669 . . . . 0.0 112.097 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.35 132.89 47.85 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 173.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.718 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 80.4 p -75.22 161.8 29.03 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.27 0.557 . . . . 0.0 110.621 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.69 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 53.0 t -64.93 -28.69 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.415 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.261 172.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.89 -38.88 92.44 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.223 0.609 . . . . 0.0 111.542 174.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -73.5 -35.12 65.59 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.739 177.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.472 HD13 HD12 ' A' ' 54' ' ' LEU . 20.3 mm -53.19 -47.94 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 123.571 0.748 . . . . 0.0 109.857 170.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.493 ' NZ ' ' SD ' ' A' ' 71' ' ' MET . 97.8 mttt -57.7 -55.05 39.88 Favored 'General case' 0 C--N 1.359 0.991 0 O-C-N 124.121 0.888 . . . . 0.0 110.658 174.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.77 -42.0 64.6 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 123.965 0.791 . . . . 0.0 112.121 -176.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -71.17 -46.27 61.75 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.634 0.773 . . . . 0.0 111.755 -177.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.406 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 14.6 p -69.94 -30.95 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.426 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . . . -68.2 -36.72 80.01 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.841 0.856 . . . . 0.0 111.351 177.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.1 t -63.66 -41.69 98.17 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.541 0.736 . . . . 0.0 110.273 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.7 mt -69.12 -48.76 61.61 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.448 0.699 . . . . 0.0 112.29 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.43 ' HB2' HG12 ' A' ' 34' ' ' ILE . 13.8 mm-40 -77.86 -19.11 55.4 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.031 0.532 . . . . 0.0 111.018 -177.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.95 31.9 59.42 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.634 -177.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.43 HG12 ' HB2' ' A' ' 32' ' ' GLU . 23.9 pt -114.65 170.38 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 123.803 0.841 . . . . 0.0 110.912 -177.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.41 119.78 76.86 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 123.658 0.783 . . . . 0.0 111.499 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -65.33 -28.18 55.1 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.859 2.372 . . . . 0.0 112.283 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.92 -35.18 79.81 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.859 0.864 . . . . 0.0 111.227 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -71.39 -26.07 62.62 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.191 0.996 . . . . 0.0 111.079 -172.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.426 ' NE2' ' HB2' ' A' ' 29' ' ' ALA . 21.6 mt-30 -81.7 137.79 35.35 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.7 -173.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 p -122.82 133.64 68.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 166.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.446 HG12 ' HB3' ' A' ' 65' ' ' LEU . 54.7 t -94.26 108.34 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-O 121.384 0.611 . . . . 0.0 109.716 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 66.1 mt -97.04 114.47 26.1 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.26 1.424 . . . . 0.0 109.762 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.8 tp -94.83 104.95 16.85 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 169.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 59.67 28.3 17.71 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.236 1.014 . . . . 0.0 111.961 -173.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.31 -7.89 72.21 Favored Glycine 0 C--N 1.352 1.427 0 CA-C-N 115.946 -0.57 . . . . 0.0 113.675 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.19 116.71 66.99 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 123.757 0.823 . . . . 0.0 110.2 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.3 117.34 4.49 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.593 2.195 . . . . 0.0 111.65 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.2 mt -75.93 154.6 35.83 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.621 0.768 . . . . 0.0 111.293 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -72.51 104.19 3.75 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.69 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 3.0 p30 -72.08 -15.29 62.01 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -73.92 -24.4 59.67 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 122.909 0.484 . . . . 0.0 110.191 172.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -94.91 157.79 15.76 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 124.161 0.984 . . . . 0.0 111.069 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.718 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 67.7 p -85.24 168.05 15.1 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.618 177.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.489 ' HB3' ' HE1' ' A' ' 1' ' ' MET . 78.2 mt -66.28 -33.22 75.24 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.118 174.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.16 -29.68 68.39 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 115.287 -0.869 . . . . 0.0 112.661 175.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -72.38 -43.95 63.22 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.551 0.74 . . . . 0.0 110.57 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' A' ' 54' ' ' LEU . 22.1 p -75.79 -10.41 59.41 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.51 173.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.13 21.24 78.4 Favored Glycine 0 C--N 1.355 1.61 0 C-N-CA 123.56 0.6 . . . . 0.0 113.571 171.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.0 p -78.51 145.78 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -176.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -110.62 -164.2 0.9 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.308 0.643 . . . . 0.0 111.003 -176.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.72 175.53 9.86 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.681 0.792 . . . . 0.0 111.667 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 65.2 5.35 3.01 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.452 1.501 . . . . 0.0 112.744 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.6 m -81.63 154.21 26.26 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.407 1.083 . . . . 0.0 110.155 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.2 m -122.42 101.7 7.65 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.688 0.795 . . . . 0.0 109.663 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.446 ' HB3' HG12 ' A' ' 41' ' ' VAL . 74.7 mt -85.69 116.28 23.87 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.125 0.97 . . . . 0.0 109.175 176.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . 41.1 tt0 -93.85 128.81 40.32 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.02 0.438 . . . . 0.0 111.674 -172.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 75.0 t -87.59 128.55 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.833 0.853 . . . . 0.0 109.791 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.15 136.84 45.99 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.775 0.83 . . . . 0.0 109.649 173.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.47 89.43 1.58 Allowed Glycine 0 C--N 1.343 0.962 0 N-CA-C 112.095 -0.402 . . . . 0.0 112.095 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -141.75 -28.87 0.63 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.545 0.738 . . . . 0.0 112.353 -173.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.493 ' SD ' ' NZ ' ' A' ' 25' ' ' LYS . 56.1 ttm . . . . . 0 N--CA 1.49 1.549 0 C-N-CA 123.177 0.591 . . . . 0.0 111.989 -173.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.467 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 1.1 tmt? . . . . . 0 N--CA 1.483 1.198 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.567 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 34.1 tt0 -101.94 137.76 39.8 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.439 -177.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.452 HD13 HD11 ' A' ' 65' ' ' LEU . 4.4 pp -137.5 161.03 37.48 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.387 0.613 . . . . 0.0 110.276 175.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -107.27 135.37 48.89 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.3 t -115.98 105.41 18.39 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 C-N-CA 123.57 0.748 . . . . 0.0 109.047 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -72.26 98.69 2.23 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.853 0.861 . . . . 0.0 110.969 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -113.28 -177.07 3.04 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.649 1.18 . . . . 0.0 108.044 166.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -45.09 -31.67 1.46 Allowed 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.522 0.677 . . . . 0.0 112.133 168.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -115.34 131.84 56.8 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 124.668 1.187 . . . . 0.0 107.878 167.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -70.36 105.5 3.05 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -93.12 160.49 14.83 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.754 177.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.5 m -148.97 121.64 8.62 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -127.63 129.61 47.53 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.392 0.677 . . . . 0.0 109.666 -176.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 36.0 tt0 -94.16 110.26 22.0 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 168.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.467 ' O ' ' HB3' ' A' ' 1' ' ' MET . 35.8 m -116.84 164.37 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 124.825 1.25 . . . . 0.0 109.098 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.1 t -94.79 6.21 49.63 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.663 0.385 . . . . 0.0 110.591 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.511 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 94.66 -20.49 48.31 Favored Glycine 0 C--N 1.357 1.734 0 CA-C-O 119.351 -0.694 . . . . 0.0 113.672 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -67.62 -26.7 66.37 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -169.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -62.96 141.87 58.56 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 46.9 p -80.42 165.0 22.64 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.509 HG12 ' HB ' ' A' ' 41' ' ' VAL . 54.5 t -57.08 -31.17 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 C-N-CA 123.448 0.699 . . . . 0.0 110.045 172.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.457 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . . . -68.92 -37.84 79.18 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.493 1.117 . . . . 0.0 111.511 177.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.458 ' HG3' ' OG1' ' A' ' 20' ' ' THR . 24.8 mt-30 -72.36 -35.03 68.42 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.1 mm -64.52 -47.41 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.097 0.559 . . . . 0.0 111.046 177.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.567 ' HB3' HG22 ' A' ' 41' ' ' VAL . 60.6 pttt -67.18 -32.65 73.88 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 119.547 -0.263 . . . . 0.0 110.383 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.523 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . . . -60.09 -45.47 92.81 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 123.603 0.761 . . . . 0.0 111.471 176.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.45 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 34.0 m170 -64.85 -44.99 87.97 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.878 0.471 . . . . 0.0 110.896 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.497 HG13 HG22 ' A' ' 67' ' ' VAL . 79.0 t -62.04 -42.39 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.124 0.57 . . . . 0.0 111.035 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.21 -26.07 61.0 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.739 0.816 . . . . 0.0 111.402 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.2 t -70.24 -42.21 72.53 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 122.983 0.513 . . . . 0.0 110.275 171.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 27' ' ' HIS . 97.2 mt -62.57 -42.85 99.81 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 123.839 0.712 . . . . 0.0 111.625 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.96 -23.41 31.09 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.112 0.565 . . . . 0.0 112.174 176.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.64 29.69 47.27 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 122.979 0.175 . . . . 0.0 112.906 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.6 pt -111.87 -178.46 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 124.803 1.241 . . . . 0.0 111.215 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.71 112.65 39.14 Favored Pre-proline 0 N--CA 1.487 1.414 0 C-N-CA 124.035 0.934 . . . . 0.0 112.537 -170.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.523 ' HB3' ' HA ' ' A' ' 26' ' ' ALA . 24.2 Cg_exo -62.93 -43.17 20.86 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 123.088 2.525 . . . . 0.0 112.729 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.95 -8.71 57.1 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.381 0.672 . . . . 0.0 112.057 -176.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -77.65 -36.31 51.57 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.403 0.62 . . . . 0.0 109.577 171.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.613 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 40.2 mt-30 -99.44 -179.76 4.32 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.994 -169.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.5 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 11.4 p -162.09 154.03 3.37 Favored 'Isoleucine or valine' 0 C--O 1.246 0.877 0 C-N-CA 125.314 1.446 . . . . 0.0 107.956 171.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.567 HG22 ' HB3' ' A' ' 25' ' ' LYS . 44.4 t -103.64 125.46 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.586 HD11 ' HA ' ' A' ' 47' ' ' PRO . 1.8 mm? -108.9 141.25 41.23 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.446 1.498 . . . . 0.0 108.842 -173.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.9 tp -80.76 96.71 7.04 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 55.06 29.34 12.27 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 123.878 0.871 . . . . 0.0 111.629 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.59 -25.43 21.28 Favored Glycine 0 C--N 1.355 1.635 0 C-N-CA 123.343 0.497 . . . . 0.0 113.449 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.57 136.05 81.01 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.552 0.741 . . . . 0.0 111.311 -177.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.586 ' HA ' HD11 ' A' ' 42' ' ' LEU . 52.6 Cg_endo -64.61 111.0 1.55 Allowed 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 123.192 2.594 . . . . 0.0 113.052 -174.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.9 mt -90.2 156.26 18.45 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.376 0.67 . . . . 0.0 111.138 173.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -81.97 119.47 24.0 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 172.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.459 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 6.0 p-10 -60.67 -38.94 86.57 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.082 0.553 . . . . 0.0 112.103 -175.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -82.27 -4.89 58.02 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.119 0.568 . . . . 0.0 111.978 -176.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.49 140.49 29.48 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.312 0.645 . . . . 0.0 110.356 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 44.1 p -71.77 168.46 17.77 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.291 0.636 . . . . 0.0 110.603 178.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.511 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 3.0 mm? -59.19 -43.33 92.2 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 174.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.43 -37.9 95.52 Favored Glycine 0 C--N 1.35 1.331 0 O-C-N 123.845 0.716 . . . . 0.0 113.108 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -68.24 -39.72 82.21 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.834 0.854 . . . . 0.0 110.482 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 75.0 m -79.26 -10.09 59.73 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.928 0.891 . . . . 0.0 111.798 177.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.82 21.17 75.01 Favored Glycine 0 C--N 1.349 1.281 0 C-N-CA 123.217 0.436 . . . . 0.0 114.135 177.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.28 134.86 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 123.845 0.858 . . . . 0.0 109.436 177.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -114.39 -171.43 1.92 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.472 0.709 . . . . 0.0 111.095 -172.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.87 154.09 28.6 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.542 0.737 . . . . 0.0 110.248 174.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 59.9 21.19 10.16 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 125.216 1.407 . . . . 0.0 111.738 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.5 m -93.74 156.41 16.7 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.434 1.093 . . . . 0.0 108.804 177.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.1 m -135.43 121.82 20.49 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.632 0.729 . . . . 0.0 110.78 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.452 HD11 HD13 ' A' ' 3' ' ' LEU . 4.1 mp -105.88 179.23 4.33 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.792 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -141.2 144.41 34.74 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.607 0.763 . . . . 0.0 110.279 -173.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.497 HG22 HG13 ' A' ' 28' ' ' VAL . 44.8 t -103.43 119.41 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 121.842 -0.536 . . . . 0.0 109.67 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.18 150.63 50.18 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.043 0.537 . . . . 0.0 110.292 176.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.613 ' HA2' ' HA ' ' A' ' 39' ' ' GLN . . . -90.1 92.95 1.82 Allowed Glycine 0 C--N 1.347 1.159 0 N-CA-C 112.051 -0.42 . . . . 0.0 112.051 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 54.4 mtt180 -109.75 -11.81 14.68 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.958 0.503 . . . . 0.0 112.318 -177.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.559 ' SD ' ' NZ ' ' A' ' 25' ' ' LYS . 79.5 mtp . . . . . 0 N--CA 1.481 1.107 0 O-C-N 122.212 -0.305 . . . . 0.0 110.445 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 121.788 0.804 . . . . 0.0 108.968 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -93.01 111.38 22.98 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.683 -171.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.416 HD12 HD13 ' A' ' 65' ' ' LEU . 2.8 pp -125.51 157.51 36.83 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.481 0.712 . . . . 0.0 110.07 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -90.28 142.18 27.98 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.789 0.835 . . . . 0.0 109.85 -176.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.5 t -122.66 102.64 11.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 C-N-CA 124.648 1.179 . . . . 0.0 108.885 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -77.95 93.8 4.49 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.934 0.893 . . . . 0.0 109.71 177.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.19 -174.52 2.59 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.906 1.283 . . . . 0.0 108.168 172.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -41.16 -36.9 0.8 Allowed 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 123.841 0.857 . . . . 0.0 112.053 168.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -117.95 154.36 32.07 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.507 1.123 . . . . 0.0 108.323 167.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -77.52 127.52 32.65 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.774 0.43 . . . . 0.0 110.456 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -130.79 159.39 37.47 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.653 1.181 . . . . 0.0 109.042 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.8 m -143.53 125.17 14.93 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 175.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -132.93 141.64 48.46 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.013 0.525 . . . . 0.0 111.119 -173.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -80.92 125.77 30.54 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 164.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.44 HG22 ' HG ' ' A' ' 54' ' ' LEU . 27.6 m -109.32 152.56 11.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 C-N-CA 123.445 0.698 . . . . 0.0 109.744 -174.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 m -78.51 -14.62 59.27 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.666 -171.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.49 -56.44 5.02 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -70.5 -13.38 62.09 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.141 0.976 . . . . 0.0 111.145 171.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -63.39 139.18 58.74 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.66 1.184 . . . . 0.0 109.933 170.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 73.2 p -93.62 170.67 9.41 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.304 0.573 . . . . 0.0 111.91 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.57 HG13 ' HB ' ' A' ' 41' ' ' VAL . 40.5 t -64.81 -31.87 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.129 0.972 . . . . 0.0 110.607 172.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.06 96.25 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.735 0.814 . . . . 0.0 110.148 178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -62.65 -48.25 80.17 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.447 1.092 . . . . 0.0 110.313 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.41 ' O ' HG21 ' A' ' 28' ' ' VAL . 37.2 mm -55.97 -47.27 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 124.078 0.951 . . . . 0.0 110.923 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -62.17 -49.91 73.94 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.015 1.326 . . . . 0.0 111.183 -175.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.7 -32.94 71.82 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.976 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.463 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 11.4 t-160 -62.69 -53.52 53.25 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 124.099 0.96 . . . . 0.0 110.37 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 24' ' ' ILE . 95.0 t -59.92 -38.51 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.414 0.686 . . . . 0.0 110.552 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.04 -47.79 84.41 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.144 175.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.8 t -66.86 -35.25 79.61 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.648 0.779 . . . . 0.0 111.228 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 27' ' ' HIS . 88.6 mt -67.4 -48.79 66.33 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.82 0.848 . . . . 0.0 111.861 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -96.04 -2.57 46.54 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.685 0.394 . . . . 0.0 111.819 -172.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.58 28.24 73.3 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.278 0.361 . . . . 0.0 113.01 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.2 pt -108.82 177.58 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.125 0.97 . . . . 0.0 110.693 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.42 120.94 68.96 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 123.281 0.632 . . . . 0.0 111.438 -171.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -63.83 -31.74 67.66 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.527 2.151 . . . . 0.0 111.206 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -63.68 -22.04 66.7 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.028 0.931 . . . . 0.0 112.353 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -88.95 -12.95 40.14 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.007 0.923 . . . . 0.0 111.171 -178.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -98.65 165.29 11.87 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.922 0.889 . . . . 0.0 112.344 -171.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 m -152.57 138.4 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 126.247 1.819 . . . . 0.0 107.251 164.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.57 ' HB ' HG13 ' A' ' 21' ' ' VAL . 45.5 t -94.99 116.62 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 175.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.3 mt -112.25 134.04 54.03 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.802 1.241 . . . . 0.0 109.092 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.451 ' HB2' HD13 ' A' ' 48' ' ' LEU . 42.4 tp -89.4 98.11 11.58 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 173.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 57.18 28.84 15.68 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.754 0.821 . . . . 0.0 112.081 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.04 -25.16 21.32 Favored Glycine 0 C--N 1.353 1.505 0 CA-C-O 119.717 -0.491 . . . . 0.0 113.498 -177.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.13 117.68 60.51 Favored Pre-proline 0 N--CA 1.481 1.098 0 C-N-CA 123.422 0.689 . . . . 0.0 110.886 -177.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.5 115.57 2.64 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.329 2.686 . . . . 0.0 113.108 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.472 ' HB3' HG21 ' A' ' 21' ' ' VAL . 84.6 mt -91.02 143.75 26.38 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.18 0.592 . . . . 0.0 110.903 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -78.27 134.68 37.51 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -56.73 -41.02 76.77 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.996 0.918 . . . . 0.0 112.15 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -82.21 -14.89 54.87 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.677 -175.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.22 132.65 43.43 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.81 0.444 . . . . 0.0 109.859 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 58.6 p -84.23 166.77 17.25 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.209 0.604 . . . . 0.0 110.282 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.44 ' HG ' HG22 ' A' ' 15' ' ' VAL . 3.0 mm? -62.43 -38.52 90.06 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.01 -34.69 77.03 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.922 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -70.95 -42.62 69.55 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.475 0.71 . . . . 0.0 110.635 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 50.6 t -69.51 -18.75 63.71 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.141 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.05 17.84 80.22 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.657 -0.702 . . . . 0.0 112.804 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.552 HG22 HD12 ' A' ' 65' ' ' LEU . 2.2 p -85.61 118.37 32.21 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.1 -166.8 1.42 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.328 1.051 . . . . 0.0 110.54 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.63 163.72 26.43 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.173 0.589 . . . . 0.0 111.243 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 71.89 -2.83 2.38 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.825 1.65 . . . . 0.0 112.765 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.4 m -84.0 160.18 21.07 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.577 0.751 . . . . 0.0 109.573 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.3 m -120.16 113.31 20.27 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.15 0.58 . . . . 0.0 110.638 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.552 HD12 HG22 ' A' ' 59' ' ' VAL . 5.5 mp -94.79 161.18 14.28 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 170.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -130.52 130.66 44.43 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.964 0.505 . . . . 0.0 109.95 -177.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 95.9 t -91.85 93.39 4.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 171.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.62 -176.47 3.2 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.339 1.056 . . . . 0.0 110.13 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -123.2 91.78 0.45 Allowed Glycine 0 C--N 1.341 0.823 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 178.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -107.12 -49.23 3.31 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 53.4 ttm . . . . . 0 CA--C 1.539 0.537 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 174.55 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ttt . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -94.04 120.35 34.17 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 pp -132.16 167.22 20.14 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.074 0.55 . . . . 0.0 111.001 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -99.49 142.89 30.38 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.58 0.752 . . . . 0.0 109.553 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 80.9 t -126.12 101.13 7.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 171.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -73.25 98.74 2.71 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.548 -177.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.69 -177.31 3.33 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.097 0.959 . . . . 0.0 108.945 172.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -43.46 -32.75 0.94 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.087 0.955 . . . . 0.0 111.986 170.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -120.6 145.22 47.59 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.382 1.073 . . . . 0.0 108.178 162.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.1 tp -69.72 128.58 36.94 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 120.821 0.343 . . . . 0.0 111.084 -176.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -117.47 158.21 24.91 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.931 0.892 . . . . 0.0 109.894 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.7 m -146.63 120.96 9.59 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.348 1.059 . . . . 0.0 108.291 175.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -120.85 145.21 47.85 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.412 0.685 . . . . 0.0 110.613 -172.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -97.4 123.98 41.42 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 171.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.3 m -135.0 172.43 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.302 1.041 . . . . 0.0 109.865 -177.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.466 ' HB ' ' HG2' ' A' ' 18' ' ' GLN . 2.9 m -107.07 -18.15 13.98 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.793 0.837 . . . . 0.0 110.011 175.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.429 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 102.77 -15.52 55.51 Favored Glycine 0 C--N 1.355 1.637 0 C-N-CA 123.137 0.399 . . . . 0.0 112.458 -173.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.466 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 3.3 pt20 -81.29 -8.45 59.75 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.825 0.85 . . . . 0.0 111.719 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -74.42 134.23 42.4 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.16 0.984 . . . . 0.0 108.923 176.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 72.4 p -74.66 158.84 32.93 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 171.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.631 HG11 ' HB ' ' A' ' 41' ' ' VAL . 55.8 t -59.23 -27.9 37.74 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.475 0 C-N-CA 123.839 0.856 . . . . 0.0 110.401 173.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.64 -43.36 80.52 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.795 1.238 . . . . 0.0 110.392 174.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.431 ' HG3' ' OG1' ' A' ' 20' ' ' THR . 78.1 mt-30 -62.07 -41.56 98.28 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 123.521 0.513 . . . . 0.0 110.217 175.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.464 HD13 HD13 ' A' ' 54' ' ' LEU . 46.9 mm -59.32 -50.72 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.435 0.694 . . . . 0.0 111.217 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.475 ' HB3' HG22 ' A' ' 41' ' ' VAL . 60.3 pttt -73.08 -27.5 61.75 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.98 -37.19 86.83 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.25 0.62 . . . . 0.0 111.047 173.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 57.5 m170 -66.68 -45.81 77.66 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.359 0.663 . . . . 0.0 109.78 175.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.545 HG11 HD11 ' A' ' 34' ' ' ILE . 85.1 t -58.74 -38.02 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.59 0.756 . . . . 0.0 110.313 174.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.01 -48.15 74.95 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.275 1.03 . . . . 0.0 111.953 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.3 t -68.13 -32.75 73.26 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.328 0.651 . . . . 0.0 111.771 -177.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 97.5 mt -80.67 -51.11 9.07 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.989 0.516 . . . . 0.0 111.965 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -83.76 -2.45 56.33 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.605 0.762 . . . . 0.0 112.179 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.25 15.19 69.76 Favored Glycine 0 C--N 1.346 1.092 0 O-C-N 123.157 0.286 . . . . 0.0 113.1 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.545 HD11 HG11 ' A' ' 28' ' ' VAL . 28.6 pt -92.39 178.91 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.527 0.731 . . . . 0.0 109.81 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -109.87 129.89 23.43 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 122.87 0.468 . . . . 0.0 110.776 -174.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.28 -11.17 26.58 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.217 1.944 . . . . 0.0 112.687 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.52 -22.97 53.73 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 123.041 0.536 . . . . 0.0 112.071 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -90.86 -41.19 11.33 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 118.76 0.709 . . . . 0.0 109.518 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -81.82 152.4 26.93 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 122.198 0.999 . . . . 0.0 111.847 -175.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.32 153.11 37.34 Favored 'Isoleucine or valine' 0 C--O 1.249 1.07 0 C-N-CA 126.447 1.899 . . . . 0.0 106.347 168.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.631 ' HB ' HG11 ' A' ' 21' ' ' VAL . 43.7 t -100.21 131.65 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.7 mt -116.3 142.0 47.41 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.592 1.157 . . . . 0.0 109.398 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.6 tp -91.81 99.28 12.18 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 174.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 60.31 22.97 12.44 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.84 0.856 . . . . 0.0 112.473 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.7 -14.6 57.58 Favored Glycine 0 C--N 1.353 1.519 0 CA-C-O 119.779 -0.456 . . . . 0.0 113.436 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.62 146.13 60.1 Favored Pre-proline 0 N--CA 1.485 1.285 0 C-N-CA 123.745 0.818 . . . . 0.0 109.981 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -72.35 120.38 6.72 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.637 2.224 . . . . 0.0 113.301 -170.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.47 ' HB3' HG23 ' A' ' 21' ' ' VAL . 87.2 mt -94.63 141.1 29.0 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 170.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -80.05 120.89 24.82 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.528 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 11.1 p-10 -63.21 -39.47 94.73 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 123.491 0.494 . . . . 0.0 111.511 -171.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.58 -2.91 55.15 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.392 0.677 . . . . 0.0 111.897 -177.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.6 139.91 29.99 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.545 0.738 . . . . 0.0 110.563 173.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 75.5 p -73.58 164.34 26.78 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.978 0.511 . . . . 0.0 110.529 175.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.464 HD13 HD13 ' A' ' 24' ' ' ILE . 86.9 mt -66.83 -28.75 68.61 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.509 0.724 . . . . 0.0 110.757 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.07 -43.76 89.75 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.634 174.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -69.52 -37.3 77.07 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.847 0.459 . . . . 0.0 110.949 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 89.3 m -65.09 -23.49 67.18 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.319 0.648 . . . . 0.0 110.933 173.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.44 28.33 67.93 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 116.308 -0.405 . . . . 0.0 112.744 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.555 HG22 HD12 ' A' ' 65' ' ' LEU . 11.8 p -92.54 153.9 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -133.07 -172.19 2.87 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.674 0.79 . . . . 0.0 110.909 -173.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.77 157.45 36.41 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.341 0.657 . . . . 0.0 111.87 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 61.7 14.6 6.24 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 126.013 1.725 . . . . 0.0 112.415 -177.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.8 m -93.36 145.08 24.73 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.5 m -105.84 108.3 19.75 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.66 0.743 . . . . 0.0 110.08 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.555 HD12 HG22 ' A' ' 59' ' ' VAL . 5.6 mp -88.32 179.35 6.36 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.176 169.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 39.8 tt0 -142.53 153.34 43.5 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.101 0.56 . . . . 0.0 110.133 -175.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 79.1 t -109.08 131.83 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 170.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.98 127.19 17.56 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.305 0.642 . . . . 0.0 109.925 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.12 92.51 0.74 Allowed Glycine 0 C--N 1.344 0.99 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 175.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -132.69 -35.57 1.1 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.019 0.527 . . . . 0.0 112.296 -174.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 49.0 tpp . . . . . 0 N--CA 1.482 1.134 0 C-N-CA 122.497 0.319 . . . . 0.0 110.943 -178.593 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.6 mtm . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -76.96 114.59 15.92 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.445 HD11 HD23 ' A' ' 65' ' ' LEU . 2.3 pp -137.9 157.19 46.9 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.108 0.563 . . . . 0.0 110.155 -177.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -88.92 152.11 21.92 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.052 0.541 . . . . 0.0 109.63 -177.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 11' ' ' HIS . 55.2 t -134.65 105.23 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.294 1.037 . . . . 0.0 109.087 -176.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -82.9 93.96 7.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.468 1.107 . . . . 0.0 111.001 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -111.3 -179.96 3.87 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 168.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.99 -26.79 39.23 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 175.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -111.47 134.04 53.34 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 158.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.73 137.66 52.18 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.883 0.473 . . . . 0.0 109.738 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.507 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 39.3 m-70 -129.86 161.97 29.61 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.122 0.969 . . . . 0.0 109.049 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.0 m -142.91 112.0 6.56 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 172.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -113.39 132.32 55.66 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.792 0.837 . . . . 0.0 111.203 -172.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -83.94 114.08 21.44 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 166.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.3 m -109.65 139.58 32.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 122.918 0.487 . . . . 0.0 109.811 -174.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 m -75.37 -17.83 60.12 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.711 0.805 . . . . 0.0 111.472 -176.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.75 -56.2 1.91 Allowed Glycine 0 C--N 1.347 1.143 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 -176.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -72.53 -7.12 48.41 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.307 0.643 . . . . 0.0 111.588 172.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -63.79 145.25 56.12 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 165.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.622 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 61.2 p -94.29 153.68 17.9 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 118.213 0.461 . . . . 0.0 111.99 -177.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.58 HG13 ' HB ' ' A' ' 41' ' ' VAL . 38.1 t -57.12 -33.71 43.52 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 124.388 1.075 . . . . 0.0 110.617 171.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.17 -53.19 61.11 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.126 0.971 . . . . 0.0 110.921 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -65.2 -36.14 83.27 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.916 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 35.0 mm -60.36 -50.49 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 122.786 0.434 . . . . 0.0 111.633 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -68.25 -30.75 69.87 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.521 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . . . -65.9 -41.23 91.76 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 123.382 0.673 . . . . 0.0 111.492 175.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -62.03 -46.06 90.81 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.329 0.651 . . . . 0.0 109.722 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.8 t -56.32 -48.24 79.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.717 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.99 -28.23 64.28 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.827 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 t -77.03 -31.62 56.41 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.554 0.741 . . . . 0.0 110.956 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.0 mt -73.31 -45.09 57.45 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.229 0.612 . . . . 0.0 111.17 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -86.1 -22.0 27.35 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.168 0.587 . . . . 0.0 112.316 -176.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.23 33.8 25.11 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 116.632 -0.258 . . . . 0.0 113.266 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 pt -109.84 171.38 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.941 0.896 . . . . 0.0 110.034 175.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.69 111.61 22.66 Favored Pre-proline 0 N--CA 1.484 1.244 0 C-N-CA 123.296 0.638 . . . . 0.0 111.768 -172.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.521 ' HB3' ' HA ' ' A' ' 26' ' ' ALA . 19.8 Cg_endo -55.95 -39.47 90.97 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 123.602 2.868 . . . . 0.0 114.081 -175.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -67.3 -28.06 67.69 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.035 0.534 . . . . 0.0 111.568 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 71' ' ' MET . 22.7 t70 -67.54 -40.3 85.02 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.253 0.621 . . . . 0.0 109.9 177.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -77.03 165.72 24.25 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.953 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -162.82 146.14 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 125.04 1.336 . . . . 0.0 108.299 173.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.58 ' HB ' HG13 ' A' ' 21' ' ' VAL . 96.3 t -90.14 134.55 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.103 0.561 . . . . 0.0 110.51 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.8 mt -123.29 127.38 48.47 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.77 1.228 . . . . 0.0 108.637 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.429 ' HB2' HD13 ' A' ' 48' ' ' LEU . 33.5 tp -92.18 97.96 11.23 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 173.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 59.73 23.07 11.91 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.56 1.144 . . . . 0.0 112.732 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.75 -7.56 38.93 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-O 119.703 -0.499 . . . . 0.0 113.655 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.01 114.55 53.38 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 123.241 0.616 . . . . 0.0 109.459 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -68.16 102.58 0.81 Allowed 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 122.172 1.914 . . . . 0.0 112.27 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.429 HD13 ' HB2' ' A' ' 43' ' ' LEU . 79.5 mt -73.2 129.68 38.58 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.34 176.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -63.44 130.73 45.64 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.139 0.9 . . . . 0.0 109.387 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -61.93 -35.38 78.23 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.184 0.303 . . . . 0.0 111.483 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.19 -19.68 60.46 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.4 0.28 . . . . 0.0 111.28 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.76 135.27 41.75 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.924 0.49 . . . . 0.0 109.848 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.622 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 71.4 p -76.82 171.95 13.91 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 122.907 0.483 . . . . 0.0 109.967 172.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -66.22 -28.76 68.99 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.54 -29.53 55.3 Favored Glycine 0 C--N 1.357 1.733 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.763 175.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -74.0 -35.98 64.46 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.641 0.776 . . . . 0.0 109.855 176.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 79.8 m -74.87 -23.52 58.42 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.466 171.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.19 23.05 78.49 Favored Glycine 0 C--N 1.353 1.506 0 CA-C-N 116.009 -0.541 . . . . 0.0 113.558 177.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.8 p -80.54 148.09 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 123.522 0.729 . . . . 0.0 110.342 -175.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -99.6 -177.38 3.55 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.401 0.68 . . . . 0.0 112.181 -173.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.42 162.22 24.55 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.738 0.815 . . . . 0.0 111.029 175.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 64.63 9.29 5.03 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 125.449 1.5 . . . . 0.0 112.488 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.7 m -78.06 152.0 33.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.058 0.943 . . . . 0.0 109.706 175.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.2 m -106.87 108.25 19.67 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 173.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.445 HD23 HD11 ' A' ' 3' ' ' LEU . 3.6 mm? -92.32 135.54 33.94 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 124.175 0.99 . . . . 0.0 108.589 174.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -93.97 150.46 20.34 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.164 0.586 . . . . 0.0 109.465 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 67.1 t -119.46 131.45 72.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 174.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.72 148.55 30.15 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.406 0.682 . . . . 0.0 110.318 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.0 98.82 2.27 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 174.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.9 mtp-105 -103.44 -26.13 13.0 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.594 0.758 . . . . 0.0 111.176 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.498 ' O ' ' HA ' ' A' ' 38' ' ' ASP . 62.7 ttp . . . . . 0 N--CA 1.473 0.697 0 C-N-CA 123.361 0.664 . . . . 0.0 109.971 -170.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.537 ' SD ' HD23 ' A' ' 3' ' ' LEU . 47.9 ttm . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -87.39 123.62 32.54 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 171.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.537 HD23 ' SD ' ' A' ' 1' ' ' MET . 2.1 pp -143.12 158.47 43.58 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.619 0.768 . . . . 0.0 109.398 -175.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -96.3 139.78 31.94 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.368 0.667 . . . . 0.0 109.47 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.503 HG22 ' HB2' ' A' ' 65' ' ' LEU . 58.9 t -123.35 103.39 12.89 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 174.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -76.48 100.14 5.15 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.674 0.749 . . . . 0.0 111.038 -178.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.97 -178.2 3.59 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.412 1.085 . . . . 0.0 108.446 166.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -48.29 -35.59 12.52 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.845 0.858 . . . . 0.0 111.379 172.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -111.7 131.28 55.41 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 166.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -68.6 132.84 47.58 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.824 0.45 . . . . 0.0 109.804 -175.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -126.63 156.09 41.51 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.689 0.795 . . . . 0.0 109.451 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.1 t -136.45 135.36 38.57 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 167.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -133.55 155.1 50.22 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.609 0.764 . . . . 0.0 110.355 -175.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -106.47 120.24 41.38 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.426 HG23 ' HG ' ' A' ' 54' ' ' LEU . 32.3 m -110.44 150.3 13.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 C-N-CA 123.812 0.845 . . . . 0.0 108.999 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.3 m -81.98 -14.67 55.69 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.102 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.574 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 91.01 -42.95 2.85 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.521 -0.309 . . . . 0.0 113.043 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -72.22 -13.32 61.5 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.477 1.111 . . . . 0.0 111.92 176.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -78.23 156.84 29.54 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.129 0.572 . . . . 0.0 109.676 171.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 81.4 p -93.24 175.55 6.73 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.24 0.543 . . . . 0.0 112.285 -175.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.554 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 53.1 t -62.57 -36.55 75.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 123.761 0.825 . . . . 0.0 109.996 170.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.25 -37.95 87.4 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.564 0.745 . . . . 0.0 110.76 175.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -64.43 -48.16 76.41 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.789 0.681 . . . . 0.0 111.1 176.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.53 ' O ' HG21 ' A' ' 28' ' ' VAL . 64.2 mt -56.71 -49.23 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 122.881 0.472 . . . . 0.0 109.826 176.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.46 ' HB2' HG13 ' A' ' 41' ' ' VAL . 85.1 tttt -55.26 -45.9 76.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.849 1.66 . . . . 0.0 111.193 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.11 -42.91 88.57 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.847 0.859 . . . . 0.0 111.285 176.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -60.67 -46.83 88.86 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.594 0.758 . . . . 0.0 110.902 -178.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.53 HG21 ' O ' ' A' ' 24' ' ' ILE . 26.3 t -65.13 -44.96 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 123.815 0.697 . . . . 0.0 109.148 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.75 -41.04 90.1 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 123.537 0.735 . . . . 0.0 112.249 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.1 m -61.82 -44.61 96.5 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.807 0.843 . . . . 0.0 111.182 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.5 mt -79.7 -25.41 41.2 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.636 -176.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -85.49 -12.15 52.51 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.006 0.522 . . . . 0.0 111.434 172.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.35 25.44 68.27 Favored Glycine 0 C--N 1.351 1.377 0 C-N-CA 122.85 0.262 . . . . 0.0 113.593 176.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.3 pt -119.03 174.74 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.266 1.026 . . . . 0.0 110.238 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.05 144.22 50.73 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.244 0.618 . . . . 0.0 110.035 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.35 -22.47 59.94 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.48 2.12 . . . . 0.0 110.886 172.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -64.0 -25.54 68.17 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.228 1.411 . . . . 0.0 111.584 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -81.88 -23.06 36.53 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.663 0.785 . . . . 0.0 111.343 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.413 ' HB2' HG13 ' A' ' 67' ' ' VAL . 10.4 pt20 -123.84 -179.52 4.42 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.357 0.598 . . . . 0.0 111.178 -175.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.461 HG11 ' HB2' ' A' ' 70' ' ' ARG . 7.4 p -156.92 134.42 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.99 1.316 . . . . 0.0 107.513 166.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.46 HG13 ' HB2' ' A' ' 25' ' ' LYS . 9.9 p -96.31 110.83 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 CA-C-O 121.952 0.882 . . . . 0.0 109.929 -178.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 47' ' ' PRO . 18.1 mt -94.23 154.88 17.32 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.889 1.276 . . . . 0.0 109.409 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.508 ' HB2' HD13 ' A' ' 48' ' ' LEU . 40.3 tp -94.16 97.63 10.41 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 58.2 23.83 10.71 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.292 1.037 . . . . 0.0 112.489 -177.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.93 -5.8 36.89 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 119.483 -0.621 . . . . 0.0 113.655 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.21 116.11 65.22 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 123.49 0.716 . . . . 0.0 110.66 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.445 ' HA ' HD23 ' A' ' 42' ' ' LEU . 40.7 Cg_endo -64.63 106.62 0.76 Allowed 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.31 2.007 . . . . 0.0 111.621 174.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.508 HD13 ' HB2' ' A' ' 43' ' ' LEU . 63.8 mt -82.77 170.01 15.52 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.098 0.559 . . . . 0.0 111.0 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -78.26 124.87 28.57 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 168.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.554 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 10.2 p-10 -67.26 -19.61 65.54 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.935 0.494 . . . . 0.0 111.415 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -80.6 -21.35 41.66 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.194 0.998 . . . . 0.0 111.617 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.45 133.97 38.49 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.132 0.573 . . . . 0.0 110.781 -178.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 66.5 p -79.41 171.64 14.88 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.756 0.822 . . . . 0.0 110.626 174.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.574 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 3.4 mm? -64.1 -37.43 87.42 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 175.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.42 -39.11 95.57 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.586 175.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -70.07 -44.2 69.58 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.528 0.731 . . . . 0.0 110.946 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 51.8 t -75.75 -24.12 56.04 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.32 0.648 . . . . 0.0 111.446 -177.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.78 35.02 13.92 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.918 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.4 t -76.84 148.59 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 123.651 0.781 . . . . 0.0 109.268 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -119.61 -171.99 2.24 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.723 0.809 . . . . 0.0 110.299 -176.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.79 149.89 30.92 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 122.779 0.431 . . . . 0.0 110.281 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 60.28 26.2 15.67 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.095 1.358 . . . . 0.0 112.33 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.6 m -80.0 162.17 25.03 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.633 0.773 . . . . 0.0 109.89 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.2 m -115.78 106.06 13.42 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.889 0.852 . . . . 0.0 110.529 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.503 ' HB2' HG22 ' A' ' 5' ' ' VAL . 3.5 mm? -83.02 164.99 20.0 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.409 -1.269 . . . . 0.0 107.833 164.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -144.92 130.46 18.88 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.878 0.471 . . . . 0.0 110.613 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.455 HG22 HG13 ' A' ' 28' ' ' VAL . 83.2 t -83.02 127.45 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 172.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.78 151.79 47.38 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.85 0.86 . . . . 0.0 109.981 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -91.78 86.41 1.27 Allowed Glycine 0 C--N 1.341 0.852 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 173.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.461 ' HB2' HG11 ' A' ' 40' ' ' VAL . 71.3 mtp180 -119.31 16.13 13.08 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.154 0.981 . . . . 0.0 108.965 170.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.426 ' HE3' ' HA ' ' A' ' 71' ' ' MET . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.302 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.598 ' HA ' ' HB1' ' A' ' 61' ' ' ALA . 82.6 mtp . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -88.54 99.46 12.32 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.402 HD21 HD22 ' A' ' 54' ' ' LEU . 1.5 pp -119.99 165.52 14.56 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.52 0.728 . . . . 0.0 110.864 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -101.35 140.66 35.34 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.344 1.058 . . . . 0.0 108.918 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.37 107.33 16.55 Favored 'Isoleucine or valine' 0 C--O 1.244 0.806 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -80.36 93.78 6.03 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.712 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.92 -171.77 2.42 Favored 'General case' 0 C--O 1.245 0.84 0 C-N-CA 125.876 1.67 . . . . 0.0 108.015 165.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -38.72 -34.28 0.14 Allowed 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 123.399 0.68 . . . . 0.0 112.727 167.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -123.96 162.75 22.75 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.637 1.175 . . . . 0.0 109.319 164.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -81.94 131.76 35.25 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -133.77 124.68 27.03 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.077 0.951 . . . . 0.0 109.119 -177.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 m -99.35 123.43 43.62 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -119.56 121.31 39.07 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.463 1.105 . . . . 0.0 110.456 -176.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.22 106.2 13.01 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 163.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.2 m -110.93 156.7 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.884 0.874 . . . . 0.0 110.659 -174.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.3 p -75.14 -25.74 58.63 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.949 177.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.3 -39.24 3.11 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.921 -174.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -78.23 -10.81 59.82 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.085 0.554 . . . . 0.0 111.657 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -69.13 120.84 15.59 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 168.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 69.7 p -66.29 161.22 22.79 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.388 0.675 . . . . 0.0 111.6 -175.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.47 HG12 ' HB ' ' A' ' 41' ' ' VAL . 75.4 t -62.06 -29.89 47.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 C-N-CA 124.042 0.937 . . . . 0.0 110.947 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 50' ' ' ASP . . . -61.31 -53.18 60.07 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.639 0.775 . . . . 0.0 110.499 174.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -65.92 -37.23 85.53 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.794 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.3 mm -63.96 -47.15 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.828 0.851 . . . . 0.0 111.588 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.469 ' HB3' HG23 ' A' ' 41' ' ' VAL . 51.8 pttt -70.18 -33.81 72.2 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 118.132 0.424 . . . . 0.0 110.28 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.61 -39.41 80.86 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.603 0.761 . . . . 0.0 110.605 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -55.57 -51.95 65.38 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.649 1.58 . . . . 0.0 109.955 175.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.504 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 84.5 t -64.51 -44.03 96.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.271 178.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.83 -35.67 78.91 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.629 0.771 . . . . 0.0 112.323 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.0 m -68.62 -40.8 80.17 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.092 0.557 . . . . 0.0 110.754 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.6 mt -66.93 -40.72 87.7 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.492 177.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 28' ' ' VAL . 11.0 mm-40 -84.27 -12.67 54.3 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.731 0.813 . . . . 0.0 111.709 -177.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.59 38.68 78.73 Favored Glycine 0 C--N 1.354 1.569 0 O-C-N 123.415 0.447 . . . . 0.0 113.32 177.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.2 pt -129.22 176.13 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.442 1.097 . . . . 0.0 110.306 -175.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.73 113.91 29.14 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 123.978 0.911 . . . . 0.0 112.466 -171.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -60.44 -35.7 89.68 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.291 2.661 . . . . 0.0 113.139 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -67.33 -27.67 67.33 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.008 0.523 . . . . 0.0 110.916 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' A' ' 71' ' ' MET . 31.7 t70 -74.74 -29.47 61.17 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.282 0.633 . . . . 0.0 110.607 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -75.98 152.6 36.96 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.403 0.621 . . . . 0.0 111.52 -173.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.3 p -142.63 142.8 26.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-N 114.331 -1.304 . . . . 0.0 107.581 169.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.47 ' HB ' HG12 ' A' ' 21' ' ' VAL . 98.5 t -98.89 123.36 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 173.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.467 HD22 ' HA ' ' A' ' 47' ' ' PRO . 86.6 mt -116.34 118.61 33.22 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.825 1.25 . . . . 0.0 108.681 -176.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.3 tp -86.03 97.75 10.46 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 173.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 57.65 24.54 10.65 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.041 0.936 . . . . 0.0 111.645 -174.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.1 -20.87 30.24 Favored Glycine 0 C--N 1.354 1.555 0 C-N-CA 123.521 0.581 . . . . 0.0 113.649 -177.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.34 117.69 60.94 Favored Pre-proline 0 CA--C 1.554 1.111 0 CA-C-N 117.489 0.645 . . . . 0.0 110.602 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.467 ' HA ' HD22 ' A' ' 42' ' ' LEU . 19.8 Cg_exo -65.26 101.59 0.42 Allowed 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.003 2.469 . . . . 0.0 112.508 -176.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.428 ' HB3' HG23 ' A' ' 21' ' ' VAL . 61.7 mt -68.9 127.16 32.12 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.957 176.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.83 127.95 33.65 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 123.463 0.705 . . . . 0.0 109.812 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.473 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 9.4 p-10 -62.07 -29.53 70.37 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.938 0.895 . . . . 0.0 111.663 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -76.35 -24.11 54.21 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.827 0.851 . . . . 0.0 111.214 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.1 146.27 30.67 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.503 0.721 . . . . 0.0 110.533 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 80.9 p -85.81 165.24 17.02 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.321 0.648 . . . . 0.0 109.893 173.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.402 HD22 HD21 ' A' ' 3' ' ' LEU . 9.7 mp -66.57 -28.79 68.8 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.184 0.594 . . . . 0.0 110.486 175.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.41 -40.45 86.86 Favored Glycine 0 C--N 1.35 1.332 0 O-C-N 123.796 0.685 . . . . 0.0 112.262 174.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -73.08 -36.5 66.84 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.268 0.627 . . . . 0.0 110.652 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 84.0 m -71.7 -17.81 62.2 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.788 0.835 . . . . 0.0 111.567 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.16 19.84 78.77 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 123.578 0.549 . . . . 0.0 113.385 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.502 HG22 HD12 ' A' ' 65' ' ' LEU . 2.2 p -88.15 99.67 9.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -81.92 -174.66 5.18 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.249 -1.341 . . . . 0.0 112.061 -171.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.598 ' HB1' ' HA ' ' A' ' 1' ' ' MET . . . -62.9 155.45 27.14 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.758 172.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 61.59 24.91 14.93 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.642 1.177 . . . . 0.0 112.565 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.4 m -107.88 157.98 17.72 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.713 0.805 . . . . 0.0 109.069 175.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.3 m -114.59 121.9 44.87 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.907 0.483 . . . . 0.0 110.54 -178.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.502 HD12 HG22 ' A' ' 59' ' ' VAL . 3.0 mm? -94.22 162.56 13.8 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.644 1.178 . . . . 0.0 109.478 171.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -122.69 130.98 53.58 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.457 1.103 . . . . 0.0 108.751 173.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 86.8 t -104.65 114.02 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.23 161.03 21.07 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.742 0.817 . . . . 0.0 111.016 -177.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.09 106.26 3.35 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -131.39 -57.8 1.0 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.617 0.767 . . . . 0.0 111.414 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.539 ' O ' ' HA ' ' A' ' 38' ' ' ASP . 41.2 tpp . . . . . 0 N--CA 1.478 0.965 0 C-N-CA 123.238 0.615 . . . . 0.0 110.562 -171.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.568 ' HE1' HD22 ' A' ' 3' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -113.07 132.78 55.28 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.581 0.753 . . . . 0.0 108.978 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.568 HD22 ' HE1' ' A' ' 1' ' ' MET . 4.0 pp -131.35 158.92 39.42 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -101.9 152.2 21.2 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.648 0.779 . . . . 0.0 109.106 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.8 t -126.11 124.9 66.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.675 1.19 . . . . 0.0 108.631 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -95.21 93.41 7.29 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.147 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -108.43 -176.59 3.09 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 168.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.432 HE22 ' HG2' ' A' ' 9' ' ' GLU . 4.0 pp0? -46.86 -29.04 1.78 Allowed 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 123.429 0.692 . . . . 0.0 112.49 174.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.432 ' HG2' HE22 ' A' ' 8' ' ' GLN . 1.1 pt-20 -123.06 159.44 28.44 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.167 0.987 . . . . 0.0 108.698 163.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.4 mt -79.58 128.35 33.27 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.245 0.545 . . . . 0.0 110.789 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -113.23 163.19 15.1 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.708 1.203 . . . . 0.0 108.174 173.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 t -141.44 146.32 36.38 Favored 'General case' 0 C--O 1.244 0.763 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 169.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -138.81 131.54 29.16 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.842 0.857 . . . . 0.0 109.877 -175.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.42 132.16 43.39 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 170.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.452 HG11 HD11 ' A' ' 24' ' ' ILE . 16.1 m -141.6 -169.38 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 125.025 1.33 . . . . 0.0 109.083 -177.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.5 m -113.18 -9.33 13.49 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.85 0.86 . . . . 0.0 109.854 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.39 -36.61 3.69 Favored Glycine 0 C--N 1.357 1.738 0 N-CA-C 112.245 -0.342 . . . . 0.0 112.245 -174.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -67.88 -16.85 64.27 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.505 0.722 . . . . 0.0 110.989 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -67.61 146.74 53.57 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 122.926 0.49 . . . . 0.0 110.313 172.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.682 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 76.7 p -84.74 157.19 21.12 Favored 'General case' 0 C--O 1.244 0.763 0 CA-C-O 121.608 0.718 . . . . 0.0 112.029 -176.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.595 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 82.6 t -60.63 -27.36 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.747 173.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.74 -52.71 48.94 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.009 0.923 . . . . 0.0 111.695 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -64.88 -30.63 71.64 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 119.456 -0.307 . . . . 0.0 111.203 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.459 ' O ' HG21 ' A' ' 28' ' ' VAL . 37.6 mm -58.65 -56.66 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 123.536 0.523 . . . . 0.0 110.631 173.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -68.82 -29.18 67.47 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.449 0.3 . . . . 0.0 110.352 -177.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.471 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . . . -67.51 -40.81 85.15 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.645 0.778 . . . . 0.0 111.335 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -67.5 -40.97 85.18 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.531 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 65.0 t -59.19 -45.03 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.609 174.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.37 -39.11 82.24 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.095 0.958 . . . . 0.0 111.795 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.4 m -63.3 -37.93 89.18 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.728 0.811 . . . . 0.0 111.344 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.5 mt -77.23 -30.12 54.44 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.758 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 28' ' ' VAL . 17.6 mm-40 -78.11 -27.82 48.42 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.914 0.885 . . . . 0.0 110.908 176.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.75 15.54 59.56 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 116.152 -0.476 . . . . 0.0 113.519 -175.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.9 pt -120.2 -176.9 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 124.224 1.01 . . . . 0.0 110.5 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.82 145.75 30.28 Favored Pre-proline 0 CA--C 1.562 1.427 0 C-N-CA 123.312 0.645 . . . . 0.0 111.382 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.471 ' HB3' ' HA ' ' A' ' 26' ' ' ALA . 30.3 Cg_endo -62.7 -21.23 72.78 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 123.165 2.577 . . . . 0.0 113.913 177.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.73 -17.95 65.12 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.026 0.93 . . . . 0.0 111.805 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -80.58 -40.22 26.19 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.591 0.71 . . . . 0.0 110.101 174.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.434 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 24.9 mt-30 -90.13 154.34 19.85 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 114.419 -1.264 . . . . 0.0 112.348 -168.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.4 134.24 17.29 Favored 'Isoleucine or valine' 0 C--O 1.252 1.215 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.51 172.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.621 HG21 HG21 ' A' ' 67' ' ' VAL . 74.5 t -82.24 129.31 37.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.648 177.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.5 mt -117.19 124.02 48.09 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.293 1.437 . . . . 0.0 108.529 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.406 ' HB2' HD13 ' A' ' 48' ' ' LEU . 30.7 tp -100.18 107.62 19.53 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 171.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 61.64 22.85 13.26 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.651 1.18 . . . . 0.0 111.943 -174.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.68 -20.84 38.17 Favored Glycine 0 C--N 1.355 1.594 0 CA-C-N 116.105 -0.498 . . . . 0.0 113.222 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.4 120.47 74.38 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 123.487 0.715 . . . . 0.0 110.628 -176.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.94 121.79 9.82 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.197 2.598 . . . . 0.0 113.033 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.406 HD13 ' HB2' ' A' ' 43' ' ' LEU . 84.9 mt -82.63 152.77 25.75 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 123.76 0.824 . . . . 0.0 109.792 174.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -73.37 110.04 7.36 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.595 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 14.9 p-10 -63.45 -32.77 74.31 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.551 -177.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -71.18 -17.91 62.51 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.935 0.894 . . . . 0.0 111.347 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.32 153.33 22.05 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.693 0.797 . . . . 0.0 111.013 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.682 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 62.9 p -82.09 158.15 23.83 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.67 0.788 . . . . 0.0 110.374 178.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.12 -35.12 79.23 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.873 0.869 . . . . 0.0 111.129 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.08 -46.9 68.19 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.149 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -72.76 -30.1 63.85 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.044 0.537 . . . . 0.0 110.981 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.4 ' SG ' HD21 ' A' ' 48' ' ' LEU . 42.9 t -67.33 -26.65 66.6 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.71 0.804 . . . . 0.0 111.056 173.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.27 22.61 47.42 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.305 177.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.49 HG22 HD22 ' A' ' 65' ' ' LEU . 2.4 p -98.39 131.75 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 176.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -121.08 -168.27 1.64 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.136 0.974 . . . . 0.0 110.881 -172.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 1' ' ' MET . . . -67.44 160.04 28.3 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.296 0.638 . . . . 0.0 111.087 175.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 61.25 19.03 9.73 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.781 1.232 . . . . 0.0 112.399 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.9 m -101.06 161.15 13.8 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.826 0.85 . . . . 0.0 108.826 174.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.8 m -128.33 124.2 35.86 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.495 ' HB3' HG12 ' A' ' 41' ' ' VAL . 3.1 mm? -109.61 128.27 55.11 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 124.795 1.238 . . . . 0.0 108.727 -178.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -93.54 108.17 19.91 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.751 0.82 . . . . 0.0 109.109 -174.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.621 HG21 HG21 ' A' ' 41' ' ' VAL . 76.8 t -94.95 106.09 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -178.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.48 136.34 54.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.281 -176.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 39' ' ' GLN . . . -82.17 89.74 1.46 Allowed Glycine 0 C--N 1.34 0.766 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 176.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -118.73 -21.54 7.81 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.425 0.69 . . . . 0.0 111.327 -175.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.8 ttm . . . . . 0 CA--C 1.546 0.791 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -178.567 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.43 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 26.0 ttt . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -89.86 98.61 11.87 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.602 -175.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.0 pp -114.7 150.4 35.32 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 175.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -87.77 145.45 26.1 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.857 0.863 . . . . 0.0 108.839 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.41 HG13 HG22 ' A' ' 28' ' ' VAL . 73.0 t -125.79 111.35 26.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 170.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -74.73 92.55 2.48 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.282 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.69 -175.39 3.57 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.781 1.232 . . . . 0.0 108.086 170.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -49.32 -28.54 4.97 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.082 0.553 . . . . 0.0 111.613 173.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -122.76 151.17 41.87 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.039 0.935 . . . . 0.0 108.522 161.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -73.22 128.44 35.49 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -177.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -127.6 159.81 33.51 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.504 0.721 . . . . 0.0 110.079 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.8 m -129.2 137.73 51.31 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -130.84 114.85 15.81 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.887 0.875 . . . . 0.0 111.302 -170.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -76.81 103.56 6.83 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 163.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.43 ' O ' ' HB3' ' A' ' 1' ' ' MET . 30.8 m -110.9 169.47 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.893 0.877 . . . . 0.0 109.434 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.1 m -94.93 -28.79 15.0 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.007 0.523 . . . . 0.0 110.108 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.42 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 102.18 -13.1 57.3 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 116.251 -0.432 . . . . 0.0 112.662 -176.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -91.99 -9.39 43.09 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.462 0.705 . . . . 0.0 111.186 -176.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -73.02 152.63 41.23 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 78.2 p -80.72 164.38 22.82 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.516 0.674 . . . . 0.0 109.569 171.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 53.9 t -62.98 -27.21 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.34 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.842 171.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.472 ' HB3' ' HB2' ' A' ' 50' ' ' ASP . . . -64.0 -40.14 95.69 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.404 0.682 . . . . 0.0 111.483 172.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.408 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 85.9 mm-40 -66.91 -36.75 82.98 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.797 0.439 . . . . 0.0 110.515 177.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.9 mm -61.18 -47.76 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.35 0.66 . . . . 0.0 110.417 174.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -55.23 -49.42 72.05 Favored 'General case' 0 C--N 1.359 1.005 0 O-C-N 123.714 0.634 . . . . 0.0 109.943 175.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.68 -48.36 72.5 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.916 0.886 . . . . 0.0 111.904 -178.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -64.87 -45.95 83.87 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.239 0.616 . . . . 0.0 110.853 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.565 HG12 HG22 ' A' ' 67' ' ' VAL . 84.1 t -64.88 -39.97 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 122.632 0.373 . . . . 0.0 110.542 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 34' ' ' ILE . . . -68.65 -32.28 72.02 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.647 0.779 . . . . 0.0 111.763 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.8 t -66.33 -42.02 88.77 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.186 0.594 . . . . 0.0 110.703 173.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.3 mt -70.41 -45.61 65.58 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.082 0.553 . . . . 0.0 112.063 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -88.54 -3.98 58.69 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.498 0.719 . . . . 0.0 111.747 -175.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.54 33.48 72.14 Favored Glycine 0 C--N 1.356 1.675 0 O-C-N 123.529 0.518 . . . . 0.0 113.725 174.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.412 ' O ' ' HB1' ' A' ' 29' ' ' ALA . 9.6 pt -123.01 -179.92 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.035 0.934 . . . . 0.0 110.576 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.58 125.61 53.09 Favored Pre-proline 0 CA--C 1.557 1.24 0 C-N-CA 123.392 0.677 . . . . 0.0 110.931 -176.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.65 -18.87 37.27 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.485 2.123 . . . . 0.0 112.685 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -66.73 -33.94 76.75 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.07 0.948 . . . . 0.0 111.846 -177.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -92.49 -8.08 45.57 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -176.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -80.1 147.05 31.57 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.247 0.546 . . . . 0.0 111.008 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.2 m -130.1 142.25 44.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 168.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 65' ' ' LEU . 73.2 t -106.29 105.53 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.3 mt -87.81 122.5 31.53 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.274 1.03 . . . . 0.0 110.291 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.2 tp -91.27 97.17 10.95 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 167.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 55.96 30.61 16.37 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.252 1.021 . . . . 0.0 112.082 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.1 -23.58 24.98 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-N 115.93 -0.577 . . . . 0.0 113.568 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.43 113.61 38.28 Favored Pre-proline 0 N--CA 1.479 0.977 0 CA-C-N 117.487 0.643 . . . . 0.0 110.929 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -65.92 109.22 1.44 Allowed 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.512 2.142 . . . . 0.0 112.143 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.6 mt -73.76 148.15 42.82 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.738 0.815 . . . . 0.0 110.996 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -77.25 121.88 24.3 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 124.286 0.991 . . . . 0.0 109.989 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.566 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 0.8 OUTLIER -65.75 -21.95 66.55 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 123.913 0.758 . . . . 0.0 112.546 176.142 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -72.39 -26.8 62.02 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.226 0.61 . . . . 0.0 111.099 174.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.89 143.11 27.3 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.767 0.827 . . . . 0.0 111.454 -174.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 45.6 p -73.74 168.06 20.14 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.549 0.74 . . . . 0.0 111.067 172.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.42 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 3.1 mm? -64.46 -30.39 71.43 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 171.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.88 -39.29 93.37 Favored Glycine 0 C--N 1.358 1.755 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.621 173.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -71.24 -37.26 72.0 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.741 0.416 . . . . 0.0 109.9 177.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 40.6 t -66.48 -22.45 66.19 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.414 0.685 . . . . 0.0 111.37 173.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.44 21.31 78.66 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.584 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.2 p -91.58 152.76 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 123.572 0.749 . . . . 0.0 109.606 -176.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -132.21 -168.3 2.02 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.764 0.826 . . . . 0.0 110.948 -176.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.8 167.4 13.49 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.537 0.735 . . . . 0.0 112.491 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 68.14 -5.33 0.9 Allowed 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 126.247 1.819 . . . . 0.0 113.737 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.3 m -77.6 153.71 32.98 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.776 0.83 . . . . 0.0 109.939 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.7 m -119.07 110.16 16.76 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.756 0.822 . . . . 0.0 109.633 175.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.441 ' HB3' HG11 ' A' ' 41' ' ' VAL . 84.8 mt -87.04 144.65 26.79 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 171.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -117.28 121.61 41.65 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.561 0.619 . . . . 0.0 110.857 -175.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.565 HG22 HG12 ' A' ' 28' ' ' VAL . 77.0 t -83.75 115.93 26.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 122.804 0.441 . . . . 0.0 109.971 173.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -123.89 167.21 14.41 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.562 1.145 . . . . 0.0 109.765 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.64 88.88 0.5 Allowed Glycine 0 C--N 1.342 0.871 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -109.35 -36.34 6.03 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.836 0.855 . . . . 0.0 109.706 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 47.4 ttm . . . . . 0 CA--C 1.549 0.904 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.185 175.667 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -102.61 118.39 36.75 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.682 0.793 . . . . 0.0 110.252 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 pp -133.55 165.26 25.31 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.302 0.641 . . . . 0.0 110.35 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -101.05 142.39 32.58 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.057 0.943 . . . . 0.0 109.528 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.1 t -125.46 109.62 22.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 C-N-CA 123.903 0.881 . . . . 0.0 108.674 171.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 35.5 ttt85 -79.48 95.35 5.78 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.084 1.353 . . . . 0.0 110.862 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.17 -174.82 3.33 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.582 1.153 . . . . 0.0 108.032 165.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -42.15 -36.18 1.12 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 123.567 0.747 . . . . 0.0 111.62 167.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -111.05 136.25 50.34 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 164.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -70.88 123.28 21.62 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 173.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -126.1 154.42 43.13 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.498 0.719 . . . . 0.0 109.769 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.3 m -113.91 143.15 45.18 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.812 0.845 . . . . 0.0 108.809 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -136.61 129.36 30.66 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.793 0.837 . . . . 0.0 110.043 -174.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -90.74 114.71 27.13 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 166.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.3 m -115.37 155.48 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.192 0.997 . . . . 0.0 110.463 -169.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.0 m -83.03 -9.9 59.03 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -171.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.5 -50.68 4.07 Favored Glycine 0 C--N 1.358 1.776 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -174.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -79.65 7.06 9.11 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.855 0.862 . . . . 0.0 110.802 167.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -59.57 121.05 10.6 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.765 1.226 . . . . 0.0 109.176 168.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.674 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 51.1 p -78.88 167.41 21.19 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 118.765 0.711 . . . . 0.0 110.385 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.52 HG22 ' HB3' ' A' ' 48' ' ' LEU . 80.3 t -67.52 -32.52 57.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 123.157 0.583 . . . . 0.0 110.069 174.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.65 -36.43 84.25 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.601 0.761 . . . . 0.0 110.635 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -69.3 -40.86 77.43 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.307 0.643 . . . . 0.0 110.963 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.526 HD12 HD13 ' A' ' 54' ' ' LEU . 40.9 mm -57.95 -45.82 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.591 0.757 . . . . 0.0 110.151 175.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.557 ' HE2' ' HA ' ' A' ' 40' ' ' VAL . 92.6 mttt -59.6 -49.59 77.19 Favored 'General case' 0 C--O 1.21 -1.017 0 O-C-N 124.52 1.137 . . . . 0.0 110.603 176.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.01 -42.96 91.36 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.007 0.923 . . . . 0.0 112.025 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -59.41 -53.15 61.45 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.871 0.868 . . . . 0.0 111.019 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.438 HG11 HG22 ' A' ' 67' ' ' VAL . 11.6 p -75.39 -27.57 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.46 -175.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.77 -37.15 79.13 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.726 0.81 . . . . 0.0 110.985 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.4 t -67.13 -40.88 86.87 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 123.39 0.431 . . . . 0.0 110.44 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.1 mt -61.9 -49.71 75.11 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 123.445 0.466 . . . . 0.0 111.916 176.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 28' ' ' VAL . 3.2 mm-40 -86.58 -3.43 59.02 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.115 0.566 . . . . 0.0 111.693 -175.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.56 16.87 70.21 Favored Glycine 0 C--N 1.357 1.711 0 O-C-N 123.315 0.384 . . . . 0.0 113.285 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 36.1 pt -98.65 175.84 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.936 0.894 . . . . 0.0 110.937 -175.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.39 133.29 38.75 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.814 0.846 . . . . 0.0 110.355 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -66.76 -16.77 51.2 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.699 2.266 . . . . 0.0 111.964 171.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -76.71 -19.34 57.8 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.642 0.777 . . . . 0.0 111.579 174.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -97.89 19.7 13.38 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.588 0.755 . . . . 0.0 111.131 -172.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -152.87 166.43 32.34 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.651 -0.656 . . . . 0.0 112.024 -172.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.557 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . 11.2 p -142.29 149.22 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.653 1.181 . . . . 0.0 108.993 172.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.432 ' HB ' HG11 ' A' ' 21' ' ' VAL . 63.1 t -102.65 132.55 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.22 0.608 . . . . 0.0 109.638 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.438 HD11 ' HA ' ' A' ' 47' ' ' PRO . 2.7 mm? -117.75 113.54 21.99 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.648 1.579 . . . . 0.0 108.657 -174.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.541 HD11 ' HB ' ' A' ' 59' ' ' VAL . 2.9 tt -80.15 98.26 7.24 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 57.85 26.48 13.29 Favored 'General case' 0 CA--C 1.556 1.175 0 O-C-N 124.007 0.817 . . . . 0.0 111.842 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.27 -18.79 32.85 Favored Glycine 0 C--N 1.357 1.719 0 CA-C-N 115.927 -0.578 . . . . 0.0 114.207 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.84 117.31 67.81 Favored Pre-proline 0 N--CA 1.483 1.184 0 C-N-CA 123.516 0.726 . . . . 0.0 111.422 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.438 ' HA ' HD11 ' A' ' 42' ' ' LEU . 36.3 Cg_endo -62.11 108.95 0.73 Allowed 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.09 2.527 . . . . 0.0 113.204 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.52 ' HB3' HG22 ' A' ' 21' ' ' VAL . 73.7 mt -82.78 139.97 33.27 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.133 177.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -80.56 131.9 35.58 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.024 0.93 . . . . 0.0 110.334 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.24 -49.87 22.4 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.038 1.335 . . . . 0.0 113.628 -174.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -18.79 49.89 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.955 0.502 . . . . 0.0 112.173 -173.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.73 140.36 45.92 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.107 0.563 . . . . 0.0 110.791 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.674 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 47.6 p -85.43 170.87 12.28 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.734 0.414 . . . . 0.0 110.673 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.526 HD13 HD12 ' A' ' 24' ' ' ILE . 36.8 mt -68.74 -29.93 68.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.117 0.567 . . . . 0.0 111.117 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.02 -42.39 92.52 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.05 172.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -68.89 -31.34 70.19 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.842 0.857 . . . . 0.0 111.271 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 79.0 m -71.96 -28.87 63.73 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.304 0.642 . . . . 0.0 110.635 172.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.76 22.07 54.23 Favored Glycine 0 C--N 1.348 1.21 0 O-C-N 123.495 0.497 . . . . 0.0 112.91 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.541 ' HB ' HD11 ' A' ' 43' ' ' LEU . 7.5 p -96.94 135.7 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.44 0.696 . . . . 0.0 110.235 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -106.77 -168.57 1.43 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.247 1.019 . . . . 0.0 109.925 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.35 175.79 6.6 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.107 0.563 . . . . 0.0 111.26 176.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 58.59 26.02 13.91 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.869 1.268 . . . . 0.0 112.439 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.6 m -111.63 153.94 25.61 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.854 0.862 . . . . 0.0 109.832 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 54.5 m -114.44 108.82 17.39 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.08 0.552 . . . . 0.0 109.889 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.57 149.96 21.03 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 171.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -125.19 139.25 53.91 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 119.087 0.858 . . . . 0.0 110.758 -176.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.438 HG22 HG11 ' A' ' 28' ' ' VAL . 77.1 t -97.14 122.23 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.526 0.731 . . . . 0.0 110.071 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -118.3 149.91 40.36 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.426 0.69 . . . . 0.0 110.543 173.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.39 90.57 1.68 Allowed Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -123.3 10.29 9.25 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.708 0.803 . . . . 0.0 110.422 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 37.7 tpp -140.18 160.82 39.09 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.868 0.467 . . . . 0.0 110.698 -169.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -149.47 -44.6 0.14 Allowed 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 135.14 -116.81 1.61 Allowed Glycine 0 C--N 1.342 0.883 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.659 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.279 0 CA-C-O 119.113 -0.826 . . . . 0.0 111.624 177.023 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.498 ' HE3' HD21 ' A' ' 3' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 30.1 tt0 -145.26 123.06 11.9 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.498 HD21 ' HE3' ' A' ' 1' ' ' MET . 4.6 pp -119.9 166.79 12.85 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.312 0.577 . . . . 0.0 110.715 -174.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -102.57 137.62 40.57 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.9 t -107.15 114.39 46.01 Favored 'Isoleucine or valine' 0 C--O 1.248 0.995 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 172.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.5 ttt85 -83.09 90.51 7.06 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.231 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.59 -176.8 3.19 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 114.373 -1.285 . . . . 0.0 107.988 174.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -43.66 -29.22 0.48 Allowed 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 124.352 1.061 . . . . 0.0 112.316 170.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -135.68 140.89 44.82 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.908 1.283 . . . . 0.0 107.921 166.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.9 126.28 30.09 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.24 0.616 . . . . 0.0 110.076 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -119.96 160.38 22.87 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.058 0.943 . . . . 0.0 108.93 172.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.0 m -124.58 131.65 53.47 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -132.16 126.51 33.8 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.598 0.759 . . . . 0.0 109.939 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 11.3 pt-20 -89.15 135.54 33.51 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.097 0.475 . . . . 0.0 109.764 173.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.467 ' O ' ' HB3' ' A' ' 1' ' ' MET . 30.1 m -134.74 150.21 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.8 0.84 . . . . 0.0 109.598 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.1 p -93.58 12.51 25.03 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.164 0.585 . . . . 0.0 111.26 172.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.409 ' O ' ' HB ' ' A' ' 53' ' ' THR . . . 93.62 -35.4 4.16 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-O 119.647 -0.529 . . . . 0.0 112.798 176.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -68.0 -21.13 65.06 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.974 0.91 . . . . 0.0 112.301 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -62.0 134.64 56.9 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 26.4 p -82.6 168.6 17.16 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.36 0.6 . . . . 0.0 110.637 174.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.528 HG21 ' HB3' ' A' ' 48' ' ' LEU . 55.9 t -63.16 -32.78 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.425 170.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' A' ' 50' ' ' ASP . . . -60.74 -42.42 97.31 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.36 0.664 . . . . 0.0 111.064 173.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -67.83 -37.47 81.95 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.348 0.259 . . . . 0.0 111.232 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.402 HD13 HD22 ' A' ' 54' ' ' LEU . 44.0 mm -57.32 -48.1 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 122.837 0.455 . . . . 0.0 110.032 173.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 21' ' ' VAL . 96.6 mttt -61.26 -40.81 95.44 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.783 0.833 . . . . 0.0 111.223 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.87 -43.56 94.64 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.884 0.874 . . . . 0.0 112.069 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -65.54 -42.59 91.77 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.034 0.533 . . . . 0.0 111.044 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.8 t -64.71 -39.88 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.086 0.555 . . . . 0.0 109.76 176.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.98 -35.19 79.36 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.258 1.023 . . . . 0.0 112.316 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.5 m -64.81 -50.13 67.92 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.345 0.658 . . . . 0.0 110.843 175.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.5 mt -71.59 -38.44 70.89 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -174.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -91.35 -14.61 30.43 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.055 0.542 . . . . 0.0 111.662 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.92 27.26 69.17 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 116.405 -0.362 . . . . 0.0 112.565 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.2 pt -108.09 177.97 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.793 0.837 . . . . 0.0 109.795 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.27 138.92 20.62 Favored Pre-proline 0 N--CA 1.478 0.957 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.61 -20.48 70.95 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 123.296 2.664 . . . . 0.0 113.053 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -67.95 -35.36 78.27 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.573 0.749 . . . . 0.0 111.006 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 71' ' ' MET . 10.6 m-20 -73.26 -18.06 61.26 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.073 0.549 . . . . 0.0 112.261 -172.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.53 ' HB2' HG11 ' A' ' 67' ' ' VAL . 12.3 pt20 -112.95 151.22 30.8 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.399 0.679 . . . . 0.0 111.074 -174.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -132.12 132.94 61.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 124.744 1.218 . . . . 0.0 107.986 171.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.6 t -88.78 131.2 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.0 mt -122.93 115.19 21.52 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.952 1.301 . . . . 0.0 108.983 -174.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.509 ' HB2' HD11 ' A' ' 48' ' ' LEU . 42.2 tp -81.94 95.14 7.28 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 176.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 56.97 24.52 9.55 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.058 0.943 . . . . 0.0 112.027 -174.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.6 -8.19 37.1 Favored Glycine 0 C--N 1.354 1.528 0 CA-C-O 119.597 -0.557 . . . . 0.0 113.86 -177.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.72 118.84 74.55 Favored Pre-proline 0 N--CA 1.483 1.211 0 CA-C-N 117.444 0.622 . . . . 0.0 110.849 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.29 102.04 0.31 Allowed 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.746 2.298 . . . . 0.0 112.519 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.528 ' HB3' HG21 ' A' ' 21' ' ' VAL . 67.1 mt -81.0 134.4 35.67 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.463 177.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -82.52 139.0 34.14 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.834 0.854 . . . . 0.0 110.333 -176.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.487 ' HB3' ' HB3' ' A' ' 22' ' ' ALA . 2.0 m-20 -59.96 -30.13 68.88 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.792 0.837 . . . . 0.0 111.835 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -73.35 -25.55 60.65 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.215 1.006 . . . . 0.0 111.206 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.98 131.74 35.87 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.921 -174.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 81.1 p -80.59 167.71 19.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.27 0.628 . . . . 0.0 109.541 172.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.402 HD22 HD13 ' A' ' 24' ' ' ILE . 2.7 mm? -65.51 -30.66 71.45 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.241 0.473 . . . . 0.0 110.42 176.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.27 -36.0 70.33 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.511 173.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -72.11 -38.05 69.4 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.465 0.706 . . . . 0.0 110.638 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 76.6 m -71.32 -18.63 62.39 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.905 0.882 . . . . 0.0 111.088 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.92 29.52 75.21 Favored Glycine 0 C--N 1.352 1.431 0 O-C-N 123.497 0.498 . . . . 0.0 112.663 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.453 HG23 HD12 ' A' ' 65' ' ' LEU . 4.5 p -87.08 133.29 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -81.77 174.24 11.52 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.505 0.722 . . . . 0.0 110.979 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.403 ' HB3' ' HA ' ' A' ' 1' ' ' MET . . . -72.71 160.37 32.33 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.784 175.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 64.84 12.16 7.52 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.743 1.617 . . . . 0.0 112.96 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.4 m -85.11 154.37 22.08 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.3 m -114.32 116.08 28.4 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.146 0.498 . . . . 0.0 110.181 -177.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.453 HD12 HG23 ' A' ' 59' ' ' VAL . 6.9 mp -103.57 122.14 44.36 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.085 1.354 . . . . 0.0 108.142 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -94.71 145.32 24.93 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.025 0.53 . . . . 0.0 111.841 -171.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.53 HG11 ' HB2' ' A' ' 39' ' ' GLN . 73.6 t -94.12 135.97 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 124.211 1.004 . . . . 0.0 109.989 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.63 141.26 51.67 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.113 0.965 . . . . 0.0 109.503 171.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.14 92.06 1.52 Allowed Glycine 0 N--CA 1.472 1.065 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -121.97 -68.5 0.89 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 117.321 0.561 . . . . 0.0 111.959 -172.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.449 ' O ' ' HA ' ' A' ' 38' ' ' ASP . 51.2 tpp -61.61 140.04 58.19 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.456 0.703 . . . . 0.0 111.141 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -150.13 117.64 6.12 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -135.22 43.81 1.22 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.217 0 CA-C-O 119.2 -0.778 . . . . 0.0 112.303 -178.22 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 60.8 tt0 -122.14 114.33 20.73 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.922 0.889 . . . . 0.0 109.389 -175.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.3 pp -120.79 165.13 15.57 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.938 0.495 . . . . 0.0 111.635 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -98.51 152.24 19.76 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.636 0.774 . . . . 0.0 109.254 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.7 t -135.13 109.31 10.99 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 C-N-CA 124.767 1.227 . . . . 0.0 108.179 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -76.33 92.83 3.37 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.866 0.866 . . . . 0.0 110.776 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.31 -176.87 4.26 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.297 1.039 . . . . 0.0 108.398 165.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -47.55 -30.15 3.35 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.17 0.588 . . . . 0.0 112.156 171.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -124.0 144.07 50.04 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.175 0.99 . . . . 0.0 108.661 161.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.86 133.95 47.94 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 122.947 0.499 . . . . 0.0 110.391 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -131.02 148.49 52.76 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.837 0.855 . . . . 0.0 109.406 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.2 m -119.5 133.74 55.54 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -128.45 119.3 24.66 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.977 0.911 . . . . 0.0 109.997 -175.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 42.0 tt0 -95.35 104.43 16.32 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 171.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.0 m -112.8 174.44 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.126 0.97 . . . . 0.0 110.864 -172.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.7 m -83.09 -45.53 13.88 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.678 0.791 . . . . 0.0 110.106 174.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.23 -35.06 3.2 Favored Glycine 0 C--N 1.35 1.321 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -174.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -65.55 -10.13 32.42 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.476 0.71 . . . . 0.0 111.53 173.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -52.64 129.08 28.3 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.854 1.261 . . . . 0.0 110.408 169.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.658 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 45.5 p -84.77 164.73 18.33 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 118.272 0.487 . . . . 0.0 109.94 173.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.447 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 68.4 t -67.22 -30.27 48.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.235 174.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 50' ' ' ASP . . . -62.12 -40.42 95.85 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.572 0.749 . . . . 0.0 110.802 174.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -68.5 -40.17 81.0 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.746 177.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.9 mm -57.97 -42.84 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 123.229 0.612 . . . . 0.0 110.529 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.429 ' HE2' ' HA ' ' A' ' 40' ' ' VAL . 94.9 mttt -59.43 -51.87 68.04 Favored 'General case' 0 C--N 1.359 0.998 0 O-C-N 123.975 0.797 . . . . 0.0 110.015 174.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.61 -42.97 75.63 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.861 0.726 . . . . 0.0 111.924 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.411 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 48.5 m-70 -61.54 -54.62 40.79 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.686 0.794 . . . . 0.0 111.655 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.485 HG13 HG22 ' A' ' 67' ' ' VAL . 12.8 p -72.42 -30.01 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.637 -174.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.404 ' HB1' ' NE2' ' A' ' 39' ' ' GLN . . . -72.45 -34.69 67.95 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.388 0.675 . . . . 0.0 111.526 177.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 t -67.16 -37.65 84.12 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.957 0.503 . . . . 0.0 110.309 176.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 27' ' ' HIS . 88.5 mt -63.4 -45.81 89.29 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 123.705 0.628 . . . . 0.0 111.711 177.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.15 -20.0 45.93 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.082 0.553 . . . . 0.0 111.785 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.27 30.81 66.73 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 112.014 -0.434 . . . . 0.0 112.014 -173.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.3 pt -111.57 179.83 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.189 0.996 . . . . 0.0 110.634 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.74 123.43 88.34 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 124.237 1.015 . . . . 0.0 112.576 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.23 -31.59 35.41 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 122.548 2.165 . . . . 0.0 112.567 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.98 5.95 34.69 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.34 0.656 . . . . 0.0 112.062 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -78.83 -31.45 45.77 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 122.35 1.071 . . . . 0.0 109.205 166.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.404 ' NE2' ' HB1' ' A' ' 29' ' ' ALA . 18.8 mt-30 -89.85 147.39 23.8 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 113.725 -1.579 . . . . 0.0 112.337 -167.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.429 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . 7.7 p -131.05 129.18 63.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 165.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.446 ' HB ' HG13 ' A' ' 21' ' ' VAL . 59.3 t -87.89 131.69 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.6 mt -118.59 148.78 42.33 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.927 1.291 . . . . 0.0 109.519 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.432 ' HB2' HD12 ' A' ' 48' ' ' LEU . 42.3 tp -131.44 102.15 5.82 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 171.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 58.66 33.83 23.37 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.457 1.103 . . . . 0.0 111.398 -175.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.84 -24.01 33.96 Favored Glycine 0 C--N 1.354 1.554 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.297 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.35 119.4 76.84 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 123.325 0.65 . . . . 0.0 110.506 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.28 106.44 1.02 Allowed 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.881 2.387 . . . . 0.0 111.964 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.432 HD12 ' HB2' ' A' ' 43' ' ' LEU . 90.8 mt -69.56 124.12 23.1 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.356 0.663 . . . . 0.0 110.014 173.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -72.46 131.7 42.9 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.366 0.666 . . . . 0.0 110.63 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.476 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 7.8 p-10 -58.79 -36.79 75.01 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.008 0.923 . . . . 0.0 112.832 -173.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -74.75 -25.72 59.29 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.1 0.56 . . . . 0.0 111.05 -176.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.72 139.51 40.49 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.504 0.722 . . . . 0.0 110.609 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.658 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 53.2 p -83.67 170.36 14.34 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.925 0.393 . . . . 0.0 110.751 177.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.7 mp -72.8 -26.48 61.53 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.9 0.88 . . . . 0.0 110.292 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.3 -43.19 71.79 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.037 172.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -64.42 -39.16 93.3 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.237 0.615 . . . . 0.0 110.77 175.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 46.1 t -63.73 -31.35 72.49 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.624 0.77 . . . . 0.0 111.406 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.38 23.96 69.43 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.272 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.429 HG22 HG22 ' A' ' 63' ' ' THR . 14.7 p -79.44 150.24 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.072 0.549 . . . . 0.0 109.551 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -127.42 -171.68 2.48 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.362 0.665 . . . . 0.0 111.262 -169.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.76 154.8 41.31 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.468 0.707 . . . . 0.0 111.404 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 62.9 1.48 0.84 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 126.183 1.793 . . . . 0.0 114.06 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.429 HG22 HG22 ' A' ' 59' ' ' VAL . 32.3 m -72.37 147.76 45.94 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 47.1 m -113.34 103.71 11.58 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 122.072 -0.393 . . . . 0.0 109.951 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.402 HD21 HD13 ' A' ' 43' ' ' LEU . 62.2 mt -78.18 169.92 17.46 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 170.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -136.08 155.16 50.62 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.485 HG22 HG13 ' A' ' 28' ' ' VAL . 48.7 t -120.38 126.55 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.263 1.025 . . . . 0.0 108.956 175.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.01 142.65 51.5 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.671 0.789 . . . . 0.0 109.805 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.24 89.79 1.64 Allowed Glycine 0 C--N 1.342 0.909 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -130.03 5.06 4.91 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.89 0.876 . . . . 0.0 110.72 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.1 ttm -124.67 149.43 47.18 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.438 0.695 . . . . 0.0 109.403 -170.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 pp -166.44 176.86 7.09 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.362 0.665 . . . . 0.0 111.554 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.14 12.58 84.49 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 114.731 0.652 . . . . 0.0 114.731 173.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.134 0 CA-C-O 118.858 -0.968 . . . . 0.0 112.59 178.834 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.444 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 44.1 ttm . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -91.01 105.03 17.54 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 170.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.5 pp -114.85 163.89 14.89 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.645 0.778 . . . . 0.0 109.985 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -107.41 158.8 16.88 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.513 0.725 . . . . 0.0 109.391 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.9 t -129.66 111.88 23.09 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 C-N-CA 124.037 0.935 . . . . 0.0 109.884 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -70.89 91.33 0.85 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.111 0.964 . . . . 0.0 109.42 173.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.03 -179.37 3.9 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 125.478 1.511 . . . . 0.0 107.808 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -59.21 -33.16 70.65 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 118.581 0.628 . . . . 0.0 109.715 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -111.18 127.5 55.61 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 165.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.99 120.07 14.28 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 -111.33 158.3 19.19 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.571 0.749 . . . . 0.0 109.622 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.7 m -134.0 135.73 43.61 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.297 1.039 . . . . 0.0 108.735 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -133.06 124.79 28.28 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.88 0.872 . . . . 0.0 110.46 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -98.1 105.74 17.93 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 170.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.476 HG11 HD13 ' A' ' 24' ' ' ILE . 28.8 m -120.53 157.77 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.952 1.301 . . . . 0.0 109.412 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.603 ' HB ' ' HG2' ' A' ' 18' ' ' GLN . 20.4 m -75.94 -14.24 60.25 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-O 121.058 0.456 . . . . 0.0 110.907 173.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.439 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 103.26 -31.79 8.32 Favored Glycine 0 C--N 1.351 1.411 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -172.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.603 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 12.6 pt20 -70.74 -4.43 23.74 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.924 0.89 . . . . 0.0 112.304 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -79.23 145.5 33.55 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.754 0.422 . . . . 0.0 109.936 175.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.6 p -82.38 153.46 25.72 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.181 0.515 . . . . 0.0 111.134 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.0 t -62.35 -28.17 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 124.277 1.031 . . . . 0.0 110.522 175.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.62 -50.09 75.23 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 124.331 1.052 . . . . 0.0 110.793 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -67.43 -36.15 80.66 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.312 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.476 HD13 HG11 ' A' ' 15' ' ' VAL . 48.0 mm -57.59 -54.86 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 O-C-N 123.829 0.705 . . . . 0.0 110.301 177.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -73.0 -27.9 62.05 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.105 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.15 -46.48 90.35 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.52 0.728 . . . . 0.0 110.571 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -66.08 -40.18 90.63 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.266 0.627 . . . . 0.0 110.348 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.482 HG13 HG21 ' A' ' 67' ' ' VAL . 72.6 t -56.92 -49.72 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 173.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.33 -34.86 77.47 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.048 0.939 . . . . 0.0 112.609 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.5 t -65.58 -36.74 84.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.488 0.715 . . . . 0.0 110.746 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.1 mt -80.45 -34.84 35.69 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.933 0.893 . . . . 0.0 112.24 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.49 ' HB2' HG12 ' A' ' 34' ' ' ILE . 6.1 mm-40 -75.65 -36.14 60.24 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.891 0.876 . . . . 0.0 110.172 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.93 36.5 15.28 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.479 -171.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.49 HG12 ' HB2' ' A' ' 32' ' ' GLU . 25.0 pt -127.2 -179.56 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 123.897 0.879 . . . . 0.0 111.03 -176.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.18 114.19 37.75 Favored Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 123.937 0.895 . . . . 0.0 112.218 -176.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.85 -33.1 85.38 Favored 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 123.521 2.814 . . . . 0.0 114.009 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.487 ' HG3' ' H ' ' A' ' 74' ' ' GLY . 1.3 pm0 -69.39 -37.56 77.58 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.247 0.342 . . . . 0.0 110.691 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -64.84 -44.55 89.44 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 123.812 0.695 . . . . 0.0 111.116 -170.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.553 ' HB2' HG12 ' A' ' 67' ' ' VAL . 11.7 pt20 -75.75 150.96 37.69 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.976 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.2 144.15 37.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 124.975 1.31 . . . . 0.0 108.139 175.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.7 t -90.46 133.35 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 122.915 0.486 . . . . 0.0 109.86 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 66.5 mt -117.28 108.87 16.15 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.896 1.278 . . . . 0.0 108.961 -176.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.2 tp -80.44 96.63 6.79 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 175.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 57.85 28.34 15.9 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.059 0.944 . . . . 0.0 112.036 -176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.46 -25.38 19.84 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-O 119.608 -0.551 . . . . 0.0 113.556 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.3 113.54 32.18 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 123.132 0.573 . . . . 0.0 110.563 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -64.61 115.15 3.05 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.501 2.134 . . . . 0.0 111.526 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 93.2 mt -79.86 158.16 26.81 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.537 0.735 . . . . 0.0 111.358 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -86.29 128.71 34.96 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -62.57 -36.59 83.16 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 121.057 0.456 . . . . 0.0 110.911 -176.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -78.8 -9.41 59.44 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.736 0.815 . . . . 0.0 111.843 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.87 148.16 24.77 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 123.356 0.662 . . . . 0.0 109.974 175.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.4 p -92.34 166.34 12.63 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.467 0.707 . . . . 0.0 110.62 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.439 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 3.5 mm? -65.19 -28.47 69.41 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.638 0.775 . . . . 0.0 110.107 175.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.1 -37.02 44.24 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.231 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -67.76 -41.85 82.7 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.019 0.527 . . . . 0.0 110.05 174.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 80.7 m -63.5 -25.84 68.44 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.144 0.578 . . . . 0.0 110.773 174.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.99 25.88 70.32 Favored Glycine 0 C--N 1.35 1.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.667 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.414 HG12 HD12 ' A' ' 54' ' ' LEU . 7.7 p -81.52 160.81 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 122.891 0.477 . . . . 0.0 109.795 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -110.87 -177.08 3.13 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.395 0.678 . . . . 0.0 110.67 -178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.444 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -76.86 166.25 23.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.294 0.638 . . . . 0.0 111.022 177.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 67.92 6.29 5.05 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.965 1.306 . . . . 0.0 112.909 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.1 m -79.94 150.89 30.36 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.164 0.585 . . . . 0.0 109.746 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.2 m -117.17 112.06 20.32 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.4 mp -96.42 146.9 24.36 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 124.65 1.18 . . . . 0.0 108.112 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -102.01 156.21 17.68 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.065 0.546 . . . . 0.0 110.88 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.553 HG12 ' HB2' ' A' ' 39' ' ' GLN . 6.6 t -118.62 131.29 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.368 1.067 . . . . 0.0 109.311 173.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.32 126.74 20.08 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.121 0.968 . . . . 0.0 109.992 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 39' ' ' GLN . . . -75.97 96.01 1.06 Allowed Glycine 0 C--N 1.344 0.982 0 N-CA-C 111.961 -0.455 . . . . 0.0 111.961 -178.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -120.6 -68.38 0.91 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.778 0.831 . . . . 0.0 111.438 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 21.3 mmt -88.23 78.65 8.02 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.712 0.405 . . . . 0.0 111.862 -168.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.63 109.92 2.17 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.272 0.629 . . . . 0.0 109.608 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.85 -61.45 2.55 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.043 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.487 ' H ' ' HG3' ' A' ' 37' ' ' GLU . . . . . . . . 0 C--O 1.247 0.955 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.926 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.466 ' HE2' HD22 ' A' ' 3' ' ' LEU . 20.8 ttt . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -85.32 127.54 34.37 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.466 HD22 ' HE2' ' A' ' 1' ' ' MET . 4.4 pp -136.2 167.24 21.65 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -109.64 147.95 32.18 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.112 0.565 . . . . 0.0 109.8 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.6 t -122.26 109.09 23.28 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 C-N-CA 125.128 1.371 . . . . 0.0 108.059 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -79.76 91.69 5.34 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.462 -1.244 . . . . 0.0 109.58 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.8 -177.84 3.49 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 114.262 -1.335 . . . . 0.0 108.345 177.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -52.29 -27.49 15.36 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.29 0.567 . . . . 0.0 110.847 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.415 ' HB2' ' HE2' ' A' ' 11' ' ' HIS . 14.2 mm-40 -117.36 141.07 48.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.006 1.322 . . . . 0.0 108.468 163.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -83.29 109.45 17.27 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.436 ' CD2' HG22 ' A' ' 28' ' ' VAL . 88.9 m-70 -110.61 132.46 54.17 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.694 0.798 . . . . 0.0 109.704 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.4 t -106.07 136.09 46.37 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -125.63 128.03 47.24 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.695 0.798 . . . . 0.0 109.923 -176.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -90.11 104.82 17.35 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 170.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.8 m -111.85 172.35 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.362 1.065 . . . . 0.0 109.428 176.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.1 m -107.49 -9.96 15.83 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.376 0.671 . . . . 0.0 109.801 174.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.525 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 108.41 -35.78 4.76 Favored Glycine 0 C--N 1.353 1.473 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.754 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -4.89 39.47 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -176.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -78.11 147.33 34.69 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.854 0.462 . . . . 0.0 109.815 170.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.633 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 61.7 p -86.42 164.59 16.92 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.349 0.595 . . . . 0.0 111.745 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.409 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 71.3 t -66.32 -27.69 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.04 172.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.69 -41.86 95.74 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.83 0.852 . . . . 0.0 110.664 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -69.62 -38.97 77.45 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.608 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 27.9 mm -54.49 -45.59 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 123.661 0.784 . . . . 0.0 110.387 173.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 21' ' ' VAL . 92.4 mttt -61.35 -49.2 77.9 Favored 'General case' 0 C--N 1.36 1.061 0 O-C-N 124.049 0.843 . . . . 0.0 111.068 176.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.85 -38.54 78.97 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 124.328 1.017 . . . . 0.0 111.365 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -61.27 -58.14 9.49 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.726 0.811 . . . . 0.0 110.961 177.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.436 HG22 ' CD2' ' A' ' 11' ' ' HIS . 6.3 p -66.8 -30.94 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.449 -174.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.26 -43.39 77.92 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.935 0.894 . . . . 0.0 111.444 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.1 t -61.79 -41.5 97.82 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.384 0.673 . . . . 0.0 110.597 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.7 mt -65.0 -49.99 68.07 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.932 0.893 . . . . 0.0 111.863 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -90.44 -2.71 57.95 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.341 0.656 . . . . 0.0 112.185 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.1 17.82 77.47 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-O 120.159 -0.245 . . . . 0.0 113.511 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.1 pt -102.08 -179.1 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.939 0.895 . . . . 0.0 110.248 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.45 ' HB1' ' HG2' ' A' ' 37' ' ' GLU . . . -102.69 133.82 20.23 Favored Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 123.052 0.541 . . . . 0.0 111.756 -175.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.448 ' HA ' ' HG2' ' A' ' 39' ' ' GLN . 68.3 Cg_endo -70.61 -17.84 33.43 Favored 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 122.678 2.252 . . . . 0.0 111.583 175.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.45 ' HG2' ' HB1' ' A' ' 35' ' ' ALA . 10.0 pt-20 -89.4 -2.16 58.31 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.924 1.29 . . . . 0.0 112.012 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.403 ' HB2' ' HA3' ' A' ' 73' ' ' GLY . 30.2 t70 -107.62 -20.8 13.12 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.532 0.733 . . . . 0.0 110.164 175.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.489 ' HB2' HG13 ' A' ' 67' ' ' VAL . 11.3 pt20 -106.79 157.85 17.43 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.703 0.763 . . . . 0.0 110.671 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.6 m -132.37 158.98 43.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 C-N-CA 125.166 1.386 . . . . 0.0 108.356 169.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.473 HG11 HD11 ' A' ' 48' ' ' LEU . 66.2 t -111.68 124.6 68.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 176.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.5 mt -108.44 154.14 22.3 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 124.902 1.281 . . . . 0.0 109.346 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.2 tp -130.91 106.67 8.58 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 169.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 59.92 24.42 13.5 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.005 0.922 . . . . 0.0 111.317 -174.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.53 -28.47 14.86 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.155 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.99 120.59 80.36 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.101 0.56 . . . . 0.0 110.767 -174.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.04 106.22 0.64 Allowed 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 123.082 2.521 . . . . 0.0 112.407 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.473 HD11 HG11 ' A' ' 41' ' ' VAL . 80.2 mt -68.13 121.24 15.73 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.967 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -60.19 126.63 28.26 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.968 0.793 . . . . 0.0 110.004 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -58.85 -43.28 90.72 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.447 0.699 . . . . 0.0 111.846 -174.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -77.14 -17.62 58.49 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.639 0.375 . . . . 0.0 111.441 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.77 133.63 40.65 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.633 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 55.2 p -78.2 168.26 20.12 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.696 0.798 . . . . 0.0 110.537 177.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.525 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 2.5 mm? -61.49 -35.54 77.96 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 120.958 0.409 . . . . 0.0 110.165 177.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.37 -33.77 61.22 Favored Glycine 0 C--N 1.355 1.625 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.536 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -72.57 -37.69 68.12 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.215 0.606 . . . . 0.0 110.681 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 78.6 m -68.23 -28.6 67.37 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.35 0.66 . . . . 0.0 110.321 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.35 24.98 69.38 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.755 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.584 HG21 HD21 ' A' ' 65' ' ' LEU . 6.2 p -77.87 138.64 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -91.14 178.95 5.85 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.125 0.57 . . . . 0.0 110.95 -175.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.65 160.32 31.75 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.28 0.632 . . . . 0.0 111.205 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 61.4 10.65 3.25 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.454 1.501 . . . . 0.0 113.423 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.1 m -82.53 147.05 28.87 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.097 0.475 . . . . 0.0 110.156 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.4 m -104.59 106.49 17.01 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.841 0.856 . . . . 0.0 109.838 -175.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.584 HD21 HG21 ' A' ' 59' ' ' VAL . 43.9 mt -92.14 128.05 37.85 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.415 1.086 . . . . 0.0 108.444 176.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -99.0 140.97 32.35 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.758 0.708 . . . . 0.0 111.965 -172.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.489 HG13 ' HB2' ' A' ' 39' ' ' GLN . 69.4 t -95.78 125.47 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.067 0.947 . . . . 0.0 109.42 173.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.01 149.35 48.78 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.093 0.957 . . . . 0.0 109.294 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.19 89.28 1.39 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -106.62 -40.3 5.58 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.387 0.675 . . . . 0.0 109.88 176.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 48.4 tpp -75.07 146.97 41.05 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 172.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -103.65 113.28 26.67 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.053 0.454 . . . . 0.0 109.835 -175.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.403 ' HA3' ' HB2' ' A' ' 38' ' ' ASP . . . -101.91 137.14 13.16 Favored Glycine 0 C--N 1.342 0.874 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 172.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.515 0 CA-C-O 119.234 -0.759 . . . . 0.0 113.652 -178.176 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.413 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 22.1 ttt . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 121.312 0.577 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 53.3 tt0 -91.36 140.15 30.05 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.505 HD11 HD11 ' A' ' 65' ' ' LEU . 4.5 pp -146.91 159.85 43.04 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.274 0.63 . . . . 0.0 109.443 176.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -103.45 116.12 31.8 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.696 0.798 . . . . 0.0 109.505 -174.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.1 t -88.72 106.59 16.89 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 170.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.48 ' HB3' ' HA ' ' A' ' 66' ' ' GLU . 19.9 ttt180 -76.86 91.4 3.54 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.527 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -109.55 -176.43 3.01 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 125.347 1.459 . . . . 0.0 108.608 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -46.23 -39.57 10.06 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.538 0.735 . . . . 0.0 112.277 174.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -106.2 156.06 18.84 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 163.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.67 108.63 7.55 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -107.34 141.83 38.09 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.437 0.695 . . . . 0.0 109.505 175.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.7 t -126.8 135.13 50.63 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -128.36 131.55 48.57 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.337 1.055 . . . . 0.0 108.792 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 43.7 tt0 -91.36 113.77 26.12 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 167.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.525 HG23 ' HG ' ' A' ' 54' ' ' LEU . 27.6 m -110.3 144.82 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.953 0.901 . . . . 0.0 110.121 -174.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.6 p -85.95 3.34 42.47 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.073 0.549 . . . . 0.0 111.499 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 89.9 -38.31 3.23 Favored Glycine 0 C--N 1.353 1.495 0 CA-C-O 119.682 -0.51 . . . . 0.0 113.325 175.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -70.25 -19.81 63.1 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.988 0.915 . . . . 0.0 112.459 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -64.9 135.78 56.09 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.331 0.652 . . . . 0.0 109.483 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.673 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 70.1 p -83.59 165.55 18.94 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.326 0.584 . . . . 0.0 111.269 -177.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.6 t -66.42 -29.13 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 123.189 0.596 . . . . 0.0 110.351 174.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.476 ' HB1' ' HB3' ' A' ' 50' ' ' ASP . . . -63.25 -39.9 95.9 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.284 0.634 . . . . 0.0 111.254 173.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -71.66 -35.08 70.23 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.906 0.482 . . . . 0.0 110.955 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 31.4 mm -58.32 -47.12 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.272 0.629 . . . . 0.0 110.384 171.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' A' ' 40' ' ' VAL . 98.6 mttt -61.52 -42.09 98.29 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.212 0.605 . . . . 0.0 111.342 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.81 80.68 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 124.138 0.899 . . . . 0.0 111.586 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.0 m-70 -60.16 -51.08 71.14 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.875 0.47 . . . . 0.0 111.041 175.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.438 HG11 HD13 ' A' ' 34' ' ' ILE . 49.0 t -67.26 -28.49 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.722 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.64 -34.97 62.87 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.875 0.87 . . . . 0.0 111.441 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.7 t -73.43 -40.1 64.49 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.118 0.567 . . . . 0.0 111.053 178.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.5 mt -77.18 -53.08 8.2 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.219 0.607 . . . . 0.0 111.633 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.31 -17.37 46.04 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.558 0.743 . . . . 0.0 111.738 -177.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.33 17.45 78.89 Favored Glycine 0 N--CA 1.471 0.984 0 N-CA-C 112.605 -0.198 . . . . 0.0 112.605 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.438 HD13 HG11 ' A' ' 28' ' ' VAL . 37.0 pt -91.41 166.23 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.596 0.758 . . . . 0.0 111.099 -175.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.99 118.1 67.87 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 123.257 0.623 . . . . 0.0 110.704 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.92 -19.85 51.9 Favored 'Trans proline' 0 C--N 1.387 2.57 0 C-N-CA 122.584 2.189 . . . . 0.0 111.84 176.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -74.41 -29.58 61.57 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.263 1.025 . . . . 0.0 111.836 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -85.93 -41.31 15.04 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.302 0.641 . . . . 0.0 110.697 -175.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.478 ' HB2' HG12 ' A' ' 67' ' ' VAL . 12.9 pt20 -76.58 157.08 32.28 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.998 -172.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.568 HG11 ' HB2' ' A' ' 70' ' ' ARG . 9.8 p -142.39 148.0 20.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 C-N-CA 125.186 1.394 . . . . 0.0 108.297 177.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.1 t -101.56 117.77 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.8 0.84 . . . . 0.0 109.308 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.419 HD21 ' HB3' ' A' ' 68' ' ' ALA . 2.3 mm? -103.89 104.61 14.62 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.47 1.108 . . . . 0.0 109.69 -175.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.3 tp -81.75 97.19 7.83 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 58.31 26.05 13.5 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.952 0.901 . . . . 0.0 112.016 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.5 -19.82 33.29 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.511 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.83 114.99 48.66 Favored Pre-proline 0 N--CA 1.477 0.903 0 C-N-CA 123.456 0.702 . . . . 0.0 111.001 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -67.96 110.88 2.27 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 122.673 2.249 . . . . 0.0 111.018 174.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.5 mt -72.4 170.46 14.2 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.844 177.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -96.05 138.6 33.45 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.476 ' HB3' ' HB1' ' A' ' 22' ' ' ALA . 1.8 m-20 -55.92 -38.67 70.58 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.261 0.624 . . . . 0.0 111.402 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.45 -24.28 46.13 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.748 0.819 . . . . 0.0 111.48 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.97 132.89 42.86 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.061 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.673 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 21.1 p -81.35 173.5 12.4 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.525 ' HG ' HG23 ' A' ' 15' ' ' VAL . 3.3 mm? -64.26 -23.45 67.31 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 118.285 0.493 . . . . 0.0 110.258 174.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.42 -39.26 26.61 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.942 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.449 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 14.5 mm-40 -73.75 -29.75 62.41 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.411 0.684 . . . . 0.0 110.422 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 74.2 m -81.32 -18.17 46.68 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.791 0.837 . . . . 0.0 110.724 172.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.38 33.18 81.29 Favored Glycine 0 C--N 1.353 1.476 0 O-C-N 123.416 0.448 . . . . 0.0 113.461 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.1 t -70.49 135.59 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.336 0.654 . . . . 0.0 110.056 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -93.49 172.15 8.45 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.371 0.668 . . . . 0.0 110.534 176.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.23 165.05 25.44 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.065 0.546 . . . . 0.0 111.277 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 58.31 16.6 4.14 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 125.228 1.411 . . . . 0.0 112.798 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.8 m -90.98 147.84 22.82 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.656 0.782 . . . . 0.0 109.845 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 42.5 m -113.52 105.22 13.09 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.718 0.807 . . . . 0.0 109.26 -175.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.505 HD11 HD11 ' A' ' 3' ' ' LEU . 4.5 mp -103.03 123.44 46.63 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.48 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . 38.0 tt0 -93.56 150.7 20.22 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.9 0.48 . . . . 0.0 111.436 -171.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.478 HG12 ' HB2' ' A' ' 39' ' ' GLN . 73.3 t -104.11 118.59 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.911 0.884 . . . . 0.0 108.932 175.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.419 ' HB3' HD21 ' A' ' 42' ' ' LEU . . . -126.58 165.74 18.59 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.907 0.883 . . . . 0.0 109.669 175.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -98.22 90.12 1.02 Allowed Glycine 0 N--CA 1.471 0.977 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 175.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.568 ' HB2' HG11 ' A' ' 40' ' ' VAL . 73.7 mtp180 -134.74 17.29 3.57 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.407 0.683 . . . . 0.0 110.8 -176.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.471 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 44.5 tpp -129.71 156.05 44.91 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.489 ' H ' HD23 ' A' ' 72' ' ' LEU . 2.5 pt? -120.29 1.89 10.79 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.45 0.7 . . . . 0.0 111.546 -177.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.471 ' H ' ' HG3' ' A' ' 71' ' ' MET . . . 84.62 -71.76 2.91 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-N 116.471 -0.331 . . . . 0.0 112.546 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.492 0 CA-C-O 119.038 -0.868 . . . . 0.0 112.1 -178.848 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.456 ' HG3' ' HB3' ' A' ' 61' ' ' ALA . 62.1 ttp . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -77.01 118.56 19.7 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.212 1.005 . . . . 0.0 109.62 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.1 pp -137.74 161.23 37.09 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.113 0.565 . . . . 0.0 109.775 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -96.53 152.42 18.64 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.656 0.782 . . . . 0.0 109.836 -175.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.0 t -137.85 101.82 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 124.676 1.191 . . . . 0.0 107.962 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -76.33 94.88 3.67 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.057 0.943 . . . . 0.0 111.843 -175.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.78 -176.51 3.11 Favored 'General case' 0 C--O 1.245 0.867 0 C-N-CA 124.811 1.245 . . . . 0.0 108.099 165.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -45.29 -31.41 1.57 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.514 0.726 . . . . 0.0 112.153 171.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -114.72 137.29 52.1 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 162.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.32 113.47 8.4 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -91.82 155.76 17.99 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.647 0.779 . . . . 0.0 109.482 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.3 m -141.5 115.6 9.31 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 173.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -116.25 134.54 54.8 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.386 0.675 . . . . 0.0 110.601 -173.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -89.17 103.56 16.17 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 166.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.451 HG21 ' HG ' ' A' ' 54' ' ' LEU . 18.7 m -112.15 141.61 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.208 1.003 . . . . 0.0 109.225 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.2 t -91.41 5.55 48.93 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 120.657 0.265 . . . . 0.0 110.806 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.503 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 101.19 -25.97 26.32 Favored Glycine 0 C--N 1.357 1.718 0 CA-C-O 119.727 -0.485 . . . . 0.0 113.513 171.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -80.56 -14.32 58.32 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.881 0.473 . . . . 0.0 111.985 -174.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.404 ' O ' HD22 ' A' ' 54' ' ' LEU . 25.4 mp0 -65.31 130.62 43.98 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 69.0 p -75.13 168.81 19.26 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.189 0.518 . . . . 0.0 110.04 174.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.447 HG13 ' HE3' ' A' ' 25' ' ' LYS . 33.6 t -65.59 -29.21 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.464 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . . . -62.47 -41.82 99.04 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.69 0.796 . . . . 0.0 110.553 171.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -67.52 -36.84 81.83 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.869 0.468 . . . . 0.0 111.079 177.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.494 HD12 HD23 ' A' ' 54' ' ' LEU . 39.6 mm -60.13 -48.11 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.284 0.634 . . . . 0.0 110.177 175.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.447 ' HE3' HG13 ' A' ' 21' ' ' VAL . 92.5 mttt -60.05 -43.07 95.64 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.446 0.698 . . . . 0.0 110.745 176.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.26 -45.55 90.9 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.858 1.263 . . . . 0.0 111.7 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -61.74 -47.37 85.51 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.612 0.765 . . . . 0.0 110.448 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.8 t -63.1 -40.48 89.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 123.763 0.664 . . . . 0.0 110.296 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.31 -33.35 71.42 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.739 1.216 . . . . 0.0 112.258 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.7 t -70.78 -38.05 73.38 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.474 0.71 . . . . 0.0 110.512 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.1 mt -72.71 -51.69 18.24 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.15 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -86.58 -19.27 29.65 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -172.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.68 29.84 58.89 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 112.303 -0.319 . . . . 0.0 112.303 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.7 pt -101.62 176.96 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.474 0.709 . . . . 0.0 110.618 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -96.26 120.41 62.61 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 123.425 0.69 . . . . 0.0 110.422 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.01 -7.06 20.21 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.557 2.171 . . . . 0.0 111.813 172.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -60.7 -38.99 86.86 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 125.373 1.469 . . . . 0.0 110.492 171.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -88.21 -25.52 22.85 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.686 -178.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -75.27 133.0 41.44 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.706 -174.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.15 138.98 52.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 C-N-CA 124.353 1.061 . . . . 0.0 108.241 165.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.2 t -97.88 133.5 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.2 mt -117.76 128.62 55.05 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.604 1.161 . . . . 0.0 109.445 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.501 ' HB2' HD12 ' A' ' 48' ' ' LEU . 54.6 tp -105.99 104.85 14.65 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 169.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 60.33 26.51 16.03 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.845 0.858 . . . . 0.0 111.675 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.22 -15.59 58.91 Favored Glycine 0 C--N 1.352 1.448 0 CA-C-O 119.745 -0.475 . . . . 0.0 113.664 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.8 120.22 77.18 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 117.44 0.62 . . . . 0.0 109.668 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.8 112.2 1.93 Allowed 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.564 2.176 . . . . 0.0 112.06 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.501 HD12 ' HB2' ' A' ' 43' ' ' LEU . 80.4 mt -81.81 131.27 35.25 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.847 0.859 . . . . 0.0 110.158 175.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -72.01 142.96 49.33 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.718 0.636 . . . . 0.0 110.865 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.464 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . 11.1 p-10 -61.45 -26.17 67.71 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.293 1.037 . . . . 0.0 111.976 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -76.02 -25.91 56.14 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.829 0.851 . . . . 0.0 111.583 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.18 133.3 37.8 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.849 0.86 . . . . 0.0 110.965 -175.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 70.3 p -80.64 173.4 12.65 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.951 0.5 . . . . 0.0 110.395 174.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.503 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 2.9 mm? -61.81 -35.14 77.34 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 173.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.16 -43.6 96.9 Favored Glycine 0 C--N 1.355 1.616 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.975 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -69.63 -38.06 77.03 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.231 0.612 . . . . 0.0 111.397 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 83.9 m -73.63 -16.11 61.24 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.426 0.69 . . . . 0.0 111.155 175.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.29 26.48 71.68 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 123.582 0.551 . . . . 0.0 113.493 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.9 p -90.15 117.02 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.443 0.697 . . . . 0.0 109.68 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -87.22 -172.79 4.11 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.19 0.996 . . . . 0.0 111.932 -172.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.456 ' HB3' ' HG3' ' A' ' 1' ' ' MET . . . -71.82 154.0 41.56 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.653 0.781 . . . . 0.0 111.043 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 67.85 4.03 3.78 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.595 1.558 . . . . 0.0 112.679 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.9 m -85.15 151.67 23.94 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 34.4 m -113.9 111.48 21.77 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.247 0.546 . . . . 0.0 110.33 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.1 mt -78.68 160.85 27.29 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 165.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -132.61 142.28 49.06 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 122.115 -0.366 . . . . 0.0 110.886 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.8 t -95.95 132.62 39.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.892 0.877 . . . . 0.0 109.113 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.87 167.15 22.86 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.84 0.856 . . . . 0.0 109.83 177.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -109.97 90.36 0.59 Allowed Glycine 0 C--N 1.341 0.812 0 N-CA-C 112.29 -0.324 . . . . 0.0 112.29 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -103.56 -48.59 3.92 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.534 0.734 . . . . 0.0 109.056 171.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 42.4 tpp -78.48 162.37 26.4 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.656 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 50.6 tp -129.03 -30.93 2.17 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.665 0.786 . . . . 0.0 109.557 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.72 -178.97 39.68 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.704 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.327 0 CA-C-O 119.16 -0.8 . . . . 0.0 111.533 -178.255 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.435 ' HE2' ' HA ' ' A' ' 60' ' ' GLU . 27.3 ttt . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -101.46 124.26 46.85 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.2 pp -137.49 166.57 23.56 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.486 0.715 . . . . 0.0 110.627 -178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -98.58 161.5 13.63 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.288 0.635 . . . . 0.0 110.615 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.489 HG23 ' HB2' ' A' ' 65' ' ' LEU . 44.7 t -133.32 117.08 26.95 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 C-N-CA 124.55 1.14 . . . . 0.0 108.512 173.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -71.13 94.11 1.11 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.741 1.216 . . . . 0.0 109.207 174.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -118.77 -179.45 3.81 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.544 1.138 . . . . 0.0 108.998 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -44.86 -35.32 2.73 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 123.54 0.736 . . . . 0.0 111.234 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -128.98 137.38 51.33 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 166.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.5 mt -66.69 128.83 37.77 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.077 0.551 . . . . 0.0 110.861 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -124.26 160.91 26.91 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.381 0.673 . . . . 0.0 109.926 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.4 m -130.26 125.33 34.54 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.01 0.924 . . . . 0.0 108.966 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -120.73 132.55 55.13 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.268 1.027 . . . . 0.0 110.588 -173.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -92.36 106.31 18.34 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 169.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.3 167.84 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.497 1.119 . . . . 0.0 110.741 -172.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.3 p -100.44 -4.29 29.21 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.98 -52.36 4.72 Favored Glycine 0 C--N 1.358 1.804 0 N-CA-C 112.147 -0.381 . . . . 0.0 112.147 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -66.1 -10.84 44.35 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.0 0.92 . . . . 0.0 110.986 169.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -57.45 127.05 30.06 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.226 1.01 . . . . 0.0 110.754 170.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 82.8 p -85.64 160.23 19.64 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.678 0.391 . . . . 0.0 110.737 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.549 HG11 ' HB ' ' A' ' 41' ' ' VAL . 50.8 t -63.93 -31.68 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 123.963 0.905 . . . . 0.0 111.668 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.421 ' HB1' ' HB2' ' A' ' 50' ' ' ASP . . . -66.53 -42.28 87.48 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.512 0.725 . . . . 0.0 110.674 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -74.88 -29.61 61.06 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.14 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.515 HD12 HD13 ' A' ' 54' ' ' LEU . 30.4 mm -57.58 -50.33 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 168.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -57.01 -45.88 82.74 Favored 'General case' 0 C--N 1.36 1.036 0 O-C-N 123.86 0.725 . . . . 0.0 111.054 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.09 -48.05 76.87 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 124.604 1.19 . . . . 0.0 111.987 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -71.47 -41.33 69.5 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.242 0.217 . . . . 0.0 111.056 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.9 t -59.97 -41.53 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.13 -42.36 93.94 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.225 1.01 . . . . 0.0 111.702 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.5 t -62.13 -40.09 94.76 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 123.862 0.727 . . . . 0.0 111.496 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 33.0 mt -80.16 -39.94 28.31 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 120.928 0.394 . . . . 0.0 111.502 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.92 -6.07 59.13 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.792 0.837 . . . . 0.0 111.95 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.56 20.32 77.07 Favored Glycine 0 CA--C 1.532 1.104 0 O-C-N 123.506 0.504 . . . . 0.0 113.651 176.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.0 pt -107.63 -179.27 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.048 0.939 . . . . 0.0 110.454 -176.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.83 134.49 30.33 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 123.274 0.63 . . . . 0.0 110.265 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -68.12 -24.67 38.3 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.622 2.214 . . . . 0.0 112.311 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -67.68 -29.84 69.22 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.929 0.891 . . . . 0.0 111.464 175.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -81.05 -18.7 45.79 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.995 0.918 . . . . 0.0 111.902 -170.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.428 ' HB2' HG11 ' A' ' 67' ' ' VAL . 12.3 pt20 -107.57 158.18 17.44 Favored 'General case' 0 C--O 1.245 0.818 0 C-N-CA 123.069 0.548 . . . . 0.0 110.86 -176.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.434 HG13 ' HB2' ' A' ' 70' ' ' ARG . 12.6 p -128.94 134.56 64.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.649 172.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.549 ' HB ' HG11 ' A' ' 21' ' ' VAL . 95.2 t -98.7 121.91 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 66' ' ' GLU . 27.4 mt -113.62 157.72 21.76 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.687 1.595 . . . . 0.0 108.426 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 tt -105.06 96.85 6.82 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 106.266 -1.754 . . . . 0.0 106.266 163.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 51.45 40.62 27.13 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.513 1.125 . . . . 0.0 112.41 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.69 -30.78 8.4 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-O 119.405 -0.664 . . . . 0.0 114.106 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.98 116.85 54.64 Favored Pre-proline 0 N--CA 1.484 1.27 0 CA-C-N 117.704 0.752 . . . . 0.0 111.466 -176.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -60.78 108.7 0.57 Allowed 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.008 2.472 . . . . 0.0 113.246 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.09 137.19 33.69 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.949 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -77.41 136.33 38.39 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.808 0.692 . . . . 0.0 109.904 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.421 ' HB2' ' HB1' ' A' ' 22' ' ' ALA . 7.8 p-10 -58.78 -41.66 87.16 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.713 0.805 . . . . 0.0 112.284 -174.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -79.57 -15.58 57.43 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.204 0.601 . . . . 0.0 111.468 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.83 136.62 38.93 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 123.224 0.61 . . . . 0.0 110.276 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 43.7 p -80.09 165.88 22.06 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.205 0.602 . . . . 0.0 110.144 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.515 HD13 HD12 ' A' ' 24' ' ' ILE . 86.5 mt -64.73 -38.1 89.84 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.988 0.515 . . . . 0.0 111.243 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.97 -41.82 99.69 Favored Glycine 0 C--N 1.349 1.285 0 O-C-N 123.854 0.721 . . . . 0.0 112.623 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -74.82 -29.93 61.23 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.818 0.447 . . . . 0.0 111.386 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 89.1 m -75.41 -7.47 54.15 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.55 0.74 . . . . 0.0 111.728 173.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.17 15.88 81.16 Favored Glycine 0 C--N 1.351 1.404 0 C-N-CA 123.05 0.357 . . . . 0.0 113.866 173.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 p -99.34 132.72 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.136 0.574 . . . . 0.0 109.605 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.435 ' HA ' ' HE2' ' A' ' 1' ' ' MET . 44.9 mt-10 -121.54 -168.14 1.64 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.359 1.063 . . . . 0.0 110.495 -175.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.34 150.74 48.59 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.172 0.589 . . . . 0.0 111.057 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 70.22 2.5 4.01 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.678 1.591 . . . . 0.0 113.0 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.6 m -88.05 163.6 16.18 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 174.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.2 m -123.8 116.84 23.64 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.562 0.745 . . . . 0.0 109.664 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.489 ' HB2' HG23 ' A' ' 5' ' ' VAL . 3.2 mm? -75.05 -178.95 4.05 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.422 0.689 . . . . 0.0 109.595 170.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 35.7 tt0 -144.24 108.86 4.88 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.563 0.345 . . . . 0.0 110.703 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.428 HG11 ' HB2' ' A' ' 39' ' ' GLN . 55.5 t -85.94 117.84 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 172.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.42 168.94 10.79 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 123.943 0.897 . . . . 0.0 109.971 175.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.57 87.5 1.1 Allowed Glycine 0 C--N 1.344 1.02 0 N-CA-C 111.881 -0.488 . . . . 0.0 111.881 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.434 ' HB2' HG13 ' A' ' 40' ' ' VAL . 39.0 mtp180 -143.63 141.55 30.65 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.745 1.218 . . . . 0.0 107.75 170.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -148.03 148.53 30.8 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.14 0.576 . . . . 0.0 110.204 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.8 tp -154.5 129.35 9.41 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.23 15.98 81.01 Favored Glycine 0 C--N 1.343 0.968 0 O-C-N 123.763 0.664 . . . . 0.0 113.133 -175.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.605 0 CA-C-O 119.06 -0.856 . . . . 0.0 111.351 178.995 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.432 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 62.9 mtp . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -88.34 116.16 26.36 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.417 HD13 HD12 ' A' ' 65' ' ' LEU . 3.4 pp -132.21 150.4 52.16 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.432 0.693 . . . . 0.0 109.981 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -89.05 152.17 21.83 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.292 1.037 . . . . 0.0 109.8 -177.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -135.93 109.75 9.85 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 C-N-CA 124.343 1.057 . . . . 0.0 108.484 -177.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.425 ' HA ' HD11 ' A' ' 10' ' ' LEU . 3.7 tmm_? -73.66 94.96 2.26 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.45 1.1 . . . . 0.0 110.022 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -112.85 -177.41 3.13 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.283 1.033 . . . . 0.0 108.811 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -45.69 -25.45 0.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.15 0.98 . . . . 0.0 113.044 171.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -127.24 150.0 49.74 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.176 0.99 . . . . 0.0 108.913 158.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.425 HD11 ' HA ' ' A' ' 6' ' ' ARG . 4.5 mm? -76.2 109.57 9.99 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 122.987 0.515 . . . . 0.0 110.144 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -94.03 162.24 13.97 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.119 0.968 . . . . 0.0 110.168 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.7 t -141.03 142.23 34.24 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 164.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -133.97 131.57 39.14 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.653 0.781 . . . . 0.0 110.178 -175.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -92.47 104.13 16.48 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.753 174.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.8 m -111.18 161.26 9.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 C-N-CA 123.858 0.863 . . . . 0.0 110.259 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.4 m -87.12 -29.68 21.65 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.853 0.861 . . . . 0.0 110.366 176.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.529 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 116.45 -29.36 7.01 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.19 -173.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -85.77 -4.13 59.08 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.506 0.723 . . . . 0.0 112.532 -173.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -76.06 145.68 39.94 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.445 ' HB ' ' O ' ' A' ' 50' ' ' ASP . 59.0 p -82.82 160.89 22.13 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.354 0.597 . . . . 0.0 110.516 175.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.609 HG11 ' HB ' ' A' ' 41' ' ' VAL . 52.8 t -60.42 -30.53 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 123.715 0.806 . . . . 0.0 110.428 175.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 50' ' ' ASP . . . -58.57 -47.07 85.48 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 124.08 0.952 . . . . 0.0 111.051 171.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -64.58 -39.83 94.45 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.611 0.364 . . . . 0.0 110.624 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.526 HD11 HD22 ' A' ' 54' ' ' LEU . 41.8 mm -60.09 -49.27 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 122.979 0.512 . . . . 0.0 111.364 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.487 ' HB3' HG22 ' A' ' 41' ' ' VAL . 62.9 pttt -74.51 -29.58 61.46 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 119.686 -0.197 . . . . 0.0 110.702 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.404 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . . . -64.18 -34.21 77.56 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.306 0.642 . . . . 0.0 110.92 175.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.445 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 32.6 m170 -68.38 -46.25 70.56 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.117 0.567 . . . . 0.0 110.378 174.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.5 t -56.08 -39.96 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.449 0.642 . . . . 0.0 110.14 174.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.85 -45.65 77.52 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.903 1.281 . . . . 0.0 112.369 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.2 p -69.43 -27.63 65.42 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.01 0.524 . . . . 0.0 111.539 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 27' ' ' HIS . 86.1 mt -76.82 -48.47 18.4 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.817 0.447 . . . . 0.0 111.202 178.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -91.9 -5.47 53.17 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -174.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.04 5.98 85.52 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 113.859 0.304 . . . . 0.0 113.859 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.9 pt -81.74 169.06 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.325 0.65 . . . . 0.0 110.303 178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.32 136.5 43.09 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.605 0.762 . . . . 0.0 109.986 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.404 ' HB3' ' HA ' ' A' ' 26' ' ' ALA . 56.3 Cg_endo -68.71 -22.68 37.01 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.394 2.063 . . . . 0.0 111.741 174.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -80.02 -8.98 59.64 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.974 0.91 . . . . 0.0 111.626 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -75.52 -29.04 59.34 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.197 0.599 . . . . 0.0 111.987 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.427 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -144.76 179.9 7.01 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.14 0.495 . . . . 0.0 111.372 -170.552 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.2 p -145.4 149.92 16.22 Favored 'Isoleucine or valine' 0 C--O 1.25 1.101 0 C-N-CA 124.867 1.267 . . . . 0.0 108.138 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.609 ' HB ' HG11 ' A' ' 21' ' ' VAL . 46.5 t -86.65 138.04 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.361 0.601 . . . . 0.0 109.763 176.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -116.21 140.41 49.33 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -179.524 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.3 tp -86.48 95.91 9.87 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 169.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 55.17 28.92 11.75 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.858 0.863 . . . . 0.0 112.661 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.72 -14.01 35.1 Favored Glycine 0 CA--C 1.536 1.398 0 CA-C-O 119.5 -0.611 . . . . 0.0 114.001 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.57 110.83 24.33 Favored Pre-proline 0 N--CA 1.484 1.261 0 CA-C-N 117.845 0.823 . . . . 0.0 110.622 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.405 ' HA ' HD12 ' A' ' 42' ' ' LEU . 50.2 Cg_exo -56.45 107.07 0.24 Allowed 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 123.645 2.897 . . . . 0.0 114.077 -176.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.517 ' HB3' HG22 ' A' ' 21' ' ' VAL . 96.4 mt -80.45 139.74 36.3 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.485 0.714 . . . . 0.0 110.735 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -71.57 130.21 40.66 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.771 0.669 . . . . 0.0 109.667 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 22' ' ' ALA . 71.3 m-20 -62.25 -27.57 69.09 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.079 0.552 . . . . 0.0 112.216 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -80.06 -21.18 43.71 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.663 0.785 . . . . 0.0 111.617 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.26 138.54 39.46 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.516 0.726 . . . . 0.0 110.517 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 58.2 p -88.0 168.28 12.98 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.037 0.535 . . . . 0.0 110.587 177.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.529 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 2.5 mm? -62.28 -33.68 75.1 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 174.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.03 -30.78 56.87 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.891 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -76.18 -36.41 58.69 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 52.9 t -67.63 -35.65 79.32 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.2 0.6 . . . . 0.0 110.303 173.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.52 18.52 61.94 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.256 -177.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.56 135.88 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.037 0.535 . . . . 0.0 110.043 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -97.3 -169.26 1.82 Allowed 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.625 0.77 . . . . 0.0 111.896 -176.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.432 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -79.5 169.96 17.27 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.52 0.728 . . . . 0.0 111.091 173.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 58.34 18.67 5.69 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.301 1.44 . . . . 0.0 112.669 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.5 m -90.09 161.37 15.83 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 56.5 m -121.96 104.58 9.63 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 173.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.417 HD12 HD13 ' A' ' 3' ' ' LEU . 6.8 mp -84.31 -176.07 6.08 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.498 172.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 44.9 tt0 -139.38 157.43 45.89 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.974 0.509 . . . . 0.0 110.575 -172.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.7 t -119.13 131.65 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.401 1.081 . . . . 0.0 108.688 171.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.455 ' HB3' HD22 ' A' ' 42' ' ' LEU . . . -152.01 144.71 24.29 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.398 0.679 . . . . 0.0 109.664 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 39' ' ' GLN . . . -82.07 84.42 1.5 Allowed Glycine 0 C--N 1.345 1.077 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -110.93 7.59 21.77 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.922 0.889 . . . . 0.0 109.146 170.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 48.0 tpp -120.96 158.06 28.55 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.036 1.334 . . . . 0.0 107.788 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.6 tt -144.87 -44.17 0.23 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 116.5 157.56 11.05 Favored Glycine 0 C--N 1.342 0.871 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.905 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.196 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.505 ' SD ' ' HA ' ' A' ' 60' ' ' GLU . 63.6 ttp . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 35.1 tt0 -78.44 131.52 36.93 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 pp -141.84 166.19 25.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.938 0.895 . . . . 0.0 110.0 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -102.14 137.23 40.68 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.841 0.856 . . . . 0.0 109.76 -177.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.5 t -117.18 114.91 47.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 172.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.485 ' HB3' ' HA ' ' A' ' 66' ' ' GLU . 40.4 ttt85 -80.55 92.47 5.92 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.443 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.68 -177.29 3.74 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.471 1.108 . . . . 0.0 108.059 168.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -47.18 -32.79 4.68 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 122.945 0.498 . . . . 0.0 111.316 170.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -112.6 137.23 51.16 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 125.057 1.343 . . . . 0.0 108.016 164.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -71.0 118.99 14.48 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -116.93 162.01 18.44 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.946 0.898 . . . . 0.0 109.784 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.3 t -130.02 146.77 51.71 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 172.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -137.61 129.28 28.43 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.423 1.089 . . . . 0.0 108.643 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 34.2 tt0 -87.97 106.28 18.02 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 169.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.7 m -112.43 178.96 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.025 1.33 . . . . 0.0 108.976 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 58.6 p -107.07 -37.4 6.31 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.583 0.753 . . . . 0.0 110.797 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.5 -23.21 4.06 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-N 116.422 -0.354 . . . . 0.0 112.53 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -82.51 -12.63 57.65 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.0 0.52 . . . . 0.0 112.274 -175.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.442 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 22.7 mp0 -65.79 133.08 50.24 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.943 0.897 . . . . 0.0 108.671 177.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.618 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 82.2 p -80.07 166.24 21.72 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 121.59 0.709 . . . . 0.0 110.095 176.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.487 HG12 ' HE3' ' A' ' 25' ' ' LYS . 56.0 t -61.38 -31.11 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.187 173.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.63 -41.67 95.33 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.1 0.96 . . . . 0.0 111.208 173.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -66.24 -38.76 88.67 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.123 0.569 . . . . 0.0 111.098 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.521 HD11 HD13 ' A' ' 54' ' ' LEU . 50.5 mm -63.18 -45.27 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 O-C-N 123.716 0.635 . . . . 0.0 110.331 176.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.559 ' HE2' ' HA ' ' A' ' 40' ' ' VAL . 93.6 mttt -57.5 -45.81 84.49 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 123.645 0.59 . . . . 0.0 110.352 176.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.44 -45.57 91.2 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.334 1.054 . . . . 0.0 112.166 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -68.93 -43.3 75.38 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.86 0.464 . . . . 0.0 111.894 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.8 t -67.76 -32.03 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 122.813 0.445 . . . . 0.0 110.39 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.47 -37.99 80.67 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.191 0.996 . . . . 0.0 111.566 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.6 t -64.46 -44.37 91.31 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.571 0.748 . . . . 0.0 110.535 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.8 mt -72.87 -58.07 3.6 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.06 0.544 . . . . 0.0 111.558 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.31 -14.29 60.11 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.452 1.101 . . . . 0.0 112.405 -176.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.51 16.58 75.81 Favored Glycine 0 N--CA 1.473 1.135 0 CA-C-N 117.484 0.129 . . . . 0.0 113.078 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.7 pt -93.35 171.82 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.36 1.064 . . . . 0.0 110.397 -176.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.03 118.19 71.13 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 122.862 0.465 . . . . 0.0 110.849 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.412 ' HA ' HE21 ' A' ' 39' ' ' GLN . 47.5 Cg_endo -64.39 -24.96 63.92 Favored 'Trans proline' 0 C--N 1.388 2.621 0 C-N-CA 123.009 2.472 . . . . 0.0 111.484 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.658 ' HB3' ' HA2' ' A' ' 73' ' ' GLY . 45.9 mt-10 -68.42 -35.7 78.01 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.547 1.139 . . . . 0.0 111.148 177.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -85.39 -16.91 38.27 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.331 0.653 . . . . 0.0 111.213 -175.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.412 HE21 ' HA ' ' A' ' 36' ' ' PRO . 51.4 mt-30 -77.71 152.45 33.68 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.573 0.701 . . . . 0.0 112.16 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.559 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . 13.9 p -141.04 148.55 21.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 113.934 -1.485 . . . . 0.0 107.575 162.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.437 ' HB ' HG11 ' A' ' 21' ' ' VAL . 97.8 t -103.96 128.05 57.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 68.7 mt -115.62 116.66 28.51 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.645 1.178 . . . . 0.0 108.779 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.512 ' HB2' HD11 ' A' ' 48' ' ' LEU . 41.2 tp -90.47 98.13 11.59 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 57.04 32.24 21.32 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.029 0.932 . . . . 0.0 111.691 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.4 -32.4 7.2 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.246 -178.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.4 116.65 39.07 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 123.271 0.628 . . . . 0.0 111.499 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -63.44 105.53 0.51 Allowed 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 123.223 2.615 . . . . 0.0 112.262 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.512 HD11 ' HB2' ' A' ' 43' ' ' LEU . 43.0 mt -78.11 129.81 35.64 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.881 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -64.88 134.74 54.67 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.238 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.435 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 8.0 p-10 -61.54 -27.2 68.45 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.356 0.663 . . . . 0.0 111.727 -178.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -80.72 -25.98 37.74 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.62 0.768 . . . . 0.0 111.76 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.09 133.35 46.19 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 123.213 0.605 . . . . 0.0 110.542 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.618 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 31.1 p -79.1 170.64 16.35 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 176.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.599 ' HA ' ' SG ' ' A' ' 57' ' ' CYS . 86.2 mt -69.15 -25.72 64.51 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.548 0.739 . . . . 0.0 110.896 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.84 -36.41 42.15 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.327 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.401 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 87.2 mm-40 -79.22 -34.8 42.51 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.92 0.488 . . . . 0.0 111.703 -177.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.599 ' SG ' ' HA ' ' A' ' 54' ' ' LEU . 31.3 p -77.84 -22.22 50.28 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.927 0.491 . . . . 0.0 110.312 175.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.85 38.79 9.11 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.68 169.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.554 HG23 HD12 ' A' ' 65' ' ' LEU . 8.7 p -101.76 148.86 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 123.043 0.537 . . . . 0.0 109.849 176.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.505 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 10.7 pt-20 -136.32 -165.56 1.74 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.949 0.9 . . . . 0.0 111.085 -174.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.14 149.5 50.19 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 124.017 0.927 . . . . 0.0 112.587 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 68.18 -5.07 0.93 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.119 1.768 . . . . 0.0 113.263 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.7 m -77.26 147.9 36.05 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.124 0.57 . . . . 0.0 109.528 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.3 m -119.01 112.5 19.65 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 123.758 0.823 . . . . 0.0 109.825 -174.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.554 HD12 HG23 ' A' ' 59' ' ' VAL . 2.1 mp -104.18 132.71 50.14 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.462 1.105 . . . . 0.0 108.261 -178.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.485 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . 45.5 tt0 -96.13 140.17 31.23 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.055 0.542 . . . . 0.0 111.37 -172.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 78.8 t -93.8 128.37 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.806 0.842 . . . . 0.0 108.965 174.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.05 -168.04 2.83 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.875 0.87 . . . . 0.0 109.749 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -121.67 108.16 1.29 Allowed Glycine 0 C--N 1.35 1.352 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -122.26 -60.27 1.57 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -79.42 112.59 16.81 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 114.636 -1.166 . . . . 0.0 108.43 174.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -77.65 -22.95 49.88 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.234 0.613 . . . . 0.0 111.562 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.658 ' HA2' ' HB3' ' A' ' 37' ' ' GLU . . . -156.53 -98.27 0.14 Allowed Glycine 0 C--N 1.348 1.228 0 N-CA-C 111.871 -0.492 . . . . 0.0 111.871 -177.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.084 0 CA-C-O 118.932 -0.926 . . . . 0.0 111.086 -179.972 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.4 mtp . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -78.92 119.87 22.71 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.945 0.498 . . . . 0.0 109.702 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 pp -142.63 167.49 21.97 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.417 0.687 . . . . 0.0 110.564 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -100.68 148.37 24.94 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.3 t -133.19 107.13 10.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.892 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 172.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -76.7 93.09 3.6 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.252 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.95 -178.5 5.23 Favored 'General case' 0 C--O 1.248 0.977 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 160.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -51.52 -30.33 19.98 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.719 0.408 . . . . 0.0 111.217 172.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -107.33 130.67 54.75 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 161.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -72.61 125.61 27.89 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -125.66 146.05 49.9 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.171 0.589 . . . . 0.0 109.88 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.5 m -108.41 128.41 54.75 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.487 0.715 . . . . 0.0 109.389 175.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -120.73 143.06 48.97 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.193 0.997 . . . . 0.0 109.758 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -105.59 110.22 22.46 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.517 HG22 ' HG ' ' A' ' 54' ' ' LEU . 4.6 m -108.72 151.01 11.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 C-N-CA 124.154 0.982 . . . . 0.0 109.282 -171.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.414 ' H ' ' HB2' ' A' ' 19' ' ' GLU . 8.1 m -81.21 -11.82 59.31 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.746 -175.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.66 -55.59 2.67 Favored Glycine 0 C--N 1.353 1.523 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -174.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -76.27 2.87 12.1 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.081 0.952 . . . . 0.0 110.759 167.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.414 ' HB2' ' H ' ' A' ' 16' ' ' THR . 8.8 tp10 -60.21 118.05 5.91 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.921 1.289 . . . . 0.0 108.734 165.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 74.8 p -76.41 158.43 31.39 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.38 0.536 . . . . 0.0 110.81 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 t -64.53 -31.34 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 124.032 0.933 . . . . 0.0 110.254 175.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.64 -47.73 81.44 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.848 0.718 . . . . 0.0 110.82 173.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -64.15 -42.89 96.6 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 123.86 0.725 . . . . 0.0 111.141 177.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.464 ' O ' HG22 ' A' ' 28' ' ' VAL . 48.1 mm -56.87 -51.33 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 123.757 0.823 . . . . 0.0 110.708 176.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.53 ' NZ ' ' SD ' ' A' ' 71' ' ' MET . 85.3 tttt -62.42 -45.46 93.02 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.126 1.37 . . . . 0.0 110.424 -174.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.515 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . . . -67.99 -35.84 79.01 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.338 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -64.27 -46.53 83.28 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.33 0.652 . . . . 0.0 110.045 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 24' ' ' ILE . 73.2 t -60.02 -46.08 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 O-C-N 123.791 0.682 . . . . 0.0 109.91 177.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.37 -41.02 92.86 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.894 0.878 . . . . 0.0 112.434 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.3 t -65.25 -38.85 91.62 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.445 0.698 . . . . 0.0 110.649 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.5 mt -71.41 -37.34 71.52 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.636 0.374 . . . . 0.0 111.362 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -78.18 -13.8 59.71 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.897 0.879 . . . . 0.0 111.54 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.77 17.83 79.36 Favored Glycine 0 C--N 1.35 1.311 0 C-N-CA 123.147 0.404 . . . . 0.0 113.641 178.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.4 pt -111.27 176.67 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.866 0.866 . . . . 0.0 110.052 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.24 136.32 46.61 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 123.057 0.543 . . . . 0.0 109.855 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.515 ' HB3' ' HA ' ' A' ' 26' ' ' ALA . 18.6 Cg_endo -57.11 -33.9 96.69 Favored 'Trans proline' 0 C--N 1.383 2.38 0 C-N-CA 123.458 2.772 . . . . 0.0 112.683 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -60.0 -24.12 64.21 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.964 0.905 . . . . 0.0 113.061 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -76.51 -12.79 60.09 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.19 0.596 . . . . 0.0 111.965 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.43 ' O ' ' HB3' ' A' ' 71' ' ' MET . 22.3 mt-30 -104.09 173.17 6.42 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.792 0.837 . . . . 0.0 111.992 -171.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.403 HG13 ' HB2' ' A' ' 70' ' ' ARG . 7.1 p -160.87 134.42 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 169.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.6 p -106.23 136.05 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 121.628 0.727 . . . . 0.0 110.428 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -120.56 143.32 48.67 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.163 1.785 . . . . 0.0 108.495 -171.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.1 tp -110.93 99.16 8.11 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 167.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 59.98 26.44 15.73 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.195 0.998 . . . . 0.0 111.611 -176.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.78 -21.77 31.46 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 115.716 -0.675 . . . . 0.0 113.232 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.37 116.27 54.72 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.397 0.679 . . . . 0.0 111.023 -177.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.76 114.39 2.56 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.948 2.432 . . . . 0.0 112.41 -177.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.516 HD13 HD13 ' A' ' 65' ' ' LEU . 96.7 mt -72.98 130.25 39.93 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.937 0.895 . . . . 0.0 110.647 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -66.18 125.71 26.41 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.807 0.692 . . . . 0.0 110.216 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -65.25 -28.05 69.08 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.32 0.648 . . . . 0.0 112.13 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -77.78 -20.36 53.46 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.212 0.605 . . . . 0.0 110.711 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.66 145.67 28.67 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.301 0.64 . . . . 0.0 111.264 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 59.5 p -91.6 177.55 6.18 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.427 0.691 . . . . 0.0 110.16 173.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.517 ' HG ' HG22 ' A' ' 15' ' ' VAL . 3.8 mm? -63.4 -36.62 84.33 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 173.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.43 -31.94 65.34 Favored Glycine 0 C--N 1.354 1.547 0 CA-C-N 115.605 -0.725 . . . . 0.0 113.144 177.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 61.0 tp60 -71.24 -39.38 71.69 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.405 0.682 . . . . 0.0 110.451 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.449 ' HB2' HG13 ' A' ' 59' ' ' VAL . 62.4 m -68.1 -26.28 65.74 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.187 173.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.62 23.06 68.3 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 123.793 0.683 . . . . 0.0 112.269 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.449 HG13 ' HB2' ' A' ' 57' ' ' CYS . 7.3 p -99.95 134.63 38.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.565 0.746 . . . . 0.0 109.355 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -90.56 -175.45 4.44 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.811 0.845 . . . . 0.0 111.718 -173.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.93 169.25 17.27 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.83 171.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 68.54 3.14 3.68 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 125.298 1.439 . . . . 0.0 112.935 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.3 m -81.84 155.5 25.35 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.347 0.659 . . . . 0.0 109.303 176.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.8 m -113.12 106.93 15.25 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.516 HD13 HD13 ' A' ' 48' ' ' LEU . 2.2 mm? -80.67 171.66 14.74 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 169.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -140.87 125.3 17.68 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 118.585 0.63 . . . . 0.0 111.172 -177.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.2 t -96.4 109.84 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 122.898 0.479 . . . . 0.0 110.098 177.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.56 176.7 5.24 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.488 1.115 . . . . 0.0 109.281 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -124.41 89.86 0.4 Allowed Glycine 0 N--CA 1.469 0.889 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.403 ' HB2' HG13 ' A' ' 40' ' ' VAL . 65.6 mtp180 -126.01 -48.47 1.61 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.634 0.774 . . . . 0.0 110.501 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.53 ' SD ' ' NZ ' ' A' ' 25' ' ' LYS . 46.3 ttm -68.24 144.37 54.93 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.942 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.44 168.35 21.38 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.28 0.632 . . . . 0.0 109.796 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.5 -52.04 0.19 Allowed Glycine 0 N--CA 1.472 1.078 0 C-N-CA 122.829 0.252 . . . . 0.0 112.499 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.549 -1.139 . . . . 0.0 112.138 -179.326 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.489 ' HE1' ' HB3' ' A' ' 54' ' ' LEU . 25.5 ttt . . . . . 0 N--CA 1.478 0.947 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -98.99 117.44 33.51 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.425 0.69 . . . . 0.0 110.387 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.464 HD23 ' HE3' ' A' ' 1' ' ' MET . 3.8 pp -131.11 154.44 48.3 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.711 0.767 . . . . 0.0 111.398 175.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -90.33 144.28 25.98 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.817 1.247 . . . . 0.0 108.561 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.1 t -123.23 113.81 39.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 174.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.423 ' HB3' ' HA ' ' A' ' 66' ' ' GLU . 20.4 tpt180 -85.5 93.18 8.71 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.537 -172.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -111.6 -178.93 3.57 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 124.35 1.06 . . . . 0.0 108.333 169.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -45.38 -35.22 3.48 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.557 0.743 . . . . 0.0 111.324 167.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -111.63 127.36 55.73 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.153 0.981 . . . . 0.0 108.493 167.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -75.85 115.69 15.8 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -116.86 131.73 56.88 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.64 0.776 . . . . 0.0 109.662 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.5 m -105.74 118.63 37.09 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -102.71 140.78 36.53 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.118 0.967 . . . . 0.0 111.119 -175.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -94.6 104.76 16.7 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 165.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.0 m -113.72 163.61 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.142 0.977 . . . . 0.0 110.423 -177.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.8 m -99.9 -3.54 32.21 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.46 0.704 . . . . 0.0 111.513 -174.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.16 -45.26 3.38 Favored Glycine 0 C--N 1.352 1.464 0 O-C-N 122.027 -0.421 . . . . 0.0 112.247 -177.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -65.14 -14.04 59.6 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.372 0.669 . . . . 0.0 112.097 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.35 132.89 47.85 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 173.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.718 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 80.4 p -75.22 161.8 29.03 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.27 0.557 . . . . 0.0 110.621 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.69 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 53.0 t -64.93 -28.69 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.415 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.261 172.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.89 -38.88 92.44 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.223 0.609 . . . . 0.0 111.542 174.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -73.5 -35.12 65.59 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.739 177.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.472 HD13 HD12 ' A' ' 54' ' ' LEU . 20.3 mm -53.19 -47.94 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 123.571 0.748 . . . . 0.0 109.857 170.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.493 ' NZ ' ' SD ' ' A' ' 71' ' ' MET . 97.8 mttt -57.7 -55.05 39.88 Favored 'General case' 0 C--N 1.359 0.991 0 O-C-N 124.121 0.888 . . . . 0.0 110.658 174.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.77 -42.0 64.6 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 123.965 0.791 . . . . 0.0 112.121 -176.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -71.17 -46.27 61.75 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.634 0.773 . . . . 0.0 111.755 -177.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.406 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 14.6 p -69.94 -30.95 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.426 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . . . -68.2 -36.72 80.01 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.841 0.856 . . . . 0.0 111.351 177.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.1 t -63.66 -41.69 98.17 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.541 0.736 . . . . 0.0 110.273 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.7 mt -69.12 -48.76 61.61 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.448 0.699 . . . . 0.0 112.29 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.43 ' HB2' HG12 ' A' ' 34' ' ' ILE . 13.8 mm-40 -77.86 -19.11 55.4 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.031 0.532 . . . . 0.0 111.018 -177.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.95 31.9 59.42 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.634 -177.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.43 HG12 ' HB2' ' A' ' 32' ' ' GLU . 23.9 pt -114.65 170.38 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 123.803 0.841 . . . . 0.0 110.912 -177.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.41 119.78 76.86 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 123.658 0.783 . . . . 0.0 111.499 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -65.33 -28.18 55.1 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.859 2.372 . . . . 0.0 112.283 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.92 -35.18 79.81 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.859 0.864 . . . . 0.0 111.227 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -71.39 -26.07 62.62 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.191 0.996 . . . . 0.0 111.079 -172.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.426 ' NE2' ' HB2' ' A' ' 29' ' ' ALA . 21.6 mt-30 -81.7 137.79 35.35 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.7 -173.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 p -122.82 133.64 68.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 166.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.446 HG12 ' HB3' ' A' ' 65' ' ' LEU . 54.7 t -94.26 108.34 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-O 121.384 0.611 . . . . 0.0 109.716 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 66.1 mt -97.04 114.47 26.1 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.26 1.424 . . . . 0.0 109.762 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.8 tp -94.83 104.95 16.85 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 169.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 59.67 28.3 17.71 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.236 1.014 . . . . 0.0 111.961 -173.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.31 -7.89 72.21 Favored Glycine 0 C--N 1.352 1.427 0 CA-C-N 115.946 -0.57 . . . . 0.0 113.675 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.19 116.71 66.99 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 123.757 0.823 . . . . 0.0 110.2 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.3 117.34 4.49 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.593 2.195 . . . . 0.0 111.65 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.2 mt -75.93 154.6 35.83 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.621 0.768 . . . . 0.0 111.293 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -72.51 104.19 3.75 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.69 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 3.0 p30 -72.08 -15.29 62.01 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -73.92 -24.4 59.67 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 122.909 0.484 . . . . 0.0 110.191 172.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -94.91 157.79 15.76 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 124.161 0.984 . . . . 0.0 111.069 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.718 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 67.7 p -85.24 168.05 15.1 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.618 177.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.489 ' HB3' ' HE1' ' A' ' 1' ' ' MET . 78.2 mt -66.28 -33.22 75.24 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.118 174.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.16 -29.68 68.39 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 115.287 -0.869 . . . . 0.0 112.661 175.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -72.38 -43.95 63.22 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.551 0.74 . . . . 0.0 110.57 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' A' ' 54' ' ' LEU . 22.1 p -75.79 -10.41 59.41 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.51 173.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.13 21.24 78.4 Favored Glycine 0 C--N 1.355 1.61 0 C-N-CA 123.56 0.6 . . . . 0.0 113.571 171.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.0 p -78.51 145.78 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -176.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -110.62 -164.2 0.9 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.308 0.643 . . . . 0.0 111.003 -176.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.72 175.53 9.86 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.681 0.792 . . . . 0.0 111.667 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 65.2 5.35 3.01 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.452 1.501 . . . . 0.0 112.744 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.6 m -81.63 154.21 26.26 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.407 1.083 . . . . 0.0 110.155 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.2 m -122.42 101.7 7.65 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.688 0.795 . . . . 0.0 109.663 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.446 ' HB3' HG12 ' A' ' 41' ' ' VAL . 74.7 mt -85.69 116.28 23.87 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.125 0.97 . . . . 0.0 109.175 176.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . 41.1 tt0 -93.85 128.81 40.32 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.02 0.438 . . . . 0.0 111.674 -172.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 75.0 t -87.59 128.55 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.833 0.853 . . . . 0.0 109.791 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.15 136.84 45.99 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.775 0.83 . . . . 0.0 109.649 173.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.47 89.43 1.58 Allowed Glycine 0 C--N 1.343 0.962 0 N-CA-C 112.095 -0.402 . . . . 0.0 112.095 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -141.75 -28.87 0.63 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.545 0.738 . . . . 0.0 112.353 -173.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.493 ' SD ' ' NZ ' ' A' ' 25' ' ' LYS . 56.1 ttm -85.46 17.5 3.16 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.177 0.591 . . . . 0.0 111.989 -173.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -52.84 120.94 6.36 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.353 1.061 . . . . 0.0 110.662 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -166.49 -69.22 0.03 OUTLIER Glycine 0 C--N 1.349 1.263 0 O-C-N 123.312 0.382 . . . . 0.0 112.26 -177.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.728 -1.04 . . . . 0.0 111.37 -178.097 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.467 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 1.1 tmt? . . . . . 0 N--CA 1.483 1.198 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.567 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 34.1 tt0 -101.94 137.76 39.8 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.439 -177.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.452 HD13 HD11 ' A' ' 65' ' ' LEU . 4.4 pp -137.5 161.03 37.48 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.387 0.613 . . . . 0.0 110.276 175.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -107.27 135.37 48.89 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.3 t -115.98 105.41 18.39 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 C-N-CA 123.57 0.748 . . . . 0.0 109.047 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -72.26 98.69 2.23 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.853 0.861 . . . . 0.0 110.969 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -113.28 -177.07 3.04 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.649 1.18 . . . . 0.0 108.044 166.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -45.09 -31.67 1.46 Allowed 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.522 0.677 . . . . 0.0 112.133 168.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -115.34 131.84 56.8 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 124.668 1.187 . . . . 0.0 107.878 167.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -70.36 105.5 3.05 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -93.12 160.49 14.83 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.754 177.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.5 m -148.97 121.64 8.62 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -127.63 129.61 47.53 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.392 0.677 . . . . 0.0 109.666 -176.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 36.0 tt0 -94.16 110.26 22.0 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 168.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.467 ' O ' ' HB3' ' A' ' 1' ' ' MET . 35.8 m -116.84 164.37 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 124.825 1.25 . . . . 0.0 109.098 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.1 t -94.79 6.21 49.63 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.663 0.385 . . . . 0.0 110.591 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.511 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 94.66 -20.49 48.31 Favored Glycine 0 C--N 1.357 1.734 0 CA-C-O 119.351 -0.694 . . . . 0.0 113.672 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -67.62 -26.7 66.37 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -169.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -62.96 141.87 58.56 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 46.9 p -80.42 165.0 22.64 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.509 HG12 ' HB ' ' A' ' 41' ' ' VAL . 54.5 t -57.08 -31.17 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 C-N-CA 123.448 0.699 . . . . 0.0 110.045 172.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.457 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . . . -68.92 -37.84 79.18 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.493 1.117 . . . . 0.0 111.511 177.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.458 ' HG3' ' OG1' ' A' ' 20' ' ' THR . 24.8 mt-30 -72.36 -35.03 68.42 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.1 mm -64.52 -47.41 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.097 0.559 . . . . 0.0 111.046 177.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.567 ' HB3' HG22 ' A' ' 41' ' ' VAL . 60.6 pttt -67.18 -32.65 73.88 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 119.547 -0.263 . . . . 0.0 110.383 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.523 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . . . -60.09 -45.47 92.81 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 123.603 0.761 . . . . 0.0 111.471 176.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.45 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 34.0 m170 -64.85 -44.99 87.97 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.878 0.471 . . . . 0.0 110.896 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.497 HG13 HG22 ' A' ' 67' ' ' VAL . 79.0 t -62.04 -42.39 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.124 0.57 . . . . 0.0 111.035 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.21 -26.07 61.0 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.739 0.816 . . . . 0.0 111.402 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.2 t -70.24 -42.21 72.53 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 122.983 0.513 . . . . 0.0 110.275 171.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 27' ' ' HIS . 97.2 mt -62.57 -42.85 99.81 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 123.839 0.712 . . . . 0.0 111.625 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.96 -23.41 31.09 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.112 0.565 . . . . 0.0 112.174 176.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.64 29.69 47.27 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 122.979 0.175 . . . . 0.0 112.906 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.6 pt -111.87 -178.46 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 124.803 1.241 . . . . 0.0 111.215 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.71 112.65 39.14 Favored Pre-proline 0 N--CA 1.487 1.414 0 C-N-CA 124.035 0.934 . . . . 0.0 112.537 -170.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.523 ' HB3' ' HA ' ' A' ' 26' ' ' ALA . 24.2 Cg_exo -62.93 -43.17 20.86 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 123.088 2.525 . . . . 0.0 112.729 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.95 -8.71 57.1 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.381 0.672 . . . . 0.0 112.057 -176.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -77.65 -36.31 51.57 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.403 0.62 . . . . 0.0 109.577 171.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.613 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 40.2 mt-30 -99.44 -179.76 4.32 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.994 -169.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.5 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 11.4 p -162.09 154.03 3.37 Favored 'Isoleucine or valine' 0 C--O 1.246 0.877 0 C-N-CA 125.314 1.446 . . . . 0.0 107.956 171.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.567 HG22 ' HB3' ' A' ' 25' ' ' LYS . 44.4 t -103.64 125.46 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.586 HD11 ' HA ' ' A' ' 47' ' ' PRO . 1.8 mm? -108.9 141.25 41.23 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.446 1.498 . . . . 0.0 108.842 -173.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.9 tp -80.76 96.71 7.04 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 55.06 29.34 12.27 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 123.878 0.871 . . . . 0.0 111.629 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.59 -25.43 21.28 Favored Glycine 0 C--N 1.355 1.635 0 C-N-CA 123.343 0.497 . . . . 0.0 113.449 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.57 136.05 81.01 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.552 0.741 . . . . 0.0 111.311 -177.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.586 ' HA ' HD11 ' A' ' 42' ' ' LEU . 52.6 Cg_endo -64.61 111.0 1.55 Allowed 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 123.192 2.594 . . . . 0.0 113.052 -174.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.9 mt -90.2 156.26 18.45 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.376 0.67 . . . . 0.0 111.138 173.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -81.97 119.47 24.0 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 172.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.459 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 6.0 p-10 -60.67 -38.94 86.57 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.082 0.553 . . . . 0.0 112.103 -175.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -82.27 -4.89 58.02 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.119 0.568 . . . . 0.0 111.978 -176.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.49 140.49 29.48 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.312 0.645 . . . . 0.0 110.356 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 44.1 p -71.77 168.46 17.77 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.291 0.636 . . . . 0.0 110.603 178.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.511 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 3.0 mm? -59.19 -43.33 92.2 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 174.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.43 -37.9 95.52 Favored Glycine 0 C--N 1.35 1.331 0 O-C-N 123.845 0.716 . . . . 0.0 113.108 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -68.24 -39.72 82.21 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.834 0.854 . . . . 0.0 110.482 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 75.0 m -79.26 -10.09 59.73 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.928 0.891 . . . . 0.0 111.798 177.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.82 21.17 75.01 Favored Glycine 0 C--N 1.349 1.281 0 C-N-CA 123.217 0.436 . . . . 0.0 114.135 177.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.28 134.86 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 123.845 0.858 . . . . 0.0 109.436 177.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -114.39 -171.43 1.92 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.472 0.709 . . . . 0.0 111.095 -172.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.87 154.09 28.6 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.542 0.737 . . . . 0.0 110.248 174.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 59.9 21.19 10.16 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 125.216 1.407 . . . . 0.0 111.738 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.5 m -93.74 156.41 16.7 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.434 1.093 . . . . 0.0 108.804 177.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.1 m -135.43 121.82 20.49 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.632 0.729 . . . . 0.0 110.78 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.452 HD11 HD13 ' A' ' 3' ' ' LEU . 4.1 mp -105.88 179.23 4.33 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.792 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -141.2 144.41 34.74 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.607 0.763 . . . . 0.0 110.279 -173.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.497 HG22 HG13 ' A' ' 28' ' ' VAL . 44.8 t -103.43 119.41 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 121.842 -0.536 . . . . 0.0 109.67 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.18 150.63 50.18 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.043 0.537 . . . . 0.0 110.292 176.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.613 ' HA2' ' HA ' ' A' ' 39' ' ' GLN . . . -90.1 92.95 1.82 Allowed Glycine 0 C--N 1.347 1.159 0 N-CA-C 112.051 -0.42 . . . . 0.0 112.051 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 54.4 mtt180 -109.75 -11.81 14.68 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.958 0.503 . . . . 0.0 112.318 -177.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.559 ' SD ' ' NZ ' ' A' ' 25' ' ' LYS . 79.5 mtp -97.45 110.07 22.7 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 122.212 -0.305 . . . . 0.0 110.445 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.4 tp -75.5 -46.71 30.64 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.019 0.437 . . . . 0.0 109.972 176.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.6 150.94 17.17 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.005 176.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.289 0 CA-C-O 119.149 -0.806 . . . . 0.0 112.865 178.914 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 121.788 0.804 . . . . 0.0 108.968 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -93.01 111.38 22.98 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.683 -171.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.416 HD12 HD13 ' A' ' 65' ' ' LEU . 2.8 pp -125.51 157.51 36.83 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.481 0.712 . . . . 0.0 110.07 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -90.28 142.18 27.98 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.789 0.835 . . . . 0.0 109.85 -176.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.5 t -122.66 102.64 11.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 C-N-CA 124.648 1.179 . . . . 0.0 108.885 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -77.95 93.8 4.49 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.934 0.893 . . . . 0.0 109.71 177.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.19 -174.52 2.59 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.906 1.283 . . . . 0.0 108.168 172.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -41.16 -36.9 0.8 Allowed 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 123.841 0.857 . . . . 0.0 112.053 168.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -117.95 154.36 32.07 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.507 1.123 . . . . 0.0 108.323 167.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -77.52 127.52 32.65 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.774 0.43 . . . . 0.0 110.456 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -130.79 159.39 37.47 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.653 1.181 . . . . 0.0 109.042 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.8 m -143.53 125.17 14.93 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 175.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -132.93 141.64 48.46 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.013 0.525 . . . . 0.0 111.119 -173.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -80.92 125.77 30.54 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 164.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.44 HG22 ' HG ' ' A' ' 54' ' ' LEU . 27.6 m -109.32 152.56 11.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 C-N-CA 123.445 0.698 . . . . 0.0 109.744 -174.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 m -78.51 -14.62 59.27 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.666 -171.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.49 -56.44 5.02 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -70.5 -13.38 62.09 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.141 0.976 . . . . 0.0 111.145 171.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -63.39 139.18 58.74 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.66 1.184 . . . . 0.0 109.933 170.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 73.2 p -93.62 170.67 9.41 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.304 0.573 . . . . 0.0 111.91 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.57 HG13 ' HB ' ' A' ' 41' ' ' VAL . 40.5 t -64.81 -31.87 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.129 0.972 . . . . 0.0 110.607 172.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.06 96.25 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.735 0.814 . . . . 0.0 110.148 178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -62.65 -48.25 80.17 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.447 1.092 . . . . 0.0 110.313 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.41 ' O ' HG21 ' A' ' 28' ' ' VAL . 37.2 mm -55.97 -47.27 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 124.078 0.951 . . . . 0.0 110.923 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -62.17 -49.91 73.94 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.015 1.326 . . . . 0.0 111.183 -175.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.7 -32.94 71.82 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.976 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.463 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 11.4 t-160 -62.69 -53.52 53.25 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 124.099 0.96 . . . . 0.0 110.37 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 24' ' ' ILE . 95.0 t -59.92 -38.51 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.414 0.686 . . . . 0.0 110.552 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.04 -47.79 84.41 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.144 175.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.8 t -66.86 -35.25 79.61 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.648 0.779 . . . . 0.0 111.228 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 27' ' ' HIS . 88.6 mt -67.4 -48.79 66.33 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.82 0.848 . . . . 0.0 111.861 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -96.04 -2.57 46.54 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.685 0.394 . . . . 0.0 111.819 -172.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.58 28.24 73.3 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.278 0.361 . . . . 0.0 113.01 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.2 pt -108.82 177.58 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.125 0.97 . . . . 0.0 110.693 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.42 120.94 68.96 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 123.281 0.632 . . . . 0.0 111.438 -171.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -63.83 -31.74 67.66 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.527 2.151 . . . . 0.0 111.206 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -63.68 -22.04 66.7 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.028 0.931 . . . . 0.0 112.353 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -88.95 -12.95 40.14 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.007 0.923 . . . . 0.0 111.171 -178.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -98.65 165.29 11.87 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.922 0.889 . . . . 0.0 112.344 -171.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 m -152.57 138.4 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 126.247 1.819 . . . . 0.0 107.251 164.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.57 ' HB ' HG13 ' A' ' 21' ' ' VAL . 45.5 t -94.99 116.62 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 175.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.3 mt -112.25 134.04 54.03 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.802 1.241 . . . . 0.0 109.092 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.451 ' HB2' HD13 ' A' ' 48' ' ' LEU . 42.4 tp -89.4 98.11 11.58 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 173.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 57.18 28.84 15.68 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.754 0.821 . . . . 0.0 112.081 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.04 -25.16 21.32 Favored Glycine 0 C--N 1.353 1.505 0 CA-C-O 119.717 -0.491 . . . . 0.0 113.498 -177.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.13 117.68 60.51 Favored Pre-proline 0 N--CA 1.481 1.098 0 C-N-CA 123.422 0.689 . . . . 0.0 110.886 -177.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.5 115.57 2.64 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.329 2.686 . . . . 0.0 113.108 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.472 ' HB3' HG21 ' A' ' 21' ' ' VAL . 84.6 mt -91.02 143.75 26.38 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.18 0.592 . . . . 0.0 110.903 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -78.27 134.68 37.51 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -56.73 -41.02 76.77 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.996 0.918 . . . . 0.0 112.15 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -82.21 -14.89 54.87 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.677 -175.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.22 132.65 43.43 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.81 0.444 . . . . 0.0 109.859 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 58.6 p -84.23 166.77 17.25 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.209 0.604 . . . . 0.0 110.282 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.44 ' HG ' HG22 ' A' ' 15' ' ' VAL . 3.0 mm? -62.43 -38.52 90.06 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.01 -34.69 77.03 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.922 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -70.95 -42.62 69.55 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.475 0.71 . . . . 0.0 110.635 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 50.6 t -69.51 -18.75 63.71 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.141 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.05 17.84 80.22 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.657 -0.702 . . . . 0.0 112.804 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.552 HG22 HD12 ' A' ' 65' ' ' LEU . 2.2 p -85.61 118.37 32.21 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.1 -166.8 1.42 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.328 1.051 . . . . 0.0 110.54 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.63 163.72 26.43 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.173 0.589 . . . . 0.0 111.243 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 71.89 -2.83 2.38 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.825 1.65 . . . . 0.0 112.765 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.4 m -84.0 160.18 21.07 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.577 0.751 . . . . 0.0 109.573 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.3 m -120.16 113.31 20.27 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.15 0.58 . . . . 0.0 110.638 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.552 HD12 HG22 ' A' ' 59' ' ' VAL . 5.5 mp -94.79 161.18 14.28 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 170.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -130.52 130.66 44.43 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.964 0.505 . . . . 0.0 109.95 -177.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 95.9 t -91.85 93.39 4.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 171.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.62 -176.47 3.2 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.339 1.056 . . . . 0.0 110.13 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -123.2 91.78 0.45 Allowed Glycine 0 C--N 1.341 0.823 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 178.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -107.12 -49.23 3.31 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 53.4 ttm -73.4 101.63 3.53 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 174.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -75.59 -45.65 36.35 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.77 146.06 10.92 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.864 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.413 0 CA-C-O 118.647 -1.085 . . . . 0.0 112.672 179.944 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ttt . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -94.04 120.35 34.17 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 pp -132.16 167.22 20.14 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.074 0.55 . . . . 0.0 111.001 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -99.49 142.89 30.38 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.58 0.752 . . . . 0.0 109.553 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 80.9 t -126.12 101.13 7.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 171.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -73.25 98.74 2.71 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.548 -177.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.69 -177.31 3.33 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.097 0.959 . . . . 0.0 108.945 172.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -43.46 -32.75 0.94 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.087 0.955 . . . . 0.0 111.986 170.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -120.6 145.22 47.59 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.382 1.073 . . . . 0.0 108.178 162.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.1 tp -69.72 128.58 36.94 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 120.821 0.343 . . . . 0.0 111.084 -176.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -117.47 158.21 24.91 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.931 0.892 . . . . 0.0 109.894 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.7 m -146.63 120.96 9.59 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.348 1.059 . . . . 0.0 108.291 175.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -120.85 145.21 47.85 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.412 0.685 . . . . 0.0 110.613 -172.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -97.4 123.98 41.42 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 171.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.3 m -135.0 172.43 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.302 1.041 . . . . 0.0 109.865 -177.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.466 ' HB ' ' HG2' ' A' ' 18' ' ' GLN . 2.9 m -107.07 -18.15 13.98 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.793 0.837 . . . . 0.0 110.011 175.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.429 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 102.77 -15.52 55.51 Favored Glycine 0 C--N 1.355 1.637 0 C-N-CA 123.137 0.399 . . . . 0.0 112.458 -173.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.466 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 3.3 pt20 -81.29 -8.45 59.75 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.825 0.85 . . . . 0.0 111.719 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -74.42 134.23 42.4 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.16 0.984 . . . . 0.0 108.923 176.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 72.4 p -74.66 158.84 32.93 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 171.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.631 HG11 ' HB ' ' A' ' 41' ' ' VAL . 55.8 t -59.23 -27.9 37.74 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.475 0 C-N-CA 123.839 0.856 . . . . 0.0 110.401 173.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.64 -43.36 80.52 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.795 1.238 . . . . 0.0 110.392 174.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.431 ' HG3' ' OG1' ' A' ' 20' ' ' THR . 78.1 mt-30 -62.07 -41.56 98.28 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 123.521 0.513 . . . . 0.0 110.217 175.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.464 HD13 HD13 ' A' ' 54' ' ' LEU . 46.9 mm -59.32 -50.72 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.435 0.694 . . . . 0.0 111.217 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.475 ' HB3' HG22 ' A' ' 41' ' ' VAL . 60.3 pttt -73.08 -27.5 61.75 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.98 -37.19 86.83 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.25 0.62 . . . . 0.0 111.047 173.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 57.5 m170 -66.68 -45.81 77.66 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.359 0.663 . . . . 0.0 109.78 175.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.545 HG11 HD11 ' A' ' 34' ' ' ILE . 85.1 t -58.74 -38.02 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.59 0.756 . . . . 0.0 110.313 174.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.01 -48.15 74.95 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.275 1.03 . . . . 0.0 111.953 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.3 t -68.13 -32.75 73.26 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.328 0.651 . . . . 0.0 111.771 -177.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 97.5 mt -80.67 -51.11 9.07 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.989 0.516 . . . . 0.0 111.965 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -83.76 -2.45 56.33 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.605 0.762 . . . . 0.0 112.179 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.25 15.19 69.76 Favored Glycine 0 C--N 1.346 1.092 0 O-C-N 123.157 0.286 . . . . 0.0 113.1 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.545 HD11 HG11 ' A' ' 28' ' ' VAL . 28.6 pt -92.39 178.91 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.527 0.731 . . . . 0.0 109.81 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -109.87 129.89 23.43 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 122.87 0.468 . . . . 0.0 110.776 -174.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.28 -11.17 26.58 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.217 1.944 . . . . 0.0 112.687 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.52 -22.97 53.73 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 123.041 0.536 . . . . 0.0 112.071 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.401 ' HA ' ' H ' ' A' ' 72' ' ' LEU . 1.7 p30 -90.86 -41.19 11.33 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 118.76 0.709 . . . . 0.0 109.518 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -81.82 152.4 26.93 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 122.198 0.999 . . . . 0.0 111.847 -175.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.32 153.11 37.34 Favored 'Isoleucine or valine' 0 C--O 1.249 1.07 0 C-N-CA 126.447 1.899 . . . . 0.0 106.347 168.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.631 ' HB ' HG11 ' A' ' 21' ' ' VAL . 43.7 t -100.21 131.65 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.7 mt -116.3 142.0 47.41 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.592 1.157 . . . . 0.0 109.398 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.6 tp -91.81 99.28 12.18 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 174.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 60.31 22.97 12.44 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.84 0.856 . . . . 0.0 112.473 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.7 -14.6 57.58 Favored Glycine 0 C--N 1.353 1.519 0 CA-C-O 119.779 -0.456 . . . . 0.0 113.436 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.62 146.13 60.1 Favored Pre-proline 0 N--CA 1.485 1.285 0 C-N-CA 123.745 0.818 . . . . 0.0 109.981 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -72.35 120.38 6.72 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.637 2.224 . . . . 0.0 113.301 -170.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.47 ' HB3' HG23 ' A' ' 21' ' ' VAL . 87.2 mt -94.63 141.1 29.0 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 170.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -80.05 120.89 24.82 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.528 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 11.1 p-10 -63.21 -39.47 94.73 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 123.491 0.494 . . . . 0.0 111.511 -171.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.58 -2.91 55.15 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.392 0.677 . . . . 0.0 111.897 -177.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.6 139.91 29.99 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.545 0.738 . . . . 0.0 110.563 173.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 75.5 p -73.58 164.34 26.78 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.978 0.511 . . . . 0.0 110.529 175.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.464 HD13 HD13 ' A' ' 24' ' ' ILE . 86.9 mt -66.83 -28.75 68.61 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.509 0.724 . . . . 0.0 110.757 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.07 -43.76 89.75 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.634 174.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -69.52 -37.3 77.07 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.847 0.459 . . . . 0.0 110.949 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 89.3 m -65.09 -23.49 67.18 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.319 0.648 . . . . 0.0 110.933 173.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.44 28.33 67.93 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 116.308 -0.405 . . . . 0.0 112.744 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.555 HG22 HD12 ' A' ' 65' ' ' LEU . 11.8 p -92.54 153.9 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -133.07 -172.19 2.87 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.674 0.79 . . . . 0.0 110.909 -173.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.77 157.45 36.41 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.341 0.657 . . . . 0.0 111.87 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 61.7 14.6 6.24 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 126.013 1.725 . . . . 0.0 112.415 -177.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.8 m -93.36 145.08 24.73 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.5 m -105.84 108.3 19.75 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.66 0.743 . . . . 0.0 110.08 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.555 HD12 HG22 ' A' ' 59' ' ' VAL . 5.6 mp -88.32 179.35 6.36 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.176 169.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 39.8 tt0 -142.53 153.34 43.5 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.101 0.56 . . . . 0.0 110.133 -175.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 79.1 t -109.08 131.83 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 170.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.98 127.19 17.56 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.305 0.642 . . . . 0.0 109.925 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.12 92.51 0.74 Allowed Glycine 0 C--N 1.344 0.99 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 175.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -132.69 -35.57 1.1 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.019 0.527 . . . . 0.0 112.296 -174.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.4 ' HG3' ' H ' ' A' ' 74' ' ' GLY . 49.0 tpp -60.25 -51.39 69.75 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.497 0.319 . . . . 0.0 110.943 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.401 ' H ' ' HA ' ' A' ' 38' ' ' ASP . 0.6 OUTLIER 50.89 67.56 0.92 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 125.57 1.548 . . . . 0.0 111.061 173.547 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 56.28 40.07 83.85 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.706 -0.679 . . . . 0.0 113.469 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.4 ' H ' ' HG3' ' A' ' 71' ' ' MET . . . . . . . . 0 CA--C 1.536 1.384 0 CA-C-O 118.986 -0.897 . . . . 0.0 113.042 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.6 mtm . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -76.96 114.59 15.92 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.445 HD11 HD23 ' A' ' 65' ' ' LEU . 2.3 pp -137.9 157.19 46.9 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.108 0.563 . . . . 0.0 110.155 -177.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -88.92 152.11 21.92 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.052 0.541 . . . . 0.0 109.63 -177.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 11' ' ' HIS . 55.2 t -134.65 105.23 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.294 1.037 . . . . 0.0 109.087 -176.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -82.9 93.96 7.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.468 1.107 . . . . 0.0 111.001 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -111.3 -179.96 3.87 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 168.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.99 -26.79 39.23 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 175.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -111.47 134.04 53.34 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 158.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.73 137.66 52.18 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.883 0.473 . . . . 0.0 109.738 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.507 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 39.3 m-70 -129.86 161.97 29.61 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.122 0.969 . . . . 0.0 109.049 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.0 m -142.91 112.0 6.56 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 172.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -113.39 132.32 55.66 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.792 0.837 . . . . 0.0 111.203 -172.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -83.94 114.08 21.44 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 166.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.3 m -109.65 139.58 32.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 122.918 0.487 . . . . 0.0 109.811 -174.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 m -75.37 -17.83 60.12 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.711 0.805 . . . . 0.0 111.472 -176.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.75 -56.2 1.91 Allowed Glycine 0 C--N 1.347 1.143 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 -176.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -72.53 -7.12 48.41 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.307 0.643 . . . . 0.0 111.588 172.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -63.79 145.25 56.12 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 165.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.622 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 61.2 p -94.29 153.68 17.9 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 118.213 0.461 . . . . 0.0 111.99 -177.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.58 HG13 ' HB ' ' A' ' 41' ' ' VAL . 38.1 t -57.12 -33.71 43.52 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 124.388 1.075 . . . . 0.0 110.617 171.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.17 -53.19 61.11 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.126 0.971 . . . . 0.0 110.921 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -65.2 -36.14 83.27 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.916 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 35.0 mm -60.36 -50.49 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 122.786 0.434 . . . . 0.0 111.633 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -68.25 -30.75 69.87 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.521 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . . . -65.9 -41.23 91.76 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 123.382 0.673 . . . . 0.0 111.492 175.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -62.03 -46.06 90.81 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.329 0.651 . . . . 0.0 109.722 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.8 t -56.32 -48.24 79.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.717 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.99 -28.23 64.28 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.827 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 t -77.03 -31.62 56.41 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.554 0.741 . . . . 0.0 110.956 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.0 mt -73.31 -45.09 57.45 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.229 0.612 . . . . 0.0 111.17 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -86.1 -22.0 27.35 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.168 0.587 . . . . 0.0 112.316 -176.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.23 33.8 25.11 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 116.632 -0.258 . . . . 0.0 113.266 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 pt -109.84 171.38 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.941 0.896 . . . . 0.0 110.034 175.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.69 111.61 22.66 Favored Pre-proline 0 N--CA 1.484 1.244 0 C-N-CA 123.296 0.638 . . . . 0.0 111.768 -172.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.521 ' HB3' ' HA ' ' A' ' 26' ' ' ALA . 19.8 Cg_endo -55.95 -39.47 90.97 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 123.602 2.868 . . . . 0.0 114.081 -175.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -67.3 -28.06 67.69 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.035 0.534 . . . . 0.0 111.568 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 71' ' ' MET . 22.7 t70 -67.54 -40.3 85.02 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.253 0.621 . . . . 0.0 109.9 177.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -77.03 165.72 24.25 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.953 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -162.82 146.14 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 125.04 1.336 . . . . 0.0 108.299 173.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.58 ' HB ' HG13 ' A' ' 21' ' ' VAL . 96.3 t -90.14 134.55 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.103 0.561 . . . . 0.0 110.51 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.8 mt -123.29 127.38 48.47 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.77 1.228 . . . . 0.0 108.637 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.429 ' HB2' HD13 ' A' ' 48' ' ' LEU . 33.5 tp -92.18 97.96 11.23 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 173.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 59.73 23.07 11.91 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.56 1.144 . . . . 0.0 112.732 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.75 -7.56 38.93 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-O 119.703 -0.499 . . . . 0.0 113.655 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.01 114.55 53.38 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 123.241 0.616 . . . . 0.0 109.459 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -68.16 102.58 0.81 Allowed 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 122.172 1.914 . . . . 0.0 112.27 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.429 HD13 ' HB2' ' A' ' 43' ' ' LEU . 79.5 mt -73.2 129.68 38.58 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.34 176.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -63.44 130.73 45.64 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.139 0.9 . . . . 0.0 109.387 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -61.93 -35.38 78.23 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.184 0.303 . . . . 0.0 111.483 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.19 -19.68 60.46 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.4 0.28 . . . . 0.0 111.28 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.76 135.27 41.75 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.924 0.49 . . . . 0.0 109.848 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.622 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 71.4 p -76.82 171.95 13.91 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 122.907 0.483 . . . . 0.0 109.967 172.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -66.22 -28.76 68.99 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.54 -29.53 55.3 Favored Glycine 0 C--N 1.357 1.733 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.763 175.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -74.0 -35.98 64.46 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.641 0.776 . . . . 0.0 109.855 176.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 79.8 m -74.87 -23.52 58.42 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.466 171.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.19 23.05 78.49 Favored Glycine 0 C--N 1.353 1.506 0 CA-C-N 116.009 -0.541 . . . . 0.0 113.558 177.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.8 p -80.54 148.09 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 123.522 0.729 . . . . 0.0 110.342 -175.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -99.6 -177.38 3.55 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.401 0.68 . . . . 0.0 112.181 -173.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.42 162.22 24.55 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.738 0.815 . . . . 0.0 111.029 175.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 64.63 9.29 5.03 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 125.449 1.5 . . . . 0.0 112.488 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.7 m -78.06 152.0 33.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.058 0.943 . . . . 0.0 109.706 175.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.2 m -106.87 108.25 19.67 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 173.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.445 HD23 HD11 ' A' ' 3' ' ' LEU . 3.6 mm? -92.32 135.54 33.94 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 124.175 0.99 . . . . 0.0 108.589 174.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -93.97 150.46 20.34 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.164 0.586 . . . . 0.0 109.465 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 67.1 t -119.46 131.45 72.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 174.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.72 148.55 30.15 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.406 0.682 . . . . 0.0 110.318 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.0 98.82 2.27 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 174.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.9 mtp-105 -103.44 -26.13 13.0 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.594 0.758 . . . . 0.0 111.176 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.498 ' O ' ' HA ' ' A' ' 38' ' ' ASP . 62.7 ttp -121.73 105.33 10.3 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.361 0.664 . . . . 0.0 109.971 -170.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.5 mt -66.0 108.64 2.27 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -110.28 -162.77 18.81 Favored Glycine 0 N--CA 1.47 0.918 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.185 -175.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.523 0 CA-C-O 119.21 -0.772 . . . . 0.0 113.488 177.746 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.537 ' SD ' HD23 ' A' ' 3' ' ' LEU . 47.9 ttm . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -87.39 123.62 32.54 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 171.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.537 HD23 ' SD ' ' A' ' 1' ' ' MET . 2.1 pp -143.12 158.47 43.58 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.619 0.768 . . . . 0.0 109.398 -175.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -96.3 139.78 31.94 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.368 0.667 . . . . 0.0 109.47 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.503 HG22 ' HB2' ' A' ' 65' ' ' LEU . 58.9 t -123.35 103.39 12.89 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 174.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -76.48 100.14 5.15 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.674 0.749 . . . . 0.0 111.038 -178.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.97 -178.2 3.59 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.412 1.085 . . . . 0.0 108.446 166.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -48.29 -35.59 12.52 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.845 0.858 . . . . 0.0 111.379 172.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -111.7 131.28 55.41 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 166.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -68.6 132.84 47.58 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.824 0.45 . . . . 0.0 109.804 -175.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -126.63 156.09 41.51 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.689 0.795 . . . . 0.0 109.451 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.1 t -136.45 135.36 38.57 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 167.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -133.55 155.1 50.22 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.609 0.764 . . . . 0.0 110.355 -175.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -106.47 120.24 41.38 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.426 HG23 ' HG ' ' A' ' 54' ' ' LEU . 32.3 m -110.44 150.3 13.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 C-N-CA 123.812 0.845 . . . . 0.0 108.999 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.3 m -81.98 -14.67 55.69 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.102 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.574 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 91.01 -42.95 2.85 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.521 -0.309 . . . . 0.0 113.043 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -72.22 -13.32 61.5 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.477 1.111 . . . . 0.0 111.92 176.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -78.23 156.84 29.54 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.129 0.572 . . . . 0.0 109.676 171.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 81.4 p -93.24 175.55 6.73 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.24 0.543 . . . . 0.0 112.285 -175.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.554 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 53.1 t -62.57 -36.55 75.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 123.761 0.825 . . . . 0.0 109.996 170.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.25 -37.95 87.4 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.564 0.745 . . . . 0.0 110.76 175.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -64.43 -48.16 76.41 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.789 0.681 . . . . 0.0 111.1 176.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.53 ' O ' HG21 ' A' ' 28' ' ' VAL . 64.2 mt -56.71 -49.23 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 122.881 0.472 . . . . 0.0 109.826 176.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.46 ' HB2' HG13 ' A' ' 41' ' ' VAL . 85.1 tttt -55.26 -45.9 76.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.849 1.66 . . . . 0.0 111.193 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.11 -42.91 88.57 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.847 0.859 . . . . 0.0 111.285 176.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -60.67 -46.83 88.86 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.594 0.758 . . . . 0.0 110.902 -178.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.53 HG21 ' O ' ' A' ' 24' ' ' ILE . 26.3 t -65.13 -44.96 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 123.815 0.697 . . . . 0.0 109.148 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.75 -41.04 90.1 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 123.537 0.735 . . . . 0.0 112.249 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.1 m -61.82 -44.61 96.5 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.807 0.843 . . . . 0.0 111.182 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.5 mt -79.7 -25.41 41.2 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.636 -176.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -85.49 -12.15 52.51 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.006 0.522 . . . . 0.0 111.434 172.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.35 25.44 68.27 Favored Glycine 0 C--N 1.351 1.377 0 C-N-CA 122.85 0.262 . . . . 0.0 113.593 176.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.3 pt -119.03 174.74 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.266 1.026 . . . . 0.0 110.238 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.05 144.22 50.73 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.244 0.618 . . . . 0.0 110.035 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.35 -22.47 59.94 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.48 2.12 . . . . 0.0 110.886 172.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.452 ' HB3' ' HA2' ' A' ' 73' ' ' GLY . 29.4 mt-10 -64.0 -25.54 68.17 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.228 1.411 . . . . 0.0 111.584 175.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -81.88 -23.06 36.53 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.663 0.785 . . . . 0.0 111.343 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.413 ' HB2' HG13 ' A' ' 67' ' ' VAL . 10.4 pt20 -123.84 -179.52 4.42 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.357 0.598 . . . . 0.0 111.178 -175.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.461 HG11 ' HB2' ' A' ' 70' ' ' ARG . 7.4 p -156.92 134.42 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.99 1.316 . . . . 0.0 107.513 166.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.46 HG13 ' HB2' ' A' ' 25' ' ' LYS . 9.9 p -96.31 110.83 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 CA-C-O 121.952 0.882 . . . . 0.0 109.929 -178.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 47' ' ' PRO . 18.1 mt -94.23 154.88 17.32 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.889 1.276 . . . . 0.0 109.409 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.508 ' HB2' HD13 ' A' ' 48' ' ' LEU . 40.3 tp -94.16 97.63 10.41 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 58.2 23.83 10.71 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.292 1.037 . . . . 0.0 112.489 -177.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.93 -5.8 36.89 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 119.483 -0.621 . . . . 0.0 113.655 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.21 116.11 65.22 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 123.49 0.716 . . . . 0.0 110.66 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.445 ' HA ' HD23 ' A' ' 42' ' ' LEU . 40.7 Cg_endo -64.63 106.62 0.76 Allowed 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.31 2.007 . . . . 0.0 111.621 174.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.508 HD13 ' HB2' ' A' ' 43' ' ' LEU . 63.8 mt -82.77 170.01 15.52 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.098 0.559 . . . . 0.0 111.0 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -78.26 124.87 28.57 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 168.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.554 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 10.2 p-10 -67.26 -19.61 65.54 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.935 0.494 . . . . 0.0 111.415 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -80.6 -21.35 41.66 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.194 0.998 . . . . 0.0 111.617 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.45 133.97 38.49 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.132 0.573 . . . . 0.0 110.781 -178.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 66.5 p -79.41 171.64 14.88 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.756 0.822 . . . . 0.0 110.626 174.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.574 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 3.4 mm? -64.1 -37.43 87.42 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 175.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.42 -39.11 95.57 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.586 175.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -70.07 -44.2 69.58 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.528 0.731 . . . . 0.0 110.946 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 51.8 t -75.75 -24.12 56.04 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.32 0.648 . . . . 0.0 111.446 -177.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.78 35.02 13.92 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.918 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.4 t -76.84 148.59 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 123.651 0.781 . . . . 0.0 109.268 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -119.61 -171.99 2.24 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.723 0.809 . . . . 0.0 110.299 -176.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.79 149.89 30.92 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 122.779 0.431 . . . . 0.0 110.281 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 60.28 26.2 15.67 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.095 1.358 . . . . 0.0 112.33 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.6 m -80.0 162.17 25.03 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.633 0.773 . . . . 0.0 109.89 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.2 m -115.78 106.06 13.42 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.889 0.852 . . . . 0.0 110.529 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.503 ' HB2' HG22 ' A' ' 5' ' ' VAL . 3.5 mm? -83.02 164.99 20.0 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.409 -1.269 . . . . 0.0 107.833 164.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -144.92 130.46 18.88 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.878 0.471 . . . . 0.0 110.613 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.455 HG22 HG13 ' A' ' 28' ' ' VAL . 83.2 t -83.02 127.45 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 172.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.78 151.79 47.38 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.85 0.86 . . . . 0.0 109.981 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -91.78 86.41 1.27 Allowed Glycine 0 C--N 1.341 0.852 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 173.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.461 ' HB2' HG11 ' A' ' 40' ' ' VAL . 71.3 mtp180 -119.31 16.13 13.08 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.154 0.981 . . . . 0.0 108.965 170.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.426 ' HE3' ' HA ' ' A' ' 71' ' ' MET . 0.5 OUTLIER -145.05 104.82 4.01 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 -179.693 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -77.33 -17.88 57.9 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.415 0.286 . . . . 0.0 111.06 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.452 ' HA2' ' HB3' ' A' ' 37' ' ' GLU . . . 163.17 -93.33 0.11 Allowed Glycine 0 C--N 1.349 1.26 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.45 -1.195 . . . . 0.0 111.867 -179.838 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.598 ' HA ' ' HB1' ' A' ' 61' ' ' ALA . 82.6 mtp . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -88.54 99.46 12.32 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.402 HD21 HD22 ' A' ' 54' ' ' LEU . 1.5 pp -119.99 165.52 14.56 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.52 0.728 . . . . 0.0 110.864 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -101.35 140.66 35.34 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.344 1.058 . . . . 0.0 108.918 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.37 107.33 16.55 Favored 'Isoleucine or valine' 0 C--O 1.244 0.806 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -80.36 93.78 6.03 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.712 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.92 -171.77 2.42 Favored 'General case' 0 C--O 1.245 0.84 0 C-N-CA 125.876 1.67 . . . . 0.0 108.015 165.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -38.72 -34.28 0.14 Allowed 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 123.399 0.68 . . . . 0.0 112.727 167.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -123.96 162.75 22.75 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.637 1.175 . . . . 0.0 109.319 164.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -81.94 131.76 35.25 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -133.77 124.68 27.03 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.077 0.951 . . . . 0.0 109.119 -177.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 m -99.35 123.43 43.62 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -119.56 121.31 39.07 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.463 1.105 . . . . 0.0 110.456 -176.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.22 106.2 13.01 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 163.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.2 m -110.93 156.7 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.884 0.874 . . . . 0.0 110.659 -174.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.3 p -75.14 -25.74 58.63 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.949 177.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.3 -39.24 3.11 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.921 -174.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -78.23 -10.81 59.82 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.085 0.554 . . . . 0.0 111.657 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -69.13 120.84 15.59 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 168.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 69.7 p -66.29 161.22 22.79 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.388 0.675 . . . . 0.0 111.6 -175.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.47 HG12 ' HB ' ' A' ' 41' ' ' VAL . 75.4 t -62.06 -29.89 47.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 C-N-CA 124.042 0.937 . . . . 0.0 110.947 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 50' ' ' ASP . . . -61.31 -53.18 60.07 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.639 0.775 . . . . 0.0 110.499 174.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -65.92 -37.23 85.53 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.794 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.3 mm -63.96 -47.15 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.828 0.851 . . . . 0.0 111.588 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.469 ' HB3' HG23 ' A' ' 41' ' ' VAL . 51.8 pttt -70.18 -33.81 72.2 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 118.132 0.424 . . . . 0.0 110.28 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.61 -39.41 80.86 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.603 0.761 . . . . 0.0 110.605 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -55.57 -51.95 65.38 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.649 1.58 . . . . 0.0 109.955 175.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.504 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 84.5 t -64.51 -44.03 96.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.271 178.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.83 -35.67 78.91 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.629 0.771 . . . . 0.0 112.323 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.0 m -68.62 -40.8 80.17 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.092 0.557 . . . . 0.0 110.754 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.6 mt -66.93 -40.72 87.7 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.492 177.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 28' ' ' VAL . 11.0 mm-40 -84.27 -12.67 54.3 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.731 0.813 . . . . 0.0 111.709 -177.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.59 38.68 78.73 Favored Glycine 0 C--N 1.354 1.569 0 O-C-N 123.415 0.447 . . . . 0.0 113.32 177.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.2 pt -129.22 176.13 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.442 1.097 . . . . 0.0 110.306 -175.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.73 113.91 29.14 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 123.978 0.911 . . . . 0.0 112.466 -171.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -60.44 -35.7 89.68 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.291 2.661 . . . . 0.0 113.139 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.466 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 2.6 pm0 -67.33 -27.67 67.33 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.008 0.523 . . . . 0.0 110.916 178.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' A' ' 71' ' ' MET . 31.7 t70 -74.74 -29.47 61.17 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.282 0.633 . . . . 0.0 110.607 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -75.98 152.6 36.96 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.403 0.621 . . . . 0.0 111.52 -173.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.3 p -142.63 142.8 26.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-N 114.331 -1.304 . . . . 0.0 107.581 169.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.47 ' HB ' HG12 ' A' ' 21' ' ' VAL . 98.5 t -98.89 123.36 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 173.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.467 HD22 ' HA ' ' A' ' 47' ' ' PRO . 86.6 mt -116.34 118.61 33.22 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.825 1.25 . . . . 0.0 108.681 -176.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.3 tp -86.03 97.75 10.46 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 173.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 57.65 24.54 10.65 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.041 0.936 . . . . 0.0 111.645 -174.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.1 -20.87 30.24 Favored Glycine 0 C--N 1.354 1.555 0 C-N-CA 123.521 0.581 . . . . 0.0 113.649 -177.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.34 117.69 60.94 Favored Pre-proline 0 CA--C 1.554 1.111 0 CA-C-N 117.489 0.645 . . . . 0.0 110.602 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.467 ' HA ' HD22 ' A' ' 42' ' ' LEU . 19.8 Cg_exo -65.26 101.59 0.42 Allowed 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.003 2.469 . . . . 0.0 112.508 -176.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.428 ' HB3' HG23 ' A' ' 21' ' ' VAL . 61.7 mt -68.9 127.16 32.12 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.957 176.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.83 127.95 33.65 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 123.463 0.705 . . . . 0.0 109.812 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.473 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 9.4 p-10 -62.07 -29.53 70.37 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.938 0.895 . . . . 0.0 111.663 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -76.35 -24.11 54.21 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.827 0.851 . . . . 0.0 111.214 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.1 146.27 30.67 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.503 0.721 . . . . 0.0 110.533 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 80.9 p -85.81 165.24 17.02 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.321 0.648 . . . . 0.0 109.893 173.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.402 HD22 HD21 ' A' ' 3' ' ' LEU . 9.7 mp -66.57 -28.79 68.8 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.184 0.594 . . . . 0.0 110.486 175.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.41 -40.45 86.86 Favored Glycine 0 C--N 1.35 1.332 0 O-C-N 123.796 0.685 . . . . 0.0 112.262 174.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -73.08 -36.5 66.84 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.268 0.627 . . . . 0.0 110.652 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 84.0 m -71.7 -17.81 62.2 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.788 0.835 . . . . 0.0 111.567 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.16 19.84 78.77 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 123.578 0.549 . . . . 0.0 113.385 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.502 HG22 HD12 ' A' ' 65' ' ' LEU . 2.2 p -88.15 99.67 9.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -81.92 -174.66 5.18 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.249 -1.341 . . . . 0.0 112.061 -171.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.598 ' HB1' ' HA ' ' A' ' 1' ' ' MET . . . -62.9 155.45 27.14 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.758 172.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 61.59 24.91 14.93 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.642 1.177 . . . . 0.0 112.565 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.4 m -107.88 157.98 17.72 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.713 0.805 . . . . 0.0 109.069 175.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.3 m -114.59 121.9 44.87 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.907 0.483 . . . . 0.0 110.54 -178.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.502 HD12 HG22 ' A' ' 59' ' ' VAL . 3.0 mm? -94.22 162.56 13.8 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.644 1.178 . . . . 0.0 109.478 171.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -122.69 130.98 53.58 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.457 1.103 . . . . 0.0 108.751 173.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 86.8 t -104.65 114.02 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.23 161.03 21.07 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.742 0.817 . . . . 0.0 111.016 -177.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.09 106.26 3.35 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -131.39 -57.8 1.0 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.617 0.767 . . . . 0.0 111.414 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.539 ' O ' ' HA ' ' A' ' 38' ' ' ASP . 41.2 tpp -86.77 170.16 11.97 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.238 0.615 . . . . 0.0 110.562 -171.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 59.2 tp -149.82 147.41 27.94 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.753 0.821 . . . . 0.0 108.859 171.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.466 ' H ' ' HG3' ' A' ' 37' ' ' GLU . . . -67.2 110.17 3.32 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 123.787 0.679 . . . . 0.0 112.093 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.113 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -178.841 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.568 ' HE1' HD22 ' A' ' 3' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -113.07 132.78 55.28 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.581 0.753 . . . . 0.0 108.978 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.568 HD22 ' HE1' ' A' ' 1' ' ' MET . 4.0 pp -131.35 158.92 39.42 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -101.9 152.2 21.2 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.648 0.779 . . . . 0.0 109.106 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.8 t -126.11 124.9 66.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.675 1.19 . . . . 0.0 108.631 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -95.21 93.41 7.29 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.147 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -108.43 -176.59 3.09 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 168.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.432 HE22 ' HG2' ' A' ' 9' ' ' GLU . 4.0 pp0? -46.86 -29.04 1.78 Allowed 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 123.429 0.692 . . . . 0.0 112.49 174.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.432 ' HG2' HE22 ' A' ' 8' ' ' GLN . 1.1 pt-20 -123.06 159.44 28.44 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.167 0.987 . . . . 0.0 108.698 163.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.4 mt -79.58 128.35 33.27 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.245 0.545 . . . . 0.0 110.789 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -113.23 163.19 15.1 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.708 1.203 . . . . 0.0 108.174 173.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 t -141.44 146.32 36.38 Favored 'General case' 0 C--O 1.244 0.763 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 169.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -138.81 131.54 29.16 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.842 0.857 . . . . 0.0 109.877 -175.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.42 132.16 43.39 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 170.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.452 HG11 HD11 ' A' ' 24' ' ' ILE . 16.1 m -141.6 -169.38 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 125.025 1.33 . . . . 0.0 109.083 -177.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.5 m -113.18 -9.33 13.49 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.85 0.86 . . . . 0.0 109.854 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.39 -36.61 3.69 Favored Glycine 0 C--N 1.357 1.738 0 N-CA-C 112.245 -0.342 . . . . 0.0 112.245 -174.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -67.88 -16.85 64.27 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.505 0.722 . . . . 0.0 110.989 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -67.61 146.74 53.57 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 122.926 0.49 . . . . 0.0 110.313 172.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.682 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 76.7 p -84.74 157.19 21.12 Favored 'General case' 0 C--O 1.244 0.763 0 CA-C-O 121.608 0.718 . . . . 0.0 112.029 -176.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.595 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 82.6 t -60.63 -27.36 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.747 173.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.74 -52.71 48.94 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.009 0.923 . . . . 0.0 111.695 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -64.88 -30.63 71.64 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 119.456 -0.307 . . . . 0.0 111.203 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.459 ' O ' HG21 ' A' ' 28' ' ' VAL . 37.6 mm -58.65 -56.66 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 123.536 0.523 . . . . 0.0 110.631 173.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -68.82 -29.18 67.47 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.449 0.3 . . . . 0.0 110.352 -177.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.471 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . . . -67.51 -40.81 85.15 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.645 0.778 . . . . 0.0 111.335 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -67.5 -40.97 85.18 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.531 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 65.0 t -59.19 -45.03 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.609 174.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.37 -39.11 82.24 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.095 0.958 . . . . 0.0 111.795 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.4 m -63.3 -37.93 89.18 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.728 0.811 . . . . 0.0 111.344 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.5 mt -77.23 -30.12 54.44 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.758 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 28' ' ' VAL . 17.6 mm-40 -78.11 -27.82 48.42 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.914 0.885 . . . . 0.0 110.908 176.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.75 15.54 59.56 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 116.152 -0.476 . . . . 0.0 113.519 -175.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.9 pt -120.2 -176.9 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 124.224 1.01 . . . . 0.0 110.5 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.82 145.75 30.28 Favored Pre-proline 0 CA--C 1.562 1.427 0 C-N-CA 123.312 0.645 . . . . 0.0 111.382 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.471 ' HB3' ' HA ' ' A' ' 26' ' ' ALA . 30.3 Cg_endo -62.7 -21.23 72.78 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 123.165 2.577 . . . . 0.0 113.913 177.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.444 ' HG3' ' HA3' ' A' ' 73' ' ' GLY . 12.3 pt-20 -66.73 -17.95 65.12 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.026 0.93 . . . . 0.0 111.805 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -80.58 -40.22 26.19 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.591 0.71 . . . . 0.0 110.101 174.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.434 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 24.9 mt-30 -90.13 154.34 19.85 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 114.419 -1.264 . . . . 0.0 112.348 -168.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.4 134.24 17.29 Favored 'Isoleucine or valine' 0 C--O 1.252 1.215 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.51 172.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.621 HG21 HG21 ' A' ' 67' ' ' VAL . 74.5 t -82.24 129.31 37.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.648 177.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.5 mt -117.19 124.02 48.09 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.293 1.437 . . . . 0.0 108.529 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.406 ' HB2' HD13 ' A' ' 48' ' ' LEU . 30.7 tp -100.18 107.62 19.53 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 171.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 61.64 22.85 13.26 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.651 1.18 . . . . 0.0 111.943 -174.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.68 -20.84 38.17 Favored Glycine 0 C--N 1.355 1.594 0 CA-C-N 116.105 -0.498 . . . . 0.0 113.222 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.4 120.47 74.38 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 123.487 0.715 . . . . 0.0 110.628 -176.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.94 121.79 9.82 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.197 2.598 . . . . 0.0 113.033 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.406 HD13 ' HB2' ' A' ' 43' ' ' LEU . 84.9 mt -82.63 152.77 25.75 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 123.76 0.824 . . . . 0.0 109.792 174.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -73.37 110.04 7.36 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.595 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 14.9 p-10 -63.45 -32.77 74.31 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.551 -177.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -71.18 -17.91 62.51 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.935 0.894 . . . . 0.0 111.347 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.32 153.33 22.05 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.693 0.797 . . . . 0.0 111.013 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.682 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 62.9 p -82.09 158.15 23.83 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.67 0.788 . . . . 0.0 110.374 178.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.12 -35.12 79.23 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.873 0.869 . . . . 0.0 111.129 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.08 -46.9 68.19 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.149 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -72.76 -30.1 63.85 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.044 0.537 . . . . 0.0 110.981 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.4 ' SG ' HD21 ' A' ' 48' ' ' LEU . 42.9 t -67.33 -26.65 66.6 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.71 0.804 . . . . 0.0 111.056 173.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.27 22.61 47.42 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.305 177.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.49 HG22 HD22 ' A' ' 65' ' ' LEU . 2.4 p -98.39 131.75 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 176.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -121.08 -168.27 1.64 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.136 0.974 . . . . 0.0 110.881 -172.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 1' ' ' MET . . . -67.44 160.04 28.3 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.296 0.638 . . . . 0.0 111.087 175.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 61.25 19.03 9.73 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.781 1.232 . . . . 0.0 112.399 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.9 m -101.06 161.15 13.8 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.826 0.85 . . . . 0.0 108.826 174.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.8 m -128.33 124.2 35.86 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.495 ' HB3' HG12 ' A' ' 41' ' ' VAL . 3.1 mm? -109.61 128.27 55.11 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 124.795 1.238 . . . . 0.0 108.727 -178.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -93.54 108.17 19.91 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.751 0.82 . . . . 0.0 109.109 -174.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.621 HG21 HG21 ' A' ' 41' ' ' VAL . 76.8 t -94.95 106.09 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -178.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.48 136.34 54.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.281 -176.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 39' ' ' GLN . . . -82.17 89.74 1.46 Allowed Glycine 0 C--N 1.34 0.766 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 176.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -118.73 -21.54 7.81 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.425 0.69 . . . . 0.0 111.327 -175.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.8 ttm -78.54 -44.35 24.47 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.6 tm? 62.95 108.49 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.609 1.563 . . . . 0.0 111.382 175.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.444 ' HA3' ' HG3' ' A' ' 37' ' ' GLU . . . -113.84 158.97 13.95 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.033 174.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.761 -1.022 . . . . 0.0 112.172 178.241 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.43 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 26.0 ttt . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -89.86 98.61 11.87 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.602 -175.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.0 pp -114.7 150.4 35.32 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 175.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -87.77 145.45 26.1 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.857 0.863 . . . . 0.0 108.839 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.41 HG13 HG22 ' A' ' 28' ' ' VAL . 73.0 t -125.79 111.35 26.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 170.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -74.73 92.55 2.48 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.282 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.69 -175.39 3.57 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.781 1.232 . . . . 0.0 108.086 170.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -49.32 -28.54 4.97 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.082 0.553 . . . . 0.0 111.613 173.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -122.76 151.17 41.87 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.039 0.935 . . . . 0.0 108.522 161.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -73.22 128.44 35.49 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -177.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -127.6 159.81 33.51 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.504 0.721 . . . . 0.0 110.079 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.8 m -129.2 137.73 51.31 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -130.84 114.85 15.81 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.887 0.875 . . . . 0.0 111.302 -170.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -76.81 103.56 6.83 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 163.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.43 ' O ' ' HB3' ' A' ' 1' ' ' MET . 30.8 m -110.9 169.47 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.893 0.877 . . . . 0.0 109.434 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.1 m -94.93 -28.79 15.0 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.007 0.523 . . . . 0.0 110.108 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.42 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 102.18 -13.1 57.3 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 116.251 -0.432 . . . . 0.0 112.662 -176.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -91.99 -9.39 43.09 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.462 0.705 . . . . 0.0 111.186 -176.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -73.02 152.63 41.23 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 78.2 p -80.72 164.38 22.82 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.516 0.674 . . . . 0.0 109.569 171.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 53.9 t -62.98 -27.21 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.34 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.842 171.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.472 ' HB3' ' HB2' ' A' ' 50' ' ' ASP . . . -64.0 -40.14 95.69 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.404 0.682 . . . . 0.0 111.483 172.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.408 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 85.9 mm-40 -66.91 -36.75 82.98 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.797 0.439 . . . . 0.0 110.515 177.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.9 mm -61.18 -47.76 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.35 0.66 . . . . 0.0 110.417 174.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -55.23 -49.42 72.05 Favored 'General case' 0 C--N 1.359 1.005 0 O-C-N 123.714 0.634 . . . . 0.0 109.943 175.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.68 -48.36 72.5 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.916 0.886 . . . . 0.0 111.904 -178.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -64.87 -45.95 83.87 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.239 0.616 . . . . 0.0 110.853 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.565 HG12 HG22 ' A' ' 67' ' ' VAL . 84.1 t -64.88 -39.97 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 122.632 0.373 . . . . 0.0 110.542 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 34' ' ' ILE . . . -68.65 -32.28 72.02 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.647 0.779 . . . . 0.0 111.763 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.8 t -66.33 -42.02 88.77 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.186 0.594 . . . . 0.0 110.703 173.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.3 mt -70.41 -45.61 65.58 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.082 0.553 . . . . 0.0 112.063 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -88.54 -3.98 58.69 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.498 0.719 . . . . 0.0 111.747 -175.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.54 33.48 72.14 Favored Glycine 0 C--N 1.356 1.675 0 O-C-N 123.529 0.518 . . . . 0.0 113.725 174.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.412 ' O ' ' HB1' ' A' ' 29' ' ' ALA . 9.6 pt -123.01 -179.92 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.035 0.934 . . . . 0.0 110.576 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.58 125.61 53.09 Favored Pre-proline 0 CA--C 1.557 1.24 0 C-N-CA 123.392 0.677 . . . . 0.0 110.931 -176.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.65 -18.87 37.27 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.485 2.123 . . . . 0.0 112.685 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -66.73 -33.94 76.75 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.07 0.948 . . . . 0.0 111.846 -177.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -92.49 -8.08 45.57 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -176.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -80.1 147.05 31.57 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.247 0.546 . . . . 0.0 111.008 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.2 m -130.1 142.25 44.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 168.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 65' ' ' LEU . 73.2 t -106.29 105.53 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.3 mt -87.81 122.5 31.53 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.274 1.03 . . . . 0.0 110.291 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.2 tp -91.27 97.17 10.95 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 167.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 55.96 30.61 16.37 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.252 1.021 . . . . 0.0 112.082 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.1 -23.58 24.98 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-N 115.93 -0.577 . . . . 0.0 113.568 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.43 113.61 38.28 Favored Pre-proline 0 N--CA 1.479 0.977 0 CA-C-N 117.487 0.643 . . . . 0.0 110.929 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -65.92 109.22 1.44 Allowed 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.512 2.142 . . . . 0.0 112.143 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.6 mt -73.76 148.15 42.82 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.738 0.815 . . . . 0.0 110.996 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -77.25 121.88 24.3 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 124.286 0.991 . . . . 0.0 109.989 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.566 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 0.8 OUTLIER -65.75 -21.95 66.55 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 123.913 0.758 . . . . 0.0 112.546 176.142 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -72.39 -26.8 62.02 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.226 0.61 . . . . 0.0 111.099 174.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.89 143.11 27.3 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.767 0.827 . . . . 0.0 111.454 -174.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 45.6 p -73.74 168.06 20.14 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.549 0.74 . . . . 0.0 111.067 172.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.42 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 3.1 mm? -64.46 -30.39 71.43 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 171.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.88 -39.29 93.37 Favored Glycine 0 C--N 1.358 1.755 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.621 173.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -71.24 -37.26 72.0 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.741 0.416 . . . . 0.0 109.9 177.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 40.6 t -66.48 -22.45 66.19 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.414 0.685 . . . . 0.0 111.37 173.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.44 21.31 78.66 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.584 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.2 p -91.58 152.76 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 123.572 0.749 . . . . 0.0 109.606 -176.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -132.21 -168.3 2.02 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.764 0.826 . . . . 0.0 110.948 -176.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.8 167.4 13.49 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.537 0.735 . . . . 0.0 112.491 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 68.14 -5.33 0.9 Allowed 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 126.247 1.819 . . . . 0.0 113.737 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.3 m -77.6 153.71 32.98 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.776 0.83 . . . . 0.0 109.939 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.7 m -119.07 110.16 16.76 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.756 0.822 . . . . 0.0 109.633 175.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.441 ' HB3' HG11 ' A' ' 41' ' ' VAL . 84.8 mt -87.04 144.65 26.79 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 171.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -117.28 121.61 41.65 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.561 0.619 . . . . 0.0 110.857 -175.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.565 HG22 HG12 ' A' ' 28' ' ' VAL . 77.0 t -83.75 115.93 26.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 122.804 0.441 . . . . 0.0 109.971 173.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -123.89 167.21 14.41 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.562 1.145 . . . . 0.0 109.765 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.64 88.88 0.5 Allowed Glycine 0 C--N 1.342 0.871 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -109.35 -36.34 6.03 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.836 0.855 . . . . 0.0 109.706 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 47.4 ttm -83.2 146.66 28.48 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.185 175.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -92.15 -32.48 15.1 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.49 -144.21 12.46 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.79 174.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.436 0 CA-C-O 118.937 -0.924 . . . . 0.0 112.629 177.916 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -102.61 118.39 36.75 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.682 0.793 . . . . 0.0 110.252 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 pp -133.55 165.26 25.31 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.302 0.641 . . . . 0.0 110.35 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -101.05 142.39 32.58 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.057 0.943 . . . . 0.0 109.528 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.1 t -125.46 109.62 22.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 C-N-CA 123.903 0.881 . . . . 0.0 108.674 171.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 35.5 ttt85 -79.48 95.35 5.78 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.084 1.353 . . . . 0.0 110.862 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.17 -174.82 3.33 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.582 1.153 . . . . 0.0 108.032 165.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -42.15 -36.18 1.12 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 123.567 0.747 . . . . 0.0 111.62 167.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -111.05 136.25 50.34 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 164.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -70.88 123.28 21.62 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 173.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -126.1 154.42 43.13 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.498 0.719 . . . . 0.0 109.769 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.3 m -113.91 143.15 45.18 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.812 0.845 . . . . 0.0 108.809 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -136.61 129.36 30.66 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.793 0.837 . . . . 0.0 110.043 -174.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -90.74 114.71 27.13 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 166.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.3 m -115.37 155.48 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.192 0.997 . . . . 0.0 110.463 -169.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.0 m -83.03 -9.9 59.03 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -171.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.5 -50.68 4.07 Favored Glycine 0 C--N 1.358 1.776 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -174.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -79.65 7.06 9.11 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.855 0.862 . . . . 0.0 110.802 167.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -59.57 121.05 10.6 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.765 1.226 . . . . 0.0 109.176 168.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.688 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 51.1 p -78.88 167.41 21.19 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 118.765 0.711 . . . . 0.0 110.385 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.589 HG21 ' HB3' ' A' ' 48' ' ' LEU . 80.3 t -67.52 -32.52 57.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 123.157 0.583 . . . . 0.0 110.069 174.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.65 -36.43 84.25 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.601 0.761 . . . . 0.0 110.635 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -69.3 -40.86 77.43 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.307 0.643 . . . . 0.0 110.963 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.573 HD11 HD11 ' A' ' 54' ' ' LEU . 40.9 mm -57.95 -45.82 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.591 0.757 . . . . 0.0 110.151 175.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.532 ' HE2' ' HA ' ' A' ' 40' ' ' VAL . 92.6 mttt -59.6 -49.59 77.19 Favored 'General case' 0 C--O 1.21 -1.017 0 O-C-N 124.52 1.137 . . . . 0.0 110.603 176.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.01 -42.96 91.36 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.007 0.923 . . . . 0.0 112.025 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -59.41 -53.15 61.45 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.871 0.868 . . . . 0.0 111.019 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.469 HG11 HG21 ' A' ' 67' ' ' VAL . 11.6 p -75.39 -27.57 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.46 -175.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.77 -37.15 79.13 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.726 0.81 . . . . 0.0 110.985 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.4 t -67.13 -40.88 86.87 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 123.39 0.431 . . . . 0.0 110.44 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.1 mt -61.9 -49.71 75.11 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 123.445 0.466 . . . . 0.0 111.916 176.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 28' ' ' VAL . 3.2 mm-40 -86.58 -3.43 59.02 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.115 0.566 . . . . 0.0 111.693 -175.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.56 16.87 70.21 Favored Glycine 0 C--N 1.357 1.711 0 O-C-N 123.315 0.384 . . . . 0.0 113.285 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 36.1 pt -98.65 175.84 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.936 0.894 . . . . 0.0 110.937 -175.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.39 133.29 38.75 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.814 0.846 . . . . 0.0 110.355 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -66.76 -16.77 51.2 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.699 2.266 . . . . 0.0 111.964 171.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -76.71 -19.34 57.8 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.642 0.777 . . . . 0.0 111.579 174.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -97.89 19.7 13.38 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.588 0.755 . . . . 0.0 111.131 -172.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -152.87 166.43 32.34 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.651 -0.656 . . . . 0.0 112.024 -172.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.532 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . 11.2 p -142.29 149.22 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.653 1.181 . . . . 0.0 108.993 172.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.428 ' HB ' HG13 ' A' ' 21' ' ' VAL . 63.1 t -102.65 132.55 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.22 0.608 . . . . 0.0 109.638 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 47' ' ' PRO . 2.7 mm? -117.75 113.54 21.99 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.648 1.579 . . . . 0.0 108.657 -174.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.618 HD11 ' HB ' ' A' ' 59' ' ' VAL . 2.9 tt -80.15 98.26 7.24 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 57.85 26.48 13.29 Favored 'General case' 0 CA--C 1.556 1.175 0 O-C-N 124.007 0.817 . . . . 0.0 111.842 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.27 -18.79 32.85 Favored Glycine 0 C--N 1.357 1.719 0 CA-C-N 115.927 -0.578 . . . . 0.0 114.207 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.84 117.31 67.81 Favored Pre-proline 0 N--CA 1.483 1.184 0 C-N-CA 123.516 0.726 . . . . 0.0 111.422 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.411 ' HA ' HD13 ' A' ' 42' ' ' LEU . 36.3 Cg_endo -62.11 108.95 0.73 Allowed 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.09 2.527 . . . . 0.0 113.204 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.589 ' HB3' HG21 ' A' ' 21' ' ' VAL . 73.7 mt -82.78 139.97 33.27 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.133 177.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -80.56 131.9 35.58 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.024 0.93 . . . . 0.0 110.334 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.24 -49.87 22.4 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.038 1.335 . . . . 0.0 113.628 -174.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -18.79 49.89 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.955 0.502 . . . . 0.0 112.173 -173.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.73 140.36 45.92 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.107 0.563 . . . . 0.0 110.791 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.688 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 47.6 p -85.43 170.87 12.28 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.734 0.414 . . . . 0.0 110.673 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.573 HD11 HD11 ' A' ' 24' ' ' ILE . 36.8 mt -68.74 -29.93 68.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.117 0.567 . . . . 0.0 111.117 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.02 -42.39 92.52 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.05 172.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -68.89 -31.34 70.19 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.842 0.857 . . . . 0.0 111.271 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 79.0 m -71.96 -28.87 63.73 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.304 0.642 . . . . 0.0 110.635 172.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.76 22.07 54.23 Favored Glycine 0 C--N 1.348 1.21 0 O-C-N 123.495 0.497 . . . . 0.0 112.91 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.618 ' HB ' HD11 ' A' ' 43' ' ' LEU . 7.5 p -96.94 135.7 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.44 0.696 . . . . 0.0 110.235 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -106.77 -168.57 1.43 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.247 1.019 . . . . 0.0 109.925 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.35 175.79 6.6 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.107 0.563 . . . . 0.0 111.26 176.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 58.59 26.02 13.91 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.869 1.268 . . . . 0.0 112.439 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.6 m -111.63 153.94 25.61 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.854 0.862 . . . . 0.0 109.832 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 54.5 m -114.44 108.82 17.39 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.08 0.552 . . . . 0.0 109.889 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.57 149.96 21.03 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 171.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -125.19 139.25 53.91 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 119.087 0.858 . . . . 0.0 110.758 -176.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.469 HG21 HG11 ' A' ' 28' ' ' VAL . 77.1 t -97.14 122.23 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.526 0.731 . . . . 0.0 110.071 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -118.3 149.91 40.36 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.426 0.69 . . . . 0.0 110.543 173.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.39 90.57 1.68 Allowed Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -123.3 10.29 9.25 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.708 0.803 . . . . 0.0 110.422 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 37.7 tpp . . . . . 0 N--CA 1.479 1.01 0 C-N-CA 122.868 0.467 . . . . 0.0 110.698 -169.138 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.474 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 30.1 tt0 -145.26 123.06 11.9 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.6 pp -119.9 166.79 12.85 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.312 0.577 . . . . 0.0 110.715 -174.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -102.57 137.62 40.57 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.9 t -107.15 114.39 46.01 Favored 'Isoleucine or valine' 0 C--O 1.248 0.995 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 172.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.5 ttt85 -83.09 90.51 7.06 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.231 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.59 -176.8 3.19 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 114.373 -1.285 . . . . 0.0 107.988 174.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -43.66 -29.22 0.48 Allowed 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 124.352 1.061 . . . . 0.0 112.316 170.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -135.68 140.89 44.82 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.908 1.283 . . . . 0.0 107.921 166.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.9 126.28 30.09 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.24 0.616 . . . . 0.0 110.076 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -119.96 160.38 22.87 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.058 0.943 . . . . 0.0 108.93 172.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.0 m -124.58 131.65 53.47 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -132.16 126.51 33.8 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.598 0.759 . . . . 0.0 109.939 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 11.3 pt-20 -89.15 135.54 33.51 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.097 0.475 . . . . 0.0 109.764 173.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 1' ' ' MET . 30.1 m -134.74 150.21 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.8 0.84 . . . . 0.0 109.598 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.1 p -93.58 12.51 25.03 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.164 0.585 . . . . 0.0 111.26 172.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.411 ' O ' ' HB ' ' A' ' 53' ' ' THR . . . 93.62 -35.4 4.16 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-O 119.647 -0.529 . . . . 0.0 112.798 176.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -68.0 -21.13 65.06 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.974 0.91 . . . . 0.0 112.301 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -62.0 134.64 56.9 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 26.4 p -82.6 168.6 17.16 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.36 0.6 . . . . 0.0 110.637 174.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.567 HG21 ' HB3' ' A' ' 48' ' ' LEU . 55.9 t -63.16 -32.78 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.425 170.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.508 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . . . -60.74 -42.42 97.31 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.36 0.664 . . . . 0.0 111.064 173.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -67.83 -37.47 81.95 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.348 0.259 . . . . 0.0 111.232 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.415 HD11 HG11 ' A' ' 15' ' ' VAL . 44.0 mm -57.32 -48.1 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 122.837 0.455 . . . . 0.0 110.032 173.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.444 ' HE3' HG12 ' A' ' 21' ' ' VAL . 96.6 mttt -61.26 -40.81 95.44 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.783 0.833 . . . . 0.0 111.223 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.87 -43.56 94.64 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.884 0.874 . . . . 0.0 112.069 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -65.54 -42.59 91.77 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.034 0.533 . . . . 0.0 111.044 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.8 t -64.71 -39.88 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.086 0.555 . . . . 0.0 109.76 176.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.98 -35.19 79.36 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.258 1.023 . . . . 0.0 112.316 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.5 m -64.81 -50.13 67.92 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.345 0.658 . . . . 0.0 110.843 175.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.5 mt -71.59 -38.44 70.89 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -174.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -91.35 -14.61 30.43 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.055 0.542 . . . . 0.0 111.662 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.92 27.26 69.17 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 116.405 -0.362 . . . . 0.0 112.565 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.2 pt -108.09 177.97 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.793 0.837 . . . . 0.0 109.795 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.27 138.92 20.62 Favored Pre-proline 0 N--CA 1.478 0.957 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.61 -20.48 70.95 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 123.296 2.664 . . . . 0.0 113.053 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -67.95 -35.36 78.27 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.573 0.749 . . . . 0.0 111.006 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 71' ' ' MET . 10.6 m-20 -73.26 -18.06 61.26 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.073 0.549 . . . . 0.0 112.261 -172.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.546 ' HB2' HG13 ' A' ' 67' ' ' VAL . 12.3 pt20 -112.95 151.22 30.8 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.399 0.679 . . . . 0.0 111.074 -174.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -132.12 132.94 61.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 124.744 1.218 . . . . 0.0 107.986 171.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.6 t -88.78 131.2 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.0 mt -122.93 115.19 21.52 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.952 1.301 . . . . 0.0 108.983 -174.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.524 ' HB2' HD11 ' A' ' 48' ' ' LEU . 42.2 tp -81.94 95.14 7.28 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 176.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 56.97 24.52 9.55 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.058 0.943 . . . . 0.0 112.027 -174.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.6 -8.19 37.1 Favored Glycine 0 C--N 1.354 1.528 0 CA-C-O 119.597 -0.557 . . . . 0.0 113.86 -177.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.72 118.84 74.55 Favored Pre-proline 0 N--CA 1.483 1.211 0 CA-C-N 117.444 0.622 . . . . 0.0 110.849 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.29 102.04 0.31 Allowed 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.746 2.298 . . . . 0.0 112.519 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.567 ' HB3' HG21 ' A' ' 21' ' ' VAL . 67.1 mt -81.0 134.4 35.67 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.463 177.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -82.52 139.0 34.14 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.834 0.854 . . . . 0.0 110.333 -176.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 22' ' ' ALA . 2.0 m-20 -59.96 -30.13 68.88 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.792 0.837 . . . . 0.0 111.835 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -73.35 -25.55 60.65 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.215 1.006 . . . . 0.0 111.206 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.98 131.74 35.87 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.921 -174.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 81.1 p -80.59 167.71 19.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.27 0.628 . . . . 0.0 109.541 172.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -65.51 -30.66 71.45 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.241 0.473 . . . . 0.0 110.42 176.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.27 -36.0 70.33 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.511 173.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -72.11 -38.05 69.4 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.465 0.706 . . . . 0.0 110.638 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 76.6 m -71.32 -18.63 62.39 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.905 0.882 . . . . 0.0 111.088 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.92 29.52 75.21 Favored Glycine 0 C--N 1.352 1.431 0 O-C-N 123.497 0.498 . . . . 0.0 112.663 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.469 HG21 HD11 ' A' ' 65' ' ' LEU . 4.5 p -87.08 133.29 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -81.77 174.24 11.52 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.505 0.722 . . . . 0.0 110.979 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.462 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -72.71 160.37 32.33 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.784 175.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 64.84 12.16 7.52 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.743 1.617 . . . . 0.0 112.96 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.4 m -85.11 154.37 22.08 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.3 m -114.32 116.08 28.4 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.146 0.498 . . . . 0.0 110.181 -177.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.469 HD11 HG21 ' A' ' 59' ' ' VAL . 6.9 mp -103.57 122.14 44.36 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.085 1.354 . . . . 0.0 108.142 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -94.71 145.32 24.93 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.025 0.53 . . . . 0.0 111.841 -171.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.546 HG13 ' HB2' ' A' ' 39' ' ' GLN . 73.6 t -94.12 135.97 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 124.211 1.004 . . . . 0.0 109.989 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.63 141.26 51.67 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.113 0.965 . . . . 0.0 109.503 171.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.14 92.06 1.52 Allowed Glycine 0 N--CA 1.472 1.065 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -121.97 -68.5 0.89 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 117.321 0.561 . . . . 0.0 111.959 -172.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.457 ' O ' ' HA ' ' A' ' 38' ' ' ASP . 51.2 tpp . . . . . 0 N--CA 1.482 1.153 0 C-N-CA 123.456 0.703 . . . . 0.0 111.141 -174.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 60.8 tt0 -122.14 114.33 20.73 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.922 0.889 . . . . 0.0 109.389 -175.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.3 pp -120.79 165.13 15.57 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.938 0.495 . . . . 0.0 111.635 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -98.51 152.24 19.76 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.636 0.774 . . . . 0.0 109.254 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.7 t -135.13 109.31 10.99 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 C-N-CA 124.767 1.227 . . . . 0.0 108.179 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -76.33 92.83 3.37 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.866 0.866 . . . . 0.0 110.776 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.31 -176.87 4.26 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.297 1.039 . . . . 0.0 108.398 165.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -47.55 -30.15 3.35 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.17 0.588 . . . . 0.0 112.156 171.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -124.0 144.07 50.04 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.175 0.99 . . . . 0.0 108.661 161.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.86 133.95 47.94 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 122.947 0.499 . . . . 0.0 110.391 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -131.02 148.49 52.76 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.837 0.855 . . . . 0.0 109.406 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.2 m -119.5 133.74 55.54 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -128.45 119.3 24.66 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.977 0.911 . . . . 0.0 109.997 -175.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 42.0 tt0 -95.35 104.43 16.32 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 171.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.0 m -112.8 174.44 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.126 0.97 . . . . 0.0 110.864 -172.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.7 m -83.09 -45.53 13.88 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.678 0.791 . . . . 0.0 110.106 174.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.23 -35.06 3.2 Favored Glycine 0 C--N 1.35 1.321 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -174.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -65.55 -10.13 32.42 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.476 0.71 . . . . 0.0 111.53 173.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -52.64 129.08 28.3 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.854 1.261 . . . . 0.0 110.408 169.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.675 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 45.5 p -84.77 164.73 18.33 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 118.272 0.487 . . . . 0.0 109.94 173.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.491 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 68.4 t -67.22 -30.27 48.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.235 174.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.504 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . . . -62.12 -40.42 95.85 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.572 0.749 . . . . 0.0 110.802 174.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -68.5 -40.17 81.0 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.746 177.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.9 mm -57.97 -42.84 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 123.229 0.612 . . . . 0.0 110.529 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.43 -51.87 68.04 Favored 'General case' 0 C--N 1.359 0.998 0 O-C-N 123.975 0.797 . . . . 0.0 110.015 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.61 -42.97 75.63 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.861 0.726 . . . . 0.0 111.924 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.416 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 48.5 m-70 -61.54 -54.62 40.79 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.686 0.794 . . . . 0.0 111.655 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.526 HG11 HG21 ' A' ' 67' ' ' VAL . 12.8 p -72.42 -30.01 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.637 -174.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.402 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . . . -72.45 -34.69 67.95 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.388 0.675 . . . . 0.0 111.526 177.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 t -67.16 -37.65 84.12 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.957 0.503 . . . . 0.0 110.309 176.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 27' ' ' HIS . 88.5 mt -63.4 -45.81 89.29 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 123.705 0.628 . . . . 0.0 111.711 177.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.15 -20.0 45.93 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.082 0.553 . . . . 0.0 111.785 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.27 30.81 66.73 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 112.014 -0.434 . . . . 0.0 112.014 -173.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.3 pt -111.57 179.83 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.189 0.996 . . . . 0.0 110.634 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.74 123.43 88.34 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 124.237 1.015 . . . . 0.0 112.576 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.23 -31.59 35.41 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 122.548 2.165 . . . . 0.0 112.567 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.98 5.95 34.69 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.34 0.656 . . . . 0.0 112.062 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -78.83 -31.45 45.77 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 122.35 1.071 . . . . 0.0 109.205 166.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.402 ' NE2' ' HB2' ' A' ' 29' ' ' ALA . 18.8 mt-30 -89.85 147.39 23.8 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 113.725 -1.579 . . . . 0.0 112.337 -167.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -131.05 129.18 63.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 165.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.446 ' HB ' HG13 ' A' ' 21' ' ' VAL . 59.3 t -87.89 131.69 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.6 mt -118.59 148.78 42.33 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.927 1.291 . . . . 0.0 109.519 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.431 ' HB2' HD11 ' A' ' 48' ' ' LEU . 42.3 tp -131.44 102.15 5.82 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 171.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 58.66 33.83 23.37 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.457 1.103 . . . . 0.0 111.398 -175.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.84 -24.01 33.96 Favored Glycine 0 C--N 1.354 1.554 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.297 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.35 119.4 76.84 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 123.325 0.65 . . . . 0.0 110.506 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.28 106.44 1.02 Allowed 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.881 2.387 . . . . 0.0 111.964 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.432 ' HB3' HG21 ' A' ' 21' ' ' VAL . 90.8 mt -69.56 124.12 23.1 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.356 0.663 . . . . 0.0 110.014 173.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -72.46 131.7 42.9 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.366 0.666 . . . . 0.0 110.63 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.504 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . 7.8 p-10 -58.79 -36.79 75.01 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.008 0.923 . . . . 0.0 112.832 -173.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -74.75 -25.72 59.29 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.1 0.56 . . . . 0.0 111.05 -176.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.72 139.51 40.49 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.504 0.722 . . . . 0.0 110.609 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.675 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 53.2 p -83.67 170.36 14.34 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.925 0.393 . . . . 0.0 110.751 177.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.7 mp -72.8 -26.48 61.53 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.9 0.88 . . . . 0.0 110.292 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.3 -43.19 71.79 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.037 172.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -64.42 -39.16 93.3 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.237 0.615 . . . . 0.0 110.77 175.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 46.1 t -63.73 -31.35 72.49 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.624 0.77 . . . . 0.0 111.406 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.38 23.96 69.43 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.272 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.451 HG23 HG21 ' A' ' 63' ' ' THR . 14.7 p -79.44 150.24 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.072 0.549 . . . . 0.0 109.551 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -127.42 -171.68 2.48 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.362 0.665 . . . . 0.0 111.262 -169.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.76 154.8 41.31 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.468 0.707 . . . . 0.0 111.404 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 62.9 1.48 0.84 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 126.183 1.793 . . . . 0.0 114.06 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.451 HG21 HG23 ' A' ' 59' ' ' VAL . 32.3 m -72.37 147.76 45.94 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 47.1 m -113.34 103.71 11.58 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 122.072 -0.393 . . . . 0.0 109.951 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.408 HD23 HD13 ' A' ' 43' ' ' LEU . 62.2 mt -78.18 169.92 17.46 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 170.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -136.08 155.16 50.62 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.526 HG21 HG11 ' A' ' 28' ' ' VAL . 48.7 t -120.38 126.55 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.263 1.025 . . . . 0.0 108.956 175.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.01 142.65 51.5 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.671 0.789 . . . . 0.0 109.805 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.24 89.79 1.64 Allowed Glycine 0 C--N 1.342 0.909 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -130.03 5.06 4.91 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.89 0.876 . . . . 0.0 110.72 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.1 ttm . . . . . 0 N--CA 1.474 0.77 0 C-N-CA 123.438 0.695 . . . . 0.0 109.403 -170.881 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.49 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 44.1 ttm . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -91.01 105.03 17.54 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 170.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.5 pp -114.85 163.89 14.89 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.645 0.778 . . . . 0.0 109.985 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -107.41 158.8 16.88 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.513 0.725 . . . . 0.0 109.391 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.406 HG11 HG21 ' A' ' 28' ' ' VAL . 76.9 t -129.66 111.88 23.09 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 C-N-CA 124.037 0.935 . . . . 0.0 109.884 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -70.89 91.33 0.85 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.111 0.964 . . . . 0.0 109.42 173.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.03 -179.37 3.9 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 125.478 1.511 . . . . 0.0 107.808 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -59.21 -33.16 70.65 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 118.581 0.628 . . . . 0.0 109.715 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -111.18 127.5 55.61 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 165.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.99 120.07 14.28 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -111.33 158.3 19.19 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.571 0.749 . . . . 0.0 109.622 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.7 m -134.0 135.73 43.61 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.297 1.039 . . . . 0.0 108.735 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -133.06 124.79 28.28 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.88 0.872 . . . . 0.0 110.46 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -98.1 105.74 17.93 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 170.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.493 HG11 HD11 ' A' ' 24' ' ' ILE . 28.8 m -120.53 157.77 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.952 1.301 . . . . 0.0 109.412 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.62 ' HB ' ' HG2' ' A' ' 18' ' ' GLN . 20.4 m -75.94 -14.24 60.25 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-O 121.058 0.456 . . . . 0.0 110.907 173.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.452 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 103.26 -31.79 8.32 Favored Glycine 0 C--N 1.351 1.411 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -172.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.62 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 12.6 pt20 -70.74 -4.43 23.74 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.924 0.89 . . . . 0.0 112.304 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -79.23 145.5 33.55 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.754 0.422 . . . . 0.0 109.936 175.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.6 p -82.38 153.46 25.72 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.181 0.515 . . . . 0.0 111.134 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.0 t -62.35 -28.17 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 124.277 1.031 . . . . 0.0 110.522 175.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.62 -50.09 75.23 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 124.331 1.052 . . . . 0.0 110.793 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -67.43 -36.15 80.66 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.312 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.493 HD11 HG11 ' A' ' 15' ' ' VAL . 48.0 mm -57.59 -54.86 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 O-C-N 123.829 0.705 . . . . 0.0 110.301 177.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -73.0 -27.9 62.05 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.105 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.15 -46.48 90.35 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.52 0.728 . . . . 0.0 110.571 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -66.08 -40.18 90.63 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.266 0.627 . . . . 0.0 110.348 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.501 HG11 HG21 ' A' ' 67' ' ' VAL . 72.6 t -56.92 -49.72 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 173.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.33 -34.86 77.47 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.048 0.939 . . . . 0.0 112.609 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.5 t -65.58 -36.74 84.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.488 0.715 . . . . 0.0 110.746 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.1 mt -80.45 -34.84 35.69 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.933 0.893 . . . . 0.0 112.24 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.498 ' HB2' HG12 ' A' ' 34' ' ' ILE . 6.1 mm-40 -75.65 -36.14 60.24 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.891 0.876 . . . . 0.0 110.172 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.93 36.5 15.28 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.479 -171.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.498 HG12 ' HB2' ' A' ' 32' ' ' GLU . 25.0 pt -127.2 -179.56 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 123.897 0.879 . . . . 0.0 111.03 -176.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.18 114.19 37.75 Favored Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 123.937 0.895 . . . . 0.0 112.218 -176.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.85 -33.1 85.38 Favored 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 123.521 2.814 . . . . 0.0 114.009 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -69.39 -37.56 77.58 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.247 0.342 . . . . 0.0 110.691 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -64.84 -44.55 89.44 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 123.812 0.695 . . . . 0.0 111.116 -170.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.572 ' HB2' HG13 ' A' ' 67' ' ' VAL . 11.7 pt20 -75.75 150.96 37.69 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.976 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.2 144.15 37.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 124.975 1.31 . . . . 0.0 108.139 175.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.7 t -90.46 133.35 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 122.915 0.486 . . . . 0.0 109.86 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 66.5 mt -117.28 108.87 16.15 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.896 1.278 . . . . 0.0 108.961 -176.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.4 ' HB2' HD11 ' A' ' 48' ' ' LEU . 46.2 tp -80.44 96.63 6.79 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 175.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 57.85 28.34 15.9 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.059 0.944 . . . . 0.0 112.036 -176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.46 -25.38 19.84 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-O 119.608 -0.551 . . . . 0.0 113.556 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.3 113.54 32.18 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 123.132 0.573 . . . . 0.0 110.563 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -64.61 115.15 3.05 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.501 2.134 . . . . 0.0 111.526 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.4 HD11 ' HB2' ' A' ' 43' ' ' LEU . 93.2 mt -79.86 158.16 26.81 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.537 0.735 . . . . 0.0 111.358 178.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -86.29 128.71 34.96 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -62.57 -36.59 83.16 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 121.057 0.456 . . . . 0.0 110.911 -176.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -78.8 -9.41 59.44 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.736 0.815 . . . . 0.0 111.843 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.87 148.16 24.77 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 123.356 0.662 . . . . 0.0 109.974 175.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.4 p -92.34 166.34 12.63 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.467 0.707 . . . . 0.0 110.62 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.452 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 3.5 mm? -65.19 -28.47 69.41 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.638 0.775 . . . . 0.0 110.107 175.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.1 -37.02 44.24 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.231 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -67.76 -41.85 82.7 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.019 0.527 . . . . 0.0 110.05 174.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 80.7 m -63.5 -25.84 68.44 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.144 0.578 . . . . 0.0 110.773 174.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.99 25.88 70.32 Favored Glycine 0 C--N 1.35 1.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.667 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.52 160.81 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 122.891 0.477 . . . . 0.0 109.795 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -110.87 -177.08 3.13 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.395 0.678 . . . . 0.0 110.67 -178.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.49 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -76.86 166.25 23.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.294 0.638 . . . . 0.0 111.022 177.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 67.92 6.29 5.05 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.965 1.306 . . . . 0.0 112.909 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.1 m -79.94 150.89 30.36 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.164 0.585 . . . . 0.0 109.746 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.2 m -117.17 112.06 20.32 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.4 mp -96.42 146.9 24.36 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 124.65 1.18 . . . . 0.0 108.112 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -102.01 156.21 17.68 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.065 0.546 . . . . 0.0 110.88 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.572 HG13 ' HB2' ' A' ' 39' ' ' GLN . 6.6 t -118.62 131.29 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.368 1.067 . . . . 0.0 109.311 173.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.32 126.74 20.08 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.121 0.968 . . . . 0.0 109.992 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 39' ' ' GLN . . . -75.97 96.01 1.06 Allowed Glycine 0 C--N 1.344 0.982 0 N-CA-C 111.961 -0.455 . . . . 0.0 111.961 -178.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -120.6 -68.38 0.91 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.778 0.831 . . . . 0.0 111.438 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 21.3 mmt . . . . . 0 N--CA 1.487 1.41 0 C-N-CA 122.712 0.405 . . . . 0.0 111.862 -168.516 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 ttt . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -85.32 127.54 34.37 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.4 pp -136.2 167.24 21.65 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -109.64 147.95 32.18 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.112 0.565 . . . . 0.0 109.8 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.6 t -122.26 109.09 23.28 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 C-N-CA 125.128 1.371 . . . . 0.0 108.059 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -79.76 91.69 5.34 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.462 -1.244 . . . . 0.0 109.58 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.8 -177.84 3.49 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 114.262 -1.335 . . . . 0.0 108.345 177.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -52.29 -27.49 15.36 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.29 0.567 . . . . 0.0 110.847 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -117.36 141.07 48.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.006 1.322 . . . . 0.0 108.468 163.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -83.29 109.45 17.27 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.481 ' CD2' HG23 ' A' ' 28' ' ' VAL . 88.9 m-70 -110.61 132.46 54.17 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.694 0.798 . . . . 0.0 109.704 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.4 t -106.07 136.09 46.37 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -125.63 128.03 47.24 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.695 0.798 . . . . 0.0 109.923 -176.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -90.11 104.82 17.35 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 170.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.8 m -111.85 172.35 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.362 1.065 . . . . 0.0 109.428 176.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.1 m -107.49 -9.96 15.83 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.376 0.671 . . . . 0.0 109.801 174.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.533 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 108.41 -35.78 4.76 Favored Glycine 0 C--N 1.353 1.473 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.754 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -4.89 39.47 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -176.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -78.11 147.33 34.69 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.854 0.462 . . . . 0.0 109.815 170.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 61.7 p -86.42 164.59 16.92 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.349 0.595 . . . . 0.0 111.745 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.415 HG21 ' HB3' ' A' ' 48' ' ' LEU . 71.3 t -66.32 -27.69 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.04 172.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.69 -41.86 95.74 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.83 0.852 . . . . 0.0 110.664 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -69.62 -38.97 77.45 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.608 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 27.9 mm -54.49 -45.59 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 123.661 0.784 . . . . 0.0 110.387 173.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 21' ' ' VAL . 92.4 mttt -61.35 -49.2 77.9 Favored 'General case' 0 C--N 1.36 1.061 0 O-C-N 124.049 0.843 . . . . 0.0 111.068 176.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.85 -38.54 78.97 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 124.328 1.017 . . . . 0.0 111.365 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -61.27 -58.14 9.49 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.726 0.811 . . . . 0.0 110.961 177.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.481 HG23 ' CD2' ' A' ' 11' ' ' HIS . 6.3 p -66.8 -30.94 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.449 -174.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.26 -43.39 77.92 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.935 0.894 . . . . 0.0 111.444 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.1 t -61.79 -41.5 97.82 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.384 0.673 . . . . 0.0 110.597 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.7 mt -65.0 -49.99 68.07 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.932 0.893 . . . . 0.0 111.863 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -90.44 -2.71 57.95 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.341 0.656 . . . . 0.0 112.185 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.1 17.82 77.47 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-O 120.159 -0.245 . . . . 0.0 113.511 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.1 pt -102.08 -179.1 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.939 0.895 . . . . 0.0 110.248 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.473 ' HB1' ' HG2' ' A' ' 37' ' ' GLU . . . -102.69 133.82 20.23 Favored Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 123.052 0.541 . . . . 0.0 111.756 -175.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.505 ' HA ' ' HG2' ' A' ' 39' ' ' GLN . 68.3 Cg_endo -70.61 -17.84 33.43 Favored 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 122.678 2.252 . . . . 0.0 111.583 175.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.473 ' HG2' ' HB1' ' A' ' 35' ' ' ALA . 10.0 pt-20 -89.4 -2.16 58.31 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.924 1.29 . . . . 0.0 112.012 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -107.62 -20.8 13.12 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.532 0.733 . . . . 0.0 110.164 175.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.505 ' HG2' ' HA ' ' A' ' 36' ' ' PRO . 11.3 pt20 -106.79 157.85 17.43 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.703 0.763 . . . . 0.0 110.671 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.6 m -132.37 158.98 43.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 C-N-CA 125.166 1.386 . . . . 0.0 108.356 169.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.489 HG12 HD12 ' A' ' 48' ' ' LEU . 66.2 t -111.68 124.6 68.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 176.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.5 mt -108.44 154.14 22.3 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 124.902 1.281 . . . . 0.0 109.346 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.2 tp -130.91 106.67 8.58 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 169.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 59.92 24.42 13.5 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.005 0.922 . . . . 0.0 111.317 -174.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.53 -28.47 14.86 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.155 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.99 120.59 80.36 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.101 0.56 . . . . 0.0 110.767 -174.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.04 106.22 0.64 Allowed 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 123.082 2.521 . . . . 0.0 112.407 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.489 HD12 HG12 ' A' ' 41' ' ' VAL . 80.2 mt -68.13 121.24 15.73 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.967 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -60.19 126.63 28.26 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.968 0.793 . . . . 0.0 110.004 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -58.85 -43.28 90.72 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.447 0.699 . . . . 0.0 111.846 -174.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -77.14 -17.62 58.49 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.639 0.375 . . . . 0.0 111.441 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.77 133.63 40.65 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 55.2 p -78.2 168.26 20.12 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.696 0.798 . . . . 0.0 110.537 177.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.533 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 2.5 mm? -61.49 -35.54 77.96 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 120.958 0.409 . . . . 0.0 110.165 177.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.37 -33.77 61.22 Favored Glycine 0 C--N 1.355 1.625 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.536 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -72.57 -37.69 68.12 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.215 0.606 . . . . 0.0 110.681 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 78.6 m -68.23 -28.6 67.37 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.35 0.66 . . . . 0.0 110.321 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.35 24.98 69.38 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.755 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.592 HG21 HD21 ' A' ' 65' ' ' LEU . 6.2 p -77.87 138.64 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -91.14 178.95 5.85 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.125 0.57 . . . . 0.0 110.95 -175.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.65 160.32 31.75 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.28 0.632 . . . . 0.0 111.205 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 61.4 10.65 3.25 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.454 1.501 . . . . 0.0 113.423 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.1 m -82.53 147.05 28.87 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.097 0.475 . . . . 0.0 110.156 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.4 m -104.59 106.49 17.01 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.841 0.856 . . . . 0.0 109.838 -175.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.592 HD21 HG21 ' A' ' 59' ' ' VAL . 43.9 mt -92.14 128.05 37.85 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.415 1.086 . . . . 0.0 108.444 176.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -99.0 140.97 32.35 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.758 0.708 . . . . 0.0 111.965 -172.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.492 HG13 ' HB2' ' A' ' 39' ' ' GLN . 69.4 t -95.78 125.47 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.067 0.947 . . . . 0.0 109.42 173.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.01 149.35 48.78 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.093 0.957 . . . . 0.0 109.294 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.19 89.28 1.39 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -106.62 -40.3 5.58 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.387 0.675 . . . . 0.0 109.88 176.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 48.4 tpp . . . . . 0 CA--C 1.547 0.841 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 172.73 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.415 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 22.1 ttt . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 121.312 0.577 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.492 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 53.3 tt0 -91.36 140.15 30.05 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.525 HD13 HD13 ' A' ' 65' ' ' LEU . 4.5 pp -146.91 159.85 43.04 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.274 0.63 . . . . 0.0 109.443 176.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -103.45 116.12 31.8 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.696 0.798 . . . . 0.0 109.505 -174.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.1 t -88.72 106.59 16.89 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 170.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.463 ' HB3' ' HA ' ' A' ' 66' ' ' GLU . 19.9 ttt180 -76.86 91.4 3.54 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.527 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -109.55 -176.43 3.01 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 125.347 1.459 . . . . 0.0 108.608 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -46.23 -39.57 10.06 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.538 0.735 . . . . 0.0 112.277 174.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -106.2 156.06 18.84 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 163.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.67 108.63 7.55 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -107.34 141.83 38.09 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.437 0.695 . . . . 0.0 109.505 175.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.7 t -126.8 135.13 50.63 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -128.36 131.55 48.57 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.337 1.055 . . . . 0.0 108.792 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 43.7 tt0 -91.36 113.77 26.12 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 167.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.539 HG21 ' HG ' ' A' ' 54' ' ' LEU . 27.6 m -110.3 144.82 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.953 0.901 . . . . 0.0 110.121 -174.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.6 p -85.95 3.34 42.47 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.073 0.549 . . . . 0.0 111.499 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.423 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 89.9 -38.31 3.23 Favored Glycine 0 C--N 1.353 1.495 0 CA-C-O 119.682 -0.51 . . . . 0.0 113.325 175.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -70.25 -19.81 63.1 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.988 0.915 . . . . 0.0 112.459 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -64.9 135.78 56.09 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.331 0.652 . . . . 0.0 109.483 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 70.1 p -83.59 165.55 18.94 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.326 0.584 . . . . 0.0 111.269 -177.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.6 t -66.42 -29.13 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 123.189 0.596 . . . . 0.0 110.351 174.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.506 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . . . -63.25 -39.9 95.9 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.284 0.634 . . . . 0.0 111.254 173.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -71.66 -35.08 70.23 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.906 0.482 . . . . 0.0 110.955 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 31.4 mm -58.32 -47.12 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.272 0.629 . . . . 0.0 110.384 171.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.489 ' HE2' ' HA ' ' A' ' 40' ' ' VAL . 98.6 mttt -61.52 -42.09 98.29 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.212 0.605 . . . . 0.0 111.342 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.81 80.68 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 124.138 0.899 . . . . 0.0 111.586 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.0 m-70 -60.16 -51.08 71.14 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.875 0.47 . . . . 0.0 111.041 175.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.491 HG12 HD11 ' A' ' 34' ' ' ILE . 49.0 t -67.26 -28.49 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.722 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.64 -34.97 62.87 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.875 0.87 . . . . 0.0 111.441 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.7 t -73.43 -40.1 64.49 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.118 0.567 . . . . 0.0 111.053 178.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.5 mt -77.18 -53.08 8.2 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.219 0.607 . . . . 0.0 111.633 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.31 -17.37 46.04 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.558 0.743 . . . . 0.0 111.738 -177.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.33 17.45 78.89 Favored Glycine 0 N--CA 1.471 0.984 0 N-CA-C 112.605 -0.198 . . . . 0.0 112.605 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.491 HD11 HG12 ' A' ' 28' ' ' VAL . 37.0 pt -91.41 166.23 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.596 0.758 . . . . 0.0 111.099 -175.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.99 118.1 67.87 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 123.257 0.623 . . . . 0.0 110.704 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HA ' ' HG2' ' A' ' 39' ' ' GLN . 56.2 Cg_endo -66.92 -19.85 51.9 Favored 'Trans proline' 0 C--N 1.387 2.57 0 C-N-CA 122.584 2.189 . . . . 0.0 111.84 176.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -74.41 -29.58 61.57 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.263 1.025 . . . . 0.0 111.836 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -85.93 -41.31 15.04 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.302 0.641 . . . . 0.0 110.697 -175.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.48 ' HB2' HG13 ' A' ' 67' ' ' VAL . 12.9 pt20 -76.58 157.08 32.28 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.998 -172.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.616 HG11 ' HB2' ' A' ' 70' ' ' ARG . 9.8 p -142.39 148.0 20.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 C-N-CA 125.186 1.394 . . . . 0.0 108.297 177.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.1 t -101.56 117.77 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.8 0.84 . . . . 0.0 109.308 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 68' ' ' ALA . 2.3 mm? -103.89 104.61 14.62 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.47 1.108 . . . . 0.0 109.69 -175.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.3 tp -81.75 97.19 7.83 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 58.31 26.05 13.5 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.952 0.901 . . . . 0.0 112.016 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.5 -19.82 33.29 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.511 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.83 114.99 48.66 Favored Pre-proline 0 N--CA 1.477 0.903 0 C-N-CA 123.456 0.702 . . . . 0.0 111.001 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -67.96 110.88 2.27 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 122.673 2.249 . . . . 0.0 111.018 174.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.5 mt -72.4 170.46 14.2 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.844 177.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -96.05 138.6 33.45 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' A' ' 22' ' ' ALA . 1.8 m-20 -55.92 -38.67 70.58 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.261 0.624 . . . . 0.0 111.402 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.45 -24.28 46.13 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.748 0.819 . . . . 0.0 111.48 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.97 132.89 42.86 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.061 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 21.1 p -81.35 173.5 12.4 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.539 ' HG ' HG21 ' A' ' 15' ' ' VAL . 3.3 mm? -64.26 -23.45 67.31 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 118.285 0.493 . . . . 0.0 110.258 174.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.42 -39.26 26.61 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.942 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.463 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 14.5 mm-40 -73.75 -29.75 62.41 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.411 0.684 . . . . 0.0 110.422 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 74.2 m -81.32 -18.17 46.68 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.791 0.837 . . . . 0.0 110.724 172.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.38 33.18 81.29 Favored Glycine 0 C--N 1.353 1.476 0 O-C-N 123.416 0.448 . . . . 0.0 113.461 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.1 t -70.49 135.59 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.336 0.654 . . . . 0.0 110.056 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -93.49 172.15 8.45 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.371 0.668 . . . . 0.0 110.534 176.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.23 165.05 25.44 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.065 0.546 . . . . 0.0 111.277 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 58.31 16.6 4.14 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 125.228 1.411 . . . . 0.0 112.798 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.8 m -90.98 147.84 22.82 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.656 0.782 . . . . 0.0 109.845 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 42.5 m -113.52 105.22 13.09 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.718 0.807 . . . . 0.0 109.26 -175.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.525 HD13 HD13 ' A' ' 3' ' ' LEU . 4.5 mp -103.03 123.44 46.63 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . 38.0 tt0 -93.56 150.7 20.22 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.9 0.48 . . . . 0.0 111.436 -171.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.48 HG13 ' HB2' ' A' ' 39' ' ' GLN . 73.3 t -104.11 118.59 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.911 0.884 . . . . 0.0 108.932 175.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.42 ' HB3' HD21 ' A' ' 42' ' ' LEU . . . -126.58 165.74 18.59 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.907 0.883 . . . . 0.0 109.669 175.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -98.22 90.12 1.02 Allowed Glycine 0 N--CA 1.471 0.977 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 175.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.616 ' HB2' HG11 ' A' ' 40' ' ' VAL . 73.7 mtp180 -134.74 17.29 3.57 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.407 0.683 . . . . 0.0 110.8 -176.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 44.5 tpp . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.214 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.48 ' HG3' ' HB2' ' A' ' 61' ' ' ALA . 62.1 ttp . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -77.01 118.56 19.7 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.212 1.005 . . . . 0.0 109.62 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.1 pp -137.74 161.23 37.09 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.113 0.565 . . . . 0.0 109.775 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -96.53 152.42 18.64 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.656 0.782 . . . . 0.0 109.836 -175.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.0 t -137.85 101.82 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 124.676 1.191 . . . . 0.0 107.962 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -76.33 94.88 3.67 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.057 0.943 . . . . 0.0 111.843 -175.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.78 -176.51 3.11 Favored 'General case' 0 C--O 1.245 0.867 0 C-N-CA 124.811 1.245 . . . . 0.0 108.099 165.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -45.29 -31.41 1.57 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.514 0.726 . . . . 0.0 112.153 171.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -114.72 137.29 52.1 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 162.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.32 113.47 8.4 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -91.82 155.76 17.99 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.647 0.779 . . . . 0.0 109.482 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.3 m -141.5 115.6 9.31 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 173.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -116.25 134.54 54.8 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.386 0.675 . . . . 0.0 110.601 -173.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -89.17 103.56 16.17 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 166.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.447 HG21 ' HG ' ' A' ' 54' ' ' LEU . 18.7 m -112.15 141.61 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.208 1.003 . . . . 0.0 109.225 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.2 t -91.41 5.55 48.93 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 120.657 0.265 . . . . 0.0 110.806 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.506 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 101.19 -25.97 26.32 Favored Glycine 0 C--N 1.357 1.718 0 CA-C-O 119.727 -0.485 . . . . 0.0 113.513 171.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -80.56 -14.32 58.32 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.881 0.473 . . . . 0.0 111.985 -174.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.426 ' O ' HD22 ' A' ' 54' ' ' LEU . 25.4 mp0 -65.31 130.62 43.98 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 69.0 p -75.13 168.81 19.26 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.189 0.518 . . . . 0.0 110.04 174.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.465 HG12 ' HE3' ' A' ' 25' ' ' LYS . 33.6 t -65.59 -29.21 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . . . -62.47 -41.82 99.04 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.69 0.796 . . . . 0.0 110.553 171.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -67.52 -36.84 81.83 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.869 0.468 . . . . 0.0 111.079 177.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.523 HD11 HD21 ' A' ' 54' ' ' LEU . 39.6 mm -60.13 -48.11 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.284 0.634 . . . . 0.0 110.177 175.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.465 ' HE3' HG12 ' A' ' 21' ' ' VAL . 92.5 mttt -60.05 -43.07 95.64 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.446 0.698 . . . . 0.0 110.745 176.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.26 -45.55 90.9 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.858 1.263 . . . . 0.0 111.7 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -61.74 -47.37 85.51 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.612 0.765 . . . . 0.0 110.448 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 24' ' ' ILE . 90.8 t -63.1 -40.48 89.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 123.763 0.664 . . . . 0.0 110.296 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.31 -33.35 71.42 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.739 1.216 . . . . 0.0 112.258 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.7 t -70.78 -38.05 73.38 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.474 0.71 . . . . 0.0 110.512 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.1 mt -72.71 -51.69 18.24 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.15 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -86.58 -19.27 29.65 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -172.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.68 29.84 58.89 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 112.303 -0.319 . . . . 0.0 112.303 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.7 pt -101.62 176.96 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.474 0.709 . . . . 0.0 110.618 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -96.26 120.41 62.61 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 123.425 0.69 . . . . 0.0 110.422 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.01 -7.06 20.21 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.557 2.171 . . . . 0.0 111.813 172.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -60.7 -38.99 86.86 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 125.373 1.469 . . . . 0.0 110.492 171.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -88.21 -25.52 22.85 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.686 -178.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -75.27 133.0 41.44 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.706 -174.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.15 138.98 52.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 C-N-CA 124.353 1.061 . . . . 0.0 108.241 165.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.2 t -97.88 133.5 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.2 mt -117.76 128.62 55.05 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.604 1.161 . . . . 0.0 109.445 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.517 ' HB2' HD11 ' A' ' 48' ' ' LEU . 54.6 tp -105.99 104.85 14.65 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 169.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 60.33 26.51 16.03 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.845 0.858 . . . . 0.0 111.675 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.22 -15.59 58.91 Favored Glycine 0 C--N 1.352 1.448 0 CA-C-O 119.745 -0.475 . . . . 0.0 113.664 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.8 120.22 77.18 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 117.44 0.62 . . . . 0.0 109.668 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.8 112.2 1.93 Allowed 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.564 2.176 . . . . 0.0 112.06 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.517 HD11 ' HB2' ' A' ' 43' ' ' LEU . 80.4 mt -81.81 131.27 35.25 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.847 0.859 . . . . 0.0 110.158 175.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -72.01 142.96 49.33 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.718 0.636 . . . . 0.0 110.865 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . 11.1 p-10 -61.45 -26.17 67.71 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.293 1.037 . . . . 0.0 111.976 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -76.02 -25.91 56.14 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.829 0.851 . . . . 0.0 111.583 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.18 133.3 37.8 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.849 0.86 . . . . 0.0 110.965 -175.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 70.3 p -80.64 173.4 12.65 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.951 0.5 . . . . 0.0 110.395 174.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.523 HD21 HD11 ' A' ' 24' ' ' ILE . 2.9 mm? -61.81 -35.14 77.34 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 173.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.16 -43.6 96.9 Favored Glycine 0 C--N 1.355 1.616 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.975 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -69.63 -38.06 77.03 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.231 0.612 . . . . 0.0 111.397 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 83.9 m -73.63 -16.11 61.24 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.426 0.69 . . . . 0.0 111.155 175.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.29 26.48 71.68 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 123.582 0.551 . . . . 0.0 113.493 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.9 p -90.15 117.02 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.443 0.697 . . . . 0.0 109.68 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -87.22 -172.79 4.11 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.19 0.996 . . . . 0.0 111.932 -172.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.48 ' HB2' ' HG3' ' A' ' 1' ' ' MET . . . -71.82 154.0 41.56 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.653 0.781 . . . . 0.0 111.043 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 67.85 4.03 3.78 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.595 1.558 . . . . 0.0 112.679 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.9 m -85.15 151.67 23.94 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 34.4 m -113.9 111.48 21.77 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.247 0.546 . . . . 0.0 110.33 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.1 mt -78.68 160.85 27.29 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 165.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -132.61 142.28 49.06 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 122.115 -0.366 . . . . 0.0 110.886 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.8 t -95.95 132.62 39.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.892 0.877 . . . . 0.0 109.113 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.87 167.15 22.86 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.84 0.856 . . . . 0.0 109.83 177.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -109.97 90.36 0.59 Allowed Glycine 0 C--N 1.341 0.812 0 N-CA-C 112.29 -0.324 . . . . 0.0 112.29 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -103.56 -48.59 3.92 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.534 0.734 . . . . 0.0 109.056 171.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 42.4 tpp . . . . . 0 CA--C 1.549 0.929 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.656 -178.973 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -101.46 124.26 46.85 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.2 pp -137.49 166.57 23.56 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.486 0.715 . . . . 0.0 110.627 -178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -98.58 161.5 13.63 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.288 0.635 . . . . 0.0 110.615 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.497 HG22 ' HB2' ' A' ' 65' ' ' LEU . 44.7 t -133.32 117.08 26.95 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 C-N-CA 124.55 1.14 . . . . 0.0 108.512 173.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -71.13 94.11 1.11 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.741 1.216 . . . . 0.0 109.207 174.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -118.77 -179.45 3.81 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.544 1.138 . . . . 0.0 108.998 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -44.86 -35.32 2.73 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 123.54 0.736 . . . . 0.0 111.234 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -128.98 137.38 51.33 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 166.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.5 mt -66.69 128.83 37.77 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.077 0.551 . . . . 0.0 110.861 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -124.26 160.91 26.91 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.381 0.673 . . . . 0.0 109.926 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.4 m -130.26 125.33 34.54 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.01 0.924 . . . . 0.0 108.966 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -120.73 132.55 55.13 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.268 1.027 . . . . 0.0 110.588 -173.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -92.36 106.31 18.34 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 169.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.3 167.84 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.497 1.119 . . . . 0.0 110.741 -172.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.3 p -100.44 -4.29 29.21 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.98 -52.36 4.72 Favored Glycine 0 C--N 1.358 1.804 0 N-CA-C 112.147 -0.381 . . . . 0.0 112.147 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -66.1 -10.84 44.35 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.0 0.92 . . . . 0.0 110.986 169.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -57.45 127.05 30.06 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.226 1.01 . . . . 0.0 110.754 170.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.633 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 82.8 p -85.64 160.23 19.64 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.678 0.391 . . . . 0.0 110.737 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.569 HG13 ' HB ' ' A' ' 41' ' ' VAL . 50.8 t -63.93 -31.68 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 123.963 0.905 . . . . 0.0 111.668 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.448 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . . . -66.53 -42.28 87.48 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.512 0.725 . . . . 0.0 110.674 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -74.88 -29.61 61.06 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.14 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.554 HD11 HD11 ' A' ' 54' ' ' LEU . 30.4 mm -57.58 -50.33 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 168.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -57.01 -45.88 82.74 Favored 'General case' 0 C--N 1.36 1.036 0 O-C-N 123.86 0.725 . . . . 0.0 111.054 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.09 -48.05 76.87 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 124.604 1.19 . . . . 0.0 111.987 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -71.47 -41.33 69.5 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.242 0.217 . . . . 0.0 111.056 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 24' ' ' ILE . 68.9 t -59.97 -41.53 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.13 -42.36 93.94 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.225 1.01 . . . . 0.0 111.702 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.5 t -62.13 -40.09 94.76 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 123.862 0.727 . . . . 0.0 111.496 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 33.0 mt -80.16 -39.94 28.31 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 120.928 0.394 . . . . 0.0 111.502 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.92 -6.07 59.13 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.792 0.837 . . . . 0.0 111.95 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.56 20.32 77.07 Favored Glycine 0 CA--C 1.532 1.104 0 O-C-N 123.506 0.504 . . . . 0.0 113.651 176.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.0 pt -107.63 -179.27 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.048 0.939 . . . . 0.0 110.454 -176.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.432 ' HB1' ' HG2' ' A' ' 37' ' ' GLU . . . -90.83 134.49 30.33 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 123.274 0.63 . . . . 0.0 110.265 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -68.12 -24.67 38.3 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.622 2.214 . . . . 0.0 112.311 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.432 ' HG2' ' HB1' ' A' ' 35' ' ' ALA . 11.2 pt-20 -67.68 -29.84 69.22 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.929 0.891 . . . . 0.0 111.464 175.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -81.05 -18.7 45.79 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.995 0.918 . . . . 0.0 111.902 -170.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.432 ' HB2' HG13 ' A' ' 67' ' ' VAL . 12.3 pt20 -107.57 158.18 17.44 Favored 'General case' 0 C--O 1.245 0.818 0 C-N-CA 123.069 0.548 . . . . 0.0 110.86 -176.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.415 HG11 ' HB2' ' A' ' 70' ' ' ARG . 12.6 p -128.94 134.56 64.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.649 172.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.569 ' HB ' HG13 ' A' ' 21' ' ' VAL . 95.2 t -98.7 121.91 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 66' ' ' GLU . 27.4 mt -113.62 157.72 21.76 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.687 1.595 . . . . 0.0 108.426 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 tt -105.06 96.85 6.82 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 106.266 -1.754 . . . . 0.0 106.266 163.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 51.45 40.62 27.13 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.513 1.125 . . . . 0.0 112.41 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.69 -30.78 8.4 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-O 119.405 -0.664 . . . . 0.0 114.106 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.98 116.85 54.64 Favored Pre-proline 0 N--CA 1.484 1.27 0 CA-C-N 117.704 0.752 . . . . 0.0 111.466 -176.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -60.78 108.7 0.57 Allowed 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.008 2.472 . . . . 0.0 113.246 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.09 137.19 33.69 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.949 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -77.41 136.33 38.39 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.808 0.692 . . . . 0.0 109.904 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.448 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . 7.8 p-10 -58.78 -41.66 87.16 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.713 0.805 . . . . 0.0 112.284 -174.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -79.57 -15.58 57.43 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.204 0.601 . . . . 0.0 111.468 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.83 136.62 38.93 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 123.224 0.61 . . . . 0.0 110.276 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.633 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 43.7 p -80.09 165.88 22.06 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.205 0.602 . . . . 0.0 110.144 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.554 HD11 HD11 ' A' ' 24' ' ' ILE . 86.5 mt -64.73 -38.1 89.84 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.988 0.515 . . . . 0.0 111.243 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.97 -41.82 99.69 Favored Glycine 0 C--N 1.349 1.285 0 O-C-N 123.854 0.721 . . . . 0.0 112.623 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -74.82 -29.93 61.23 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.818 0.447 . . . . 0.0 111.386 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 89.1 m -75.41 -7.47 54.15 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.55 0.74 . . . . 0.0 111.728 173.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.17 15.88 81.16 Favored Glycine 0 C--N 1.351 1.404 0 C-N-CA 123.05 0.357 . . . . 0.0 113.866 173.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 p -99.34 132.72 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.136 0.574 . . . . 0.0 109.605 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -121.54 -168.14 1.64 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.359 1.063 . . . . 0.0 110.495 -175.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.34 150.74 48.59 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.172 0.589 . . . . 0.0 111.057 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 70.22 2.5 4.01 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.678 1.591 . . . . 0.0 113.0 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.6 m -88.05 163.6 16.18 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 174.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.2 m -123.8 116.84 23.64 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.562 0.745 . . . . 0.0 109.664 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.497 ' HB2' HG22 ' A' ' 5' ' ' VAL . 3.2 mm? -75.05 -178.95 4.05 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.422 0.689 . . . . 0.0 109.595 170.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 35.7 tt0 -144.24 108.86 4.88 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.563 0.345 . . . . 0.0 110.703 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.432 HG13 ' HB2' ' A' ' 39' ' ' GLN . 55.5 t -85.94 117.84 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 172.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.42 168.94 10.79 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 123.943 0.897 . . . . 0.0 109.971 175.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.57 87.5 1.1 Allowed Glycine 0 C--N 1.344 1.02 0 N-CA-C 111.881 -0.488 . . . . 0.0 111.881 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.415 ' HB2' HG11 ' A' ' 40' ' ' VAL . 39.0 mtp180 -143.63 141.55 30.65 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.745 1.218 . . . . 0.0 107.75 170.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 C--O 1.242 0.701 0 C-N-CA 123.14 0.576 . . . . 0.0 110.204 -178.045 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.488 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 62.9 mtp . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -88.34 116.16 26.36 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.426 HD13 HD13 ' A' ' 65' ' ' LEU . 3.4 pp -132.21 150.4 52.16 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.432 0.693 . . . . 0.0 109.981 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -89.05 152.17 21.83 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.292 1.037 . . . . 0.0 109.8 -177.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -135.93 109.75 9.85 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 C-N-CA 124.343 1.057 . . . . 0.0 108.484 -177.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.404 ' HA ' HD13 ' A' ' 10' ' ' LEU . 3.7 tmm_? -73.66 94.96 2.26 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.45 1.1 . . . . 0.0 110.022 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -112.85 -177.41 3.13 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.283 1.033 . . . . 0.0 108.811 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -45.69 -25.45 0.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.15 0.98 . . . . 0.0 113.044 171.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -127.24 150.0 49.74 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.176 0.99 . . . . 0.0 108.913 158.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 6' ' ' ARG . 4.5 mm? -76.2 109.57 9.99 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 122.987 0.515 . . . . 0.0 110.144 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -94.03 162.24 13.97 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.119 0.968 . . . . 0.0 110.168 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.7 t -141.03 142.23 34.24 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 164.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -133.97 131.57 39.14 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.653 0.781 . . . . 0.0 110.178 -175.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -92.47 104.13 16.48 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.753 174.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.8 m -111.18 161.26 9.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 C-N-CA 123.858 0.863 . . . . 0.0 110.259 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.4 m -87.12 -29.68 21.65 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.853 0.861 . . . . 0.0 110.366 176.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.538 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 116.45 -29.36 7.01 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.19 -173.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -85.77 -4.13 59.08 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.506 0.723 . . . . 0.0 112.532 -173.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.405 ' O ' HD22 ' A' ' 54' ' ' LEU . 23.0 mp0 -76.06 145.68 39.94 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 50' ' ' ASP . 59.0 p -82.82 160.89 22.13 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.354 0.597 . . . . 0.0 110.516 175.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.615 HG13 ' HB ' ' A' ' 41' ' ' VAL . 52.8 t -60.42 -30.53 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 123.715 0.806 . . . . 0.0 110.428 175.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.505 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . . . -58.57 -47.07 85.48 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 124.08 0.952 . . . . 0.0 111.051 171.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -64.58 -39.83 94.45 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.611 0.364 . . . . 0.0 110.624 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.551 HD11 HD21 ' A' ' 54' ' ' LEU . 41.8 mm -60.09 -49.27 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 122.979 0.512 . . . . 0.0 111.364 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.499 ' HB3' HG23 ' A' ' 41' ' ' VAL . 62.9 pttt -74.51 -29.58 61.46 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 119.686 -0.197 . . . . 0.0 110.702 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.403 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . . . -64.18 -34.21 77.56 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.306 0.642 . . . . 0.0 110.92 175.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.45 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 32.6 m170 -68.38 -46.25 70.56 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.117 0.567 . . . . 0.0 110.378 174.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.5 t -56.08 -39.96 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.449 0.642 . . . . 0.0 110.14 174.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.85 -45.65 77.52 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.903 1.281 . . . . 0.0 112.369 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.2 p -69.43 -27.63 65.42 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.01 0.524 . . . . 0.0 111.539 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 27' ' ' HIS . 86.1 mt -76.82 -48.47 18.4 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.817 0.447 . . . . 0.0 111.202 178.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -91.9 -5.47 53.17 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -174.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.04 5.98 85.52 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 113.859 0.304 . . . . 0.0 113.859 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.9 pt -81.74 169.06 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.325 0.65 . . . . 0.0 110.303 178.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.404 ' HB1' ' HG2' ' A' ' 37' ' ' GLU . . . -83.32 136.5 43.09 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.605 0.762 . . . . 0.0 109.986 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.403 ' HB3' ' HA ' ' A' ' 26' ' ' ALA . 56.3 Cg_endo -68.71 -22.68 37.01 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.394 2.063 . . . . 0.0 111.741 174.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.404 ' HG2' ' HB1' ' A' ' 35' ' ' ALA . 11.5 pt-20 -80.02 -8.98 59.64 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.974 0.91 . . . . 0.0 111.626 177.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -75.52 -29.04 59.34 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.197 0.599 . . . . 0.0 111.987 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.43 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -144.76 179.9 7.01 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.14 0.495 . . . . 0.0 111.372 -170.552 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.2 p -145.4 149.92 16.22 Favored 'Isoleucine or valine' 0 C--O 1.25 1.101 0 C-N-CA 124.867 1.267 . . . . 0.0 108.138 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.615 ' HB ' HG13 ' A' ' 21' ' ' VAL . 46.5 t -86.65 138.04 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.361 0.601 . . . . 0.0 109.763 176.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -116.21 140.41 49.33 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -179.524 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.3 tp -86.48 95.91 9.87 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 169.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 55.17 28.92 11.75 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.858 0.863 . . . . 0.0 112.661 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.72 -14.01 35.1 Favored Glycine 0 CA--C 1.536 1.398 0 CA-C-O 119.5 -0.611 . . . . 0.0 114.001 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.57 110.83 24.33 Favored Pre-proline 0 N--CA 1.484 1.261 0 CA-C-N 117.845 0.823 . . . . 0.0 110.622 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.45 107.07 0.24 Allowed 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 123.645 2.897 . . . . 0.0 114.077 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.544 ' HB3' HG21 ' A' ' 21' ' ' VAL . 96.4 mt -80.45 139.74 36.3 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.485 0.714 . . . . 0.0 110.735 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -71.57 130.21 40.66 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.771 0.669 . . . . 0.0 109.667 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' A' ' 22' ' ' ALA . 71.3 m-20 -62.25 -27.57 69.09 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.079 0.552 . . . . 0.0 112.216 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -80.06 -21.18 43.71 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.663 0.785 . . . . 0.0 111.617 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.26 138.54 39.46 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.516 0.726 . . . . 0.0 110.517 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 58.2 p -88.0 168.28 12.98 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.037 0.535 . . . . 0.0 110.587 177.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.551 HD21 HD11 ' A' ' 24' ' ' ILE . 2.5 mm? -62.28 -33.68 75.1 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 174.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.03 -30.78 56.87 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.891 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -76.18 -36.41 58.69 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 52.9 t -67.63 -35.65 79.32 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.2 0.6 . . . . 0.0 110.303 173.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.52 18.52 61.94 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.256 -177.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.56 135.88 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.037 0.535 . . . . 0.0 110.043 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -97.3 -169.26 1.82 Allowed 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.625 0.77 . . . . 0.0 111.896 -176.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -79.5 169.96 17.27 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.52 0.728 . . . . 0.0 111.091 173.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 58.34 18.67 5.69 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.301 1.44 . . . . 0.0 112.669 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.5 m -90.09 161.37 15.83 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 56.5 m -121.96 104.58 9.63 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 173.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.426 HD13 HD13 ' A' ' 3' ' ' LEU . 6.8 mp -84.31 -176.07 6.08 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.498 172.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 44.9 tt0 -139.38 157.43 45.89 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.974 0.509 . . . . 0.0 110.575 -172.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.7 t -119.13 131.65 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.401 1.081 . . . . 0.0 108.688 171.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.504 ' HB3' HD21 ' A' ' 42' ' ' LEU . . . -152.01 144.71 24.29 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.398 0.679 . . . . 0.0 109.664 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 39' ' ' GLN . . . -82.07 84.42 1.5 Allowed Glycine 0 C--N 1.345 1.077 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -110.93 7.59 21.77 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.922 0.889 . . . . 0.0 109.146 170.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 48.0 tpp . . . . . 0 CA--C 1.541 0.613 0 C-N-CA 125.036 1.334 . . . . 0.0 107.788 176.313 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.518 ' SD ' ' HA ' ' A' ' 60' ' ' GLU . 63.6 ttp . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 35.1 tt0 -78.44 131.52 36.93 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 pp -141.84 166.19 25.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.938 0.895 . . . . 0.0 110.0 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 64' ' ' THR . 68.8 m-85 -102.14 137.23 40.68 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.841 0.856 . . . . 0.0 109.76 -177.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.5 t -117.18 114.91 47.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 172.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.453 ' HB3' ' HA ' ' A' ' 66' ' ' GLU . 40.4 ttt85 -80.55 92.47 5.92 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.443 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.68 -177.29 3.74 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.471 1.108 . . . . 0.0 108.059 168.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -47.18 -32.79 4.68 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 122.945 0.498 . . . . 0.0 111.316 170.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -112.6 137.23 51.16 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 125.057 1.343 . . . . 0.0 108.016 164.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -71.0 118.99 14.48 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -116.93 162.01 18.44 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.946 0.898 . . . . 0.0 109.784 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.3 t -130.02 146.77 51.71 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 172.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -137.61 129.28 28.43 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.423 1.089 . . . . 0.0 108.643 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 34.2 tt0 -87.97 106.28 18.02 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 169.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.7 m -112.43 178.96 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.025 1.33 . . . . 0.0 108.976 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 58.6 p -107.07 -37.4 6.31 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.583 0.753 . . . . 0.0 110.797 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.5 -23.21 4.06 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-N 116.422 -0.354 . . . . 0.0 112.53 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -82.51 -12.63 57.65 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.0 0.52 . . . . 0.0 112.274 -175.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.451 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 22.7 mp0 -65.79 133.08 50.24 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.943 0.897 . . . . 0.0 108.671 177.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 82.2 p -80.07 166.24 21.72 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 121.59 0.709 . . . . 0.0 110.095 176.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.518 HG12 ' HE3' ' A' ' 25' ' ' LYS . 56.0 t -61.38 -31.11 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.187 173.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.63 -41.67 95.33 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.1 0.96 . . . . 0.0 111.208 173.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -66.24 -38.76 88.67 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.123 0.569 . . . . 0.0 111.098 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.569 HD11 HD11 ' A' ' 54' ' ' LEU . 50.5 mm -63.18 -45.27 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 O-C-N 123.716 0.635 . . . . 0.0 110.331 176.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.541 ' HE2' ' HA ' ' A' ' 40' ' ' VAL . 93.6 mttt -57.5 -45.81 84.49 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 123.645 0.59 . . . . 0.0 110.352 176.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.44 -45.57 91.2 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.334 1.054 . . . . 0.0 112.166 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -68.93 -43.3 75.38 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.86 0.464 . . . . 0.0 111.894 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.8 t -67.76 -32.03 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 122.813 0.445 . . . . 0.0 110.39 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.47 -37.99 80.67 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.191 0.996 . . . . 0.0 111.566 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.6 t -64.46 -44.37 91.31 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.571 0.748 . . . . 0.0 110.535 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.8 mt -72.87 -58.07 3.6 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.06 0.544 . . . . 0.0 111.558 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.31 -14.29 60.11 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.452 1.101 . . . . 0.0 112.405 -176.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.51 16.58 75.81 Favored Glycine 0 N--CA 1.473 1.135 0 CA-C-N 117.484 0.129 . . . . 0.0 113.078 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.7 pt -93.35 171.82 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.36 1.064 . . . . 0.0 110.397 -176.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.03 118.19 71.13 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 122.862 0.465 . . . . 0.0 110.849 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.444 ' HA ' HE21 ' A' ' 39' ' ' GLN . 47.5 Cg_endo -64.39 -24.96 63.92 Favored 'Trans proline' 0 C--N 1.388 2.621 0 C-N-CA 123.009 2.472 . . . . 0.0 111.484 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -68.42 -35.7 78.01 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.547 1.139 . . . . 0.0 111.148 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -85.39 -16.91 38.27 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.331 0.653 . . . . 0.0 111.213 -175.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.444 HE21 ' HA ' ' A' ' 36' ' ' PRO . 51.4 mt-30 -77.71 152.45 33.68 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.573 0.701 . . . . 0.0 112.16 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.541 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . 13.9 p -141.04 148.55 21.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 113.934 -1.485 . . . . 0.0 107.575 162.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.418 ' HB ' HG13 ' A' ' 21' ' ' VAL . 97.8 t -103.96 128.05 57.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 68.7 mt -115.62 116.66 28.51 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.645 1.178 . . . . 0.0 108.779 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.531 ' HB2' HD11 ' A' ' 48' ' ' LEU . 41.2 tp -90.47 98.13 11.59 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 57.04 32.24 21.32 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.029 0.932 . . . . 0.0 111.691 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.4 -32.4 7.2 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.246 -178.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.4 116.65 39.07 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 123.271 0.628 . . . . 0.0 111.499 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -63.44 105.53 0.51 Allowed 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 123.223 2.615 . . . . 0.0 112.262 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.531 HD11 ' HB2' ' A' ' 43' ' ' LEU . 43.0 mt -78.11 129.81 35.64 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.881 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -64.88 134.74 54.67 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.238 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.477 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 8.0 p-10 -61.54 -27.2 68.45 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.356 0.663 . . . . 0.0 111.727 -178.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -80.72 -25.98 37.74 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.62 0.768 . . . . 0.0 111.76 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.09 133.35 46.19 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 123.213 0.605 . . . . 0.0 110.542 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 31.1 p -79.1 170.64 16.35 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 176.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.616 ' HA ' ' SG ' ' A' ' 57' ' ' CYS . 86.2 mt -69.15 -25.72 64.51 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.548 0.739 . . . . 0.0 110.896 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.84 -36.41 42.15 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.327 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.41 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 87.2 mm-40 -79.22 -34.8 42.51 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.92 0.488 . . . . 0.0 111.703 -177.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.616 ' SG ' ' HA ' ' A' ' 54' ' ' LEU . 31.3 p -77.84 -22.22 50.28 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.927 0.491 . . . . 0.0 110.312 175.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.85 38.79 9.11 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.68 169.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.576 HG21 HD11 ' A' ' 65' ' ' LEU . 8.7 p -101.76 148.86 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 123.043 0.537 . . . . 0.0 109.849 176.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.518 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 10.7 pt-20 -136.32 -165.56 1.74 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.949 0.9 . . . . 0.0 111.085 -174.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.14 149.5 50.19 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 124.017 0.927 . . . . 0.0 112.587 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 68.18 -5.07 0.93 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.119 1.768 . . . . 0.0 113.263 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.7 m -77.26 147.9 36.05 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.124 0.57 . . . . 0.0 109.528 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 29.3 m -119.01 112.5 19.65 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 123.758 0.823 . . . . 0.0 109.825 -174.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.576 HD11 HG21 ' A' ' 59' ' ' VAL . 2.1 mp -104.18 132.71 50.14 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.462 1.105 . . . . 0.0 108.261 -178.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.453 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . 45.5 tt0 -96.13 140.17 31.23 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.055 0.542 . . . . 0.0 111.37 -172.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 78.8 t -93.8 128.37 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.806 0.842 . . . . 0.0 108.965 174.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.05 -168.04 2.83 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.875 0.87 . . . . 0.0 109.749 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -121.67 108.16 1.29 Allowed Glycine 0 C--N 1.35 1.352 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -122.26 -60.27 1.57 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 CA--C 1.533 0.31 0 CA-C-N 114.636 -1.166 . . . . 0.0 108.43 174.022 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.4 mtp . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -78.92 119.87 22.71 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.945 0.498 . . . . 0.0 109.702 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 pp -142.63 167.49 21.97 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.417 0.687 . . . . 0.0 110.564 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -100.68 148.37 24.94 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.3 t -133.19 107.13 10.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.892 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 172.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -76.7 93.09 3.6 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.252 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.95 -178.5 5.23 Favored 'General case' 0 C--O 1.248 0.977 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 160.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -51.52 -30.33 19.98 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.719 0.408 . . . . 0.0 111.217 172.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -107.33 130.67 54.75 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 161.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -72.61 125.61 27.89 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -125.66 146.05 49.9 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.171 0.589 . . . . 0.0 109.88 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.5 m -108.41 128.41 54.75 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.487 0.715 . . . . 0.0 109.389 175.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -120.73 143.06 48.97 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.193 0.997 . . . . 0.0 109.758 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -105.59 110.22 22.46 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.539 HG21 ' HG ' ' A' ' 54' ' ' LEU . 4.6 m -108.72 151.01 11.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 C-N-CA 124.154 0.982 . . . . 0.0 109.282 -171.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.467 ' H ' ' HB2' ' A' ' 19' ' ' GLU . 8.1 m -81.21 -11.82 59.31 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.746 -175.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.66 -55.59 2.67 Favored Glycine 0 C--N 1.353 1.523 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -174.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -76.27 2.87 12.1 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.081 0.952 . . . . 0.0 110.759 167.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.467 ' HB2' ' H ' ' A' ' 16' ' ' THR . 8.8 tp10 -60.21 118.05 5.91 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.921 1.289 . . . . 0.0 108.734 165.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 74.8 p -76.41 158.43 31.39 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.38 0.536 . . . . 0.0 110.81 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 t -64.53 -31.34 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 124.032 0.933 . . . . 0.0 110.254 175.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.64 -47.73 81.44 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.848 0.718 . . . . 0.0 110.82 173.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -64.15 -42.89 96.6 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 123.86 0.725 . . . . 0.0 111.141 177.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.494 ' O ' HG23 ' A' ' 28' ' ' VAL . 48.1 mm -56.87 -51.33 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 123.757 0.823 . . . . 0.0 110.708 176.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.53 ' NZ ' ' SD ' ' A' ' 71' ' ' MET . 85.3 tttt -62.42 -45.46 93.02 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.126 1.37 . . . . 0.0 110.424 -174.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.494 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . . . -67.99 -35.84 79.01 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.338 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -64.27 -46.53 83.28 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.33 0.652 . . . . 0.0 110.045 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 24' ' ' ILE . 73.2 t -60.02 -46.08 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 O-C-N 123.791 0.682 . . . . 0.0 109.91 177.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.37 -41.02 92.86 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.894 0.878 . . . . 0.0 112.434 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.3 t -65.25 -38.85 91.62 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.445 0.698 . . . . 0.0 110.649 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.5 mt -71.41 -37.34 71.52 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.636 0.374 . . . . 0.0 111.362 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -78.18 -13.8 59.71 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.897 0.879 . . . . 0.0 111.54 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.77 17.83 79.36 Favored Glycine 0 C--N 1.35 1.311 0 C-N-CA 123.147 0.404 . . . . 0.0 113.641 178.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.4 pt -111.27 176.67 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.866 0.866 . . . . 0.0 110.052 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.24 136.32 46.61 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 123.057 0.543 . . . . 0.0 109.855 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.494 ' HB3' ' HA ' ' A' ' 26' ' ' ALA . 18.6 Cg_endo -57.11 -33.9 96.69 Favored 'Trans proline' 0 C--N 1.383 2.38 0 C-N-CA 123.458 2.772 . . . . 0.0 112.683 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -60.0 -24.12 64.21 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.964 0.905 . . . . 0.0 113.061 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -76.51 -12.79 60.09 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.19 0.596 . . . . 0.0 111.965 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.435 ' O ' ' HB3' ' A' ' 71' ' ' MET . 22.3 mt-30 -104.09 173.17 6.42 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.792 0.837 . . . . 0.0 111.992 -171.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -160.87 134.42 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 169.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.6 p -106.23 136.05 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 121.628 0.727 . . . . 0.0 110.428 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -120.56 143.32 48.67 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.163 1.785 . . . . 0.0 108.495 -171.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.1 tp -110.93 99.16 8.11 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 167.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 59.98 26.44 15.73 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.195 0.998 . . . . 0.0 111.611 -176.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.78 -21.77 31.46 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 115.716 -0.675 . . . . 0.0 113.232 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.37 116.27 54.72 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.397 0.679 . . . . 0.0 111.023 -177.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.76 114.39 2.56 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.948 2.432 . . . . 0.0 112.41 -177.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.555 HD11 HD12 ' A' ' 65' ' ' LEU . 96.7 mt -72.98 130.25 39.93 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.937 0.895 . . . . 0.0 110.647 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -66.18 125.71 26.41 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.807 0.692 . . . . 0.0 110.216 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -65.25 -28.05 69.08 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.32 0.648 . . . . 0.0 112.13 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -77.78 -20.36 53.46 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.212 0.605 . . . . 0.0 110.711 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.66 145.67 28.67 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.301 0.64 . . . . 0.0 111.264 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 59.5 p -91.6 177.55 6.18 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.427 0.691 . . . . 0.0 110.16 173.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.539 ' HG ' HG21 ' A' ' 15' ' ' VAL . 3.8 mm? -63.4 -36.62 84.33 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 173.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.43 -31.94 65.34 Favored Glycine 0 C--N 1.354 1.547 0 CA-C-N 115.605 -0.725 . . . . 0.0 113.144 177.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 61.0 tp60 -71.24 -39.38 71.69 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.405 0.682 . . . . 0.0 110.451 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.487 ' HB2' HG12 ' A' ' 59' ' ' VAL . 62.4 m -68.1 -26.28 65.74 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.187 173.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.62 23.06 68.3 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 123.793 0.683 . . . . 0.0 112.269 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.487 HG12 ' HB2' ' A' ' 57' ' ' CYS . 7.3 p -99.95 134.63 38.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.565 0.746 . . . . 0.0 109.355 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -90.56 -175.45 4.44 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.811 0.845 . . . . 0.0 111.718 -173.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.93 169.25 17.27 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.83 171.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 68.54 3.14 3.68 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 125.298 1.439 . . . . 0.0 112.935 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.3 m -81.84 155.5 25.35 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.347 0.659 . . . . 0.0 109.303 176.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.8 m -113.12 106.93 15.25 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.555 HD12 HD11 ' A' ' 48' ' ' LEU . 2.2 mm? -80.67 171.66 14.74 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 169.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -140.87 125.3 17.68 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 118.585 0.63 . . . . 0.0 111.172 -177.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.2 t -96.4 109.84 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 122.898 0.479 . . . . 0.0 110.098 177.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.56 176.7 5.24 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.488 1.115 . . . . 0.0 109.281 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -124.41 89.86 0.4 Allowed Glycine 0 N--CA 1.469 0.889 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -126.01 -48.47 1.61 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.634 0.774 . . . . 0.0 110.501 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.53 ' SD ' ' NZ ' ' A' ' 25' ' ' LYS . 46.3 ttm . . . . . 0 N--CA 1.473 0.679 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.942 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.478 0.947 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -98.99 117.44 33.51 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.425 0.69 . . . . 0.0 110.387 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 pp -131.11 154.44 48.3 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.711 0.767 . . . . 0.0 111.398 175.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -90.33 144.28 25.98 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.817 1.247 . . . . 0.0 108.561 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.1 t -123.23 113.81 39.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 174.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.408 ' HB3' ' HA ' ' A' ' 66' ' ' GLU . 20.4 tpt180 -85.5 93.18 8.71 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.537 -172.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -111.6 -178.93 3.57 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 124.35 1.06 . . . . 0.0 108.333 169.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -45.38 -35.22 3.48 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.557 0.743 . . . . 0.0 111.324 167.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -111.63 127.36 55.73 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.153 0.981 . . . . 0.0 108.493 167.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -75.85 115.69 15.8 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -116.86 131.73 56.88 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.64 0.776 . . . . 0.0 109.662 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.5 m -105.74 118.63 37.09 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -102.71 140.78 36.53 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.118 0.967 . . . . 0.0 111.119 -175.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -94.6 104.76 16.7 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 165.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.0 m -113.72 163.61 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.142 0.977 . . . . 0.0 110.423 -177.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.8 m -99.9 -3.54 32.21 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.46 0.704 . . . . 0.0 111.513 -174.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.16 -45.26 3.38 Favored Glycine 0 C--N 1.352 1.464 0 O-C-N 122.027 -0.421 . . . . 0.0 112.247 -177.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -65.14 -14.04 59.6 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.372 0.669 . . . . 0.0 112.097 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.35 132.89 47.85 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 173.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.728 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 80.4 p -75.22 161.8 29.03 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.27 0.557 . . . . 0.0 110.621 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.718 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 53.0 t -64.93 -28.69 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.415 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.261 172.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.89 -38.88 92.44 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.223 0.609 . . . . 0.0 111.542 174.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -73.5 -35.12 65.59 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.739 177.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.49 HD11 HD11 ' A' ' 54' ' ' LEU . 20.3 mm -53.19 -47.94 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 123.571 0.748 . . . . 0.0 109.857 170.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.493 ' NZ ' ' SD ' ' A' ' 71' ' ' MET . 97.8 mttt -57.7 -55.05 39.88 Favored 'General case' 0 C--N 1.359 0.991 0 O-C-N 124.121 0.888 . . . . 0.0 110.658 174.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.77 -42.0 64.6 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 123.965 0.791 . . . . 0.0 112.121 -176.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -71.17 -46.27 61.75 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.634 0.773 . . . . 0.0 111.755 -177.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.409 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 14.6 p -69.94 -30.95 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.429 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . . . -68.2 -36.72 80.01 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.841 0.856 . . . . 0.0 111.351 177.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.1 t -63.66 -41.69 98.17 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.541 0.736 . . . . 0.0 110.273 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.7 mt -69.12 -48.76 61.61 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.448 0.699 . . . . 0.0 112.29 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.429 ' HB2' HG12 ' A' ' 34' ' ' ILE . 13.8 mm-40 -77.86 -19.11 55.4 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.031 0.532 . . . . 0.0 111.018 -177.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.95 31.9 59.42 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.634 -177.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.429 HG12 ' HB2' ' A' ' 32' ' ' GLU . 23.9 pt -114.65 170.38 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 123.803 0.841 . . . . 0.0 110.912 -177.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.41 119.78 76.86 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 123.658 0.783 . . . . 0.0 111.499 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -65.33 -28.18 55.1 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.859 2.372 . . . . 0.0 112.283 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.92 -35.18 79.81 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.859 0.864 . . . . 0.0 111.227 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -71.39 -26.07 62.62 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.191 0.996 . . . . 0.0 111.079 -172.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.429 ' NE2' ' HB2' ' A' ' 29' ' ' ALA . 21.6 mt-30 -81.7 137.79 35.35 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.7 -173.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 p -122.82 133.64 68.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 166.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.457 HG13 ' HB3' ' A' ' 65' ' ' LEU . 54.7 t -94.26 108.34 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-O 121.384 0.611 . . . . 0.0 109.716 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 66.1 mt -97.04 114.47 26.1 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.26 1.424 . . . . 0.0 109.762 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.8 tp -94.83 104.95 16.85 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 169.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 59.67 28.3 17.71 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.236 1.014 . . . . 0.0 111.961 -173.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.31 -7.89 72.21 Favored Glycine 0 C--N 1.352 1.427 0 CA-C-N 115.946 -0.57 . . . . 0.0 113.675 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.19 116.71 66.99 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 123.757 0.823 . . . . 0.0 110.2 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.3 117.34 4.49 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.593 2.195 . . . . 0.0 111.65 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.2 mt -75.93 154.6 35.83 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.621 0.768 . . . . 0.0 111.293 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -72.51 104.19 3.75 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.718 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 3.0 p30 -72.08 -15.29 62.01 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -73.92 -24.4 59.67 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 122.909 0.484 . . . . 0.0 110.191 172.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -94.91 157.79 15.76 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 124.161 0.984 . . . . 0.0 111.069 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.728 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 67.7 p -85.24 168.05 15.1 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.618 177.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.5 ' HA ' ' SG ' ' A' ' 57' ' ' CYS . 78.2 mt -66.28 -33.22 75.24 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.118 174.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.16 -29.68 68.39 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 115.287 -0.869 . . . . 0.0 112.661 175.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -72.38 -43.95 63.22 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.551 0.74 . . . . 0.0 110.57 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' A' ' 54' ' ' LEU . 22.1 p -75.79 -10.41 59.41 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.51 173.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.13 21.24 78.4 Favored Glycine 0 C--N 1.355 1.61 0 C-N-CA 123.56 0.6 . . . . 0.0 113.571 171.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.4 HG21 HG21 ' A' ' 63' ' ' THR . 13.0 p -78.51 145.78 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -176.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -110.62 -164.2 0.9 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.308 0.643 . . . . 0.0 111.003 -176.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.72 175.53 9.86 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.681 0.792 . . . . 0.0 111.667 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 65.2 5.35 3.01 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.452 1.501 . . . . 0.0 112.744 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.4 HG21 HG21 ' A' ' 59' ' ' VAL . 90.6 m -81.63 154.21 26.26 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.407 1.083 . . . . 0.0 110.155 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.2 m -122.42 101.7 7.65 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.688 0.795 . . . . 0.0 109.663 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.457 ' HB3' HG13 ' A' ' 41' ' ' VAL . 74.7 mt -85.69 116.28 23.87 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.125 0.97 . . . . 0.0 109.175 176.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.408 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . 41.1 tt0 -93.85 128.81 40.32 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.02 0.438 . . . . 0.0 111.674 -172.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 75.0 t -87.59 128.55 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.833 0.853 . . . . 0.0 109.791 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.15 136.84 45.99 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.775 0.83 . . . . 0.0 109.649 173.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.47 89.43 1.58 Allowed Glycine 0 C--N 1.343 0.962 0 N-CA-C 112.095 -0.402 . . . . 0.0 112.095 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -141.75 -28.87 0.63 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.545 0.738 . . . . 0.0 112.353 -173.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.493 ' SD ' ' NZ ' ' A' ' 25' ' ' LYS . 56.1 ttm . . . . . 0 N--CA 1.49 1.549 0 C-N-CA 123.177 0.591 . . . . 0.0 111.989 -173.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.472 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 1.1 tmt? . . . . . 0 N--CA 1.483 1.198 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 34.1 tt0 -101.94 137.76 39.8 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.439 -177.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.473 HD13 HD13 ' A' ' 65' ' ' LEU . 4.4 pp -137.5 161.03 37.48 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.387 0.613 . . . . 0.0 110.276 175.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -107.27 135.37 48.89 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.3 t -115.98 105.41 18.39 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 C-N-CA 123.57 0.748 . . . . 0.0 109.047 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -72.26 98.69 2.23 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.853 0.861 . . . . 0.0 110.969 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -113.28 -177.07 3.04 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.649 1.18 . . . . 0.0 108.044 166.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -45.09 -31.67 1.46 Allowed 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.522 0.677 . . . . 0.0 112.133 168.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -115.34 131.84 56.8 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 124.668 1.187 . . . . 0.0 107.878 167.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -70.36 105.5 3.05 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -93.12 160.49 14.83 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.754 177.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.5 m -148.97 121.64 8.62 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -127.63 129.61 47.53 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.392 0.677 . . . . 0.0 109.666 -176.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 36.0 tt0 -94.16 110.26 22.0 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 168.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 1' ' ' MET . 35.8 m -116.84 164.37 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 124.825 1.25 . . . . 0.0 109.098 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.1 t -94.79 6.21 49.63 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.663 0.385 . . . . 0.0 110.591 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.536 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 94.66 -20.49 48.31 Favored Glycine 0 C--N 1.357 1.734 0 CA-C-O 119.351 -0.694 . . . . 0.0 113.672 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -67.62 -26.7 66.37 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -169.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -62.96 141.87 58.56 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 46.9 p -80.42 165.0 22.64 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.524 HG13 ' HB ' ' A' ' 41' ' ' VAL . 54.5 t -57.08 -31.17 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 C-N-CA 123.448 0.699 . . . . 0.0 110.045 172.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.461 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . . . -68.92 -37.84 79.18 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.493 1.117 . . . . 0.0 111.511 177.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.464 ' HG3' ' OG1' ' A' ' 20' ' ' THR . 24.8 mt-30 -72.36 -35.03 68.42 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.1 mm -64.52 -47.41 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.097 0.559 . . . . 0.0 111.046 177.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.585 ' HB3' HG23 ' A' ' 41' ' ' VAL . 60.6 pttt -67.18 -32.65 73.88 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 119.547 -0.263 . . . . 0.0 110.383 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.523 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . . . -60.09 -45.47 92.81 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 123.603 0.761 . . . . 0.0 111.471 176.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.459 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 34.0 m170 -64.85 -44.99 87.97 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.878 0.471 . . . . 0.0 110.896 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.521 HG11 HG21 ' A' ' 67' ' ' VAL . 79.0 t -62.04 -42.39 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.124 0.57 . . . . 0.0 111.035 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.21 -26.07 61.0 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.739 0.816 . . . . 0.0 111.402 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.2 t -70.24 -42.21 72.53 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 122.983 0.513 . . . . 0.0 110.275 171.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 27' ' ' HIS . 97.2 mt -62.57 -42.85 99.81 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 123.839 0.712 . . . . 0.0 111.625 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.96 -23.41 31.09 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.112 0.565 . . . . 0.0 112.174 176.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.64 29.69 47.27 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 122.979 0.175 . . . . 0.0 112.906 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.6 pt -111.87 -178.46 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 124.803 1.241 . . . . 0.0 111.215 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.71 112.65 39.14 Favored Pre-proline 0 N--CA 1.487 1.414 0 C-N-CA 124.035 0.934 . . . . 0.0 112.537 -170.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.523 ' HB3' ' HA ' ' A' ' 26' ' ' ALA . 24.2 Cg_exo -62.93 -43.17 20.86 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 123.088 2.525 . . . . 0.0 112.729 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.95 -8.71 57.1 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.381 0.672 . . . . 0.0 112.057 -176.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -77.65 -36.31 51.57 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.403 0.62 . . . . 0.0 109.577 171.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.629 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 45.6 mt-30 -99.44 -179.76 4.32 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.994 -169.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.504 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 11.4 p -162.09 154.03 3.37 Favored 'Isoleucine or valine' 0 C--O 1.246 0.877 0 C-N-CA 125.314 1.446 . . . . 0.0 107.956 171.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.585 HG23 ' HB3' ' A' ' 25' ' ' LYS . 44.4 t -103.64 125.46 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.642 HD12 ' HA ' ' A' ' 47' ' ' PRO . 1.8 mm? -108.9 141.25 41.23 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.446 1.498 . . . . 0.0 108.842 -173.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.9 tp -80.76 96.71 7.04 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.402 ' H ' ' HA ' ' A' ' 65' ' ' LEU . . . 55.06 29.34 12.27 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 123.878 0.871 . . . . 0.0 111.629 -176.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.59 -25.43 21.28 Favored Glycine 0 C--N 1.355 1.635 0 C-N-CA 123.343 0.497 . . . . 0.0 113.449 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.57 136.05 81.01 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.552 0.741 . . . . 0.0 111.311 -177.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.642 ' HA ' HD12 ' A' ' 42' ' ' LEU . 52.6 Cg_endo -64.61 111.0 1.55 Allowed 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 123.192 2.594 . . . . 0.0 113.052 -174.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.9 mt -90.2 156.26 18.45 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.376 0.67 . . . . 0.0 111.138 173.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -81.97 119.47 24.0 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 172.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.487 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 6.0 p-10 -60.67 -38.94 86.57 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.082 0.553 . . . . 0.0 112.103 -175.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -82.27 -4.89 58.02 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.119 0.568 . . . . 0.0 111.978 -176.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.49 140.49 29.48 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.312 0.645 . . . . 0.0 110.356 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 44.1 p -71.77 168.46 17.77 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.291 0.636 . . . . 0.0 110.603 178.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.536 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 3.0 mm? -59.19 -43.33 92.2 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 174.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.43 -37.9 95.52 Favored Glycine 0 C--N 1.35 1.331 0 O-C-N 123.845 0.716 . . . . 0.0 113.108 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -68.24 -39.72 82.21 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.834 0.854 . . . . 0.0 110.482 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 75.0 m -79.26 -10.09 59.73 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.928 0.891 . . . . 0.0 111.798 177.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.82 21.17 75.01 Favored Glycine 0 C--N 1.349 1.281 0 C-N-CA 123.217 0.436 . . . . 0.0 114.135 177.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.28 134.86 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 123.845 0.858 . . . . 0.0 109.436 177.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -114.39 -171.43 1.92 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.472 0.709 . . . . 0.0 111.095 -172.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.87 154.09 28.6 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.542 0.737 . . . . 0.0 110.248 174.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 59.9 21.19 10.16 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 125.216 1.407 . . . . 0.0 111.738 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.5 m -93.74 156.41 16.7 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.434 1.093 . . . . 0.0 108.804 177.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.1 m -135.43 121.82 20.49 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.632 0.729 . . . . 0.0 110.78 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.473 HD13 HD13 ' A' ' 3' ' ' LEU . 4.1 mp -105.88 179.23 4.33 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.792 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -141.2 144.41 34.74 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.607 0.763 . . . . 0.0 110.279 -173.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.521 HG21 HG11 ' A' ' 28' ' ' VAL . 44.8 t -103.43 119.41 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 121.842 -0.536 . . . . 0.0 109.67 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.18 150.63 50.18 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.043 0.537 . . . . 0.0 110.292 176.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.629 ' HA2' ' HA ' ' A' ' 39' ' ' GLN . . . -90.1 92.95 1.82 Allowed Glycine 0 C--N 1.347 1.159 0 N-CA-C 112.051 -0.42 . . . . 0.0 112.051 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 54.4 mtt180 -109.75 -11.81 14.68 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.958 0.503 . . . . 0.0 112.318 -177.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.559 ' SD ' ' NZ ' ' A' ' 25' ' ' LYS . 79.5 mtp . . . . . 0 N--CA 1.481 1.107 0 O-C-N 122.212 -0.305 . . . . 0.0 110.445 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 121.788 0.804 . . . . 0.0 108.968 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -93.01 111.38 22.98 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.683 -171.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.444 HD13 HD13 ' A' ' 65' ' ' LEU . 2.8 pp -125.51 157.51 36.83 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.481 0.712 . . . . 0.0 110.07 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -90.28 142.18 27.98 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.789 0.835 . . . . 0.0 109.85 -176.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.5 t -122.66 102.64 11.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 C-N-CA 124.648 1.179 . . . . 0.0 108.885 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -77.95 93.8 4.49 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.934 0.893 . . . . 0.0 109.71 177.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.19 -174.52 2.59 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.906 1.283 . . . . 0.0 108.168 172.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -41.16 -36.9 0.8 Allowed 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 123.841 0.857 . . . . 0.0 112.053 168.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -117.95 154.36 32.07 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.507 1.123 . . . . 0.0 108.323 167.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -77.52 127.52 32.65 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.774 0.43 . . . . 0.0 110.456 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -130.79 159.39 37.47 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.653 1.181 . . . . 0.0 109.042 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.8 m -143.53 125.17 14.93 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 175.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -132.93 141.64 48.46 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.013 0.525 . . . . 0.0 111.119 -173.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -80.92 125.77 30.54 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 164.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.447 HG21 ' HG ' ' A' ' 54' ' ' LEU . 27.6 m -109.32 152.56 11.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 C-N-CA 123.445 0.698 . . . . 0.0 109.744 -174.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 m -78.51 -14.62 59.27 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.666 -171.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.49 -56.44 5.02 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -70.5 -13.38 62.09 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.141 0.976 . . . . 0.0 111.145 171.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -63.39 139.18 58.74 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.66 1.184 . . . . 0.0 109.933 170.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 73.2 p -93.62 170.67 9.41 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.304 0.573 . . . . 0.0 111.91 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.606 HG13 ' HB ' ' A' ' 41' ' ' VAL . 40.5 t -64.81 -31.87 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.129 0.972 . . . . 0.0 110.607 172.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.06 96.25 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.735 0.814 . . . . 0.0 110.148 178.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.408 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 18.7 mm-40 -62.65 -48.25 80.17 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.447 1.092 . . . . 0.0 110.313 175.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 28' ' ' VAL . 37.2 mm -55.97 -47.27 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 124.078 0.951 . . . . 0.0 110.923 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -62.17 -49.91 73.94 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.015 1.326 . . . . 0.0 111.183 -175.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.7 -32.94 71.82 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.976 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.469 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 11.4 t-160 -62.69 -53.52 53.25 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 124.099 0.96 . . . . 0.0 110.37 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 24' ' ' ILE . 95.0 t -59.92 -38.51 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.414 0.686 . . . . 0.0 110.552 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.04 -47.79 84.41 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.144 175.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.8 t -66.86 -35.25 79.61 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.648 0.779 . . . . 0.0 111.228 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 27' ' ' HIS . 88.6 mt -67.4 -48.79 66.33 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.82 0.848 . . . . 0.0 111.861 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -96.04 -2.57 46.54 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.685 0.394 . . . . 0.0 111.819 -172.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.58 28.24 73.3 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.278 0.361 . . . . 0.0 113.01 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.2 pt -108.82 177.58 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.125 0.97 . . . . 0.0 110.693 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.42 120.94 68.96 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 123.281 0.632 . . . . 0.0 111.438 -171.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -63.83 -31.74 67.66 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.527 2.151 . . . . 0.0 111.206 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -63.68 -22.04 66.7 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.028 0.931 . . . . 0.0 112.353 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -88.95 -12.95 40.14 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.007 0.923 . . . . 0.0 111.171 -178.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -98.65 165.29 11.87 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.922 0.889 . . . . 0.0 112.344 -171.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 m -152.57 138.4 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 126.247 1.819 . . . . 0.0 107.251 164.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.606 ' HB ' HG13 ' A' ' 21' ' ' VAL . 45.5 t -94.99 116.62 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 175.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.3 mt -112.25 134.04 54.03 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.802 1.241 . . . . 0.0 109.092 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.468 ' HB2' HD11 ' A' ' 48' ' ' LEU . 42.4 tp -89.4 98.11 11.58 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 173.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 57.18 28.84 15.68 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.754 0.821 . . . . 0.0 112.081 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.04 -25.16 21.32 Favored Glycine 0 C--N 1.353 1.505 0 CA-C-O 119.717 -0.491 . . . . 0.0 113.498 -177.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.13 117.68 60.51 Favored Pre-proline 0 N--CA 1.481 1.098 0 C-N-CA 123.422 0.689 . . . . 0.0 110.886 -177.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.5 115.57 2.64 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.329 2.686 . . . . 0.0 113.108 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.506 ' HB3' HG21 ' A' ' 21' ' ' VAL . 84.6 mt -91.02 143.75 26.38 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.18 0.592 . . . . 0.0 110.903 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -78.27 134.68 37.51 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -56.73 -41.02 76.77 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.996 0.918 . . . . 0.0 112.15 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -82.21 -14.89 54.87 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.677 -175.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.22 132.65 43.43 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.81 0.444 . . . . 0.0 109.859 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 58.6 p -84.23 166.77 17.25 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.209 0.604 . . . . 0.0 110.282 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.447 ' HG ' HG21 ' A' ' 15' ' ' VAL . 3.0 mm? -62.43 -38.52 90.06 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.01 -34.69 77.03 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.922 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -70.95 -42.62 69.55 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.475 0.71 . . . . 0.0 110.635 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 50.6 t -69.51 -18.75 63.71 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.141 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.05 17.84 80.22 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.657 -0.702 . . . . 0.0 112.804 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.582 HG21 HD11 ' A' ' 65' ' ' LEU . 2.2 p -85.61 118.37 32.21 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.1 -166.8 1.42 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.328 1.051 . . . . 0.0 110.54 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.63 163.72 26.43 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.173 0.589 . . . . 0.0 111.243 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 71.89 -2.83 2.38 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.825 1.65 . . . . 0.0 112.765 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.4 m -84.0 160.18 21.07 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.577 0.751 . . . . 0.0 109.573 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.3 m -120.16 113.31 20.27 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.15 0.58 . . . . 0.0 110.638 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.582 HD11 HG21 ' A' ' 59' ' ' VAL . 5.5 mp -94.79 161.18 14.28 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 170.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -130.52 130.66 44.43 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.964 0.505 . . . . 0.0 109.95 -177.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 95.9 t -91.85 93.39 4.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 171.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.62 -176.47 3.2 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.339 1.056 . . . . 0.0 110.13 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -123.2 91.78 0.45 Allowed Glycine 0 C--N 1.341 0.823 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 178.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -107.12 -49.23 3.31 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 53.4 ttm . . . . . 0 CA--C 1.539 0.537 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 174.55 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ttt . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -94.04 120.35 34.17 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.403 HD13 HD13 ' A' ' 65' ' ' LEU . 3.3 pp -132.16 167.22 20.14 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.074 0.55 . . . . 0.0 111.001 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -99.49 142.89 30.38 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.58 0.752 . . . . 0.0 109.553 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 80.9 t -126.12 101.13 7.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 171.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -73.25 98.74 2.71 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.548 -177.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.69 -177.31 3.33 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.097 0.959 . . . . 0.0 108.945 172.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -43.46 -32.75 0.94 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.087 0.955 . . . . 0.0 111.986 170.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -120.6 145.22 47.59 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.382 1.073 . . . . 0.0 108.178 162.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.1 tp -69.72 128.58 36.94 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 120.821 0.343 . . . . 0.0 111.084 -176.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -117.47 158.21 24.91 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.931 0.892 . . . . 0.0 109.894 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.7 m -146.63 120.96 9.59 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.348 1.059 . . . . 0.0 108.291 175.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -120.85 145.21 47.85 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.412 0.685 . . . . 0.0 110.613 -172.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -97.4 123.98 41.42 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 171.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.3 m -135.0 172.43 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.302 1.041 . . . . 0.0 109.865 -177.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.437 ' HB ' ' HG2' ' A' ' 18' ' ' GLN . 2.9 m -107.07 -18.15 13.98 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.793 0.837 . . . . 0.0 110.011 175.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.448 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 102.77 -15.52 55.51 Favored Glycine 0 C--N 1.355 1.637 0 C-N-CA 123.137 0.399 . . . . 0.0 112.458 -173.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.437 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 14.8 pt20 -81.29 -8.45 59.75 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.825 0.85 . . . . 0.0 111.719 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -74.42 134.23 42.4 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.16 0.984 . . . . 0.0 108.923 176.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.697 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 72.4 p -74.66 158.84 32.93 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 171.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.636 HG13 ' HB ' ' A' ' 41' ' ' VAL . 55.8 t -59.23 -27.9 37.74 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.475 0 C-N-CA 123.839 0.856 . . . . 0.0 110.401 173.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.64 -43.36 80.52 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.795 1.238 . . . . 0.0 110.392 174.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.428 ' HG3' ' OG1' ' A' ' 20' ' ' THR . 78.1 mt-30 -62.07 -41.56 98.28 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 123.521 0.513 . . . . 0.0 110.217 175.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.461 HD11 HD11 ' A' ' 54' ' ' LEU . 46.9 mm -59.32 -50.72 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.435 0.694 . . . . 0.0 111.217 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.478 ' HB3' HG23 ' A' ' 41' ' ' VAL . 60.3 pttt -73.08 -27.5 61.75 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.98 -37.19 86.83 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.25 0.62 . . . . 0.0 111.047 173.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 57.5 m170 -66.68 -45.81 77.66 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.359 0.663 . . . . 0.0 109.78 175.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.566 HG12 HD11 ' A' ' 34' ' ' ILE . 85.1 t -58.74 -38.02 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.59 0.756 . . . . 0.0 110.313 174.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.01 -48.15 74.95 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.275 1.03 . . . . 0.0 111.953 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.3 t -68.13 -32.75 73.26 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.328 0.651 . . . . 0.0 111.771 -177.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 97.5 mt -80.67 -51.11 9.07 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.989 0.516 . . . . 0.0 111.965 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -83.76 -2.45 56.33 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.605 0.762 . . . . 0.0 112.179 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.25 15.19 69.76 Favored Glycine 0 C--N 1.346 1.092 0 O-C-N 123.157 0.286 . . . . 0.0 113.1 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.566 HD11 HG12 ' A' ' 28' ' ' VAL . 28.6 pt -92.39 178.91 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.527 0.731 . . . . 0.0 109.81 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -109.87 129.89 23.43 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 122.87 0.468 . . . . 0.0 110.776 -174.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.28 -11.17 26.58 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.217 1.944 . . . . 0.0 112.687 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.52 -22.97 53.73 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 123.041 0.536 . . . . 0.0 112.071 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -90.86 -41.19 11.33 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 118.76 0.709 . . . . 0.0 109.518 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -81.82 152.4 26.93 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 122.198 0.999 . . . . 0.0 111.847 -175.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.32 153.11 37.34 Favored 'Isoleucine or valine' 0 C--O 1.249 1.07 0 C-N-CA 126.447 1.899 . . . . 0.0 106.347 168.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.636 ' HB ' HG13 ' A' ' 21' ' ' VAL . 43.7 t -100.21 131.65 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.7 mt -116.3 142.0 47.41 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.592 1.157 . . . . 0.0 109.398 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.6 tp -91.81 99.28 12.18 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 174.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 60.31 22.97 12.44 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.84 0.856 . . . . 0.0 112.473 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.7 -14.6 57.58 Favored Glycine 0 C--N 1.353 1.519 0 CA-C-O 119.779 -0.456 . . . . 0.0 113.436 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.62 146.13 60.1 Favored Pre-proline 0 N--CA 1.485 1.285 0 C-N-CA 123.745 0.818 . . . . 0.0 109.981 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -72.35 120.38 6.72 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.637 2.224 . . . . 0.0 113.301 -170.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.475 ' HB3' HG21 ' A' ' 21' ' ' VAL . 87.2 mt -94.63 141.1 29.0 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 170.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -80.05 120.89 24.82 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.546 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 11.1 p-10 -63.21 -39.47 94.73 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 123.491 0.494 . . . . 0.0 111.511 -171.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.58 -2.91 55.15 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.392 0.677 . . . . 0.0 111.897 -177.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.6 139.91 29.99 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.545 0.738 . . . . 0.0 110.563 173.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.697 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 75.5 p -73.58 164.34 26.78 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.978 0.511 . . . . 0.0 110.529 175.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.461 HD11 HD11 ' A' ' 24' ' ' ILE . 86.9 mt -66.83 -28.75 68.61 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.509 0.724 . . . . 0.0 110.757 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.07 -43.76 89.75 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.634 174.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -69.52 -37.3 77.07 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.847 0.459 . . . . 0.0 110.949 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 89.3 m -65.09 -23.49 67.18 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.319 0.648 . . . . 0.0 110.933 173.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.44 28.33 67.93 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 116.308 -0.405 . . . . 0.0 112.744 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.588 HG21 HD11 ' A' ' 65' ' ' LEU . 11.8 p -92.54 153.9 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -133.07 -172.19 2.87 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.674 0.79 . . . . 0.0 110.909 -173.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.77 157.45 36.41 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.341 0.657 . . . . 0.0 111.87 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 61.7 14.6 6.24 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 126.013 1.725 . . . . 0.0 112.415 -177.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.8 m -93.36 145.08 24.73 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.5 m -105.84 108.3 19.75 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.66 0.743 . . . . 0.0 110.08 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.588 HD11 HG21 ' A' ' 59' ' ' VAL . 5.6 mp -88.32 179.35 6.36 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.176 169.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 39.8 tt0 -142.53 153.34 43.5 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.101 0.56 . . . . 0.0 110.133 -175.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 79.1 t -109.08 131.83 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 170.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.98 127.19 17.56 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.305 0.642 . . . . 0.0 109.925 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.12 92.51 0.74 Allowed Glycine 0 C--N 1.344 0.99 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 175.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -132.69 -35.57 1.1 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.019 0.527 . . . . 0.0 112.296 -174.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 49.0 tpp . . . . . 0 N--CA 1.482 1.134 0 C-N-CA 122.497 0.319 . . . . 0.0 110.943 -178.593 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.6 mtm . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -76.96 114.59 15.92 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.482 HD13 HD23 ' A' ' 65' ' ' LEU . 2.3 pp -137.9 157.19 46.9 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.108 0.563 . . . . 0.0 110.155 -177.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -88.92 152.11 21.92 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.052 0.541 . . . . 0.0 109.63 -177.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.52 ' HB ' ' HB2' ' A' ' 11' ' ' HIS . 55.2 t -134.65 105.23 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.294 1.037 . . . . 0.0 109.087 -176.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -82.9 93.96 7.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.468 1.107 . . . . 0.0 111.001 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -111.3 -179.96 3.87 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 168.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.99 -26.79 39.23 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 175.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -111.47 134.04 53.34 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 158.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.73 137.66 52.18 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.883 0.473 . . . . 0.0 109.738 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.52 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 39.3 m-70 -129.86 161.97 29.61 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.122 0.969 . . . . 0.0 109.049 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.0 m -142.91 112.0 6.56 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 172.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -113.39 132.32 55.66 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.792 0.837 . . . . 0.0 111.203 -172.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -83.94 114.08 21.44 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 166.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.409 HG21 ' HG ' ' A' ' 54' ' ' LEU . 13.3 m -109.65 139.58 32.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 122.918 0.487 . . . . 0.0 109.811 -174.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 m -75.37 -17.83 60.12 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.711 0.805 . . . . 0.0 111.472 -176.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.75 -56.2 1.91 Allowed Glycine 0 C--N 1.347 1.143 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 -176.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -72.53 -7.12 48.41 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.307 0.643 . . . . 0.0 111.588 172.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -63.79 145.25 56.12 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 165.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 61.2 p -94.29 153.68 17.9 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 118.213 0.461 . . . . 0.0 111.99 -177.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.619 HG13 ' HB ' ' A' ' 41' ' ' VAL . 38.1 t -57.12 -33.71 43.52 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 124.388 1.075 . . . . 0.0 110.617 171.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.17 -53.19 61.11 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.126 0.971 . . . . 0.0 110.921 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -65.2 -36.14 83.27 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.916 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 28' ' ' VAL . 35.0 mm -60.36 -50.49 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 122.786 0.434 . . . . 0.0 111.633 178.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.4 ' HB3' HG23 ' A' ' 41' ' ' VAL . 61.3 pttt -68.25 -30.75 69.87 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.526 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . . . -65.9 -41.23 91.76 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 123.382 0.673 . . . . 0.0 111.492 175.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -62.03 -46.06 90.81 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.329 0.651 . . . . 0.0 109.722 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 24' ' ' ILE . 76.8 t -56.32 -48.24 79.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.717 176.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.99 -28.23 64.28 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.827 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 t -77.03 -31.62 56.41 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.554 0.741 . . . . 0.0 110.956 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.0 mt -73.31 -45.09 57.45 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.229 0.612 . . . . 0.0 111.17 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -86.1 -22.0 27.35 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.168 0.587 . . . . 0.0 112.316 -176.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.23 33.8 25.11 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 116.632 -0.258 . . . . 0.0 113.266 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 pt -109.84 171.38 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.941 0.896 . . . . 0.0 110.034 175.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.69 111.61 22.66 Favored Pre-proline 0 N--CA 1.484 1.244 0 C-N-CA 123.296 0.638 . . . . 0.0 111.768 -172.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.526 ' HB3' ' HA ' ' A' ' 26' ' ' ALA . 19.8 Cg_endo -55.95 -39.47 90.97 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 123.602 2.868 . . . . 0.0 114.081 -175.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -67.3 -28.06 67.69 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.035 0.534 . . . . 0.0 111.568 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 71' ' ' MET . 22.7 t70 -67.54 -40.3 85.02 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.253 0.621 . . . . 0.0 109.9 177.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -77.03 165.72 24.25 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.953 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -162.82 146.14 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 125.04 1.336 . . . . 0.0 108.299 173.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.619 ' HB ' HG13 ' A' ' 21' ' ' VAL . 96.3 t -90.14 134.55 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.103 0.561 . . . . 0.0 110.51 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.8 mt -123.29 127.38 48.47 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.77 1.228 . . . . 0.0 108.637 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.436 ' HB2' HD11 ' A' ' 48' ' ' LEU . 33.5 tp -92.18 97.96 11.23 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 173.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 59.73 23.07 11.91 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.56 1.144 . . . . 0.0 112.732 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.75 -7.56 38.93 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-O 119.703 -0.499 . . . . 0.0 113.655 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.01 114.55 53.38 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 123.241 0.616 . . . . 0.0 109.459 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -68.16 102.58 0.81 Allowed 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 122.172 1.914 . . . . 0.0 112.27 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.436 HD11 ' HB2' ' A' ' 43' ' ' LEU . 79.5 mt -73.2 129.68 38.58 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.34 176.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -63.44 130.73 45.64 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.139 0.9 . . . . 0.0 109.387 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -61.93 -35.38 78.23 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.184 0.303 . . . . 0.0 111.483 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.19 -19.68 60.46 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.4 0.28 . . . . 0.0 111.28 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.76 135.27 41.75 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.924 0.49 . . . . 0.0 109.848 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 71.4 p -76.82 171.95 13.91 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 122.907 0.483 . . . . 0.0 109.967 172.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.409 ' HG ' HG21 ' A' ' 15' ' ' VAL . 3.1 mm? -66.22 -28.76 68.99 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.54 -29.53 55.3 Favored Glycine 0 C--N 1.357 1.733 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.763 175.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -74.0 -35.98 64.46 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.641 0.776 . . . . 0.0 109.855 176.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 79.8 m -74.87 -23.52 58.42 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.466 171.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.19 23.05 78.49 Favored Glycine 0 C--N 1.353 1.506 0 CA-C-N 116.009 -0.541 . . . . 0.0 113.558 177.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.8 p -80.54 148.09 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 123.522 0.729 . . . . 0.0 110.342 -175.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -99.6 -177.38 3.55 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.401 0.68 . . . . 0.0 112.181 -173.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.42 162.22 24.55 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.738 0.815 . . . . 0.0 111.029 175.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 64.63 9.29 5.03 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 125.449 1.5 . . . . 0.0 112.488 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.7 m -78.06 152.0 33.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.058 0.943 . . . . 0.0 109.706 175.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.2 m -106.87 108.25 19.67 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 173.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.482 HD23 HD13 ' A' ' 3' ' ' LEU . 3.6 mm? -92.32 135.54 33.94 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 124.175 0.99 . . . . 0.0 108.589 174.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -93.97 150.46 20.34 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.164 0.586 . . . . 0.0 109.465 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 67.1 t -119.46 131.45 72.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 174.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.72 148.55 30.15 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.406 0.682 . . . . 0.0 110.318 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.0 98.82 2.27 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 174.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.9 mtp-105 -103.44 -26.13 13.0 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.594 0.758 . . . . 0.0 111.176 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.513 ' O ' ' HA ' ' A' ' 38' ' ' ASP . 62.7 ttp . . . . . 0 N--CA 1.473 0.697 0 C-N-CA 123.361 0.664 . . . . 0.0 109.971 -170.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.552 ' SD ' HD23 ' A' ' 3' ' ' LEU . 47.9 ttm . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -87.39 123.62 32.54 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 171.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.552 HD23 ' SD ' ' A' ' 1' ' ' MET . 2.1 pp -143.12 158.47 43.58 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.619 0.768 . . . . 0.0 109.398 -175.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -96.3 139.78 31.94 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.368 0.667 . . . . 0.0 109.47 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.517 HG22 ' HB2' ' A' ' 65' ' ' LEU . 58.9 t -123.35 103.39 12.89 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 174.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -76.48 100.14 5.15 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.674 0.749 . . . . 0.0 111.038 -178.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.97 -178.2 3.59 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.412 1.085 . . . . 0.0 108.446 166.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -48.29 -35.59 12.52 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.845 0.858 . . . . 0.0 111.379 172.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -111.7 131.28 55.41 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 166.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -68.6 132.84 47.58 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.824 0.45 . . . . 0.0 109.804 -175.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -126.63 156.09 41.51 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.689 0.795 . . . . 0.0 109.451 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.1 t -136.45 135.36 38.57 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 167.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -133.55 155.1 50.22 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.609 0.764 . . . . 0.0 110.355 -175.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -106.47 120.24 41.38 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.412 HG21 ' HG ' ' A' ' 54' ' ' LEU . 32.3 m -110.44 150.3 13.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 C-N-CA 123.812 0.845 . . . . 0.0 108.999 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.3 m -81.98 -14.67 55.69 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.102 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.603 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 91.01 -42.95 2.85 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.521 -0.309 . . . . 0.0 113.043 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -72.22 -13.32 61.5 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.477 1.111 . . . . 0.0 111.92 176.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -78.23 156.84 29.54 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.129 0.572 . . . . 0.0 109.676 171.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 81.4 p -93.24 175.55 6.73 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.24 0.543 . . . . 0.0 112.285 -175.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.585 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 53.1 t -62.57 -36.55 75.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 123.761 0.825 . . . . 0.0 109.996 170.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . . . -62.25 -37.95 87.4 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.564 0.745 . . . . 0.0 110.76 175.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -64.43 -48.16 76.41 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.789 0.681 . . . . 0.0 111.1 176.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.553 ' O ' HG23 ' A' ' 28' ' ' VAL . 64.2 mt -56.71 -49.23 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 122.881 0.472 . . . . 0.0 109.826 176.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.487 ' HB2' HG12 ' A' ' 41' ' ' VAL . 85.1 tttt -55.26 -45.9 76.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.849 1.66 . . . . 0.0 111.193 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.11 -42.91 88.57 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.847 0.859 . . . . 0.0 111.285 176.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -60.67 -46.83 88.86 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.594 0.758 . . . . 0.0 110.902 -178.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 24' ' ' ILE . 26.3 t -65.13 -44.96 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 123.815 0.697 . . . . 0.0 109.148 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.75 -41.04 90.1 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 123.537 0.735 . . . . 0.0 112.249 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.1 m -61.82 -44.61 96.5 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.807 0.843 . . . . 0.0 111.182 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.5 mt -79.7 -25.41 41.2 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.636 -176.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -85.49 -12.15 52.51 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.006 0.522 . . . . 0.0 111.434 172.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.35 25.44 68.27 Favored Glycine 0 C--N 1.351 1.377 0 C-N-CA 122.85 0.262 . . . . 0.0 113.593 176.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.3 pt -119.03 174.74 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.266 1.026 . . . . 0.0 110.238 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.05 144.22 50.73 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.244 0.618 . . . . 0.0 110.035 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.35 -22.47 59.94 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.48 2.12 . . . . 0.0 110.886 172.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -64.0 -25.54 68.17 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.228 1.411 . . . . 0.0 111.584 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -81.88 -23.06 36.53 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.663 0.785 . . . . 0.0 111.343 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.428 ' O ' ' HE3' ' A' ' 25' ' ' LYS . 10.4 pt20 -123.84 -179.52 4.42 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.357 0.598 . . . . 0.0 111.178 -175.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.454 HG11 ' HB2' ' A' ' 70' ' ' ARG . 7.4 p -156.92 134.42 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.99 1.316 . . . . 0.0 107.513 166.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.487 HG12 ' HB2' ' A' ' 25' ' ' LYS . 9.9 p -96.31 110.83 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 CA-C-O 121.952 0.882 . . . . 0.0 109.929 -178.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 47' ' ' PRO . 18.1 mt -94.23 154.88 17.32 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.889 1.276 . . . . 0.0 109.409 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.554 ' HB2' HD11 ' A' ' 48' ' ' LEU . 40.3 tp -94.16 97.63 10.41 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 58.2 23.83 10.71 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.292 1.037 . . . . 0.0 112.489 -177.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.93 -5.8 36.89 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 119.483 -0.621 . . . . 0.0 113.655 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.21 116.11 65.22 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 123.49 0.716 . . . . 0.0 110.66 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.409 ' HA ' HD22 ' A' ' 42' ' ' LEU . 40.7 Cg_endo -64.63 106.62 0.76 Allowed 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.31 2.007 . . . . 0.0 111.621 174.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' A' ' 43' ' ' LEU . 63.8 mt -82.77 170.01 15.52 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.098 0.559 . . . . 0.0 111.0 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -78.26 124.87 28.57 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 168.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.585 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 10.2 p-10 -67.26 -19.61 65.54 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.935 0.494 . . . . 0.0 111.415 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -80.6 -21.35 41.66 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.194 0.998 . . . . 0.0 111.617 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.45 133.97 38.49 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.132 0.573 . . . . 0.0 110.781 -178.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 66.5 p -79.41 171.64 14.88 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.756 0.822 . . . . 0.0 110.626 174.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.603 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 3.4 mm? -64.1 -37.43 87.42 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 175.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.42 -39.11 95.57 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.586 175.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -70.07 -44.2 69.58 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.528 0.731 . . . . 0.0 110.946 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 51.8 t -75.75 -24.12 56.04 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.32 0.648 . . . . 0.0 111.446 -177.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.78 35.02 13.92 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.918 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.4 t -76.84 148.59 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 123.651 0.781 . . . . 0.0 109.268 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -119.61 -171.99 2.24 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.723 0.809 . . . . 0.0 110.299 -176.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.79 149.89 30.92 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 122.779 0.431 . . . . 0.0 110.281 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 60.28 26.2 15.67 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.095 1.358 . . . . 0.0 112.33 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.6 m -80.0 162.17 25.03 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.633 0.773 . . . . 0.0 109.89 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.2 m -115.78 106.06 13.42 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.889 0.852 . . . . 0.0 110.529 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.517 ' HB2' HG22 ' A' ' 5' ' ' VAL . 3.5 mm? -83.02 164.99 20.0 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.409 -1.269 . . . . 0.0 107.833 164.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -144.92 130.46 18.88 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.878 0.471 . . . . 0.0 110.613 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.447 HG21 HG11 ' A' ' 28' ' ' VAL . 83.2 t -83.02 127.45 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 172.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.78 151.79 47.38 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.85 0.86 . . . . 0.0 109.981 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -91.78 86.41 1.27 Allowed Glycine 0 C--N 1.341 0.852 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 173.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.454 ' HB2' HG11 ' A' ' 40' ' ' VAL . 71.3 mtp180 -119.31 16.13 13.08 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.154 0.981 . . . . 0.0 108.965 170.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.302 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.663 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 82.6 mtp . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -88.54 99.46 12.32 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.409 HD21 HD23 ' A' ' 54' ' ' LEU . 1.5 pp -119.99 165.52 14.56 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.52 0.728 . . . . 0.0 110.864 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.441 ' HB3' HD21 ' A' ' 10' ' ' LEU . 29.7 m-85 -101.35 140.66 35.34 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.344 1.058 . . . . 0.0 108.918 -176.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.37 107.33 16.55 Favored 'Isoleucine or valine' 0 C--O 1.244 0.806 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -80.36 93.78 6.03 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.712 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.92 -171.77 2.42 Favored 'General case' 0 C--O 1.245 0.84 0 C-N-CA 125.876 1.67 . . . . 0.0 108.015 165.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -38.72 -34.28 0.14 Allowed 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 123.399 0.68 . . . . 0.0 112.727 167.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -123.96 162.75 22.75 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.637 1.175 . . . . 0.0 109.319 164.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.441 HD21 ' HB3' ' A' ' 4' ' ' PHE . 3.2 tm? -81.94 131.76 35.25 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -133.77 124.68 27.03 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.077 0.951 . . . . 0.0 109.119 -177.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 m -99.35 123.43 43.62 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -119.56 121.31 39.07 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.463 1.105 . . . . 0.0 110.456 -176.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.22 106.2 13.01 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 163.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.2 m -110.93 156.7 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.884 0.874 . . . . 0.0 110.659 -174.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.3 p -75.14 -25.74 58.63 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.949 177.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.3 -39.24 3.11 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.921 -174.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -78.23 -10.81 59.82 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.085 0.554 . . . . 0.0 111.657 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -69.13 120.84 15.59 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 168.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 69.7 p -66.29 161.22 22.79 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.388 0.675 . . . . 0.0 111.6 -175.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.465 HG13 ' HB ' ' A' ' 41' ' ' VAL . 75.4 t -62.06 -29.89 47.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 C-N-CA 124.042 0.937 . . . . 0.0 110.947 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . . . -61.31 -53.18 60.07 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.639 0.775 . . . . 0.0 110.499 174.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -65.92 -37.23 85.53 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.794 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.3 mm -63.96 -47.15 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.828 0.851 . . . . 0.0 111.588 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.48 ' HB3' HG23 ' A' ' 41' ' ' VAL . 51.8 pttt -70.18 -33.81 72.2 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 118.132 0.424 . . . . 0.0 110.28 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.61 -39.41 80.86 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.603 0.761 . . . . 0.0 110.605 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -55.57 -51.95 65.38 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.649 1.58 . . . . 0.0 109.955 175.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.506 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 84.5 t -64.51 -44.03 96.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.271 178.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.83 -35.67 78.91 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.629 0.771 . . . . 0.0 112.323 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.0 m -68.62 -40.8 80.17 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.092 0.557 . . . . 0.0 110.754 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.6 mt -66.93 -40.72 87.7 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.492 177.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 28' ' ' VAL . 11.0 mm-40 -84.27 -12.67 54.3 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.731 0.813 . . . . 0.0 111.709 -177.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.59 38.68 78.73 Favored Glycine 0 C--N 1.354 1.569 0 O-C-N 123.415 0.447 . . . . 0.0 113.32 177.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.2 pt -129.22 176.13 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.442 1.097 . . . . 0.0 110.306 -175.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.73 113.91 29.14 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 123.978 0.911 . . . . 0.0 112.466 -171.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -60.44 -35.7 89.68 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.291 2.661 . . . . 0.0 113.139 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -67.33 -27.67 67.33 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.008 0.523 . . . . 0.0 110.916 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 71' ' ' MET . 31.7 t70 -74.74 -29.47 61.17 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.282 0.633 . . . . 0.0 110.607 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -75.98 152.6 36.96 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.403 0.621 . . . . 0.0 111.52 -173.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.3 p -142.63 142.8 26.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-N 114.331 -1.304 . . . . 0.0 107.581 169.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.48 HG23 ' HB3' ' A' ' 25' ' ' LYS . 98.5 t -98.89 123.36 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 173.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 47' ' ' PRO . 86.6 mt -116.34 118.61 33.22 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.825 1.25 . . . . 0.0 108.681 -176.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.3 tp -86.03 97.75 10.46 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 173.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 57.65 24.54 10.65 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.041 0.936 . . . . 0.0 111.645 -174.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.1 -20.87 30.24 Favored Glycine 0 C--N 1.354 1.555 0 C-N-CA 123.521 0.581 . . . . 0.0 113.649 -177.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.34 117.69 60.94 Favored Pre-proline 0 CA--C 1.554 1.111 0 CA-C-N 117.489 0.645 . . . . 0.0 110.602 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.438 ' HA ' HD23 ' A' ' 42' ' ' LEU . 19.8 Cg_exo -65.26 101.59 0.42 Allowed 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.003 2.469 . . . . 0.0 112.508 -176.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.461 ' HB3' HG21 ' A' ' 21' ' ' VAL . 61.7 mt -68.9 127.16 32.12 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.957 176.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.83 127.95 33.65 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 123.463 0.705 . . . . 0.0 109.812 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.495 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . 9.4 p-10 -62.07 -29.53 70.37 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.938 0.895 . . . . 0.0 111.663 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -76.35 -24.11 54.21 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.827 0.851 . . . . 0.0 111.214 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.1 146.27 30.67 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.503 0.721 . . . . 0.0 110.533 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 80.9 p -85.81 165.24 17.02 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.321 0.648 . . . . 0.0 109.893 173.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.409 HD23 HD21 ' A' ' 3' ' ' LEU . 9.7 mp -66.57 -28.79 68.8 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.184 0.594 . . . . 0.0 110.486 175.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.41 -40.45 86.86 Favored Glycine 0 C--N 1.35 1.332 0 O-C-N 123.796 0.685 . . . . 0.0 112.262 174.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -73.08 -36.5 66.84 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.268 0.627 . . . . 0.0 110.652 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 84.0 m -71.7 -17.81 62.2 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.788 0.835 . . . . 0.0 111.567 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.16 19.84 78.77 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 123.578 0.549 . . . . 0.0 113.385 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.562 HG21 HD11 ' A' ' 65' ' ' LEU . 2.2 p -88.15 99.67 9.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -81.92 -174.66 5.18 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.249 -1.341 . . . . 0.0 112.061 -171.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.663 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -62.9 155.45 27.14 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.758 172.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 61.59 24.91 14.93 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.642 1.177 . . . . 0.0 112.565 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.4 m -107.88 157.98 17.72 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.713 0.805 . . . . 0.0 109.069 175.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.3 m -114.59 121.9 44.87 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.907 0.483 . . . . 0.0 110.54 -178.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.562 HD11 HG21 ' A' ' 59' ' ' VAL . 3.0 mm? -94.22 162.56 13.8 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.644 1.178 . . . . 0.0 109.478 171.111 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -122.69 130.98 53.58 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.457 1.103 . . . . 0.0 108.751 173.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 86.8 t -104.65 114.02 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.23 161.03 21.07 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.742 0.817 . . . . 0.0 111.016 -177.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.09 106.26 3.35 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -131.39 -57.8 1.0 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.617 0.767 . . . . 0.0 111.414 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.548 ' O ' ' HA ' ' A' ' 38' ' ' ASP . 41.2 tpp . . . . . 0 N--CA 1.478 0.965 0 C-N-CA 123.238 0.615 . . . . 0.0 110.562 -171.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.542 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -113.07 132.78 55.28 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.581 0.753 . . . . 0.0 108.978 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.484 HD13 HD23 ' A' ' 65' ' ' LEU . 4.0 pp -131.35 158.92 39.42 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -101.9 152.2 21.2 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.648 0.779 . . . . 0.0 109.106 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.41 ' HB ' ' HB2' ' A' ' 11' ' ' HIS . 8.8 t -126.11 124.9 66.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.675 1.19 . . . . 0.0 108.631 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -95.21 93.41 7.29 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.147 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -108.43 -176.59 3.09 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 168.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.86 -29.04 1.78 Allowed 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 123.429 0.692 . . . . 0.0 112.49 174.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -123.06 159.44 28.44 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.167 0.987 . . . . 0.0 108.698 163.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.4 mt -79.58 128.35 33.27 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.245 0.545 . . . . 0.0 110.789 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 56.2 m-70 -113.23 163.19 15.1 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.708 1.203 . . . . 0.0 108.174 173.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 t -141.44 146.32 36.38 Favored 'General case' 0 C--O 1.244 0.763 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 169.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -138.81 131.54 29.16 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.842 0.857 . . . . 0.0 109.877 -175.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.42 132.16 43.39 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 170.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.48 HG11 HD11 ' A' ' 24' ' ' ILE . 16.1 m -141.6 -169.38 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 125.025 1.33 . . . . 0.0 109.083 -177.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.5 m -113.18 -9.33 13.49 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.85 0.86 . . . . 0.0 109.854 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.39 -36.61 3.69 Favored Glycine 0 C--N 1.357 1.738 0 N-CA-C 112.245 -0.342 . . . . 0.0 112.245 -174.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -67.88 -16.85 64.27 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.505 0.722 . . . . 0.0 110.989 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -67.61 146.74 53.57 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 122.926 0.49 . . . . 0.0 110.313 172.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 76.7 p -84.74 157.19 21.12 Favored 'General case' 0 C--O 1.244 0.763 0 CA-C-O 121.608 0.718 . . . . 0.0 112.029 -176.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.6 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 82.6 t -60.63 -27.36 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.747 173.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.74 -52.71 48.94 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.009 0.923 . . . . 0.0 111.695 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -64.88 -30.63 71.64 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 119.456 -0.307 . . . . 0.0 111.203 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.487 ' O ' HG23 ' A' ' 28' ' ' VAL . 37.6 mm -58.65 -56.66 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 123.536 0.523 . . . . 0.0 110.631 173.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -68.82 -29.18 67.47 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.449 0.3 . . . . 0.0 110.352 -177.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.44 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . . . -67.51 -40.81 85.15 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.645 0.778 . . . . 0.0 111.335 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -67.5 -40.97 85.18 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.539 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 65.0 t -59.19 -45.03 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.609 174.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.37 -39.11 82.24 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.095 0.958 . . . . 0.0 111.795 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.4 m -63.3 -37.93 89.18 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.728 0.811 . . . . 0.0 111.344 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.5 mt -77.23 -30.12 54.44 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.758 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 28' ' ' VAL . 17.6 mm-40 -78.11 -27.82 48.42 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.914 0.885 . . . . 0.0 110.908 176.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.75 15.54 59.56 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 116.152 -0.476 . . . . 0.0 113.519 -175.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.9 pt -120.2 -176.9 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 124.224 1.01 . . . . 0.0 110.5 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.82 145.75 30.28 Favored Pre-proline 0 CA--C 1.562 1.427 0 C-N-CA 123.312 0.645 . . . . 0.0 111.382 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.44 ' HB3' ' HA ' ' A' ' 26' ' ' ALA . 30.3 Cg_endo -62.7 -21.23 72.78 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 123.165 2.577 . . . . 0.0 113.913 177.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.73 -17.95 65.12 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.026 0.93 . . . . 0.0 111.805 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -80.58 -40.22 26.19 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.591 0.71 . . . . 0.0 110.101 174.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.433 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 96.5 mt-30 -90.13 154.34 19.85 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 114.419 -1.264 . . . . 0.0 112.348 -168.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.4 134.24 17.29 Favored 'Isoleucine or valine' 0 C--O 1.252 1.215 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.51 172.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.632 HG22 HG22 ' A' ' 67' ' ' VAL . 74.5 t -82.24 129.31 37.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.648 177.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.5 mt -117.19 124.02 48.09 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.293 1.437 . . . . 0.0 108.529 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.413 ' HB2' HD11 ' A' ' 48' ' ' LEU . 30.7 tp -100.18 107.62 19.53 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 171.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 61.64 22.85 13.26 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.651 1.18 . . . . 0.0 111.943 -174.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.68 -20.84 38.17 Favored Glycine 0 C--N 1.355 1.594 0 CA-C-N 116.105 -0.498 . . . . 0.0 113.222 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.4 120.47 74.38 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 123.487 0.715 . . . . 0.0 110.628 -176.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.94 121.79 9.82 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.197 2.598 . . . . 0.0 113.033 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.417 HD22 ' SG ' ' A' ' 57' ' ' CYS . 84.9 mt -82.63 152.77 25.75 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 123.76 0.824 . . . . 0.0 109.792 174.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -73.37 110.04 7.36 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.6 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 14.9 p-10 -63.45 -32.77 74.31 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.551 -177.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -71.18 -17.91 62.51 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.935 0.894 . . . . 0.0 111.347 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.32 153.33 22.05 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.693 0.797 . . . . 0.0 111.013 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 62.9 p -82.09 158.15 23.83 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.67 0.788 . . . . 0.0 110.374 178.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.12 -35.12 79.23 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.873 0.869 . . . . 0.0 111.129 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.08 -46.9 68.19 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.149 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -72.76 -30.1 63.85 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.044 0.537 . . . . 0.0 110.981 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.417 ' SG ' HD22 ' A' ' 48' ' ' LEU . 42.9 t -67.33 -26.65 66.6 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.71 0.804 . . . . 0.0 111.056 173.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.27 22.61 47.42 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.305 177.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.517 HG21 HD21 ' A' ' 65' ' ' LEU . 2.4 p -98.39 131.75 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 176.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -121.08 -168.27 1.64 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.136 0.974 . . . . 0.0 110.881 -172.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.542 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -67.44 160.04 28.3 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.296 0.638 . . . . 0.0 111.087 175.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 61.25 19.03 9.73 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.781 1.232 . . . . 0.0 112.399 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.404 HG21 HG23 ' A' ' 59' ' ' VAL . 9.9 m -101.06 161.15 13.8 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.826 0.85 . . . . 0.0 108.826 174.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.8 m -128.33 124.2 35.86 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.517 HD21 HG21 ' A' ' 59' ' ' VAL . 3.1 mm? -109.61 128.27 55.11 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 124.795 1.238 . . . . 0.0 108.727 -178.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -93.54 108.17 19.91 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.751 0.82 . . . . 0.0 109.109 -174.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.632 HG22 HG22 ' A' ' 41' ' ' VAL . 76.8 t -94.95 106.09 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -178.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.48 136.34 54.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.281 -176.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 39' ' ' GLN . . . -82.17 89.74 1.46 Allowed Glycine 0 C--N 1.34 0.766 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 176.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -118.73 -21.54 7.81 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.425 0.69 . . . . 0.0 111.327 -175.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.8 ttm . . . . . 0 CA--C 1.546 0.791 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -178.567 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.437 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 26.0 ttt . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -89.86 98.61 11.87 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.602 -175.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.0 pp -114.7 150.4 35.32 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 175.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -87.77 145.45 26.1 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.857 0.863 . . . . 0.0 108.839 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.436 HG11 HG21 ' A' ' 28' ' ' VAL . 73.0 t -125.79 111.35 26.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 170.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -74.73 92.55 2.48 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.282 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.69 -175.39 3.57 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.781 1.232 . . . . 0.0 108.086 170.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -49.32 -28.54 4.97 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.082 0.553 . . . . 0.0 111.613 173.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -122.76 151.17 41.87 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.039 0.935 . . . . 0.0 108.522 161.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -73.22 128.44 35.49 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -177.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -127.6 159.81 33.51 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.504 0.721 . . . . 0.0 110.079 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.8 m -129.2 137.73 51.31 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -130.84 114.85 15.81 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.887 0.875 . . . . 0.0 111.302 -170.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -76.81 103.56 6.83 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 163.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.437 ' O ' ' HB3' ' A' ' 1' ' ' MET . 30.8 m -110.9 169.47 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.893 0.877 . . . . 0.0 109.434 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.1 m -94.93 -28.79 15.0 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.007 0.523 . . . . 0.0 110.108 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.429 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 102.18 -13.1 57.3 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 116.251 -0.432 . . . . 0.0 112.662 -176.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -91.99 -9.39 43.09 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.462 0.705 . . . . 0.0 111.186 -176.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -73.02 152.63 41.23 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 78.2 p -80.72 164.38 22.82 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.516 0.674 . . . . 0.0 109.569 171.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.597 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 53.9 t -62.98 -27.21 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.34 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.842 171.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . . . -64.0 -40.14 95.69 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.404 0.682 . . . . 0.0 111.483 172.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.415 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 85.9 mm-40 -66.91 -36.75 82.98 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.797 0.439 . . . . 0.0 110.515 177.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.9 mm -61.18 -47.76 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.35 0.66 . . . . 0.0 110.417 174.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -55.23 -49.42 72.05 Favored 'General case' 0 C--N 1.359 1.005 0 O-C-N 123.714 0.634 . . . . 0.0 109.943 175.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.68 -48.36 72.5 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.916 0.886 . . . . 0.0 111.904 -178.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -64.87 -45.95 83.87 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.239 0.616 . . . . 0.0 110.853 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.592 HG11 HG21 ' A' ' 67' ' ' VAL . 84.1 t -64.88 -39.97 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 122.632 0.373 . . . . 0.0 110.542 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 34' ' ' ILE . . . -68.65 -32.28 72.02 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.647 0.779 . . . . 0.0 111.763 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.8 t -66.33 -42.02 88.77 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.186 0.594 . . . . 0.0 110.703 173.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.3 mt -70.41 -45.61 65.58 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.082 0.553 . . . . 0.0 112.063 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -88.54 -3.98 58.69 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.498 0.719 . . . . 0.0 111.747 -175.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.54 33.48 72.14 Favored Glycine 0 C--N 1.356 1.675 0 O-C-N 123.529 0.518 . . . . 0.0 113.725 174.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.428 ' O ' ' HB1' ' A' ' 29' ' ' ALA . 9.6 pt -123.01 -179.92 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.035 0.934 . . . . 0.0 110.576 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.58 125.61 53.09 Favored Pre-proline 0 CA--C 1.557 1.24 0 C-N-CA 123.392 0.677 . . . . 0.0 110.931 -176.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.65 -18.87 37.27 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.485 2.123 . . . . 0.0 112.685 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -66.73 -33.94 76.75 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.07 0.948 . . . . 0.0 111.846 -177.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -92.49 -8.08 45.57 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -176.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -80.1 147.05 31.57 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.247 0.546 . . . . 0.0 111.008 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.2 m -130.1 142.25 44.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 168.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.442 HG13 ' HB3' ' A' ' 65' ' ' LEU . 73.2 t -106.29 105.53 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.3 mt -87.81 122.5 31.53 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.274 1.03 . . . . 0.0 110.291 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.2 tp -91.27 97.17 10.95 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 167.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 55.96 30.61 16.37 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.252 1.021 . . . . 0.0 112.082 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.1 -23.58 24.98 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-N 115.93 -0.577 . . . . 0.0 113.568 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.43 113.61 38.28 Favored Pre-proline 0 N--CA 1.479 0.977 0 CA-C-N 117.487 0.643 . . . . 0.0 110.929 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -65.92 109.22 1.44 Allowed 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.512 2.142 . . . . 0.0 112.143 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.6 mt -73.76 148.15 42.82 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.738 0.815 . . . . 0.0 110.996 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.411 ' HB3' ' HG2' ' A' ' 51' ' ' GLU . 44.6 mm-40 -77.25 121.88 24.3 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 124.286 0.991 . . . . 0.0 109.989 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.597 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 0.8 OUTLIER -65.75 -21.95 66.55 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 123.913 0.758 . . . . 0.0 112.546 176.142 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.411 ' HG2' ' HB3' ' A' ' 49' ' ' GLU . 11.2 pt-20 -72.39 -26.8 62.02 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.226 0.61 . . . . 0.0 111.099 174.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.89 143.11 27.3 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.767 0.827 . . . . 0.0 111.454 -174.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 45.6 p -73.74 168.06 20.14 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.549 0.74 . . . . 0.0 111.067 172.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.429 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 3.1 mm? -64.46 -30.39 71.43 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 171.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.88 -39.29 93.37 Favored Glycine 0 C--N 1.358 1.755 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.621 173.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -71.24 -37.26 72.0 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.741 0.416 . . . . 0.0 109.9 177.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 40.6 t -66.48 -22.45 66.19 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.414 0.685 . . . . 0.0 111.37 173.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.44 21.31 78.66 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.584 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.2 p -91.58 152.76 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 123.572 0.749 . . . . 0.0 109.606 -176.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -132.21 -168.3 2.02 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.764 0.826 . . . . 0.0 110.948 -176.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.8 167.4 13.49 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.537 0.735 . . . . 0.0 112.491 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 68.14 -5.33 0.9 Allowed 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 126.247 1.819 . . . . 0.0 113.737 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.3 m -77.6 153.71 32.98 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.776 0.83 . . . . 0.0 109.939 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.7 m -119.07 110.16 16.76 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.756 0.822 . . . . 0.0 109.633 175.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.442 ' HB3' HG13 ' A' ' 41' ' ' VAL . 84.8 mt -87.04 144.65 26.79 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 171.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -117.28 121.61 41.65 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.561 0.619 . . . . 0.0 110.857 -175.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.592 HG21 HG11 ' A' ' 28' ' ' VAL . 77.0 t -83.75 115.93 26.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 122.804 0.441 . . . . 0.0 109.971 173.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -123.89 167.21 14.41 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.562 1.145 . . . . 0.0 109.765 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.64 88.88 0.5 Allowed Glycine 0 C--N 1.342 0.871 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -109.35 -36.34 6.03 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.836 0.855 . . . . 0.0 109.706 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 47.4 ttm . . . . . 0 CA--C 1.549 0.904 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.185 175.667 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -102.61 118.39 36.75 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.682 0.793 . . . . 0.0 110.252 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 pp -133.55 165.26 25.31 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.302 0.641 . . . . 0.0 110.35 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -101.05 142.39 32.58 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.057 0.943 . . . . 0.0 109.528 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.1 t -125.46 109.62 22.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 C-N-CA 123.903 0.881 . . . . 0.0 108.674 171.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 35.5 ttt85 -79.48 95.35 5.78 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.084 1.353 . . . . 0.0 110.862 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.17 -174.82 3.33 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.582 1.153 . . . . 0.0 108.032 165.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -42.15 -36.18 1.12 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 123.567 0.747 . . . . 0.0 111.62 167.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -111.05 136.25 50.34 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 164.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -70.88 123.28 21.62 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 173.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -126.1 154.42 43.13 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.498 0.719 . . . . 0.0 109.769 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.3 m -113.91 143.15 45.18 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.812 0.845 . . . . 0.0 108.809 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -136.61 129.36 30.66 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.793 0.837 . . . . 0.0 110.043 -174.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -90.74 114.71 27.13 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 166.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.3 m -115.37 155.48 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.192 0.997 . . . . 0.0 110.463 -169.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.0 m -83.03 -9.9 59.03 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -171.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.5 -50.68 4.07 Favored Glycine 0 C--N 1.358 1.776 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -174.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -79.65 7.06 9.11 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.855 0.862 . . . . 0.0 110.802 167.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -59.57 121.05 10.6 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.765 1.226 . . . . 0.0 109.176 168.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.688 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 51.1 p -78.88 167.41 21.19 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 118.765 0.711 . . . . 0.0 110.385 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.589 HG21 ' HB3' ' A' ' 48' ' ' LEU . 80.3 t -67.52 -32.52 57.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 123.157 0.583 . . . . 0.0 110.069 174.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.65 -36.43 84.25 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.601 0.761 . . . . 0.0 110.635 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -69.3 -40.86 77.43 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.307 0.643 . . . . 0.0 110.963 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.573 HD11 HD11 ' A' ' 54' ' ' LEU . 40.9 mm -57.95 -45.82 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.591 0.757 . . . . 0.0 110.151 175.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.532 ' HE2' ' HA ' ' A' ' 40' ' ' VAL . 92.6 mttt -59.6 -49.59 77.19 Favored 'General case' 0 C--O 1.21 -1.017 0 O-C-N 124.52 1.137 . . . . 0.0 110.603 176.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.01 -42.96 91.36 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.007 0.923 . . . . 0.0 112.025 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -59.41 -53.15 61.45 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.871 0.868 . . . . 0.0 111.019 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.469 HG11 HG21 ' A' ' 67' ' ' VAL . 11.6 p -75.39 -27.57 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.46 -175.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.77 -37.15 79.13 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.726 0.81 . . . . 0.0 110.985 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.4 t -67.13 -40.88 86.87 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 123.39 0.431 . . . . 0.0 110.44 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.1 mt -61.9 -49.71 75.11 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 123.445 0.466 . . . . 0.0 111.916 176.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 28' ' ' VAL . 3.2 mm-40 -86.58 -3.43 59.02 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.115 0.566 . . . . 0.0 111.693 -175.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.56 16.87 70.21 Favored Glycine 0 C--N 1.357 1.711 0 O-C-N 123.315 0.384 . . . . 0.0 113.285 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 36.1 pt -98.65 175.84 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.936 0.894 . . . . 0.0 110.937 -175.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.39 133.29 38.75 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.814 0.846 . . . . 0.0 110.355 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -66.76 -16.77 51.2 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.699 2.266 . . . . 0.0 111.964 171.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -76.71 -19.34 57.8 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.642 0.777 . . . . 0.0 111.579 174.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -97.89 19.7 13.38 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.588 0.755 . . . . 0.0 111.131 -172.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -152.87 166.43 32.34 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.651 -0.656 . . . . 0.0 112.024 -172.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.532 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . 11.2 p -142.29 149.22 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.653 1.181 . . . . 0.0 108.993 172.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.428 ' HB ' HG13 ' A' ' 21' ' ' VAL . 63.1 t -102.65 132.55 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.22 0.608 . . . . 0.0 109.638 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 47' ' ' PRO . 2.7 mm? -117.75 113.54 21.99 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.648 1.579 . . . . 0.0 108.657 -174.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.618 HD11 ' HB ' ' A' ' 59' ' ' VAL . 2.9 tt -80.15 98.26 7.24 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 57.85 26.48 13.29 Favored 'General case' 0 CA--C 1.556 1.175 0 O-C-N 124.007 0.817 . . . . 0.0 111.842 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.27 -18.79 32.85 Favored Glycine 0 C--N 1.357 1.719 0 CA-C-N 115.927 -0.578 . . . . 0.0 114.207 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.84 117.31 67.81 Favored Pre-proline 0 N--CA 1.483 1.184 0 C-N-CA 123.516 0.726 . . . . 0.0 111.422 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.411 ' HA ' HD13 ' A' ' 42' ' ' LEU . 36.3 Cg_endo -62.11 108.95 0.73 Allowed 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.09 2.527 . . . . 0.0 113.204 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.589 ' HB3' HG21 ' A' ' 21' ' ' VAL . 73.7 mt -82.78 139.97 33.27 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.133 177.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -80.56 131.9 35.58 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.024 0.93 . . . . 0.0 110.334 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.24 -49.87 22.4 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.038 1.335 . . . . 0.0 113.628 -174.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -18.79 49.89 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.955 0.502 . . . . 0.0 112.173 -173.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.73 140.36 45.92 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.107 0.563 . . . . 0.0 110.791 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.688 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 47.6 p -85.43 170.87 12.28 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.734 0.414 . . . . 0.0 110.673 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.573 HD11 HD11 ' A' ' 24' ' ' ILE . 36.8 mt -68.74 -29.93 68.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.117 0.567 . . . . 0.0 111.117 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.02 -42.39 92.52 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.05 172.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -68.89 -31.34 70.19 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.842 0.857 . . . . 0.0 111.271 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 79.0 m -71.96 -28.87 63.73 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.304 0.642 . . . . 0.0 110.635 172.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.76 22.07 54.23 Favored Glycine 0 C--N 1.348 1.21 0 O-C-N 123.495 0.497 . . . . 0.0 112.91 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.618 ' HB ' HD11 ' A' ' 43' ' ' LEU . 7.5 p -96.94 135.7 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.44 0.696 . . . . 0.0 110.235 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -106.77 -168.57 1.43 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.247 1.019 . . . . 0.0 109.925 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.35 175.79 6.6 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.107 0.563 . . . . 0.0 111.26 176.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 58.59 26.02 13.91 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.869 1.268 . . . . 0.0 112.439 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.6 m -111.63 153.94 25.61 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.854 0.862 . . . . 0.0 109.832 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 54.5 m -114.44 108.82 17.39 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.08 0.552 . . . . 0.0 109.889 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.57 149.96 21.03 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 171.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -125.19 139.25 53.91 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 119.087 0.858 . . . . 0.0 110.758 -176.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.469 HG21 HG11 ' A' ' 28' ' ' VAL . 77.1 t -97.14 122.23 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.526 0.731 . . . . 0.0 110.071 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -118.3 149.91 40.36 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.426 0.69 . . . . 0.0 110.543 173.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.39 90.57 1.68 Allowed Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -123.3 10.29 9.25 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.708 0.803 . . . . 0.0 110.422 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 37.7 tpp -140.18 160.82 39.09 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.868 0.467 . . . . 0.0 110.698 -169.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -149.47 -44.6 0.14 Allowed 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 135.14 -116.81 1.61 Allowed Glycine 0 C--N 1.342 0.883 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.659 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.279 0 CA-C-O 119.113 -0.826 . . . . 0.0 111.624 177.023 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.474 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 30.1 tt0 -145.26 123.06 11.9 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.6 pp -119.9 166.79 12.85 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.312 0.577 . . . . 0.0 110.715 -174.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -102.57 137.62 40.57 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.9 t -107.15 114.39 46.01 Favored 'Isoleucine or valine' 0 C--O 1.248 0.995 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 172.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.5 ttt85 -83.09 90.51 7.06 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.231 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.59 -176.8 3.19 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 114.373 -1.285 . . . . 0.0 107.988 174.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -43.66 -29.22 0.48 Allowed 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 124.352 1.061 . . . . 0.0 112.316 170.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -135.68 140.89 44.82 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.908 1.283 . . . . 0.0 107.921 166.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.9 126.28 30.09 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.24 0.616 . . . . 0.0 110.076 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -119.96 160.38 22.87 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.058 0.943 . . . . 0.0 108.93 172.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.0 m -124.58 131.65 53.47 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -132.16 126.51 33.8 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.598 0.759 . . . . 0.0 109.939 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 11.3 pt-20 -89.15 135.54 33.51 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.097 0.475 . . . . 0.0 109.764 173.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 1' ' ' MET . 30.1 m -134.74 150.21 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.8 0.84 . . . . 0.0 109.598 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.1 p -93.58 12.51 25.03 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.164 0.585 . . . . 0.0 111.26 172.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.411 ' O ' ' HB ' ' A' ' 53' ' ' THR . . . 93.62 -35.4 4.16 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-O 119.647 -0.529 . . . . 0.0 112.798 176.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -68.0 -21.13 65.06 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.974 0.91 . . . . 0.0 112.301 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -62.0 134.64 56.9 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 26.4 p -82.6 168.6 17.16 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.36 0.6 . . . . 0.0 110.637 174.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.567 HG21 ' HB3' ' A' ' 48' ' ' LEU . 55.9 t -63.16 -32.78 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.425 170.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.508 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . . . -60.74 -42.42 97.31 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.36 0.664 . . . . 0.0 111.064 173.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -67.83 -37.47 81.95 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.348 0.259 . . . . 0.0 111.232 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.415 HD11 HG11 ' A' ' 15' ' ' VAL . 44.0 mm -57.32 -48.1 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 122.837 0.455 . . . . 0.0 110.032 173.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.444 ' HE3' HG12 ' A' ' 21' ' ' VAL . 96.6 mttt -61.26 -40.81 95.44 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.783 0.833 . . . . 0.0 111.223 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.87 -43.56 94.64 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.884 0.874 . . . . 0.0 112.069 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -65.54 -42.59 91.77 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.034 0.533 . . . . 0.0 111.044 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.8 t -64.71 -39.88 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.086 0.555 . . . . 0.0 109.76 176.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.98 -35.19 79.36 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.258 1.023 . . . . 0.0 112.316 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.5 m -64.81 -50.13 67.92 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.345 0.658 . . . . 0.0 110.843 175.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.5 mt -71.59 -38.44 70.89 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -174.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -91.35 -14.61 30.43 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.055 0.542 . . . . 0.0 111.662 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.92 27.26 69.17 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 116.405 -0.362 . . . . 0.0 112.565 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.2 pt -108.09 177.97 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.793 0.837 . . . . 0.0 109.795 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.27 138.92 20.62 Favored Pre-proline 0 N--CA 1.478 0.957 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.61 -20.48 70.95 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 123.296 2.664 . . . . 0.0 113.053 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -67.95 -35.36 78.27 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.573 0.749 . . . . 0.0 111.006 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 71' ' ' MET . 10.6 m-20 -73.26 -18.06 61.26 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.073 0.549 . . . . 0.0 112.261 -172.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.546 ' HB2' HG13 ' A' ' 67' ' ' VAL . 12.3 pt20 -112.95 151.22 30.8 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.399 0.679 . . . . 0.0 111.074 -174.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -132.12 132.94 61.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 124.744 1.218 . . . . 0.0 107.986 171.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.6 t -88.78 131.2 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.0 mt -122.93 115.19 21.52 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.952 1.301 . . . . 0.0 108.983 -174.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.524 ' HB2' HD11 ' A' ' 48' ' ' LEU . 42.2 tp -81.94 95.14 7.28 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 176.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 56.97 24.52 9.55 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.058 0.943 . . . . 0.0 112.027 -174.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.6 -8.19 37.1 Favored Glycine 0 C--N 1.354 1.528 0 CA-C-O 119.597 -0.557 . . . . 0.0 113.86 -177.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.72 118.84 74.55 Favored Pre-proline 0 N--CA 1.483 1.211 0 CA-C-N 117.444 0.622 . . . . 0.0 110.849 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.29 102.04 0.31 Allowed 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.746 2.298 . . . . 0.0 112.519 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.567 ' HB3' HG21 ' A' ' 21' ' ' VAL . 67.1 mt -81.0 134.4 35.67 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.463 177.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -82.52 139.0 34.14 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.834 0.854 . . . . 0.0 110.333 -176.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 22' ' ' ALA . 2.0 m-20 -59.96 -30.13 68.88 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.792 0.837 . . . . 0.0 111.835 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -73.35 -25.55 60.65 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.215 1.006 . . . . 0.0 111.206 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.98 131.74 35.87 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.921 -174.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 81.1 p -80.59 167.71 19.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.27 0.628 . . . . 0.0 109.541 172.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -65.51 -30.66 71.45 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.241 0.473 . . . . 0.0 110.42 176.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.27 -36.0 70.33 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.511 173.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -72.11 -38.05 69.4 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.465 0.706 . . . . 0.0 110.638 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 76.6 m -71.32 -18.63 62.39 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.905 0.882 . . . . 0.0 111.088 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.92 29.52 75.21 Favored Glycine 0 C--N 1.352 1.431 0 O-C-N 123.497 0.498 . . . . 0.0 112.663 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.469 HG21 HD11 ' A' ' 65' ' ' LEU . 4.5 p -87.08 133.29 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -81.77 174.24 11.52 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.505 0.722 . . . . 0.0 110.979 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.462 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -72.71 160.37 32.33 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.784 175.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 64.84 12.16 7.52 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.743 1.617 . . . . 0.0 112.96 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.4 m -85.11 154.37 22.08 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.3 m -114.32 116.08 28.4 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.146 0.498 . . . . 0.0 110.181 -177.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.469 HD11 HG21 ' A' ' 59' ' ' VAL . 6.9 mp -103.57 122.14 44.36 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.085 1.354 . . . . 0.0 108.142 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -94.71 145.32 24.93 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.025 0.53 . . . . 0.0 111.841 -171.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.546 HG13 ' HB2' ' A' ' 39' ' ' GLN . 73.6 t -94.12 135.97 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 124.211 1.004 . . . . 0.0 109.989 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.63 141.26 51.67 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.113 0.965 . . . . 0.0 109.503 171.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.14 92.06 1.52 Allowed Glycine 0 N--CA 1.472 1.065 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -121.97 -68.5 0.89 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 117.321 0.561 . . . . 0.0 111.959 -172.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.457 ' O ' ' HA ' ' A' ' 38' ' ' ASP . 51.2 tpp -61.61 140.04 58.19 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.456 0.703 . . . . 0.0 111.141 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -150.13 117.64 6.12 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -135.22 43.81 1.22 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.217 0 CA-C-O 119.2 -0.778 . . . . 0.0 112.303 -178.22 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 60.8 tt0 -122.14 114.33 20.73 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.922 0.889 . . . . 0.0 109.389 -175.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.3 pp -120.79 165.13 15.57 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.938 0.495 . . . . 0.0 111.635 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -98.51 152.24 19.76 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.636 0.774 . . . . 0.0 109.254 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.7 t -135.13 109.31 10.99 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 C-N-CA 124.767 1.227 . . . . 0.0 108.179 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -76.33 92.83 3.37 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.866 0.866 . . . . 0.0 110.776 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.31 -176.87 4.26 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.297 1.039 . . . . 0.0 108.398 165.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -47.55 -30.15 3.35 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.17 0.588 . . . . 0.0 112.156 171.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -124.0 144.07 50.04 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.175 0.99 . . . . 0.0 108.661 161.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.86 133.95 47.94 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 122.947 0.499 . . . . 0.0 110.391 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -131.02 148.49 52.76 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.837 0.855 . . . . 0.0 109.406 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.2 m -119.5 133.74 55.54 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -128.45 119.3 24.66 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.977 0.911 . . . . 0.0 109.997 -175.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 42.0 tt0 -95.35 104.43 16.32 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 171.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.0 m -112.8 174.44 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.126 0.97 . . . . 0.0 110.864 -172.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.7 m -83.09 -45.53 13.88 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.678 0.791 . . . . 0.0 110.106 174.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.23 -35.06 3.2 Favored Glycine 0 C--N 1.35 1.321 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -174.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -65.55 -10.13 32.42 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.476 0.71 . . . . 0.0 111.53 173.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -52.64 129.08 28.3 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.854 1.261 . . . . 0.0 110.408 169.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.675 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 45.5 p -84.77 164.73 18.33 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 118.272 0.487 . . . . 0.0 109.94 173.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.491 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 68.4 t -67.22 -30.27 48.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.235 174.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.504 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . . . -62.12 -40.42 95.85 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.572 0.749 . . . . 0.0 110.802 174.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -68.5 -40.17 81.0 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.746 177.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.9 mm -57.97 -42.84 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 123.229 0.612 . . . . 0.0 110.529 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.43 -51.87 68.04 Favored 'General case' 0 C--N 1.359 0.998 0 O-C-N 123.975 0.797 . . . . 0.0 110.015 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.61 -42.97 75.63 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.861 0.726 . . . . 0.0 111.924 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.416 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 48.5 m-70 -61.54 -54.62 40.79 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.686 0.794 . . . . 0.0 111.655 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.526 HG11 HG21 ' A' ' 67' ' ' VAL . 12.8 p -72.42 -30.01 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.637 -174.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.402 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . . . -72.45 -34.69 67.95 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.388 0.675 . . . . 0.0 111.526 177.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 t -67.16 -37.65 84.12 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.957 0.503 . . . . 0.0 110.309 176.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 27' ' ' HIS . 88.5 mt -63.4 -45.81 89.29 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 123.705 0.628 . . . . 0.0 111.711 177.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.15 -20.0 45.93 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.082 0.553 . . . . 0.0 111.785 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.27 30.81 66.73 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 112.014 -0.434 . . . . 0.0 112.014 -173.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.3 pt -111.57 179.83 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.189 0.996 . . . . 0.0 110.634 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.74 123.43 88.34 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 124.237 1.015 . . . . 0.0 112.576 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.23 -31.59 35.41 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 122.548 2.165 . . . . 0.0 112.567 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.98 5.95 34.69 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.34 0.656 . . . . 0.0 112.062 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -78.83 -31.45 45.77 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 122.35 1.071 . . . . 0.0 109.205 166.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.402 ' NE2' ' HB2' ' A' ' 29' ' ' ALA . 18.8 mt-30 -89.85 147.39 23.8 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 113.725 -1.579 . . . . 0.0 112.337 -167.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -131.05 129.18 63.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 165.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.446 ' HB ' HG13 ' A' ' 21' ' ' VAL . 59.3 t -87.89 131.69 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.6 mt -118.59 148.78 42.33 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.927 1.291 . . . . 0.0 109.519 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.431 ' HB2' HD11 ' A' ' 48' ' ' LEU . 42.3 tp -131.44 102.15 5.82 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 171.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 58.66 33.83 23.37 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.457 1.103 . . . . 0.0 111.398 -175.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.84 -24.01 33.96 Favored Glycine 0 C--N 1.354 1.554 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.297 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.35 119.4 76.84 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 123.325 0.65 . . . . 0.0 110.506 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.28 106.44 1.02 Allowed 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.881 2.387 . . . . 0.0 111.964 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.432 ' HB3' HG21 ' A' ' 21' ' ' VAL . 90.8 mt -69.56 124.12 23.1 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.356 0.663 . . . . 0.0 110.014 173.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -72.46 131.7 42.9 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.366 0.666 . . . . 0.0 110.63 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.504 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . 7.8 p-10 -58.79 -36.79 75.01 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.008 0.923 . . . . 0.0 112.832 -173.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -74.75 -25.72 59.29 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.1 0.56 . . . . 0.0 111.05 -176.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.72 139.51 40.49 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.504 0.722 . . . . 0.0 110.609 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.675 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 53.2 p -83.67 170.36 14.34 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.925 0.393 . . . . 0.0 110.751 177.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.7 mp -72.8 -26.48 61.53 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.9 0.88 . . . . 0.0 110.292 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.3 -43.19 71.79 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.037 172.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -64.42 -39.16 93.3 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.237 0.615 . . . . 0.0 110.77 175.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 46.1 t -63.73 -31.35 72.49 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.624 0.77 . . . . 0.0 111.406 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.38 23.96 69.43 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.272 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.451 HG23 HG21 ' A' ' 63' ' ' THR . 14.7 p -79.44 150.24 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.072 0.549 . . . . 0.0 109.551 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -127.42 -171.68 2.48 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.362 0.665 . . . . 0.0 111.262 -169.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.76 154.8 41.31 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.468 0.707 . . . . 0.0 111.404 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 62.9 1.48 0.84 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 126.183 1.793 . . . . 0.0 114.06 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.451 HG21 HG23 ' A' ' 59' ' ' VAL . 32.3 m -72.37 147.76 45.94 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 47.1 m -113.34 103.71 11.58 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 122.072 -0.393 . . . . 0.0 109.951 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.408 HD23 HD13 ' A' ' 43' ' ' LEU . 62.2 mt -78.18 169.92 17.46 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 170.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -136.08 155.16 50.62 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.526 HG21 HG11 ' A' ' 28' ' ' VAL . 48.7 t -120.38 126.55 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.263 1.025 . . . . 0.0 108.956 175.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.01 142.65 51.5 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.671 0.789 . . . . 0.0 109.805 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.24 89.79 1.64 Allowed Glycine 0 C--N 1.342 0.909 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -130.03 5.06 4.91 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.89 0.876 . . . . 0.0 110.72 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.1 ttm -124.67 149.43 47.18 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.438 0.695 . . . . 0.0 109.403 -170.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 pp -166.44 176.86 7.09 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.362 0.665 . . . . 0.0 111.554 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.14 12.58 84.49 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 114.731 0.652 . . . . 0.0 114.731 173.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.134 0 CA-C-O 118.858 -0.968 . . . . 0.0 112.59 178.834 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.49 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 44.1 ttm . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -91.01 105.03 17.54 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 170.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.5 pp -114.85 163.89 14.89 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.645 0.778 . . . . 0.0 109.985 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -107.41 158.8 16.88 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.513 0.725 . . . . 0.0 109.391 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.406 HG11 HG21 ' A' ' 28' ' ' VAL . 76.9 t -129.66 111.88 23.09 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 C-N-CA 124.037 0.935 . . . . 0.0 109.884 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -70.89 91.33 0.85 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.111 0.964 . . . . 0.0 109.42 173.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.03 -179.37 3.9 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 125.478 1.511 . . . . 0.0 107.808 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -59.21 -33.16 70.65 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 118.581 0.628 . . . . 0.0 109.715 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -111.18 127.5 55.61 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 165.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.99 120.07 14.28 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -111.33 158.3 19.19 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.571 0.749 . . . . 0.0 109.622 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.7 m -134.0 135.73 43.61 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.297 1.039 . . . . 0.0 108.735 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -133.06 124.79 28.28 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.88 0.872 . . . . 0.0 110.46 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -98.1 105.74 17.93 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 170.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.493 HG11 HD11 ' A' ' 24' ' ' ILE . 28.8 m -120.53 157.77 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.952 1.301 . . . . 0.0 109.412 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.62 ' HB ' ' HG2' ' A' ' 18' ' ' GLN . 20.4 m -75.94 -14.24 60.25 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-O 121.058 0.456 . . . . 0.0 110.907 173.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.452 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 103.26 -31.79 8.32 Favored Glycine 0 C--N 1.351 1.411 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -172.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.62 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 12.6 pt20 -70.74 -4.43 23.74 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.924 0.89 . . . . 0.0 112.304 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -79.23 145.5 33.55 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.754 0.422 . . . . 0.0 109.936 175.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.6 p -82.38 153.46 25.72 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.181 0.515 . . . . 0.0 111.134 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.0 t -62.35 -28.17 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 124.277 1.031 . . . . 0.0 110.522 175.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.62 -50.09 75.23 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 124.331 1.052 . . . . 0.0 110.793 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -67.43 -36.15 80.66 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.312 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.493 HD11 HG11 ' A' ' 15' ' ' VAL . 48.0 mm -57.59 -54.86 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 O-C-N 123.829 0.705 . . . . 0.0 110.301 177.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -73.0 -27.9 62.05 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.105 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.15 -46.48 90.35 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.52 0.728 . . . . 0.0 110.571 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -66.08 -40.18 90.63 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.266 0.627 . . . . 0.0 110.348 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.501 HG11 HG21 ' A' ' 67' ' ' VAL . 72.6 t -56.92 -49.72 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 173.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.33 -34.86 77.47 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.048 0.939 . . . . 0.0 112.609 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.5 t -65.58 -36.74 84.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.488 0.715 . . . . 0.0 110.746 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.1 mt -80.45 -34.84 35.69 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.933 0.893 . . . . 0.0 112.24 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.498 ' HB2' HG12 ' A' ' 34' ' ' ILE . 6.1 mm-40 -75.65 -36.14 60.24 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.891 0.876 . . . . 0.0 110.172 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.93 36.5 15.28 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.479 -171.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.498 HG12 ' HB2' ' A' ' 32' ' ' GLU . 25.0 pt -127.2 -179.56 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 123.897 0.879 . . . . 0.0 111.03 -176.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.18 114.19 37.75 Favored Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 123.937 0.895 . . . . 0.0 112.218 -176.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.85 -33.1 85.38 Favored 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 123.521 2.814 . . . . 0.0 114.009 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.487 ' HG3' ' H ' ' A' ' 74' ' ' GLY . 1.3 pm0 -69.39 -37.56 77.58 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.247 0.342 . . . . 0.0 110.691 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -64.84 -44.55 89.44 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 123.812 0.695 . . . . 0.0 111.116 -170.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.572 ' HB2' HG13 ' A' ' 67' ' ' VAL . 11.7 pt20 -75.75 150.96 37.69 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.976 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.2 144.15 37.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 124.975 1.31 . . . . 0.0 108.139 175.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.7 t -90.46 133.35 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 122.915 0.486 . . . . 0.0 109.86 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 66.5 mt -117.28 108.87 16.15 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.896 1.278 . . . . 0.0 108.961 -176.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.4 ' HB2' HD11 ' A' ' 48' ' ' LEU . 46.2 tp -80.44 96.63 6.79 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 175.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 57.85 28.34 15.9 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.059 0.944 . . . . 0.0 112.036 -176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.46 -25.38 19.84 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-O 119.608 -0.551 . . . . 0.0 113.556 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.3 113.54 32.18 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 123.132 0.573 . . . . 0.0 110.563 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -64.61 115.15 3.05 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.501 2.134 . . . . 0.0 111.526 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.4 HD11 ' HB2' ' A' ' 43' ' ' LEU . 93.2 mt -79.86 158.16 26.81 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.537 0.735 . . . . 0.0 111.358 178.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -86.29 128.71 34.96 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -62.57 -36.59 83.16 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 121.057 0.456 . . . . 0.0 110.911 -176.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -78.8 -9.41 59.44 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.736 0.815 . . . . 0.0 111.843 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.87 148.16 24.77 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 123.356 0.662 . . . . 0.0 109.974 175.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.4 p -92.34 166.34 12.63 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.467 0.707 . . . . 0.0 110.62 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.452 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 3.5 mm? -65.19 -28.47 69.41 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.638 0.775 . . . . 0.0 110.107 175.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.1 -37.02 44.24 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.231 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -67.76 -41.85 82.7 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.019 0.527 . . . . 0.0 110.05 174.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 80.7 m -63.5 -25.84 68.44 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.144 0.578 . . . . 0.0 110.773 174.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.99 25.88 70.32 Favored Glycine 0 C--N 1.35 1.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.667 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.52 160.81 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 122.891 0.477 . . . . 0.0 109.795 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -110.87 -177.08 3.13 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.395 0.678 . . . . 0.0 110.67 -178.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.49 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -76.86 166.25 23.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.294 0.638 . . . . 0.0 111.022 177.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 67.92 6.29 5.05 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.965 1.306 . . . . 0.0 112.909 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.1 m -79.94 150.89 30.36 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.164 0.585 . . . . 0.0 109.746 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.2 m -117.17 112.06 20.32 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.4 mp -96.42 146.9 24.36 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 124.65 1.18 . . . . 0.0 108.112 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -102.01 156.21 17.68 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.065 0.546 . . . . 0.0 110.88 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.572 HG13 ' HB2' ' A' ' 39' ' ' GLN . 6.6 t -118.62 131.29 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.368 1.067 . . . . 0.0 109.311 173.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.32 126.74 20.08 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.121 0.968 . . . . 0.0 109.992 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 39' ' ' GLN . . . -75.97 96.01 1.06 Allowed Glycine 0 C--N 1.344 0.982 0 N-CA-C 111.961 -0.455 . . . . 0.0 111.961 -178.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -120.6 -68.38 0.91 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.778 0.831 . . . . 0.0 111.438 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 21.3 mmt -88.23 78.65 8.02 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.712 0.405 . . . . 0.0 111.862 -168.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.63 109.92 2.17 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.272 0.629 . . . . 0.0 109.608 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.85 -61.45 2.55 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.043 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.487 ' H ' ' HG3' ' A' ' 37' ' ' GLU . . . . . . . . 0 C--O 1.247 0.955 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.926 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 ttt . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -85.32 127.54 34.37 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.4 pp -136.2 167.24 21.65 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -109.64 147.95 32.18 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.112 0.565 . . . . 0.0 109.8 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.6 t -122.26 109.09 23.28 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 C-N-CA 125.128 1.371 . . . . 0.0 108.059 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -79.76 91.69 5.34 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.462 -1.244 . . . . 0.0 109.58 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.8 -177.84 3.49 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 114.262 -1.335 . . . . 0.0 108.345 177.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -52.29 -27.49 15.36 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.29 0.567 . . . . 0.0 110.847 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -117.36 141.07 48.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.006 1.322 . . . . 0.0 108.468 163.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -83.29 109.45 17.27 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.481 ' CD2' HG23 ' A' ' 28' ' ' VAL . 88.9 m-70 -110.61 132.46 54.17 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.694 0.798 . . . . 0.0 109.704 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.4 t -106.07 136.09 46.37 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -125.63 128.03 47.24 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.695 0.798 . . . . 0.0 109.923 -176.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -90.11 104.82 17.35 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 170.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.8 m -111.85 172.35 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.362 1.065 . . . . 0.0 109.428 176.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.1 m -107.49 -9.96 15.83 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.376 0.671 . . . . 0.0 109.801 174.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.533 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 108.41 -35.78 4.76 Favored Glycine 0 C--N 1.353 1.473 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.754 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -4.89 39.47 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -176.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -78.11 147.33 34.69 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.854 0.462 . . . . 0.0 109.815 170.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 61.7 p -86.42 164.59 16.92 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.349 0.595 . . . . 0.0 111.745 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.415 HG21 ' HB3' ' A' ' 48' ' ' LEU . 71.3 t -66.32 -27.69 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.04 172.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.69 -41.86 95.74 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.83 0.852 . . . . 0.0 110.664 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -69.62 -38.97 77.45 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.608 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 27.9 mm -54.49 -45.59 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 123.661 0.784 . . . . 0.0 110.387 173.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 21' ' ' VAL . 92.4 mttt -61.35 -49.2 77.9 Favored 'General case' 0 C--N 1.36 1.061 0 O-C-N 124.049 0.843 . . . . 0.0 111.068 176.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.85 -38.54 78.97 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 124.328 1.017 . . . . 0.0 111.365 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -61.27 -58.14 9.49 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.726 0.811 . . . . 0.0 110.961 177.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.481 HG23 ' CD2' ' A' ' 11' ' ' HIS . 6.3 p -66.8 -30.94 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.449 -174.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.26 -43.39 77.92 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.935 0.894 . . . . 0.0 111.444 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.1 t -61.79 -41.5 97.82 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.384 0.673 . . . . 0.0 110.597 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.7 mt -65.0 -49.99 68.07 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.932 0.893 . . . . 0.0 111.863 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -90.44 -2.71 57.95 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.341 0.656 . . . . 0.0 112.185 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.1 17.82 77.47 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-O 120.159 -0.245 . . . . 0.0 113.511 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.1 pt -102.08 -179.1 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.939 0.895 . . . . 0.0 110.248 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.473 ' HB1' ' HG2' ' A' ' 37' ' ' GLU . . . -102.69 133.82 20.23 Favored Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 123.052 0.541 . . . . 0.0 111.756 -175.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.505 ' HA ' ' HG2' ' A' ' 39' ' ' GLN . 68.3 Cg_endo -70.61 -17.84 33.43 Favored 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 122.678 2.252 . . . . 0.0 111.583 175.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.473 ' HG2' ' HB1' ' A' ' 35' ' ' ALA . 10.0 pt-20 -89.4 -2.16 58.31 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.924 1.29 . . . . 0.0 112.012 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -107.62 -20.8 13.12 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.532 0.733 . . . . 0.0 110.164 175.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.505 ' HG2' ' HA ' ' A' ' 36' ' ' PRO . 11.3 pt20 -106.79 157.85 17.43 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.703 0.763 . . . . 0.0 110.671 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.6 m -132.37 158.98 43.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 C-N-CA 125.166 1.386 . . . . 0.0 108.356 169.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.489 HG12 HD12 ' A' ' 48' ' ' LEU . 66.2 t -111.68 124.6 68.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 176.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.5 mt -108.44 154.14 22.3 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 124.902 1.281 . . . . 0.0 109.346 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.2 tp -130.91 106.67 8.58 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 169.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 59.92 24.42 13.5 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.005 0.922 . . . . 0.0 111.317 -174.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.53 -28.47 14.86 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.155 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.99 120.59 80.36 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.101 0.56 . . . . 0.0 110.767 -174.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.04 106.22 0.64 Allowed 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 123.082 2.521 . . . . 0.0 112.407 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.489 HD12 HG12 ' A' ' 41' ' ' VAL . 80.2 mt -68.13 121.24 15.73 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.967 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -60.19 126.63 28.26 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.968 0.793 . . . . 0.0 110.004 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -58.85 -43.28 90.72 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.447 0.699 . . . . 0.0 111.846 -174.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -77.14 -17.62 58.49 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.639 0.375 . . . . 0.0 111.441 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.77 133.63 40.65 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 55.2 p -78.2 168.26 20.12 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.696 0.798 . . . . 0.0 110.537 177.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.533 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 2.5 mm? -61.49 -35.54 77.96 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 120.958 0.409 . . . . 0.0 110.165 177.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.37 -33.77 61.22 Favored Glycine 0 C--N 1.355 1.625 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.536 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -72.57 -37.69 68.12 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.215 0.606 . . . . 0.0 110.681 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 78.6 m -68.23 -28.6 67.37 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.35 0.66 . . . . 0.0 110.321 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.35 24.98 69.38 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.755 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.592 HG21 HD21 ' A' ' 65' ' ' LEU . 6.2 p -77.87 138.64 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -91.14 178.95 5.85 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.125 0.57 . . . . 0.0 110.95 -175.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.65 160.32 31.75 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.28 0.632 . . . . 0.0 111.205 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 61.4 10.65 3.25 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.454 1.501 . . . . 0.0 113.423 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.1 m -82.53 147.05 28.87 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.097 0.475 . . . . 0.0 110.156 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.4 m -104.59 106.49 17.01 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.841 0.856 . . . . 0.0 109.838 -175.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.592 HD21 HG21 ' A' ' 59' ' ' VAL . 43.9 mt -92.14 128.05 37.85 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.415 1.086 . . . . 0.0 108.444 176.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -99.0 140.97 32.35 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.758 0.708 . . . . 0.0 111.965 -172.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.492 HG13 ' HB2' ' A' ' 39' ' ' GLN . 69.4 t -95.78 125.47 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.067 0.947 . . . . 0.0 109.42 173.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.01 149.35 48.78 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.093 0.957 . . . . 0.0 109.294 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.19 89.28 1.39 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -106.62 -40.3 5.58 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.387 0.675 . . . . 0.0 109.88 176.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 48.4 tpp -75.07 146.97 41.05 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 172.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -103.65 113.28 26.67 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.053 0.454 . . . . 0.0 109.835 -175.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -101.91 137.14 13.16 Favored Glycine 0 C--N 1.342 0.874 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 172.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.515 0 CA-C-O 119.234 -0.759 . . . . 0.0 113.652 -178.176 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.415 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 22.1 ttt . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 121.312 0.577 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.492 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 53.3 tt0 -91.36 140.15 30.05 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.525 HD13 HD13 ' A' ' 65' ' ' LEU . 4.5 pp -146.91 159.85 43.04 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.274 0.63 . . . . 0.0 109.443 176.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -103.45 116.12 31.8 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.696 0.798 . . . . 0.0 109.505 -174.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.1 t -88.72 106.59 16.89 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 170.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.463 ' HB3' ' HA ' ' A' ' 66' ' ' GLU . 19.9 ttt180 -76.86 91.4 3.54 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.527 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -109.55 -176.43 3.01 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 125.347 1.459 . . . . 0.0 108.608 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -46.23 -39.57 10.06 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.538 0.735 . . . . 0.0 112.277 174.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -106.2 156.06 18.84 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 163.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.67 108.63 7.55 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -107.34 141.83 38.09 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.437 0.695 . . . . 0.0 109.505 175.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.7 t -126.8 135.13 50.63 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -128.36 131.55 48.57 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.337 1.055 . . . . 0.0 108.792 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 43.7 tt0 -91.36 113.77 26.12 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 167.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.539 HG21 ' HG ' ' A' ' 54' ' ' LEU . 27.6 m -110.3 144.82 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.953 0.901 . . . . 0.0 110.121 -174.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.6 p -85.95 3.34 42.47 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.073 0.549 . . . . 0.0 111.499 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.423 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 89.9 -38.31 3.23 Favored Glycine 0 C--N 1.353 1.495 0 CA-C-O 119.682 -0.51 . . . . 0.0 113.325 175.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -70.25 -19.81 63.1 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.988 0.915 . . . . 0.0 112.459 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -64.9 135.78 56.09 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.331 0.652 . . . . 0.0 109.483 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 70.1 p -83.59 165.55 18.94 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.326 0.584 . . . . 0.0 111.269 -177.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.6 t -66.42 -29.13 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 123.189 0.596 . . . . 0.0 110.351 174.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.506 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . . . -63.25 -39.9 95.9 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.284 0.634 . . . . 0.0 111.254 173.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -71.66 -35.08 70.23 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.906 0.482 . . . . 0.0 110.955 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 31.4 mm -58.32 -47.12 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.272 0.629 . . . . 0.0 110.384 171.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.489 ' HE2' ' HA ' ' A' ' 40' ' ' VAL . 98.6 mttt -61.52 -42.09 98.29 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.212 0.605 . . . . 0.0 111.342 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.81 80.68 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 124.138 0.899 . . . . 0.0 111.586 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.0 m-70 -60.16 -51.08 71.14 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.875 0.47 . . . . 0.0 111.041 175.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.491 HG12 HD11 ' A' ' 34' ' ' ILE . 49.0 t -67.26 -28.49 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.722 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.64 -34.97 62.87 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.875 0.87 . . . . 0.0 111.441 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.7 t -73.43 -40.1 64.49 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.118 0.567 . . . . 0.0 111.053 178.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.5 mt -77.18 -53.08 8.2 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.219 0.607 . . . . 0.0 111.633 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.31 -17.37 46.04 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.558 0.743 . . . . 0.0 111.738 -177.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.33 17.45 78.89 Favored Glycine 0 N--CA 1.471 0.984 0 N-CA-C 112.605 -0.198 . . . . 0.0 112.605 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.491 HD11 HG12 ' A' ' 28' ' ' VAL . 37.0 pt -91.41 166.23 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.596 0.758 . . . . 0.0 111.099 -175.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.99 118.1 67.87 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 123.257 0.623 . . . . 0.0 110.704 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HA ' ' HG2' ' A' ' 39' ' ' GLN . 56.2 Cg_endo -66.92 -19.85 51.9 Favored 'Trans proline' 0 C--N 1.387 2.57 0 C-N-CA 122.584 2.189 . . . . 0.0 111.84 176.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -74.41 -29.58 61.57 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.263 1.025 . . . . 0.0 111.836 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -85.93 -41.31 15.04 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.302 0.641 . . . . 0.0 110.697 -175.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.48 ' HB2' HG13 ' A' ' 67' ' ' VAL . 12.9 pt20 -76.58 157.08 32.28 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.998 -172.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.616 HG11 ' HB2' ' A' ' 70' ' ' ARG . 9.8 p -142.39 148.0 20.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 C-N-CA 125.186 1.394 . . . . 0.0 108.297 177.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.1 t -101.56 117.77 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.8 0.84 . . . . 0.0 109.308 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 68' ' ' ALA . 2.3 mm? -103.89 104.61 14.62 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.47 1.108 . . . . 0.0 109.69 -175.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.3 tp -81.75 97.19 7.83 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 58.31 26.05 13.5 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.952 0.901 . . . . 0.0 112.016 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.5 -19.82 33.29 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.511 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.83 114.99 48.66 Favored Pre-proline 0 N--CA 1.477 0.903 0 C-N-CA 123.456 0.702 . . . . 0.0 111.001 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -67.96 110.88 2.27 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 122.673 2.249 . . . . 0.0 111.018 174.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.5 mt -72.4 170.46 14.2 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.844 177.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -96.05 138.6 33.45 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' A' ' 22' ' ' ALA . 1.8 m-20 -55.92 -38.67 70.58 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.261 0.624 . . . . 0.0 111.402 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.45 -24.28 46.13 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.748 0.819 . . . . 0.0 111.48 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.97 132.89 42.86 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.061 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 21.1 p -81.35 173.5 12.4 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.539 ' HG ' HG21 ' A' ' 15' ' ' VAL . 3.3 mm? -64.26 -23.45 67.31 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 118.285 0.493 . . . . 0.0 110.258 174.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.42 -39.26 26.61 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.942 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.463 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 14.5 mm-40 -73.75 -29.75 62.41 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.411 0.684 . . . . 0.0 110.422 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 74.2 m -81.32 -18.17 46.68 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.791 0.837 . . . . 0.0 110.724 172.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.38 33.18 81.29 Favored Glycine 0 C--N 1.353 1.476 0 O-C-N 123.416 0.448 . . . . 0.0 113.461 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.1 t -70.49 135.59 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.336 0.654 . . . . 0.0 110.056 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -93.49 172.15 8.45 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.371 0.668 . . . . 0.0 110.534 176.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.23 165.05 25.44 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.065 0.546 . . . . 0.0 111.277 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 58.31 16.6 4.14 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 125.228 1.411 . . . . 0.0 112.798 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.8 m -90.98 147.84 22.82 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.656 0.782 . . . . 0.0 109.845 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 42.5 m -113.52 105.22 13.09 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.718 0.807 . . . . 0.0 109.26 -175.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.525 HD13 HD13 ' A' ' 3' ' ' LEU . 4.5 mp -103.03 123.44 46.63 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . 38.0 tt0 -93.56 150.7 20.22 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.9 0.48 . . . . 0.0 111.436 -171.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.48 HG13 ' HB2' ' A' ' 39' ' ' GLN . 73.3 t -104.11 118.59 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.911 0.884 . . . . 0.0 108.932 175.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.42 ' HB3' HD21 ' A' ' 42' ' ' LEU . . . -126.58 165.74 18.59 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.907 0.883 . . . . 0.0 109.669 175.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -98.22 90.12 1.02 Allowed Glycine 0 N--CA 1.471 0.977 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 175.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.616 ' HB2' HG11 ' A' ' 40' ' ' VAL . 73.7 mtp180 -134.74 17.29 3.57 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.407 0.683 . . . . 0.0 110.8 -176.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.517 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 44.5 tpp -129.71 156.05 44.91 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.546 ' H ' HD23 ' A' ' 72' ' ' LEU . 2.5 pt? -120.29 1.89 10.79 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.45 0.7 . . . . 0.0 111.546 -177.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.517 ' H ' ' HG3' ' A' ' 71' ' ' MET . . . 84.62 -71.76 2.91 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-N 116.471 -0.331 . . . . 0.0 112.546 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.492 0 CA-C-O 119.038 -0.868 . . . . 0.0 112.1 -178.848 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.48 ' HG3' ' HB2' ' A' ' 61' ' ' ALA . 62.1 ttp . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -77.01 118.56 19.7 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.212 1.005 . . . . 0.0 109.62 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.1 pp -137.74 161.23 37.09 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.113 0.565 . . . . 0.0 109.775 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -96.53 152.42 18.64 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.656 0.782 . . . . 0.0 109.836 -175.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.0 t -137.85 101.82 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 124.676 1.191 . . . . 0.0 107.962 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -76.33 94.88 3.67 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.057 0.943 . . . . 0.0 111.843 -175.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.78 -176.51 3.11 Favored 'General case' 0 C--O 1.245 0.867 0 C-N-CA 124.811 1.245 . . . . 0.0 108.099 165.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -45.29 -31.41 1.57 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.514 0.726 . . . . 0.0 112.153 171.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -114.72 137.29 52.1 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 162.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.32 113.47 8.4 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -91.82 155.76 17.99 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.647 0.779 . . . . 0.0 109.482 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.3 m -141.5 115.6 9.31 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 173.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -116.25 134.54 54.8 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.386 0.675 . . . . 0.0 110.601 -173.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -89.17 103.56 16.17 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 166.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.447 HG21 ' HG ' ' A' ' 54' ' ' LEU . 18.7 m -112.15 141.61 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.208 1.003 . . . . 0.0 109.225 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.2 t -91.41 5.55 48.93 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 120.657 0.265 . . . . 0.0 110.806 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.506 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 101.19 -25.97 26.32 Favored Glycine 0 C--N 1.357 1.718 0 CA-C-O 119.727 -0.485 . . . . 0.0 113.513 171.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -80.56 -14.32 58.32 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.881 0.473 . . . . 0.0 111.985 -174.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.426 ' O ' HD22 ' A' ' 54' ' ' LEU . 25.4 mp0 -65.31 130.62 43.98 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 69.0 p -75.13 168.81 19.26 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.189 0.518 . . . . 0.0 110.04 174.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.465 HG12 ' HE3' ' A' ' 25' ' ' LYS . 33.6 t -65.59 -29.21 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . . . -62.47 -41.82 99.04 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.69 0.796 . . . . 0.0 110.553 171.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -67.52 -36.84 81.83 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.869 0.468 . . . . 0.0 111.079 177.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.523 HD11 HD21 ' A' ' 54' ' ' LEU . 39.6 mm -60.13 -48.11 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.284 0.634 . . . . 0.0 110.177 175.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.465 ' HE3' HG12 ' A' ' 21' ' ' VAL . 92.5 mttt -60.05 -43.07 95.64 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.446 0.698 . . . . 0.0 110.745 176.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.26 -45.55 90.9 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.858 1.263 . . . . 0.0 111.7 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -61.74 -47.37 85.51 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.612 0.765 . . . . 0.0 110.448 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 24' ' ' ILE . 90.8 t -63.1 -40.48 89.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 123.763 0.664 . . . . 0.0 110.296 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.31 -33.35 71.42 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.739 1.216 . . . . 0.0 112.258 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.7 t -70.78 -38.05 73.38 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.474 0.71 . . . . 0.0 110.512 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.1 mt -72.71 -51.69 18.24 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.15 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -86.58 -19.27 29.65 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -172.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.68 29.84 58.89 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 112.303 -0.319 . . . . 0.0 112.303 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.7 pt -101.62 176.96 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.474 0.709 . . . . 0.0 110.618 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -96.26 120.41 62.61 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 123.425 0.69 . . . . 0.0 110.422 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.01 -7.06 20.21 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.557 2.171 . . . . 0.0 111.813 172.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -60.7 -38.99 86.86 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 125.373 1.469 . . . . 0.0 110.492 171.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -88.21 -25.52 22.85 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.686 -178.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -75.27 133.0 41.44 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.706 -174.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.15 138.98 52.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 C-N-CA 124.353 1.061 . . . . 0.0 108.241 165.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.2 t -97.88 133.5 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.2 mt -117.76 128.62 55.05 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.604 1.161 . . . . 0.0 109.445 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.517 ' HB2' HD11 ' A' ' 48' ' ' LEU . 54.6 tp -105.99 104.85 14.65 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 169.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 60.33 26.51 16.03 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.845 0.858 . . . . 0.0 111.675 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.22 -15.59 58.91 Favored Glycine 0 C--N 1.352 1.448 0 CA-C-O 119.745 -0.475 . . . . 0.0 113.664 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.8 120.22 77.18 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 117.44 0.62 . . . . 0.0 109.668 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.8 112.2 1.93 Allowed 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.564 2.176 . . . . 0.0 112.06 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.517 HD11 ' HB2' ' A' ' 43' ' ' LEU . 80.4 mt -81.81 131.27 35.25 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.847 0.859 . . . . 0.0 110.158 175.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -72.01 142.96 49.33 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.718 0.636 . . . . 0.0 110.865 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . 11.1 p-10 -61.45 -26.17 67.71 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.293 1.037 . . . . 0.0 111.976 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -76.02 -25.91 56.14 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.829 0.851 . . . . 0.0 111.583 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.18 133.3 37.8 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.849 0.86 . . . . 0.0 110.965 -175.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 70.3 p -80.64 173.4 12.65 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.951 0.5 . . . . 0.0 110.395 174.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.523 HD21 HD11 ' A' ' 24' ' ' ILE . 2.9 mm? -61.81 -35.14 77.34 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 173.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.16 -43.6 96.9 Favored Glycine 0 C--N 1.355 1.616 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.975 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -69.63 -38.06 77.03 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.231 0.612 . . . . 0.0 111.397 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 83.9 m -73.63 -16.11 61.24 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.426 0.69 . . . . 0.0 111.155 175.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.29 26.48 71.68 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 123.582 0.551 . . . . 0.0 113.493 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.9 p -90.15 117.02 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.443 0.697 . . . . 0.0 109.68 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -87.22 -172.79 4.11 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.19 0.996 . . . . 0.0 111.932 -172.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.48 ' HB2' ' HG3' ' A' ' 1' ' ' MET . . . -71.82 154.0 41.56 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.653 0.781 . . . . 0.0 111.043 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 67.85 4.03 3.78 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.595 1.558 . . . . 0.0 112.679 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.9 m -85.15 151.67 23.94 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 34.4 m -113.9 111.48 21.77 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.247 0.546 . . . . 0.0 110.33 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.1 mt -78.68 160.85 27.29 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 165.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -132.61 142.28 49.06 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 122.115 -0.366 . . . . 0.0 110.886 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.8 t -95.95 132.62 39.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.892 0.877 . . . . 0.0 109.113 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.87 167.15 22.86 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.84 0.856 . . . . 0.0 109.83 177.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -109.97 90.36 0.59 Allowed Glycine 0 C--N 1.341 0.812 0 N-CA-C 112.29 -0.324 . . . . 0.0 112.29 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -103.56 -48.59 3.92 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.534 0.734 . . . . 0.0 109.056 171.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 42.4 tpp -78.48 162.37 26.4 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.656 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 50.6 tp -129.03 -30.93 2.17 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.665 0.786 . . . . 0.0 109.557 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.72 -178.97 39.68 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.704 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.327 0 CA-C-O 119.16 -0.8 . . . . 0.0 111.533 -178.255 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -101.46 124.26 46.85 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.2 pp -137.49 166.57 23.56 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.486 0.715 . . . . 0.0 110.627 -178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -98.58 161.5 13.63 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.288 0.635 . . . . 0.0 110.615 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.497 HG22 ' HB2' ' A' ' 65' ' ' LEU . 44.7 t -133.32 117.08 26.95 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 C-N-CA 124.55 1.14 . . . . 0.0 108.512 173.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -71.13 94.11 1.11 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.741 1.216 . . . . 0.0 109.207 174.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -118.77 -179.45 3.81 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.544 1.138 . . . . 0.0 108.998 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -44.86 -35.32 2.73 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 123.54 0.736 . . . . 0.0 111.234 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -128.98 137.38 51.33 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 166.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.5 mt -66.69 128.83 37.77 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.077 0.551 . . . . 0.0 110.861 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -124.26 160.91 26.91 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.381 0.673 . . . . 0.0 109.926 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.4 m -130.26 125.33 34.54 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.01 0.924 . . . . 0.0 108.966 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -120.73 132.55 55.13 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.268 1.027 . . . . 0.0 110.588 -173.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -92.36 106.31 18.34 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 169.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.3 167.84 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.497 1.119 . . . . 0.0 110.741 -172.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.3 p -100.44 -4.29 29.21 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.98 -52.36 4.72 Favored Glycine 0 C--N 1.358 1.804 0 N-CA-C 112.147 -0.381 . . . . 0.0 112.147 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -66.1 -10.84 44.35 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.0 0.92 . . . . 0.0 110.986 169.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -57.45 127.05 30.06 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.226 1.01 . . . . 0.0 110.754 170.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.633 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 82.8 p -85.64 160.23 19.64 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.678 0.391 . . . . 0.0 110.737 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.569 HG13 ' HB ' ' A' ' 41' ' ' VAL . 50.8 t -63.93 -31.68 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 123.963 0.905 . . . . 0.0 111.668 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.448 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . . . -66.53 -42.28 87.48 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.512 0.725 . . . . 0.0 110.674 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -74.88 -29.61 61.06 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.14 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.554 HD11 HD11 ' A' ' 54' ' ' LEU . 30.4 mm -57.58 -50.33 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 168.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -57.01 -45.88 82.74 Favored 'General case' 0 C--N 1.36 1.036 0 O-C-N 123.86 0.725 . . . . 0.0 111.054 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.09 -48.05 76.87 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 124.604 1.19 . . . . 0.0 111.987 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -71.47 -41.33 69.5 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.242 0.217 . . . . 0.0 111.056 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 24' ' ' ILE . 68.9 t -59.97 -41.53 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.13 -42.36 93.94 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.225 1.01 . . . . 0.0 111.702 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.5 t -62.13 -40.09 94.76 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 123.862 0.727 . . . . 0.0 111.496 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 33.0 mt -80.16 -39.94 28.31 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 120.928 0.394 . . . . 0.0 111.502 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.92 -6.07 59.13 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.792 0.837 . . . . 0.0 111.95 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.56 20.32 77.07 Favored Glycine 0 CA--C 1.532 1.104 0 O-C-N 123.506 0.504 . . . . 0.0 113.651 176.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.0 pt -107.63 -179.27 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.048 0.939 . . . . 0.0 110.454 -176.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.432 ' HB1' ' HG2' ' A' ' 37' ' ' GLU . . . -90.83 134.49 30.33 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 123.274 0.63 . . . . 0.0 110.265 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -68.12 -24.67 38.3 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.622 2.214 . . . . 0.0 112.311 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.432 ' HG2' ' HB1' ' A' ' 35' ' ' ALA . 11.2 pt-20 -67.68 -29.84 69.22 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.929 0.891 . . . . 0.0 111.464 175.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -81.05 -18.7 45.79 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.995 0.918 . . . . 0.0 111.902 -170.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.432 ' HB2' HG13 ' A' ' 67' ' ' VAL . 12.3 pt20 -107.57 158.18 17.44 Favored 'General case' 0 C--O 1.245 0.818 0 C-N-CA 123.069 0.548 . . . . 0.0 110.86 -176.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.415 HG11 ' HB2' ' A' ' 70' ' ' ARG . 12.6 p -128.94 134.56 64.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.649 172.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.569 ' HB ' HG13 ' A' ' 21' ' ' VAL . 95.2 t -98.7 121.91 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 66' ' ' GLU . 27.4 mt -113.62 157.72 21.76 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.687 1.595 . . . . 0.0 108.426 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 tt -105.06 96.85 6.82 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 106.266 -1.754 . . . . 0.0 106.266 163.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 51.45 40.62 27.13 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.513 1.125 . . . . 0.0 112.41 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.69 -30.78 8.4 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-O 119.405 -0.664 . . . . 0.0 114.106 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.98 116.85 54.64 Favored Pre-proline 0 N--CA 1.484 1.27 0 CA-C-N 117.704 0.752 . . . . 0.0 111.466 -176.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -60.78 108.7 0.57 Allowed 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.008 2.472 . . . . 0.0 113.246 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.09 137.19 33.69 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.949 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -77.41 136.33 38.39 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.808 0.692 . . . . 0.0 109.904 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.448 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . 7.8 p-10 -58.78 -41.66 87.16 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.713 0.805 . . . . 0.0 112.284 -174.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -79.57 -15.58 57.43 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.204 0.601 . . . . 0.0 111.468 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.83 136.62 38.93 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 123.224 0.61 . . . . 0.0 110.276 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.633 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 43.7 p -80.09 165.88 22.06 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.205 0.602 . . . . 0.0 110.144 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.554 HD11 HD11 ' A' ' 24' ' ' ILE . 86.5 mt -64.73 -38.1 89.84 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.988 0.515 . . . . 0.0 111.243 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.97 -41.82 99.69 Favored Glycine 0 C--N 1.349 1.285 0 O-C-N 123.854 0.721 . . . . 0.0 112.623 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -74.82 -29.93 61.23 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.818 0.447 . . . . 0.0 111.386 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 89.1 m -75.41 -7.47 54.15 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.55 0.74 . . . . 0.0 111.728 173.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.17 15.88 81.16 Favored Glycine 0 C--N 1.351 1.404 0 C-N-CA 123.05 0.357 . . . . 0.0 113.866 173.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 p -99.34 132.72 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.136 0.574 . . . . 0.0 109.605 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -121.54 -168.14 1.64 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.359 1.063 . . . . 0.0 110.495 -175.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.34 150.74 48.59 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.172 0.589 . . . . 0.0 111.057 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 70.22 2.5 4.01 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.678 1.591 . . . . 0.0 113.0 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.6 m -88.05 163.6 16.18 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 174.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.2 m -123.8 116.84 23.64 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.562 0.745 . . . . 0.0 109.664 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.497 ' HB2' HG22 ' A' ' 5' ' ' VAL . 3.2 mm? -75.05 -178.95 4.05 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.422 0.689 . . . . 0.0 109.595 170.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 35.7 tt0 -144.24 108.86 4.88 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.563 0.345 . . . . 0.0 110.703 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.432 HG13 ' HB2' ' A' ' 39' ' ' GLN . 55.5 t -85.94 117.84 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 172.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.42 168.94 10.79 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 123.943 0.897 . . . . 0.0 109.971 175.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.57 87.5 1.1 Allowed Glycine 0 C--N 1.344 1.02 0 N-CA-C 111.881 -0.488 . . . . 0.0 111.881 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.415 ' HB2' HG11 ' A' ' 40' ' ' VAL . 39.0 mtp180 -143.63 141.55 30.65 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.745 1.218 . . . . 0.0 107.75 170.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -148.03 148.53 30.8 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.14 0.576 . . . . 0.0 110.204 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.8 tp -154.5 129.35 9.41 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.23 15.98 81.01 Favored Glycine 0 C--N 1.343 0.968 0 O-C-N 123.763 0.664 . . . . 0.0 113.133 -175.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.605 0 CA-C-O 119.06 -0.856 . . . . 0.0 111.351 178.995 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.488 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 62.9 mtp . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -88.34 116.16 26.36 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.426 HD13 HD13 ' A' ' 65' ' ' LEU . 3.4 pp -132.21 150.4 52.16 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.432 0.693 . . . . 0.0 109.981 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -89.05 152.17 21.83 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.292 1.037 . . . . 0.0 109.8 -177.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -135.93 109.75 9.85 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 C-N-CA 124.343 1.057 . . . . 0.0 108.484 -177.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.404 ' HA ' HD13 ' A' ' 10' ' ' LEU . 3.7 tmm_? -73.66 94.96 2.26 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.45 1.1 . . . . 0.0 110.022 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -112.85 -177.41 3.13 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.283 1.033 . . . . 0.0 108.811 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -45.69 -25.45 0.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.15 0.98 . . . . 0.0 113.044 171.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -127.24 150.0 49.74 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.176 0.99 . . . . 0.0 108.913 158.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 6' ' ' ARG . 4.5 mm? -76.2 109.57 9.99 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 122.987 0.515 . . . . 0.0 110.144 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -94.03 162.24 13.97 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.119 0.968 . . . . 0.0 110.168 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.7 t -141.03 142.23 34.24 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 164.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -133.97 131.57 39.14 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.653 0.781 . . . . 0.0 110.178 -175.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -92.47 104.13 16.48 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.753 174.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.8 m -111.18 161.26 9.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 C-N-CA 123.858 0.863 . . . . 0.0 110.259 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.4 m -87.12 -29.68 21.65 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.853 0.861 . . . . 0.0 110.366 176.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.538 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 116.45 -29.36 7.01 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.19 -173.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -85.77 -4.13 59.08 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.506 0.723 . . . . 0.0 112.532 -173.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.405 ' O ' HD22 ' A' ' 54' ' ' LEU . 23.0 mp0 -76.06 145.68 39.94 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 50' ' ' ASP . 59.0 p -82.82 160.89 22.13 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.354 0.597 . . . . 0.0 110.516 175.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.615 HG13 ' HB ' ' A' ' 41' ' ' VAL . 52.8 t -60.42 -30.53 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 123.715 0.806 . . . . 0.0 110.428 175.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.505 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . . . -58.57 -47.07 85.48 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 124.08 0.952 . . . . 0.0 111.051 171.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -64.58 -39.83 94.45 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.611 0.364 . . . . 0.0 110.624 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.551 HD11 HD21 ' A' ' 54' ' ' LEU . 41.8 mm -60.09 -49.27 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 122.979 0.512 . . . . 0.0 111.364 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.499 ' HB3' HG23 ' A' ' 41' ' ' VAL . 62.9 pttt -74.51 -29.58 61.46 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 119.686 -0.197 . . . . 0.0 110.702 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.403 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . . . -64.18 -34.21 77.56 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.306 0.642 . . . . 0.0 110.92 175.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.45 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 32.6 m170 -68.38 -46.25 70.56 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.117 0.567 . . . . 0.0 110.378 174.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.5 t -56.08 -39.96 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.449 0.642 . . . . 0.0 110.14 174.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.85 -45.65 77.52 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.903 1.281 . . . . 0.0 112.369 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.2 p -69.43 -27.63 65.42 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.01 0.524 . . . . 0.0 111.539 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 27' ' ' HIS . 86.1 mt -76.82 -48.47 18.4 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.817 0.447 . . . . 0.0 111.202 178.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -91.9 -5.47 53.17 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -174.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.04 5.98 85.52 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 113.859 0.304 . . . . 0.0 113.859 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.9 pt -81.74 169.06 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.325 0.65 . . . . 0.0 110.303 178.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.404 ' HB1' ' HG2' ' A' ' 37' ' ' GLU . . . -83.32 136.5 43.09 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.605 0.762 . . . . 0.0 109.986 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.403 ' HB3' ' HA ' ' A' ' 26' ' ' ALA . 56.3 Cg_endo -68.71 -22.68 37.01 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.394 2.063 . . . . 0.0 111.741 174.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.404 ' HG2' ' HB1' ' A' ' 35' ' ' ALA . 11.5 pt-20 -80.02 -8.98 59.64 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.974 0.91 . . . . 0.0 111.626 177.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -75.52 -29.04 59.34 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.197 0.599 . . . . 0.0 111.987 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.43 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -144.76 179.9 7.01 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.14 0.495 . . . . 0.0 111.372 -170.552 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.2 p -145.4 149.92 16.22 Favored 'Isoleucine or valine' 0 C--O 1.25 1.101 0 C-N-CA 124.867 1.267 . . . . 0.0 108.138 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.615 ' HB ' HG13 ' A' ' 21' ' ' VAL . 46.5 t -86.65 138.04 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.361 0.601 . . . . 0.0 109.763 176.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -116.21 140.41 49.33 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -179.524 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.3 tp -86.48 95.91 9.87 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 169.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 55.17 28.92 11.75 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.858 0.863 . . . . 0.0 112.661 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.72 -14.01 35.1 Favored Glycine 0 CA--C 1.536 1.398 0 CA-C-O 119.5 -0.611 . . . . 0.0 114.001 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.57 110.83 24.33 Favored Pre-proline 0 N--CA 1.484 1.261 0 CA-C-N 117.845 0.823 . . . . 0.0 110.622 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.45 107.07 0.24 Allowed 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 123.645 2.897 . . . . 0.0 114.077 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.544 ' HB3' HG21 ' A' ' 21' ' ' VAL . 96.4 mt -80.45 139.74 36.3 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.485 0.714 . . . . 0.0 110.735 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -71.57 130.21 40.66 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.771 0.669 . . . . 0.0 109.667 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' A' ' 22' ' ' ALA . 71.3 m-20 -62.25 -27.57 69.09 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.079 0.552 . . . . 0.0 112.216 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -80.06 -21.18 43.71 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.663 0.785 . . . . 0.0 111.617 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.26 138.54 39.46 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.516 0.726 . . . . 0.0 110.517 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 58.2 p -88.0 168.28 12.98 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.037 0.535 . . . . 0.0 110.587 177.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.551 HD21 HD11 ' A' ' 24' ' ' ILE . 2.5 mm? -62.28 -33.68 75.1 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 174.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.03 -30.78 56.87 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.891 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -76.18 -36.41 58.69 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 52.9 t -67.63 -35.65 79.32 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.2 0.6 . . . . 0.0 110.303 173.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.52 18.52 61.94 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.256 -177.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.56 135.88 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.037 0.535 . . . . 0.0 110.043 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -97.3 -169.26 1.82 Allowed 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.625 0.77 . . . . 0.0 111.896 -176.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -79.5 169.96 17.27 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.52 0.728 . . . . 0.0 111.091 173.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 58.34 18.67 5.69 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.301 1.44 . . . . 0.0 112.669 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.5 m -90.09 161.37 15.83 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 56.5 m -121.96 104.58 9.63 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 173.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.426 HD13 HD13 ' A' ' 3' ' ' LEU . 6.8 mp -84.31 -176.07 6.08 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.498 172.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 44.9 tt0 -139.38 157.43 45.89 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.974 0.509 . . . . 0.0 110.575 -172.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.7 t -119.13 131.65 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.401 1.081 . . . . 0.0 108.688 171.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.504 ' HB3' HD21 ' A' ' 42' ' ' LEU . . . -152.01 144.71 24.29 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.398 0.679 . . . . 0.0 109.664 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 39' ' ' GLN . . . -82.07 84.42 1.5 Allowed Glycine 0 C--N 1.345 1.077 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -110.93 7.59 21.77 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.922 0.889 . . . . 0.0 109.146 170.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 48.0 tpp -120.96 158.06 28.55 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.036 1.334 . . . . 0.0 107.788 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.6 tt -144.87 -44.17 0.23 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 116.5 157.56 11.05 Favored Glycine 0 C--N 1.342 0.871 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.905 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.196 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.518 ' SD ' ' HA ' ' A' ' 60' ' ' GLU . 63.6 ttp . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 35.1 tt0 -78.44 131.52 36.93 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 pp -141.84 166.19 25.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.938 0.895 . . . . 0.0 110.0 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 64' ' ' THR . 68.8 m-85 -102.14 137.23 40.68 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.841 0.856 . . . . 0.0 109.76 -177.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.5 t -117.18 114.91 47.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 172.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.453 ' HB3' ' HA ' ' A' ' 66' ' ' GLU . 40.4 ttt85 -80.55 92.47 5.92 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.443 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.68 -177.29 3.74 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.471 1.108 . . . . 0.0 108.059 168.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -47.18 -32.79 4.68 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 122.945 0.498 . . . . 0.0 111.316 170.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -112.6 137.23 51.16 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 125.057 1.343 . . . . 0.0 108.016 164.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -71.0 118.99 14.48 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -116.93 162.01 18.44 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.946 0.898 . . . . 0.0 109.784 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.3 t -130.02 146.77 51.71 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 172.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -137.61 129.28 28.43 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.423 1.089 . . . . 0.0 108.643 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 34.2 tt0 -87.97 106.28 18.02 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 169.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.7 m -112.43 178.96 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.025 1.33 . . . . 0.0 108.976 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 58.6 p -107.07 -37.4 6.31 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.583 0.753 . . . . 0.0 110.797 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.5 -23.21 4.06 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-N 116.422 -0.354 . . . . 0.0 112.53 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -82.51 -12.63 57.65 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.0 0.52 . . . . 0.0 112.274 -175.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.451 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 22.7 mp0 -65.79 133.08 50.24 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.943 0.897 . . . . 0.0 108.671 177.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 82.2 p -80.07 166.24 21.72 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 121.59 0.709 . . . . 0.0 110.095 176.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.518 HG12 ' HE3' ' A' ' 25' ' ' LYS . 56.0 t -61.38 -31.11 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.187 173.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.63 -41.67 95.33 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.1 0.96 . . . . 0.0 111.208 173.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -66.24 -38.76 88.67 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.123 0.569 . . . . 0.0 111.098 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.569 HD11 HD11 ' A' ' 54' ' ' LEU . 50.5 mm -63.18 -45.27 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 O-C-N 123.716 0.635 . . . . 0.0 110.331 176.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.541 ' HE2' ' HA ' ' A' ' 40' ' ' VAL . 93.6 mttt -57.5 -45.81 84.49 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 123.645 0.59 . . . . 0.0 110.352 176.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.44 -45.57 91.2 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.334 1.054 . . . . 0.0 112.166 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -68.93 -43.3 75.38 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.86 0.464 . . . . 0.0 111.894 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.8 t -67.76 -32.03 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 122.813 0.445 . . . . 0.0 110.39 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.47 -37.99 80.67 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.191 0.996 . . . . 0.0 111.566 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.6 t -64.46 -44.37 91.31 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.571 0.748 . . . . 0.0 110.535 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.8 mt -72.87 -58.07 3.6 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.06 0.544 . . . . 0.0 111.558 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.31 -14.29 60.11 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.452 1.101 . . . . 0.0 112.405 -176.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.51 16.58 75.81 Favored Glycine 0 N--CA 1.473 1.135 0 CA-C-N 117.484 0.129 . . . . 0.0 113.078 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.7 pt -93.35 171.82 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.36 1.064 . . . . 0.0 110.397 -176.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.03 118.19 71.13 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 122.862 0.465 . . . . 0.0 110.849 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.444 ' HA ' HE21 ' A' ' 39' ' ' GLN . 47.5 Cg_endo -64.39 -24.96 63.92 Favored 'Trans proline' 0 C--N 1.388 2.621 0 C-N-CA 123.009 2.472 . . . . 0.0 111.484 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.67 ' HB3' ' HA2' ' A' ' 73' ' ' GLY . 45.9 mt-10 -68.42 -35.7 78.01 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.547 1.139 . . . . 0.0 111.148 177.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -85.39 -16.91 38.27 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.331 0.653 . . . . 0.0 111.213 -175.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.444 HE21 ' HA ' ' A' ' 36' ' ' PRO . 51.4 mt-30 -77.71 152.45 33.68 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.573 0.701 . . . . 0.0 112.16 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.541 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . 13.9 p -141.04 148.55 21.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 113.934 -1.485 . . . . 0.0 107.575 162.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.418 ' HB ' HG13 ' A' ' 21' ' ' VAL . 97.8 t -103.96 128.05 57.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 68.7 mt -115.62 116.66 28.51 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.645 1.178 . . . . 0.0 108.779 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.531 ' HB2' HD11 ' A' ' 48' ' ' LEU . 41.2 tp -90.47 98.13 11.59 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 57.04 32.24 21.32 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.029 0.932 . . . . 0.0 111.691 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.4 -32.4 7.2 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.246 -178.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.4 116.65 39.07 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 123.271 0.628 . . . . 0.0 111.499 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -63.44 105.53 0.51 Allowed 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 123.223 2.615 . . . . 0.0 112.262 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.531 HD11 ' HB2' ' A' ' 43' ' ' LEU . 43.0 mt -78.11 129.81 35.64 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.881 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -64.88 134.74 54.67 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.238 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.477 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 8.0 p-10 -61.54 -27.2 68.45 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.356 0.663 . . . . 0.0 111.727 -178.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -80.72 -25.98 37.74 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.62 0.768 . . . . 0.0 111.76 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.09 133.35 46.19 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 123.213 0.605 . . . . 0.0 110.542 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 31.1 p -79.1 170.64 16.35 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 176.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.616 ' HA ' ' SG ' ' A' ' 57' ' ' CYS . 86.2 mt -69.15 -25.72 64.51 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.548 0.739 . . . . 0.0 110.896 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.84 -36.41 42.15 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.327 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.41 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 87.2 mm-40 -79.22 -34.8 42.51 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.92 0.488 . . . . 0.0 111.703 -177.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.616 ' SG ' ' HA ' ' A' ' 54' ' ' LEU . 31.3 p -77.84 -22.22 50.28 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.927 0.491 . . . . 0.0 110.312 175.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.85 38.79 9.11 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.68 169.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.576 HG21 HD11 ' A' ' 65' ' ' LEU . 8.7 p -101.76 148.86 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 123.043 0.537 . . . . 0.0 109.849 176.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.518 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 10.7 pt-20 -136.32 -165.56 1.74 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.949 0.9 . . . . 0.0 111.085 -174.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.14 149.5 50.19 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 124.017 0.927 . . . . 0.0 112.587 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 68.18 -5.07 0.93 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.119 1.768 . . . . 0.0 113.263 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.7 m -77.26 147.9 36.05 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.124 0.57 . . . . 0.0 109.528 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 29.3 m -119.01 112.5 19.65 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 123.758 0.823 . . . . 0.0 109.825 -174.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.576 HD11 HG21 ' A' ' 59' ' ' VAL . 2.1 mp -104.18 132.71 50.14 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.462 1.105 . . . . 0.0 108.261 -178.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.453 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . 45.5 tt0 -96.13 140.17 31.23 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.055 0.542 . . . . 0.0 111.37 -172.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 78.8 t -93.8 128.37 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.806 0.842 . . . . 0.0 108.965 174.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.05 -168.04 2.83 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.875 0.87 . . . . 0.0 109.749 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -121.67 108.16 1.29 Allowed Glycine 0 C--N 1.35 1.352 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -122.26 -60.27 1.57 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -79.42 112.59 16.81 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 114.636 -1.166 . . . . 0.0 108.43 174.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -77.65 -22.95 49.88 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.234 0.613 . . . . 0.0 111.562 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.67 ' HA2' ' HB3' ' A' ' 37' ' ' GLU . . . -156.53 -98.27 0.14 Allowed Glycine 0 C--N 1.348 1.228 0 N-CA-C 111.871 -0.492 . . . . 0.0 111.871 -177.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.084 0 CA-C-O 118.932 -0.926 . . . . 0.0 111.086 -179.972 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.4 mtp . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -78.92 119.87 22.71 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.945 0.498 . . . . 0.0 109.702 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 pp -142.63 167.49 21.97 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.417 0.687 . . . . 0.0 110.564 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -100.68 148.37 24.94 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.3 t -133.19 107.13 10.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.892 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 172.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -76.7 93.09 3.6 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.252 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.95 -178.5 5.23 Favored 'General case' 0 C--O 1.248 0.977 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 160.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -51.52 -30.33 19.98 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.719 0.408 . . . . 0.0 111.217 172.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -107.33 130.67 54.75 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 161.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -72.61 125.61 27.89 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -125.66 146.05 49.9 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.171 0.589 . . . . 0.0 109.88 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.5 m -108.41 128.41 54.75 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.487 0.715 . . . . 0.0 109.389 175.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -120.73 143.06 48.97 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.193 0.997 . . . . 0.0 109.758 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -105.59 110.22 22.46 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.539 HG21 ' HG ' ' A' ' 54' ' ' LEU . 4.6 m -108.72 151.01 11.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 C-N-CA 124.154 0.982 . . . . 0.0 109.282 -171.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.467 ' H ' ' HB2' ' A' ' 19' ' ' GLU . 8.1 m -81.21 -11.82 59.31 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.746 -175.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.66 -55.59 2.67 Favored Glycine 0 C--N 1.353 1.523 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -174.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -76.27 2.87 12.1 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.081 0.952 . . . . 0.0 110.759 167.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.467 ' HB2' ' H ' ' A' ' 16' ' ' THR . 8.8 tp10 -60.21 118.05 5.91 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.921 1.289 . . . . 0.0 108.734 165.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 74.8 p -76.41 158.43 31.39 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.38 0.536 . . . . 0.0 110.81 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 t -64.53 -31.34 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 124.032 0.933 . . . . 0.0 110.254 175.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.64 -47.73 81.44 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.848 0.718 . . . . 0.0 110.82 173.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -64.15 -42.89 96.6 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 123.86 0.725 . . . . 0.0 111.141 177.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.494 ' O ' HG23 ' A' ' 28' ' ' VAL . 48.1 mm -56.87 -51.33 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 123.757 0.823 . . . . 0.0 110.708 176.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.53 ' NZ ' ' SD ' ' A' ' 71' ' ' MET . 85.3 tttt -62.42 -45.46 93.02 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.126 1.37 . . . . 0.0 110.424 -174.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.494 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . . . -67.99 -35.84 79.01 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.338 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -64.27 -46.53 83.28 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.33 0.652 . . . . 0.0 110.045 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 24' ' ' ILE . 73.2 t -60.02 -46.08 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 O-C-N 123.791 0.682 . . . . 0.0 109.91 177.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.37 -41.02 92.86 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.894 0.878 . . . . 0.0 112.434 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.3 t -65.25 -38.85 91.62 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.445 0.698 . . . . 0.0 110.649 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.5 mt -71.41 -37.34 71.52 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.636 0.374 . . . . 0.0 111.362 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -78.18 -13.8 59.71 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.897 0.879 . . . . 0.0 111.54 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.77 17.83 79.36 Favored Glycine 0 C--N 1.35 1.311 0 C-N-CA 123.147 0.404 . . . . 0.0 113.641 178.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.4 pt -111.27 176.67 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.866 0.866 . . . . 0.0 110.052 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.24 136.32 46.61 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 123.057 0.543 . . . . 0.0 109.855 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.494 ' HB3' ' HA ' ' A' ' 26' ' ' ALA . 18.6 Cg_endo -57.11 -33.9 96.69 Favored 'Trans proline' 0 C--N 1.383 2.38 0 C-N-CA 123.458 2.772 . . . . 0.0 112.683 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -60.0 -24.12 64.21 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.964 0.905 . . . . 0.0 113.061 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -76.51 -12.79 60.09 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.19 0.596 . . . . 0.0 111.965 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.435 ' O ' ' HB3' ' A' ' 71' ' ' MET . 22.3 mt-30 -104.09 173.17 6.42 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.792 0.837 . . . . 0.0 111.992 -171.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -160.87 134.42 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 169.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.6 p -106.23 136.05 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 121.628 0.727 . . . . 0.0 110.428 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -120.56 143.32 48.67 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.163 1.785 . . . . 0.0 108.495 -171.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.1 tp -110.93 99.16 8.11 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 167.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 59.98 26.44 15.73 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.195 0.998 . . . . 0.0 111.611 -176.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.78 -21.77 31.46 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 115.716 -0.675 . . . . 0.0 113.232 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.37 116.27 54.72 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.397 0.679 . . . . 0.0 111.023 -177.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.76 114.39 2.56 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.948 2.432 . . . . 0.0 112.41 -177.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.555 HD11 HD12 ' A' ' 65' ' ' LEU . 96.7 mt -72.98 130.25 39.93 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.937 0.895 . . . . 0.0 110.647 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -66.18 125.71 26.41 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.807 0.692 . . . . 0.0 110.216 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -65.25 -28.05 69.08 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.32 0.648 . . . . 0.0 112.13 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -77.78 -20.36 53.46 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.212 0.605 . . . . 0.0 110.711 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.66 145.67 28.67 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.301 0.64 . . . . 0.0 111.264 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 59.5 p -91.6 177.55 6.18 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.427 0.691 . . . . 0.0 110.16 173.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.539 ' HG ' HG21 ' A' ' 15' ' ' VAL . 3.8 mm? -63.4 -36.62 84.33 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 173.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.43 -31.94 65.34 Favored Glycine 0 C--N 1.354 1.547 0 CA-C-N 115.605 -0.725 . . . . 0.0 113.144 177.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 61.0 tp60 -71.24 -39.38 71.69 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.405 0.682 . . . . 0.0 110.451 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.487 ' HB2' HG12 ' A' ' 59' ' ' VAL . 62.4 m -68.1 -26.28 65.74 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.187 173.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.62 23.06 68.3 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 123.793 0.683 . . . . 0.0 112.269 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.487 HG12 ' HB2' ' A' ' 57' ' ' CYS . 7.3 p -99.95 134.63 38.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.565 0.746 . . . . 0.0 109.355 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -90.56 -175.45 4.44 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.811 0.845 . . . . 0.0 111.718 -173.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.93 169.25 17.27 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.83 171.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 68.54 3.14 3.68 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 125.298 1.439 . . . . 0.0 112.935 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.3 m -81.84 155.5 25.35 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.347 0.659 . . . . 0.0 109.303 176.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.8 m -113.12 106.93 15.25 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.555 HD12 HD11 ' A' ' 48' ' ' LEU . 2.2 mm? -80.67 171.66 14.74 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 169.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -140.87 125.3 17.68 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 118.585 0.63 . . . . 0.0 111.172 -177.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.2 t -96.4 109.84 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 122.898 0.479 . . . . 0.0 110.098 177.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.56 176.7 5.24 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.488 1.115 . . . . 0.0 109.281 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -124.41 89.86 0.4 Allowed Glycine 0 N--CA 1.469 0.889 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -126.01 -48.47 1.61 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.634 0.774 . . . . 0.0 110.501 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.53 ' SD ' ' NZ ' ' A' ' 25' ' ' LYS . 46.3 ttm -68.24 144.37 54.93 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.942 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.44 168.35 21.38 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.28 0.632 . . . . 0.0 109.796 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.5 -52.04 0.19 Allowed Glycine 0 N--CA 1.472 1.078 0 C-N-CA 122.829 0.252 . . . . 0.0 112.499 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.549 -1.139 . . . . 0.0 112.138 -179.326 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.478 0.947 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -98.99 117.44 33.51 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.425 0.69 . . . . 0.0 110.387 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 pp -131.11 154.44 48.3 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.711 0.767 . . . . 0.0 111.398 175.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -90.33 144.28 25.98 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.817 1.247 . . . . 0.0 108.561 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.1 t -123.23 113.81 39.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 174.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.408 ' HB3' ' HA ' ' A' ' 66' ' ' GLU . 20.4 tpt180 -85.5 93.18 8.71 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.537 -172.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -111.6 -178.93 3.57 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 124.35 1.06 . . . . 0.0 108.333 169.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -45.38 -35.22 3.48 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.557 0.743 . . . . 0.0 111.324 167.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -111.63 127.36 55.73 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.153 0.981 . . . . 0.0 108.493 167.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -75.85 115.69 15.8 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -116.86 131.73 56.88 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.64 0.776 . . . . 0.0 109.662 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.5 m -105.74 118.63 37.09 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -102.71 140.78 36.53 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.118 0.967 . . . . 0.0 111.119 -175.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -94.6 104.76 16.7 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 165.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.0 m -113.72 163.61 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.142 0.977 . . . . 0.0 110.423 -177.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.8 m -99.9 -3.54 32.21 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.46 0.704 . . . . 0.0 111.513 -174.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.16 -45.26 3.38 Favored Glycine 0 C--N 1.352 1.464 0 O-C-N 122.027 -0.421 . . . . 0.0 112.247 -177.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -65.14 -14.04 59.6 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.372 0.669 . . . . 0.0 112.097 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.35 132.89 47.85 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 173.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.728 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 80.4 p -75.22 161.8 29.03 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.27 0.557 . . . . 0.0 110.621 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.718 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 53.0 t -64.93 -28.69 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.415 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.261 172.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.89 -38.88 92.44 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.223 0.609 . . . . 0.0 111.542 174.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -73.5 -35.12 65.59 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.739 177.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.49 HD11 HD11 ' A' ' 54' ' ' LEU . 20.3 mm -53.19 -47.94 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 123.571 0.748 . . . . 0.0 109.857 170.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.493 ' NZ ' ' SD ' ' A' ' 71' ' ' MET . 97.8 mttt -57.7 -55.05 39.88 Favored 'General case' 0 C--N 1.359 0.991 0 O-C-N 124.121 0.888 . . . . 0.0 110.658 174.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.77 -42.0 64.6 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 123.965 0.791 . . . . 0.0 112.121 -176.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -71.17 -46.27 61.75 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.634 0.773 . . . . 0.0 111.755 -177.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.409 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 14.6 p -69.94 -30.95 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.429 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . . . -68.2 -36.72 80.01 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.841 0.856 . . . . 0.0 111.351 177.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.1 t -63.66 -41.69 98.17 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.541 0.736 . . . . 0.0 110.273 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.7 mt -69.12 -48.76 61.61 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.448 0.699 . . . . 0.0 112.29 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.429 ' HB2' HG12 ' A' ' 34' ' ' ILE . 13.8 mm-40 -77.86 -19.11 55.4 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.031 0.532 . . . . 0.0 111.018 -177.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.95 31.9 59.42 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.634 -177.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.429 HG12 ' HB2' ' A' ' 32' ' ' GLU . 23.9 pt -114.65 170.38 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 123.803 0.841 . . . . 0.0 110.912 -177.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.41 119.78 76.86 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 123.658 0.783 . . . . 0.0 111.499 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -65.33 -28.18 55.1 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.859 2.372 . . . . 0.0 112.283 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.92 -35.18 79.81 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.859 0.864 . . . . 0.0 111.227 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -71.39 -26.07 62.62 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.191 0.996 . . . . 0.0 111.079 -172.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.429 ' NE2' ' HB2' ' A' ' 29' ' ' ALA . 21.6 mt-30 -81.7 137.79 35.35 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.7 -173.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 p -122.82 133.64 68.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 166.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.457 HG13 ' HB3' ' A' ' 65' ' ' LEU . 54.7 t -94.26 108.34 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-O 121.384 0.611 . . . . 0.0 109.716 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 66.1 mt -97.04 114.47 26.1 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.26 1.424 . . . . 0.0 109.762 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.8 tp -94.83 104.95 16.85 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 169.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 59.67 28.3 17.71 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.236 1.014 . . . . 0.0 111.961 -173.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.31 -7.89 72.21 Favored Glycine 0 C--N 1.352 1.427 0 CA-C-N 115.946 -0.57 . . . . 0.0 113.675 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.19 116.71 66.99 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 123.757 0.823 . . . . 0.0 110.2 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.3 117.34 4.49 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.593 2.195 . . . . 0.0 111.65 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.2 mt -75.93 154.6 35.83 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.621 0.768 . . . . 0.0 111.293 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -72.51 104.19 3.75 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.718 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 3.0 p30 -72.08 -15.29 62.01 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -73.92 -24.4 59.67 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 122.909 0.484 . . . . 0.0 110.191 172.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -94.91 157.79 15.76 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 124.161 0.984 . . . . 0.0 111.069 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.728 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 67.7 p -85.24 168.05 15.1 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.618 177.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.5 ' HA ' ' SG ' ' A' ' 57' ' ' CYS . 78.2 mt -66.28 -33.22 75.24 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.118 174.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.16 -29.68 68.39 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 115.287 -0.869 . . . . 0.0 112.661 175.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -72.38 -43.95 63.22 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.551 0.74 . . . . 0.0 110.57 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' A' ' 54' ' ' LEU . 22.1 p -75.79 -10.41 59.41 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.51 173.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.13 21.24 78.4 Favored Glycine 0 C--N 1.355 1.61 0 C-N-CA 123.56 0.6 . . . . 0.0 113.571 171.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.4 HG21 HG21 ' A' ' 63' ' ' THR . 13.0 p -78.51 145.78 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -176.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -110.62 -164.2 0.9 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.308 0.643 . . . . 0.0 111.003 -176.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.72 175.53 9.86 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.681 0.792 . . . . 0.0 111.667 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 65.2 5.35 3.01 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.452 1.501 . . . . 0.0 112.744 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.4 HG21 HG21 ' A' ' 59' ' ' VAL . 90.6 m -81.63 154.21 26.26 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.407 1.083 . . . . 0.0 110.155 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.2 m -122.42 101.7 7.65 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.688 0.795 . . . . 0.0 109.663 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.457 ' HB3' HG13 ' A' ' 41' ' ' VAL . 74.7 mt -85.69 116.28 23.87 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.125 0.97 . . . . 0.0 109.175 176.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.408 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . 41.1 tt0 -93.85 128.81 40.32 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.02 0.438 . . . . 0.0 111.674 -172.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 75.0 t -87.59 128.55 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.833 0.853 . . . . 0.0 109.791 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.15 136.84 45.99 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.775 0.83 . . . . 0.0 109.649 173.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.47 89.43 1.58 Allowed Glycine 0 C--N 1.343 0.962 0 N-CA-C 112.095 -0.402 . . . . 0.0 112.095 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -141.75 -28.87 0.63 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.545 0.738 . . . . 0.0 112.353 -173.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.493 ' SD ' ' NZ ' ' A' ' 25' ' ' LYS . 56.1 ttm -85.46 17.5 3.16 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.177 0.591 . . . . 0.0 111.989 -173.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -52.84 120.94 6.36 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.353 1.061 . . . . 0.0 110.662 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -166.49 -69.22 0.03 OUTLIER Glycine 0 C--N 1.349 1.263 0 O-C-N 123.312 0.382 . . . . 0.0 112.26 -177.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.728 -1.04 . . . . 0.0 111.37 -178.097 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.472 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 1.1 tmt? . . . . . 0 N--CA 1.483 1.198 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 34.1 tt0 -101.94 137.76 39.8 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.439 -177.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.473 HD13 HD13 ' A' ' 65' ' ' LEU . 4.4 pp -137.5 161.03 37.48 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.387 0.613 . . . . 0.0 110.276 175.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -107.27 135.37 48.89 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.3 t -115.98 105.41 18.39 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 C-N-CA 123.57 0.748 . . . . 0.0 109.047 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -72.26 98.69 2.23 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.853 0.861 . . . . 0.0 110.969 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -113.28 -177.07 3.04 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.649 1.18 . . . . 0.0 108.044 166.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -45.09 -31.67 1.46 Allowed 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.522 0.677 . . . . 0.0 112.133 168.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -115.34 131.84 56.8 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 124.668 1.187 . . . . 0.0 107.878 167.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -70.36 105.5 3.05 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -93.12 160.49 14.83 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.754 177.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.5 m -148.97 121.64 8.62 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -127.63 129.61 47.53 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.392 0.677 . . . . 0.0 109.666 -176.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 36.0 tt0 -94.16 110.26 22.0 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 168.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 1' ' ' MET . 35.8 m -116.84 164.37 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 124.825 1.25 . . . . 0.0 109.098 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.1 t -94.79 6.21 49.63 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.663 0.385 . . . . 0.0 110.591 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.536 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 94.66 -20.49 48.31 Favored Glycine 0 C--N 1.357 1.734 0 CA-C-O 119.351 -0.694 . . . . 0.0 113.672 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -67.62 -26.7 66.37 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -169.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -62.96 141.87 58.56 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 46.9 p -80.42 165.0 22.64 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.524 HG13 ' HB ' ' A' ' 41' ' ' VAL . 54.5 t -57.08 -31.17 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 C-N-CA 123.448 0.699 . . . . 0.0 110.045 172.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.461 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . . . -68.92 -37.84 79.18 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.493 1.117 . . . . 0.0 111.511 177.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.464 ' HG3' ' OG1' ' A' ' 20' ' ' THR . 24.8 mt-30 -72.36 -35.03 68.42 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.1 mm -64.52 -47.41 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.097 0.559 . . . . 0.0 111.046 177.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.585 ' HB3' HG23 ' A' ' 41' ' ' VAL . 60.6 pttt -67.18 -32.65 73.88 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 119.547 -0.263 . . . . 0.0 110.383 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.523 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . . . -60.09 -45.47 92.81 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 123.603 0.761 . . . . 0.0 111.471 176.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.459 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 34.0 m170 -64.85 -44.99 87.97 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.878 0.471 . . . . 0.0 110.896 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.521 HG11 HG21 ' A' ' 67' ' ' VAL . 79.0 t -62.04 -42.39 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.124 0.57 . . . . 0.0 111.035 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.21 -26.07 61.0 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.739 0.816 . . . . 0.0 111.402 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.2 t -70.24 -42.21 72.53 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 122.983 0.513 . . . . 0.0 110.275 171.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 27' ' ' HIS . 97.2 mt -62.57 -42.85 99.81 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 123.839 0.712 . . . . 0.0 111.625 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.96 -23.41 31.09 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.112 0.565 . . . . 0.0 112.174 176.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.64 29.69 47.27 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 122.979 0.175 . . . . 0.0 112.906 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.6 pt -111.87 -178.46 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 124.803 1.241 . . . . 0.0 111.215 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.71 112.65 39.14 Favored Pre-proline 0 N--CA 1.487 1.414 0 C-N-CA 124.035 0.934 . . . . 0.0 112.537 -170.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.523 ' HB3' ' HA ' ' A' ' 26' ' ' ALA . 24.2 Cg_exo -62.93 -43.17 20.86 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 123.088 2.525 . . . . 0.0 112.729 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.95 -8.71 57.1 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.381 0.672 . . . . 0.0 112.057 -176.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -77.65 -36.31 51.57 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.403 0.62 . . . . 0.0 109.577 171.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.629 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 45.6 mt-30 -99.44 -179.76 4.32 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.994 -169.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.504 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 11.4 p -162.09 154.03 3.37 Favored 'Isoleucine or valine' 0 C--O 1.246 0.877 0 C-N-CA 125.314 1.446 . . . . 0.0 107.956 171.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.585 HG23 ' HB3' ' A' ' 25' ' ' LYS . 44.4 t -103.64 125.46 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.642 HD12 ' HA ' ' A' ' 47' ' ' PRO . 1.8 mm? -108.9 141.25 41.23 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.446 1.498 . . . . 0.0 108.842 -173.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.9 tp -80.76 96.71 7.04 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.402 ' H ' ' HA ' ' A' ' 65' ' ' LEU . . . 55.06 29.34 12.27 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 123.878 0.871 . . . . 0.0 111.629 -176.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.59 -25.43 21.28 Favored Glycine 0 C--N 1.355 1.635 0 C-N-CA 123.343 0.497 . . . . 0.0 113.449 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.57 136.05 81.01 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.552 0.741 . . . . 0.0 111.311 -177.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.642 ' HA ' HD12 ' A' ' 42' ' ' LEU . 52.6 Cg_endo -64.61 111.0 1.55 Allowed 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 123.192 2.594 . . . . 0.0 113.052 -174.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.9 mt -90.2 156.26 18.45 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.376 0.67 . . . . 0.0 111.138 173.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -81.97 119.47 24.0 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 172.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.487 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 6.0 p-10 -60.67 -38.94 86.57 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.082 0.553 . . . . 0.0 112.103 -175.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -82.27 -4.89 58.02 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.119 0.568 . . . . 0.0 111.978 -176.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.49 140.49 29.48 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.312 0.645 . . . . 0.0 110.356 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 44.1 p -71.77 168.46 17.77 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.291 0.636 . . . . 0.0 110.603 178.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.536 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 3.0 mm? -59.19 -43.33 92.2 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 174.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.43 -37.9 95.52 Favored Glycine 0 C--N 1.35 1.331 0 O-C-N 123.845 0.716 . . . . 0.0 113.108 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -68.24 -39.72 82.21 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.834 0.854 . . . . 0.0 110.482 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 75.0 m -79.26 -10.09 59.73 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.928 0.891 . . . . 0.0 111.798 177.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.82 21.17 75.01 Favored Glycine 0 C--N 1.349 1.281 0 C-N-CA 123.217 0.436 . . . . 0.0 114.135 177.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.28 134.86 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 123.845 0.858 . . . . 0.0 109.436 177.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -114.39 -171.43 1.92 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.472 0.709 . . . . 0.0 111.095 -172.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.87 154.09 28.6 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.542 0.737 . . . . 0.0 110.248 174.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 59.9 21.19 10.16 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 125.216 1.407 . . . . 0.0 111.738 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.5 m -93.74 156.41 16.7 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.434 1.093 . . . . 0.0 108.804 177.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.1 m -135.43 121.82 20.49 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.632 0.729 . . . . 0.0 110.78 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.473 HD13 HD13 ' A' ' 3' ' ' LEU . 4.1 mp -105.88 179.23 4.33 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.792 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -141.2 144.41 34.74 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.607 0.763 . . . . 0.0 110.279 -173.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.521 HG21 HG11 ' A' ' 28' ' ' VAL . 44.8 t -103.43 119.41 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 121.842 -0.536 . . . . 0.0 109.67 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.18 150.63 50.18 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.043 0.537 . . . . 0.0 110.292 176.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.629 ' HA2' ' HA ' ' A' ' 39' ' ' GLN . . . -90.1 92.95 1.82 Allowed Glycine 0 C--N 1.347 1.159 0 N-CA-C 112.051 -0.42 . . . . 0.0 112.051 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 54.4 mtt180 -109.75 -11.81 14.68 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.958 0.503 . . . . 0.0 112.318 -177.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.559 ' SD ' ' NZ ' ' A' ' 25' ' ' LYS . 79.5 mtp -97.45 110.07 22.7 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 122.212 -0.305 . . . . 0.0 110.445 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.4 tp -75.5 -46.71 30.64 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.019 0.437 . . . . 0.0 109.972 176.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.6 150.94 17.17 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.005 176.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.289 0 CA-C-O 119.149 -0.806 . . . . 0.0 112.865 178.914 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 121.788 0.804 . . . . 0.0 108.968 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -93.01 111.38 22.98 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.683 -171.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.444 HD13 HD13 ' A' ' 65' ' ' LEU . 2.8 pp -125.51 157.51 36.83 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.481 0.712 . . . . 0.0 110.07 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -90.28 142.18 27.98 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.789 0.835 . . . . 0.0 109.85 -176.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.5 t -122.66 102.64 11.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 C-N-CA 124.648 1.179 . . . . 0.0 108.885 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -77.95 93.8 4.49 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.934 0.893 . . . . 0.0 109.71 177.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.19 -174.52 2.59 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.906 1.283 . . . . 0.0 108.168 172.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -41.16 -36.9 0.8 Allowed 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 123.841 0.857 . . . . 0.0 112.053 168.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -117.95 154.36 32.07 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.507 1.123 . . . . 0.0 108.323 167.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -77.52 127.52 32.65 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.774 0.43 . . . . 0.0 110.456 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -130.79 159.39 37.47 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.653 1.181 . . . . 0.0 109.042 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.8 m -143.53 125.17 14.93 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 175.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -132.93 141.64 48.46 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.013 0.525 . . . . 0.0 111.119 -173.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -80.92 125.77 30.54 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 164.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.447 HG21 ' HG ' ' A' ' 54' ' ' LEU . 27.6 m -109.32 152.56 11.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 C-N-CA 123.445 0.698 . . . . 0.0 109.744 -174.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 m -78.51 -14.62 59.27 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.666 -171.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.49 -56.44 5.02 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -70.5 -13.38 62.09 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.141 0.976 . . . . 0.0 111.145 171.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -63.39 139.18 58.74 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.66 1.184 . . . . 0.0 109.933 170.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 73.2 p -93.62 170.67 9.41 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.304 0.573 . . . . 0.0 111.91 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.606 HG13 ' HB ' ' A' ' 41' ' ' VAL . 40.5 t -64.81 -31.87 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.129 0.972 . . . . 0.0 110.607 172.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.06 96.25 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.735 0.814 . . . . 0.0 110.148 178.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.408 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 18.7 mm-40 -62.65 -48.25 80.17 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.447 1.092 . . . . 0.0 110.313 175.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 28' ' ' VAL . 37.2 mm -55.97 -47.27 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 124.078 0.951 . . . . 0.0 110.923 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -62.17 -49.91 73.94 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.015 1.326 . . . . 0.0 111.183 -175.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.7 -32.94 71.82 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.976 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.469 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 11.4 t-160 -62.69 -53.52 53.25 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 124.099 0.96 . . . . 0.0 110.37 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 24' ' ' ILE . 95.0 t -59.92 -38.51 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.414 0.686 . . . . 0.0 110.552 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.04 -47.79 84.41 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.144 175.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.8 t -66.86 -35.25 79.61 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.648 0.779 . . . . 0.0 111.228 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 27' ' ' HIS . 88.6 mt -67.4 -48.79 66.33 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.82 0.848 . . . . 0.0 111.861 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -96.04 -2.57 46.54 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.685 0.394 . . . . 0.0 111.819 -172.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.58 28.24 73.3 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.278 0.361 . . . . 0.0 113.01 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.2 pt -108.82 177.58 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.125 0.97 . . . . 0.0 110.693 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.42 120.94 68.96 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 123.281 0.632 . . . . 0.0 111.438 -171.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -63.83 -31.74 67.66 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.527 2.151 . . . . 0.0 111.206 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -63.68 -22.04 66.7 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.028 0.931 . . . . 0.0 112.353 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -88.95 -12.95 40.14 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.007 0.923 . . . . 0.0 111.171 -178.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -98.65 165.29 11.87 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.922 0.889 . . . . 0.0 112.344 -171.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 m -152.57 138.4 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 126.247 1.819 . . . . 0.0 107.251 164.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.606 ' HB ' HG13 ' A' ' 21' ' ' VAL . 45.5 t -94.99 116.62 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 175.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.3 mt -112.25 134.04 54.03 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.802 1.241 . . . . 0.0 109.092 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.468 ' HB2' HD11 ' A' ' 48' ' ' LEU . 42.4 tp -89.4 98.11 11.58 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 173.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 57.18 28.84 15.68 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.754 0.821 . . . . 0.0 112.081 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.04 -25.16 21.32 Favored Glycine 0 C--N 1.353 1.505 0 CA-C-O 119.717 -0.491 . . . . 0.0 113.498 -177.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.13 117.68 60.51 Favored Pre-proline 0 N--CA 1.481 1.098 0 C-N-CA 123.422 0.689 . . . . 0.0 110.886 -177.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.5 115.57 2.64 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.329 2.686 . . . . 0.0 113.108 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.506 ' HB3' HG21 ' A' ' 21' ' ' VAL . 84.6 mt -91.02 143.75 26.38 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.18 0.592 . . . . 0.0 110.903 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -78.27 134.68 37.51 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -56.73 -41.02 76.77 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.996 0.918 . . . . 0.0 112.15 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -82.21 -14.89 54.87 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.677 -175.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.22 132.65 43.43 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.81 0.444 . . . . 0.0 109.859 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 58.6 p -84.23 166.77 17.25 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.209 0.604 . . . . 0.0 110.282 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.447 ' HG ' HG21 ' A' ' 15' ' ' VAL . 3.0 mm? -62.43 -38.52 90.06 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.01 -34.69 77.03 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.922 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -70.95 -42.62 69.55 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.475 0.71 . . . . 0.0 110.635 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 50.6 t -69.51 -18.75 63.71 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.141 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.05 17.84 80.22 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.657 -0.702 . . . . 0.0 112.804 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.582 HG21 HD11 ' A' ' 65' ' ' LEU . 2.2 p -85.61 118.37 32.21 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.1 -166.8 1.42 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.328 1.051 . . . . 0.0 110.54 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.63 163.72 26.43 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.173 0.589 . . . . 0.0 111.243 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 71.89 -2.83 2.38 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.825 1.65 . . . . 0.0 112.765 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.4 m -84.0 160.18 21.07 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.577 0.751 . . . . 0.0 109.573 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.3 m -120.16 113.31 20.27 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.15 0.58 . . . . 0.0 110.638 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.582 HD11 HG21 ' A' ' 59' ' ' VAL . 5.5 mp -94.79 161.18 14.28 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 170.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -130.52 130.66 44.43 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.964 0.505 . . . . 0.0 109.95 -177.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 95.9 t -91.85 93.39 4.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 171.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.62 -176.47 3.2 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.339 1.056 . . . . 0.0 110.13 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -123.2 91.78 0.45 Allowed Glycine 0 C--N 1.341 0.823 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 178.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -107.12 -49.23 3.31 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 53.4 ttm -73.4 101.63 3.53 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 174.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -75.59 -45.65 36.35 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.77 146.06 10.92 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.864 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.413 0 CA-C-O 118.647 -1.085 . . . . 0.0 112.672 179.944 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ttt . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -94.04 120.35 34.17 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.403 HD13 HD13 ' A' ' 65' ' ' LEU . 3.3 pp -132.16 167.22 20.14 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.074 0.55 . . . . 0.0 111.001 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -99.49 142.89 30.38 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.58 0.752 . . . . 0.0 109.553 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 80.9 t -126.12 101.13 7.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 171.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -73.25 98.74 2.71 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.548 -177.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.69 -177.31 3.33 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.097 0.959 . . . . 0.0 108.945 172.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -43.46 -32.75 0.94 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.087 0.955 . . . . 0.0 111.986 170.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -120.6 145.22 47.59 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.382 1.073 . . . . 0.0 108.178 162.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.1 tp -69.72 128.58 36.94 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 120.821 0.343 . . . . 0.0 111.084 -176.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -117.47 158.21 24.91 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.931 0.892 . . . . 0.0 109.894 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.7 m -146.63 120.96 9.59 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.348 1.059 . . . . 0.0 108.291 175.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -120.85 145.21 47.85 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.412 0.685 . . . . 0.0 110.613 -172.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -97.4 123.98 41.42 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 171.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.3 m -135.0 172.43 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.302 1.041 . . . . 0.0 109.865 -177.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.437 ' HB ' ' HG2' ' A' ' 18' ' ' GLN . 2.9 m -107.07 -18.15 13.98 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.793 0.837 . . . . 0.0 110.011 175.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.448 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 102.77 -15.52 55.51 Favored Glycine 0 C--N 1.355 1.637 0 C-N-CA 123.137 0.399 . . . . 0.0 112.458 -173.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.437 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 14.8 pt20 -81.29 -8.45 59.75 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.825 0.85 . . . . 0.0 111.719 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -74.42 134.23 42.4 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.16 0.984 . . . . 0.0 108.923 176.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.697 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 72.4 p -74.66 158.84 32.93 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 171.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.636 HG13 ' HB ' ' A' ' 41' ' ' VAL . 55.8 t -59.23 -27.9 37.74 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.475 0 C-N-CA 123.839 0.856 . . . . 0.0 110.401 173.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.64 -43.36 80.52 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.795 1.238 . . . . 0.0 110.392 174.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.428 ' HG3' ' OG1' ' A' ' 20' ' ' THR . 78.1 mt-30 -62.07 -41.56 98.28 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 123.521 0.513 . . . . 0.0 110.217 175.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.461 HD11 HD11 ' A' ' 54' ' ' LEU . 46.9 mm -59.32 -50.72 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.435 0.694 . . . . 0.0 111.217 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.478 ' HB3' HG23 ' A' ' 41' ' ' VAL . 60.3 pttt -73.08 -27.5 61.75 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.98 -37.19 86.83 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.25 0.62 . . . . 0.0 111.047 173.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 57.5 m170 -66.68 -45.81 77.66 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.359 0.663 . . . . 0.0 109.78 175.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.566 HG12 HD11 ' A' ' 34' ' ' ILE . 85.1 t -58.74 -38.02 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.59 0.756 . . . . 0.0 110.313 174.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.01 -48.15 74.95 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.275 1.03 . . . . 0.0 111.953 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.3 t -68.13 -32.75 73.26 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.328 0.651 . . . . 0.0 111.771 -177.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 97.5 mt -80.67 -51.11 9.07 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.989 0.516 . . . . 0.0 111.965 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -83.76 -2.45 56.33 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.605 0.762 . . . . 0.0 112.179 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.25 15.19 69.76 Favored Glycine 0 C--N 1.346 1.092 0 O-C-N 123.157 0.286 . . . . 0.0 113.1 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.566 HD11 HG12 ' A' ' 28' ' ' VAL . 28.6 pt -92.39 178.91 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.527 0.731 . . . . 0.0 109.81 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -109.87 129.89 23.43 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 122.87 0.468 . . . . 0.0 110.776 -174.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.28 -11.17 26.58 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.217 1.944 . . . . 0.0 112.687 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.52 -22.97 53.73 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 123.041 0.536 . . . . 0.0 112.071 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.45 ' HA ' ' H ' ' A' ' 72' ' ' LEU . 1.7 p30 -90.86 -41.19 11.33 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 118.76 0.709 . . . . 0.0 109.518 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -81.82 152.4 26.93 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 122.198 0.999 . . . . 0.0 111.847 -175.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.32 153.11 37.34 Favored 'Isoleucine or valine' 0 C--O 1.249 1.07 0 C-N-CA 126.447 1.899 . . . . 0.0 106.347 168.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.636 ' HB ' HG13 ' A' ' 21' ' ' VAL . 43.7 t -100.21 131.65 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.7 mt -116.3 142.0 47.41 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.592 1.157 . . . . 0.0 109.398 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.6 tp -91.81 99.28 12.18 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 174.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 60.31 22.97 12.44 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.84 0.856 . . . . 0.0 112.473 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.7 -14.6 57.58 Favored Glycine 0 C--N 1.353 1.519 0 CA-C-O 119.779 -0.456 . . . . 0.0 113.436 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.62 146.13 60.1 Favored Pre-proline 0 N--CA 1.485 1.285 0 C-N-CA 123.745 0.818 . . . . 0.0 109.981 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -72.35 120.38 6.72 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.637 2.224 . . . . 0.0 113.301 -170.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.475 ' HB3' HG21 ' A' ' 21' ' ' VAL . 87.2 mt -94.63 141.1 29.0 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 170.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -80.05 120.89 24.82 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.546 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 11.1 p-10 -63.21 -39.47 94.73 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 123.491 0.494 . . . . 0.0 111.511 -171.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.58 -2.91 55.15 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.392 0.677 . . . . 0.0 111.897 -177.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.6 139.91 29.99 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.545 0.738 . . . . 0.0 110.563 173.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.697 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 75.5 p -73.58 164.34 26.78 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.978 0.511 . . . . 0.0 110.529 175.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.461 HD11 HD11 ' A' ' 24' ' ' ILE . 86.9 mt -66.83 -28.75 68.61 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.509 0.724 . . . . 0.0 110.757 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.07 -43.76 89.75 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.634 174.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -69.52 -37.3 77.07 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.847 0.459 . . . . 0.0 110.949 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 89.3 m -65.09 -23.49 67.18 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.319 0.648 . . . . 0.0 110.933 173.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.44 28.33 67.93 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 116.308 -0.405 . . . . 0.0 112.744 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.588 HG21 HD11 ' A' ' 65' ' ' LEU . 11.8 p -92.54 153.9 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -133.07 -172.19 2.87 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.674 0.79 . . . . 0.0 110.909 -173.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.77 157.45 36.41 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.341 0.657 . . . . 0.0 111.87 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 61.7 14.6 6.24 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 126.013 1.725 . . . . 0.0 112.415 -177.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.8 m -93.36 145.08 24.73 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.5 m -105.84 108.3 19.75 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.66 0.743 . . . . 0.0 110.08 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.588 HD11 HG21 ' A' ' 59' ' ' VAL . 5.6 mp -88.32 179.35 6.36 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.176 169.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 39.8 tt0 -142.53 153.34 43.5 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.101 0.56 . . . . 0.0 110.133 -175.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 79.1 t -109.08 131.83 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 170.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.98 127.19 17.56 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.305 0.642 . . . . 0.0 109.925 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.12 92.51 0.74 Allowed Glycine 0 C--N 1.344 0.99 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 175.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -132.69 -35.57 1.1 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.019 0.527 . . . . 0.0 112.296 -174.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.479 ' HG3' ' H ' ' A' ' 74' ' ' GLY . 49.0 tpp -60.25 -51.39 69.75 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.497 0.319 . . . . 0.0 110.943 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.45 ' H ' ' HA ' ' A' ' 38' ' ' ASP . 0.6 OUTLIER 50.89 67.56 0.92 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 125.57 1.548 . . . . 0.0 111.061 173.547 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 56.28 40.07 83.85 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.706 -0.679 . . . . 0.0 113.469 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.479 ' H ' ' HG3' ' A' ' 71' ' ' MET . . . . . . . . 0 CA--C 1.536 1.384 0 CA-C-O 118.986 -0.897 . . . . 0.0 113.042 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.6 mtm . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -76.96 114.59 15.92 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.482 HD13 HD23 ' A' ' 65' ' ' LEU . 2.3 pp -137.9 157.19 46.9 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.108 0.563 . . . . 0.0 110.155 -177.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -88.92 152.11 21.92 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.052 0.541 . . . . 0.0 109.63 -177.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.52 ' HB ' ' HB2' ' A' ' 11' ' ' HIS . 55.2 t -134.65 105.23 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.294 1.037 . . . . 0.0 109.087 -176.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -82.9 93.96 7.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.468 1.107 . . . . 0.0 111.001 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -111.3 -179.96 3.87 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 168.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.99 -26.79 39.23 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 175.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -111.47 134.04 53.34 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 158.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.73 137.66 52.18 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.883 0.473 . . . . 0.0 109.738 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.52 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 39.3 m-70 -129.86 161.97 29.61 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.122 0.969 . . . . 0.0 109.049 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.0 m -142.91 112.0 6.56 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 172.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -113.39 132.32 55.66 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.792 0.837 . . . . 0.0 111.203 -172.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -83.94 114.08 21.44 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 166.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.409 HG21 ' HG ' ' A' ' 54' ' ' LEU . 13.3 m -109.65 139.58 32.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 122.918 0.487 . . . . 0.0 109.811 -174.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 m -75.37 -17.83 60.12 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.711 0.805 . . . . 0.0 111.472 -176.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.75 -56.2 1.91 Allowed Glycine 0 C--N 1.347 1.143 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 -176.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -72.53 -7.12 48.41 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.307 0.643 . . . . 0.0 111.588 172.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -63.79 145.25 56.12 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 165.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 61.2 p -94.29 153.68 17.9 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 118.213 0.461 . . . . 0.0 111.99 -177.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.619 HG13 ' HB ' ' A' ' 41' ' ' VAL . 38.1 t -57.12 -33.71 43.52 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 124.388 1.075 . . . . 0.0 110.617 171.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.17 -53.19 61.11 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.126 0.971 . . . . 0.0 110.921 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -65.2 -36.14 83.27 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.916 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 28' ' ' VAL . 35.0 mm -60.36 -50.49 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 122.786 0.434 . . . . 0.0 111.633 178.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.4 ' HB3' HG23 ' A' ' 41' ' ' VAL . 61.3 pttt -68.25 -30.75 69.87 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.526 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . . . -65.9 -41.23 91.76 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 123.382 0.673 . . . . 0.0 111.492 175.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -62.03 -46.06 90.81 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.329 0.651 . . . . 0.0 109.722 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 24' ' ' ILE . 76.8 t -56.32 -48.24 79.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.717 176.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.99 -28.23 64.28 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.827 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 t -77.03 -31.62 56.41 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.554 0.741 . . . . 0.0 110.956 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.0 mt -73.31 -45.09 57.45 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.229 0.612 . . . . 0.0 111.17 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -86.1 -22.0 27.35 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.168 0.587 . . . . 0.0 112.316 -176.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.23 33.8 25.11 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 116.632 -0.258 . . . . 0.0 113.266 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 pt -109.84 171.38 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.941 0.896 . . . . 0.0 110.034 175.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.69 111.61 22.66 Favored Pre-proline 0 N--CA 1.484 1.244 0 C-N-CA 123.296 0.638 . . . . 0.0 111.768 -172.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.526 ' HB3' ' HA ' ' A' ' 26' ' ' ALA . 19.8 Cg_endo -55.95 -39.47 90.97 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 123.602 2.868 . . . . 0.0 114.081 -175.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -67.3 -28.06 67.69 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.035 0.534 . . . . 0.0 111.568 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 71' ' ' MET . 22.7 t70 -67.54 -40.3 85.02 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.253 0.621 . . . . 0.0 109.9 177.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -77.03 165.72 24.25 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.953 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -162.82 146.14 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 125.04 1.336 . . . . 0.0 108.299 173.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.619 ' HB ' HG13 ' A' ' 21' ' ' VAL . 96.3 t -90.14 134.55 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.103 0.561 . . . . 0.0 110.51 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.8 mt -123.29 127.38 48.47 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.77 1.228 . . . . 0.0 108.637 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.436 ' HB2' HD11 ' A' ' 48' ' ' LEU . 33.5 tp -92.18 97.96 11.23 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 173.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 59.73 23.07 11.91 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.56 1.144 . . . . 0.0 112.732 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.75 -7.56 38.93 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-O 119.703 -0.499 . . . . 0.0 113.655 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.01 114.55 53.38 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 123.241 0.616 . . . . 0.0 109.459 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -68.16 102.58 0.81 Allowed 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 122.172 1.914 . . . . 0.0 112.27 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.436 HD11 ' HB2' ' A' ' 43' ' ' LEU . 79.5 mt -73.2 129.68 38.58 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.34 176.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -63.44 130.73 45.64 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.139 0.9 . . . . 0.0 109.387 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -61.93 -35.38 78.23 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.184 0.303 . . . . 0.0 111.483 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.19 -19.68 60.46 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.4 0.28 . . . . 0.0 111.28 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.76 135.27 41.75 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.924 0.49 . . . . 0.0 109.848 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 71.4 p -76.82 171.95 13.91 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 122.907 0.483 . . . . 0.0 109.967 172.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.409 ' HG ' HG21 ' A' ' 15' ' ' VAL . 3.1 mm? -66.22 -28.76 68.99 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.54 -29.53 55.3 Favored Glycine 0 C--N 1.357 1.733 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.763 175.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -74.0 -35.98 64.46 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.641 0.776 . . . . 0.0 109.855 176.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 79.8 m -74.87 -23.52 58.42 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.466 171.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.19 23.05 78.49 Favored Glycine 0 C--N 1.353 1.506 0 CA-C-N 116.009 -0.541 . . . . 0.0 113.558 177.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.8 p -80.54 148.09 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 123.522 0.729 . . . . 0.0 110.342 -175.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -99.6 -177.38 3.55 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.401 0.68 . . . . 0.0 112.181 -173.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.42 162.22 24.55 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.738 0.815 . . . . 0.0 111.029 175.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 64.63 9.29 5.03 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 125.449 1.5 . . . . 0.0 112.488 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.7 m -78.06 152.0 33.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.058 0.943 . . . . 0.0 109.706 175.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.2 m -106.87 108.25 19.67 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 173.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.482 HD23 HD13 ' A' ' 3' ' ' LEU . 3.6 mm? -92.32 135.54 33.94 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 124.175 0.99 . . . . 0.0 108.589 174.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -93.97 150.46 20.34 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.164 0.586 . . . . 0.0 109.465 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 67.1 t -119.46 131.45 72.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 174.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.72 148.55 30.15 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.406 0.682 . . . . 0.0 110.318 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.0 98.82 2.27 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 174.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.9 mtp-105 -103.44 -26.13 13.0 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.594 0.758 . . . . 0.0 111.176 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.513 ' O ' ' HA ' ' A' ' 38' ' ' ASP . 62.7 ttp -121.73 105.33 10.3 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.361 0.664 . . . . 0.0 109.971 -170.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.5 mt -66.0 108.64 2.27 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -110.28 -162.77 18.81 Favored Glycine 0 N--CA 1.47 0.918 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.185 -175.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.523 0 CA-C-O 119.21 -0.772 . . . . 0.0 113.488 177.746 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.552 ' SD ' HD23 ' A' ' 3' ' ' LEU . 47.9 ttm . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -87.39 123.62 32.54 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 171.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.552 HD23 ' SD ' ' A' ' 1' ' ' MET . 2.1 pp -143.12 158.47 43.58 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.619 0.768 . . . . 0.0 109.398 -175.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -96.3 139.78 31.94 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.368 0.667 . . . . 0.0 109.47 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.517 HG22 ' HB2' ' A' ' 65' ' ' LEU . 58.9 t -123.35 103.39 12.89 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 174.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -76.48 100.14 5.15 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.674 0.749 . . . . 0.0 111.038 -178.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.97 -178.2 3.59 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.412 1.085 . . . . 0.0 108.446 166.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -48.29 -35.59 12.52 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.845 0.858 . . . . 0.0 111.379 172.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -111.7 131.28 55.41 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 166.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -68.6 132.84 47.58 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.824 0.45 . . . . 0.0 109.804 -175.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -126.63 156.09 41.51 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.689 0.795 . . . . 0.0 109.451 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.1 t -136.45 135.36 38.57 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 167.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -133.55 155.1 50.22 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.609 0.764 . . . . 0.0 110.355 -175.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -106.47 120.24 41.38 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.412 HG21 ' HG ' ' A' ' 54' ' ' LEU . 32.3 m -110.44 150.3 13.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 C-N-CA 123.812 0.845 . . . . 0.0 108.999 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.3 m -81.98 -14.67 55.69 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.102 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.603 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 91.01 -42.95 2.85 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.521 -0.309 . . . . 0.0 113.043 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -72.22 -13.32 61.5 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.477 1.111 . . . . 0.0 111.92 176.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -78.23 156.84 29.54 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.129 0.572 . . . . 0.0 109.676 171.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 81.4 p -93.24 175.55 6.73 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.24 0.543 . . . . 0.0 112.285 -175.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.585 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 53.1 t -62.57 -36.55 75.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 123.761 0.825 . . . . 0.0 109.996 170.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . . . -62.25 -37.95 87.4 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.564 0.745 . . . . 0.0 110.76 175.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -64.43 -48.16 76.41 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.789 0.681 . . . . 0.0 111.1 176.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.553 ' O ' HG23 ' A' ' 28' ' ' VAL . 64.2 mt -56.71 -49.23 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 122.881 0.472 . . . . 0.0 109.826 176.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.487 ' HB2' HG12 ' A' ' 41' ' ' VAL . 85.1 tttt -55.26 -45.9 76.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.849 1.66 . . . . 0.0 111.193 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.11 -42.91 88.57 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.847 0.859 . . . . 0.0 111.285 176.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -60.67 -46.83 88.86 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.594 0.758 . . . . 0.0 110.902 -178.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 24' ' ' ILE . 26.3 t -65.13 -44.96 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 123.815 0.697 . . . . 0.0 109.148 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.75 -41.04 90.1 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 123.537 0.735 . . . . 0.0 112.249 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.1 m -61.82 -44.61 96.5 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.807 0.843 . . . . 0.0 111.182 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.5 mt -79.7 -25.41 41.2 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.636 -176.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -85.49 -12.15 52.51 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.006 0.522 . . . . 0.0 111.434 172.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.35 25.44 68.27 Favored Glycine 0 C--N 1.351 1.377 0 C-N-CA 122.85 0.262 . . . . 0.0 113.593 176.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.3 pt -119.03 174.74 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.266 1.026 . . . . 0.0 110.238 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.05 144.22 50.73 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.244 0.618 . . . . 0.0 110.035 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.35 -22.47 59.94 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.48 2.12 . . . . 0.0 110.886 172.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.472 ' HB3' ' HA2' ' A' ' 73' ' ' GLY . 29.4 mt-10 -64.0 -25.54 68.17 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.228 1.411 . . . . 0.0 111.584 175.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -81.88 -23.06 36.53 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.663 0.785 . . . . 0.0 111.343 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.428 ' O ' ' HE3' ' A' ' 25' ' ' LYS . 10.4 pt20 -123.84 -179.52 4.42 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.357 0.598 . . . . 0.0 111.178 -175.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.454 HG11 ' HB2' ' A' ' 70' ' ' ARG . 7.4 p -156.92 134.42 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.99 1.316 . . . . 0.0 107.513 166.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.487 HG12 ' HB2' ' A' ' 25' ' ' LYS . 9.9 p -96.31 110.83 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 CA-C-O 121.952 0.882 . . . . 0.0 109.929 -178.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 47' ' ' PRO . 18.1 mt -94.23 154.88 17.32 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.889 1.276 . . . . 0.0 109.409 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.554 ' HB2' HD11 ' A' ' 48' ' ' LEU . 40.3 tp -94.16 97.63 10.41 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 58.2 23.83 10.71 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.292 1.037 . . . . 0.0 112.489 -177.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.93 -5.8 36.89 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 119.483 -0.621 . . . . 0.0 113.655 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.21 116.11 65.22 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 123.49 0.716 . . . . 0.0 110.66 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.409 ' HA ' HD22 ' A' ' 42' ' ' LEU . 40.7 Cg_endo -64.63 106.62 0.76 Allowed 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.31 2.007 . . . . 0.0 111.621 174.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' A' ' 43' ' ' LEU . 63.8 mt -82.77 170.01 15.52 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.098 0.559 . . . . 0.0 111.0 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -78.26 124.87 28.57 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 168.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.585 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 10.2 p-10 -67.26 -19.61 65.54 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.935 0.494 . . . . 0.0 111.415 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -80.6 -21.35 41.66 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.194 0.998 . . . . 0.0 111.617 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.45 133.97 38.49 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.132 0.573 . . . . 0.0 110.781 -178.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 66.5 p -79.41 171.64 14.88 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.756 0.822 . . . . 0.0 110.626 174.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.603 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 3.4 mm? -64.1 -37.43 87.42 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 175.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.42 -39.11 95.57 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.586 175.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -70.07 -44.2 69.58 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.528 0.731 . . . . 0.0 110.946 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 51.8 t -75.75 -24.12 56.04 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.32 0.648 . . . . 0.0 111.446 -177.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.78 35.02 13.92 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.918 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.4 t -76.84 148.59 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 123.651 0.781 . . . . 0.0 109.268 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -119.61 -171.99 2.24 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.723 0.809 . . . . 0.0 110.299 -176.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.79 149.89 30.92 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 122.779 0.431 . . . . 0.0 110.281 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 60.28 26.2 15.67 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.095 1.358 . . . . 0.0 112.33 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.6 m -80.0 162.17 25.03 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.633 0.773 . . . . 0.0 109.89 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.2 m -115.78 106.06 13.42 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.889 0.852 . . . . 0.0 110.529 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.517 ' HB2' HG22 ' A' ' 5' ' ' VAL . 3.5 mm? -83.02 164.99 20.0 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.409 -1.269 . . . . 0.0 107.833 164.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -144.92 130.46 18.88 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.878 0.471 . . . . 0.0 110.613 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.447 HG21 HG11 ' A' ' 28' ' ' VAL . 83.2 t -83.02 127.45 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 172.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.78 151.79 47.38 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.85 0.86 . . . . 0.0 109.981 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -91.78 86.41 1.27 Allowed Glycine 0 C--N 1.341 0.852 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 173.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.454 ' HB2' HG11 ' A' ' 40' ' ' VAL . 71.3 mtp180 -119.31 16.13 13.08 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.154 0.981 . . . . 0.0 108.965 170.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -145.05 104.82 4.01 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -77.33 -17.88 57.9 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.415 0.286 . . . . 0.0 111.06 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.472 ' HA2' ' HB3' ' A' ' 37' ' ' GLU . . . 163.17 -93.33 0.11 Allowed Glycine 0 C--N 1.349 1.26 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.45 -1.195 . . . . 0.0 111.867 -179.838 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.663 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 82.6 mtp . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -88.54 99.46 12.32 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.409 HD21 HD23 ' A' ' 54' ' ' LEU . 1.5 pp -119.99 165.52 14.56 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.52 0.728 . . . . 0.0 110.864 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.441 ' HB3' HD21 ' A' ' 10' ' ' LEU . 29.7 m-85 -101.35 140.66 35.34 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.344 1.058 . . . . 0.0 108.918 -176.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.37 107.33 16.55 Favored 'Isoleucine or valine' 0 C--O 1.244 0.806 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -80.36 93.78 6.03 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.712 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.92 -171.77 2.42 Favored 'General case' 0 C--O 1.245 0.84 0 C-N-CA 125.876 1.67 . . . . 0.0 108.015 165.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -38.72 -34.28 0.14 Allowed 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 123.399 0.68 . . . . 0.0 112.727 167.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -123.96 162.75 22.75 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.637 1.175 . . . . 0.0 109.319 164.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.441 HD21 ' HB3' ' A' ' 4' ' ' PHE . 3.2 tm? -81.94 131.76 35.25 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -133.77 124.68 27.03 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.077 0.951 . . . . 0.0 109.119 -177.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 m -99.35 123.43 43.62 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -119.56 121.31 39.07 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.463 1.105 . . . . 0.0 110.456 -176.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.22 106.2 13.01 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 163.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.2 m -110.93 156.7 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.884 0.874 . . . . 0.0 110.659 -174.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.3 p -75.14 -25.74 58.63 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.949 177.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.3 -39.24 3.11 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.921 -174.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -78.23 -10.81 59.82 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.085 0.554 . . . . 0.0 111.657 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -69.13 120.84 15.59 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 168.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 69.7 p -66.29 161.22 22.79 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.388 0.675 . . . . 0.0 111.6 -175.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.465 HG13 ' HB ' ' A' ' 41' ' ' VAL . 75.4 t -62.06 -29.89 47.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 C-N-CA 124.042 0.937 . . . . 0.0 110.947 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . . . -61.31 -53.18 60.07 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.639 0.775 . . . . 0.0 110.499 174.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -65.92 -37.23 85.53 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.794 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.3 mm -63.96 -47.15 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.828 0.851 . . . . 0.0 111.588 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.48 ' HB3' HG23 ' A' ' 41' ' ' VAL . 51.8 pttt -70.18 -33.81 72.2 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 118.132 0.424 . . . . 0.0 110.28 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.61 -39.41 80.86 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.603 0.761 . . . . 0.0 110.605 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -55.57 -51.95 65.38 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.649 1.58 . . . . 0.0 109.955 175.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.506 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 84.5 t -64.51 -44.03 96.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.271 178.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.83 -35.67 78.91 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.629 0.771 . . . . 0.0 112.323 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.0 m -68.62 -40.8 80.17 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.092 0.557 . . . . 0.0 110.754 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.6 mt -66.93 -40.72 87.7 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.492 177.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 28' ' ' VAL . 11.0 mm-40 -84.27 -12.67 54.3 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.731 0.813 . . . . 0.0 111.709 -177.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.59 38.68 78.73 Favored Glycine 0 C--N 1.354 1.569 0 O-C-N 123.415 0.447 . . . . 0.0 113.32 177.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.2 pt -129.22 176.13 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.442 1.097 . . . . 0.0 110.306 -175.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.73 113.91 29.14 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 123.978 0.911 . . . . 0.0 112.466 -171.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -60.44 -35.7 89.68 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.291 2.661 . . . . 0.0 113.139 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.531 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 2.6 pm0 -67.33 -27.67 67.33 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.008 0.523 . . . . 0.0 110.916 178.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 71' ' ' MET . 31.7 t70 -74.74 -29.47 61.17 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.282 0.633 . . . . 0.0 110.607 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -75.98 152.6 36.96 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.403 0.621 . . . . 0.0 111.52 -173.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.3 p -142.63 142.8 26.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-N 114.331 -1.304 . . . . 0.0 107.581 169.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.48 HG23 ' HB3' ' A' ' 25' ' ' LYS . 98.5 t -98.89 123.36 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 173.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 47' ' ' PRO . 86.6 mt -116.34 118.61 33.22 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.825 1.25 . . . . 0.0 108.681 -176.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.3 tp -86.03 97.75 10.46 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 173.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 57.65 24.54 10.65 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.041 0.936 . . . . 0.0 111.645 -174.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.1 -20.87 30.24 Favored Glycine 0 C--N 1.354 1.555 0 C-N-CA 123.521 0.581 . . . . 0.0 113.649 -177.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.34 117.69 60.94 Favored Pre-proline 0 CA--C 1.554 1.111 0 CA-C-N 117.489 0.645 . . . . 0.0 110.602 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.438 ' HA ' HD23 ' A' ' 42' ' ' LEU . 19.8 Cg_exo -65.26 101.59 0.42 Allowed 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.003 2.469 . . . . 0.0 112.508 -176.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.461 ' HB3' HG21 ' A' ' 21' ' ' VAL . 61.7 mt -68.9 127.16 32.12 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.957 176.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.83 127.95 33.65 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 123.463 0.705 . . . . 0.0 109.812 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.495 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . 9.4 p-10 -62.07 -29.53 70.37 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.938 0.895 . . . . 0.0 111.663 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -76.35 -24.11 54.21 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.827 0.851 . . . . 0.0 111.214 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.1 146.27 30.67 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.503 0.721 . . . . 0.0 110.533 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 80.9 p -85.81 165.24 17.02 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.321 0.648 . . . . 0.0 109.893 173.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.409 HD23 HD21 ' A' ' 3' ' ' LEU . 9.7 mp -66.57 -28.79 68.8 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.184 0.594 . . . . 0.0 110.486 175.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.41 -40.45 86.86 Favored Glycine 0 C--N 1.35 1.332 0 O-C-N 123.796 0.685 . . . . 0.0 112.262 174.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -73.08 -36.5 66.84 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.268 0.627 . . . . 0.0 110.652 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 84.0 m -71.7 -17.81 62.2 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.788 0.835 . . . . 0.0 111.567 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.16 19.84 78.77 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 123.578 0.549 . . . . 0.0 113.385 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.562 HG21 HD11 ' A' ' 65' ' ' LEU . 2.2 p -88.15 99.67 9.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -81.92 -174.66 5.18 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.249 -1.341 . . . . 0.0 112.061 -171.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.663 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -62.9 155.45 27.14 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.758 172.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 61.59 24.91 14.93 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.642 1.177 . . . . 0.0 112.565 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.4 m -107.88 157.98 17.72 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.713 0.805 . . . . 0.0 109.069 175.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.3 m -114.59 121.9 44.87 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.907 0.483 . . . . 0.0 110.54 -178.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.562 HD11 HG21 ' A' ' 59' ' ' VAL . 3.0 mm? -94.22 162.56 13.8 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.644 1.178 . . . . 0.0 109.478 171.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -122.69 130.98 53.58 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.457 1.103 . . . . 0.0 108.751 173.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 86.8 t -104.65 114.02 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.23 161.03 21.07 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.742 0.817 . . . . 0.0 111.016 -177.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.09 106.26 3.35 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -131.39 -57.8 1.0 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.617 0.767 . . . . 0.0 111.414 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.548 ' O ' ' HA ' ' A' ' 38' ' ' ASP . 41.2 tpp -86.77 170.16 11.97 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.238 0.615 . . . . 0.0 110.562 -171.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 59.2 tp -149.82 147.41 27.94 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.753 0.821 . . . . 0.0 108.859 171.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.531 ' H ' ' HG3' ' A' ' 37' ' ' GLU . . . -67.2 110.17 3.32 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 123.787 0.679 . . . . 0.0 112.093 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.113 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -178.841 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.542 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -113.07 132.78 55.28 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.581 0.753 . . . . 0.0 108.978 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.484 HD13 HD23 ' A' ' 65' ' ' LEU . 4.0 pp -131.35 158.92 39.42 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -101.9 152.2 21.2 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.648 0.779 . . . . 0.0 109.106 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.41 ' HB ' ' HB2' ' A' ' 11' ' ' HIS . 8.8 t -126.11 124.9 66.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.675 1.19 . . . . 0.0 108.631 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -95.21 93.41 7.29 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.147 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -108.43 -176.59 3.09 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 168.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.86 -29.04 1.78 Allowed 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 123.429 0.692 . . . . 0.0 112.49 174.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -123.06 159.44 28.44 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.167 0.987 . . . . 0.0 108.698 163.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.4 mt -79.58 128.35 33.27 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.245 0.545 . . . . 0.0 110.789 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 56.2 m-70 -113.23 163.19 15.1 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.708 1.203 . . . . 0.0 108.174 173.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 t -141.44 146.32 36.38 Favored 'General case' 0 C--O 1.244 0.763 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 169.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -138.81 131.54 29.16 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.842 0.857 . . . . 0.0 109.877 -175.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.42 132.16 43.39 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 170.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.48 HG11 HD11 ' A' ' 24' ' ' ILE . 16.1 m -141.6 -169.38 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 125.025 1.33 . . . . 0.0 109.083 -177.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.5 m -113.18 -9.33 13.49 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.85 0.86 . . . . 0.0 109.854 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.39 -36.61 3.69 Favored Glycine 0 C--N 1.357 1.738 0 N-CA-C 112.245 -0.342 . . . . 0.0 112.245 -174.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -67.88 -16.85 64.27 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.505 0.722 . . . . 0.0 110.989 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -67.61 146.74 53.57 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 122.926 0.49 . . . . 0.0 110.313 172.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 76.7 p -84.74 157.19 21.12 Favored 'General case' 0 C--O 1.244 0.763 0 CA-C-O 121.608 0.718 . . . . 0.0 112.029 -176.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.6 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 82.6 t -60.63 -27.36 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.747 173.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.74 -52.71 48.94 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.009 0.923 . . . . 0.0 111.695 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -64.88 -30.63 71.64 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 119.456 -0.307 . . . . 0.0 111.203 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.487 ' O ' HG23 ' A' ' 28' ' ' VAL . 37.6 mm -58.65 -56.66 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 123.536 0.523 . . . . 0.0 110.631 173.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -68.82 -29.18 67.47 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.449 0.3 . . . . 0.0 110.352 -177.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.44 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . . . -67.51 -40.81 85.15 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.645 0.778 . . . . 0.0 111.335 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -67.5 -40.97 85.18 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.539 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 65.0 t -59.19 -45.03 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.609 174.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.37 -39.11 82.24 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.095 0.958 . . . . 0.0 111.795 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.4 m -63.3 -37.93 89.18 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.728 0.811 . . . . 0.0 111.344 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.5 mt -77.23 -30.12 54.44 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.758 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 28' ' ' VAL . 17.6 mm-40 -78.11 -27.82 48.42 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.914 0.885 . . . . 0.0 110.908 176.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.75 15.54 59.56 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 116.152 -0.476 . . . . 0.0 113.519 -175.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.9 pt -120.2 -176.9 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 124.224 1.01 . . . . 0.0 110.5 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.82 145.75 30.28 Favored Pre-proline 0 CA--C 1.562 1.427 0 C-N-CA 123.312 0.645 . . . . 0.0 111.382 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.44 ' HB3' ' HA ' ' A' ' 26' ' ' ALA . 30.3 Cg_endo -62.7 -21.23 72.78 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 123.165 2.577 . . . . 0.0 113.913 177.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.424 ' HG3' ' HA3' ' A' ' 73' ' ' GLY . 12.3 pt-20 -66.73 -17.95 65.12 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.026 0.93 . . . . 0.0 111.805 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -80.58 -40.22 26.19 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.591 0.71 . . . . 0.0 110.101 174.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.433 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 96.5 mt-30 -90.13 154.34 19.85 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 114.419 -1.264 . . . . 0.0 112.348 -168.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.4 134.24 17.29 Favored 'Isoleucine or valine' 0 C--O 1.252 1.215 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.51 172.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.632 HG22 HG22 ' A' ' 67' ' ' VAL . 74.5 t -82.24 129.31 37.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.648 177.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.5 mt -117.19 124.02 48.09 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.293 1.437 . . . . 0.0 108.529 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.413 ' HB2' HD11 ' A' ' 48' ' ' LEU . 30.7 tp -100.18 107.62 19.53 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 171.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 61.64 22.85 13.26 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.651 1.18 . . . . 0.0 111.943 -174.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.68 -20.84 38.17 Favored Glycine 0 C--N 1.355 1.594 0 CA-C-N 116.105 -0.498 . . . . 0.0 113.222 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.4 120.47 74.38 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 123.487 0.715 . . . . 0.0 110.628 -176.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.94 121.79 9.82 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.197 2.598 . . . . 0.0 113.033 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.417 HD22 ' SG ' ' A' ' 57' ' ' CYS . 84.9 mt -82.63 152.77 25.75 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 123.76 0.824 . . . . 0.0 109.792 174.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -73.37 110.04 7.36 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.6 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 14.9 p-10 -63.45 -32.77 74.31 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.551 -177.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -71.18 -17.91 62.51 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.935 0.894 . . . . 0.0 111.347 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.32 153.33 22.05 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.693 0.797 . . . . 0.0 111.013 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 62.9 p -82.09 158.15 23.83 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.67 0.788 . . . . 0.0 110.374 178.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.12 -35.12 79.23 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.873 0.869 . . . . 0.0 111.129 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.08 -46.9 68.19 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.149 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -72.76 -30.1 63.85 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.044 0.537 . . . . 0.0 110.981 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.417 ' SG ' HD22 ' A' ' 48' ' ' LEU . 42.9 t -67.33 -26.65 66.6 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.71 0.804 . . . . 0.0 111.056 173.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.27 22.61 47.42 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.305 177.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.517 HG21 HD21 ' A' ' 65' ' ' LEU . 2.4 p -98.39 131.75 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 176.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -121.08 -168.27 1.64 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.136 0.974 . . . . 0.0 110.881 -172.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.542 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -67.44 160.04 28.3 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.296 0.638 . . . . 0.0 111.087 175.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 61.25 19.03 9.73 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.781 1.232 . . . . 0.0 112.399 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.404 HG21 HG23 ' A' ' 59' ' ' VAL . 9.9 m -101.06 161.15 13.8 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.826 0.85 . . . . 0.0 108.826 174.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.8 m -128.33 124.2 35.86 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.517 HD21 HG21 ' A' ' 59' ' ' VAL . 3.1 mm? -109.61 128.27 55.11 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 124.795 1.238 . . . . 0.0 108.727 -178.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -93.54 108.17 19.91 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.751 0.82 . . . . 0.0 109.109 -174.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.632 HG22 HG22 ' A' ' 41' ' ' VAL . 76.8 t -94.95 106.09 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -178.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.48 136.34 54.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.281 -176.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 39' ' ' GLN . . . -82.17 89.74 1.46 Allowed Glycine 0 C--N 1.34 0.766 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 176.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -118.73 -21.54 7.81 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.425 0.69 . . . . 0.0 111.327 -175.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.8 ttm -78.54 -44.35 24.47 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.6 tm? 62.95 108.49 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.609 1.563 . . . . 0.0 111.382 175.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.424 ' HA3' ' HG3' ' A' ' 37' ' ' GLU . . . -113.84 158.97 13.95 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.033 174.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.761 -1.022 . . . . 0.0 112.172 178.241 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.437 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 26.0 ttt . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -89.86 98.61 11.87 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.602 -175.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.0 pp -114.7 150.4 35.32 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 175.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -87.77 145.45 26.1 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.857 0.863 . . . . 0.0 108.839 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.436 HG11 HG21 ' A' ' 28' ' ' VAL . 73.0 t -125.79 111.35 26.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 170.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -74.73 92.55 2.48 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.282 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.69 -175.39 3.57 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.781 1.232 . . . . 0.0 108.086 170.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -49.32 -28.54 4.97 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.082 0.553 . . . . 0.0 111.613 173.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -122.76 151.17 41.87 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.039 0.935 . . . . 0.0 108.522 161.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -73.22 128.44 35.49 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -177.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -127.6 159.81 33.51 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.504 0.721 . . . . 0.0 110.079 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.8 m -129.2 137.73 51.31 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -130.84 114.85 15.81 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.887 0.875 . . . . 0.0 111.302 -170.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -76.81 103.56 6.83 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 163.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.437 ' O ' ' HB3' ' A' ' 1' ' ' MET . 30.8 m -110.9 169.47 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.893 0.877 . . . . 0.0 109.434 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.1 m -94.93 -28.79 15.0 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.007 0.523 . . . . 0.0 110.108 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.429 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 102.18 -13.1 57.3 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 116.251 -0.432 . . . . 0.0 112.662 -176.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -91.99 -9.39 43.09 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.462 0.705 . . . . 0.0 111.186 -176.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -73.02 152.63 41.23 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 78.2 p -80.72 164.38 22.82 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.516 0.674 . . . . 0.0 109.569 171.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.597 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 53.9 t -62.98 -27.21 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.34 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.842 171.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . . . -64.0 -40.14 95.69 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.404 0.682 . . . . 0.0 111.483 172.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.415 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 85.9 mm-40 -66.91 -36.75 82.98 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.797 0.439 . . . . 0.0 110.515 177.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.9 mm -61.18 -47.76 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.35 0.66 . . . . 0.0 110.417 174.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -55.23 -49.42 72.05 Favored 'General case' 0 C--N 1.359 1.005 0 O-C-N 123.714 0.634 . . . . 0.0 109.943 175.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.68 -48.36 72.5 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.916 0.886 . . . . 0.0 111.904 -178.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -64.87 -45.95 83.87 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.239 0.616 . . . . 0.0 110.853 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.592 HG11 HG21 ' A' ' 67' ' ' VAL . 84.1 t -64.88 -39.97 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 122.632 0.373 . . . . 0.0 110.542 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 34' ' ' ILE . . . -68.65 -32.28 72.02 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.647 0.779 . . . . 0.0 111.763 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.8 t -66.33 -42.02 88.77 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.186 0.594 . . . . 0.0 110.703 173.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.3 mt -70.41 -45.61 65.58 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.082 0.553 . . . . 0.0 112.063 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -88.54 -3.98 58.69 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.498 0.719 . . . . 0.0 111.747 -175.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.54 33.48 72.14 Favored Glycine 0 C--N 1.356 1.675 0 O-C-N 123.529 0.518 . . . . 0.0 113.725 174.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.428 ' O ' ' HB1' ' A' ' 29' ' ' ALA . 9.6 pt -123.01 -179.92 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.035 0.934 . . . . 0.0 110.576 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.58 125.61 53.09 Favored Pre-proline 0 CA--C 1.557 1.24 0 C-N-CA 123.392 0.677 . . . . 0.0 110.931 -176.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.65 -18.87 37.27 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.485 2.123 . . . . 0.0 112.685 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -66.73 -33.94 76.75 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.07 0.948 . . . . 0.0 111.846 -177.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -92.49 -8.08 45.57 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -176.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -80.1 147.05 31.57 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.247 0.546 . . . . 0.0 111.008 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.2 m -130.1 142.25 44.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 168.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.442 HG13 ' HB3' ' A' ' 65' ' ' LEU . 73.2 t -106.29 105.53 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.3 mt -87.81 122.5 31.53 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.274 1.03 . . . . 0.0 110.291 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.2 tp -91.27 97.17 10.95 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 167.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 55.96 30.61 16.37 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.252 1.021 . . . . 0.0 112.082 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.1 -23.58 24.98 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-N 115.93 -0.577 . . . . 0.0 113.568 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.43 113.61 38.28 Favored Pre-proline 0 N--CA 1.479 0.977 0 CA-C-N 117.487 0.643 . . . . 0.0 110.929 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -65.92 109.22 1.44 Allowed 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.512 2.142 . . . . 0.0 112.143 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.6 mt -73.76 148.15 42.82 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.738 0.815 . . . . 0.0 110.996 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.411 ' HB3' ' HG2' ' A' ' 51' ' ' GLU . 44.6 mm-40 -77.25 121.88 24.3 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 124.286 0.991 . . . . 0.0 109.989 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.597 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 0.8 OUTLIER -65.75 -21.95 66.55 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 123.913 0.758 . . . . 0.0 112.546 176.142 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.411 ' HG2' ' HB3' ' A' ' 49' ' ' GLU . 11.2 pt-20 -72.39 -26.8 62.02 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.226 0.61 . . . . 0.0 111.099 174.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.89 143.11 27.3 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.767 0.827 . . . . 0.0 111.454 -174.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 45.6 p -73.74 168.06 20.14 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.549 0.74 . . . . 0.0 111.067 172.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.429 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 3.1 mm? -64.46 -30.39 71.43 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 171.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.88 -39.29 93.37 Favored Glycine 0 C--N 1.358 1.755 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.621 173.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -71.24 -37.26 72.0 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.741 0.416 . . . . 0.0 109.9 177.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 40.6 t -66.48 -22.45 66.19 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.414 0.685 . . . . 0.0 111.37 173.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.44 21.31 78.66 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.584 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.2 p -91.58 152.76 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 123.572 0.749 . . . . 0.0 109.606 -176.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -132.21 -168.3 2.02 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.764 0.826 . . . . 0.0 110.948 -176.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.8 167.4 13.49 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.537 0.735 . . . . 0.0 112.491 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 68.14 -5.33 0.9 Allowed 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 126.247 1.819 . . . . 0.0 113.737 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.3 m -77.6 153.71 32.98 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.776 0.83 . . . . 0.0 109.939 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.7 m -119.07 110.16 16.76 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.756 0.822 . . . . 0.0 109.633 175.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.442 ' HB3' HG13 ' A' ' 41' ' ' VAL . 84.8 mt -87.04 144.65 26.79 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 171.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -117.28 121.61 41.65 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.561 0.619 . . . . 0.0 110.857 -175.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.592 HG21 HG11 ' A' ' 28' ' ' VAL . 77.0 t -83.75 115.93 26.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 122.804 0.441 . . . . 0.0 109.971 173.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -123.89 167.21 14.41 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.562 1.145 . . . . 0.0 109.765 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.64 88.88 0.5 Allowed Glycine 0 C--N 1.342 0.871 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -109.35 -36.34 6.03 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.836 0.855 . . . . 0.0 109.706 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 47.4 ttm -83.2 146.66 28.48 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.185 175.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -92.15 -32.48 15.1 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.49 -144.21 12.46 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.79 174.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.436 0 CA-C-O 118.937 -0.924 . . . . 0.0 112.629 177.916 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -102.61 118.39 36.75 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.682 0.793 . . . . 0.0 110.252 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 pp -133.55 165.26 25.31 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.302 0.641 . . . . 0.0 110.35 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -101.05 142.39 32.58 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.057 0.943 . . . . 0.0 109.528 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.1 t -125.46 109.62 22.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 C-N-CA 123.903 0.881 . . . . 0.0 108.674 171.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 35.5 ttt85 -79.48 95.35 5.78 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.084 1.353 . . . . 0.0 110.862 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.17 -174.82 3.33 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.582 1.153 . . . . 0.0 108.032 165.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -42.15 -36.18 1.12 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 123.567 0.747 . . . . 0.0 111.62 167.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -111.05 136.25 50.34 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 164.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -70.88 123.28 21.62 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 173.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -126.1 154.42 43.13 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.498 0.719 . . . . 0.0 109.769 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.3 m -113.91 143.15 45.18 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.812 0.845 . . . . 0.0 108.809 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -136.61 129.36 30.66 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.793 0.837 . . . . 0.0 110.043 -174.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -90.74 114.71 27.13 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 166.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.3 m -115.37 155.48 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.192 0.997 . . . . 0.0 110.463 -169.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.0 m -83.03 -9.9 59.03 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -171.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.5 -50.68 4.07 Favored Glycine 0 C--N 1.358 1.776 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -174.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -79.65 7.06 9.11 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.855 0.862 . . . . 0.0 110.802 167.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -59.57 121.05 10.6 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.765 1.226 . . . . 0.0 109.176 168.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.688 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 51.1 p -78.88 167.41 21.19 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 118.765 0.711 . . . . 0.0 110.385 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.589 HG21 ' HB3' ' A' ' 48' ' ' LEU . 80.3 t -67.52 -32.52 57.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 123.157 0.583 . . . . 0.0 110.069 174.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.65 -36.43 84.25 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.601 0.761 . . . . 0.0 110.635 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -69.3 -40.86 77.43 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.307 0.643 . . . . 0.0 110.963 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.573 HD11 HD11 ' A' ' 54' ' ' LEU . 40.9 mm -57.95 -45.82 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.591 0.757 . . . . 0.0 110.151 175.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.532 ' HE2' ' HA ' ' A' ' 40' ' ' VAL . 92.6 mttt -59.6 -49.59 77.19 Favored 'General case' 0 C--O 1.21 -1.017 0 O-C-N 124.52 1.137 . . . . 0.0 110.603 176.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.01 -42.96 91.36 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.007 0.923 . . . . 0.0 112.025 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -59.41 -53.15 61.45 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.871 0.868 . . . . 0.0 111.019 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.469 HG11 HG21 ' A' ' 67' ' ' VAL . 11.6 p -75.39 -27.57 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.46 -175.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.77 -37.15 79.13 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.726 0.81 . . . . 0.0 110.985 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.4 t -67.13 -40.88 86.87 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 123.39 0.431 . . . . 0.0 110.44 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.1 mt -61.9 -49.71 75.11 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 123.445 0.466 . . . . 0.0 111.916 176.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 28' ' ' VAL . 3.2 mm-40 -86.58 -3.43 59.02 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.115 0.566 . . . . 0.0 111.693 -175.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.56 16.87 70.21 Favored Glycine 0 C--N 1.357 1.711 0 O-C-N 123.315 0.384 . . . . 0.0 113.285 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 36.1 pt -98.65 175.84 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.936 0.894 . . . . 0.0 110.937 -175.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.39 133.29 38.75 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.814 0.846 . . . . 0.0 110.355 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -66.76 -16.77 51.2 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.699 2.266 . . . . 0.0 111.964 171.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -76.71 -19.34 57.8 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.642 0.777 . . . . 0.0 111.579 174.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -97.89 19.7 13.38 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.588 0.755 . . . . 0.0 111.131 -172.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -152.87 166.43 32.34 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.651 -0.656 . . . . 0.0 112.024 -172.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.532 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . 11.2 p -142.29 149.22 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.653 1.181 . . . . 0.0 108.993 172.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.428 ' HB ' HG13 ' A' ' 21' ' ' VAL . 63.1 t -102.65 132.55 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.22 0.608 . . . . 0.0 109.638 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 47' ' ' PRO . 2.7 mm? -117.75 113.54 21.99 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.648 1.579 . . . . 0.0 108.657 -174.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.618 HD11 ' HB ' ' A' ' 59' ' ' VAL . 2.9 tt -80.15 98.26 7.24 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 57.85 26.48 13.29 Favored 'General case' 0 CA--C 1.556 1.175 0 O-C-N 124.007 0.817 . . . . 0.0 111.842 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.27 -18.79 32.85 Favored Glycine 0 C--N 1.357 1.719 0 CA-C-N 115.927 -0.578 . . . . 0.0 114.207 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.84 117.31 67.81 Favored Pre-proline 0 N--CA 1.483 1.184 0 C-N-CA 123.516 0.726 . . . . 0.0 111.422 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.411 ' HA ' HD13 ' A' ' 42' ' ' LEU . 36.3 Cg_endo -62.11 108.95 0.73 Allowed 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.09 2.527 . . . . 0.0 113.204 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.589 ' HB3' HG21 ' A' ' 21' ' ' VAL . 73.7 mt -82.78 139.97 33.27 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.133 177.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -80.56 131.9 35.58 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.024 0.93 . . . . 0.0 110.334 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.24 -49.87 22.4 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.038 1.335 . . . . 0.0 113.628 -174.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -18.79 49.89 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.955 0.502 . . . . 0.0 112.173 -173.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.73 140.36 45.92 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.107 0.563 . . . . 0.0 110.791 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.688 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 47.6 p -85.43 170.87 12.28 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.734 0.414 . . . . 0.0 110.673 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.573 HD11 HD11 ' A' ' 24' ' ' ILE . 36.8 mt -68.74 -29.93 68.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.117 0.567 . . . . 0.0 111.117 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.02 -42.39 92.52 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.05 172.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -68.89 -31.34 70.19 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.842 0.857 . . . . 0.0 111.271 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 79.0 m -71.96 -28.87 63.73 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.304 0.642 . . . . 0.0 110.635 172.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.76 22.07 54.23 Favored Glycine 0 C--N 1.348 1.21 0 O-C-N 123.495 0.497 . . . . 0.0 112.91 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.618 ' HB ' HD11 ' A' ' 43' ' ' LEU . 7.5 p -96.94 135.7 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.44 0.696 . . . . 0.0 110.235 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -106.77 -168.57 1.43 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.247 1.019 . . . . 0.0 109.925 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.35 175.79 6.6 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.107 0.563 . . . . 0.0 111.26 176.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 58.59 26.02 13.91 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.869 1.268 . . . . 0.0 112.439 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.6 m -111.63 153.94 25.61 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.854 0.862 . . . . 0.0 109.832 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 54.5 m -114.44 108.82 17.39 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.08 0.552 . . . . 0.0 109.889 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.57 149.96 21.03 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 171.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -125.19 139.25 53.91 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 119.087 0.858 . . . . 0.0 110.758 -176.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.469 HG21 HG11 ' A' ' 28' ' ' VAL . 77.1 t -97.14 122.23 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.526 0.731 . . . . 0.0 110.071 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -118.3 149.91 40.36 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.426 0.69 . . . . 0.0 110.543 173.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.39 90.57 1.68 Allowed Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -123.3 10.29 9.25 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.708 0.803 . . . . 0.0 110.422 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 37.7 tpp . . . . . 0 N--CA 1.479 1.01 0 C-N-CA 122.868 0.467 . . . . 0.0 110.698 -169.138 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.474 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 30.1 tt0 -145.26 123.06 11.9 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.6 pp -119.9 166.79 12.85 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.312 0.577 . . . . 0.0 110.715 -174.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -102.57 137.62 40.57 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.9 t -107.15 114.39 46.01 Favored 'Isoleucine or valine' 0 C--O 1.248 0.995 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 172.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.5 ttt85 -83.09 90.51 7.06 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.231 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.59 -176.8 3.19 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 114.373 -1.285 . . . . 0.0 107.988 174.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -43.66 -29.22 0.48 Allowed 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 124.352 1.061 . . . . 0.0 112.316 170.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -135.68 140.89 44.82 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.908 1.283 . . . . 0.0 107.921 166.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.9 126.28 30.09 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.24 0.616 . . . . 0.0 110.076 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -119.96 160.38 22.87 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.058 0.943 . . . . 0.0 108.93 172.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.0 m -124.58 131.65 53.47 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -132.16 126.51 33.8 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.598 0.759 . . . . 0.0 109.939 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 11.3 pt-20 -89.15 135.54 33.51 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.097 0.475 . . . . 0.0 109.764 173.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 1' ' ' MET . 30.1 m -134.74 150.21 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.8 0.84 . . . . 0.0 109.598 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.1 p -93.58 12.51 25.03 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.164 0.585 . . . . 0.0 111.26 172.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.411 ' O ' ' HB ' ' A' ' 53' ' ' THR . . . 93.62 -35.4 4.16 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-O 119.647 -0.529 . . . . 0.0 112.798 176.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -68.0 -21.13 65.06 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.974 0.91 . . . . 0.0 112.301 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -62.0 134.64 56.9 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 26.4 p -82.6 168.6 17.16 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.36 0.6 . . . . 0.0 110.637 174.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.567 HG21 ' HB3' ' A' ' 48' ' ' LEU . 55.9 t -63.16 -32.78 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.425 170.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.508 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . . . -60.74 -42.42 97.31 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.36 0.664 . . . . 0.0 111.064 173.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -67.83 -37.47 81.95 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.348 0.259 . . . . 0.0 111.232 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.415 HD11 HG11 ' A' ' 15' ' ' VAL . 44.0 mm -57.32 -48.1 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 122.837 0.455 . . . . 0.0 110.032 173.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.444 ' HE3' HG12 ' A' ' 21' ' ' VAL . 96.6 mttt -61.26 -40.81 95.44 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.783 0.833 . . . . 0.0 111.223 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.87 -43.56 94.64 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.884 0.874 . . . . 0.0 112.069 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -65.54 -42.59 91.77 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.034 0.533 . . . . 0.0 111.044 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.8 t -64.71 -39.88 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.086 0.555 . . . . 0.0 109.76 176.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.98 -35.19 79.36 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.258 1.023 . . . . 0.0 112.316 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.5 m -64.81 -50.13 67.92 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.345 0.658 . . . . 0.0 110.843 175.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.5 mt -71.59 -38.44 70.89 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -174.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -91.35 -14.61 30.43 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.055 0.542 . . . . 0.0 111.662 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.92 27.26 69.17 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 116.405 -0.362 . . . . 0.0 112.565 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.2 pt -108.09 177.97 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.793 0.837 . . . . 0.0 109.795 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.27 138.92 20.62 Favored Pre-proline 0 N--CA 1.478 0.957 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.61 -20.48 70.95 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 123.296 2.664 . . . . 0.0 113.053 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -67.95 -35.36 78.27 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.573 0.749 . . . . 0.0 111.006 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 71' ' ' MET . 10.6 m-20 -73.26 -18.06 61.26 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.073 0.549 . . . . 0.0 112.261 -172.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.546 ' HB2' HG13 ' A' ' 67' ' ' VAL . 12.3 pt20 -112.95 151.22 30.8 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.399 0.679 . . . . 0.0 111.074 -174.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -132.12 132.94 61.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 124.744 1.218 . . . . 0.0 107.986 171.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.6 t -88.78 131.2 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.0 mt -122.93 115.19 21.52 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.952 1.301 . . . . 0.0 108.983 -174.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.524 ' HB2' HD11 ' A' ' 48' ' ' LEU . 42.2 tp -81.94 95.14 7.28 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 176.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 56.97 24.52 9.55 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.058 0.943 . . . . 0.0 112.027 -174.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.6 -8.19 37.1 Favored Glycine 0 C--N 1.354 1.528 0 CA-C-O 119.597 -0.557 . . . . 0.0 113.86 -177.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.72 118.84 74.55 Favored Pre-proline 0 N--CA 1.483 1.211 0 CA-C-N 117.444 0.622 . . . . 0.0 110.849 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.29 102.04 0.31 Allowed 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.746 2.298 . . . . 0.0 112.519 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.567 ' HB3' HG21 ' A' ' 21' ' ' VAL . 67.1 mt -81.0 134.4 35.67 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.463 177.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -82.52 139.0 34.14 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.834 0.854 . . . . 0.0 110.333 -176.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 22' ' ' ALA . 2.0 m-20 -59.96 -30.13 68.88 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.792 0.837 . . . . 0.0 111.835 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -73.35 -25.55 60.65 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.215 1.006 . . . . 0.0 111.206 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.98 131.74 35.87 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.921 -174.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 81.1 p -80.59 167.71 19.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.27 0.628 . . . . 0.0 109.541 172.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -65.51 -30.66 71.45 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.241 0.473 . . . . 0.0 110.42 176.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.27 -36.0 70.33 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.511 173.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -72.11 -38.05 69.4 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.465 0.706 . . . . 0.0 110.638 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 76.6 m -71.32 -18.63 62.39 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.905 0.882 . . . . 0.0 111.088 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.92 29.52 75.21 Favored Glycine 0 C--N 1.352 1.431 0 O-C-N 123.497 0.498 . . . . 0.0 112.663 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.469 HG21 HD11 ' A' ' 65' ' ' LEU . 4.5 p -87.08 133.29 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -81.77 174.24 11.52 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.505 0.722 . . . . 0.0 110.979 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.462 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -72.71 160.37 32.33 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.784 175.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 64.84 12.16 7.52 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.743 1.617 . . . . 0.0 112.96 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.4 m -85.11 154.37 22.08 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.3 m -114.32 116.08 28.4 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.146 0.498 . . . . 0.0 110.181 -177.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.469 HD11 HG21 ' A' ' 59' ' ' VAL . 6.9 mp -103.57 122.14 44.36 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.085 1.354 . . . . 0.0 108.142 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -94.71 145.32 24.93 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.025 0.53 . . . . 0.0 111.841 -171.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.546 HG13 ' HB2' ' A' ' 39' ' ' GLN . 73.6 t -94.12 135.97 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 124.211 1.004 . . . . 0.0 109.989 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.63 141.26 51.67 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.113 0.965 . . . . 0.0 109.503 171.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.14 92.06 1.52 Allowed Glycine 0 N--CA 1.472 1.065 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -121.97 -68.5 0.89 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 117.321 0.561 . . . . 0.0 111.959 -172.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.457 ' O ' ' HA ' ' A' ' 38' ' ' ASP . 51.2 tpp . . . . . 0 N--CA 1.482 1.153 0 C-N-CA 123.456 0.703 . . . . 0.0 111.141 -174.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 60.8 tt0 -122.14 114.33 20.73 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.922 0.889 . . . . 0.0 109.389 -175.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.3 pp -120.79 165.13 15.57 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.938 0.495 . . . . 0.0 111.635 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -98.51 152.24 19.76 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.636 0.774 . . . . 0.0 109.254 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.7 t -135.13 109.31 10.99 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 C-N-CA 124.767 1.227 . . . . 0.0 108.179 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -76.33 92.83 3.37 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.866 0.866 . . . . 0.0 110.776 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.31 -176.87 4.26 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.297 1.039 . . . . 0.0 108.398 165.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -47.55 -30.15 3.35 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.17 0.588 . . . . 0.0 112.156 171.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -124.0 144.07 50.04 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.175 0.99 . . . . 0.0 108.661 161.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.86 133.95 47.94 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 122.947 0.499 . . . . 0.0 110.391 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -131.02 148.49 52.76 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.837 0.855 . . . . 0.0 109.406 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.2 m -119.5 133.74 55.54 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -128.45 119.3 24.66 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.977 0.911 . . . . 0.0 109.997 -175.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 42.0 tt0 -95.35 104.43 16.32 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 171.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.0 m -112.8 174.44 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.126 0.97 . . . . 0.0 110.864 -172.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.7 m -83.09 -45.53 13.88 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.678 0.791 . . . . 0.0 110.106 174.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.23 -35.06 3.2 Favored Glycine 0 C--N 1.35 1.321 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -174.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -65.55 -10.13 32.42 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.476 0.71 . . . . 0.0 111.53 173.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -52.64 129.08 28.3 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.854 1.261 . . . . 0.0 110.408 169.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.675 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 45.5 p -84.77 164.73 18.33 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 118.272 0.487 . . . . 0.0 109.94 173.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.491 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 68.4 t -67.22 -30.27 48.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.235 174.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.504 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . . . -62.12 -40.42 95.85 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.572 0.749 . . . . 0.0 110.802 174.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -68.5 -40.17 81.0 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.746 177.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.9 mm -57.97 -42.84 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 123.229 0.612 . . . . 0.0 110.529 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.43 -51.87 68.04 Favored 'General case' 0 C--N 1.359 0.998 0 O-C-N 123.975 0.797 . . . . 0.0 110.015 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.61 -42.97 75.63 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.861 0.726 . . . . 0.0 111.924 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.416 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 48.5 m-70 -61.54 -54.62 40.79 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.686 0.794 . . . . 0.0 111.655 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.526 HG11 HG21 ' A' ' 67' ' ' VAL . 12.8 p -72.42 -30.01 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.637 -174.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.402 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . . . -72.45 -34.69 67.95 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.388 0.675 . . . . 0.0 111.526 177.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 t -67.16 -37.65 84.12 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.957 0.503 . . . . 0.0 110.309 176.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 27' ' ' HIS . 88.5 mt -63.4 -45.81 89.29 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 123.705 0.628 . . . . 0.0 111.711 177.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.15 -20.0 45.93 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.082 0.553 . . . . 0.0 111.785 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.27 30.81 66.73 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 112.014 -0.434 . . . . 0.0 112.014 -173.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.3 pt -111.57 179.83 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.189 0.996 . . . . 0.0 110.634 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.74 123.43 88.34 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 124.237 1.015 . . . . 0.0 112.576 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.23 -31.59 35.41 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 122.548 2.165 . . . . 0.0 112.567 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.98 5.95 34.69 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.34 0.656 . . . . 0.0 112.062 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -78.83 -31.45 45.77 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 122.35 1.071 . . . . 0.0 109.205 166.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.402 ' NE2' ' HB2' ' A' ' 29' ' ' ALA . 18.8 mt-30 -89.85 147.39 23.8 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 113.725 -1.579 . . . . 0.0 112.337 -167.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -131.05 129.18 63.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 165.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.446 ' HB ' HG13 ' A' ' 21' ' ' VAL . 59.3 t -87.89 131.69 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.6 mt -118.59 148.78 42.33 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.927 1.291 . . . . 0.0 109.519 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.431 ' HB2' HD11 ' A' ' 48' ' ' LEU . 42.3 tp -131.44 102.15 5.82 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 171.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 58.66 33.83 23.37 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.457 1.103 . . . . 0.0 111.398 -175.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.84 -24.01 33.96 Favored Glycine 0 C--N 1.354 1.554 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.297 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.35 119.4 76.84 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 123.325 0.65 . . . . 0.0 110.506 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.28 106.44 1.02 Allowed 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.881 2.387 . . . . 0.0 111.964 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.432 ' HB3' HG21 ' A' ' 21' ' ' VAL . 90.8 mt -69.56 124.12 23.1 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.356 0.663 . . . . 0.0 110.014 173.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -72.46 131.7 42.9 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.366 0.666 . . . . 0.0 110.63 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.504 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . 7.8 p-10 -58.79 -36.79 75.01 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.008 0.923 . . . . 0.0 112.832 -173.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -74.75 -25.72 59.29 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.1 0.56 . . . . 0.0 111.05 -176.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.72 139.51 40.49 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.504 0.722 . . . . 0.0 110.609 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.675 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 53.2 p -83.67 170.36 14.34 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.925 0.393 . . . . 0.0 110.751 177.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.7 mp -72.8 -26.48 61.53 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.9 0.88 . . . . 0.0 110.292 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.3 -43.19 71.79 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.037 172.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -64.42 -39.16 93.3 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.237 0.615 . . . . 0.0 110.77 175.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 46.1 t -63.73 -31.35 72.49 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.624 0.77 . . . . 0.0 111.406 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.38 23.96 69.43 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.272 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.451 HG23 HG21 ' A' ' 63' ' ' THR . 14.7 p -79.44 150.24 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.072 0.549 . . . . 0.0 109.551 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -127.42 -171.68 2.48 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.362 0.665 . . . . 0.0 111.262 -169.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.76 154.8 41.31 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.468 0.707 . . . . 0.0 111.404 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 62.9 1.48 0.84 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 126.183 1.793 . . . . 0.0 114.06 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.451 HG21 HG23 ' A' ' 59' ' ' VAL . 32.3 m -72.37 147.76 45.94 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 47.1 m -113.34 103.71 11.58 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 122.072 -0.393 . . . . 0.0 109.951 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.408 HD23 HD13 ' A' ' 43' ' ' LEU . 62.2 mt -78.18 169.92 17.46 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 170.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -136.08 155.16 50.62 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.526 HG21 HG11 ' A' ' 28' ' ' VAL . 48.7 t -120.38 126.55 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.263 1.025 . . . . 0.0 108.956 175.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.01 142.65 51.5 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.671 0.789 . . . . 0.0 109.805 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.24 89.79 1.64 Allowed Glycine 0 C--N 1.342 0.909 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -130.03 5.06 4.91 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.89 0.876 . . . . 0.0 110.72 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.1 ttm . . . . . 0 N--CA 1.474 0.77 0 C-N-CA 123.438 0.695 . . . . 0.0 109.403 -170.881 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.49 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 44.1 ttm . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -91.01 105.03 17.54 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 170.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.5 pp -114.85 163.89 14.89 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.645 0.778 . . . . 0.0 109.985 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -107.41 158.8 16.88 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.513 0.725 . . . . 0.0 109.391 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.406 HG11 HG21 ' A' ' 28' ' ' VAL . 76.9 t -129.66 111.88 23.09 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 C-N-CA 124.037 0.935 . . . . 0.0 109.884 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -70.89 91.33 0.85 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.111 0.964 . . . . 0.0 109.42 173.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.03 -179.37 3.9 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 125.478 1.511 . . . . 0.0 107.808 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -59.21 -33.16 70.65 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 118.581 0.628 . . . . 0.0 109.715 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -111.18 127.5 55.61 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 165.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.99 120.07 14.28 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 -111.33 158.3 19.19 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.571 0.749 . . . . 0.0 109.622 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.7 m -134.0 135.73 43.61 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.297 1.039 . . . . 0.0 108.735 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -133.06 124.79 28.28 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.88 0.872 . . . . 0.0 110.46 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -98.1 105.74 17.93 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 170.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.493 HG11 HD11 ' A' ' 24' ' ' ILE . 28.8 m -120.53 157.77 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.952 1.301 . . . . 0.0 109.412 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.62 ' HB ' ' HG2' ' A' ' 18' ' ' GLN . 20.4 m -75.94 -14.24 60.25 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-O 121.058 0.456 . . . . 0.0 110.907 173.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.452 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 103.26 -31.79 8.32 Favored Glycine 0 C--N 1.351 1.411 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -172.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.62 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 12.6 pt20 -70.74 -4.43 23.74 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.924 0.89 . . . . 0.0 112.304 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -79.23 145.5 33.55 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.754 0.422 . . . . 0.0 109.936 175.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.6 p -82.38 153.46 25.72 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.181 0.515 . . . . 0.0 111.134 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.0 t -62.35 -28.17 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 124.277 1.031 . . . . 0.0 110.522 175.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.62 -50.09 75.23 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 124.331 1.052 . . . . 0.0 110.793 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -67.43 -36.15 80.66 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.312 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.493 HD11 HG11 ' A' ' 15' ' ' VAL . 48.0 mm -57.59 -54.86 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 O-C-N 123.829 0.705 . . . . 0.0 110.301 177.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -73.0 -27.9 62.05 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.105 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.15 -46.48 90.35 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.52 0.728 . . . . 0.0 110.571 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -66.08 -40.18 90.63 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.266 0.627 . . . . 0.0 110.348 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.501 HG11 HG21 ' A' ' 67' ' ' VAL . 72.6 t -56.92 -49.72 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 173.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.33 -34.86 77.47 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.048 0.939 . . . . 0.0 112.609 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.5 t -65.58 -36.74 84.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.488 0.715 . . . . 0.0 110.746 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.1 mt -80.45 -34.84 35.69 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.933 0.893 . . . . 0.0 112.24 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.498 ' HB2' HG12 ' A' ' 34' ' ' ILE . 6.1 mm-40 -75.65 -36.14 60.24 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.891 0.876 . . . . 0.0 110.172 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.93 36.5 15.28 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.479 -171.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.498 HG12 ' HB2' ' A' ' 32' ' ' GLU . 25.0 pt -127.2 -179.56 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 123.897 0.879 . . . . 0.0 111.03 -176.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.18 114.19 37.75 Favored Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 123.937 0.895 . . . . 0.0 112.218 -176.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.85 -33.1 85.38 Favored 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 123.521 2.814 . . . . 0.0 114.009 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -69.39 -37.56 77.58 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.247 0.342 . . . . 0.0 110.691 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -64.84 -44.55 89.44 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 123.812 0.695 . . . . 0.0 111.116 -170.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.572 ' HB2' HG13 ' A' ' 67' ' ' VAL . 11.7 pt20 -75.75 150.96 37.69 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.976 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.2 144.15 37.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 124.975 1.31 . . . . 0.0 108.139 175.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.7 t -90.46 133.35 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 122.915 0.486 . . . . 0.0 109.86 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 66.5 mt -117.28 108.87 16.15 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.896 1.278 . . . . 0.0 108.961 -176.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.4 ' HB2' HD11 ' A' ' 48' ' ' LEU . 46.2 tp -80.44 96.63 6.79 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 175.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 57.85 28.34 15.9 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.059 0.944 . . . . 0.0 112.036 -176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.46 -25.38 19.84 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-O 119.608 -0.551 . . . . 0.0 113.556 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.3 113.54 32.18 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 123.132 0.573 . . . . 0.0 110.563 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -64.61 115.15 3.05 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.501 2.134 . . . . 0.0 111.526 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.4 HD11 ' HB2' ' A' ' 43' ' ' LEU . 93.2 mt -79.86 158.16 26.81 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.537 0.735 . . . . 0.0 111.358 178.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -86.29 128.71 34.96 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -62.57 -36.59 83.16 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 121.057 0.456 . . . . 0.0 110.911 -176.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -78.8 -9.41 59.44 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.736 0.815 . . . . 0.0 111.843 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.87 148.16 24.77 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 123.356 0.662 . . . . 0.0 109.974 175.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.4 p -92.34 166.34 12.63 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.467 0.707 . . . . 0.0 110.62 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.452 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 3.5 mm? -65.19 -28.47 69.41 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.638 0.775 . . . . 0.0 110.107 175.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.1 -37.02 44.24 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.231 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -67.76 -41.85 82.7 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.019 0.527 . . . . 0.0 110.05 174.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 80.7 m -63.5 -25.84 68.44 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.144 0.578 . . . . 0.0 110.773 174.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.99 25.88 70.32 Favored Glycine 0 C--N 1.35 1.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.667 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.52 160.81 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 122.891 0.477 . . . . 0.0 109.795 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -110.87 -177.08 3.13 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.395 0.678 . . . . 0.0 110.67 -178.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.49 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -76.86 166.25 23.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.294 0.638 . . . . 0.0 111.022 177.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 67.92 6.29 5.05 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.965 1.306 . . . . 0.0 112.909 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.1 m -79.94 150.89 30.36 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.164 0.585 . . . . 0.0 109.746 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.2 m -117.17 112.06 20.32 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.4 mp -96.42 146.9 24.36 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 124.65 1.18 . . . . 0.0 108.112 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -102.01 156.21 17.68 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.065 0.546 . . . . 0.0 110.88 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.572 HG13 ' HB2' ' A' ' 39' ' ' GLN . 6.6 t -118.62 131.29 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.368 1.067 . . . . 0.0 109.311 173.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.32 126.74 20.08 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.121 0.968 . . . . 0.0 109.992 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 39' ' ' GLN . . . -75.97 96.01 1.06 Allowed Glycine 0 C--N 1.344 0.982 0 N-CA-C 111.961 -0.455 . . . . 0.0 111.961 -178.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -120.6 -68.38 0.91 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.778 0.831 . . . . 0.0 111.438 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 21.3 mmt . . . . . 0 N--CA 1.487 1.41 0 C-N-CA 122.712 0.405 . . . . 0.0 111.862 -168.516 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 ttt . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -85.32 127.54 34.37 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.4 pp -136.2 167.24 21.65 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -109.64 147.95 32.18 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.112 0.565 . . . . 0.0 109.8 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.6 t -122.26 109.09 23.28 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 C-N-CA 125.128 1.371 . . . . 0.0 108.059 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -79.76 91.69 5.34 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.462 -1.244 . . . . 0.0 109.58 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.8 -177.84 3.49 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 114.262 -1.335 . . . . 0.0 108.345 177.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -52.29 -27.49 15.36 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.29 0.567 . . . . 0.0 110.847 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -117.36 141.07 48.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.006 1.322 . . . . 0.0 108.468 163.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -83.29 109.45 17.27 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.481 ' CD2' HG23 ' A' ' 28' ' ' VAL . 88.9 m-70 -110.61 132.46 54.17 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.694 0.798 . . . . 0.0 109.704 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.4 t -106.07 136.09 46.37 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -125.63 128.03 47.24 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.695 0.798 . . . . 0.0 109.923 -176.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -90.11 104.82 17.35 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 170.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.8 m -111.85 172.35 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.362 1.065 . . . . 0.0 109.428 176.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.1 m -107.49 -9.96 15.83 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.376 0.671 . . . . 0.0 109.801 174.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.533 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 108.41 -35.78 4.76 Favored Glycine 0 C--N 1.353 1.473 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.754 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -4.89 39.47 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -176.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -78.11 147.33 34.69 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.854 0.462 . . . . 0.0 109.815 170.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 61.7 p -86.42 164.59 16.92 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.349 0.595 . . . . 0.0 111.745 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.415 HG21 ' HB3' ' A' ' 48' ' ' LEU . 71.3 t -66.32 -27.69 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.04 172.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.69 -41.86 95.74 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.83 0.852 . . . . 0.0 110.664 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -69.62 -38.97 77.45 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.608 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 27.9 mm -54.49 -45.59 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 123.661 0.784 . . . . 0.0 110.387 173.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 21' ' ' VAL . 92.4 mttt -61.35 -49.2 77.9 Favored 'General case' 0 C--N 1.36 1.061 0 O-C-N 124.049 0.843 . . . . 0.0 111.068 176.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.85 -38.54 78.97 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 124.328 1.017 . . . . 0.0 111.365 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -61.27 -58.14 9.49 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.726 0.811 . . . . 0.0 110.961 177.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.481 HG23 ' CD2' ' A' ' 11' ' ' HIS . 6.3 p -66.8 -30.94 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.449 -174.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.26 -43.39 77.92 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.935 0.894 . . . . 0.0 111.444 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.1 t -61.79 -41.5 97.82 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.384 0.673 . . . . 0.0 110.597 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.7 mt -65.0 -49.99 68.07 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.932 0.893 . . . . 0.0 111.863 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -90.44 -2.71 57.95 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.341 0.656 . . . . 0.0 112.185 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.1 17.82 77.47 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-O 120.159 -0.245 . . . . 0.0 113.511 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.1 pt -102.08 -179.1 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.939 0.895 . . . . 0.0 110.248 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.473 ' HB1' ' HG2' ' A' ' 37' ' ' GLU . . . -102.69 133.82 20.23 Favored Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 123.052 0.541 . . . . 0.0 111.756 -175.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.505 ' HA ' ' HG2' ' A' ' 39' ' ' GLN . 68.3 Cg_endo -70.61 -17.84 33.43 Favored 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 122.678 2.252 . . . . 0.0 111.583 175.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.473 ' HG2' ' HB1' ' A' ' 35' ' ' ALA . 10.0 pt-20 -89.4 -2.16 58.31 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.924 1.29 . . . . 0.0 112.012 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -107.62 -20.8 13.12 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.532 0.733 . . . . 0.0 110.164 175.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.505 ' HG2' ' HA ' ' A' ' 36' ' ' PRO . 11.3 pt20 -106.79 157.85 17.43 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.703 0.763 . . . . 0.0 110.671 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.6 m -132.37 158.98 43.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 C-N-CA 125.166 1.386 . . . . 0.0 108.356 169.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.489 HG12 HD12 ' A' ' 48' ' ' LEU . 66.2 t -111.68 124.6 68.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 176.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.5 mt -108.44 154.14 22.3 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 124.902 1.281 . . . . 0.0 109.346 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.2 tp -130.91 106.67 8.58 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 169.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 59.92 24.42 13.5 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.005 0.922 . . . . 0.0 111.317 -174.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.53 -28.47 14.86 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.155 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.99 120.59 80.36 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.101 0.56 . . . . 0.0 110.767 -174.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.04 106.22 0.64 Allowed 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 123.082 2.521 . . . . 0.0 112.407 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.489 HD12 HG12 ' A' ' 41' ' ' VAL . 80.2 mt -68.13 121.24 15.73 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.967 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -60.19 126.63 28.26 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.968 0.793 . . . . 0.0 110.004 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -58.85 -43.28 90.72 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.447 0.699 . . . . 0.0 111.846 -174.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -77.14 -17.62 58.49 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.639 0.375 . . . . 0.0 111.441 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.77 133.63 40.65 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 55.2 p -78.2 168.26 20.12 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.696 0.798 . . . . 0.0 110.537 177.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.533 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 2.5 mm? -61.49 -35.54 77.96 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 120.958 0.409 . . . . 0.0 110.165 177.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.37 -33.77 61.22 Favored Glycine 0 C--N 1.355 1.625 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.536 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -72.57 -37.69 68.12 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.215 0.606 . . . . 0.0 110.681 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 78.6 m -68.23 -28.6 67.37 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.35 0.66 . . . . 0.0 110.321 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.35 24.98 69.38 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.755 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.592 HG21 HD21 ' A' ' 65' ' ' LEU . 6.2 p -77.87 138.64 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -91.14 178.95 5.85 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.125 0.57 . . . . 0.0 110.95 -175.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.65 160.32 31.75 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.28 0.632 . . . . 0.0 111.205 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 61.4 10.65 3.25 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.454 1.501 . . . . 0.0 113.423 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.1 m -82.53 147.05 28.87 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.097 0.475 . . . . 0.0 110.156 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.4 m -104.59 106.49 17.01 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.841 0.856 . . . . 0.0 109.838 -175.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.592 HD21 HG21 ' A' ' 59' ' ' VAL . 43.9 mt -92.14 128.05 37.85 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.415 1.086 . . . . 0.0 108.444 176.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -99.0 140.97 32.35 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.758 0.708 . . . . 0.0 111.965 -172.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.492 HG13 ' HB2' ' A' ' 39' ' ' GLN . 69.4 t -95.78 125.47 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.067 0.947 . . . . 0.0 109.42 173.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.01 149.35 48.78 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.093 0.957 . . . . 0.0 109.294 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.19 89.28 1.39 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -106.62 -40.3 5.58 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.387 0.675 . . . . 0.0 109.88 176.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 48.4 tpp . . . . . 0 CA--C 1.547 0.841 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 172.73 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.415 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 22.1 ttt . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 121.312 0.577 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.492 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 53.3 tt0 -91.36 140.15 30.05 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.525 HD13 HD13 ' A' ' 65' ' ' LEU . 4.5 pp -146.91 159.85 43.04 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.274 0.63 . . . . 0.0 109.443 176.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -103.45 116.12 31.8 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.696 0.798 . . . . 0.0 109.505 -174.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.1 t -88.72 106.59 16.89 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 170.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.463 ' HB3' ' HA ' ' A' ' 66' ' ' GLU . 19.9 ttt180 -76.86 91.4 3.54 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.527 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -109.55 -176.43 3.01 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 125.347 1.459 . . . . 0.0 108.608 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -46.23 -39.57 10.06 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.538 0.735 . . . . 0.0 112.277 174.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -106.2 156.06 18.84 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 163.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.67 108.63 7.55 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -107.34 141.83 38.09 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.437 0.695 . . . . 0.0 109.505 175.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.7 t -126.8 135.13 50.63 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -128.36 131.55 48.57 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.337 1.055 . . . . 0.0 108.792 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 43.7 tt0 -91.36 113.77 26.12 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 167.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.539 HG21 ' HG ' ' A' ' 54' ' ' LEU . 27.6 m -110.3 144.82 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.953 0.901 . . . . 0.0 110.121 -174.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.6 p -85.95 3.34 42.47 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.073 0.549 . . . . 0.0 111.499 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.423 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 89.9 -38.31 3.23 Favored Glycine 0 C--N 1.353 1.495 0 CA-C-O 119.682 -0.51 . . . . 0.0 113.325 175.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -70.25 -19.81 63.1 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.988 0.915 . . . . 0.0 112.459 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -64.9 135.78 56.09 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.331 0.652 . . . . 0.0 109.483 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 70.1 p -83.59 165.55 18.94 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.326 0.584 . . . . 0.0 111.269 -177.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.6 t -66.42 -29.13 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 123.189 0.596 . . . . 0.0 110.351 174.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.506 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . . . -63.25 -39.9 95.9 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.284 0.634 . . . . 0.0 111.254 173.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -71.66 -35.08 70.23 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.906 0.482 . . . . 0.0 110.955 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 31.4 mm -58.32 -47.12 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.272 0.629 . . . . 0.0 110.384 171.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.489 ' HE2' ' HA ' ' A' ' 40' ' ' VAL . 98.6 mttt -61.52 -42.09 98.29 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.212 0.605 . . . . 0.0 111.342 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.81 80.68 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 124.138 0.899 . . . . 0.0 111.586 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.0 m-70 -60.16 -51.08 71.14 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.875 0.47 . . . . 0.0 111.041 175.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.491 HG12 HD11 ' A' ' 34' ' ' ILE . 49.0 t -67.26 -28.49 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.722 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.64 -34.97 62.87 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.875 0.87 . . . . 0.0 111.441 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.7 t -73.43 -40.1 64.49 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.118 0.567 . . . . 0.0 111.053 178.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.5 mt -77.18 -53.08 8.2 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.219 0.607 . . . . 0.0 111.633 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.31 -17.37 46.04 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.558 0.743 . . . . 0.0 111.738 -177.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.33 17.45 78.89 Favored Glycine 0 N--CA 1.471 0.984 0 N-CA-C 112.605 -0.198 . . . . 0.0 112.605 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.491 HD11 HG12 ' A' ' 28' ' ' VAL . 37.0 pt -91.41 166.23 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.596 0.758 . . . . 0.0 111.099 -175.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.99 118.1 67.87 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 123.257 0.623 . . . . 0.0 110.704 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HA ' ' HG2' ' A' ' 39' ' ' GLN . 56.2 Cg_endo -66.92 -19.85 51.9 Favored 'Trans proline' 0 C--N 1.387 2.57 0 C-N-CA 122.584 2.189 . . . . 0.0 111.84 176.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -74.41 -29.58 61.57 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.263 1.025 . . . . 0.0 111.836 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -85.93 -41.31 15.04 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.302 0.641 . . . . 0.0 110.697 -175.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.48 ' HB2' HG13 ' A' ' 67' ' ' VAL . 12.9 pt20 -76.58 157.08 32.28 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.998 -172.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.616 HG11 ' HB2' ' A' ' 70' ' ' ARG . 9.8 p -142.39 148.0 20.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 C-N-CA 125.186 1.394 . . . . 0.0 108.297 177.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.1 t -101.56 117.77 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.8 0.84 . . . . 0.0 109.308 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 68' ' ' ALA . 2.3 mm? -103.89 104.61 14.62 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.47 1.108 . . . . 0.0 109.69 -175.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.3 tp -81.75 97.19 7.83 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 58.31 26.05 13.5 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.952 0.901 . . . . 0.0 112.016 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.5 -19.82 33.29 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.511 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.83 114.99 48.66 Favored Pre-proline 0 N--CA 1.477 0.903 0 C-N-CA 123.456 0.702 . . . . 0.0 111.001 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -67.96 110.88 2.27 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 122.673 2.249 . . . . 0.0 111.018 174.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.5 mt -72.4 170.46 14.2 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.844 177.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -96.05 138.6 33.45 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' A' ' 22' ' ' ALA . 1.8 m-20 -55.92 -38.67 70.58 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.261 0.624 . . . . 0.0 111.402 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.45 -24.28 46.13 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.748 0.819 . . . . 0.0 111.48 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.97 132.89 42.86 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.061 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 21.1 p -81.35 173.5 12.4 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.539 ' HG ' HG21 ' A' ' 15' ' ' VAL . 3.3 mm? -64.26 -23.45 67.31 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 118.285 0.493 . . . . 0.0 110.258 174.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.42 -39.26 26.61 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.942 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.463 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 14.5 mm-40 -73.75 -29.75 62.41 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.411 0.684 . . . . 0.0 110.422 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 74.2 m -81.32 -18.17 46.68 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.791 0.837 . . . . 0.0 110.724 172.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.38 33.18 81.29 Favored Glycine 0 C--N 1.353 1.476 0 O-C-N 123.416 0.448 . . . . 0.0 113.461 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.1 t -70.49 135.59 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.336 0.654 . . . . 0.0 110.056 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -93.49 172.15 8.45 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.371 0.668 . . . . 0.0 110.534 176.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.23 165.05 25.44 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.065 0.546 . . . . 0.0 111.277 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 58.31 16.6 4.14 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 125.228 1.411 . . . . 0.0 112.798 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.8 m -90.98 147.84 22.82 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.656 0.782 . . . . 0.0 109.845 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 42.5 m -113.52 105.22 13.09 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.718 0.807 . . . . 0.0 109.26 -175.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.525 HD13 HD13 ' A' ' 3' ' ' LEU . 4.5 mp -103.03 123.44 46.63 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . 38.0 tt0 -93.56 150.7 20.22 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.9 0.48 . . . . 0.0 111.436 -171.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.48 HG13 ' HB2' ' A' ' 39' ' ' GLN . 73.3 t -104.11 118.59 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.911 0.884 . . . . 0.0 108.932 175.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.42 ' HB3' HD21 ' A' ' 42' ' ' LEU . . . -126.58 165.74 18.59 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.907 0.883 . . . . 0.0 109.669 175.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -98.22 90.12 1.02 Allowed Glycine 0 N--CA 1.471 0.977 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 175.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.616 ' HB2' HG11 ' A' ' 40' ' ' VAL . 73.7 mtp180 -134.74 17.29 3.57 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.407 0.683 . . . . 0.0 110.8 -176.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 44.5 tpp . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.214 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.48 ' HG3' ' HB2' ' A' ' 61' ' ' ALA . 62.1 ttp . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -77.01 118.56 19.7 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.212 1.005 . . . . 0.0 109.62 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.1 pp -137.74 161.23 37.09 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.113 0.565 . . . . 0.0 109.775 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -96.53 152.42 18.64 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.656 0.782 . . . . 0.0 109.836 -175.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.0 t -137.85 101.82 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 124.676 1.191 . . . . 0.0 107.962 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -76.33 94.88 3.67 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.057 0.943 . . . . 0.0 111.843 -175.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.78 -176.51 3.11 Favored 'General case' 0 C--O 1.245 0.867 0 C-N-CA 124.811 1.245 . . . . 0.0 108.099 165.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -45.29 -31.41 1.57 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.514 0.726 . . . . 0.0 112.153 171.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -114.72 137.29 52.1 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 162.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.32 113.47 8.4 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -91.82 155.76 17.99 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.647 0.779 . . . . 0.0 109.482 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.3 m -141.5 115.6 9.31 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 173.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -116.25 134.54 54.8 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.386 0.675 . . . . 0.0 110.601 -173.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -89.17 103.56 16.17 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 166.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.447 HG21 ' HG ' ' A' ' 54' ' ' LEU . 18.7 m -112.15 141.61 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.208 1.003 . . . . 0.0 109.225 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.2 t -91.41 5.55 48.93 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 120.657 0.265 . . . . 0.0 110.806 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.506 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 101.19 -25.97 26.32 Favored Glycine 0 C--N 1.357 1.718 0 CA-C-O 119.727 -0.485 . . . . 0.0 113.513 171.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -80.56 -14.32 58.32 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.881 0.473 . . . . 0.0 111.985 -174.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.426 ' O ' HD22 ' A' ' 54' ' ' LEU . 25.4 mp0 -65.31 130.62 43.98 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 69.0 p -75.13 168.81 19.26 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.189 0.518 . . . . 0.0 110.04 174.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.465 HG12 ' HE3' ' A' ' 25' ' ' LYS . 33.6 t -65.59 -29.21 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . . . -62.47 -41.82 99.04 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.69 0.796 . . . . 0.0 110.553 171.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -67.52 -36.84 81.83 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.869 0.468 . . . . 0.0 111.079 177.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.523 HD11 HD21 ' A' ' 54' ' ' LEU . 39.6 mm -60.13 -48.11 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.284 0.634 . . . . 0.0 110.177 175.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.465 ' HE3' HG12 ' A' ' 21' ' ' VAL . 92.5 mttt -60.05 -43.07 95.64 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.446 0.698 . . . . 0.0 110.745 176.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.26 -45.55 90.9 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.858 1.263 . . . . 0.0 111.7 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -61.74 -47.37 85.51 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.612 0.765 . . . . 0.0 110.448 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 24' ' ' ILE . 90.8 t -63.1 -40.48 89.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 123.763 0.664 . . . . 0.0 110.296 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.31 -33.35 71.42 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.739 1.216 . . . . 0.0 112.258 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.7 t -70.78 -38.05 73.38 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.474 0.71 . . . . 0.0 110.512 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.1 mt -72.71 -51.69 18.24 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.15 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -86.58 -19.27 29.65 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -172.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.68 29.84 58.89 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 112.303 -0.319 . . . . 0.0 112.303 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.7 pt -101.62 176.96 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.474 0.709 . . . . 0.0 110.618 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -96.26 120.41 62.61 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 123.425 0.69 . . . . 0.0 110.422 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.01 -7.06 20.21 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.557 2.171 . . . . 0.0 111.813 172.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -60.7 -38.99 86.86 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 125.373 1.469 . . . . 0.0 110.492 171.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -88.21 -25.52 22.85 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.686 -178.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -75.27 133.0 41.44 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.706 -174.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.15 138.98 52.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 C-N-CA 124.353 1.061 . . . . 0.0 108.241 165.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.2 t -97.88 133.5 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.2 mt -117.76 128.62 55.05 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.604 1.161 . . . . 0.0 109.445 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.517 ' HB2' HD11 ' A' ' 48' ' ' LEU . 54.6 tp -105.99 104.85 14.65 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 169.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 60.33 26.51 16.03 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.845 0.858 . . . . 0.0 111.675 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.22 -15.59 58.91 Favored Glycine 0 C--N 1.352 1.448 0 CA-C-O 119.745 -0.475 . . . . 0.0 113.664 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.8 120.22 77.18 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 117.44 0.62 . . . . 0.0 109.668 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.8 112.2 1.93 Allowed 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.564 2.176 . . . . 0.0 112.06 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.517 HD11 ' HB2' ' A' ' 43' ' ' LEU . 80.4 mt -81.81 131.27 35.25 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.847 0.859 . . . . 0.0 110.158 175.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -72.01 142.96 49.33 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.718 0.636 . . . . 0.0 110.865 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . 11.1 p-10 -61.45 -26.17 67.71 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.293 1.037 . . . . 0.0 111.976 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -76.02 -25.91 56.14 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.829 0.851 . . . . 0.0 111.583 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.18 133.3 37.8 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.849 0.86 . . . . 0.0 110.965 -175.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 70.3 p -80.64 173.4 12.65 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.951 0.5 . . . . 0.0 110.395 174.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.523 HD21 HD11 ' A' ' 24' ' ' ILE . 2.9 mm? -61.81 -35.14 77.34 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 173.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.16 -43.6 96.9 Favored Glycine 0 C--N 1.355 1.616 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.975 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -69.63 -38.06 77.03 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.231 0.612 . . . . 0.0 111.397 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 83.9 m -73.63 -16.11 61.24 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.426 0.69 . . . . 0.0 111.155 175.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.29 26.48 71.68 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 123.582 0.551 . . . . 0.0 113.493 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.9 p -90.15 117.02 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.443 0.697 . . . . 0.0 109.68 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -87.22 -172.79 4.11 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.19 0.996 . . . . 0.0 111.932 -172.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.48 ' HB2' ' HG3' ' A' ' 1' ' ' MET . . . -71.82 154.0 41.56 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.653 0.781 . . . . 0.0 111.043 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 67.85 4.03 3.78 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.595 1.558 . . . . 0.0 112.679 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.9 m -85.15 151.67 23.94 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 34.4 m -113.9 111.48 21.77 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.247 0.546 . . . . 0.0 110.33 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.1 mt -78.68 160.85 27.29 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 165.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -132.61 142.28 49.06 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 122.115 -0.366 . . . . 0.0 110.886 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.8 t -95.95 132.62 39.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.892 0.877 . . . . 0.0 109.113 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.87 167.15 22.86 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.84 0.856 . . . . 0.0 109.83 177.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -109.97 90.36 0.59 Allowed Glycine 0 C--N 1.341 0.812 0 N-CA-C 112.29 -0.324 . . . . 0.0 112.29 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -103.56 -48.59 3.92 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.534 0.734 . . . . 0.0 109.056 171.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 42.4 tpp . . . . . 0 CA--C 1.549 0.929 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.656 -178.973 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -101.46 124.26 46.85 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.2 pp -137.49 166.57 23.56 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.486 0.715 . . . . 0.0 110.627 -178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -98.58 161.5 13.63 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.288 0.635 . . . . 0.0 110.615 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.497 HG22 ' HB2' ' A' ' 65' ' ' LEU . 44.7 t -133.32 117.08 26.95 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 C-N-CA 124.55 1.14 . . . . 0.0 108.512 173.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -71.13 94.11 1.11 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.741 1.216 . . . . 0.0 109.207 174.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -118.77 -179.45 3.81 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.544 1.138 . . . . 0.0 108.998 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -44.86 -35.32 2.73 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 123.54 0.736 . . . . 0.0 111.234 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -128.98 137.38 51.33 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 166.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.5 mt -66.69 128.83 37.77 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.077 0.551 . . . . 0.0 110.861 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -124.26 160.91 26.91 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.381 0.673 . . . . 0.0 109.926 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.4 m -130.26 125.33 34.54 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.01 0.924 . . . . 0.0 108.966 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -120.73 132.55 55.13 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.268 1.027 . . . . 0.0 110.588 -173.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -92.36 106.31 18.34 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 169.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.3 167.84 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.497 1.119 . . . . 0.0 110.741 -172.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.3 p -100.44 -4.29 29.21 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.98 -52.36 4.72 Favored Glycine 0 C--N 1.358 1.804 0 N-CA-C 112.147 -0.381 . . . . 0.0 112.147 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -66.1 -10.84 44.35 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.0 0.92 . . . . 0.0 110.986 169.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -57.45 127.05 30.06 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.226 1.01 . . . . 0.0 110.754 170.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.633 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 82.8 p -85.64 160.23 19.64 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.678 0.391 . . . . 0.0 110.737 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.569 HG13 ' HB ' ' A' ' 41' ' ' VAL . 50.8 t -63.93 -31.68 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 123.963 0.905 . . . . 0.0 111.668 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.448 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . . . -66.53 -42.28 87.48 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.512 0.725 . . . . 0.0 110.674 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -74.88 -29.61 61.06 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.14 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.554 HD11 HD11 ' A' ' 54' ' ' LEU . 30.4 mm -57.58 -50.33 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 168.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -57.01 -45.88 82.74 Favored 'General case' 0 C--N 1.36 1.036 0 O-C-N 123.86 0.725 . . . . 0.0 111.054 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.09 -48.05 76.87 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 124.604 1.19 . . . . 0.0 111.987 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -71.47 -41.33 69.5 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.242 0.217 . . . . 0.0 111.056 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 24' ' ' ILE . 68.9 t -59.97 -41.53 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.13 -42.36 93.94 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.225 1.01 . . . . 0.0 111.702 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.5 t -62.13 -40.09 94.76 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 123.862 0.727 . . . . 0.0 111.496 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 33.0 mt -80.16 -39.94 28.31 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 120.928 0.394 . . . . 0.0 111.502 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.92 -6.07 59.13 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.792 0.837 . . . . 0.0 111.95 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.56 20.32 77.07 Favored Glycine 0 CA--C 1.532 1.104 0 O-C-N 123.506 0.504 . . . . 0.0 113.651 176.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.0 pt -107.63 -179.27 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.048 0.939 . . . . 0.0 110.454 -176.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.432 ' HB1' ' HG2' ' A' ' 37' ' ' GLU . . . -90.83 134.49 30.33 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 123.274 0.63 . . . . 0.0 110.265 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -68.12 -24.67 38.3 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.622 2.214 . . . . 0.0 112.311 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.432 ' HG2' ' HB1' ' A' ' 35' ' ' ALA . 11.2 pt-20 -67.68 -29.84 69.22 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.929 0.891 . . . . 0.0 111.464 175.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -81.05 -18.7 45.79 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.995 0.918 . . . . 0.0 111.902 -170.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.432 ' HB2' HG13 ' A' ' 67' ' ' VAL . 12.3 pt20 -107.57 158.18 17.44 Favored 'General case' 0 C--O 1.245 0.818 0 C-N-CA 123.069 0.548 . . . . 0.0 110.86 -176.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.415 HG11 ' HB2' ' A' ' 70' ' ' ARG . 12.6 p -128.94 134.56 64.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.649 172.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.569 ' HB ' HG13 ' A' ' 21' ' ' VAL . 95.2 t -98.7 121.91 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 66' ' ' GLU . 27.4 mt -113.62 157.72 21.76 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.687 1.595 . . . . 0.0 108.426 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 tt -105.06 96.85 6.82 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 106.266 -1.754 . . . . 0.0 106.266 163.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 51.45 40.62 27.13 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.513 1.125 . . . . 0.0 112.41 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.69 -30.78 8.4 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-O 119.405 -0.664 . . . . 0.0 114.106 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.98 116.85 54.64 Favored Pre-proline 0 N--CA 1.484 1.27 0 CA-C-N 117.704 0.752 . . . . 0.0 111.466 -176.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -60.78 108.7 0.57 Allowed 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.008 2.472 . . . . 0.0 113.246 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.09 137.19 33.69 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.949 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -77.41 136.33 38.39 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.808 0.692 . . . . 0.0 109.904 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.448 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . 7.8 p-10 -58.78 -41.66 87.16 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.713 0.805 . . . . 0.0 112.284 -174.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -79.57 -15.58 57.43 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.204 0.601 . . . . 0.0 111.468 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.83 136.62 38.93 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 123.224 0.61 . . . . 0.0 110.276 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.633 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 43.7 p -80.09 165.88 22.06 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.205 0.602 . . . . 0.0 110.144 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.554 HD11 HD11 ' A' ' 24' ' ' ILE . 86.5 mt -64.73 -38.1 89.84 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.988 0.515 . . . . 0.0 111.243 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.97 -41.82 99.69 Favored Glycine 0 C--N 1.349 1.285 0 O-C-N 123.854 0.721 . . . . 0.0 112.623 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -74.82 -29.93 61.23 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.818 0.447 . . . . 0.0 111.386 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 89.1 m -75.41 -7.47 54.15 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.55 0.74 . . . . 0.0 111.728 173.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.17 15.88 81.16 Favored Glycine 0 C--N 1.351 1.404 0 C-N-CA 123.05 0.357 . . . . 0.0 113.866 173.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 p -99.34 132.72 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.136 0.574 . . . . 0.0 109.605 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -121.54 -168.14 1.64 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.359 1.063 . . . . 0.0 110.495 -175.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.34 150.74 48.59 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.172 0.589 . . . . 0.0 111.057 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 70.22 2.5 4.01 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.678 1.591 . . . . 0.0 113.0 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.6 m -88.05 163.6 16.18 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 174.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.2 m -123.8 116.84 23.64 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.562 0.745 . . . . 0.0 109.664 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.497 ' HB2' HG22 ' A' ' 5' ' ' VAL . 3.2 mm? -75.05 -178.95 4.05 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.422 0.689 . . . . 0.0 109.595 170.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 35.7 tt0 -144.24 108.86 4.88 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.563 0.345 . . . . 0.0 110.703 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.432 HG13 ' HB2' ' A' ' 39' ' ' GLN . 55.5 t -85.94 117.84 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 172.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.42 168.94 10.79 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 123.943 0.897 . . . . 0.0 109.971 175.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.57 87.5 1.1 Allowed Glycine 0 C--N 1.344 1.02 0 N-CA-C 111.881 -0.488 . . . . 0.0 111.881 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.415 ' HB2' HG11 ' A' ' 40' ' ' VAL . 39.0 mtp180 -143.63 141.55 30.65 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.745 1.218 . . . . 0.0 107.75 170.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 C--O 1.242 0.701 0 C-N-CA 123.14 0.576 . . . . 0.0 110.204 -178.045 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.488 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 62.9 mtp . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -88.34 116.16 26.36 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.426 HD13 HD13 ' A' ' 65' ' ' LEU . 3.4 pp -132.21 150.4 52.16 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.432 0.693 . . . . 0.0 109.981 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -89.05 152.17 21.83 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.292 1.037 . . . . 0.0 109.8 -177.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -135.93 109.75 9.85 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 C-N-CA 124.343 1.057 . . . . 0.0 108.484 -177.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.404 ' HA ' HD13 ' A' ' 10' ' ' LEU . 3.7 tmm_? -73.66 94.96 2.26 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.45 1.1 . . . . 0.0 110.022 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -112.85 -177.41 3.13 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.283 1.033 . . . . 0.0 108.811 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -45.69 -25.45 0.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.15 0.98 . . . . 0.0 113.044 171.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -127.24 150.0 49.74 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.176 0.99 . . . . 0.0 108.913 158.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 6' ' ' ARG . 4.5 mm? -76.2 109.57 9.99 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 122.987 0.515 . . . . 0.0 110.144 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -94.03 162.24 13.97 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.119 0.968 . . . . 0.0 110.168 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.7 t -141.03 142.23 34.24 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 164.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -133.97 131.57 39.14 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.653 0.781 . . . . 0.0 110.178 -175.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -92.47 104.13 16.48 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.753 174.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.8 m -111.18 161.26 9.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 C-N-CA 123.858 0.863 . . . . 0.0 110.259 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.4 m -87.12 -29.68 21.65 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.853 0.861 . . . . 0.0 110.366 176.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.538 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 116.45 -29.36 7.01 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.19 -173.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -85.77 -4.13 59.08 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.506 0.723 . . . . 0.0 112.532 -173.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.405 ' O ' HD22 ' A' ' 54' ' ' LEU . 23.0 mp0 -76.06 145.68 39.94 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 50' ' ' ASP . 59.0 p -82.82 160.89 22.13 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.354 0.597 . . . . 0.0 110.516 175.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.615 HG13 ' HB ' ' A' ' 41' ' ' VAL . 52.8 t -60.42 -30.53 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 123.715 0.806 . . . . 0.0 110.428 175.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.505 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . . . -58.57 -47.07 85.48 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 124.08 0.952 . . . . 0.0 111.051 171.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -64.58 -39.83 94.45 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.611 0.364 . . . . 0.0 110.624 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.551 HD11 HD21 ' A' ' 54' ' ' LEU . 41.8 mm -60.09 -49.27 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 122.979 0.512 . . . . 0.0 111.364 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.499 ' HB3' HG23 ' A' ' 41' ' ' VAL . 62.9 pttt -74.51 -29.58 61.46 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 119.686 -0.197 . . . . 0.0 110.702 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.403 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . . . -64.18 -34.21 77.56 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.306 0.642 . . . . 0.0 110.92 175.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.45 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 32.6 m170 -68.38 -46.25 70.56 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.117 0.567 . . . . 0.0 110.378 174.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.5 t -56.08 -39.96 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.449 0.642 . . . . 0.0 110.14 174.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.85 -45.65 77.52 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.903 1.281 . . . . 0.0 112.369 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.2 p -69.43 -27.63 65.42 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.01 0.524 . . . . 0.0 111.539 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 27' ' ' HIS . 86.1 mt -76.82 -48.47 18.4 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.817 0.447 . . . . 0.0 111.202 178.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -91.9 -5.47 53.17 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -174.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.04 5.98 85.52 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 113.859 0.304 . . . . 0.0 113.859 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.9 pt -81.74 169.06 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.325 0.65 . . . . 0.0 110.303 178.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.404 ' HB1' ' HG2' ' A' ' 37' ' ' GLU . . . -83.32 136.5 43.09 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.605 0.762 . . . . 0.0 109.986 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.403 ' HB3' ' HA ' ' A' ' 26' ' ' ALA . 56.3 Cg_endo -68.71 -22.68 37.01 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.394 2.063 . . . . 0.0 111.741 174.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.404 ' HG2' ' HB1' ' A' ' 35' ' ' ALA . 11.5 pt-20 -80.02 -8.98 59.64 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.974 0.91 . . . . 0.0 111.626 177.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -75.52 -29.04 59.34 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.197 0.599 . . . . 0.0 111.987 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.43 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -144.76 179.9 7.01 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.14 0.495 . . . . 0.0 111.372 -170.552 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.2 p -145.4 149.92 16.22 Favored 'Isoleucine or valine' 0 C--O 1.25 1.101 0 C-N-CA 124.867 1.267 . . . . 0.0 108.138 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.615 ' HB ' HG13 ' A' ' 21' ' ' VAL . 46.5 t -86.65 138.04 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.361 0.601 . . . . 0.0 109.763 176.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -116.21 140.41 49.33 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -179.524 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.3 tp -86.48 95.91 9.87 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 169.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 55.17 28.92 11.75 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.858 0.863 . . . . 0.0 112.661 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.72 -14.01 35.1 Favored Glycine 0 CA--C 1.536 1.398 0 CA-C-O 119.5 -0.611 . . . . 0.0 114.001 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.57 110.83 24.33 Favored Pre-proline 0 N--CA 1.484 1.261 0 CA-C-N 117.845 0.823 . . . . 0.0 110.622 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.45 107.07 0.24 Allowed 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 123.645 2.897 . . . . 0.0 114.077 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.544 ' HB3' HG21 ' A' ' 21' ' ' VAL . 96.4 mt -80.45 139.74 36.3 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.485 0.714 . . . . 0.0 110.735 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -71.57 130.21 40.66 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.771 0.669 . . . . 0.0 109.667 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' A' ' 22' ' ' ALA . 71.3 m-20 -62.25 -27.57 69.09 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.079 0.552 . . . . 0.0 112.216 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -80.06 -21.18 43.71 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.663 0.785 . . . . 0.0 111.617 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.26 138.54 39.46 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.516 0.726 . . . . 0.0 110.517 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 58.2 p -88.0 168.28 12.98 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.037 0.535 . . . . 0.0 110.587 177.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.551 HD21 HD11 ' A' ' 24' ' ' ILE . 2.5 mm? -62.28 -33.68 75.1 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 174.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.03 -30.78 56.87 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.891 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -76.18 -36.41 58.69 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 52.9 t -67.63 -35.65 79.32 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.2 0.6 . . . . 0.0 110.303 173.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.52 18.52 61.94 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.256 -177.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.56 135.88 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.037 0.535 . . . . 0.0 110.043 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -97.3 -169.26 1.82 Allowed 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.625 0.77 . . . . 0.0 111.896 -176.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -79.5 169.96 17.27 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.52 0.728 . . . . 0.0 111.091 173.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 58.34 18.67 5.69 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.301 1.44 . . . . 0.0 112.669 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.5 m -90.09 161.37 15.83 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 56.5 m -121.96 104.58 9.63 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 173.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.426 HD13 HD13 ' A' ' 3' ' ' LEU . 6.8 mp -84.31 -176.07 6.08 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.498 172.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 44.9 tt0 -139.38 157.43 45.89 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.974 0.509 . . . . 0.0 110.575 -172.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.7 t -119.13 131.65 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.401 1.081 . . . . 0.0 108.688 171.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.504 ' HB3' HD21 ' A' ' 42' ' ' LEU . . . -152.01 144.71 24.29 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.398 0.679 . . . . 0.0 109.664 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 39' ' ' GLN . . . -82.07 84.42 1.5 Allowed Glycine 0 C--N 1.345 1.077 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -110.93 7.59 21.77 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.922 0.889 . . . . 0.0 109.146 170.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 48.0 tpp . . . . . 0 CA--C 1.541 0.613 0 C-N-CA 125.036 1.334 . . . . 0.0 107.788 176.313 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.518 ' SD ' ' HA ' ' A' ' 60' ' ' GLU . 63.6 ttp . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 35.1 tt0 -78.44 131.52 36.93 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 pp -141.84 166.19 25.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.938 0.895 . . . . 0.0 110.0 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 64' ' ' THR . 68.8 m-85 -102.14 137.23 40.68 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.841 0.856 . . . . 0.0 109.76 -177.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.5 t -117.18 114.91 47.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 172.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.453 ' HB3' ' HA ' ' A' ' 66' ' ' GLU . 40.4 ttt85 -80.55 92.47 5.92 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.443 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.68 -177.29 3.74 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.471 1.108 . . . . 0.0 108.059 168.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -47.18 -32.79 4.68 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 122.945 0.498 . . . . 0.0 111.316 170.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -112.6 137.23 51.16 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 125.057 1.343 . . . . 0.0 108.016 164.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -71.0 118.99 14.48 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -116.93 162.01 18.44 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.946 0.898 . . . . 0.0 109.784 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.3 t -130.02 146.77 51.71 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 172.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -137.61 129.28 28.43 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.423 1.089 . . . . 0.0 108.643 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 34.2 tt0 -87.97 106.28 18.02 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 169.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.7 m -112.43 178.96 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.025 1.33 . . . . 0.0 108.976 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 58.6 p -107.07 -37.4 6.31 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.583 0.753 . . . . 0.0 110.797 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.5 -23.21 4.06 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-N 116.422 -0.354 . . . . 0.0 112.53 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -82.51 -12.63 57.65 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.0 0.52 . . . . 0.0 112.274 -175.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.451 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 22.7 mp0 -65.79 133.08 50.24 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.943 0.897 . . . . 0.0 108.671 177.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 82.2 p -80.07 166.24 21.72 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 121.59 0.709 . . . . 0.0 110.095 176.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.518 HG12 ' HE3' ' A' ' 25' ' ' LYS . 56.0 t -61.38 -31.11 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.187 173.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.63 -41.67 95.33 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.1 0.96 . . . . 0.0 111.208 173.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -66.24 -38.76 88.67 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.123 0.569 . . . . 0.0 111.098 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.569 HD11 HD11 ' A' ' 54' ' ' LEU . 50.5 mm -63.18 -45.27 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 O-C-N 123.716 0.635 . . . . 0.0 110.331 176.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.541 ' HE2' ' HA ' ' A' ' 40' ' ' VAL . 93.6 mttt -57.5 -45.81 84.49 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 123.645 0.59 . . . . 0.0 110.352 176.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.44 -45.57 91.2 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.334 1.054 . . . . 0.0 112.166 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -68.93 -43.3 75.38 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.86 0.464 . . . . 0.0 111.894 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.8 t -67.76 -32.03 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 122.813 0.445 . . . . 0.0 110.39 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.47 -37.99 80.67 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.191 0.996 . . . . 0.0 111.566 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.6 t -64.46 -44.37 91.31 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.571 0.748 . . . . 0.0 110.535 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.8 mt -72.87 -58.07 3.6 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.06 0.544 . . . . 0.0 111.558 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.31 -14.29 60.11 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.452 1.101 . . . . 0.0 112.405 -176.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.51 16.58 75.81 Favored Glycine 0 N--CA 1.473 1.135 0 CA-C-N 117.484 0.129 . . . . 0.0 113.078 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.7 pt -93.35 171.82 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.36 1.064 . . . . 0.0 110.397 -176.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.03 118.19 71.13 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 122.862 0.465 . . . . 0.0 110.849 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.444 ' HA ' HE21 ' A' ' 39' ' ' GLN . 47.5 Cg_endo -64.39 -24.96 63.92 Favored 'Trans proline' 0 C--N 1.388 2.621 0 C-N-CA 123.009 2.472 . . . . 0.0 111.484 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -68.42 -35.7 78.01 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.547 1.139 . . . . 0.0 111.148 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -85.39 -16.91 38.27 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.331 0.653 . . . . 0.0 111.213 -175.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.444 HE21 ' HA ' ' A' ' 36' ' ' PRO . 51.4 mt-30 -77.71 152.45 33.68 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.573 0.701 . . . . 0.0 112.16 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.541 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . 13.9 p -141.04 148.55 21.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 113.934 -1.485 . . . . 0.0 107.575 162.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.418 ' HB ' HG13 ' A' ' 21' ' ' VAL . 97.8 t -103.96 128.05 57.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 68.7 mt -115.62 116.66 28.51 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.645 1.178 . . . . 0.0 108.779 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.531 ' HB2' HD11 ' A' ' 48' ' ' LEU . 41.2 tp -90.47 98.13 11.59 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 57.04 32.24 21.32 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.029 0.932 . . . . 0.0 111.691 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.4 -32.4 7.2 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.246 -178.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.4 116.65 39.07 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 123.271 0.628 . . . . 0.0 111.499 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -63.44 105.53 0.51 Allowed 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 123.223 2.615 . . . . 0.0 112.262 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.531 HD11 ' HB2' ' A' ' 43' ' ' LEU . 43.0 mt -78.11 129.81 35.64 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.881 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -64.88 134.74 54.67 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.238 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.477 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 8.0 p-10 -61.54 -27.2 68.45 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.356 0.663 . . . . 0.0 111.727 -178.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -80.72 -25.98 37.74 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.62 0.768 . . . . 0.0 111.76 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.09 133.35 46.19 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 123.213 0.605 . . . . 0.0 110.542 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 31.1 p -79.1 170.64 16.35 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 176.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.616 ' HA ' ' SG ' ' A' ' 57' ' ' CYS . 86.2 mt -69.15 -25.72 64.51 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.548 0.739 . . . . 0.0 110.896 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.84 -36.41 42.15 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.327 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.41 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 87.2 mm-40 -79.22 -34.8 42.51 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.92 0.488 . . . . 0.0 111.703 -177.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.616 ' SG ' ' HA ' ' A' ' 54' ' ' LEU . 31.3 p -77.84 -22.22 50.28 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.927 0.491 . . . . 0.0 110.312 175.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.85 38.79 9.11 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.68 169.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.576 HG21 HD11 ' A' ' 65' ' ' LEU . 8.7 p -101.76 148.86 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 123.043 0.537 . . . . 0.0 109.849 176.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.518 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 10.7 pt-20 -136.32 -165.56 1.74 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.949 0.9 . . . . 0.0 111.085 -174.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.14 149.5 50.19 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 124.017 0.927 . . . . 0.0 112.587 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 68.18 -5.07 0.93 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.119 1.768 . . . . 0.0 113.263 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.7 m -77.26 147.9 36.05 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.124 0.57 . . . . 0.0 109.528 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 29.3 m -119.01 112.5 19.65 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 123.758 0.823 . . . . 0.0 109.825 -174.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.576 HD11 HG21 ' A' ' 59' ' ' VAL . 2.1 mp -104.18 132.71 50.14 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.462 1.105 . . . . 0.0 108.261 -178.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.453 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . 45.5 tt0 -96.13 140.17 31.23 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.055 0.542 . . . . 0.0 111.37 -172.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 78.8 t -93.8 128.37 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.806 0.842 . . . . 0.0 108.965 174.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.05 -168.04 2.83 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.875 0.87 . . . . 0.0 109.749 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -121.67 108.16 1.29 Allowed Glycine 0 C--N 1.35 1.352 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -122.26 -60.27 1.57 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 CA--C 1.533 0.31 0 CA-C-N 114.636 -1.166 . . . . 0.0 108.43 174.022 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.4 mtp . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -78.92 119.87 22.71 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.945 0.498 . . . . 0.0 109.702 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 pp -142.63 167.49 21.97 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.417 0.687 . . . . 0.0 110.564 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -100.68 148.37 24.94 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.3 t -133.19 107.13 10.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.892 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 172.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -76.7 93.09 3.6 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.252 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.95 -178.5 5.23 Favored 'General case' 0 C--O 1.248 0.977 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 160.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -51.52 -30.33 19.98 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.719 0.408 . . . . 0.0 111.217 172.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -107.33 130.67 54.75 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 161.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -72.61 125.61 27.89 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -125.66 146.05 49.9 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.171 0.589 . . . . 0.0 109.88 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.5 m -108.41 128.41 54.75 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.487 0.715 . . . . 0.0 109.389 175.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -120.73 143.06 48.97 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.193 0.997 . . . . 0.0 109.758 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -105.59 110.22 22.46 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.539 HG21 ' HG ' ' A' ' 54' ' ' LEU . 4.6 m -108.72 151.01 11.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 C-N-CA 124.154 0.982 . . . . 0.0 109.282 -171.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.467 ' H ' ' HB2' ' A' ' 19' ' ' GLU . 8.1 m -81.21 -11.82 59.31 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.746 -175.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.66 -55.59 2.67 Favored Glycine 0 C--N 1.353 1.523 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -174.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -76.27 2.87 12.1 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.081 0.952 . . . . 0.0 110.759 167.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.467 ' HB2' ' H ' ' A' ' 16' ' ' THR . 8.8 tp10 -60.21 118.05 5.91 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.921 1.289 . . . . 0.0 108.734 165.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 74.8 p -76.41 158.43 31.39 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.38 0.536 . . . . 0.0 110.81 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 t -64.53 -31.34 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 124.032 0.933 . . . . 0.0 110.254 175.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.64 -47.73 81.44 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.848 0.718 . . . . 0.0 110.82 173.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -64.15 -42.89 96.6 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 123.86 0.725 . . . . 0.0 111.141 177.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.494 ' O ' HG23 ' A' ' 28' ' ' VAL . 48.1 mm -56.87 -51.33 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 123.757 0.823 . . . . 0.0 110.708 176.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.53 ' NZ ' ' SD ' ' A' ' 71' ' ' MET . 85.3 tttt -62.42 -45.46 93.02 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.126 1.37 . . . . 0.0 110.424 -174.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.494 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . . . -67.99 -35.84 79.01 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.338 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -64.27 -46.53 83.28 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.33 0.652 . . . . 0.0 110.045 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 24' ' ' ILE . 73.2 t -60.02 -46.08 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 O-C-N 123.791 0.682 . . . . 0.0 109.91 177.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.37 -41.02 92.86 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.894 0.878 . . . . 0.0 112.434 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.3 t -65.25 -38.85 91.62 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.445 0.698 . . . . 0.0 110.649 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.5 mt -71.41 -37.34 71.52 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.636 0.374 . . . . 0.0 111.362 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -78.18 -13.8 59.71 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.897 0.879 . . . . 0.0 111.54 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.77 17.83 79.36 Favored Glycine 0 C--N 1.35 1.311 0 C-N-CA 123.147 0.404 . . . . 0.0 113.641 178.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.4 pt -111.27 176.67 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.866 0.866 . . . . 0.0 110.052 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.24 136.32 46.61 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 123.057 0.543 . . . . 0.0 109.855 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.494 ' HB3' ' HA ' ' A' ' 26' ' ' ALA . 18.6 Cg_endo -57.11 -33.9 96.69 Favored 'Trans proline' 0 C--N 1.383 2.38 0 C-N-CA 123.458 2.772 . . . . 0.0 112.683 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -60.0 -24.12 64.21 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.964 0.905 . . . . 0.0 113.061 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -76.51 -12.79 60.09 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.19 0.596 . . . . 0.0 111.965 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.435 ' O ' ' HB3' ' A' ' 71' ' ' MET . 22.3 mt-30 -104.09 173.17 6.42 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.792 0.837 . . . . 0.0 111.992 -171.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -160.87 134.42 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 169.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.6 p -106.23 136.05 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 121.628 0.727 . . . . 0.0 110.428 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -120.56 143.32 48.67 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.163 1.785 . . . . 0.0 108.495 -171.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.1 tp -110.93 99.16 8.11 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 167.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 59.98 26.44 15.73 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.195 0.998 . . . . 0.0 111.611 -176.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.78 -21.77 31.46 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 115.716 -0.675 . . . . 0.0 113.232 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.37 116.27 54.72 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.397 0.679 . . . . 0.0 111.023 -177.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.76 114.39 2.56 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.948 2.432 . . . . 0.0 112.41 -177.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.555 HD11 HD12 ' A' ' 65' ' ' LEU . 96.7 mt -72.98 130.25 39.93 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.937 0.895 . . . . 0.0 110.647 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -66.18 125.71 26.41 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.807 0.692 . . . . 0.0 110.216 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -65.25 -28.05 69.08 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.32 0.648 . . . . 0.0 112.13 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -77.78 -20.36 53.46 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.212 0.605 . . . . 0.0 110.711 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.66 145.67 28.67 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.301 0.64 . . . . 0.0 111.264 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 59.5 p -91.6 177.55 6.18 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.427 0.691 . . . . 0.0 110.16 173.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.539 ' HG ' HG21 ' A' ' 15' ' ' VAL . 3.8 mm? -63.4 -36.62 84.33 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 173.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.43 -31.94 65.34 Favored Glycine 0 C--N 1.354 1.547 0 CA-C-N 115.605 -0.725 . . . . 0.0 113.144 177.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 61.0 tp60 -71.24 -39.38 71.69 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.405 0.682 . . . . 0.0 110.451 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.487 ' HB2' HG12 ' A' ' 59' ' ' VAL . 62.4 m -68.1 -26.28 65.74 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.187 173.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.62 23.06 68.3 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 123.793 0.683 . . . . 0.0 112.269 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.487 HG12 ' HB2' ' A' ' 57' ' ' CYS . 7.3 p -99.95 134.63 38.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.565 0.746 . . . . 0.0 109.355 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -90.56 -175.45 4.44 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.811 0.845 . . . . 0.0 111.718 -173.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.93 169.25 17.27 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.83 171.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 68.54 3.14 3.68 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 125.298 1.439 . . . . 0.0 112.935 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.3 m -81.84 155.5 25.35 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.347 0.659 . . . . 0.0 109.303 176.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.8 m -113.12 106.93 15.25 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.555 HD12 HD11 ' A' ' 48' ' ' LEU . 2.2 mm? -80.67 171.66 14.74 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 169.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -140.87 125.3 17.68 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 118.585 0.63 . . . . 0.0 111.172 -177.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.2 t -96.4 109.84 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 122.898 0.479 . . . . 0.0 110.098 177.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.56 176.7 5.24 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.488 1.115 . . . . 0.0 109.281 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -124.41 89.86 0.4 Allowed Glycine 0 N--CA 1.469 0.889 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -126.01 -48.47 1.61 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.634 0.774 . . . . 0.0 110.501 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.53 ' SD ' ' NZ ' ' A' ' 25' ' ' LYS . 46.3 ttm . . . . . 0 N--CA 1.473 0.679 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.942 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.478 0.947 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -98.99 117.44 33.51 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.425 0.69 . . . . 0.0 110.387 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 pp -131.11 154.44 48.3 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.711 0.767 . . . . 0.0 111.398 175.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -90.33 144.28 25.98 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.817 1.247 . . . . 0.0 108.561 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.1 t -123.23 113.81 39.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 174.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.408 ' HB3' ' HA ' ' A' ' 66' ' ' GLU . 20.4 tpt180 -85.5 93.18 8.71 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.537 -172.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -111.6 -178.93 3.57 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 124.35 1.06 . . . . 0.0 108.333 169.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -45.38 -35.22 3.48 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.557 0.743 . . . . 0.0 111.324 167.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -111.63 127.36 55.73 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.153 0.981 . . . . 0.0 108.493 167.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -75.85 115.69 15.8 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -116.86 131.73 56.88 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.64 0.776 . . . . 0.0 109.662 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.5 m -105.74 118.63 37.09 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -102.71 140.78 36.53 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.118 0.967 . . . . 0.0 111.119 -175.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -94.6 104.76 16.7 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 165.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.0 m -113.72 163.61 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.142 0.977 . . . . 0.0 110.423 -177.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.8 m -99.9 -3.54 32.21 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.46 0.704 . . . . 0.0 111.513 -174.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.16 -45.26 3.38 Favored Glycine 0 C--N 1.352 1.464 0 O-C-N 122.027 -0.421 . . . . 0.0 112.247 -177.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -65.14 -14.04 59.6 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.372 0.669 . . . . 0.0 112.097 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.35 132.89 47.85 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 173.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.728 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 80.4 p -75.22 161.8 29.03 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.27 0.557 . . . . 0.0 110.621 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.718 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 53.0 t -64.93 -28.69 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.415 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.261 172.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.89 -38.88 92.44 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.223 0.609 . . . . 0.0 111.542 174.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -73.5 -35.12 65.59 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.739 177.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.49 HD11 HD11 ' A' ' 54' ' ' LEU . 20.3 mm -53.19 -47.94 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 123.571 0.748 . . . . 0.0 109.857 170.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.493 ' NZ ' ' SD ' ' A' ' 71' ' ' MET . 97.8 mttt -57.7 -55.05 39.88 Favored 'General case' 0 C--N 1.359 0.991 0 O-C-N 124.121 0.888 . . . . 0.0 110.658 174.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.77 -42.0 64.6 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 123.965 0.791 . . . . 0.0 112.121 -176.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -71.17 -46.27 61.75 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.634 0.773 . . . . 0.0 111.755 -177.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.409 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 14.6 p -69.94 -30.95 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.429 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . . . -68.2 -36.72 80.01 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.841 0.856 . . . . 0.0 111.351 177.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.1 t -63.66 -41.69 98.17 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.541 0.736 . . . . 0.0 110.273 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.7 mt -69.12 -48.76 61.61 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.448 0.699 . . . . 0.0 112.29 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.429 ' HB2' HG12 ' A' ' 34' ' ' ILE . 13.8 mm-40 -77.86 -19.11 55.4 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.031 0.532 . . . . 0.0 111.018 -177.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.95 31.9 59.42 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.634 -177.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.429 HG12 ' HB2' ' A' ' 32' ' ' GLU . 23.9 pt -114.65 170.38 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 123.803 0.841 . . . . 0.0 110.912 -177.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.41 119.78 76.86 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 123.658 0.783 . . . . 0.0 111.499 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -65.33 -28.18 55.1 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.859 2.372 . . . . 0.0 112.283 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.92 -35.18 79.81 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.859 0.864 . . . . 0.0 111.227 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -71.39 -26.07 62.62 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.191 0.996 . . . . 0.0 111.079 -172.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.429 ' NE2' ' HB2' ' A' ' 29' ' ' ALA . 21.6 mt-30 -81.7 137.79 35.35 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.7 -173.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 p -122.82 133.64 68.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 166.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.457 HG13 ' HB3' ' A' ' 65' ' ' LEU . 54.7 t -94.26 108.34 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-O 121.384 0.611 . . . . 0.0 109.716 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 66.1 mt -97.04 114.47 26.1 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.26 1.424 . . . . 0.0 109.762 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.8 tp -94.83 104.95 16.85 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 169.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 59.67 28.3 17.71 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.236 1.014 . . . . 0.0 111.961 -173.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.31 -7.89 72.21 Favored Glycine 0 C--N 1.352 1.427 0 CA-C-N 115.946 -0.57 . . . . 0.0 113.675 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.19 116.71 66.99 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 123.757 0.823 . . . . 0.0 110.2 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.3 117.34 4.49 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.593 2.195 . . . . 0.0 111.65 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.2 mt -75.93 154.6 35.83 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.621 0.768 . . . . 0.0 111.293 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -72.51 104.19 3.75 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.718 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 3.0 p30 -72.08 -15.29 62.01 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -73.92 -24.4 59.67 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 122.909 0.484 . . . . 0.0 110.191 172.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -94.91 157.79 15.76 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 124.161 0.984 . . . . 0.0 111.069 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.728 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 67.7 p -85.24 168.05 15.1 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.618 177.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.5 ' HA ' ' SG ' ' A' ' 57' ' ' CYS . 78.2 mt -66.28 -33.22 75.24 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.118 174.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.16 -29.68 68.39 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 115.287 -0.869 . . . . 0.0 112.661 175.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -72.38 -43.95 63.22 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.551 0.74 . . . . 0.0 110.57 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' A' ' 54' ' ' LEU . 22.1 p -75.79 -10.41 59.41 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.51 173.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.13 21.24 78.4 Favored Glycine 0 C--N 1.355 1.61 0 C-N-CA 123.56 0.6 . . . . 0.0 113.571 171.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.4 HG21 HG21 ' A' ' 63' ' ' THR . 13.0 p -78.51 145.78 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -176.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -110.62 -164.2 0.9 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.308 0.643 . . . . 0.0 111.003 -176.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.72 175.53 9.86 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.681 0.792 . . . . 0.0 111.667 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 65.2 5.35 3.01 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.452 1.501 . . . . 0.0 112.744 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.4 HG21 HG21 ' A' ' 59' ' ' VAL . 90.6 m -81.63 154.21 26.26 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.407 1.083 . . . . 0.0 110.155 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.2 m -122.42 101.7 7.65 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.688 0.795 . . . . 0.0 109.663 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.457 ' HB3' HG13 ' A' ' 41' ' ' VAL . 74.7 mt -85.69 116.28 23.87 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.125 0.97 . . . . 0.0 109.175 176.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.408 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . 41.1 tt0 -93.85 128.81 40.32 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.02 0.438 . . . . 0.0 111.674 -172.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 75.0 t -87.59 128.55 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.833 0.853 . . . . 0.0 109.791 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.15 136.84 45.99 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.775 0.83 . . . . 0.0 109.649 173.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.47 89.43 1.58 Allowed Glycine 0 C--N 1.343 0.962 0 N-CA-C 112.095 -0.402 . . . . 0.0 112.095 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -141.75 -28.87 0.63 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.545 0.738 . . . . 0.0 112.353 -173.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.493 ' SD ' ' NZ ' ' A' ' 25' ' ' LYS . 56.1 ttm . . . . . 0 N--CA 1.49 1.549 0 C-N-CA 123.177 0.591 . . . . 0.0 111.989 -173.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.472 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 1.1 tmt? . . . . . 0 N--CA 1.483 1.198 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 34.1 tt0 -101.94 137.76 39.8 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.439 -177.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.473 HD13 HD13 ' A' ' 65' ' ' LEU . 4.4 pp -137.5 161.03 37.48 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.387 0.613 . . . . 0.0 110.276 175.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -107.27 135.37 48.89 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.3 t -115.98 105.41 18.39 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 C-N-CA 123.57 0.748 . . . . 0.0 109.047 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -72.26 98.69 2.23 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.853 0.861 . . . . 0.0 110.969 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -113.28 -177.07 3.04 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.649 1.18 . . . . 0.0 108.044 166.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -45.09 -31.67 1.46 Allowed 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.522 0.677 . . . . 0.0 112.133 168.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -115.34 131.84 56.8 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 124.668 1.187 . . . . 0.0 107.878 167.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -70.36 105.5 3.05 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -93.12 160.49 14.83 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.754 177.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.5 m -148.97 121.64 8.62 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -127.63 129.61 47.53 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.392 0.677 . . . . 0.0 109.666 -176.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 36.0 tt0 -94.16 110.26 22.0 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 168.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 1' ' ' MET . 35.8 m -116.84 164.37 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 124.825 1.25 . . . . 0.0 109.098 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.1 t -94.79 6.21 49.63 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.663 0.385 . . . . 0.0 110.591 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.536 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 94.66 -20.49 48.31 Favored Glycine 0 C--N 1.357 1.734 0 CA-C-O 119.351 -0.694 . . . . 0.0 113.672 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -67.62 -26.7 66.37 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -169.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -62.96 141.87 58.56 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 46.9 p -80.42 165.0 22.64 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.524 HG13 ' HB ' ' A' ' 41' ' ' VAL . 54.5 t -57.08 -31.17 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 C-N-CA 123.448 0.699 . . . . 0.0 110.045 172.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.461 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . . . -68.92 -37.84 79.18 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.493 1.117 . . . . 0.0 111.511 177.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.464 ' HG3' ' OG1' ' A' ' 20' ' ' THR . 24.8 mt-30 -72.36 -35.03 68.42 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.1 mm -64.52 -47.41 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.097 0.559 . . . . 0.0 111.046 177.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.585 ' HB3' HG23 ' A' ' 41' ' ' VAL . 60.6 pttt -67.18 -32.65 73.88 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 119.547 -0.263 . . . . 0.0 110.383 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.523 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . . . -60.09 -45.47 92.81 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 123.603 0.761 . . . . 0.0 111.471 176.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.459 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 34.0 m170 -64.85 -44.99 87.97 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.878 0.471 . . . . 0.0 110.896 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.521 HG11 HG21 ' A' ' 67' ' ' VAL . 79.0 t -62.04 -42.39 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.124 0.57 . . . . 0.0 111.035 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.21 -26.07 61.0 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.739 0.816 . . . . 0.0 111.402 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.2 t -70.24 -42.21 72.53 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 122.983 0.513 . . . . 0.0 110.275 171.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 27' ' ' HIS . 97.2 mt -62.57 -42.85 99.81 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 123.839 0.712 . . . . 0.0 111.625 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.96 -23.41 31.09 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.112 0.565 . . . . 0.0 112.174 176.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.64 29.69 47.27 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 122.979 0.175 . . . . 0.0 112.906 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.6 pt -111.87 -178.46 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 124.803 1.241 . . . . 0.0 111.215 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.71 112.65 39.14 Favored Pre-proline 0 N--CA 1.487 1.414 0 C-N-CA 124.035 0.934 . . . . 0.0 112.537 -170.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.523 ' HB3' ' HA ' ' A' ' 26' ' ' ALA . 24.2 Cg_exo -62.93 -43.17 20.86 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 123.088 2.525 . . . . 0.0 112.729 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.95 -8.71 57.1 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.381 0.672 . . . . 0.0 112.057 -176.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -77.65 -36.31 51.57 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.403 0.62 . . . . 0.0 109.577 171.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.629 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 40.2 mt-30 -99.44 -179.76 4.32 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.994 -169.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.504 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 11.4 p -162.09 154.03 3.37 Favored 'Isoleucine or valine' 0 C--O 1.246 0.877 0 C-N-CA 125.314 1.446 . . . . 0.0 107.956 171.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.585 HG23 ' HB3' ' A' ' 25' ' ' LYS . 44.4 t -103.64 125.46 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.642 HD12 ' HA ' ' A' ' 47' ' ' PRO . 1.8 mm? -108.9 141.25 41.23 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.446 1.498 . . . . 0.0 108.842 -173.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.9 tp -80.76 96.71 7.04 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.402 ' H ' ' HA ' ' A' ' 65' ' ' LEU . . . 55.06 29.34 12.27 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 123.878 0.871 . . . . 0.0 111.629 -176.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.59 -25.43 21.28 Favored Glycine 0 C--N 1.355 1.635 0 C-N-CA 123.343 0.497 . . . . 0.0 113.449 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.57 136.05 81.01 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.552 0.741 . . . . 0.0 111.311 -177.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.642 ' HA ' HD12 ' A' ' 42' ' ' LEU . 52.6 Cg_endo -64.61 111.0 1.55 Allowed 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 123.192 2.594 . . . . 0.0 113.052 -174.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.9 mt -90.2 156.26 18.45 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.376 0.67 . . . . 0.0 111.138 173.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -81.97 119.47 24.0 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 172.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.487 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 6.0 p-10 -60.67 -38.94 86.57 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.082 0.553 . . . . 0.0 112.103 -175.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -82.27 -4.89 58.02 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.119 0.568 . . . . 0.0 111.978 -176.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.49 140.49 29.48 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.312 0.645 . . . . 0.0 110.356 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 44.1 p -71.77 168.46 17.77 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.291 0.636 . . . . 0.0 110.603 178.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.536 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 3.0 mm? -59.19 -43.33 92.2 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 174.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.43 -37.9 95.52 Favored Glycine 0 C--N 1.35 1.331 0 O-C-N 123.845 0.716 . . . . 0.0 113.108 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -68.24 -39.72 82.21 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.834 0.854 . . . . 0.0 110.482 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 75.0 m -79.26 -10.09 59.73 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.928 0.891 . . . . 0.0 111.798 177.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.82 21.17 75.01 Favored Glycine 0 C--N 1.349 1.281 0 C-N-CA 123.217 0.436 . . . . 0.0 114.135 177.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.28 134.86 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 123.845 0.858 . . . . 0.0 109.436 177.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -114.39 -171.43 1.92 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.472 0.709 . . . . 0.0 111.095 -172.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.87 154.09 28.6 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.542 0.737 . . . . 0.0 110.248 174.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 59.9 21.19 10.16 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 125.216 1.407 . . . . 0.0 111.738 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.5 m -93.74 156.41 16.7 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.434 1.093 . . . . 0.0 108.804 177.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.1 m -135.43 121.82 20.49 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.632 0.729 . . . . 0.0 110.78 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.473 HD13 HD13 ' A' ' 3' ' ' LEU . 4.1 mp -105.88 179.23 4.33 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.792 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -141.2 144.41 34.74 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.607 0.763 . . . . 0.0 110.279 -173.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.521 HG21 HG11 ' A' ' 28' ' ' VAL . 44.8 t -103.43 119.41 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 121.842 -0.536 . . . . 0.0 109.67 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.18 150.63 50.18 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.043 0.537 . . . . 0.0 110.292 176.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.629 ' HA2' ' HA ' ' A' ' 39' ' ' GLN . . . -90.1 92.95 1.82 Allowed Glycine 0 C--N 1.347 1.159 0 N-CA-C 112.051 -0.42 . . . . 0.0 112.051 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 54.4 mtt180 -109.75 -11.81 14.68 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.958 0.503 . . . . 0.0 112.318 -177.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.559 ' SD ' ' NZ ' ' A' ' 25' ' ' LYS . 79.5 mtp . . . . . 0 N--CA 1.481 1.107 0 O-C-N 122.212 -0.305 . . . . 0.0 110.445 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 121.788 0.804 . . . . 0.0 108.968 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -93.01 111.38 22.98 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.683 -171.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.444 HD13 HD13 ' A' ' 65' ' ' LEU . 2.8 pp -125.51 157.51 36.83 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.481 0.712 . . . . 0.0 110.07 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -90.28 142.18 27.98 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.789 0.835 . . . . 0.0 109.85 -176.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.5 t -122.66 102.64 11.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 C-N-CA 124.648 1.179 . . . . 0.0 108.885 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -77.95 93.8 4.49 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.934 0.893 . . . . 0.0 109.71 177.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.19 -174.52 2.59 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.906 1.283 . . . . 0.0 108.168 172.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -41.16 -36.9 0.8 Allowed 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 123.841 0.857 . . . . 0.0 112.053 168.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -117.95 154.36 32.07 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.507 1.123 . . . . 0.0 108.323 167.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -77.52 127.52 32.65 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.774 0.43 . . . . 0.0 110.456 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -130.79 159.39 37.47 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.653 1.181 . . . . 0.0 109.042 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.8 m -143.53 125.17 14.93 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 175.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -132.93 141.64 48.46 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.013 0.525 . . . . 0.0 111.119 -173.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -80.92 125.77 30.54 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 164.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.447 HG21 ' HG ' ' A' ' 54' ' ' LEU . 27.6 m -109.32 152.56 11.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 C-N-CA 123.445 0.698 . . . . 0.0 109.744 -174.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 m -78.51 -14.62 59.27 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.666 -171.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.49 -56.44 5.02 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -70.5 -13.38 62.09 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.141 0.976 . . . . 0.0 111.145 171.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -63.39 139.18 58.74 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.66 1.184 . . . . 0.0 109.933 170.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 73.2 p -93.62 170.67 9.41 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.304 0.573 . . . . 0.0 111.91 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.606 HG13 ' HB ' ' A' ' 41' ' ' VAL . 40.5 t -64.81 -31.87 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.129 0.972 . . . . 0.0 110.607 172.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.06 96.25 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.735 0.814 . . . . 0.0 110.148 178.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.408 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 18.7 mm-40 -62.65 -48.25 80.17 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.447 1.092 . . . . 0.0 110.313 175.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 28' ' ' VAL . 37.2 mm -55.97 -47.27 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 124.078 0.951 . . . . 0.0 110.923 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -62.17 -49.91 73.94 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.015 1.326 . . . . 0.0 111.183 -175.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.7 -32.94 71.82 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.976 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.469 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 11.4 t-160 -62.69 -53.52 53.25 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 124.099 0.96 . . . . 0.0 110.37 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 24' ' ' ILE . 95.0 t -59.92 -38.51 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.414 0.686 . . . . 0.0 110.552 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.04 -47.79 84.41 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.144 175.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.8 t -66.86 -35.25 79.61 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.648 0.779 . . . . 0.0 111.228 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 27' ' ' HIS . 88.6 mt -67.4 -48.79 66.33 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.82 0.848 . . . . 0.0 111.861 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -96.04 -2.57 46.54 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.685 0.394 . . . . 0.0 111.819 -172.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.58 28.24 73.3 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.278 0.361 . . . . 0.0 113.01 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.2 pt -108.82 177.58 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.125 0.97 . . . . 0.0 110.693 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.42 120.94 68.96 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 123.281 0.632 . . . . 0.0 111.438 -171.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -63.83 -31.74 67.66 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.527 2.151 . . . . 0.0 111.206 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -63.68 -22.04 66.7 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.028 0.931 . . . . 0.0 112.353 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -88.95 -12.95 40.14 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.007 0.923 . . . . 0.0 111.171 -178.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -98.65 165.29 11.87 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.922 0.889 . . . . 0.0 112.344 -171.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 m -152.57 138.4 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 126.247 1.819 . . . . 0.0 107.251 164.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.606 ' HB ' HG13 ' A' ' 21' ' ' VAL . 45.5 t -94.99 116.62 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 175.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.3 mt -112.25 134.04 54.03 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.802 1.241 . . . . 0.0 109.092 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.468 ' HB2' HD11 ' A' ' 48' ' ' LEU . 42.4 tp -89.4 98.11 11.58 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 173.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 57.18 28.84 15.68 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.754 0.821 . . . . 0.0 112.081 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.04 -25.16 21.32 Favored Glycine 0 C--N 1.353 1.505 0 CA-C-O 119.717 -0.491 . . . . 0.0 113.498 -177.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.13 117.68 60.51 Favored Pre-proline 0 N--CA 1.481 1.098 0 C-N-CA 123.422 0.689 . . . . 0.0 110.886 -177.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.5 115.57 2.64 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.329 2.686 . . . . 0.0 113.108 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.506 ' HB3' HG21 ' A' ' 21' ' ' VAL . 84.6 mt -91.02 143.75 26.38 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.18 0.592 . . . . 0.0 110.903 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -78.27 134.68 37.51 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -56.73 -41.02 76.77 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.996 0.918 . . . . 0.0 112.15 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -82.21 -14.89 54.87 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.677 -175.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.22 132.65 43.43 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.81 0.444 . . . . 0.0 109.859 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 58.6 p -84.23 166.77 17.25 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.209 0.604 . . . . 0.0 110.282 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.447 ' HG ' HG21 ' A' ' 15' ' ' VAL . 3.0 mm? -62.43 -38.52 90.06 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.01 -34.69 77.03 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.922 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -70.95 -42.62 69.55 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.475 0.71 . . . . 0.0 110.635 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 50.6 t -69.51 -18.75 63.71 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.141 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.05 17.84 80.22 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.657 -0.702 . . . . 0.0 112.804 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.582 HG21 HD11 ' A' ' 65' ' ' LEU . 2.2 p -85.61 118.37 32.21 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.1 -166.8 1.42 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.328 1.051 . . . . 0.0 110.54 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.63 163.72 26.43 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.173 0.589 . . . . 0.0 111.243 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 71.89 -2.83 2.38 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.825 1.65 . . . . 0.0 112.765 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.4 m -84.0 160.18 21.07 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.577 0.751 . . . . 0.0 109.573 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.3 m -120.16 113.31 20.27 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.15 0.58 . . . . 0.0 110.638 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.582 HD11 HG21 ' A' ' 59' ' ' VAL . 5.5 mp -94.79 161.18 14.28 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 170.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -130.52 130.66 44.43 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.964 0.505 . . . . 0.0 109.95 -177.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 95.9 t -91.85 93.39 4.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 171.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.62 -176.47 3.2 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.339 1.056 . . . . 0.0 110.13 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -123.2 91.78 0.45 Allowed Glycine 0 C--N 1.341 0.823 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 178.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -107.12 -49.23 3.31 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 53.4 ttm . . . . . 0 CA--C 1.539 0.537 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 174.55 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ttt . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -94.04 120.35 34.17 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.403 HD13 HD13 ' A' ' 65' ' ' LEU . 3.3 pp -132.16 167.22 20.14 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.074 0.55 . . . . 0.0 111.001 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -99.49 142.89 30.38 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.58 0.752 . . . . 0.0 109.553 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 80.9 t -126.12 101.13 7.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 171.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -73.25 98.74 2.71 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.548 -177.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.69 -177.31 3.33 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.097 0.959 . . . . 0.0 108.945 172.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -43.46 -32.75 0.94 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.087 0.955 . . . . 0.0 111.986 170.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -120.6 145.22 47.59 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.382 1.073 . . . . 0.0 108.178 162.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.1 tp -69.72 128.58 36.94 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 120.821 0.343 . . . . 0.0 111.084 -176.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -117.47 158.21 24.91 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.931 0.892 . . . . 0.0 109.894 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.7 m -146.63 120.96 9.59 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.348 1.059 . . . . 0.0 108.291 175.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -120.85 145.21 47.85 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.412 0.685 . . . . 0.0 110.613 -172.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -97.4 123.98 41.42 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 171.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.3 m -135.0 172.43 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.302 1.041 . . . . 0.0 109.865 -177.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.437 ' HB ' ' HG2' ' A' ' 18' ' ' GLN . 2.9 m -107.07 -18.15 13.98 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.793 0.837 . . . . 0.0 110.011 175.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.448 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 102.77 -15.52 55.51 Favored Glycine 0 C--N 1.355 1.637 0 C-N-CA 123.137 0.399 . . . . 0.0 112.458 -173.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.437 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 3.3 pt20 -81.29 -8.45 59.75 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.825 0.85 . . . . 0.0 111.719 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -74.42 134.23 42.4 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.16 0.984 . . . . 0.0 108.923 176.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.697 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 72.4 p -74.66 158.84 32.93 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 171.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.636 HG13 ' HB ' ' A' ' 41' ' ' VAL . 55.8 t -59.23 -27.9 37.74 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.475 0 C-N-CA 123.839 0.856 . . . . 0.0 110.401 173.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.64 -43.36 80.52 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.795 1.238 . . . . 0.0 110.392 174.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.428 ' HG3' ' OG1' ' A' ' 20' ' ' THR . 78.1 mt-30 -62.07 -41.56 98.28 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 123.521 0.513 . . . . 0.0 110.217 175.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.461 HD11 HD11 ' A' ' 54' ' ' LEU . 46.9 mm -59.32 -50.72 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.435 0.694 . . . . 0.0 111.217 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.478 ' HB3' HG23 ' A' ' 41' ' ' VAL . 60.3 pttt -73.08 -27.5 61.75 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.98 -37.19 86.83 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.25 0.62 . . . . 0.0 111.047 173.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 57.5 m170 -66.68 -45.81 77.66 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.359 0.663 . . . . 0.0 109.78 175.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.566 HG12 HD11 ' A' ' 34' ' ' ILE . 85.1 t -58.74 -38.02 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.59 0.756 . . . . 0.0 110.313 174.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.01 -48.15 74.95 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.275 1.03 . . . . 0.0 111.953 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.3 t -68.13 -32.75 73.26 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.328 0.651 . . . . 0.0 111.771 -177.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 97.5 mt -80.67 -51.11 9.07 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.989 0.516 . . . . 0.0 111.965 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -83.76 -2.45 56.33 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.605 0.762 . . . . 0.0 112.179 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.25 15.19 69.76 Favored Glycine 0 C--N 1.346 1.092 0 O-C-N 123.157 0.286 . . . . 0.0 113.1 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.566 HD11 HG12 ' A' ' 28' ' ' VAL . 28.6 pt -92.39 178.91 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.527 0.731 . . . . 0.0 109.81 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -109.87 129.89 23.43 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 122.87 0.468 . . . . 0.0 110.776 -174.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.28 -11.17 26.58 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.217 1.944 . . . . 0.0 112.687 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.52 -22.97 53.73 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 123.041 0.536 . . . . 0.0 112.071 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -90.86 -41.19 11.33 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 118.76 0.709 . . . . 0.0 109.518 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -81.82 152.4 26.93 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 122.198 0.999 . . . . 0.0 111.847 -175.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.32 153.11 37.34 Favored 'Isoleucine or valine' 0 C--O 1.249 1.07 0 C-N-CA 126.447 1.899 . . . . 0.0 106.347 168.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.636 ' HB ' HG13 ' A' ' 21' ' ' VAL . 43.7 t -100.21 131.65 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.7 mt -116.3 142.0 47.41 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.592 1.157 . . . . 0.0 109.398 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.6 tp -91.81 99.28 12.18 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 174.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 60.31 22.97 12.44 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.84 0.856 . . . . 0.0 112.473 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.7 -14.6 57.58 Favored Glycine 0 C--N 1.353 1.519 0 CA-C-O 119.779 -0.456 . . . . 0.0 113.436 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.62 146.13 60.1 Favored Pre-proline 0 N--CA 1.485 1.285 0 C-N-CA 123.745 0.818 . . . . 0.0 109.981 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -72.35 120.38 6.72 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.637 2.224 . . . . 0.0 113.301 -170.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.475 ' HB3' HG21 ' A' ' 21' ' ' VAL . 87.2 mt -94.63 141.1 29.0 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 170.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -80.05 120.89 24.82 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.546 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 11.1 p-10 -63.21 -39.47 94.73 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 123.491 0.494 . . . . 0.0 111.511 -171.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.58 -2.91 55.15 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.392 0.677 . . . . 0.0 111.897 -177.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.6 139.91 29.99 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.545 0.738 . . . . 0.0 110.563 173.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.697 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 75.5 p -73.58 164.34 26.78 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.978 0.511 . . . . 0.0 110.529 175.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.461 HD11 HD11 ' A' ' 24' ' ' ILE . 86.9 mt -66.83 -28.75 68.61 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.509 0.724 . . . . 0.0 110.757 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.07 -43.76 89.75 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.634 174.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -69.52 -37.3 77.07 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.847 0.459 . . . . 0.0 110.949 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 89.3 m -65.09 -23.49 67.18 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.319 0.648 . . . . 0.0 110.933 173.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.44 28.33 67.93 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 116.308 -0.405 . . . . 0.0 112.744 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.588 HG21 HD11 ' A' ' 65' ' ' LEU . 11.8 p -92.54 153.9 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -133.07 -172.19 2.87 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.674 0.79 . . . . 0.0 110.909 -173.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.77 157.45 36.41 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.341 0.657 . . . . 0.0 111.87 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 61.7 14.6 6.24 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 126.013 1.725 . . . . 0.0 112.415 -177.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.8 m -93.36 145.08 24.73 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.5 m -105.84 108.3 19.75 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.66 0.743 . . . . 0.0 110.08 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.588 HD11 HG21 ' A' ' 59' ' ' VAL . 5.6 mp -88.32 179.35 6.36 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.176 169.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 39.8 tt0 -142.53 153.34 43.5 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.101 0.56 . . . . 0.0 110.133 -175.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 79.1 t -109.08 131.83 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 170.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.98 127.19 17.56 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.305 0.642 . . . . 0.0 109.925 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.12 92.51 0.74 Allowed Glycine 0 C--N 1.344 0.99 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 175.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -132.69 -35.57 1.1 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.019 0.527 . . . . 0.0 112.296 -174.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 49.0 tpp . . . . . 0 N--CA 1.482 1.134 0 C-N-CA 122.497 0.319 . . . . 0.0 110.943 -178.593 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.6 mtm . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -76.96 114.59 15.92 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.482 HD13 HD23 ' A' ' 65' ' ' LEU . 2.3 pp -137.9 157.19 46.9 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.108 0.563 . . . . 0.0 110.155 -177.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -88.92 152.11 21.92 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.052 0.541 . . . . 0.0 109.63 -177.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.52 ' HB ' ' HB2' ' A' ' 11' ' ' HIS . 55.2 t -134.65 105.23 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.294 1.037 . . . . 0.0 109.087 -176.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -82.9 93.96 7.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.468 1.107 . . . . 0.0 111.001 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -111.3 -179.96 3.87 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 168.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.455 ' NE2' ' H ' ' A' ' 8' ' ' GLN . 0.7 OUTLIER -54.99 -26.79 39.23 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 175.471 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -111.47 134.04 53.34 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 158.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.73 137.66 52.18 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.883 0.473 . . . . 0.0 109.738 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.52 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 39.3 m-70 -129.86 161.97 29.61 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.122 0.969 . . . . 0.0 109.049 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.0 m -142.91 112.0 6.56 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 172.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -113.39 132.32 55.66 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.792 0.837 . . . . 0.0 111.203 -172.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -83.94 114.08 21.44 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 166.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.409 HG21 ' HG ' ' A' ' 54' ' ' LEU . 13.3 m -109.65 139.58 32.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 122.918 0.487 . . . . 0.0 109.811 -174.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 m -75.37 -17.83 60.12 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.711 0.805 . . . . 0.0 111.472 -176.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.75 -56.2 1.91 Allowed Glycine 0 C--N 1.347 1.143 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 -176.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -72.53 -7.12 48.41 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.307 0.643 . . . . 0.0 111.588 172.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -63.79 145.25 56.12 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 165.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 61.2 p -94.29 153.68 17.9 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 118.213 0.461 . . . . 0.0 111.99 -177.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.619 HG13 ' HB ' ' A' ' 41' ' ' VAL . 38.1 t -57.12 -33.71 43.52 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 124.388 1.075 . . . . 0.0 110.617 171.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.17 -53.19 61.11 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.126 0.971 . . . . 0.0 110.921 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -65.2 -36.14 83.27 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.916 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 28' ' ' VAL . 35.0 mm -60.36 -50.49 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 122.786 0.434 . . . . 0.0 111.633 178.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.4 ' HB3' HG23 ' A' ' 41' ' ' VAL . 61.3 pttt -68.25 -30.75 69.87 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.526 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . . . -65.9 -41.23 91.76 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 123.382 0.673 . . . . 0.0 111.492 175.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -62.03 -46.06 90.81 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.329 0.651 . . . . 0.0 109.722 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 24' ' ' ILE . 76.8 t -56.32 -48.24 79.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.717 176.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.99 -28.23 64.28 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.827 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 t -77.03 -31.62 56.41 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.554 0.741 . . . . 0.0 110.956 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.0 mt -73.31 -45.09 57.45 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.229 0.612 . . . . 0.0 111.17 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -86.1 -22.0 27.35 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.168 0.587 . . . . 0.0 112.316 -176.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.23 33.8 25.11 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 116.632 -0.258 . . . . 0.0 113.266 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 pt -109.84 171.38 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.941 0.896 . . . . 0.0 110.034 175.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.69 111.61 22.66 Favored Pre-proline 0 N--CA 1.484 1.244 0 C-N-CA 123.296 0.638 . . . . 0.0 111.768 -172.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.526 ' HB3' ' HA ' ' A' ' 26' ' ' ALA . 19.8 Cg_endo -55.95 -39.47 90.97 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 123.602 2.868 . . . . 0.0 114.081 -175.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -67.3 -28.06 67.69 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.035 0.534 . . . . 0.0 111.568 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 71' ' ' MET . 22.7 t70 -67.54 -40.3 85.02 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.253 0.621 . . . . 0.0 109.9 177.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -77.03 165.72 24.25 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.953 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -162.82 146.14 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 125.04 1.336 . . . . 0.0 108.299 173.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.619 ' HB ' HG13 ' A' ' 21' ' ' VAL . 96.3 t -90.14 134.55 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.103 0.561 . . . . 0.0 110.51 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.8 mt -123.29 127.38 48.47 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.77 1.228 . . . . 0.0 108.637 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.436 ' HB2' HD11 ' A' ' 48' ' ' LEU . 33.5 tp -92.18 97.96 11.23 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 173.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 59.73 23.07 11.91 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.56 1.144 . . . . 0.0 112.732 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.75 -7.56 38.93 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-O 119.703 -0.499 . . . . 0.0 113.655 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.01 114.55 53.38 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 123.241 0.616 . . . . 0.0 109.459 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -68.16 102.58 0.81 Allowed 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 122.172 1.914 . . . . 0.0 112.27 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.436 HD11 ' HB2' ' A' ' 43' ' ' LEU . 79.5 mt -73.2 129.68 38.58 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.34 176.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -63.44 130.73 45.64 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.139 0.9 . . . . 0.0 109.387 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -61.93 -35.38 78.23 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.184 0.303 . . . . 0.0 111.483 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.19 -19.68 60.46 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.4 0.28 . . . . 0.0 111.28 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.76 135.27 41.75 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.924 0.49 . . . . 0.0 109.848 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 71.4 p -76.82 171.95 13.91 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 122.907 0.483 . . . . 0.0 109.967 172.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.409 ' HG ' HG21 ' A' ' 15' ' ' VAL . 3.1 mm? -66.22 -28.76 68.99 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.54 -29.53 55.3 Favored Glycine 0 C--N 1.357 1.733 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.763 175.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -74.0 -35.98 64.46 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.641 0.776 . . . . 0.0 109.855 176.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 79.8 m -74.87 -23.52 58.42 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.466 171.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.19 23.05 78.49 Favored Glycine 0 C--N 1.353 1.506 0 CA-C-N 116.009 -0.541 . . . . 0.0 113.558 177.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.8 p -80.54 148.09 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 123.522 0.729 . . . . 0.0 110.342 -175.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -99.6 -177.38 3.55 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.401 0.68 . . . . 0.0 112.181 -173.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.42 162.22 24.55 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.738 0.815 . . . . 0.0 111.029 175.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 64.63 9.29 5.03 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 125.449 1.5 . . . . 0.0 112.488 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.7 m -78.06 152.0 33.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.058 0.943 . . . . 0.0 109.706 175.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.2 m -106.87 108.25 19.67 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 173.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.482 HD23 HD13 ' A' ' 3' ' ' LEU . 3.6 mm? -92.32 135.54 33.94 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 124.175 0.99 . . . . 0.0 108.589 174.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -93.97 150.46 20.34 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.164 0.586 . . . . 0.0 109.465 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 67.1 t -119.46 131.45 72.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 174.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.72 148.55 30.15 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.406 0.682 . . . . 0.0 110.318 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.0 98.82 2.27 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 174.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.9 mtp-105 -103.44 -26.13 13.0 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.594 0.758 . . . . 0.0 111.176 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.513 ' O ' ' HA ' ' A' ' 38' ' ' ASP . 62.7 ttp . . . . . 0 N--CA 1.473 0.697 0 C-N-CA 123.361 0.664 . . . . 0.0 109.971 -170.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.552 ' SD ' HD23 ' A' ' 3' ' ' LEU . 47.9 ttm . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -87.39 123.62 32.54 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 171.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.552 HD23 ' SD ' ' A' ' 1' ' ' MET . 2.1 pp -143.12 158.47 43.58 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.619 0.768 . . . . 0.0 109.398 -175.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -96.3 139.78 31.94 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.368 0.667 . . . . 0.0 109.47 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.517 HG22 ' HB2' ' A' ' 65' ' ' LEU . 58.9 t -123.35 103.39 12.89 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 174.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -76.48 100.14 5.15 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.674 0.749 . . . . 0.0 111.038 -178.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.97 -178.2 3.59 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.412 1.085 . . . . 0.0 108.446 166.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -48.29 -35.59 12.52 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.845 0.858 . . . . 0.0 111.379 172.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -111.7 131.28 55.41 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 166.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -68.6 132.84 47.58 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.824 0.45 . . . . 0.0 109.804 -175.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -126.63 156.09 41.51 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.689 0.795 . . . . 0.0 109.451 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.1 t -136.45 135.36 38.57 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 167.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -133.55 155.1 50.22 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.609 0.764 . . . . 0.0 110.355 -175.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -106.47 120.24 41.38 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.412 HG21 ' HG ' ' A' ' 54' ' ' LEU . 32.3 m -110.44 150.3 13.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 C-N-CA 123.812 0.845 . . . . 0.0 108.999 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.3 m -81.98 -14.67 55.69 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.102 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.603 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 91.01 -42.95 2.85 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.521 -0.309 . . . . 0.0 113.043 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -72.22 -13.32 61.5 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.477 1.111 . . . . 0.0 111.92 176.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -78.23 156.84 29.54 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.129 0.572 . . . . 0.0 109.676 171.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 81.4 p -93.24 175.55 6.73 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.24 0.543 . . . . 0.0 112.285 -175.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.585 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 53.1 t -62.57 -36.55 75.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 123.761 0.825 . . . . 0.0 109.996 170.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . . . -62.25 -37.95 87.4 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.564 0.745 . . . . 0.0 110.76 175.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -64.43 -48.16 76.41 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.789 0.681 . . . . 0.0 111.1 176.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.553 ' O ' HG23 ' A' ' 28' ' ' VAL . 64.2 mt -56.71 -49.23 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 122.881 0.472 . . . . 0.0 109.826 176.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.487 ' HB2' HG12 ' A' ' 41' ' ' VAL . 85.1 tttt -55.26 -45.9 76.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.849 1.66 . . . . 0.0 111.193 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.11 -42.91 88.57 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.847 0.859 . . . . 0.0 111.285 176.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -60.67 -46.83 88.86 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.594 0.758 . . . . 0.0 110.902 -178.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 24' ' ' ILE . 26.3 t -65.13 -44.96 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 123.815 0.697 . . . . 0.0 109.148 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.75 -41.04 90.1 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 123.537 0.735 . . . . 0.0 112.249 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.1 m -61.82 -44.61 96.5 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.807 0.843 . . . . 0.0 111.182 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.5 mt -79.7 -25.41 41.2 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.636 -176.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -85.49 -12.15 52.51 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.006 0.522 . . . . 0.0 111.434 172.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.35 25.44 68.27 Favored Glycine 0 C--N 1.351 1.377 0 C-N-CA 122.85 0.262 . . . . 0.0 113.593 176.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.3 pt -119.03 174.74 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.266 1.026 . . . . 0.0 110.238 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.05 144.22 50.73 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.244 0.618 . . . . 0.0 110.035 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.35 -22.47 59.94 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.48 2.12 . . . . 0.0 110.886 172.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -64.0 -25.54 68.17 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.228 1.411 . . . . 0.0 111.584 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -81.88 -23.06 36.53 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.663 0.785 . . . . 0.0 111.343 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.428 ' O ' ' HE3' ' A' ' 25' ' ' LYS . 10.4 pt20 -123.84 -179.52 4.42 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.357 0.598 . . . . 0.0 111.178 -175.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.454 HG11 ' HB2' ' A' ' 70' ' ' ARG . 7.4 p -156.92 134.42 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.99 1.316 . . . . 0.0 107.513 166.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.487 HG12 ' HB2' ' A' ' 25' ' ' LYS . 9.9 p -96.31 110.83 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 CA-C-O 121.952 0.882 . . . . 0.0 109.929 -178.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 47' ' ' PRO . 18.1 mt -94.23 154.88 17.32 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.889 1.276 . . . . 0.0 109.409 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.554 ' HB2' HD11 ' A' ' 48' ' ' LEU . 40.3 tp -94.16 97.63 10.41 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 58.2 23.83 10.71 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.292 1.037 . . . . 0.0 112.489 -177.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.93 -5.8 36.89 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 119.483 -0.621 . . . . 0.0 113.655 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.21 116.11 65.22 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 123.49 0.716 . . . . 0.0 110.66 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.409 ' HA ' HD22 ' A' ' 42' ' ' LEU . 40.7 Cg_endo -64.63 106.62 0.76 Allowed 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.31 2.007 . . . . 0.0 111.621 174.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' A' ' 43' ' ' LEU . 63.8 mt -82.77 170.01 15.52 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.098 0.559 . . . . 0.0 111.0 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -78.26 124.87 28.57 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 168.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.585 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 10.2 p-10 -67.26 -19.61 65.54 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.935 0.494 . . . . 0.0 111.415 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -80.6 -21.35 41.66 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.194 0.998 . . . . 0.0 111.617 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.45 133.97 38.49 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.132 0.573 . . . . 0.0 110.781 -178.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 66.5 p -79.41 171.64 14.88 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.756 0.822 . . . . 0.0 110.626 174.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.603 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 3.4 mm? -64.1 -37.43 87.42 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 175.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.42 -39.11 95.57 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.586 175.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -70.07 -44.2 69.58 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.528 0.731 . . . . 0.0 110.946 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 51.8 t -75.75 -24.12 56.04 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.32 0.648 . . . . 0.0 111.446 -177.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.78 35.02 13.92 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.918 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.4 t -76.84 148.59 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 123.651 0.781 . . . . 0.0 109.268 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -119.61 -171.99 2.24 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.723 0.809 . . . . 0.0 110.299 -176.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.79 149.89 30.92 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 122.779 0.431 . . . . 0.0 110.281 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 60.28 26.2 15.67 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.095 1.358 . . . . 0.0 112.33 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.6 m -80.0 162.17 25.03 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.633 0.773 . . . . 0.0 109.89 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.2 m -115.78 106.06 13.42 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.889 0.852 . . . . 0.0 110.529 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.517 ' HB2' HG22 ' A' ' 5' ' ' VAL . 3.5 mm? -83.02 164.99 20.0 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.409 -1.269 . . . . 0.0 107.833 164.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -144.92 130.46 18.88 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.878 0.471 . . . . 0.0 110.613 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.447 HG21 HG11 ' A' ' 28' ' ' VAL . 83.2 t -83.02 127.45 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 172.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.78 151.79 47.38 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.85 0.86 . . . . 0.0 109.981 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -91.78 86.41 1.27 Allowed Glycine 0 C--N 1.341 0.852 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 173.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.454 ' HB2' HG11 ' A' ' 40' ' ' VAL . 71.3 mtp180 -119.31 16.13 13.08 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.154 0.981 . . . . 0.0 108.965 170.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.302 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.663 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 82.6 mtp . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -88.54 99.46 12.32 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.409 HD21 HD23 ' A' ' 54' ' ' LEU . 1.5 pp -119.99 165.52 14.56 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.52 0.728 . . . . 0.0 110.864 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.441 ' HB3' HD21 ' A' ' 10' ' ' LEU . 29.7 m-85 -101.35 140.66 35.34 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.344 1.058 . . . . 0.0 108.918 -176.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.37 107.33 16.55 Favored 'Isoleucine or valine' 0 C--O 1.244 0.806 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -80.36 93.78 6.03 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.712 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.92 -171.77 2.42 Favored 'General case' 0 C--O 1.245 0.84 0 C-N-CA 125.876 1.67 . . . . 0.0 108.015 165.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -38.72 -34.28 0.14 Allowed 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 123.399 0.68 . . . . 0.0 112.727 167.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -123.96 162.75 22.75 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.637 1.175 . . . . 0.0 109.319 164.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.441 HD21 ' HB3' ' A' ' 4' ' ' PHE . 3.2 tm? -81.94 131.76 35.25 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -133.77 124.68 27.03 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.077 0.951 . . . . 0.0 109.119 -177.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 m -99.35 123.43 43.62 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -119.56 121.31 39.07 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.463 1.105 . . . . 0.0 110.456 -176.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.22 106.2 13.01 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 163.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.2 m -110.93 156.7 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.884 0.874 . . . . 0.0 110.659 -174.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.3 p -75.14 -25.74 58.63 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.949 177.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.3 -39.24 3.11 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.921 -174.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -78.23 -10.81 59.82 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.085 0.554 . . . . 0.0 111.657 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -69.13 120.84 15.59 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 168.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 69.7 p -66.29 161.22 22.79 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.388 0.675 . . . . 0.0 111.6 -175.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.465 HG13 ' HB ' ' A' ' 41' ' ' VAL . 75.4 t -62.06 -29.89 47.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 C-N-CA 124.042 0.937 . . . . 0.0 110.947 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . . . -61.31 -53.18 60.07 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.639 0.775 . . . . 0.0 110.499 174.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -65.92 -37.23 85.53 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.794 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.3 mm -63.96 -47.15 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.828 0.851 . . . . 0.0 111.588 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.48 ' HB3' HG23 ' A' ' 41' ' ' VAL . 51.8 pttt -70.18 -33.81 72.2 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 118.132 0.424 . . . . 0.0 110.28 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.61 -39.41 80.86 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.603 0.761 . . . . 0.0 110.605 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -55.57 -51.95 65.38 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.649 1.58 . . . . 0.0 109.955 175.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.506 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 84.5 t -64.51 -44.03 96.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.271 178.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.83 -35.67 78.91 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.629 0.771 . . . . 0.0 112.323 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.0 m -68.62 -40.8 80.17 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.092 0.557 . . . . 0.0 110.754 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.6 mt -66.93 -40.72 87.7 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.492 177.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 28' ' ' VAL . 11.0 mm-40 -84.27 -12.67 54.3 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.731 0.813 . . . . 0.0 111.709 -177.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.59 38.68 78.73 Favored Glycine 0 C--N 1.354 1.569 0 O-C-N 123.415 0.447 . . . . 0.0 113.32 177.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.2 pt -129.22 176.13 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.442 1.097 . . . . 0.0 110.306 -175.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.73 113.91 29.14 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 123.978 0.911 . . . . 0.0 112.466 -171.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -60.44 -35.7 89.68 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.291 2.661 . . . . 0.0 113.139 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -67.33 -27.67 67.33 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.008 0.523 . . . . 0.0 110.916 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 71' ' ' MET . 31.7 t70 -74.74 -29.47 61.17 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.282 0.633 . . . . 0.0 110.607 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -75.98 152.6 36.96 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.403 0.621 . . . . 0.0 111.52 -173.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.3 p -142.63 142.8 26.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-N 114.331 -1.304 . . . . 0.0 107.581 169.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.48 HG23 ' HB3' ' A' ' 25' ' ' LYS . 98.5 t -98.89 123.36 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 173.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 47' ' ' PRO . 86.6 mt -116.34 118.61 33.22 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.825 1.25 . . . . 0.0 108.681 -176.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.3 tp -86.03 97.75 10.46 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 173.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 57.65 24.54 10.65 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.041 0.936 . . . . 0.0 111.645 -174.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.1 -20.87 30.24 Favored Glycine 0 C--N 1.354 1.555 0 C-N-CA 123.521 0.581 . . . . 0.0 113.649 -177.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.34 117.69 60.94 Favored Pre-proline 0 CA--C 1.554 1.111 0 CA-C-N 117.489 0.645 . . . . 0.0 110.602 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.438 ' HA ' HD23 ' A' ' 42' ' ' LEU . 19.8 Cg_exo -65.26 101.59 0.42 Allowed 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.003 2.469 . . . . 0.0 112.508 -176.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.461 ' HB3' HG21 ' A' ' 21' ' ' VAL . 61.7 mt -68.9 127.16 32.12 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.957 176.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.83 127.95 33.65 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 123.463 0.705 . . . . 0.0 109.812 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.495 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . 9.4 p-10 -62.07 -29.53 70.37 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.938 0.895 . . . . 0.0 111.663 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -76.35 -24.11 54.21 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.827 0.851 . . . . 0.0 111.214 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.1 146.27 30.67 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.503 0.721 . . . . 0.0 110.533 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 80.9 p -85.81 165.24 17.02 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.321 0.648 . . . . 0.0 109.893 173.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.409 HD23 HD21 ' A' ' 3' ' ' LEU . 9.7 mp -66.57 -28.79 68.8 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.184 0.594 . . . . 0.0 110.486 175.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.41 -40.45 86.86 Favored Glycine 0 C--N 1.35 1.332 0 O-C-N 123.796 0.685 . . . . 0.0 112.262 174.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -73.08 -36.5 66.84 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.268 0.627 . . . . 0.0 110.652 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 84.0 m -71.7 -17.81 62.2 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.788 0.835 . . . . 0.0 111.567 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.16 19.84 78.77 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 123.578 0.549 . . . . 0.0 113.385 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.562 HG21 HD11 ' A' ' 65' ' ' LEU . 2.2 p -88.15 99.67 9.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -81.92 -174.66 5.18 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.249 -1.341 . . . . 0.0 112.061 -171.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.663 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -62.9 155.45 27.14 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.758 172.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 61.59 24.91 14.93 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.642 1.177 . . . . 0.0 112.565 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.4 m -107.88 157.98 17.72 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.713 0.805 . . . . 0.0 109.069 175.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.3 m -114.59 121.9 44.87 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.907 0.483 . . . . 0.0 110.54 -178.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.562 HD11 HG21 ' A' ' 59' ' ' VAL . 3.0 mm? -94.22 162.56 13.8 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.644 1.178 . . . . 0.0 109.478 171.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -122.69 130.98 53.58 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.457 1.103 . . . . 0.0 108.751 173.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 86.8 t -104.65 114.02 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.23 161.03 21.07 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.742 0.817 . . . . 0.0 111.016 -177.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.09 106.26 3.35 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -131.39 -57.8 1.0 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.617 0.767 . . . . 0.0 111.414 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.548 ' O ' ' HA ' ' A' ' 38' ' ' ASP . 41.2 tpp . . . . . 0 N--CA 1.478 0.965 0 C-N-CA 123.238 0.615 . . . . 0.0 110.562 -171.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.542 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -113.07 132.78 55.28 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.581 0.753 . . . . 0.0 108.978 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.484 HD13 HD23 ' A' ' 65' ' ' LEU . 4.0 pp -131.35 158.92 39.42 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -101.9 152.2 21.2 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.648 0.779 . . . . 0.0 109.106 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.41 ' HB ' ' HB2' ' A' ' 11' ' ' HIS . 8.8 t -126.11 124.9 66.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.675 1.19 . . . . 0.0 108.631 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -95.21 93.41 7.29 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.147 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -108.43 -176.59 3.09 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 168.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.483 HE22 ' HG2' ' A' ' 9' ' ' GLU . 4.0 pp0? -46.86 -29.04 1.78 Allowed 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 123.429 0.692 . . . . 0.0 112.49 174.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.483 ' HG2' HE22 ' A' ' 8' ' ' GLN . 1.1 pt-20 -123.06 159.44 28.44 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.167 0.987 . . . . 0.0 108.698 163.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.4 mt -79.58 128.35 33.27 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.245 0.545 . . . . 0.0 110.789 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 56.2 m-70 -113.23 163.19 15.1 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.708 1.203 . . . . 0.0 108.174 173.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 t -141.44 146.32 36.38 Favored 'General case' 0 C--O 1.244 0.763 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 169.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -138.81 131.54 29.16 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.842 0.857 . . . . 0.0 109.877 -175.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.42 132.16 43.39 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 170.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.48 HG11 HD11 ' A' ' 24' ' ' ILE . 16.1 m -141.6 -169.38 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 125.025 1.33 . . . . 0.0 109.083 -177.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.5 m -113.18 -9.33 13.49 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.85 0.86 . . . . 0.0 109.854 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.39 -36.61 3.69 Favored Glycine 0 C--N 1.357 1.738 0 N-CA-C 112.245 -0.342 . . . . 0.0 112.245 -174.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -67.88 -16.85 64.27 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.505 0.722 . . . . 0.0 110.989 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -67.61 146.74 53.57 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 122.926 0.49 . . . . 0.0 110.313 172.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 76.7 p -84.74 157.19 21.12 Favored 'General case' 0 C--O 1.244 0.763 0 CA-C-O 121.608 0.718 . . . . 0.0 112.029 -176.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.6 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 82.6 t -60.63 -27.36 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.747 173.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.74 -52.71 48.94 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.009 0.923 . . . . 0.0 111.695 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -64.88 -30.63 71.64 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 119.456 -0.307 . . . . 0.0 111.203 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.487 ' O ' HG23 ' A' ' 28' ' ' VAL . 37.6 mm -58.65 -56.66 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 123.536 0.523 . . . . 0.0 110.631 173.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -68.82 -29.18 67.47 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.449 0.3 . . . . 0.0 110.352 -177.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.44 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . . . -67.51 -40.81 85.15 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.645 0.778 . . . . 0.0 111.335 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -67.5 -40.97 85.18 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.539 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 65.0 t -59.19 -45.03 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.609 174.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.37 -39.11 82.24 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.095 0.958 . . . . 0.0 111.795 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.4 m -63.3 -37.93 89.18 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.728 0.811 . . . . 0.0 111.344 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.5 mt -77.23 -30.12 54.44 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.758 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 28' ' ' VAL . 17.6 mm-40 -78.11 -27.82 48.42 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.914 0.885 . . . . 0.0 110.908 176.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.75 15.54 59.56 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 116.152 -0.476 . . . . 0.0 113.519 -175.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.9 pt -120.2 -176.9 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 124.224 1.01 . . . . 0.0 110.5 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.82 145.75 30.28 Favored Pre-proline 0 CA--C 1.562 1.427 0 C-N-CA 123.312 0.645 . . . . 0.0 111.382 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.44 ' HB3' ' HA ' ' A' ' 26' ' ' ALA . 30.3 Cg_endo -62.7 -21.23 72.78 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 123.165 2.577 . . . . 0.0 113.913 177.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.73 -17.95 65.12 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.026 0.93 . . . . 0.0 111.805 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -80.58 -40.22 26.19 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.591 0.71 . . . . 0.0 110.101 174.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.433 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 24.9 mt-30 -90.13 154.34 19.85 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 114.419 -1.264 . . . . 0.0 112.348 -168.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.4 134.24 17.29 Favored 'Isoleucine or valine' 0 C--O 1.252 1.215 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.51 172.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.632 HG22 HG22 ' A' ' 67' ' ' VAL . 74.5 t -82.24 129.31 37.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.648 177.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.5 mt -117.19 124.02 48.09 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.293 1.437 . . . . 0.0 108.529 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.413 ' HB2' HD11 ' A' ' 48' ' ' LEU . 30.7 tp -100.18 107.62 19.53 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 171.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 61.64 22.85 13.26 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.651 1.18 . . . . 0.0 111.943 -174.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.68 -20.84 38.17 Favored Glycine 0 C--N 1.355 1.594 0 CA-C-N 116.105 -0.498 . . . . 0.0 113.222 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.4 120.47 74.38 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 123.487 0.715 . . . . 0.0 110.628 -176.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.94 121.79 9.82 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.197 2.598 . . . . 0.0 113.033 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.417 HD22 ' SG ' ' A' ' 57' ' ' CYS . 84.9 mt -82.63 152.77 25.75 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 123.76 0.824 . . . . 0.0 109.792 174.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -73.37 110.04 7.36 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.6 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 14.9 p-10 -63.45 -32.77 74.31 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.551 -177.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -71.18 -17.91 62.51 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.935 0.894 . . . . 0.0 111.347 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.32 153.33 22.05 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.693 0.797 . . . . 0.0 111.013 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 62.9 p -82.09 158.15 23.83 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.67 0.788 . . . . 0.0 110.374 178.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.12 -35.12 79.23 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.873 0.869 . . . . 0.0 111.129 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.08 -46.9 68.19 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.149 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -72.76 -30.1 63.85 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.044 0.537 . . . . 0.0 110.981 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.417 ' SG ' HD22 ' A' ' 48' ' ' LEU . 42.9 t -67.33 -26.65 66.6 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.71 0.804 . . . . 0.0 111.056 173.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.27 22.61 47.42 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.305 177.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.517 HG21 HD21 ' A' ' 65' ' ' LEU . 2.4 p -98.39 131.75 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 176.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -121.08 -168.27 1.64 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.136 0.974 . . . . 0.0 110.881 -172.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.542 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -67.44 160.04 28.3 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.296 0.638 . . . . 0.0 111.087 175.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 61.25 19.03 9.73 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.781 1.232 . . . . 0.0 112.399 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.404 HG21 HG23 ' A' ' 59' ' ' VAL . 9.9 m -101.06 161.15 13.8 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.826 0.85 . . . . 0.0 108.826 174.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.8 m -128.33 124.2 35.86 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.517 HD21 HG21 ' A' ' 59' ' ' VAL . 3.1 mm? -109.61 128.27 55.11 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 124.795 1.238 . . . . 0.0 108.727 -178.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -93.54 108.17 19.91 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.751 0.82 . . . . 0.0 109.109 -174.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.632 HG22 HG22 ' A' ' 41' ' ' VAL . 76.8 t -94.95 106.09 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -178.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.48 136.34 54.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.281 -176.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 39' ' ' GLN . . . -82.17 89.74 1.46 Allowed Glycine 0 C--N 1.34 0.766 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 176.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -118.73 -21.54 7.81 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.425 0.69 . . . . 0.0 111.327 -175.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.8 ttm . . . . . 0 CA--C 1.546 0.791 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -178.567 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.437 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 26.0 ttt . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -89.86 98.61 11.87 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.602 -175.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.0 pp -114.7 150.4 35.32 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 175.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -87.77 145.45 26.1 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.857 0.863 . . . . 0.0 108.839 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.436 HG11 HG21 ' A' ' 28' ' ' VAL . 73.0 t -125.79 111.35 26.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 170.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -74.73 92.55 2.48 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.282 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.69 -175.39 3.57 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.781 1.232 . . . . 0.0 108.086 170.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -49.32 -28.54 4.97 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.082 0.553 . . . . 0.0 111.613 173.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -122.76 151.17 41.87 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.039 0.935 . . . . 0.0 108.522 161.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -73.22 128.44 35.49 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -177.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -127.6 159.81 33.51 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.504 0.721 . . . . 0.0 110.079 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.8 m -129.2 137.73 51.31 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -130.84 114.85 15.81 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.887 0.875 . . . . 0.0 111.302 -170.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -76.81 103.56 6.83 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 163.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.437 ' O ' ' HB3' ' A' ' 1' ' ' MET . 30.8 m -110.9 169.47 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.893 0.877 . . . . 0.0 109.434 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.1 m -94.93 -28.79 15.0 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.007 0.523 . . . . 0.0 110.108 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.429 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 102.18 -13.1 57.3 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 116.251 -0.432 . . . . 0.0 112.662 -176.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -91.99 -9.39 43.09 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.462 0.705 . . . . 0.0 111.186 -176.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -73.02 152.63 41.23 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 78.2 p -80.72 164.38 22.82 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.516 0.674 . . . . 0.0 109.569 171.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.597 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 53.9 t -62.98 -27.21 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.34 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.842 171.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . . . -64.0 -40.14 95.69 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.404 0.682 . . . . 0.0 111.483 172.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.415 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 85.9 mm-40 -66.91 -36.75 82.98 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.797 0.439 . . . . 0.0 110.515 177.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.9 mm -61.18 -47.76 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.35 0.66 . . . . 0.0 110.417 174.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -55.23 -49.42 72.05 Favored 'General case' 0 C--N 1.359 1.005 0 O-C-N 123.714 0.634 . . . . 0.0 109.943 175.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.68 -48.36 72.5 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.916 0.886 . . . . 0.0 111.904 -178.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -64.87 -45.95 83.87 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.239 0.616 . . . . 0.0 110.853 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.592 HG11 HG21 ' A' ' 67' ' ' VAL . 84.1 t -64.88 -39.97 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 122.632 0.373 . . . . 0.0 110.542 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 34' ' ' ILE . . . -68.65 -32.28 72.02 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.647 0.779 . . . . 0.0 111.763 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.8 t -66.33 -42.02 88.77 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.186 0.594 . . . . 0.0 110.703 173.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.3 mt -70.41 -45.61 65.58 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.082 0.553 . . . . 0.0 112.063 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -88.54 -3.98 58.69 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.498 0.719 . . . . 0.0 111.747 -175.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.54 33.48 72.14 Favored Glycine 0 C--N 1.356 1.675 0 O-C-N 123.529 0.518 . . . . 0.0 113.725 174.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.428 ' O ' ' HB1' ' A' ' 29' ' ' ALA . 9.6 pt -123.01 -179.92 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.035 0.934 . . . . 0.0 110.576 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.58 125.61 53.09 Favored Pre-proline 0 CA--C 1.557 1.24 0 C-N-CA 123.392 0.677 . . . . 0.0 110.931 -176.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.65 -18.87 37.27 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.485 2.123 . . . . 0.0 112.685 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -66.73 -33.94 76.75 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.07 0.948 . . . . 0.0 111.846 -177.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -92.49 -8.08 45.57 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -176.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -80.1 147.05 31.57 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.247 0.546 . . . . 0.0 111.008 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.2 m -130.1 142.25 44.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 168.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.442 HG13 ' HB3' ' A' ' 65' ' ' LEU . 73.2 t -106.29 105.53 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.3 mt -87.81 122.5 31.53 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.274 1.03 . . . . 0.0 110.291 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.2 tp -91.27 97.17 10.95 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 167.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 55.96 30.61 16.37 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.252 1.021 . . . . 0.0 112.082 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.1 -23.58 24.98 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-N 115.93 -0.577 . . . . 0.0 113.568 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.43 113.61 38.28 Favored Pre-proline 0 N--CA 1.479 0.977 0 CA-C-N 117.487 0.643 . . . . 0.0 110.929 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -65.92 109.22 1.44 Allowed 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.512 2.142 . . . . 0.0 112.143 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.6 mt -73.76 148.15 42.82 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.738 0.815 . . . . 0.0 110.996 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.411 ' HB3' ' HG2' ' A' ' 51' ' ' GLU . 44.6 mm-40 -77.25 121.88 24.3 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 124.286 0.991 . . . . 0.0 109.989 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.597 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 0.8 OUTLIER -65.75 -21.95 66.55 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 123.913 0.758 . . . . 0.0 112.546 176.142 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.411 ' HG2' ' HB3' ' A' ' 49' ' ' GLU . 11.2 pt-20 -72.39 -26.8 62.02 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.226 0.61 . . . . 0.0 111.099 174.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.89 143.11 27.3 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.767 0.827 . . . . 0.0 111.454 -174.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 45.6 p -73.74 168.06 20.14 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.549 0.74 . . . . 0.0 111.067 172.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.429 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 3.1 mm? -64.46 -30.39 71.43 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 171.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.88 -39.29 93.37 Favored Glycine 0 C--N 1.358 1.755 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.621 173.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -71.24 -37.26 72.0 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.741 0.416 . . . . 0.0 109.9 177.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 40.6 t -66.48 -22.45 66.19 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.414 0.685 . . . . 0.0 111.37 173.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.44 21.31 78.66 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.584 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.2 p -91.58 152.76 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 123.572 0.749 . . . . 0.0 109.606 -176.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -132.21 -168.3 2.02 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.764 0.826 . . . . 0.0 110.948 -176.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.8 167.4 13.49 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.537 0.735 . . . . 0.0 112.491 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 68.14 -5.33 0.9 Allowed 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 126.247 1.819 . . . . 0.0 113.737 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.3 m -77.6 153.71 32.98 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.776 0.83 . . . . 0.0 109.939 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.7 m -119.07 110.16 16.76 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.756 0.822 . . . . 0.0 109.633 175.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.442 ' HB3' HG13 ' A' ' 41' ' ' VAL . 84.8 mt -87.04 144.65 26.79 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 171.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -117.28 121.61 41.65 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.561 0.619 . . . . 0.0 110.857 -175.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.592 HG21 HG11 ' A' ' 28' ' ' VAL . 77.0 t -83.75 115.93 26.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 122.804 0.441 . . . . 0.0 109.971 173.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -123.89 167.21 14.41 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.562 1.145 . . . . 0.0 109.765 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.64 88.88 0.5 Allowed Glycine 0 C--N 1.342 0.871 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -109.35 -36.34 6.03 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.836 0.855 . . . . 0.0 109.706 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 47.4 ttm . . . . . 0 CA--C 1.549 0.904 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.185 175.667 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -102.61 118.39 36.75 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.682 0.793 . . . . 0.0 110.252 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 pp -133.55 165.26 25.31 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.302 0.641 . . . . 0.0 110.35 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -101.05 142.39 32.58 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.057 0.943 . . . . 0.0 109.528 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.1 t -125.46 109.62 22.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 C-N-CA 123.903 0.881 . . . . 0.0 108.674 171.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 35.5 ttt85 -79.48 95.35 5.78 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.084 1.353 . . . . 0.0 110.862 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.17 -174.82 3.33 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.582 1.153 . . . . 0.0 108.032 165.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -42.15 -36.18 1.12 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 123.567 0.747 . . . . 0.0 111.62 167.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -111.05 136.25 50.34 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 164.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -70.88 123.28 21.62 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 173.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -126.1 154.42 43.13 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.498 0.719 . . . . 0.0 109.769 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.3 m -113.91 143.15 45.18 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.812 0.845 . . . . 0.0 108.809 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -136.61 129.36 30.66 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.793 0.837 . . . . 0.0 110.043 -174.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -90.74 114.71 27.13 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 166.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.3 m -115.37 155.48 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.192 0.997 . . . . 0.0 110.463 -169.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.0 m -83.03 -9.9 59.03 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -171.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.5 -50.68 4.07 Favored Glycine 0 C--N 1.358 1.776 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -174.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -79.65 7.06 9.11 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.855 0.862 . . . . 0.0 110.802 167.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -59.57 121.05 10.6 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.765 1.226 . . . . 0.0 109.176 168.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.688 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 51.1 p -78.88 167.41 21.19 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 118.765 0.711 . . . . 0.0 110.385 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.589 HG21 ' HB3' ' A' ' 48' ' ' LEU . 80.3 t -67.52 -32.52 57.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 123.157 0.583 . . . . 0.0 110.069 174.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.65 -36.43 84.25 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.601 0.761 . . . . 0.0 110.635 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -69.3 -40.86 77.43 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.307 0.643 . . . . 0.0 110.963 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.573 HD11 HD11 ' A' ' 54' ' ' LEU . 40.9 mm -57.95 -45.82 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.591 0.757 . . . . 0.0 110.151 175.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.532 ' HE2' ' HA ' ' A' ' 40' ' ' VAL . 92.6 mttt -59.6 -49.59 77.19 Favored 'General case' 0 C--O 1.21 -1.017 0 O-C-N 124.52 1.137 . . . . 0.0 110.603 176.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.01 -42.96 91.36 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.007 0.923 . . . . 0.0 112.025 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -59.41 -53.15 61.45 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.871 0.868 . . . . 0.0 111.019 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.469 HG11 HG21 ' A' ' 67' ' ' VAL . 11.6 p -75.39 -27.57 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.46 -175.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.77 -37.15 79.13 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.726 0.81 . . . . 0.0 110.985 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.4 t -67.13 -40.88 86.87 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 123.39 0.431 . . . . 0.0 110.44 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.1 mt -61.9 -49.71 75.11 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 123.445 0.466 . . . . 0.0 111.916 176.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 28' ' ' VAL . 3.2 mm-40 -86.58 -3.43 59.02 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.115 0.566 . . . . 0.0 111.693 -175.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.56 16.87 70.21 Favored Glycine 0 C--N 1.357 1.711 0 O-C-N 123.315 0.384 . . . . 0.0 113.285 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 36.1 pt -98.65 175.84 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.936 0.894 . . . . 0.0 110.937 -175.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.39 133.29 38.75 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.814 0.846 . . . . 0.0 110.355 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -66.76 -16.77 51.2 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.699 2.266 . . . . 0.0 111.964 171.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -76.71 -19.34 57.8 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.642 0.777 . . . . 0.0 111.579 174.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -97.89 19.7 13.38 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.588 0.755 . . . . 0.0 111.131 -172.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -152.87 166.43 32.34 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.651 -0.656 . . . . 0.0 112.024 -172.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.532 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . 11.2 p -142.29 149.22 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.653 1.181 . . . . 0.0 108.993 172.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.428 ' HB ' HG13 ' A' ' 21' ' ' VAL . 63.1 t -102.65 132.55 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.22 0.608 . . . . 0.0 109.638 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 47' ' ' PRO . 2.7 mm? -117.75 113.54 21.99 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.648 1.579 . . . . 0.0 108.657 -174.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.618 HD11 ' HB ' ' A' ' 59' ' ' VAL . 2.9 tt -80.15 98.26 7.24 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 57.85 26.48 13.29 Favored 'General case' 0 CA--C 1.556 1.175 0 O-C-N 124.007 0.817 . . . . 0.0 111.842 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.27 -18.79 32.85 Favored Glycine 0 C--N 1.357 1.719 0 CA-C-N 115.927 -0.578 . . . . 0.0 114.207 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.84 117.31 67.81 Favored Pre-proline 0 N--CA 1.483 1.184 0 C-N-CA 123.516 0.726 . . . . 0.0 111.422 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.411 ' HA ' HD13 ' A' ' 42' ' ' LEU . 36.3 Cg_endo -62.11 108.95 0.73 Allowed 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.09 2.527 . . . . 0.0 113.204 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.589 ' HB3' HG21 ' A' ' 21' ' ' VAL . 73.7 mt -82.78 139.97 33.27 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.133 177.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -80.56 131.9 35.58 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.024 0.93 . . . . 0.0 110.334 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.24 -49.87 22.4 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.038 1.335 . . . . 0.0 113.628 -174.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -18.79 49.89 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.955 0.502 . . . . 0.0 112.173 -173.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.73 140.36 45.92 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.107 0.563 . . . . 0.0 110.791 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.688 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 47.6 p -85.43 170.87 12.28 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.734 0.414 . . . . 0.0 110.673 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.573 HD11 HD11 ' A' ' 24' ' ' ILE . 36.8 mt -68.74 -29.93 68.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.117 0.567 . . . . 0.0 111.117 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.02 -42.39 92.52 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.05 172.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -68.89 -31.34 70.19 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.842 0.857 . . . . 0.0 111.271 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 79.0 m -71.96 -28.87 63.73 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.304 0.642 . . . . 0.0 110.635 172.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.76 22.07 54.23 Favored Glycine 0 C--N 1.348 1.21 0 O-C-N 123.495 0.497 . . . . 0.0 112.91 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.618 ' HB ' HD11 ' A' ' 43' ' ' LEU . 7.5 p -96.94 135.7 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.44 0.696 . . . . 0.0 110.235 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -106.77 -168.57 1.43 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.247 1.019 . . . . 0.0 109.925 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.35 175.79 6.6 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.107 0.563 . . . . 0.0 111.26 176.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 58.59 26.02 13.91 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.869 1.268 . . . . 0.0 112.439 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.6 m -111.63 153.94 25.61 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.854 0.862 . . . . 0.0 109.832 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 54.5 m -114.44 108.82 17.39 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.08 0.552 . . . . 0.0 109.889 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.57 149.96 21.03 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 171.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -125.19 139.25 53.91 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 119.087 0.858 . . . . 0.0 110.758 -176.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.469 HG21 HG11 ' A' ' 28' ' ' VAL . 77.1 t -97.14 122.23 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.526 0.731 . . . . 0.0 110.071 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -118.3 149.91 40.36 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.426 0.69 . . . . 0.0 110.543 173.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.39 90.57 1.68 Allowed Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -123.3 10.29 9.25 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.708 0.803 . . . . 0.0 110.422 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 37.7 tpp -140.18 160.82 39.09 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.868 0.467 . . . . 0.0 110.698 -169.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -149.47 -44.6 0.14 Allowed 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 135.14 -116.81 1.61 Allowed Glycine 0 C--N 1.342 0.883 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.659 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.279 0 CA-C-O 119.113 -0.826 . . . . 0.0 111.624 177.023 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.474 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 30.1 tt0 -145.26 123.06 11.9 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.6 pp -119.9 166.79 12.85 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.312 0.577 . . . . 0.0 110.715 -174.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -102.57 137.62 40.57 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.9 t -107.15 114.39 46.01 Favored 'Isoleucine or valine' 0 C--O 1.248 0.995 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 172.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.5 ttt85 -83.09 90.51 7.06 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.231 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.59 -176.8 3.19 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 114.373 -1.285 . . . . 0.0 107.988 174.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -43.66 -29.22 0.48 Allowed 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 124.352 1.061 . . . . 0.0 112.316 170.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -135.68 140.89 44.82 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.908 1.283 . . . . 0.0 107.921 166.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.9 126.28 30.09 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.24 0.616 . . . . 0.0 110.076 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -119.96 160.38 22.87 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.058 0.943 . . . . 0.0 108.93 172.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.0 m -124.58 131.65 53.47 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -132.16 126.51 33.8 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.598 0.759 . . . . 0.0 109.939 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 11.3 pt-20 -89.15 135.54 33.51 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.097 0.475 . . . . 0.0 109.764 173.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 1' ' ' MET . 30.1 m -134.74 150.21 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.8 0.84 . . . . 0.0 109.598 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.1 p -93.58 12.51 25.03 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.164 0.585 . . . . 0.0 111.26 172.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.411 ' O ' ' HB ' ' A' ' 53' ' ' THR . . . 93.62 -35.4 4.16 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-O 119.647 -0.529 . . . . 0.0 112.798 176.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -68.0 -21.13 65.06 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.974 0.91 . . . . 0.0 112.301 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -62.0 134.64 56.9 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 26.4 p -82.6 168.6 17.16 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.36 0.6 . . . . 0.0 110.637 174.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.567 HG21 ' HB3' ' A' ' 48' ' ' LEU . 55.9 t -63.16 -32.78 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.425 170.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.508 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . . . -60.74 -42.42 97.31 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.36 0.664 . . . . 0.0 111.064 173.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -67.83 -37.47 81.95 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.348 0.259 . . . . 0.0 111.232 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.415 HD11 HG11 ' A' ' 15' ' ' VAL . 44.0 mm -57.32 -48.1 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 122.837 0.455 . . . . 0.0 110.032 173.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.444 ' HE3' HG12 ' A' ' 21' ' ' VAL . 96.6 mttt -61.26 -40.81 95.44 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.783 0.833 . . . . 0.0 111.223 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.87 -43.56 94.64 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.884 0.874 . . . . 0.0 112.069 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -65.54 -42.59 91.77 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.034 0.533 . . . . 0.0 111.044 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.8 t -64.71 -39.88 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.086 0.555 . . . . 0.0 109.76 176.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.98 -35.19 79.36 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.258 1.023 . . . . 0.0 112.316 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.5 m -64.81 -50.13 67.92 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.345 0.658 . . . . 0.0 110.843 175.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.5 mt -71.59 -38.44 70.89 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -174.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -91.35 -14.61 30.43 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.055 0.542 . . . . 0.0 111.662 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.92 27.26 69.17 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 116.405 -0.362 . . . . 0.0 112.565 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.2 pt -108.09 177.97 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.793 0.837 . . . . 0.0 109.795 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.27 138.92 20.62 Favored Pre-proline 0 N--CA 1.478 0.957 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.61 -20.48 70.95 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 123.296 2.664 . . . . 0.0 113.053 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -67.95 -35.36 78.27 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.573 0.749 . . . . 0.0 111.006 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 71' ' ' MET . 10.6 m-20 -73.26 -18.06 61.26 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.073 0.549 . . . . 0.0 112.261 -172.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.546 ' HB2' HG13 ' A' ' 67' ' ' VAL . 12.3 pt20 -112.95 151.22 30.8 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.399 0.679 . . . . 0.0 111.074 -174.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -132.12 132.94 61.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 124.744 1.218 . . . . 0.0 107.986 171.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.6 t -88.78 131.2 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.0 mt -122.93 115.19 21.52 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.952 1.301 . . . . 0.0 108.983 -174.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.524 ' HB2' HD11 ' A' ' 48' ' ' LEU . 42.2 tp -81.94 95.14 7.28 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 176.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 56.97 24.52 9.55 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.058 0.943 . . . . 0.0 112.027 -174.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.6 -8.19 37.1 Favored Glycine 0 C--N 1.354 1.528 0 CA-C-O 119.597 -0.557 . . . . 0.0 113.86 -177.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.72 118.84 74.55 Favored Pre-proline 0 N--CA 1.483 1.211 0 CA-C-N 117.444 0.622 . . . . 0.0 110.849 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.29 102.04 0.31 Allowed 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.746 2.298 . . . . 0.0 112.519 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.567 ' HB3' HG21 ' A' ' 21' ' ' VAL . 67.1 mt -81.0 134.4 35.67 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.463 177.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -82.52 139.0 34.14 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.834 0.854 . . . . 0.0 110.333 -176.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 22' ' ' ALA . 2.0 m-20 -59.96 -30.13 68.88 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.792 0.837 . . . . 0.0 111.835 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -73.35 -25.55 60.65 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.215 1.006 . . . . 0.0 111.206 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.98 131.74 35.87 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.921 -174.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 81.1 p -80.59 167.71 19.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.27 0.628 . . . . 0.0 109.541 172.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -65.51 -30.66 71.45 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.241 0.473 . . . . 0.0 110.42 176.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.27 -36.0 70.33 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.511 173.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -72.11 -38.05 69.4 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.465 0.706 . . . . 0.0 110.638 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 76.6 m -71.32 -18.63 62.39 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.905 0.882 . . . . 0.0 111.088 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.92 29.52 75.21 Favored Glycine 0 C--N 1.352 1.431 0 O-C-N 123.497 0.498 . . . . 0.0 112.663 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.469 HG21 HD11 ' A' ' 65' ' ' LEU . 4.5 p -87.08 133.29 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -81.77 174.24 11.52 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.505 0.722 . . . . 0.0 110.979 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.462 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -72.71 160.37 32.33 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.784 175.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 64.84 12.16 7.52 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.743 1.617 . . . . 0.0 112.96 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.4 m -85.11 154.37 22.08 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.3 m -114.32 116.08 28.4 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.146 0.498 . . . . 0.0 110.181 -177.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.469 HD11 HG21 ' A' ' 59' ' ' VAL . 6.9 mp -103.57 122.14 44.36 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.085 1.354 . . . . 0.0 108.142 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -94.71 145.32 24.93 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.025 0.53 . . . . 0.0 111.841 -171.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.546 HG13 ' HB2' ' A' ' 39' ' ' GLN . 73.6 t -94.12 135.97 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 124.211 1.004 . . . . 0.0 109.989 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.63 141.26 51.67 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.113 0.965 . . . . 0.0 109.503 171.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.14 92.06 1.52 Allowed Glycine 0 N--CA 1.472 1.065 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -121.97 -68.5 0.89 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 117.321 0.561 . . . . 0.0 111.959 -172.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.457 ' O ' ' HA ' ' A' ' 38' ' ' ASP . 51.2 tpp -61.61 140.04 58.19 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.456 0.703 . . . . 0.0 111.141 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -150.13 117.64 6.12 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -135.22 43.81 1.22 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.217 0 CA-C-O 119.2 -0.778 . . . . 0.0 112.303 -178.22 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 60.8 tt0 -122.14 114.33 20.73 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.922 0.889 . . . . 0.0 109.389 -175.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.3 pp -120.79 165.13 15.57 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.938 0.495 . . . . 0.0 111.635 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -98.51 152.24 19.76 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.636 0.774 . . . . 0.0 109.254 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.7 t -135.13 109.31 10.99 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 C-N-CA 124.767 1.227 . . . . 0.0 108.179 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -76.33 92.83 3.37 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.866 0.866 . . . . 0.0 110.776 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.31 -176.87 4.26 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.297 1.039 . . . . 0.0 108.398 165.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -47.55 -30.15 3.35 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.17 0.588 . . . . 0.0 112.156 171.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -124.0 144.07 50.04 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.175 0.99 . . . . 0.0 108.661 161.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.86 133.95 47.94 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 122.947 0.499 . . . . 0.0 110.391 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -131.02 148.49 52.76 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.837 0.855 . . . . 0.0 109.406 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.2 m -119.5 133.74 55.54 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -128.45 119.3 24.66 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.977 0.911 . . . . 0.0 109.997 -175.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 42.0 tt0 -95.35 104.43 16.32 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 171.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.0 m -112.8 174.44 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.126 0.97 . . . . 0.0 110.864 -172.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.7 m -83.09 -45.53 13.88 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.678 0.791 . . . . 0.0 110.106 174.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.23 -35.06 3.2 Favored Glycine 0 C--N 1.35 1.321 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -174.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -65.55 -10.13 32.42 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.476 0.71 . . . . 0.0 111.53 173.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -52.64 129.08 28.3 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.854 1.261 . . . . 0.0 110.408 169.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.675 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 45.5 p -84.77 164.73 18.33 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 118.272 0.487 . . . . 0.0 109.94 173.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.491 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 68.4 t -67.22 -30.27 48.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.235 174.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.504 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . . . -62.12 -40.42 95.85 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.572 0.749 . . . . 0.0 110.802 174.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -68.5 -40.17 81.0 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.746 177.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.9 mm -57.97 -42.84 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 123.229 0.612 . . . . 0.0 110.529 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.43 -51.87 68.04 Favored 'General case' 0 C--N 1.359 0.998 0 O-C-N 123.975 0.797 . . . . 0.0 110.015 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.61 -42.97 75.63 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.861 0.726 . . . . 0.0 111.924 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.416 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 48.5 m-70 -61.54 -54.62 40.79 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.686 0.794 . . . . 0.0 111.655 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.526 HG11 HG21 ' A' ' 67' ' ' VAL . 12.8 p -72.42 -30.01 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.637 -174.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.402 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . . . -72.45 -34.69 67.95 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.388 0.675 . . . . 0.0 111.526 177.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 t -67.16 -37.65 84.12 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.957 0.503 . . . . 0.0 110.309 176.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 27' ' ' HIS . 88.5 mt -63.4 -45.81 89.29 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 123.705 0.628 . . . . 0.0 111.711 177.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.15 -20.0 45.93 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.082 0.553 . . . . 0.0 111.785 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.27 30.81 66.73 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 112.014 -0.434 . . . . 0.0 112.014 -173.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.3 pt -111.57 179.83 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.189 0.996 . . . . 0.0 110.634 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.74 123.43 88.34 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 124.237 1.015 . . . . 0.0 112.576 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.23 -31.59 35.41 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 122.548 2.165 . . . . 0.0 112.567 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.98 5.95 34.69 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.34 0.656 . . . . 0.0 112.062 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -78.83 -31.45 45.77 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 122.35 1.071 . . . . 0.0 109.205 166.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.402 ' NE2' ' HB2' ' A' ' 29' ' ' ALA . 18.8 mt-30 -89.85 147.39 23.8 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 113.725 -1.579 . . . . 0.0 112.337 -167.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -131.05 129.18 63.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 165.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.446 ' HB ' HG13 ' A' ' 21' ' ' VAL . 59.3 t -87.89 131.69 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.6 mt -118.59 148.78 42.33 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.927 1.291 . . . . 0.0 109.519 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.431 ' HB2' HD11 ' A' ' 48' ' ' LEU . 42.3 tp -131.44 102.15 5.82 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 171.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 58.66 33.83 23.37 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.457 1.103 . . . . 0.0 111.398 -175.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.84 -24.01 33.96 Favored Glycine 0 C--N 1.354 1.554 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.297 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.35 119.4 76.84 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 123.325 0.65 . . . . 0.0 110.506 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.28 106.44 1.02 Allowed 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.881 2.387 . . . . 0.0 111.964 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.432 ' HB3' HG21 ' A' ' 21' ' ' VAL . 90.8 mt -69.56 124.12 23.1 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.356 0.663 . . . . 0.0 110.014 173.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -72.46 131.7 42.9 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.366 0.666 . . . . 0.0 110.63 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.504 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . 7.8 p-10 -58.79 -36.79 75.01 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.008 0.923 . . . . 0.0 112.832 -173.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -74.75 -25.72 59.29 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.1 0.56 . . . . 0.0 111.05 -176.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.72 139.51 40.49 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.504 0.722 . . . . 0.0 110.609 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.675 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 53.2 p -83.67 170.36 14.34 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.925 0.393 . . . . 0.0 110.751 177.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.7 mp -72.8 -26.48 61.53 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.9 0.88 . . . . 0.0 110.292 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.3 -43.19 71.79 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.037 172.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -64.42 -39.16 93.3 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.237 0.615 . . . . 0.0 110.77 175.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 46.1 t -63.73 -31.35 72.49 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.624 0.77 . . . . 0.0 111.406 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.38 23.96 69.43 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.272 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.451 HG23 HG21 ' A' ' 63' ' ' THR . 14.7 p -79.44 150.24 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.072 0.549 . . . . 0.0 109.551 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -127.42 -171.68 2.48 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.362 0.665 . . . . 0.0 111.262 -169.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.76 154.8 41.31 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.468 0.707 . . . . 0.0 111.404 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 62.9 1.48 0.84 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 126.183 1.793 . . . . 0.0 114.06 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.451 HG21 HG23 ' A' ' 59' ' ' VAL . 32.3 m -72.37 147.76 45.94 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 47.1 m -113.34 103.71 11.58 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 122.072 -0.393 . . . . 0.0 109.951 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.408 HD23 HD13 ' A' ' 43' ' ' LEU . 62.2 mt -78.18 169.92 17.46 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 170.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -136.08 155.16 50.62 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.526 HG21 HG11 ' A' ' 28' ' ' VAL . 48.7 t -120.38 126.55 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.263 1.025 . . . . 0.0 108.956 175.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.01 142.65 51.5 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.671 0.789 . . . . 0.0 109.805 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.24 89.79 1.64 Allowed Glycine 0 C--N 1.342 0.909 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -130.03 5.06 4.91 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.89 0.876 . . . . 0.0 110.72 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.1 ttm -124.67 149.43 47.18 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.438 0.695 . . . . 0.0 109.403 -170.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 pp -166.44 176.86 7.09 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.362 0.665 . . . . 0.0 111.554 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.14 12.58 84.49 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 114.731 0.652 . . . . 0.0 114.731 173.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.134 0 CA-C-O 118.858 -0.968 . . . . 0.0 112.59 178.834 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.49 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 44.1 ttm . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -91.01 105.03 17.54 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 170.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.5 pp -114.85 163.89 14.89 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.645 0.778 . . . . 0.0 109.985 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -107.41 158.8 16.88 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.513 0.725 . . . . 0.0 109.391 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.406 HG11 HG21 ' A' ' 28' ' ' VAL . 76.9 t -129.66 111.88 23.09 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 C-N-CA 124.037 0.935 . . . . 0.0 109.884 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -70.89 91.33 0.85 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.111 0.964 . . . . 0.0 109.42 173.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.03 -179.37 3.9 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 125.478 1.511 . . . . 0.0 107.808 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -59.21 -33.16 70.65 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 118.581 0.628 . . . . 0.0 109.715 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -111.18 127.5 55.61 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 165.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.99 120.07 14.28 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 -111.33 158.3 19.19 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.571 0.749 . . . . 0.0 109.622 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.7 m -134.0 135.73 43.61 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.297 1.039 . . . . 0.0 108.735 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -133.06 124.79 28.28 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.88 0.872 . . . . 0.0 110.46 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -98.1 105.74 17.93 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 170.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.493 HG11 HD11 ' A' ' 24' ' ' ILE . 28.8 m -120.53 157.77 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.952 1.301 . . . . 0.0 109.412 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.62 ' HB ' ' HG2' ' A' ' 18' ' ' GLN . 20.4 m -75.94 -14.24 60.25 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-O 121.058 0.456 . . . . 0.0 110.907 173.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.452 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 103.26 -31.79 8.32 Favored Glycine 0 C--N 1.351 1.411 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -172.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.62 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 12.6 pt20 -70.74 -4.43 23.74 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.924 0.89 . . . . 0.0 112.304 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -79.23 145.5 33.55 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.754 0.422 . . . . 0.0 109.936 175.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.6 p -82.38 153.46 25.72 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.181 0.515 . . . . 0.0 111.134 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.0 t -62.35 -28.17 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 124.277 1.031 . . . . 0.0 110.522 175.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.62 -50.09 75.23 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 124.331 1.052 . . . . 0.0 110.793 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -67.43 -36.15 80.66 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.312 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.493 HD11 HG11 ' A' ' 15' ' ' VAL . 48.0 mm -57.59 -54.86 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 O-C-N 123.829 0.705 . . . . 0.0 110.301 177.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -73.0 -27.9 62.05 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.105 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.15 -46.48 90.35 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.52 0.728 . . . . 0.0 110.571 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -66.08 -40.18 90.63 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.266 0.627 . . . . 0.0 110.348 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.501 HG11 HG21 ' A' ' 67' ' ' VAL . 72.6 t -56.92 -49.72 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 173.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.33 -34.86 77.47 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.048 0.939 . . . . 0.0 112.609 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.5 t -65.58 -36.74 84.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.488 0.715 . . . . 0.0 110.746 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.1 mt -80.45 -34.84 35.69 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.933 0.893 . . . . 0.0 112.24 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.498 ' HB2' HG12 ' A' ' 34' ' ' ILE . 6.1 mm-40 -75.65 -36.14 60.24 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.891 0.876 . . . . 0.0 110.172 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.93 36.5 15.28 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.479 -171.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.498 HG12 ' HB2' ' A' ' 32' ' ' GLU . 25.0 pt -127.2 -179.56 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 123.897 0.879 . . . . 0.0 111.03 -176.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.18 114.19 37.75 Favored Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 123.937 0.895 . . . . 0.0 112.218 -176.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.85 -33.1 85.38 Favored 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 123.521 2.814 . . . . 0.0 114.009 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.487 ' HG3' ' H ' ' A' ' 74' ' ' GLY . 1.3 pm0 -69.39 -37.56 77.58 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.247 0.342 . . . . 0.0 110.691 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -64.84 -44.55 89.44 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 123.812 0.695 . . . . 0.0 111.116 -170.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.572 ' HB2' HG13 ' A' ' 67' ' ' VAL . 11.7 pt20 -75.75 150.96 37.69 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.976 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.2 144.15 37.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 124.975 1.31 . . . . 0.0 108.139 175.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.7 t -90.46 133.35 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 122.915 0.486 . . . . 0.0 109.86 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 66.5 mt -117.28 108.87 16.15 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.896 1.278 . . . . 0.0 108.961 -176.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.4 ' HB2' HD11 ' A' ' 48' ' ' LEU . 46.2 tp -80.44 96.63 6.79 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 175.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 57.85 28.34 15.9 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.059 0.944 . . . . 0.0 112.036 -176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.46 -25.38 19.84 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-O 119.608 -0.551 . . . . 0.0 113.556 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.3 113.54 32.18 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 123.132 0.573 . . . . 0.0 110.563 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -64.61 115.15 3.05 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.501 2.134 . . . . 0.0 111.526 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.4 HD11 ' HB2' ' A' ' 43' ' ' LEU . 93.2 mt -79.86 158.16 26.81 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.537 0.735 . . . . 0.0 111.358 178.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -86.29 128.71 34.96 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -62.57 -36.59 83.16 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 121.057 0.456 . . . . 0.0 110.911 -176.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -78.8 -9.41 59.44 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.736 0.815 . . . . 0.0 111.843 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.87 148.16 24.77 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 123.356 0.662 . . . . 0.0 109.974 175.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.4 p -92.34 166.34 12.63 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.467 0.707 . . . . 0.0 110.62 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.452 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 3.5 mm? -65.19 -28.47 69.41 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.638 0.775 . . . . 0.0 110.107 175.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.1 -37.02 44.24 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.231 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -67.76 -41.85 82.7 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.019 0.527 . . . . 0.0 110.05 174.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 80.7 m -63.5 -25.84 68.44 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.144 0.578 . . . . 0.0 110.773 174.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.99 25.88 70.32 Favored Glycine 0 C--N 1.35 1.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.667 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.52 160.81 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 122.891 0.477 . . . . 0.0 109.795 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -110.87 -177.08 3.13 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.395 0.678 . . . . 0.0 110.67 -178.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.49 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -76.86 166.25 23.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.294 0.638 . . . . 0.0 111.022 177.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 67.92 6.29 5.05 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.965 1.306 . . . . 0.0 112.909 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.1 m -79.94 150.89 30.36 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.164 0.585 . . . . 0.0 109.746 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.2 m -117.17 112.06 20.32 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.4 mp -96.42 146.9 24.36 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 124.65 1.18 . . . . 0.0 108.112 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -102.01 156.21 17.68 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.065 0.546 . . . . 0.0 110.88 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.572 HG13 ' HB2' ' A' ' 39' ' ' GLN . 6.6 t -118.62 131.29 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.368 1.067 . . . . 0.0 109.311 173.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.32 126.74 20.08 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.121 0.968 . . . . 0.0 109.992 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 39' ' ' GLN . . . -75.97 96.01 1.06 Allowed Glycine 0 C--N 1.344 0.982 0 N-CA-C 111.961 -0.455 . . . . 0.0 111.961 -178.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -120.6 -68.38 0.91 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.778 0.831 . . . . 0.0 111.438 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 21.3 mmt -88.23 78.65 8.02 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.712 0.405 . . . . 0.0 111.862 -168.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.63 109.92 2.17 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.272 0.629 . . . . 0.0 109.608 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.85 -61.45 2.55 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.043 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.487 ' H ' ' HG3' ' A' ' 37' ' ' GLU . . . . . . . . 0 C--O 1.247 0.955 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.926 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 ttt . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -85.32 127.54 34.37 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.4 pp -136.2 167.24 21.65 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -109.64 147.95 32.18 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.112 0.565 . . . . 0.0 109.8 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.6 t -122.26 109.09 23.28 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 C-N-CA 125.128 1.371 . . . . 0.0 108.059 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -79.76 91.69 5.34 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.462 -1.244 . . . . 0.0 109.58 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.8 -177.84 3.49 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 114.262 -1.335 . . . . 0.0 108.345 177.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -52.29 -27.49 15.36 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.29 0.567 . . . . 0.0 110.847 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -117.36 141.07 48.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.006 1.322 . . . . 0.0 108.468 163.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -83.29 109.45 17.27 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.481 ' CD2' HG23 ' A' ' 28' ' ' VAL . 88.9 m-70 -110.61 132.46 54.17 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.694 0.798 . . . . 0.0 109.704 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.4 t -106.07 136.09 46.37 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -125.63 128.03 47.24 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.695 0.798 . . . . 0.0 109.923 -176.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -90.11 104.82 17.35 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 170.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.8 m -111.85 172.35 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.362 1.065 . . . . 0.0 109.428 176.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.1 m -107.49 -9.96 15.83 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.376 0.671 . . . . 0.0 109.801 174.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.533 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 108.41 -35.78 4.76 Favored Glycine 0 C--N 1.353 1.473 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.754 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -4.89 39.47 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -176.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -78.11 147.33 34.69 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.854 0.462 . . . . 0.0 109.815 170.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 61.7 p -86.42 164.59 16.92 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.349 0.595 . . . . 0.0 111.745 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.415 HG21 ' HB3' ' A' ' 48' ' ' LEU . 71.3 t -66.32 -27.69 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.04 172.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.69 -41.86 95.74 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.83 0.852 . . . . 0.0 110.664 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -69.62 -38.97 77.45 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.608 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 27.9 mm -54.49 -45.59 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 123.661 0.784 . . . . 0.0 110.387 173.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 21' ' ' VAL . 92.4 mttt -61.35 -49.2 77.9 Favored 'General case' 0 C--N 1.36 1.061 0 O-C-N 124.049 0.843 . . . . 0.0 111.068 176.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.85 -38.54 78.97 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 124.328 1.017 . . . . 0.0 111.365 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -61.27 -58.14 9.49 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.726 0.811 . . . . 0.0 110.961 177.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.481 HG23 ' CD2' ' A' ' 11' ' ' HIS . 6.3 p -66.8 -30.94 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.449 -174.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.26 -43.39 77.92 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.935 0.894 . . . . 0.0 111.444 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.1 t -61.79 -41.5 97.82 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.384 0.673 . . . . 0.0 110.597 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.7 mt -65.0 -49.99 68.07 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.932 0.893 . . . . 0.0 111.863 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -90.44 -2.71 57.95 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.341 0.656 . . . . 0.0 112.185 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.1 17.82 77.47 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-O 120.159 -0.245 . . . . 0.0 113.511 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.1 pt -102.08 -179.1 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.939 0.895 . . . . 0.0 110.248 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.473 ' HB1' ' HG2' ' A' ' 37' ' ' GLU . . . -102.69 133.82 20.23 Favored Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 123.052 0.541 . . . . 0.0 111.756 -175.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.505 ' HA ' ' HG2' ' A' ' 39' ' ' GLN . 68.3 Cg_endo -70.61 -17.84 33.43 Favored 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 122.678 2.252 . . . . 0.0 111.583 175.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.473 ' HG2' ' HB1' ' A' ' 35' ' ' ALA . 10.0 pt-20 -89.4 -2.16 58.31 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.924 1.29 . . . . 0.0 112.012 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -107.62 -20.8 13.12 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.532 0.733 . . . . 0.0 110.164 175.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.505 ' HG2' ' HA ' ' A' ' 36' ' ' PRO . 11.3 pt20 -106.79 157.85 17.43 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.703 0.763 . . . . 0.0 110.671 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.6 m -132.37 158.98 43.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 C-N-CA 125.166 1.386 . . . . 0.0 108.356 169.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.489 HG12 HD12 ' A' ' 48' ' ' LEU . 66.2 t -111.68 124.6 68.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 176.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.5 mt -108.44 154.14 22.3 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 124.902 1.281 . . . . 0.0 109.346 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.2 tp -130.91 106.67 8.58 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 169.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 59.92 24.42 13.5 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.005 0.922 . . . . 0.0 111.317 -174.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.53 -28.47 14.86 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.155 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.99 120.59 80.36 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.101 0.56 . . . . 0.0 110.767 -174.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.04 106.22 0.64 Allowed 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 123.082 2.521 . . . . 0.0 112.407 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.489 HD12 HG12 ' A' ' 41' ' ' VAL . 80.2 mt -68.13 121.24 15.73 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.967 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -60.19 126.63 28.26 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.968 0.793 . . . . 0.0 110.004 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -58.85 -43.28 90.72 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.447 0.699 . . . . 0.0 111.846 -174.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -77.14 -17.62 58.49 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.639 0.375 . . . . 0.0 111.441 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.77 133.63 40.65 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 55.2 p -78.2 168.26 20.12 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.696 0.798 . . . . 0.0 110.537 177.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.533 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 2.5 mm? -61.49 -35.54 77.96 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 120.958 0.409 . . . . 0.0 110.165 177.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.37 -33.77 61.22 Favored Glycine 0 C--N 1.355 1.625 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.536 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -72.57 -37.69 68.12 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.215 0.606 . . . . 0.0 110.681 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 78.6 m -68.23 -28.6 67.37 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.35 0.66 . . . . 0.0 110.321 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.35 24.98 69.38 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.755 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.592 HG21 HD21 ' A' ' 65' ' ' LEU . 6.2 p -77.87 138.64 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -91.14 178.95 5.85 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.125 0.57 . . . . 0.0 110.95 -175.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.65 160.32 31.75 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.28 0.632 . . . . 0.0 111.205 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 61.4 10.65 3.25 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.454 1.501 . . . . 0.0 113.423 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.1 m -82.53 147.05 28.87 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.097 0.475 . . . . 0.0 110.156 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.4 m -104.59 106.49 17.01 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.841 0.856 . . . . 0.0 109.838 -175.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.592 HD21 HG21 ' A' ' 59' ' ' VAL . 43.9 mt -92.14 128.05 37.85 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.415 1.086 . . . . 0.0 108.444 176.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -99.0 140.97 32.35 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.758 0.708 . . . . 0.0 111.965 -172.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.492 HG13 ' HB2' ' A' ' 39' ' ' GLN . 69.4 t -95.78 125.47 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.067 0.947 . . . . 0.0 109.42 173.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.01 149.35 48.78 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.093 0.957 . . . . 0.0 109.294 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.19 89.28 1.39 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -106.62 -40.3 5.58 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.387 0.675 . . . . 0.0 109.88 176.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 48.4 tpp -75.07 146.97 41.05 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 172.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -103.65 113.28 26.67 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.053 0.454 . . . . 0.0 109.835 -175.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -101.91 137.14 13.16 Favored Glycine 0 C--N 1.342 0.874 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 172.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.515 0 CA-C-O 119.234 -0.759 . . . . 0.0 113.652 -178.176 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.415 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 22.1 ttt . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 121.312 0.577 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.492 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 53.3 tt0 -91.36 140.15 30.05 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.525 HD13 HD13 ' A' ' 65' ' ' LEU . 4.5 pp -146.91 159.85 43.04 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.274 0.63 . . . . 0.0 109.443 176.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -103.45 116.12 31.8 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.696 0.798 . . . . 0.0 109.505 -174.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.1 t -88.72 106.59 16.89 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 170.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.463 ' HB3' ' HA ' ' A' ' 66' ' ' GLU . 19.9 ttt180 -76.86 91.4 3.54 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.527 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -109.55 -176.43 3.01 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 125.347 1.459 . . . . 0.0 108.608 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -46.23 -39.57 10.06 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.538 0.735 . . . . 0.0 112.277 174.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -106.2 156.06 18.84 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 163.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.67 108.63 7.55 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -107.34 141.83 38.09 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.437 0.695 . . . . 0.0 109.505 175.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.7 t -126.8 135.13 50.63 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -128.36 131.55 48.57 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.337 1.055 . . . . 0.0 108.792 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 43.7 tt0 -91.36 113.77 26.12 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 167.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.539 HG21 ' HG ' ' A' ' 54' ' ' LEU . 27.6 m -110.3 144.82 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.953 0.901 . . . . 0.0 110.121 -174.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.6 p -85.95 3.34 42.47 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.073 0.549 . . . . 0.0 111.499 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.423 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 89.9 -38.31 3.23 Favored Glycine 0 C--N 1.353 1.495 0 CA-C-O 119.682 -0.51 . . . . 0.0 113.325 175.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -70.25 -19.81 63.1 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.988 0.915 . . . . 0.0 112.459 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -64.9 135.78 56.09 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.331 0.652 . . . . 0.0 109.483 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 70.1 p -83.59 165.55 18.94 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.326 0.584 . . . . 0.0 111.269 -177.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.6 t -66.42 -29.13 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 123.189 0.596 . . . . 0.0 110.351 174.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.506 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . . . -63.25 -39.9 95.9 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.284 0.634 . . . . 0.0 111.254 173.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -71.66 -35.08 70.23 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.906 0.482 . . . . 0.0 110.955 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 31.4 mm -58.32 -47.12 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.272 0.629 . . . . 0.0 110.384 171.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.489 ' HE2' ' HA ' ' A' ' 40' ' ' VAL . 98.6 mttt -61.52 -42.09 98.29 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.212 0.605 . . . . 0.0 111.342 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.81 80.68 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 124.138 0.899 . . . . 0.0 111.586 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.0 m-70 -60.16 -51.08 71.14 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.875 0.47 . . . . 0.0 111.041 175.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.491 HG12 HD11 ' A' ' 34' ' ' ILE . 49.0 t -67.26 -28.49 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.722 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.64 -34.97 62.87 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.875 0.87 . . . . 0.0 111.441 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.7 t -73.43 -40.1 64.49 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.118 0.567 . . . . 0.0 111.053 178.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.5 mt -77.18 -53.08 8.2 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.219 0.607 . . . . 0.0 111.633 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.31 -17.37 46.04 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.558 0.743 . . . . 0.0 111.738 -177.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.33 17.45 78.89 Favored Glycine 0 N--CA 1.471 0.984 0 N-CA-C 112.605 -0.198 . . . . 0.0 112.605 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.491 HD11 HG12 ' A' ' 28' ' ' VAL . 37.0 pt -91.41 166.23 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.596 0.758 . . . . 0.0 111.099 -175.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.99 118.1 67.87 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 123.257 0.623 . . . . 0.0 110.704 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HA ' ' HG2' ' A' ' 39' ' ' GLN . 56.2 Cg_endo -66.92 -19.85 51.9 Favored 'Trans proline' 0 C--N 1.387 2.57 0 C-N-CA 122.584 2.189 . . . . 0.0 111.84 176.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -74.41 -29.58 61.57 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.263 1.025 . . . . 0.0 111.836 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -85.93 -41.31 15.04 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.302 0.641 . . . . 0.0 110.697 -175.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.48 ' HB2' HG13 ' A' ' 67' ' ' VAL . 12.9 pt20 -76.58 157.08 32.28 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.998 -172.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.616 HG11 ' HB2' ' A' ' 70' ' ' ARG . 9.8 p -142.39 148.0 20.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 C-N-CA 125.186 1.394 . . . . 0.0 108.297 177.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.1 t -101.56 117.77 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.8 0.84 . . . . 0.0 109.308 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 68' ' ' ALA . 2.3 mm? -103.89 104.61 14.62 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.47 1.108 . . . . 0.0 109.69 -175.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.3 tp -81.75 97.19 7.83 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 58.31 26.05 13.5 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.952 0.901 . . . . 0.0 112.016 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.5 -19.82 33.29 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.511 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.83 114.99 48.66 Favored Pre-proline 0 N--CA 1.477 0.903 0 C-N-CA 123.456 0.702 . . . . 0.0 111.001 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -67.96 110.88 2.27 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 122.673 2.249 . . . . 0.0 111.018 174.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.5 mt -72.4 170.46 14.2 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.844 177.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -96.05 138.6 33.45 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' A' ' 22' ' ' ALA . 1.8 m-20 -55.92 -38.67 70.58 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.261 0.624 . . . . 0.0 111.402 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.45 -24.28 46.13 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.748 0.819 . . . . 0.0 111.48 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.97 132.89 42.86 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.061 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 21.1 p -81.35 173.5 12.4 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.539 ' HG ' HG21 ' A' ' 15' ' ' VAL . 3.3 mm? -64.26 -23.45 67.31 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 118.285 0.493 . . . . 0.0 110.258 174.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.42 -39.26 26.61 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.942 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.463 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 14.5 mm-40 -73.75 -29.75 62.41 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.411 0.684 . . . . 0.0 110.422 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 74.2 m -81.32 -18.17 46.68 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.791 0.837 . . . . 0.0 110.724 172.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.38 33.18 81.29 Favored Glycine 0 C--N 1.353 1.476 0 O-C-N 123.416 0.448 . . . . 0.0 113.461 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.1 t -70.49 135.59 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.336 0.654 . . . . 0.0 110.056 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -93.49 172.15 8.45 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.371 0.668 . . . . 0.0 110.534 176.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.23 165.05 25.44 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.065 0.546 . . . . 0.0 111.277 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 58.31 16.6 4.14 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 125.228 1.411 . . . . 0.0 112.798 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.8 m -90.98 147.84 22.82 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.656 0.782 . . . . 0.0 109.845 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 42.5 m -113.52 105.22 13.09 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.718 0.807 . . . . 0.0 109.26 -175.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.525 HD13 HD13 ' A' ' 3' ' ' LEU . 4.5 mp -103.03 123.44 46.63 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . 38.0 tt0 -93.56 150.7 20.22 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.9 0.48 . . . . 0.0 111.436 -171.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.48 HG13 ' HB2' ' A' ' 39' ' ' GLN . 73.3 t -104.11 118.59 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.911 0.884 . . . . 0.0 108.932 175.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.42 ' HB3' HD21 ' A' ' 42' ' ' LEU . . . -126.58 165.74 18.59 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.907 0.883 . . . . 0.0 109.669 175.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -98.22 90.12 1.02 Allowed Glycine 0 N--CA 1.471 0.977 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 175.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.616 ' HB2' HG11 ' A' ' 40' ' ' VAL . 73.7 mtp180 -134.74 17.29 3.57 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.407 0.683 . . . . 0.0 110.8 -176.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.517 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 44.5 tpp -129.71 156.05 44.91 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.546 ' H ' HD23 ' A' ' 72' ' ' LEU . 2.5 pt? -120.29 1.89 10.79 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.45 0.7 . . . . 0.0 111.546 -177.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.517 ' H ' ' HG3' ' A' ' 71' ' ' MET . . . 84.62 -71.76 2.91 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-N 116.471 -0.331 . . . . 0.0 112.546 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.492 0 CA-C-O 119.038 -0.868 . . . . 0.0 112.1 -178.848 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.48 ' HG3' ' HB2' ' A' ' 61' ' ' ALA . 62.1 ttp . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -77.01 118.56 19.7 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.212 1.005 . . . . 0.0 109.62 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.1 pp -137.74 161.23 37.09 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.113 0.565 . . . . 0.0 109.775 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -96.53 152.42 18.64 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.656 0.782 . . . . 0.0 109.836 -175.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.0 t -137.85 101.82 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 124.676 1.191 . . . . 0.0 107.962 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -76.33 94.88 3.67 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.057 0.943 . . . . 0.0 111.843 -175.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.78 -176.51 3.11 Favored 'General case' 0 C--O 1.245 0.867 0 C-N-CA 124.811 1.245 . . . . 0.0 108.099 165.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -45.29 -31.41 1.57 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.514 0.726 . . . . 0.0 112.153 171.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -114.72 137.29 52.1 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 162.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.32 113.47 8.4 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -91.82 155.76 17.99 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.647 0.779 . . . . 0.0 109.482 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.3 m -141.5 115.6 9.31 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 173.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -116.25 134.54 54.8 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.386 0.675 . . . . 0.0 110.601 -173.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -89.17 103.56 16.17 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 166.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.447 HG21 ' HG ' ' A' ' 54' ' ' LEU . 18.7 m -112.15 141.61 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.208 1.003 . . . . 0.0 109.225 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.2 t -91.41 5.55 48.93 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 120.657 0.265 . . . . 0.0 110.806 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.506 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 101.19 -25.97 26.32 Favored Glycine 0 C--N 1.357 1.718 0 CA-C-O 119.727 -0.485 . . . . 0.0 113.513 171.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -80.56 -14.32 58.32 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.881 0.473 . . . . 0.0 111.985 -174.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.426 ' O ' HD22 ' A' ' 54' ' ' LEU . 25.4 mp0 -65.31 130.62 43.98 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 69.0 p -75.13 168.81 19.26 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.189 0.518 . . . . 0.0 110.04 174.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.465 HG12 ' HE3' ' A' ' 25' ' ' LYS . 33.6 t -65.59 -29.21 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . . . -62.47 -41.82 99.04 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.69 0.796 . . . . 0.0 110.553 171.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -67.52 -36.84 81.83 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.869 0.468 . . . . 0.0 111.079 177.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.523 HD11 HD21 ' A' ' 54' ' ' LEU . 39.6 mm -60.13 -48.11 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.284 0.634 . . . . 0.0 110.177 175.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.465 ' HE3' HG12 ' A' ' 21' ' ' VAL . 92.5 mttt -60.05 -43.07 95.64 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.446 0.698 . . . . 0.0 110.745 176.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.26 -45.55 90.9 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.858 1.263 . . . . 0.0 111.7 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -61.74 -47.37 85.51 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.612 0.765 . . . . 0.0 110.448 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 24' ' ' ILE . 90.8 t -63.1 -40.48 89.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 123.763 0.664 . . . . 0.0 110.296 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.31 -33.35 71.42 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.739 1.216 . . . . 0.0 112.258 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.7 t -70.78 -38.05 73.38 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.474 0.71 . . . . 0.0 110.512 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.1 mt -72.71 -51.69 18.24 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.15 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -86.58 -19.27 29.65 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -172.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.68 29.84 58.89 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 112.303 -0.319 . . . . 0.0 112.303 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.7 pt -101.62 176.96 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.474 0.709 . . . . 0.0 110.618 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -96.26 120.41 62.61 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 123.425 0.69 . . . . 0.0 110.422 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.01 -7.06 20.21 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.557 2.171 . . . . 0.0 111.813 172.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -60.7 -38.99 86.86 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 125.373 1.469 . . . . 0.0 110.492 171.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -88.21 -25.52 22.85 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.686 -178.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -75.27 133.0 41.44 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.706 -174.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.15 138.98 52.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 C-N-CA 124.353 1.061 . . . . 0.0 108.241 165.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.2 t -97.88 133.5 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.2 mt -117.76 128.62 55.05 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.604 1.161 . . . . 0.0 109.445 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.517 ' HB2' HD11 ' A' ' 48' ' ' LEU . 54.6 tp -105.99 104.85 14.65 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 169.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 60.33 26.51 16.03 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.845 0.858 . . . . 0.0 111.675 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.22 -15.59 58.91 Favored Glycine 0 C--N 1.352 1.448 0 CA-C-O 119.745 -0.475 . . . . 0.0 113.664 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.8 120.22 77.18 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 117.44 0.62 . . . . 0.0 109.668 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.8 112.2 1.93 Allowed 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.564 2.176 . . . . 0.0 112.06 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.517 HD11 ' HB2' ' A' ' 43' ' ' LEU . 80.4 mt -81.81 131.27 35.25 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.847 0.859 . . . . 0.0 110.158 175.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -72.01 142.96 49.33 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.718 0.636 . . . . 0.0 110.865 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . 11.1 p-10 -61.45 -26.17 67.71 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.293 1.037 . . . . 0.0 111.976 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -76.02 -25.91 56.14 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.829 0.851 . . . . 0.0 111.583 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.18 133.3 37.8 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.849 0.86 . . . . 0.0 110.965 -175.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 70.3 p -80.64 173.4 12.65 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.951 0.5 . . . . 0.0 110.395 174.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.523 HD21 HD11 ' A' ' 24' ' ' ILE . 2.9 mm? -61.81 -35.14 77.34 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 173.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.16 -43.6 96.9 Favored Glycine 0 C--N 1.355 1.616 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.975 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -69.63 -38.06 77.03 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.231 0.612 . . . . 0.0 111.397 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 83.9 m -73.63 -16.11 61.24 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.426 0.69 . . . . 0.0 111.155 175.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.29 26.48 71.68 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 123.582 0.551 . . . . 0.0 113.493 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.9 p -90.15 117.02 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.443 0.697 . . . . 0.0 109.68 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -87.22 -172.79 4.11 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.19 0.996 . . . . 0.0 111.932 -172.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.48 ' HB2' ' HG3' ' A' ' 1' ' ' MET . . . -71.82 154.0 41.56 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.653 0.781 . . . . 0.0 111.043 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 67.85 4.03 3.78 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.595 1.558 . . . . 0.0 112.679 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.9 m -85.15 151.67 23.94 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 34.4 m -113.9 111.48 21.77 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.247 0.546 . . . . 0.0 110.33 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.1 mt -78.68 160.85 27.29 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 165.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -132.61 142.28 49.06 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 122.115 -0.366 . . . . 0.0 110.886 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.8 t -95.95 132.62 39.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.892 0.877 . . . . 0.0 109.113 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.87 167.15 22.86 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.84 0.856 . . . . 0.0 109.83 177.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -109.97 90.36 0.59 Allowed Glycine 0 C--N 1.341 0.812 0 N-CA-C 112.29 -0.324 . . . . 0.0 112.29 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -103.56 -48.59 3.92 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.534 0.734 . . . . 0.0 109.056 171.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 42.4 tpp -78.48 162.37 26.4 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.656 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 50.6 tp -129.03 -30.93 2.17 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.665 0.786 . . . . 0.0 109.557 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.72 -178.97 39.68 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.704 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.327 0 CA-C-O 119.16 -0.8 . . . . 0.0 111.533 -178.255 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -101.46 124.26 46.85 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.2 pp -137.49 166.57 23.56 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.486 0.715 . . . . 0.0 110.627 -178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -98.58 161.5 13.63 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.288 0.635 . . . . 0.0 110.615 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.497 HG22 ' HB2' ' A' ' 65' ' ' LEU . 44.7 t -133.32 117.08 26.95 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 C-N-CA 124.55 1.14 . . . . 0.0 108.512 173.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -71.13 94.11 1.11 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.741 1.216 . . . . 0.0 109.207 174.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -118.77 -179.45 3.81 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.544 1.138 . . . . 0.0 108.998 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -44.86 -35.32 2.73 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 123.54 0.736 . . . . 0.0 111.234 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -128.98 137.38 51.33 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 166.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.5 mt -66.69 128.83 37.77 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.077 0.551 . . . . 0.0 110.861 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -124.26 160.91 26.91 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.381 0.673 . . . . 0.0 109.926 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.4 m -130.26 125.33 34.54 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.01 0.924 . . . . 0.0 108.966 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -120.73 132.55 55.13 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.268 1.027 . . . . 0.0 110.588 -173.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -92.36 106.31 18.34 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 169.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.3 167.84 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.497 1.119 . . . . 0.0 110.741 -172.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.3 p -100.44 -4.29 29.21 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.98 -52.36 4.72 Favored Glycine 0 C--N 1.358 1.804 0 N-CA-C 112.147 -0.381 . . . . 0.0 112.147 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -66.1 -10.84 44.35 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.0 0.92 . . . . 0.0 110.986 169.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -57.45 127.05 30.06 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.226 1.01 . . . . 0.0 110.754 170.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.633 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 82.8 p -85.64 160.23 19.64 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.678 0.391 . . . . 0.0 110.737 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.569 HG13 ' HB ' ' A' ' 41' ' ' VAL . 50.8 t -63.93 -31.68 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 123.963 0.905 . . . . 0.0 111.668 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.448 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . . . -66.53 -42.28 87.48 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.512 0.725 . . . . 0.0 110.674 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -74.88 -29.61 61.06 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.14 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.554 HD11 HD11 ' A' ' 54' ' ' LEU . 30.4 mm -57.58 -50.33 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 168.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -57.01 -45.88 82.74 Favored 'General case' 0 C--N 1.36 1.036 0 O-C-N 123.86 0.725 . . . . 0.0 111.054 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.09 -48.05 76.87 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 124.604 1.19 . . . . 0.0 111.987 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -71.47 -41.33 69.5 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.242 0.217 . . . . 0.0 111.056 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 24' ' ' ILE . 68.9 t -59.97 -41.53 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.13 -42.36 93.94 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.225 1.01 . . . . 0.0 111.702 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.5 t -62.13 -40.09 94.76 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 123.862 0.727 . . . . 0.0 111.496 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 33.0 mt -80.16 -39.94 28.31 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 120.928 0.394 . . . . 0.0 111.502 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.92 -6.07 59.13 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.792 0.837 . . . . 0.0 111.95 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.56 20.32 77.07 Favored Glycine 0 CA--C 1.532 1.104 0 O-C-N 123.506 0.504 . . . . 0.0 113.651 176.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.0 pt -107.63 -179.27 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.048 0.939 . . . . 0.0 110.454 -176.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.432 ' HB1' ' HG2' ' A' ' 37' ' ' GLU . . . -90.83 134.49 30.33 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 123.274 0.63 . . . . 0.0 110.265 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -68.12 -24.67 38.3 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.622 2.214 . . . . 0.0 112.311 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.432 ' HG2' ' HB1' ' A' ' 35' ' ' ALA . 11.2 pt-20 -67.68 -29.84 69.22 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.929 0.891 . . . . 0.0 111.464 175.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -81.05 -18.7 45.79 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.995 0.918 . . . . 0.0 111.902 -170.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.432 ' HB2' HG13 ' A' ' 67' ' ' VAL . 12.3 pt20 -107.57 158.18 17.44 Favored 'General case' 0 C--O 1.245 0.818 0 C-N-CA 123.069 0.548 . . . . 0.0 110.86 -176.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.415 HG11 ' HB2' ' A' ' 70' ' ' ARG . 12.6 p -128.94 134.56 64.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.649 172.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.569 ' HB ' HG13 ' A' ' 21' ' ' VAL . 95.2 t -98.7 121.91 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 66' ' ' GLU . 27.4 mt -113.62 157.72 21.76 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.687 1.595 . . . . 0.0 108.426 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 tt -105.06 96.85 6.82 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 106.266 -1.754 . . . . 0.0 106.266 163.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 51.45 40.62 27.13 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.513 1.125 . . . . 0.0 112.41 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.69 -30.78 8.4 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-O 119.405 -0.664 . . . . 0.0 114.106 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.98 116.85 54.64 Favored Pre-proline 0 N--CA 1.484 1.27 0 CA-C-N 117.704 0.752 . . . . 0.0 111.466 -176.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -60.78 108.7 0.57 Allowed 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.008 2.472 . . . . 0.0 113.246 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.09 137.19 33.69 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.949 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -77.41 136.33 38.39 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.808 0.692 . . . . 0.0 109.904 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.448 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . 7.8 p-10 -58.78 -41.66 87.16 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.713 0.805 . . . . 0.0 112.284 -174.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -79.57 -15.58 57.43 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.204 0.601 . . . . 0.0 111.468 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.83 136.62 38.93 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 123.224 0.61 . . . . 0.0 110.276 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.633 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 43.7 p -80.09 165.88 22.06 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.205 0.602 . . . . 0.0 110.144 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.554 HD11 HD11 ' A' ' 24' ' ' ILE . 86.5 mt -64.73 -38.1 89.84 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.988 0.515 . . . . 0.0 111.243 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.97 -41.82 99.69 Favored Glycine 0 C--N 1.349 1.285 0 O-C-N 123.854 0.721 . . . . 0.0 112.623 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -74.82 -29.93 61.23 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.818 0.447 . . . . 0.0 111.386 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 89.1 m -75.41 -7.47 54.15 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.55 0.74 . . . . 0.0 111.728 173.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.17 15.88 81.16 Favored Glycine 0 C--N 1.351 1.404 0 C-N-CA 123.05 0.357 . . . . 0.0 113.866 173.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 p -99.34 132.72 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.136 0.574 . . . . 0.0 109.605 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -121.54 -168.14 1.64 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.359 1.063 . . . . 0.0 110.495 -175.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.34 150.74 48.59 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.172 0.589 . . . . 0.0 111.057 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 70.22 2.5 4.01 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.678 1.591 . . . . 0.0 113.0 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.6 m -88.05 163.6 16.18 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 174.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.2 m -123.8 116.84 23.64 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.562 0.745 . . . . 0.0 109.664 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.497 ' HB2' HG22 ' A' ' 5' ' ' VAL . 3.2 mm? -75.05 -178.95 4.05 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.422 0.689 . . . . 0.0 109.595 170.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 35.7 tt0 -144.24 108.86 4.88 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.563 0.345 . . . . 0.0 110.703 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.432 HG13 ' HB2' ' A' ' 39' ' ' GLN . 55.5 t -85.94 117.84 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 172.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.42 168.94 10.79 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 123.943 0.897 . . . . 0.0 109.971 175.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.57 87.5 1.1 Allowed Glycine 0 C--N 1.344 1.02 0 N-CA-C 111.881 -0.488 . . . . 0.0 111.881 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.415 ' HB2' HG11 ' A' ' 40' ' ' VAL . 39.0 mtp180 -143.63 141.55 30.65 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.745 1.218 . . . . 0.0 107.75 170.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -148.03 148.53 30.8 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.14 0.576 . . . . 0.0 110.204 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.8 tp -154.5 129.35 9.41 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.23 15.98 81.01 Favored Glycine 0 C--N 1.343 0.968 0 O-C-N 123.763 0.664 . . . . 0.0 113.133 -175.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.605 0 CA-C-O 119.06 -0.856 . . . . 0.0 111.351 178.995 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.488 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 62.9 mtp . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -88.34 116.16 26.36 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.426 HD13 HD13 ' A' ' 65' ' ' LEU . 3.4 pp -132.21 150.4 52.16 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.432 0.693 . . . . 0.0 109.981 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -89.05 152.17 21.83 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.292 1.037 . . . . 0.0 109.8 -177.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -135.93 109.75 9.85 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 C-N-CA 124.343 1.057 . . . . 0.0 108.484 -177.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.404 ' HA ' HD13 ' A' ' 10' ' ' LEU . 3.7 tmm_? -73.66 94.96 2.26 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.45 1.1 . . . . 0.0 110.022 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -112.85 -177.41 3.13 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.283 1.033 . . . . 0.0 108.811 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -45.69 -25.45 0.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.15 0.98 . . . . 0.0 113.044 171.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -127.24 150.0 49.74 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.176 0.99 . . . . 0.0 108.913 158.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 6' ' ' ARG . 4.5 mm? -76.2 109.57 9.99 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 122.987 0.515 . . . . 0.0 110.144 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -94.03 162.24 13.97 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.119 0.968 . . . . 0.0 110.168 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.7 t -141.03 142.23 34.24 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 164.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -133.97 131.57 39.14 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.653 0.781 . . . . 0.0 110.178 -175.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -92.47 104.13 16.48 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.753 174.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.8 m -111.18 161.26 9.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 C-N-CA 123.858 0.863 . . . . 0.0 110.259 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.4 m -87.12 -29.68 21.65 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.853 0.861 . . . . 0.0 110.366 176.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.538 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 116.45 -29.36 7.01 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.19 -173.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -85.77 -4.13 59.08 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.506 0.723 . . . . 0.0 112.532 -173.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.405 ' O ' HD22 ' A' ' 54' ' ' LEU . 23.0 mp0 -76.06 145.68 39.94 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 50' ' ' ASP . 59.0 p -82.82 160.89 22.13 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.354 0.597 . . . . 0.0 110.516 175.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.615 HG13 ' HB ' ' A' ' 41' ' ' VAL . 52.8 t -60.42 -30.53 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 123.715 0.806 . . . . 0.0 110.428 175.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.505 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . . . -58.57 -47.07 85.48 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 124.08 0.952 . . . . 0.0 111.051 171.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -64.58 -39.83 94.45 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.611 0.364 . . . . 0.0 110.624 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.551 HD11 HD21 ' A' ' 54' ' ' LEU . 41.8 mm -60.09 -49.27 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 122.979 0.512 . . . . 0.0 111.364 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.499 ' HB3' HG23 ' A' ' 41' ' ' VAL . 62.9 pttt -74.51 -29.58 61.46 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 119.686 -0.197 . . . . 0.0 110.702 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.403 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . . . -64.18 -34.21 77.56 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.306 0.642 . . . . 0.0 110.92 175.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.45 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 32.6 m170 -68.38 -46.25 70.56 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.117 0.567 . . . . 0.0 110.378 174.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.5 t -56.08 -39.96 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.449 0.642 . . . . 0.0 110.14 174.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.85 -45.65 77.52 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.903 1.281 . . . . 0.0 112.369 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.2 p -69.43 -27.63 65.42 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.01 0.524 . . . . 0.0 111.539 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 27' ' ' HIS . 86.1 mt -76.82 -48.47 18.4 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.817 0.447 . . . . 0.0 111.202 178.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -91.9 -5.47 53.17 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -174.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.04 5.98 85.52 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 113.859 0.304 . . . . 0.0 113.859 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.9 pt -81.74 169.06 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.325 0.65 . . . . 0.0 110.303 178.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.404 ' HB1' ' HG2' ' A' ' 37' ' ' GLU . . . -83.32 136.5 43.09 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.605 0.762 . . . . 0.0 109.986 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.403 ' HB3' ' HA ' ' A' ' 26' ' ' ALA . 56.3 Cg_endo -68.71 -22.68 37.01 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.394 2.063 . . . . 0.0 111.741 174.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.404 ' HG2' ' HB1' ' A' ' 35' ' ' ALA . 11.5 pt-20 -80.02 -8.98 59.64 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.974 0.91 . . . . 0.0 111.626 177.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -75.52 -29.04 59.34 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.197 0.599 . . . . 0.0 111.987 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.43 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -144.76 179.9 7.01 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.14 0.495 . . . . 0.0 111.372 -170.552 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.2 p -145.4 149.92 16.22 Favored 'Isoleucine or valine' 0 C--O 1.25 1.101 0 C-N-CA 124.867 1.267 . . . . 0.0 108.138 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.615 ' HB ' HG13 ' A' ' 21' ' ' VAL . 46.5 t -86.65 138.04 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.361 0.601 . . . . 0.0 109.763 176.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -116.21 140.41 49.33 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -179.524 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.3 tp -86.48 95.91 9.87 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 169.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 55.17 28.92 11.75 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.858 0.863 . . . . 0.0 112.661 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.72 -14.01 35.1 Favored Glycine 0 CA--C 1.536 1.398 0 CA-C-O 119.5 -0.611 . . . . 0.0 114.001 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.57 110.83 24.33 Favored Pre-proline 0 N--CA 1.484 1.261 0 CA-C-N 117.845 0.823 . . . . 0.0 110.622 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.45 107.07 0.24 Allowed 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 123.645 2.897 . . . . 0.0 114.077 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.544 ' HB3' HG21 ' A' ' 21' ' ' VAL . 96.4 mt -80.45 139.74 36.3 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.485 0.714 . . . . 0.0 110.735 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -71.57 130.21 40.66 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.771 0.669 . . . . 0.0 109.667 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' A' ' 22' ' ' ALA . 71.3 m-20 -62.25 -27.57 69.09 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.079 0.552 . . . . 0.0 112.216 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -80.06 -21.18 43.71 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.663 0.785 . . . . 0.0 111.617 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.26 138.54 39.46 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.516 0.726 . . . . 0.0 110.517 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 58.2 p -88.0 168.28 12.98 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.037 0.535 . . . . 0.0 110.587 177.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.551 HD21 HD11 ' A' ' 24' ' ' ILE . 2.5 mm? -62.28 -33.68 75.1 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 174.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.03 -30.78 56.87 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.891 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -76.18 -36.41 58.69 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 52.9 t -67.63 -35.65 79.32 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.2 0.6 . . . . 0.0 110.303 173.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.52 18.52 61.94 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.256 -177.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.56 135.88 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.037 0.535 . . . . 0.0 110.043 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -97.3 -169.26 1.82 Allowed 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.625 0.77 . . . . 0.0 111.896 -176.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -79.5 169.96 17.27 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.52 0.728 . . . . 0.0 111.091 173.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 58.34 18.67 5.69 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.301 1.44 . . . . 0.0 112.669 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.5 m -90.09 161.37 15.83 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 56.5 m -121.96 104.58 9.63 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 173.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.426 HD13 HD13 ' A' ' 3' ' ' LEU . 6.8 mp -84.31 -176.07 6.08 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.498 172.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 44.9 tt0 -139.38 157.43 45.89 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.974 0.509 . . . . 0.0 110.575 -172.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.7 t -119.13 131.65 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.401 1.081 . . . . 0.0 108.688 171.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.504 ' HB3' HD21 ' A' ' 42' ' ' LEU . . . -152.01 144.71 24.29 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.398 0.679 . . . . 0.0 109.664 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 39' ' ' GLN . . . -82.07 84.42 1.5 Allowed Glycine 0 C--N 1.345 1.077 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -110.93 7.59 21.77 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.922 0.889 . . . . 0.0 109.146 170.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 48.0 tpp -120.96 158.06 28.55 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.036 1.334 . . . . 0.0 107.788 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.6 tt -144.87 -44.17 0.23 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 116.5 157.56 11.05 Favored Glycine 0 C--N 1.342 0.871 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.905 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.196 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.518 ' SD ' ' HA ' ' A' ' 60' ' ' GLU . 63.6 ttp . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 35.1 tt0 -78.44 131.52 36.93 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 pp -141.84 166.19 25.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.938 0.895 . . . . 0.0 110.0 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 64' ' ' THR . 68.8 m-85 -102.14 137.23 40.68 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.841 0.856 . . . . 0.0 109.76 -177.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.5 t -117.18 114.91 47.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 172.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.453 ' HB3' ' HA ' ' A' ' 66' ' ' GLU . 40.4 ttt85 -80.55 92.47 5.92 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.443 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.68 -177.29 3.74 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.471 1.108 . . . . 0.0 108.059 168.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -47.18 -32.79 4.68 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 122.945 0.498 . . . . 0.0 111.316 170.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -112.6 137.23 51.16 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 125.057 1.343 . . . . 0.0 108.016 164.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -71.0 118.99 14.48 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -116.93 162.01 18.44 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.946 0.898 . . . . 0.0 109.784 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.3 t -130.02 146.77 51.71 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 172.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -137.61 129.28 28.43 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.423 1.089 . . . . 0.0 108.643 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 34.2 tt0 -87.97 106.28 18.02 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 169.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.7 m -112.43 178.96 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.025 1.33 . . . . 0.0 108.976 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 58.6 p -107.07 -37.4 6.31 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.583 0.753 . . . . 0.0 110.797 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.5 -23.21 4.06 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-N 116.422 -0.354 . . . . 0.0 112.53 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -82.51 -12.63 57.65 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.0 0.52 . . . . 0.0 112.274 -175.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.451 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 22.7 mp0 -65.79 133.08 50.24 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.943 0.897 . . . . 0.0 108.671 177.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 82.2 p -80.07 166.24 21.72 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 121.59 0.709 . . . . 0.0 110.095 176.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.518 HG12 ' HE3' ' A' ' 25' ' ' LYS . 56.0 t -61.38 -31.11 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.187 173.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.63 -41.67 95.33 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.1 0.96 . . . . 0.0 111.208 173.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -66.24 -38.76 88.67 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.123 0.569 . . . . 0.0 111.098 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.569 HD11 HD11 ' A' ' 54' ' ' LEU . 50.5 mm -63.18 -45.27 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 O-C-N 123.716 0.635 . . . . 0.0 110.331 176.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.541 ' HE2' ' HA ' ' A' ' 40' ' ' VAL . 93.6 mttt -57.5 -45.81 84.49 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 123.645 0.59 . . . . 0.0 110.352 176.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.44 -45.57 91.2 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.334 1.054 . . . . 0.0 112.166 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -68.93 -43.3 75.38 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.86 0.464 . . . . 0.0 111.894 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.8 t -67.76 -32.03 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 122.813 0.445 . . . . 0.0 110.39 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.47 -37.99 80.67 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.191 0.996 . . . . 0.0 111.566 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.6 t -64.46 -44.37 91.31 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.571 0.748 . . . . 0.0 110.535 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.8 mt -72.87 -58.07 3.6 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.06 0.544 . . . . 0.0 111.558 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.31 -14.29 60.11 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.452 1.101 . . . . 0.0 112.405 -176.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.51 16.58 75.81 Favored Glycine 0 N--CA 1.473 1.135 0 CA-C-N 117.484 0.129 . . . . 0.0 113.078 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.7 pt -93.35 171.82 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.36 1.064 . . . . 0.0 110.397 -176.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.03 118.19 71.13 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 122.862 0.465 . . . . 0.0 110.849 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.444 ' HA ' HE21 ' A' ' 39' ' ' GLN . 47.5 Cg_endo -64.39 -24.96 63.92 Favored 'Trans proline' 0 C--N 1.388 2.621 0 C-N-CA 123.009 2.472 . . . . 0.0 111.484 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.67 ' HB3' ' HA2' ' A' ' 73' ' ' GLY . 45.9 mt-10 -68.42 -35.7 78.01 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.547 1.139 . . . . 0.0 111.148 177.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -85.39 -16.91 38.27 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.331 0.653 . . . . 0.0 111.213 -175.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.444 HE21 ' HA ' ' A' ' 36' ' ' PRO . 51.4 mt-30 -77.71 152.45 33.68 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.573 0.701 . . . . 0.0 112.16 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.541 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . 13.9 p -141.04 148.55 21.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 113.934 -1.485 . . . . 0.0 107.575 162.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.418 ' HB ' HG13 ' A' ' 21' ' ' VAL . 97.8 t -103.96 128.05 57.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 68.7 mt -115.62 116.66 28.51 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.645 1.178 . . . . 0.0 108.779 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.531 ' HB2' HD11 ' A' ' 48' ' ' LEU . 41.2 tp -90.47 98.13 11.59 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 57.04 32.24 21.32 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.029 0.932 . . . . 0.0 111.691 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.4 -32.4 7.2 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.246 -178.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.4 116.65 39.07 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 123.271 0.628 . . . . 0.0 111.499 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -63.44 105.53 0.51 Allowed 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 123.223 2.615 . . . . 0.0 112.262 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.531 HD11 ' HB2' ' A' ' 43' ' ' LEU . 43.0 mt -78.11 129.81 35.64 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.881 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -64.88 134.74 54.67 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.238 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.477 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 8.0 p-10 -61.54 -27.2 68.45 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.356 0.663 . . . . 0.0 111.727 -178.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -80.72 -25.98 37.74 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.62 0.768 . . . . 0.0 111.76 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.09 133.35 46.19 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 123.213 0.605 . . . . 0.0 110.542 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 31.1 p -79.1 170.64 16.35 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 176.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.616 ' HA ' ' SG ' ' A' ' 57' ' ' CYS . 86.2 mt -69.15 -25.72 64.51 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.548 0.739 . . . . 0.0 110.896 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.84 -36.41 42.15 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.327 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.41 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 87.2 mm-40 -79.22 -34.8 42.51 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.92 0.488 . . . . 0.0 111.703 -177.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.616 ' SG ' ' HA ' ' A' ' 54' ' ' LEU . 31.3 p -77.84 -22.22 50.28 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.927 0.491 . . . . 0.0 110.312 175.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.85 38.79 9.11 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.68 169.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.576 HG21 HD11 ' A' ' 65' ' ' LEU . 8.7 p -101.76 148.86 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 123.043 0.537 . . . . 0.0 109.849 176.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.518 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 10.7 pt-20 -136.32 -165.56 1.74 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.949 0.9 . . . . 0.0 111.085 -174.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.14 149.5 50.19 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 124.017 0.927 . . . . 0.0 112.587 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 68.18 -5.07 0.93 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.119 1.768 . . . . 0.0 113.263 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.7 m -77.26 147.9 36.05 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.124 0.57 . . . . 0.0 109.528 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 29.3 m -119.01 112.5 19.65 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 123.758 0.823 . . . . 0.0 109.825 -174.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.576 HD11 HG21 ' A' ' 59' ' ' VAL . 2.1 mp -104.18 132.71 50.14 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.462 1.105 . . . . 0.0 108.261 -178.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.453 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . 45.5 tt0 -96.13 140.17 31.23 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.055 0.542 . . . . 0.0 111.37 -172.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 78.8 t -93.8 128.37 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.806 0.842 . . . . 0.0 108.965 174.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.05 -168.04 2.83 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.875 0.87 . . . . 0.0 109.749 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -121.67 108.16 1.29 Allowed Glycine 0 C--N 1.35 1.352 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -122.26 -60.27 1.57 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -79.42 112.59 16.81 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 114.636 -1.166 . . . . 0.0 108.43 174.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -77.65 -22.95 49.88 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.234 0.613 . . . . 0.0 111.562 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.67 ' HA2' ' HB3' ' A' ' 37' ' ' GLU . . . -156.53 -98.27 0.14 Allowed Glycine 0 C--N 1.348 1.228 0 N-CA-C 111.871 -0.492 . . . . 0.0 111.871 -177.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.084 0 CA-C-O 118.932 -0.926 . . . . 0.0 111.086 -179.972 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.4 mtp . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -78.92 119.87 22.71 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.945 0.498 . . . . 0.0 109.702 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 pp -142.63 167.49 21.97 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.417 0.687 . . . . 0.0 110.564 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -100.68 148.37 24.94 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.3 t -133.19 107.13 10.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.892 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 172.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -76.7 93.09 3.6 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.252 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.95 -178.5 5.23 Favored 'General case' 0 C--O 1.248 0.977 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 160.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -51.52 -30.33 19.98 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.719 0.408 . . . . 0.0 111.217 172.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -107.33 130.67 54.75 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 161.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -72.61 125.61 27.89 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -125.66 146.05 49.9 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.171 0.589 . . . . 0.0 109.88 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.5 m -108.41 128.41 54.75 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.487 0.715 . . . . 0.0 109.389 175.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -120.73 143.06 48.97 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.193 0.997 . . . . 0.0 109.758 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -105.59 110.22 22.46 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.539 HG21 ' HG ' ' A' ' 54' ' ' LEU . 4.6 m -108.72 151.01 11.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 C-N-CA 124.154 0.982 . . . . 0.0 109.282 -171.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.467 ' H ' ' HB2' ' A' ' 19' ' ' GLU . 8.1 m -81.21 -11.82 59.31 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.746 -175.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.66 -55.59 2.67 Favored Glycine 0 C--N 1.353 1.523 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -174.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -76.27 2.87 12.1 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.081 0.952 . . . . 0.0 110.759 167.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.467 ' HB2' ' H ' ' A' ' 16' ' ' THR . 8.8 tp10 -60.21 118.05 5.91 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.921 1.289 . . . . 0.0 108.734 165.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 74.8 p -76.41 158.43 31.39 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.38 0.536 . . . . 0.0 110.81 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 t -64.53 -31.34 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 124.032 0.933 . . . . 0.0 110.254 175.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.64 -47.73 81.44 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.848 0.718 . . . . 0.0 110.82 173.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -64.15 -42.89 96.6 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 123.86 0.725 . . . . 0.0 111.141 177.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.494 ' O ' HG23 ' A' ' 28' ' ' VAL . 48.1 mm -56.87 -51.33 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 123.757 0.823 . . . . 0.0 110.708 176.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.53 ' NZ ' ' SD ' ' A' ' 71' ' ' MET . 85.3 tttt -62.42 -45.46 93.02 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.126 1.37 . . . . 0.0 110.424 -174.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.494 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . . . -67.99 -35.84 79.01 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.338 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -64.27 -46.53 83.28 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.33 0.652 . . . . 0.0 110.045 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 24' ' ' ILE . 73.2 t -60.02 -46.08 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 O-C-N 123.791 0.682 . . . . 0.0 109.91 177.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.37 -41.02 92.86 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.894 0.878 . . . . 0.0 112.434 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.3 t -65.25 -38.85 91.62 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.445 0.698 . . . . 0.0 110.649 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.5 mt -71.41 -37.34 71.52 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.636 0.374 . . . . 0.0 111.362 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -78.18 -13.8 59.71 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.897 0.879 . . . . 0.0 111.54 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.77 17.83 79.36 Favored Glycine 0 C--N 1.35 1.311 0 C-N-CA 123.147 0.404 . . . . 0.0 113.641 178.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.4 pt -111.27 176.67 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.866 0.866 . . . . 0.0 110.052 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.24 136.32 46.61 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 123.057 0.543 . . . . 0.0 109.855 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.494 ' HB3' ' HA ' ' A' ' 26' ' ' ALA . 18.6 Cg_endo -57.11 -33.9 96.69 Favored 'Trans proline' 0 C--N 1.383 2.38 0 C-N-CA 123.458 2.772 . . . . 0.0 112.683 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -60.0 -24.12 64.21 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.964 0.905 . . . . 0.0 113.061 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -76.51 -12.79 60.09 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.19 0.596 . . . . 0.0 111.965 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.435 ' O ' ' HB3' ' A' ' 71' ' ' MET . 22.3 mt-30 -104.09 173.17 6.42 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.792 0.837 . . . . 0.0 111.992 -171.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -160.87 134.42 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 169.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.6 p -106.23 136.05 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 121.628 0.727 . . . . 0.0 110.428 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -120.56 143.32 48.67 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.163 1.785 . . . . 0.0 108.495 -171.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.1 tp -110.93 99.16 8.11 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 167.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 59.98 26.44 15.73 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.195 0.998 . . . . 0.0 111.611 -176.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.78 -21.77 31.46 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 115.716 -0.675 . . . . 0.0 113.232 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.37 116.27 54.72 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.397 0.679 . . . . 0.0 111.023 -177.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.76 114.39 2.56 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.948 2.432 . . . . 0.0 112.41 -177.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.555 HD11 HD12 ' A' ' 65' ' ' LEU . 96.7 mt -72.98 130.25 39.93 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.937 0.895 . . . . 0.0 110.647 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -66.18 125.71 26.41 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.807 0.692 . . . . 0.0 110.216 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -65.25 -28.05 69.08 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.32 0.648 . . . . 0.0 112.13 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -77.78 -20.36 53.46 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.212 0.605 . . . . 0.0 110.711 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.66 145.67 28.67 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.301 0.64 . . . . 0.0 111.264 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 59.5 p -91.6 177.55 6.18 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.427 0.691 . . . . 0.0 110.16 173.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.539 ' HG ' HG21 ' A' ' 15' ' ' VAL . 3.8 mm? -63.4 -36.62 84.33 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 173.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.43 -31.94 65.34 Favored Glycine 0 C--N 1.354 1.547 0 CA-C-N 115.605 -0.725 . . . . 0.0 113.144 177.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 61.0 tp60 -71.24 -39.38 71.69 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.405 0.682 . . . . 0.0 110.451 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.487 ' HB2' HG12 ' A' ' 59' ' ' VAL . 62.4 m -68.1 -26.28 65.74 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.187 173.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.62 23.06 68.3 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 123.793 0.683 . . . . 0.0 112.269 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.487 HG12 ' HB2' ' A' ' 57' ' ' CYS . 7.3 p -99.95 134.63 38.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.565 0.746 . . . . 0.0 109.355 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -90.56 -175.45 4.44 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.811 0.845 . . . . 0.0 111.718 -173.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.93 169.25 17.27 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.83 171.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 68.54 3.14 3.68 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 125.298 1.439 . . . . 0.0 112.935 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.3 m -81.84 155.5 25.35 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.347 0.659 . . . . 0.0 109.303 176.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.8 m -113.12 106.93 15.25 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.555 HD12 HD11 ' A' ' 48' ' ' LEU . 2.2 mm? -80.67 171.66 14.74 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 169.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -140.87 125.3 17.68 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 118.585 0.63 . . . . 0.0 111.172 -177.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.2 t -96.4 109.84 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 122.898 0.479 . . . . 0.0 110.098 177.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.56 176.7 5.24 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.488 1.115 . . . . 0.0 109.281 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -124.41 89.86 0.4 Allowed Glycine 0 N--CA 1.469 0.889 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -126.01 -48.47 1.61 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.634 0.774 . . . . 0.0 110.501 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.53 ' SD ' ' NZ ' ' A' ' 25' ' ' LYS . 46.3 ttm -68.24 144.37 54.93 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.942 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.44 168.35 21.38 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.28 0.632 . . . . 0.0 109.796 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.5 -52.04 0.19 Allowed Glycine 0 N--CA 1.472 1.078 0 C-N-CA 122.829 0.252 . . . . 0.0 112.499 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.549 -1.139 . . . . 0.0 112.138 -179.326 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.478 0.947 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -98.99 117.44 33.51 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.425 0.69 . . . . 0.0 110.387 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 pp -131.11 154.44 48.3 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.711 0.767 . . . . 0.0 111.398 175.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -90.33 144.28 25.98 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.817 1.247 . . . . 0.0 108.561 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.1 t -123.23 113.81 39.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 174.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.408 ' HB3' ' HA ' ' A' ' 66' ' ' GLU . 20.4 tpt180 -85.5 93.18 8.71 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.537 -172.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -111.6 -178.93 3.57 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 124.35 1.06 . . . . 0.0 108.333 169.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -45.38 -35.22 3.48 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.557 0.743 . . . . 0.0 111.324 167.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -111.63 127.36 55.73 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.153 0.981 . . . . 0.0 108.493 167.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -75.85 115.69 15.8 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -116.86 131.73 56.88 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.64 0.776 . . . . 0.0 109.662 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.5 m -105.74 118.63 37.09 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -102.71 140.78 36.53 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.118 0.967 . . . . 0.0 111.119 -175.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -94.6 104.76 16.7 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 165.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.0 m -113.72 163.61 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.142 0.977 . . . . 0.0 110.423 -177.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.8 m -99.9 -3.54 32.21 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.46 0.704 . . . . 0.0 111.513 -174.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.16 -45.26 3.38 Favored Glycine 0 C--N 1.352 1.464 0 O-C-N 122.027 -0.421 . . . . 0.0 112.247 -177.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -65.14 -14.04 59.6 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.372 0.669 . . . . 0.0 112.097 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.35 132.89 47.85 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 173.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.728 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 80.4 p -75.22 161.8 29.03 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.27 0.557 . . . . 0.0 110.621 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.718 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 53.0 t -64.93 -28.69 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.415 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.261 172.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.89 -38.88 92.44 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.223 0.609 . . . . 0.0 111.542 174.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -73.5 -35.12 65.59 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.739 177.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.49 HD11 HD11 ' A' ' 54' ' ' LEU . 20.3 mm -53.19 -47.94 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 123.571 0.748 . . . . 0.0 109.857 170.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.493 ' NZ ' ' SD ' ' A' ' 71' ' ' MET . 97.8 mttt -57.7 -55.05 39.88 Favored 'General case' 0 C--N 1.359 0.991 0 O-C-N 124.121 0.888 . . . . 0.0 110.658 174.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.77 -42.0 64.6 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 123.965 0.791 . . . . 0.0 112.121 -176.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -71.17 -46.27 61.75 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.634 0.773 . . . . 0.0 111.755 -177.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.409 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 14.6 p -69.94 -30.95 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.429 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . . . -68.2 -36.72 80.01 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.841 0.856 . . . . 0.0 111.351 177.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.1 t -63.66 -41.69 98.17 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.541 0.736 . . . . 0.0 110.273 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.7 mt -69.12 -48.76 61.61 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.448 0.699 . . . . 0.0 112.29 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.429 ' HB2' HG12 ' A' ' 34' ' ' ILE . 13.8 mm-40 -77.86 -19.11 55.4 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.031 0.532 . . . . 0.0 111.018 -177.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.95 31.9 59.42 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.634 -177.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.429 HG12 ' HB2' ' A' ' 32' ' ' GLU . 23.9 pt -114.65 170.38 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 123.803 0.841 . . . . 0.0 110.912 -177.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.41 119.78 76.86 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 123.658 0.783 . . . . 0.0 111.499 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -65.33 -28.18 55.1 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.859 2.372 . . . . 0.0 112.283 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.92 -35.18 79.81 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.859 0.864 . . . . 0.0 111.227 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -71.39 -26.07 62.62 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.191 0.996 . . . . 0.0 111.079 -172.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.429 ' NE2' ' HB2' ' A' ' 29' ' ' ALA . 21.6 mt-30 -81.7 137.79 35.35 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.7 -173.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 p -122.82 133.64 68.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 166.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.457 HG13 ' HB3' ' A' ' 65' ' ' LEU . 54.7 t -94.26 108.34 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-O 121.384 0.611 . . . . 0.0 109.716 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 66.1 mt -97.04 114.47 26.1 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.26 1.424 . . . . 0.0 109.762 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.8 tp -94.83 104.95 16.85 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 169.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 59.67 28.3 17.71 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.236 1.014 . . . . 0.0 111.961 -173.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.31 -7.89 72.21 Favored Glycine 0 C--N 1.352 1.427 0 CA-C-N 115.946 -0.57 . . . . 0.0 113.675 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.19 116.71 66.99 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 123.757 0.823 . . . . 0.0 110.2 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.3 117.34 4.49 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.593 2.195 . . . . 0.0 111.65 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.2 mt -75.93 154.6 35.83 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.621 0.768 . . . . 0.0 111.293 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -72.51 104.19 3.75 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.718 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 3.0 p30 -72.08 -15.29 62.01 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -73.92 -24.4 59.67 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 122.909 0.484 . . . . 0.0 110.191 172.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -94.91 157.79 15.76 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 124.161 0.984 . . . . 0.0 111.069 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.728 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 67.7 p -85.24 168.05 15.1 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.618 177.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.5 ' HA ' ' SG ' ' A' ' 57' ' ' CYS . 78.2 mt -66.28 -33.22 75.24 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.118 174.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.16 -29.68 68.39 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 115.287 -0.869 . . . . 0.0 112.661 175.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -72.38 -43.95 63.22 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.551 0.74 . . . . 0.0 110.57 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' A' ' 54' ' ' LEU . 22.1 p -75.79 -10.41 59.41 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.51 173.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.13 21.24 78.4 Favored Glycine 0 C--N 1.355 1.61 0 C-N-CA 123.56 0.6 . . . . 0.0 113.571 171.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.4 HG21 HG21 ' A' ' 63' ' ' THR . 13.0 p -78.51 145.78 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -176.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -110.62 -164.2 0.9 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.308 0.643 . . . . 0.0 111.003 -176.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.72 175.53 9.86 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.681 0.792 . . . . 0.0 111.667 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 65.2 5.35 3.01 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.452 1.501 . . . . 0.0 112.744 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.4 HG21 HG21 ' A' ' 59' ' ' VAL . 90.6 m -81.63 154.21 26.26 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.407 1.083 . . . . 0.0 110.155 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.2 m -122.42 101.7 7.65 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.688 0.795 . . . . 0.0 109.663 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.457 ' HB3' HG13 ' A' ' 41' ' ' VAL . 74.7 mt -85.69 116.28 23.87 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.125 0.97 . . . . 0.0 109.175 176.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.408 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . 41.1 tt0 -93.85 128.81 40.32 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.02 0.438 . . . . 0.0 111.674 -172.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 75.0 t -87.59 128.55 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.833 0.853 . . . . 0.0 109.791 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.15 136.84 45.99 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.775 0.83 . . . . 0.0 109.649 173.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.47 89.43 1.58 Allowed Glycine 0 C--N 1.343 0.962 0 N-CA-C 112.095 -0.402 . . . . 0.0 112.095 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -141.75 -28.87 0.63 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.545 0.738 . . . . 0.0 112.353 -173.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.493 ' SD ' ' NZ ' ' A' ' 25' ' ' LYS . 56.1 ttm -85.46 17.5 3.16 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.177 0.591 . . . . 0.0 111.989 -173.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -52.84 120.94 6.36 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.353 1.061 . . . . 0.0 110.662 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -166.49 -69.22 0.03 OUTLIER Glycine 0 C--N 1.349 1.263 0 O-C-N 123.312 0.382 . . . . 0.0 112.26 -177.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.728 -1.04 . . . . 0.0 111.37 -178.097 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.472 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 1.1 tmt? . . . . . 0 N--CA 1.483 1.198 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 34.1 tt0 -101.94 137.76 39.8 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.439 -177.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.473 HD13 HD13 ' A' ' 65' ' ' LEU . 4.4 pp -137.5 161.03 37.48 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.387 0.613 . . . . 0.0 110.276 175.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -107.27 135.37 48.89 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.3 t -115.98 105.41 18.39 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 C-N-CA 123.57 0.748 . . . . 0.0 109.047 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -72.26 98.69 2.23 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.853 0.861 . . . . 0.0 110.969 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -113.28 -177.07 3.04 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.649 1.18 . . . . 0.0 108.044 166.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -45.09 -31.67 1.46 Allowed 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.522 0.677 . . . . 0.0 112.133 168.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -115.34 131.84 56.8 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 124.668 1.187 . . . . 0.0 107.878 167.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -70.36 105.5 3.05 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -93.12 160.49 14.83 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.754 177.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.5 m -148.97 121.64 8.62 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -127.63 129.61 47.53 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.392 0.677 . . . . 0.0 109.666 -176.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 36.0 tt0 -94.16 110.26 22.0 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 168.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 1' ' ' MET . 35.8 m -116.84 164.37 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 124.825 1.25 . . . . 0.0 109.098 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.1 t -94.79 6.21 49.63 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.663 0.385 . . . . 0.0 110.591 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.536 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 94.66 -20.49 48.31 Favored Glycine 0 C--N 1.357 1.734 0 CA-C-O 119.351 -0.694 . . . . 0.0 113.672 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -67.62 -26.7 66.37 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -169.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -62.96 141.87 58.56 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 46.9 p -80.42 165.0 22.64 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.524 HG13 ' HB ' ' A' ' 41' ' ' VAL . 54.5 t -57.08 -31.17 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 C-N-CA 123.448 0.699 . . . . 0.0 110.045 172.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.461 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . . . -68.92 -37.84 79.18 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.493 1.117 . . . . 0.0 111.511 177.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.464 ' HG3' ' OG1' ' A' ' 20' ' ' THR . 24.8 mt-30 -72.36 -35.03 68.42 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.1 mm -64.52 -47.41 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.097 0.559 . . . . 0.0 111.046 177.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.585 ' HB3' HG23 ' A' ' 41' ' ' VAL . 60.6 pttt -67.18 -32.65 73.88 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 119.547 -0.263 . . . . 0.0 110.383 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.523 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . . . -60.09 -45.47 92.81 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 123.603 0.761 . . . . 0.0 111.471 176.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.459 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 34.0 m170 -64.85 -44.99 87.97 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.878 0.471 . . . . 0.0 110.896 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.521 HG11 HG21 ' A' ' 67' ' ' VAL . 79.0 t -62.04 -42.39 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.124 0.57 . . . . 0.0 111.035 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.21 -26.07 61.0 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.739 0.816 . . . . 0.0 111.402 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.2 t -70.24 -42.21 72.53 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 122.983 0.513 . . . . 0.0 110.275 171.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 27' ' ' HIS . 97.2 mt -62.57 -42.85 99.81 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 123.839 0.712 . . . . 0.0 111.625 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.96 -23.41 31.09 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.112 0.565 . . . . 0.0 112.174 176.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.64 29.69 47.27 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 122.979 0.175 . . . . 0.0 112.906 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.6 pt -111.87 -178.46 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 124.803 1.241 . . . . 0.0 111.215 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.71 112.65 39.14 Favored Pre-proline 0 N--CA 1.487 1.414 0 C-N-CA 124.035 0.934 . . . . 0.0 112.537 -170.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.523 ' HB3' ' HA ' ' A' ' 26' ' ' ALA . 24.2 Cg_exo -62.93 -43.17 20.86 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 123.088 2.525 . . . . 0.0 112.729 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.95 -8.71 57.1 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.381 0.672 . . . . 0.0 112.057 -176.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -77.65 -36.31 51.57 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.403 0.62 . . . . 0.0 109.577 171.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.629 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 40.2 mt-30 -99.44 -179.76 4.32 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.994 -169.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.504 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 11.4 p -162.09 154.03 3.37 Favored 'Isoleucine or valine' 0 C--O 1.246 0.877 0 C-N-CA 125.314 1.446 . . . . 0.0 107.956 171.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.585 HG23 ' HB3' ' A' ' 25' ' ' LYS . 44.4 t -103.64 125.46 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.642 HD12 ' HA ' ' A' ' 47' ' ' PRO . 1.8 mm? -108.9 141.25 41.23 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.446 1.498 . . . . 0.0 108.842 -173.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.9 tp -80.76 96.71 7.04 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.402 ' H ' ' HA ' ' A' ' 65' ' ' LEU . . . 55.06 29.34 12.27 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 123.878 0.871 . . . . 0.0 111.629 -176.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.59 -25.43 21.28 Favored Glycine 0 C--N 1.355 1.635 0 C-N-CA 123.343 0.497 . . . . 0.0 113.449 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.57 136.05 81.01 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.552 0.741 . . . . 0.0 111.311 -177.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.642 ' HA ' HD12 ' A' ' 42' ' ' LEU . 52.6 Cg_endo -64.61 111.0 1.55 Allowed 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 123.192 2.594 . . . . 0.0 113.052 -174.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.9 mt -90.2 156.26 18.45 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.376 0.67 . . . . 0.0 111.138 173.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -81.97 119.47 24.0 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 172.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.487 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 6.0 p-10 -60.67 -38.94 86.57 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.082 0.553 . . . . 0.0 112.103 -175.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -82.27 -4.89 58.02 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.119 0.568 . . . . 0.0 111.978 -176.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.49 140.49 29.48 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.312 0.645 . . . . 0.0 110.356 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 44.1 p -71.77 168.46 17.77 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.291 0.636 . . . . 0.0 110.603 178.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.536 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 3.0 mm? -59.19 -43.33 92.2 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 174.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.43 -37.9 95.52 Favored Glycine 0 C--N 1.35 1.331 0 O-C-N 123.845 0.716 . . . . 0.0 113.108 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -68.24 -39.72 82.21 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.834 0.854 . . . . 0.0 110.482 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 75.0 m -79.26 -10.09 59.73 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.928 0.891 . . . . 0.0 111.798 177.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.82 21.17 75.01 Favored Glycine 0 C--N 1.349 1.281 0 C-N-CA 123.217 0.436 . . . . 0.0 114.135 177.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.28 134.86 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 123.845 0.858 . . . . 0.0 109.436 177.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -114.39 -171.43 1.92 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.472 0.709 . . . . 0.0 111.095 -172.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.87 154.09 28.6 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.542 0.737 . . . . 0.0 110.248 174.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 59.9 21.19 10.16 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 125.216 1.407 . . . . 0.0 111.738 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.5 m -93.74 156.41 16.7 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.434 1.093 . . . . 0.0 108.804 177.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.1 m -135.43 121.82 20.49 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.632 0.729 . . . . 0.0 110.78 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.473 HD13 HD13 ' A' ' 3' ' ' LEU . 4.1 mp -105.88 179.23 4.33 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.792 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -141.2 144.41 34.74 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.607 0.763 . . . . 0.0 110.279 -173.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.521 HG21 HG11 ' A' ' 28' ' ' VAL . 44.8 t -103.43 119.41 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 121.842 -0.536 . . . . 0.0 109.67 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.18 150.63 50.18 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.043 0.537 . . . . 0.0 110.292 176.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.629 ' HA2' ' HA ' ' A' ' 39' ' ' GLN . . . -90.1 92.95 1.82 Allowed Glycine 0 C--N 1.347 1.159 0 N-CA-C 112.051 -0.42 . . . . 0.0 112.051 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 54.4 mtt180 -109.75 -11.81 14.68 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.958 0.503 . . . . 0.0 112.318 -177.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.559 ' SD ' ' NZ ' ' A' ' 25' ' ' LYS . 79.5 mtp -97.45 110.07 22.7 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 122.212 -0.305 . . . . 0.0 110.445 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.4 tp -75.5 -46.71 30.64 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.019 0.437 . . . . 0.0 109.972 176.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.6 150.94 17.17 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.005 176.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.289 0 CA-C-O 119.149 -0.806 . . . . 0.0 112.865 178.914 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 121.788 0.804 . . . . 0.0 108.968 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -93.01 111.38 22.98 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.683 -171.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.444 HD13 HD13 ' A' ' 65' ' ' LEU . 2.8 pp -125.51 157.51 36.83 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.481 0.712 . . . . 0.0 110.07 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -90.28 142.18 27.98 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.789 0.835 . . . . 0.0 109.85 -176.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.5 t -122.66 102.64 11.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 C-N-CA 124.648 1.179 . . . . 0.0 108.885 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -77.95 93.8 4.49 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.934 0.893 . . . . 0.0 109.71 177.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.19 -174.52 2.59 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.906 1.283 . . . . 0.0 108.168 172.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -41.16 -36.9 0.8 Allowed 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 123.841 0.857 . . . . 0.0 112.053 168.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -117.95 154.36 32.07 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.507 1.123 . . . . 0.0 108.323 167.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -77.52 127.52 32.65 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.774 0.43 . . . . 0.0 110.456 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -130.79 159.39 37.47 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.653 1.181 . . . . 0.0 109.042 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.8 m -143.53 125.17 14.93 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 175.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -132.93 141.64 48.46 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.013 0.525 . . . . 0.0 111.119 -173.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -80.92 125.77 30.54 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 164.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.447 HG21 ' HG ' ' A' ' 54' ' ' LEU . 27.6 m -109.32 152.56 11.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 C-N-CA 123.445 0.698 . . . . 0.0 109.744 -174.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 m -78.51 -14.62 59.27 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.666 -171.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.49 -56.44 5.02 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -70.5 -13.38 62.09 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.141 0.976 . . . . 0.0 111.145 171.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -63.39 139.18 58.74 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.66 1.184 . . . . 0.0 109.933 170.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 73.2 p -93.62 170.67 9.41 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.304 0.573 . . . . 0.0 111.91 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.606 HG13 ' HB ' ' A' ' 41' ' ' VAL . 40.5 t -64.81 -31.87 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.129 0.972 . . . . 0.0 110.607 172.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.06 96.25 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.735 0.814 . . . . 0.0 110.148 178.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.408 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 18.7 mm-40 -62.65 -48.25 80.17 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.447 1.092 . . . . 0.0 110.313 175.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 28' ' ' VAL . 37.2 mm -55.97 -47.27 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 124.078 0.951 . . . . 0.0 110.923 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -62.17 -49.91 73.94 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.015 1.326 . . . . 0.0 111.183 -175.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.7 -32.94 71.82 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.976 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.469 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 11.4 t-160 -62.69 -53.52 53.25 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 124.099 0.96 . . . . 0.0 110.37 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 24' ' ' ILE . 95.0 t -59.92 -38.51 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.414 0.686 . . . . 0.0 110.552 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.04 -47.79 84.41 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.144 175.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.8 t -66.86 -35.25 79.61 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.648 0.779 . . . . 0.0 111.228 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 27' ' ' HIS . 88.6 mt -67.4 -48.79 66.33 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.82 0.848 . . . . 0.0 111.861 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -96.04 -2.57 46.54 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.685 0.394 . . . . 0.0 111.819 -172.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.58 28.24 73.3 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.278 0.361 . . . . 0.0 113.01 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.2 pt -108.82 177.58 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.125 0.97 . . . . 0.0 110.693 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.42 120.94 68.96 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 123.281 0.632 . . . . 0.0 111.438 -171.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -63.83 -31.74 67.66 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.527 2.151 . . . . 0.0 111.206 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -63.68 -22.04 66.7 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.028 0.931 . . . . 0.0 112.353 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -88.95 -12.95 40.14 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.007 0.923 . . . . 0.0 111.171 -178.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -98.65 165.29 11.87 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.922 0.889 . . . . 0.0 112.344 -171.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 m -152.57 138.4 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 126.247 1.819 . . . . 0.0 107.251 164.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.606 ' HB ' HG13 ' A' ' 21' ' ' VAL . 45.5 t -94.99 116.62 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 175.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.3 mt -112.25 134.04 54.03 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.802 1.241 . . . . 0.0 109.092 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.468 ' HB2' HD11 ' A' ' 48' ' ' LEU . 42.4 tp -89.4 98.11 11.58 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 173.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 57.18 28.84 15.68 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.754 0.821 . . . . 0.0 112.081 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.04 -25.16 21.32 Favored Glycine 0 C--N 1.353 1.505 0 CA-C-O 119.717 -0.491 . . . . 0.0 113.498 -177.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.13 117.68 60.51 Favored Pre-proline 0 N--CA 1.481 1.098 0 C-N-CA 123.422 0.689 . . . . 0.0 110.886 -177.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.5 115.57 2.64 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.329 2.686 . . . . 0.0 113.108 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.506 ' HB3' HG21 ' A' ' 21' ' ' VAL . 84.6 mt -91.02 143.75 26.38 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.18 0.592 . . . . 0.0 110.903 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -78.27 134.68 37.51 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -56.73 -41.02 76.77 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.996 0.918 . . . . 0.0 112.15 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -82.21 -14.89 54.87 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.677 -175.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.22 132.65 43.43 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.81 0.444 . . . . 0.0 109.859 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 58.6 p -84.23 166.77 17.25 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.209 0.604 . . . . 0.0 110.282 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.447 ' HG ' HG21 ' A' ' 15' ' ' VAL . 3.0 mm? -62.43 -38.52 90.06 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.01 -34.69 77.03 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.922 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -70.95 -42.62 69.55 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.475 0.71 . . . . 0.0 110.635 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 50.6 t -69.51 -18.75 63.71 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.141 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.05 17.84 80.22 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.657 -0.702 . . . . 0.0 112.804 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.582 HG21 HD11 ' A' ' 65' ' ' LEU . 2.2 p -85.61 118.37 32.21 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.1 -166.8 1.42 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.328 1.051 . . . . 0.0 110.54 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.63 163.72 26.43 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.173 0.589 . . . . 0.0 111.243 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 71.89 -2.83 2.38 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.825 1.65 . . . . 0.0 112.765 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.4 m -84.0 160.18 21.07 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.577 0.751 . . . . 0.0 109.573 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.3 m -120.16 113.31 20.27 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.15 0.58 . . . . 0.0 110.638 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.582 HD11 HG21 ' A' ' 59' ' ' VAL . 5.5 mp -94.79 161.18 14.28 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 170.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -130.52 130.66 44.43 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.964 0.505 . . . . 0.0 109.95 -177.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 95.9 t -91.85 93.39 4.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 171.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.62 -176.47 3.2 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.339 1.056 . . . . 0.0 110.13 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -123.2 91.78 0.45 Allowed Glycine 0 C--N 1.341 0.823 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 178.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -107.12 -49.23 3.31 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 53.4 ttm -73.4 101.63 3.53 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 174.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -75.59 -45.65 36.35 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.77 146.06 10.92 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.864 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.413 0 CA-C-O 118.647 -1.085 . . . . 0.0 112.672 179.944 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ttt . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -94.04 120.35 34.17 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.403 HD13 HD13 ' A' ' 65' ' ' LEU . 3.3 pp -132.16 167.22 20.14 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.074 0.55 . . . . 0.0 111.001 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -99.49 142.89 30.38 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.58 0.752 . . . . 0.0 109.553 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 80.9 t -126.12 101.13 7.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 171.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -73.25 98.74 2.71 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.548 -177.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.69 -177.31 3.33 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.097 0.959 . . . . 0.0 108.945 172.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -43.46 -32.75 0.94 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.087 0.955 . . . . 0.0 111.986 170.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -120.6 145.22 47.59 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.382 1.073 . . . . 0.0 108.178 162.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.1 tp -69.72 128.58 36.94 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 120.821 0.343 . . . . 0.0 111.084 -176.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -117.47 158.21 24.91 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.931 0.892 . . . . 0.0 109.894 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.7 m -146.63 120.96 9.59 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.348 1.059 . . . . 0.0 108.291 175.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -120.85 145.21 47.85 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.412 0.685 . . . . 0.0 110.613 -172.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -97.4 123.98 41.42 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 171.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.3 m -135.0 172.43 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.302 1.041 . . . . 0.0 109.865 -177.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.437 ' HB ' ' HG2' ' A' ' 18' ' ' GLN . 2.9 m -107.07 -18.15 13.98 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.793 0.837 . . . . 0.0 110.011 175.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.448 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 102.77 -15.52 55.51 Favored Glycine 0 C--N 1.355 1.637 0 C-N-CA 123.137 0.399 . . . . 0.0 112.458 -173.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.437 ' HG2' ' HB ' ' A' ' 16' ' ' THR . 3.3 pt20 -81.29 -8.45 59.75 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.825 0.85 . . . . 0.0 111.719 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -74.42 134.23 42.4 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.16 0.984 . . . . 0.0 108.923 176.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.697 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 72.4 p -74.66 158.84 32.93 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 171.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.636 HG13 ' HB ' ' A' ' 41' ' ' VAL . 55.8 t -59.23 -27.9 37.74 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.475 0 C-N-CA 123.839 0.856 . . . . 0.0 110.401 173.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.64 -43.36 80.52 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.795 1.238 . . . . 0.0 110.392 174.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.428 ' HG3' ' OG1' ' A' ' 20' ' ' THR . 78.1 mt-30 -62.07 -41.56 98.28 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 123.521 0.513 . . . . 0.0 110.217 175.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.461 HD11 HD11 ' A' ' 54' ' ' LEU . 46.9 mm -59.32 -50.72 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.435 0.694 . . . . 0.0 111.217 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.478 ' HB3' HG23 ' A' ' 41' ' ' VAL . 60.3 pttt -73.08 -27.5 61.75 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.98 -37.19 86.83 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.25 0.62 . . . . 0.0 111.047 173.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 57.5 m170 -66.68 -45.81 77.66 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.359 0.663 . . . . 0.0 109.78 175.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.566 HG12 HD11 ' A' ' 34' ' ' ILE . 85.1 t -58.74 -38.02 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.59 0.756 . . . . 0.0 110.313 174.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.01 -48.15 74.95 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.275 1.03 . . . . 0.0 111.953 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.3 t -68.13 -32.75 73.26 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.328 0.651 . . . . 0.0 111.771 -177.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 97.5 mt -80.67 -51.11 9.07 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.989 0.516 . . . . 0.0 111.965 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -83.76 -2.45 56.33 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.605 0.762 . . . . 0.0 112.179 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.25 15.19 69.76 Favored Glycine 0 C--N 1.346 1.092 0 O-C-N 123.157 0.286 . . . . 0.0 113.1 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.566 HD11 HG12 ' A' ' 28' ' ' VAL . 28.6 pt -92.39 178.91 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.527 0.731 . . . . 0.0 109.81 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -109.87 129.89 23.43 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 122.87 0.468 . . . . 0.0 110.776 -174.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.28 -11.17 26.58 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.217 1.944 . . . . 0.0 112.687 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.52 -22.97 53.73 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 123.041 0.536 . . . . 0.0 112.071 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.45 ' HA ' ' H ' ' A' ' 72' ' ' LEU . 1.7 p30 -90.86 -41.19 11.33 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 118.76 0.709 . . . . 0.0 109.518 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -81.82 152.4 26.93 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 122.198 0.999 . . . . 0.0 111.847 -175.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.32 153.11 37.34 Favored 'Isoleucine or valine' 0 C--O 1.249 1.07 0 C-N-CA 126.447 1.899 . . . . 0.0 106.347 168.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.636 ' HB ' HG13 ' A' ' 21' ' ' VAL . 43.7 t -100.21 131.65 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.7 mt -116.3 142.0 47.41 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.592 1.157 . . . . 0.0 109.398 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.6 tp -91.81 99.28 12.18 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 174.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 60.31 22.97 12.44 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.84 0.856 . . . . 0.0 112.473 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.7 -14.6 57.58 Favored Glycine 0 C--N 1.353 1.519 0 CA-C-O 119.779 -0.456 . . . . 0.0 113.436 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.62 146.13 60.1 Favored Pre-proline 0 N--CA 1.485 1.285 0 C-N-CA 123.745 0.818 . . . . 0.0 109.981 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -72.35 120.38 6.72 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.637 2.224 . . . . 0.0 113.301 -170.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.475 ' HB3' HG21 ' A' ' 21' ' ' VAL . 87.2 mt -94.63 141.1 29.0 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 170.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -80.05 120.89 24.82 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.546 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 11.1 p-10 -63.21 -39.47 94.73 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 123.491 0.494 . . . . 0.0 111.511 -171.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.58 -2.91 55.15 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.392 0.677 . . . . 0.0 111.897 -177.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.6 139.91 29.99 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.545 0.738 . . . . 0.0 110.563 173.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.697 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 75.5 p -73.58 164.34 26.78 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.978 0.511 . . . . 0.0 110.529 175.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.461 HD11 HD11 ' A' ' 24' ' ' ILE . 86.9 mt -66.83 -28.75 68.61 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.509 0.724 . . . . 0.0 110.757 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.07 -43.76 89.75 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.634 174.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -69.52 -37.3 77.07 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.847 0.459 . . . . 0.0 110.949 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 89.3 m -65.09 -23.49 67.18 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.319 0.648 . . . . 0.0 110.933 173.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.44 28.33 67.93 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 116.308 -0.405 . . . . 0.0 112.744 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.588 HG21 HD11 ' A' ' 65' ' ' LEU . 11.8 p -92.54 153.9 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -133.07 -172.19 2.87 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.674 0.79 . . . . 0.0 110.909 -173.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.77 157.45 36.41 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.341 0.657 . . . . 0.0 111.87 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 61.7 14.6 6.24 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 126.013 1.725 . . . . 0.0 112.415 -177.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.8 m -93.36 145.08 24.73 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.5 m -105.84 108.3 19.75 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.66 0.743 . . . . 0.0 110.08 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.588 HD11 HG21 ' A' ' 59' ' ' VAL . 5.6 mp -88.32 179.35 6.36 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.176 169.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 39.8 tt0 -142.53 153.34 43.5 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.101 0.56 . . . . 0.0 110.133 -175.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 79.1 t -109.08 131.83 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 170.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.98 127.19 17.56 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.305 0.642 . . . . 0.0 109.925 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.12 92.51 0.74 Allowed Glycine 0 C--N 1.344 0.99 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 175.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -132.69 -35.57 1.1 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.019 0.527 . . . . 0.0 112.296 -174.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.479 ' HG3' ' H ' ' A' ' 74' ' ' GLY . 49.0 tpp -60.25 -51.39 69.75 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.497 0.319 . . . . 0.0 110.943 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.45 ' H ' ' HA ' ' A' ' 38' ' ' ASP . 0.6 OUTLIER 50.89 67.56 0.92 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 125.57 1.548 . . . . 0.0 111.061 173.547 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 56.28 40.07 83.85 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.706 -0.679 . . . . 0.0 113.469 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.479 ' H ' ' HG3' ' A' ' 71' ' ' MET . . . . . . . . 0 CA--C 1.536 1.384 0 CA-C-O 118.986 -0.897 . . . . 0.0 113.042 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.6 mtm . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -76.96 114.59 15.92 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.482 HD13 HD23 ' A' ' 65' ' ' LEU . 2.3 pp -137.9 157.19 46.9 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.108 0.563 . . . . 0.0 110.155 -177.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -88.92 152.11 21.92 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.052 0.541 . . . . 0.0 109.63 -177.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.52 ' HB ' ' HB2' ' A' ' 11' ' ' HIS . 55.2 t -134.65 105.23 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.294 1.037 . . . . 0.0 109.087 -176.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -82.9 93.96 7.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.468 1.107 . . . . 0.0 111.001 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -111.3 -179.96 3.87 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 168.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.455 ' NE2' ' H ' ' A' ' 8' ' ' GLN . 0.7 OUTLIER -54.99 -26.79 39.23 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 175.471 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -111.47 134.04 53.34 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 158.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.73 137.66 52.18 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.883 0.473 . . . . 0.0 109.738 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.52 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 39.3 m-70 -129.86 161.97 29.61 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.122 0.969 . . . . 0.0 109.049 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.0 m -142.91 112.0 6.56 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 172.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -113.39 132.32 55.66 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.792 0.837 . . . . 0.0 111.203 -172.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -83.94 114.08 21.44 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 166.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.409 HG21 ' HG ' ' A' ' 54' ' ' LEU . 13.3 m -109.65 139.58 32.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 122.918 0.487 . . . . 0.0 109.811 -174.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 m -75.37 -17.83 60.12 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.711 0.805 . . . . 0.0 111.472 -176.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.75 -56.2 1.91 Allowed Glycine 0 C--N 1.347 1.143 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 -176.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -72.53 -7.12 48.41 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.307 0.643 . . . . 0.0 111.588 172.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -63.79 145.25 56.12 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 165.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 61.2 p -94.29 153.68 17.9 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 118.213 0.461 . . . . 0.0 111.99 -177.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.619 HG13 ' HB ' ' A' ' 41' ' ' VAL . 38.1 t -57.12 -33.71 43.52 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 124.388 1.075 . . . . 0.0 110.617 171.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.17 -53.19 61.11 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.126 0.971 . . . . 0.0 110.921 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -65.2 -36.14 83.27 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.916 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 28' ' ' VAL . 35.0 mm -60.36 -50.49 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 122.786 0.434 . . . . 0.0 111.633 178.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.4 ' HB3' HG23 ' A' ' 41' ' ' VAL . 61.3 pttt -68.25 -30.75 69.87 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.526 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . . . -65.9 -41.23 91.76 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 123.382 0.673 . . . . 0.0 111.492 175.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -62.03 -46.06 90.81 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.329 0.651 . . . . 0.0 109.722 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 24' ' ' ILE . 76.8 t -56.32 -48.24 79.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.717 176.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.99 -28.23 64.28 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.827 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 t -77.03 -31.62 56.41 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.554 0.741 . . . . 0.0 110.956 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.0 mt -73.31 -45.09 57.45 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.229 0.612 . . . . 0.0 111.17 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -86.1 -22.0 27.35 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.168 0.587 . . . . 0.0 112.316 -176.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.23 33.8 25.11 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 116.632 -0.258 . . . . 0.0 113.266 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 pt -109.84 171.38 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.941 0.896 . . . . 0.0 110.034 175.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -79.69 111.61 22.66 Favored Pre-proline 0 N--CA 1.484 1.244 0 C-N-CA 123.296 0.638 . . . . 0.0 111.768 -172.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.526 ' HB3' ' HA ' ' A' ' 26' ' ' ALA . 19.8 Cg_endo -55.95 -39.47 90.97 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 123.602 2.868 . . . . 0.0 114.081 -175.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -67.3 -28.06 67.69 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.035 0.534 . . . . 0.0 111.568 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 71' ' ' MET . 22.7 t70 -67.54 -40.3 85.02 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.253 0.621 . . . . 0.0 109.9 177.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -77.03 165.72 24.25 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.953 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -162.82 146.14 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 125.04 1.336 . . . . 0.0 108.299 173.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.619 ' HB ' HG13 ' A' ' 21' ' ' VAL . 96.3 t -90.14 134.55 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.103 0.561 . . . . 0.0 110.51 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.8 mt -123.29 127.38 48.47 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.77 1.228 . . . . 0.0 108.637 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.436 ' HB2' HD11 ' A' ' 48' ' ' LEU . 33.5 tp -92.18 97.96 11.23 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 173.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 59.73 23.07 11.91 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.56 1.144 . . . . 0.0 112.732 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.75 -7.56 38.93 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-O 119.703 -0.499 . . . . 0.0 113.655 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.01 114.55 53.38 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 123.241 0.616 . . . . 0.0 109.459 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -68.16 102.58 0.81 Allowed 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 122.172 1.914 . . . . 0.0 112.27 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.436 HD11 ' HB2' ' A' ' 43' ' ' LEU . 79.5 mt -73.2 129.68 38.58 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.34 176.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -63.44 130.73 45.64 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.139 0.9 . . . . 0.0 109.387 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -61.93 -35.38 78.23 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.184 0.303 . . . . 0.0 111.483 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.19 -19.68 60.46 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.4 0.28 . . . . 0.0 111.28 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.76 135.27 41.75 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.924 0.49 . . . . 0.0 109.848 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 71.4 p -76.82 171.95 13.91 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 122.907 0.483 . . . . 0.0 109.967 172.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.409 ' HG ' HG21 ' A' ' 15' ' ' VAL . 3.1 mm? -66.22 -28.76 68.99 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.54 -29.53 55.3 Favored Glycine 0 C--N 1.357 1.733 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.763 175.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -74.0 -35.98 64.46 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.641 0.776 . . . . 0.0 109.855 176.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 79.8 m -74.87 -23.52 58.42 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.466 171.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.19 23.05 78.49 Favored Glycine 0 C--N 1.353 1.506 0 CA-C-N 116.009 -0.541 . . . . 0.0 113.558 177.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.8 p -80.54 148.09 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 123.522 0.729 . . . . 0.0 110.342 -175.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -99.6 -177.38 3.55 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.401 0.68 . . . . 0.0 112.181 -173.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.42 162.22 24.55 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.738 0.815 . . . . 0.0 111.029 175.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 64.63 9.29 5.03 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 125.449 1.5 . . . . 0.0 112.488 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.7 m -78.06 152.0 33.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.058 0.943 . . . . 0.0 109.706 175.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.2 m -106.87 108.25 19.67 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 173.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.482 HD23 HD13 ' A' ' 3' ' ' LEU . 3.6 mm? -92.32 135.54 33.94 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 124.175 0.99 . . . . 0.0 108.589 174.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -93.97 150.46 20.34 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.164 0.586 . . . . 0.0 109.465 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 67.1 t -119.46 131.45 72.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 174.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.72 148.55 30.15 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.406 0.682 . . . . 0.0 110.318 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.0 98.82 2.27 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 174.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.9 mtp-105 -103.44 -26.13 13.0 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.594 0.758 . . . . 0.0 111.176 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.513 ' O ' ' HA ' ' A' ' 38' ' ' ASP . 62.7 ttp -121.73 105.33 10.3 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.361 0.664 . . . . 0.0 109.971 -170.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.5 mt -66.0 108.64 2.27 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -110.28 -162.77 18.81 Favored Glycine 0 N--CA 1.47 0.918 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.185 -175.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.523 0 CA-C-O 119.21 -0.772 . . . . 0.0 113.488 177.746 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.552 ' SD ' HD23 ' A' ' 3' ' ' LEU . 47.9 ttm . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -87.39 123.62 32.54 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 171.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.552 HD23 ' SD ' ' A' ' 1' ' ' MET . 2.1 pp -143.12 158.47 43.58 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.619 0.768 . . . . 0.0 109.398 -175.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -96.3 139.78 31.94 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.368 0.667 . . . . 0.0 109.47 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.517 HG22 ' HB2' ' A' ' 65' ' ' LEU . 58.9 t -123.35 103.39 12.89 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 174.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -76.48 100.14 5.15 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.674 0.749 . . . . 0.0 111.038 -178.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.97 -178.2 3.59 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.412 1.085 . . . . 0.0 108.446 166.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -48.29 -35.59 12.52 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.845 0.858 . . . . 0.0 111.379 172.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -111.7 131.28 55.41 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 166.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -68.6 132.84 47.58 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.824 0.45 . . . . 0.0 109.804 -175.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -126.63 156.09 41.51 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.689 0.795 . . . . 0.0 109.451 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.1 t -136.45 135.36 38.57 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 167.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -133.55 155.1 50.22 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.609 0.764 . . . . 0.0 110.355 -175.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -106.47 120.24 41.38 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.412 HG21 ' HG ' ' A' ' 54' ' ' LEU . 32.3 m -110.44 150.3 13.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 C-N-CA 123.812 0.845 . . . . 0.0 108.999 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.3 m -81.98 -14.67 55.69 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.102 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.603 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 91.01 -42.95 2.85 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.521 -0.309 . . . . 0.0 113.043 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -72.22 -13.32 61.5 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.477 1.111 . . . . 0.0 111.92 176.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -78.23 156.84 29.54 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.129 0.572 . . . . 0.0 109.676 171.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 81.4 p -93.24 175.55 6.73 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.24 0.543 . . . . 0.0 112.285 -175.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.585 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 53.1 t -62.57 -36.55 75.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 123.761 0.825 . . . . 0.0 109.996 170.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . . . -62.25 -37.95 87.4 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.564 0.745 . . . . 0.0 110.76 175.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -64.43 -48.16 76.41 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.789 0.681 . . . . 0.0 111.1 176.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.553 ' O ' HG23 ' A' ' 28' ' ' VAL . 64.2 mt -56.71 -49.23 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 122.881 0.472 . . . . 0.0 109.826 176.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.487 ' HB2' HG12 ' A' ' 41' ' ' VAL . 85.1 tttt -55.26 -45.9 76.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.849 1.66 . . . . 0.0 111.193 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.11 -42.91 88.57 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.847 0.859 . . . . 0.0 111.285 176.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -60.67 -46.83 88.86 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.594 0.758 . . . . 0.0 110.902 -178.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 24' ' ' ILE . 26.3 t -65.13 -44.96 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 123.815 0.697 . . . . 0.0 109.148 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.75 -41.04 90.1 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 123.537 0.735 . . . . 0.0 112.249 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.1 m -61.82 -44.61 96.5 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.807 0.843 . . . . 0.0 111.182 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.5 mt -79.7 -25.41 41.2 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.636 -176.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -85.49 -12.15 52.51 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.006 0.522 . . . . 0.0 111.434 172.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.35 25.44 68.27 Favored Glycine 0 C--N 1.351 1.377 0 C-N-CA 122.85 0.262 . . . . 0.0 113.593 176.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.3 pt -119.03 174.74 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.266 1.026 . . . . 0.0 110.238 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.05 144.22 50.73 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.244 0.618 . . . . 0.0 110.035 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.35 -22.47 59.94 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.48 2.12 . . . . 0.0 110.886 172.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.472 ' HB3' ' HA2' ' A' ' 73' ' ' GLY . 29.4 mt-10 -64.0 -25.54 68.17 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.228 1.411 . . . . 0.0 111.584 175.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -81.88 -23.06 36.53 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.663 0.785 . . . . 0.0 111.343 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.428 ' O ' ' HE3' ' A' ' 25' ' ' LYS . 10.4 pt20 -123.84 -179.52 4.42 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.357 0.598 . . . . 0.0 111.178 -175.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.454 HG11 ' HB2' ' A' ' 70' ' ' ARG . 7.4 p -156.92 134.42 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.99 1.316 . . . . 0.0 107.513 166.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.487 HG12 ' HB2' ' A' ' 25' ' ' LYS . 9.9 p -96.31 110.83 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 CA-C-O 121.952 0.882 . . . . 0.0 109.929 -178.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 47' ' ' PRO . 18.1 mt -94.23 154.88 17.32 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.889 1.276 . . . . 0.0 109.409 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.554 ' HB2' HD11 ' A' ' 48' ' ' LEU . 40.3 tp -94.16 97.63 10.41 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 58.2 23.83 10.71 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.292 1.037 . . . . 0.0 112.489 -177.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.93 -5.8 36.89 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 119.483 -0.621 . . . . 0.0 113.655 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.21 116.11 65.22 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 123.49 0.716 . . . . 0.0 110.66 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.409 ' HA ' HD22 ' A' ' 42' ' ' LEU . 40.7 Cg_endo -64.63 106.62 0.76 Allowed 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.31 2.007 . . . . 0.0 111.621 174.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' A' ' 43' ' ' LEU . 63.8 mt -82.77 170.01 15.52 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.098 0.559 . . . . 0.0 111.0 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -78.26 124.87 28.57 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 168.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.585 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 10.2 p-10 -67.26 -19.61 65.54 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.935 0.494 . . . . 0.0 111.415 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -80.6 -21.35 41.66 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.194 0.998 . . . . 0.0 111.617 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.45 133.97 38.49 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.132 0.573 . . . . 0.0 110.781 -178.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 66.5 p -79.41 171.64 14.88 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.756 0.822 . . . . 0.0 110.626 174.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.603 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 3.4 mm? -64.1 -37.43 87.42 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 175.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.42 -39.11 95.57 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.586 175.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -70.07 -44.2 69.58 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.528 0.731 . . . . 0.0 110.946 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 51.8 t -75.75 -24.12 56.04 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.32 0.648 . . . . 0.0 111.446 -177.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.78 35.02 13.92 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.918 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.4 t -76.84 148.59 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 123.651 0.781 . . . . 0.0 109.268 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -119.61 -171.99 2.24 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.723 0.809 . . . . 0.0 110.299 -176.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.79 149.89 30.92 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 122.779 0.431 . . . . 0.0 110.281 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 60.28 26.2 15.67 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.095 1.358 . . . . 0.0 112.33 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.6 m -80.0 162.17 25.03 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.633 0.773 . . . . 0.0 109.89 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.2 m -115.78 106.06 13.42 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.889 0.852 . . . . 0.0 110.529 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.517 ' HB2' HG22 ' A' ' 5' ' ' VAL . 3.5 mm? -83.02 164.99 20.0 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.409 -1.269 . . . . 0.0 107.833 164.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -144.92 130.46 18.88 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.878 0.471 . . . . 0.0 110.613 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.447 HG21 HG11 ' A' ' 28' ' ' VAL . 83.2 t -83.02 127.45 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 172.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.78 151.79 47.38 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.85 0.86 . . . . 0.0 109.981 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -91.78 86.41 1.27 Allowed Glycine 0 C--N 1.341 0.852 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 173.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.454 ' HB2' HG11 ' A' ' 40' ' ' VAL . 71.3 mtp180 -119.31 16.13 13.08 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.154 0.981 . . . . 0.0 108.965 170.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -145.05 104.82 4.01 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -77.33 -17.88 57.9 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.415 0.286 . . . . 0.0 111.06 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.472 ' HA2' ' HB3' ' A' ' 37' ' ' GLU . . . 163.17 -93.33 0.11 Allowed Glycine 0 C--N 1.349 1.26 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.45 -1.195 . . . . 0.0 111.867 -179.838 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.663 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 82.6 mtp . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -88.54 99.46 12.32 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.409 HD21 HD23 ' A' ' 54' ' ' LEU . 1.5 pp -119.99 165.52 14.56 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.52 0.728 . . . . 0.0 110.864 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.441 ' HB3' HD21 ' A' ' 10' ' ' LEU . 29.7 m-85 -101.35 140.66 35.34 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.344 1.058 . . . . 0.0 108.918 -176.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.37 107.33 16.55 Favored 'Isoleucine or valine' 0 C--O 1.244 0.806 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -80.36 93.78 6.03 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.712 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.92 -171.77 2.42 Favored 'General case' 0 C--O 1.245 0.84 0 C-N-CA 125.876 1.67 . . . . 0.0 108.015 165.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -38.72 -34.28 0.14 Allowed 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 123.399 0.68 . . . . 0.0 112.727 167.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -123.96 162.75 22.75 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.637 1.175 . . . . 0.0 109.319 164.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.441 HD21 ' HB3' ' A' ' 4' ' ' PHE . 3.2 tm? -81.94 131.76 35.25 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -133.77 124.68 27.03 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.077 0.951 . . . . 0.0 109.119 -177.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 m -99.35 123.43 43.62 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -119.56 121.31 39.07 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.463 1.105 . . . . 0.0 110.456 -176.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.22 106.2 13.01 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 163.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.2 m -110.93 156.7 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.884 0.874 . . . . 0.0 110.659 -174.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.3 p -75.14 -25.74 58.63 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.949 177.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.3 -39.24 3.11 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.921 -174.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -78.23 -10.81 59.82 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.085 0.554 . . . . 0.0 111.657 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -69.13 120.84 15.59 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 168.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 69.7 p -66.29 161.22 22.79 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.388 0.675 . . . . 0.0 111.6 -175.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.465 HG13 ' HB ' ' A' ' 41' ' ' VAL . 75.4 t -62.06 -29.89 47.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 C-N-CA 124.042 0.937 . . . . 0.0 110.947 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . . . -61.31 -53.18 60.07 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.639 0.775 . . . . 0.0 110.499 174.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -65.92 -37.23 85.53 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.794 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.3 mm -63.96 -47.15 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.828 0.851 . . . . 0.0 111.588 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.48 ' HB3' HG23 ' A' ' 41' ' ' VAL . 51.8 pttt -70.18 -33.81 72.2 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 118.132 0.424 . . . . 0.0 110.28 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.61 -39.41 80.86 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.603 0.761 . . . . 0.0 110.605 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -55.57 -51.95 65.38 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.649 1.58 . . . . 0.0 109.955 175.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.506 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 84.5 t -64.51 -44.03 96.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.271 178.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.83 -35.67 78.91 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.629 0.771 . . . . 0.0 112.323 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.0 m -68.62 -40.8 80.17 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.092 0.557 . . . . 0.0 110.754 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.6 mt -66.93 -40.72 87.7 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.492 177.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 28' ' ' VAL . 11.0 mm-40 -84.27 -12.67 54.3 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.731 0.813 . . . . 0.0 111.709 -177.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.59 38.68 78.73 Favored Glycine 0 C--N 1.354 1.569 0 O-C-N 123.415 0.447 . . . . 0.0 113.32 177.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.2 pt -129.22 176.13 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.442 1.097 . . . . 0.0 110.306 -175.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.73 113.91 29.14 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 123.978 0.911 . . . . 0.0 112.466 -171.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -60.44 -35.7 89.68 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.291 2.661 . . . . 0.0 113.139 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.531 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 2.6 pm0 -67.33 -27.67 67.33 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.008 0.523 . . . . 0.0 110.916 178.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 71' ' ' MET . 31.7 t70 -74.74 -29.47 61.17 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.282 0.633 . . . . 0.0 110.607 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -75.98 152.6 36.96 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.403 0.621 . . . . 0.0 111.52 -173.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.3 p -142.63 142.8 26.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-N 114.331 -1.304 . . . . 0.0 107.581 169.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.48 HG23 ' HB3' ' A' ' 25' ' ' LYS . 98.5 t -98.89 123.36 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 173.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 47' ' ' PRO . 86.6 mt -116.34 118.61 33.22 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.825 1.25 . . . . 0.0 108.681 -176.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.3 tp -86.03 97.75 10.46 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 173.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 57.65 24.54 10.65 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.041 0.936 . . . . 0.0 111.645 -174.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.1 -20.87 30.24 Favored Glycine 0 C--N 1.354 1.555 0 C-N-CA 123.521 0.581 . . . . 0.0 113.649 -177.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.34 117.69 60.94 Favored Pre-proline 0 CA--C 1.554 1.111 0 CA-C-N 117.489 0.645 . . . . 0.0 110.602 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.438 ' HA ' HD23 ' A' ' 42' ' ' LEU . 19.8 Cg_exo -65.26 101.59 0.42 Allowed 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.003 2.469 . . . . 0.0 112.508 -176.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.461 ' HB3' HG21 ' A' ' 21' ' ' VAL . 61.7 mt -68.9 127.16 32.12 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.957 176.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.83 127.95 33.65 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 123.463 0.705 . . . . 0.0 109.812 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.495 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . 9.4 p-10 -62.07 -29.53 70.37 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.938 0.895 . . . . 0.0 111.663 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -76.35 -24.11 54.21 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.827 0.851 . . . . 0.0 111.214 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.1 146.27 30.67 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.503 0.721 . . . . 0.0 110.533 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 80.9 p -85.81 165.24 17.02 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.321 0.648 . . . . 0.0 109.893 173.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.409 HD23 HD21 ' A' ' 3' ' ' LEU . 9.7 mp -66.57 -28.79 68.8 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.184 0.594 . . . . 0.0 110.486 175.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.41 -40.45 86.86 Favored Glycine 0 C--N 1.35 1.332 0 O-C-N 123.796 0.685 . . . . 0.0 112.262 174.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -73.08 -36.5 66.84 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.268 0.627 . . . . 0.0 110.652 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 84.0 m -71.7 -17.81 62.2 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.788 0.835 . . . . 0.0 111.567 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.16 19.84 78.77 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 123.578 0.549 . . . . 0.0 113.385 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.562 HG21 HD11 ' A' ' 65' ' ' LEU . 2.2 p -88.15 99.67 9.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -81.92 -174.66 5.18 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.249 -1.341 . . . . 0.0 112.061 -171.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.663 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -62.9 155.45 27.14 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.758 172.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 61.59 24.91 14.93 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.642 1.177 . . . . 0.0 112.565 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.4 m -107.88 157.98 17.72 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.713 0.805 . . . . 0.0 109.069 175.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.3 m -114.59 121.9 44.87 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.907 0.483 . . . . 0.0 110.54 -178.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.562 HD11 HG21 ' A' ' 59' ' ' VAL . 3.0 mm? -94.22 162.56 13.8 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.644 1.178 . . . . 0.0 109.478 171.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -122.69 130.98 53.58 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.457 1.103 . . . . 0.0 108.751 173.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 86.8 t -104.65 114.02 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.23 161.03 21.07 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.742 0.817 . . . . 0.0 111.016 -177.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.09 106.26 3.35 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -131.39 -57.8 1.0 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.617 0.767 . . . . 0.0 111.414 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.548 ' O ' ' HA ' ' A' ' 38' ' ' ASP . 41.2 tpp -86.77 170.16 11.97 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.238 0.615 . . . . 0.0 110.562 -171.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 59.2 tp -149.82 147.41 27.94 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.753 0.821 . . . . 0.0 108.859 171.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.531 ' H ' ' HG3' ' A' ' 37' ' ' GLU . . . -67.2 110.17 3.32 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 123.787 0.679 . . . . 0.0 112.093 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.113 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -178.841 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.542 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -113.07 132.78 55.28 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.581 0.753 . . . . 0.0 108.978 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.484 HD13 HD23 ' A' ' 65' ' ' LEU . 4.0 pp -131.35 158.92 39.42 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -101.9 152.2 21.2 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.648 0.779 . . . . 0.0 109.106 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.41 ' HB ' ' HB2' ' A' ' 11' ' ' HIS . 8.8 t -126.11 124.9 66.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.675 1.19 . . . . 0.0 108.631 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -95.21 93.41 7.29 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.147 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -108.43 -176.59 3.09 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 168.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.483 HE22 ' HG2' ' A' ' 9' ' ' GLU . 4.0 pp0? -46.86 -29.04 1.78 Allowed 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 123.429 0.692 . . . . 0.0 112.49 174.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.483 ' HG2' HE22 ' A' ' 8' ' ' GLN . 1.1 pt-20 -123.06 159.44 28.44 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.167 0.987 . . . . 0.0 108.698 163.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.4 mt -79.58 128.35 33.27 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.245 0.545 . . . . 0.0 110.789 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 56.2 m-70 -113.23 163.19 15.1 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.708 1.203 . . . . 0.0 108.174 173.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 t -141.44 146.32 36.38 Favored 'General case' 0 C--O 1.244 0.763 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 169.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -138.81 131.54 29.16 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.842 0.857 . . . . 0.0 109.877 -175.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.42 132.16 43.39 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 170.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.48 HG11 HD11 ' A' ' 24' ' ' ILE . 16.1 m -141.6 -169.38 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 125.025 1.33 . . . . 0.0 109.083 -177.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.5 m -113.18 -9.33 13.49 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.85 0.86 . . . . 0.0 109.854 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.39 -36.61 3.69 Favored Glycine 0 C--N 1.357 1.738 0 N-CA-C 112.245 -0.342 . . . . 0.0 112.245 -174.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -67.88 -16.85 64.27 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.505 0.722 . . . . 0.0 110.989 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -67.61 146.74 53.57 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 122.926 0.49 . . . . 0.0 110.313 172.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 76.7 p -84.74 157.19 21.12 Favored 'General case' 0 C--O 1.244 0.763 0 CA-C-O 121.608 0.718 . . . . 0.0 112.029 -176.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.6 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 82.6 t -60.63 -27.36 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.747 173.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.74 -52.71 48.94 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.009 0.923 . . . . 0.0 111.695 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -64.88 -30.63 71.64 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 119.456 -0.307 . . . . 0.0 111.203 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.487 ' O ' HG23 ' A' ' 28' ' ' VAL . 37.6 mm -58.65 -56.66 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 123.536 0.523 . . . . 0.0 110.631 173.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -68.82 -29.18 67.47 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.449 0.3 . . . . 0.0 110.352 -177.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.44 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . . . -67.51 -40.81 85.15 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.645 0.778 . . . . 0.0 111.335 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -67.5 -40.97 85.18 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.539 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 65.0 t -59.19 -45.03 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.609 174.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.37 -39.11 82.24 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.095 0.958 . . . . 0.0 111.795 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.4 m -63.3 -37.93 89.18 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.728 0.811 . . . . 0.0 111.344 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.5 mt -77.23 -30.12 54.44 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.758 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 28' ' ' VAL . 17.6 mm-40 -78.11 -27.82 48.42 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.914 0.885 . . . . 0.0 110.908 176.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.75 15.54 59.56 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 116.152 -0.476 . . . . 0.0 113.519 -175.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.9 pt -120.2 -176.9 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 124.224 1.01 . . . . 0.0 110.5 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.82 145.75 30.28 Favored Pre-proline 0 CA--C 1.562 1.427 0 C-N-CA 123.312 0.645 . . . . 0.0 111.382 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.44 ' HB3' ' HA ' ' A' ' 26' ' ' ALA . 30.3 Cg_endo -62.7 -21.23 72.78 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 123.165 2.577 . . . . 0.0 113.913 177.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.424 ' HG3' ' HA3' ' A' ' 73' ' ' GLY . 12.3 pt-20 -66.73 -17.95 65.12 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.026 0.93 . . . . 0.0 111.805 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -80.58 -40.22 26.19 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.591 0.71 . . . . 0.0 110.101 174.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.433 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 24.9 mt-30 -90.13 154.34 19.85 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 114.419 -1.264 . . . . 0.0 112.348 -168.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.4 134.24 17.29 Favored 'Isoleucine or valine' 0 C--O 1.252 1.215 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.51 172.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.632 HG22 HG22 ' A' ' 67' ' ' VAL . 74.5 t -82.24 129.31 37.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.648 177.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.5 mt -117.19 124.02 48.09 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.293 1.437 . . . . 0.0 108.529 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.413 ' HB2' HD11 ' A' ' 48' ' ' LEU . 30.7 tp -100.18 107.62 19.53 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 171.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 61.64 22.85 13.26 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.651 1.18 . . . . 0.0 111.943 -174.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.68 -20.84 38.17 Favored Glycine 0 C--N 1.355 1.594 0 CA-C-N 116.105 -0.498 . . . . 0.0 113.222 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.4 120.47 74.38 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 123.487 0.715 . . . . 0.0 110.628 -176.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.94 121.79 9.82 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.197 2.598 . . . . 0.0 113.033 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.417 HD22 ' SG ' ' A' ' 57' ' ' CYS . 84.9 mt -82.63 152.77 25.75 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 123.76 0.824 . . . . 0.0 109.792 174.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -73.37 110.04 7.36 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.6 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 14.9 p-10 -63.45 -32.77 74.31 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.551 -177.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -71.18 -17.91 62.51 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.935 0.894 . . . . 0.0 111.347 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.32 153.33 22.05 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.693 0.797 . . . . 0.0 111.013 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 62.9 p -82.09 158.15 23.83 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.67 0.788 . . . . 0.0 110.374 178.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.12 -35.12 79.23 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.873 0.869 . . . . 0.0 111.129 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.08 -46.9 68.19 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.149 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -72.76 -30.1 63.85 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.044 0.537 . . . . 0.0 110.981 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.417 ' SG ' HD22 ' A' ' 48' ' ' LEU . 42.9 t -67.33 -26.65 66.6 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.71 0.804 . . . . 0.0 111.056 173.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.27 22.61 47.42 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.305 177.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.517 HG21 HD21 ' A' ' 65' ' ' LEU . 2.4 p -98.39 131.75 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 176.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -121.08 -168.27 1.64 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.136 0.974 . . . . 0.0 110.881 -172.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.542 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -67.44 160.04 28.3 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.296 0.638 . . . . 0.0 111.087 175.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 61.25 19.03 9.73 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.781 1.232 . . . . 0.0 112.399 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.404 HG21 HG23 ' A' ' 59' ' ' VAL . 9.9 m -101.06 161.15 13.8 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.826 0.85 . . . . 0.0 108.826 174.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.8 m -128.33 124.2 35.86 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.517 HD21 HG21 ' A' ' 59' ' ' VAL . 3.1 mm? -109.61 128.27 55.11 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 124.795 1.238 . . . . 0.0 108.727 -178.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -93.54 108.17 19.91 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.751 0.82 . . . . 0.0 109.109 -174.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.632 HG22 HG22 ' A' ' 41' ' ' VAL . 76.8 t -94.95 106.09 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -178.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.48 136.34 54.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.281 -176.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 39' ' ' GLN . . . -82.17 89.74 1.46 Allowed Glycine 0 C--N 1.34 0.766 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 176.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -118.73 -21.54 7.81 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.425 0.69 . . . . 0.0 111.327 -175.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.8 ttm -78.54 -44.35 24.47 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.6 tm? 62.95 108.49 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.609 1.563 . . . . 0.0 111.382 175.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.424 ' HA3' ' HG3' ' A' ' 37' ' ' GLU . . . -113.84 158.97 13.95 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.033 174.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.761 -1.022 . . . . 0.0 112.172 178.241 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.437 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 26.0 ttt . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -89.86 98.61 11.87 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.602 -175.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.0 pp -114.7 150.4 35.32 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 175.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -87.77 145.45 26.1 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.857 0.863 . . . . 0.0 108.839 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.436 HG11 HG21 ' A' ' 28' ' ' VAL . 73.0 t -125.79 111.35 26.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 170.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -74.73 92.55 2.48 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.282 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.69 -175.39 3.57 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.781 1.232 . . . . 0.0 108.086 170.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -49.32 -28.54 4.97 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.082 0.553 . . . . 0.0 111.613 173.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -122.76 151.17 41.87 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.039 0.935 . . . . 0.0 108.522 161.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -73.22 128.44 35.49 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -177.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -127.6 159.81 33.51 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.504 0.721 . . . . 0.0 110.079 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.8 m -129.2 137.73 51.31 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -130.84 114.85 15.81 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.887 0.875 . . . . 0.0 111.302 -170.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -76.81 103.56 6.83 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 163.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.437 ' O ' ' HB3' ' A' ' 1' ' ' MET . 30.8 m -110.9 169.47 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.893 0.877 . . . . 0.0 109.434 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.1 m -94.93 -28.79 15.0 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.007 0.523 . . . . 0.0 110.108 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.429 ' HA2' ' HB2' ' A' ' 54' ' ' LEU . . . 102.18 -13.1 57.3 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 116.251 -0.432 . . . . 0.0 112.662 -176.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -91.99 -9.39 43.09 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.462 0.705 . . . . 0.0 111.186 -176.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -73.02 152.63 41.23 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 78.2 p -80.72 164.38 22.82 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.516 0.674 . . . . 0.0 109.569 171.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.597 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 53.9 t -62.98 -27.21 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.34 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.842 171.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . . . -64.0 -40.14 95.69 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.404 0.682 . . . . 0.0 111.483 172.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.415 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 85.9 mm-40 -66.91 -36.75 82.98 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.797 0.439 . . . . 0.0 110.515 177.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.9 mm -61.18 -47.76 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.35 0.66 . . . . 0.0 110.417 174.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -55.23 -49.42 72.05 Favored 'General case' 0 C--N 1.359 1.005 0 O-C-N 123.714 0.634 . . . . 0.0 109.943 175.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.68 -48.36 72.5 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.916 0.886 . . . . 0.0 111.904 -178.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -64.87 -45.95 83.87 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.239 0.616 . . . . 0.0 110.853 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.592 HG11 HG21 ' A' ' 67' ' ' VAL . 84.1 t -64.88 -39.97 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 122.632 0.373 . . . . 0.0 110.542 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 34' ' ' ILE . . . -68.65 -32.28 72.02 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.647 0.779 . . . . 0.0 111.763 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.8 t -66.33 -42.02 88.77 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.186 0.594 . . . . 0.0 110.703 173.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.3 mt -70.41 -45.61 65.58 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.082 0.553 . . . . 0.0 112.063 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -88.54 -3.98 58.69 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.498 0.719 . . . . 0.0 111.747 -175.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.54 33.48 72.14 Favored Glycine 0 C--N 1.356 1.675 0 O-C-N 123.529 0.518 . . . . 0.0 113.725 174.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.428 ' O ' ' HB1' ' A' ' 29' ' ' ALA . 9.6 pt -123.01 -179.92 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.035 0.934 . . . . 0.0 110.576 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.58 125.61 53.09 Favored Pre-proline 0 CA--C 1.557 1.24 0 C-N-CA 123.392 0.677 . . . . 0.0 110.931 -176.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.65 -18.87 37.27 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.485 2.123 . . . . 0.0 112.685 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -66.73 -33.94 76.75 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.07 0.948 . . . . 0.0 111.846 -177.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -92.49 -8.08 45.57 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -176.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -80.1 147.05 31.57 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.247 0.546 . . . . 0.0 111.008 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.2 m -130.1 142.25 44.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 168.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.442 HG13 ' HB3' ' A' ' 65' ' ' LEU . 73.2 t -106.29 105.53 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.3 mt -87.81 122.5 31.53 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.274 1.03 . . . . 0.0 110.291 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.2 tp -91.27 97.17 10.95 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 167.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 55.96 30.61 16.37 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.252 1.021 . . . . 0.0 112.082 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.1 -23.58 24.98 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-N 115.93 -0.577 . . . . 0.0 113.568 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.43 113.61 38.28 Favored Pre-proline 0 N--CA 1.479 0.977 0 CA-C-N 117.487 0.643 . . . . 0.0 110.929 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -65.92 109.22 1.44 Allowed 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.512 2.142 . . . . 0.0 112.143 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.6 mt -73.76 148.15 42.82 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.738 0.815 . . . . 0.0 110.996 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.411 ' HB3' ' HG2' ' A' ' 51' ' ' GLU . 44.6 mm-40 -77.25 121.88 24.3 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 124.286 0.991 . . . . 0.0 109.989 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.597 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 0.8 OUTLIER -65.75 -21.95 66.55 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 123.913 0.758 . . . . 0.0 112.546 176.142 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.411 ' HG2' ' HB3' ' A' ' 49' ' ' GLU . 11.2 pt-20 -72.39 -26.8 62.02 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.226 0.61 . . . . 0.0 111.099 174.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.89 143.11 27.3 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.767 0.827 . . . . 0.0 111.454 -174.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 45.6 p -73.74 168.06 20.14 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.549 0.74 . . . . 0.0 111.067 172.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.429 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 3.1 mm? -64.46 -30.39 71.43 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 171.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.88 -39.29 93.37 Favored Glycine 0 C--N 1.358 1.755 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.621 173.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -71.24 -37.26 72.0 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.741 0.416 . . . . 0.0 109.9 177.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 40.6 t -66.48 -22.45 66.19 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.414 0.685 . . . . 0.0 111.37 173.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.44 21.31 78.66 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.584 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.2 p -91.58 152.76 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 123.572 0.749 . . . . 0.0 109.606 -176.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -132.21 -168.3 2.02 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.764 0.826 . . . . 0.0 110.948 -176.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.8 167.4 13.49 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.537 0.735 . . . . 0.0 112.491 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 68.14 -5.33 0.9 Allowed 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 126.247 1.819 . . . . 0.0 113.737 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.3 m -77.6 153.71 32.98 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.776 0.83 . . . . 0.0 109.939 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.7 m -119.07 110.16 16.76 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.756 0.822 . . . . 0.0 109.633 175.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.442 ' HB3' HG13 ' A' ' 41' ' ' VAL . 84.8 mt -87.04 144.65 26.79 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 171.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -117.28 121.61 41.65 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.561 0.619 . . . . 0.0 110.857 -175.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.592 HG21 HG11 ' A' ' 28' ' ' VAL . 77.0 t -83.75 115.93 26.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 122.804 0.441 . . . . 0.0 109.971 173.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -123.89 167.21 14.41 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.562 1.145 . . . . 0.0 109.765 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.64 88.88 0.5 Allowed Glycine 0 C--N 1.342 0.871 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -109.35 -36.34 6.03 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.836 0.855 . . . . 0.0 109.706 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 47.4 ttm -83.2 146.66 28.48 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.185 175.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -92.15 -32.48 15.1 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.49 -144.21 12.46 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.79 174.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.436 0 CA-C-O 118.937 -0.924 . . . . 0.0 112.629 177.916 . . . . . . . . 0 0 . 1 stop_ save_